Two B-O O
cDNA B-O B-DNA
clones B-O I-DNA
were B-O O
sequenced B-O O
and B-O O
provided B-O O
2 B-O O
, B-O O
250 B-O O
nucleotides B-O O
( B-O O
nt B-O O
) B-O O
of B-O O
DNA B-O B-DNA
sequence B-O I-DNA
information B-O O
. B-O O

There B-O O
is B-O O
a B-O O
single B-O O
methionine B-O B-DNA
codon-initiated B-O I-DNA
open B-O I-DNA
reading B-O I-DNA
frame B-O I-DNA
of B-O O
1 B-O O
, B-O O
458 B-O O
nt B-O O
in B-O O
frame B-O O
with B-O O
a B-O O
homeobox B-O B-DNA
and B-O O
a B-O O
CAX B-O B-DNA
repeat B-O I-DNA
, B-O O
and B-O O
the B-O O
open B-O B-DNA
reading B-O I-DNA
frame B-O I-DNA
is B-O O
predicted B-O O
to B-O O
encode B-O O
a B-O O
protein B-O O
of B-O O
51 B-O O
, B-O O
659 B-O O
daltons B-O O
. B-O O

When B-O O
the B-O O
homeodomain B-O B-DNA
from B-O O
HB24 B-O B-DNA
was B-O O
compared B-O O
to B-O O
known B-O O
mammalian B-O B-DNA
and B-O I-DNA
Drosophila B-O I-DNA
homeodomains B-O I-DNA
it B-O O
was B-O O
found B-O O
to B-O O
be B-O O
only B-O O
moderately B-O O
conserved B-O O
, B-O O
but B-O O
when B-O O
it B-O O
was B-O O
compared B-O O
to B-O O
a B-O O
highly B-O O
diverged B-O O
Drosophila B-O B-DNA
homeodomain B-O I-DNA
, B-O O
H2.0 B-O B-cell_line
, B-O O
it B-O O
was B-O O
found B-O O
to B-O O
be B-O O
80 B-O O
% B-O O
identical B-O O
. B-O O

The B-O O
HB24 B-O B-RNA
mRNA B-O I-RNA
was B-O O
absent B-O O
or B-O O
present B-O O
at B-O O
low B-O O
levels B-O O
in B-O O
normal B-O O
B B-O O
and B-O O
T B-O B-cell_type
lymphocytes B-O I-cell_type
; B-O O
however B-O O
, B-O O
with B-O O
the B-O O
appropriate B-O O
activation B-O O
signal B-O O
HB24 B-O B-RNA
mRNA B-O I-RNA
was B-O O
induced B-O O
within B-O O
several B-O O
hours B-O O
even B-O O
in B-O O
the B-O O
presence B-O O
of B-O O
cycloheximide B-O O
. B-O O

Characterization B-O O
of B-O O
HB24 B-O B-DNA
expression B-O O
in B-O O
lymphoid B-O O
and B-O O
select B-O O
developing B-O O
tissues B-O O
was B-O O
performed B-O O
by B-O O
in B-O O
situ B-O O
hybridization B-O O
. B-O O

Positive B-O O
hybridization B-O O
was B-O O
found B-O O
in B-O O
thymus B-O O
, B-O O
tonsil B-O O
, B-O O
bone B-O O
marrow B-O O
, B-O O
developing B-O O
vessels B-O O
, B-O O
and B-O O
in B-O O
fetal B-O O
brain B-O O
. B-O O

HB24 B-O B-DNA
is B-O O
likely B-O O
to B-O O
have B-O O
an B-O O
important B-O O
role B-O O
in B-O O
lymphocytes B-O B-cell_type
as B-O O
well B-O O
as B-O O
in B-O O
certain B-O O
developing B-O O
tissues B-O O
. B-O O

Platelet-activating B-O B-protein
factor B-O I-protein
induces B-O O
phospholipid B-O O
turnover B-O O
, B-O O
calcium B-O O
flux B-O O
, B-O O
arachidonic B-O O
acid B-O O
liberation B-O O
, B-O O
eicosanoid B-O O
generation B-O O
, B-O O
and B-O O
oncogene B-O B-DNA
expression B-O O
in B-O O
a B-O O
human B-O B-cell_line
B B-O I-cell_line
cell B-O I-cell_line
line B-O I-cell_line
. B-O O

Platelet-activating B-O B-protein
factor B-O I-protein
is B-O O
a B-O O
potent B-O O
mediator B-O O
of B-O O
the B-O O
inflammatory B-O O
response B-O O
. B-O O

Studies B-O O
of B-O O
the B-O O
actions B-O O
of B-O O
platelet-activating B-O B-protein
factor B-O I-protein
have B-O O
centered B-O O
mainly B-O O
around B-O O
neutrophils B-O B-cell_type
, B-O O
monocytes B-O B-cell_type
, B-O O
and B-O O
platelets B-O B-cell_type
. B-O O

In B-O O
this B-O O
report B-O O
we B-O O
begin B-O O
to B-O O
uncover B-O O
the B-O O
influence B-O O
of B-O O
platelet-activating B-O B-protein
factor B-O I-protein
on B-O O
B B-O B-cell_type
lymphocytes B-O I-cell_type
. B-O O

Employing B-O O
the B-O O
EBV-transformed B-O B-cell_line
human B-O I-cell_line
B B-O I-cell_line
cell B-O I-cell_line
line B-O I-cell_line
SKW6.4 B-O B-cell_line
, B-O O
we B-O O
demonstrate B-O O
that B-O O
platelet-activating B-O B-protein
factor B-O I-protein
significantly B-O O
alters B-O O
membrane B-O O
phospholipid B-O O
metabolism B-O O
indicated B-O O
by B-O O
the B-O O
incorporation B-O O
of B-O O
32P B-O O
into B-O O
phosphatidylcholine B-O O
, B-O O
phosphatidylinositol B-O O
, B-O O
and B-O O
phosphatidic B-O O
acid B-O O
but B-O O
not B-O O
significantly B-O O
into B-O O
phosphatidylethanolamine B-O O
at B-O O
concentrations B-O O
ranging B-O O
from B-O O
10 B-O O
( B-O O
-9 B-O O
) B-O O
to B-O O
10 B-O O
( B-O O
-6 B-O O
) B-O O
M B-O O
. B-O O

The B-O O
inactive B-O O
precursor B-O O
, B-O O
lyso-platelet-activating B-O B-protein
factor B-O I-protein
, B-O O
at B-O O
a B-O O
concentration B-O O
as B-O O
high B-O O
as B-O O
10 B-O O
( B-O O
-7 B-O O
) B-O O
M B-O O
had B-O O
no B-O O
effect B-O O
on B-O O
any B-O O
of B-O O
the B-O O
membrane B-O O
phospholipids B-O O
. B-O O

We B-O O
also B-O O
show B-O O
that B-O O
platelet-activating B-O B-protein
factor B-O I-protein
from B-O O
10 B-O O
( B-O O
-12 B-O O
) B-O O
to B-O O
10 B-O O
( B-O O
-6 B-O O
) B-O O
M B-O O
induced B-O O
rapid B-O O
and B-O O
significant B-O O
elevation B-O O
in B-O O
intracellular B-O O
calcium B-O O
levels B-O O
, B-O O
whereas B-O O
lyso- B-O O
platelet-activating B-O B-protein
factor B-O I-protein
was B-O O
again B-O O
ineffective B-O O
. B-O O

We B-O O
further B-O O
demonstrate B-O O
the B-O O
impact B-O O
of B-O O
platelet-activating B-O B-protein
factor B-O I-protein
binding B-O O
to B-O O
B B-O B-cell_type
cells B-O I-cell_type
by B-O O
measuring B-O O
platelet-activating B-O B-protein
factor B-O I-protein
induced B-O O
arachidonic B-O O
acid B-O O
release B-O O
and B-O O
5-hydroxyeicosatetraenoic B-O O
acid B-O O
production B-O O
. B-O O

Moreover B-O O
, B-O O
platelet-activating B-O B-protein
factor B-O I-protein
was B-O O
capable B-O O
of B-O O
inducing B-O O
transcription B-O O
of B-O O
the B-O O
nuclear B-O B-DNA
proto-oncogenes B-O I-DNA
c-fos B-O B-DNA
and B-O O
c-jun B-O B-DNA
. B-O O

Finally B-O O
we B-O O
explored B-O O
the B-O O
possible B-O O
role B-O O
of B-O O
5-hydroxyeicosatetraenoic B-O O
acid B-O O
as B-O O
a B-O O
regulator B-O O
of B-O O
arachidonic B-O O
acid B-O O
liberation B-O O
demonstrating B-O O
that B-O O
endogenous B-O B-protein
5-lipoxygenase B-O I-protein
activity B-O O
modulates B-O O
platelet-activating B-O B-protein
factor B-O I-protein
induced B-O O
arachidonic B-O O
acid B-O O
release B-O O
perhaps B-O O
acting B-O O
at B-O O
the B-O O
level B-O O
of B-O O
phospholipase B-O B-protein
A2 B-O I-protein
. B-O O

In B-O O
summary B-O O
, B-O O
platelet-activating B-O B-protein
factor B-O I-protein
is B-O O
shown B-O O
here B-O O
to B-O O
have B-O O
a B-O O
direct B-O O
and B-O O
profound B-O O
effect B-O O
on B-O O
a B-O O
pure B-O B-cell_line
B B-O I-cell_line
cell B-O I-cell_line
line B-O I-cell_line
. B-O O

Positive B-O O
and B-O O
negative B-O O
regulation B-O O
of B-O O
immunoglobulin B-O B-DNA
gene B-O I-DNA
expression B-O O
by B-O O
a B-O O
novel B-O O
B-cell-specific B-O B-DNA
enhancer B-O I-DNA
element B-O I-DNA
. B-O O

A B-O O
new B-O O
B-cell-specific B-O B-DNA
enhancer B-O I-DNA
element B-O I-DNA
has B-O O
been B-O O
identified B-O O
3 B-O O
' B-O O
of B-O O
E4 B-O B-protein
and B-O O
the B-O O
octamerlike B-O B-DNA
motifs B-O I-DNA
in B-O O
the B-O O
human B-O B-DNA
immunoglobulin B-O I-DNA
heavy-chain B-O I-DNA
gene B-O I-DNA
enhancer B-O I-DNA
. B-O O

Tandem B-O O
copies B-O O
of B-O O
this B-O O
67-bp B-O B-DNA
MnlI-AluI B-O I-DNA
fragment B-O I-DNA
, B-O O
when B-O O
fused B-O O
to B-O O
the B-O O
chloramphenicol B-O B-DNA
acetyltransferase B-O I-DNA
gene B-O I-DNA
driven B-O O
by B-O O
the B-O O
conalbumin B-O B-DNA
promoter B-O I-DNA
, B-O O
stimulated B-O O
transcription B-O O
in B-O O
B B-O B-cell_type
cells B-O I-cell_type
but B-O O
not B-O O
in B-O O
Jurkat B-O B-cell_line
T B-O I-cell_line
cells B-O I-cell_line
or B-O O
HeLa B-O B-cell_line
cells B-O I-cell_line
. B-O O

Footprinting B-O O
analysis B-O O
revealed B-O O
that B-O O
the B-O O
identical B-O O
sequence B-O O
CCGAAACTGAAAAGG B-O O
, B-O O
designated B-O O
E6 B-O B-DNA
, B-O O
was B-O O
protected B-O O
by B-O O
nuclear B-O O
extracts B-O O
from B-O O
B B-O B-cell_type
cells B-O I-cell_type
, B-O O
T B-O B-cell_type
cells B-O I-cell_type
, B-O O
or B-O O
HeLa B-O B-cell_line
cells B-O I-cell_line
. B-O O

Gel B-O O
mobility B-O O
shift B-O O
assays B-O O
using B-O O
a B-O O
synthetic B-O B-DNA
E6 B-O I-DNA
motif B-O I-DNA
detected B-O O
a B-O O
B-cell-specific B-O B-protein
complex B-O I-protein
in B-O O
addition B-O O
to B-O O
a B-O O
ubiquitous B-O O
band B-O O
found B-O O
also B-O O
in B-O O
T B-O B-cell_type
cells B-O I-cell_type
and B-O O
HeLa B-O B-cell_line
cells B-O I-cell_line
. B-O O

In B-O O
agreement B-O O
with B-O O
the B-O O
results B-O O
of B-O O
gel B-O O
retardation B-O O
assays B-O O
, B-O O
tandem B-O O
copies B-O O
of B-O O
the B-O O
E6 B-O B-DNA
motif B-O I-DNA
stimulated B-O O
transcription B-O O
in B-O O
ARH77 B-O B-cell_line
and B-O O
Raji B-O B-cell_line
cells B-O I-cell_line
but B-O O
not B-O O
in B-O O
Jurkat B-O B-cell_line
or B-O O
HeLa B-O B-cell_line
cells B-O I-cell_line
. B-O O

Furthermore B-O O
, B-O O
a B-O O
mutant B-O B-DNA
E6 B-O I-DNA
motif B-O I-DNA
lost B-O O
both B-O O
in B-O O
vitro B-O O
binding B-O O
activity B-O O
and B-O O
in B-O O
vivo B-O O
enhancer B-O O
activity B-O O
. B-O O

In B-O O
striking B-O O
contrast B-O O
to B-O O
the B-O O
mouse B-O B-DNA
Ig B-O I-DNA
heavy-chain B-O I-DNA
enhancer B-O I-DNA
, B-O O
in B-O O
which B-O O
the B-O O
octamer B-O B-DNA
motif B-O I-DNA
acts B-O O
as B-O O
a B-O O
B-cell-specific B-O B-DNA
enhancer B-O I-DNA
element B-O I-DNA
, B-O O
the B-O O
human B-O B-DNA
enhancer B-O I-DNA
contains B-O O
an B-O O
octamerlike B-O B-DNA
sequence B-O I-DNA
with B-O O
one B-O O
base B-O O
substitution B-O O
which B-O O
bound B-O O
octamer-binding B-O B-protein
proteins B-O I-protein
with B-O O
only B-O O
very B-O O
low B-O O
affinity B-O O
and B-O O
showed B-O O
no B-O O
enhancer B-O O
activity B-O O
of B-O O
its B-O O
own B-O O
. B-O O

Interestingly B-O O
, B-O O
the B-O O
MnlI-AluI B-O B-DNA
fragment B-O I-DNA
could B-O O
suppress B-O O
the B-O O
basal-level B-O O
activity B-O O
of B-O O
the B-O O
conalbumin B-O B-DNA
promoter B-O I-DNA
in B-O O
both B-O O
Jurkat B-O B-cell_line
and B-O O
HeLa B-O B-cell_line
cells B-O I-cell_line
. B-O O

Moreover B-O O
, B-O O
simian B-O O
virus B-O O
40 B-O O
enhancer B-O O
activity B-O O
was B-O O
blocked B-O O
by B-O O
the B-O O
MnlI-AluI B-O B-DNA
fragment B-O I-DNA
in B-O O
HeLa B-O B-cell_line
cells B-O I-cell_line
but B-O O
not B-O O
in B-O O
B B-O B-cell_type
cells B-O I-cell_type
. B-O O

Thus B-O O
, B-O O
the B-O O
novel B-O O
enhancer B-O B-DNA
element B-O I-DNA
identified B-O O
in B-O O
this B-O O
study B-O O
is B-O O
probably B-O O
a B-O O
target B-O B-DNA
site B-O I-DNA
for B-O O
both B-O O
positive B-O B-protein
and B-O I-protein
negative B-O I-protein
factors B-O I-protein
. B-O O

Charybdotoxin-sensitive B-O O
, B-O O
Ca B-O O
( B-O O
2+ B-O O
) B-O O
-dependent B-O O
membrane B-O O
potential B-O O
changes B-O O
are B-O O
not B-O O
involved B-O O
in B-O O
human B-O O
T B-O O
or B-O O
B B-O O
cell B-O O
activation B-O O
and B-O O
proliferation B-O O
. B-O O

The B-O O
involvement B-O O
of B-O O
ion B-O O
channels B-O O
in B-O O
B B-O B-cell_type
and B-O I-cell_type
T B-O I-cell_type
lymphocyte B-O I-cell_type
activation B-O O
is B-O O
supported B-O O
by B-O O
many B-O O
reports B-O O
of B-O O
changes B-O O
in B-O O
ion B-O O
fluxes B-O O
and B-O O
membrane B-O O
potential B-O O
after B-O O
mitogen B-O B-protein
binding B-O O
. B-O O

Human B-O B-cell_type
T B-O I-cell_type
and B-O I-cell_type
B B-O I-cell_type
lymphocytes B-O I-cell_type
demonstrate B-O O
an B-O O
early B-O O
and B-O O
transient B-O O
hyperpolarization B-O O
after B-O O
ligand B-O O
binding B-O O
. B-O O

Inasmuch B-O O
as B-O O
the B-O O
change B-O O
in B-O O
membrane B-O O
potential B-O O
is B-O O
dependent B-O O
on B-O O
elevation B-O O
of B-O O
free B-O O
cytosolic B-O O
calcium B-O O
, B-O O
the B-O O
hyperpolarization B-O O
is B-O O
presumably B-O O
through B-O O
opening B-O O
of B-O O
Ca B-O B-protein
( B-O I-protein
2+ B-O I-protein
) B-O I-protein
-stimulated B-O I-protein
K+ B-O I-protein
channels B-O I-protein
. B-O O

We B-O O
have B-O O
used B-O O
charybdotoxin B-O O
, B-O O
a B-O O
known B-O O
inhibitor B-O O
of B-O O
Ca B-O B-protein
( B-O I-protein
2+ B-O I-protein
) B-O I-protein
-dependent B-O I-protein
K+ B-O I-protein
channels B-O I-protein
, B-O O
to B-O O
study B-O O
the B-O O
role B-O O
of B-O O
these B-O O
channels B-O O
in B-O O
lymphocyte B-O B-cell_type
activation B-O O
and B-O O
mitogenesis B-O O
. B-O O

We B-O O
demonstrate B-O O
that B-O O
charybdotoxin B-O O
inhibits B-O O
the B-O O
ligand-induced B-O O
transient B-O O
membrane B-O O
hyperpolarization B-O O
in B-O O
B B-O B-cell_type
and B-O I-cell_type
T B-O I-cell_type
cells B-O I-cell_type
in B-O O
a B-O O
dose-dependent B-O O
fashion B-O O
, B-O O
without B-O O
affecting B-O O
changes B-O O
in B-O O
cytosolic B-O O
Ca2+ B-O O
. B-O O

However B-O O
, B-O O
blockade B-O O
of B-O O
the B-O O
Ca B-O B-protein
( B-O I-protein
2+ B-O I-protein
) B-O I-protein
-activated B-O I-protein
K+ B-O I-protein
channel B-O I-protein
is B-O O
not B-O O
associated B-O O
with B-O O
changes B-O O
in B-O O
cell-cycle B-O O
gene B-O O
activation B-O O
, B-O O
IL-2 B-O B-protein
production B-O O
, B-O O
IL-2R B-O B-protein
expression B-O O
or B-O O
B B-O O
and B-O O
T B-O O
cell B-O O
mitogenesis B-O O
. B-O O

These B-O O
results B-O O
imply B-O O
that B-O O
membrane B-O O
potential B-O O
changes B-O O
secondary B-O O
to B-O O
the B-O O
ligand-dependent B-O O
opening B-O O
of B-O O
Ca B-O B-protein
( B-O I-protein
2+ B-O I-protein
) B-O I-protein
-activated B-O I-protein
K+ B-O I-protein
channels B-O I-protein
are B-O O
not B-O O
involved B-O O
in B-O O
B B-O B-cell_type
and B-O I-cell_type
T B-O I-cell_type
lymphocyte B-O I-cell_type
activation B-O O
and B-O O
mitogenesis B-O O
. B-O O

Activity B-O O
of B-O O
the B-O O
kappa B-O B-DNA
B B-O I-DNA
enhancer B-O I-DNA
of B-O O
the B-O O
interleukin-2 B-O B-protein
receptor B-O I-protein
alpha B-O I-protein
chain B-O I-protein
in B-O O
somatic B-O B-cell_line
cell B-O I-cell_line
hybrids B-O I-cell_line
is B-O O
accompanied B-O O
by B-O O
the B-O O
nuclear B-O O
localization B-O O
of B-O O
NF-kappa B-O B-protein
B B-O I-protein
. B-O O

The B-O O
two B-O O
nuclear B-O B-protein
proteins B-O I-protein
NF-kappa B-O B-protein
B B-O I-protein
( B-O O
consisting B-O O
of B-O O
subunits B-O O
p50 B-O B-protein
an B-O O
dp65 B-O B-protein
) B-O O
and B-O O
the B-O O
DNA-binding B-O B-protein
subunit B-O I-protein
of B-O O
NF-kappa B-O B-protein
B B-O I-protein
( B-O O
p50 B-O B-protein
) B-O O
by B-O O
itself B-O O
, B-O O
also B-O O
called B-O O
KBF1 B-O B-protein
, B-O O
are B-O O
constitutively B-O O
expressed B-O O
and B-O O
localized B-O O
in B-O O
the B-O O
nucleus B-O O
of B-O O
the B-O O
human B-O B-cell_line
T-cell B-O I-cell_line
line B-O I-cell_line
IARC B-O B-cell_line
301.5 B-O I-cell_line
. B-O O

In B-O O
order B-O O
to B-O O
define B-O O
the B-O O
roles B-O O
of B-O O
these B-O O
two B-O O
factors B-O O
, B-O O
which B-O O
bind B-O O
to B-O O
the B-O O
same B-O O
kappa B-O B-DNA
B B-O I-DNA
enhancers B-O I-DNA
, B-O O
in B-O O
transcription B-O O
activation B-O O
we B-O O
have B-O O
prepared B-O O
somatic B-O B-cell_line
cell B-O I-cell_line
hybrids B-O I-cell_line
between B-O O
IARC B-O B-cell_line
301.5 B-O I-cell_line
and B-O O
a B-O O
murine B-O B-cell_line
myeloma B-O I-cell_line
. B-O O

Most B-O O
hybrids B-O O
express B-O O
both B-O O
KBF1 B-O B-protein
and B-O O
NF-kappa B-O B-protein
B B-O I-protein
in B-O O
their B-O O
nuclei B-O O
, B-O O
but B-O O
one B-O O
hybrid B-O O
expresses B-O O
only B-O O
KBF1 B-O B-protein
. B-O O

The B-O O
kappa B-O B-DNA
B B-O I-DNA
enhancer B-O I-DNA
of B-O O
the B-O O
gene B-O O
encoding B-O O
the B-O O
interleukin-2 B-O B-protein
( B-O I-protein
IL-2 B-O I-protein
) B-O I-protein
receptor B-O I-protein
alpha B-O I-protein
chain B-O I-protein
( B-O O
IL-2R B-O B-protein
alpha B-O I-protein
) B-O O
is B-O O
functional B-O O
only B-O O
in B-O O
the B-O O
hybrids B-O B-cell_line
expressing B-O O
nuclear B-O B-protein
NF-kappa B-O I-protein
B B-O I-protein
. B-O O

These B-O O
findings B-O O
show B-O O
that B-O O
nuclear B-O B-protein
NF-kappa B-O I-protein
B B-O I-protein
is B-O O
necessary B-O O
to B-O O
activate B-O O
the B-O O
kappa B-O B-DNA
B B-O I-DNA
enhancer B-O I-DNA
, B-O O
while B-O O
KBF1 B-O B-protein
by B-O O
itself B-O O
is B-O O
not B-O O
sufficient B-O O
. B-O O

We B-O O
propose B-O O
that B-O O
KBF1 B-O B-protein
is B-O O
a B-O O
competitive B-O O
inhibitor B-O O
of B-O O
NF-kappa B-O B-protein
B B-O I-protein
and B-O O
discuss B-O O
how B-O O
these B-O O
factors B-O O
may B-O O
be B-O O
involved B-O O
in B-O O
the B-O O
transient B-O O
expression B-O O
of B-O O
IL-2 B-O B-protein
and B-O O
IL-2 B-O B-DNA
alpha B-O I-DNA
genes B-O I-DNA
during B-O O
the B-O O
immune B-O O
response B-O O
. B-O O

T-helper-cell B-O B-protein
determinants B-O I-protein
in B-O O
protein B-O B-protein
antigens B-O I-protein
are B-O O
preferentially B-O O
located B-O O
in B-O O
cysteine-rich B-O B-protein
antigen B-O I-protein
segments B-O I-protein
resistant B-O O
to B-O O
proteolytic B-O O
cleavage B-O O
by B-O O
cathepsin B-O B-protein
B B-O I-protein
, B-O O
L B-O O
, B-O O
and B-O O
D B-O O
. B-O O

We B-O O
report B-O O
on B-O O
a B-O O
computer B-O O
algorithm B-O O
capable B-O O
of B-O O
predicting B-O O
the B-O O
location B-O O
of B-O O
T-helper-cell B-O B-protein
epitopes B-O I-protein
in B-O O
protein B-O B-protein
antigen B-O I-protein
( B-O O
Ag B-O B-protein
) B-O O
by B-O O
analysing B-O O
the B-O O
Ag B-O B-protein
amino B-O O
acid B-O O
sequence B-O O
. B-O O

The B-O O
algorithm B-O O
was B-O O
constructed B-O O
with B-O O
the B-O O
aim B-O O
of B-O O
identifying B-O O
segments B-O O
in B-O O
Ag B-O B-protein
which B-O O
are B-O O
resistant B-O O
to B-O O
proteolytic B-O O
degradation B-O O
by B-O O
the B-O O
enzymes B-O O
cathepsin B-O B-protein
B B-O I-protein
, B-O O
L B-O O
, B-O O
and B-O O
D B-O O
. B-O O

These B-O O
are B-O O
prominent B-O O
enzymes B-O B-protein
in B-O O
the B-O O
endocytic B-O O
pathway B-O O
through B-O O
which B-O O
soluble B-O B-protein
protein B-O I-protein
Ag B-O I-protein
enter B-O O
APC B-O B-cell_type
, B-O O
and B-O O
resistant B-O B-protein
segments B-O I-protein
in B-O O
Ag B-O B-protein
may B-O O
, B-O O
therefore B-O O
, B-O O
be B-O O
expected B-O O
to B-O O
contain B-O O
more B-O O
T-cell B-O B-protein
determinants B-O I-protein
than B-O O
susceptible B-O B-protein
segments B-O I-protein
. B-O O

From B-O O
information B-O O
available B-O O
in B-O O
the B-O O
literature B-O O
on B-O O
the B-O O
substrate B-O O
specificity B-O O
of B-O O
the B-O O
three B-O O
enzymes B-O B-protein
, B-O O
it B-O O
is B-O O
clear B-O O
that B-O O
a B-O O
cysteine B-O O
is B-O O
not B-O O
accepted B-O O
in B-O O
any B-O O
of B-O O
the B-O O
S2 B-O B-protein
, B-O O
S1 B-O B-protein
, B-O O
S1 B-O B-protein
' B-O I-protein
, B-O O
and B-O O
S2 B-O B-protein
' B-O O
subsites B-O O
of B-O O
cathepsin B-O B-protein
B B-O I-protein
and B-O I-protein
L B-O I-protein
, B-O O
and B-O O
not B-O O
in B-O O
the B-O O
S1 B-O B-protein
and B-O O
S1 B-O O
' B-O O
subsites B-O O
of B-O O
cathepsin B-O B-protein
D B-O I-protein
. B-O O

Moreover B-O O
, B-O O
we B-O O
have B-O O
noticed B-O O
that B-O O
cysteine B-O B-protein
-containing B-O I-protein
T-cell B-O I-protein
determinants B-O I-protein
in B-O O
a B-O O
number B-O O
of B-O O
protein B-O B-protein
Ag B-O I-protein
are B-O O
particularly B-O O
rich B-O O
in B-O O
the B-O O
amino B-O O
acids B-O O
alanine B-O O
, B-O O
glycine B-O O
, B-O O
lysine B-O O
, B-O O
leucine B-O O
, B-O O
serine B-O O
, B-O O
threonine B-O O
, B-O O
and B-O O
valine B-O O
. B-O O

By B-O O
searching B-O O
protein B-O O
Ag B-O B-protein
for B-O O
clusters B-O O
of B-O O
amino B-O O
acids B-O O
containing B-O O
cysteine B-O O
and B-O O
two B-O O
of B-O O
the B-O O
other B-O O
amino B-O O
acids B-O O
we B-O O
were B-O O
able B-O O
to B-O O
predict B-O O
17 B-O O
out B-O O
of B-O O
23 B-O O
empirically B-O O
known B-O O
T-cell B-O B-protein
determinants B-O I-protein
in B-O O
the B-O O
Ag B-O B-protein
with B-O O
a B-O O
relatively B-O O
low B-O O
number B-O O
of B-O O
false B-O O
( B-O O
positive B-O O
) B-O O
predictions B-O O
. B-O O

Furthermore B-O O
, B-O O
we B-O O
present B-O O
a B-O O
new B-O O
principle B-O O
for B-O O
searching B-O O
Ag B-O B-protein
for B-O O
potential B-O O
amphipatic B-O B-protein
alpha-helical B-O I-protein
protein B-O I-protein
segments B-O I-protein
. B-O O

Such B-O O
segments B-O O
accord B-O O
well B-O O
with B-O O
empirically B-O O
known B-O O
T-cell B-O B-protein
determinants B-O I-protein
and B-O O
our B-O O
algorithm B-O O
produces B-O O
a B-O O
lower B-O O
number B-O O
of B-O O
false B-O O
positive B-O O
predictions B-O O
than B-O O
the B-O O
principle B-O O
based B-O O
on B-O O
discrete B-O O
Fourier B-O O
transformations B-O O
previously B-O O
described B-O O
. B-O O

Contribution B-O O
of B-O O
NF-kappa B-O B-protein
B B-O I-protein
and B-O O
Sp1 B-O B-DNA
binding B-O I-DNA
motifs B-O I-DNA
to B-O O
the B-O O
replicative B-O O
capacity B-O O
of B-O O
human B-O O
immunodeficiency B-O O
virus B-O O
type B-O O
1 B-O O
: B-O O
distinct B-O O
patterns B-O O
of B-O O
viral B-O O
growth B-O O
are B-O O
determined B-O O
by B-O O
T-cell B-O B-cell_type
types B-O I-cell_type
. B-O O

Starting B-O O
with B-O O
a B-O O
replication-incompetent B-O O
molecular B-O O
clone B-O O
of B-O O
human B-O O
immunodeficiency B-O O
virus B-O O
type B-O O
1 B-O O
, B-O O
lacking B-O O
all B-O O
the B-O O
NF-kappa B-O B-DNA
B B-O I-DNA
and B-O I-DNA
Sp1 B-O I-DNA
binding B-O I-DNA
sites B-O I-DNA
present B-O O
in B-O O
the B-O O
native B-O B-DNA
long B-O I-DNA
terminal B-O I-DNA
repeat B-O I-DNA
( B-O O
LTR B-O B-DNA
) B-O O
, B-O O
proviruses B-O O
containing B-O O
reconstructed B-O B-DNA
LTRs B-O I-DNA
with B-O O
individual B-O O
or B-O O
combinations B-O O
of B-O O
NF-kappa B-O B-protein
B B-O I-protein
and B-O O
Sp1 B-O B-DNA
elements B-O I-DNA
were B-O O
generated B-O O
and B-O O
evaluated B-O O
for B-O O
their B-O O
capacity B-O O
to B-O O
produce B-O O
virus B-O O
progeny B-O O
following B-O O
transfection-cocultivation B-O O
. B-O O

Virus B-O O
stocks B-O O
obtained B-O O
from B-O O
these B-O O
experiments B-O O
exhibited B-O O
a B-O O
continuum B-O O
of B-O O
replicative B-O O
capacities B-O O
in B-O O
different B-O O
human B-O B-cell_type
T-cell B-O I-cell_type
types B-O I-cell_type
depending B-O O
on B-O O
which B-O O
element B-O O
( B-O O
s B-O O
) B-O O
was B-O O
present B-O O
in B-O O
the B-O O
LTR B-O B-DNA
. B-O O

For B-O O
example B-O O
, B-O O
in B-O O
experiments B-O O
involving B-O O
proviral B-O O
clones B-O O
with B-O O
LTRs B-O B-DNA
containing B-O O
one B-O O
or B-O O
two B-O O
NF-kappa B-O B-DNA
B B-O I-DNA
elements B-O I-DNA
( B-O O
and B-O O
no B-O O
Sp1 B-O B-DNA
binding B-O I-DNA
sites B-O I-DNA
) B-O O
, B-O O
a B-O O
hierarchy B-O O
of B-O O
cellular B-O O
permissivity B-O O
to B-O O
virus B-O O
replication B-O O
( B-O O
peripheral B-O B-cell_type
blood B-O I-cell_type
lymphocytes B-O I-cell_type
= B-O O
MT4 B-O B-cell_line
greater B-O O
than B-O O
H9 B-O B-cell_line
greater B-O O
than B-O O
CEM B-O B-cell_line
greater B-O O
than B-O O
Jurkat B-O B-cell_line
) B-O O
was B-O O
observed B-O O
. B-O O

Of B-O O
note B-O O
was B-O O
the B-O O
associated B-O O
emergence B-O O
of B-O O
second-site B-O B-DNA
LTR B-O I-DNA
revertants B-O O
which B-O O
involved B-O O
an B-O O
alteration B-O O
of B-O O
the B-O O
TATA B-O B-DNA
box B-O I-DNA
. B-O O

These B-O O
results B-O O
suggest B-O O
that B-O O
the B-O O
human B-O B-DNA
immunodeficiency B-O I-DNA
virus B-O I-DNA
type B-O I-DNA
1 B-O I-DNA
LTR B-O I-DNA
possesses B-O O
functional B-O O
redundancy B-O O
which B-O O
ensures B-O O
virus B-O O
replication B-O O
in B-O O
different B-O O
T-cell B-O B-cell_type
types B-O I-cell_type
and B-O O
is B-O O
capable B-O O
of B-O O
changing B-O O
depending B-O O
on B-O O
the B-O O
particular B-O O
combination B-O O
of B-O O
transcriptional B-O B-protein
factors B-O I-protein
present B-O O
. B-O O

Stimulation B-O O
of B-O O
interferon B-O B-DNA
beta B-O I-DNA
gene B-O I-DNA
transcription B-O O
in B-O O
vitro B-O O
by B-O O
purified B-O O
NF-kappa B-O B-protein
B B-O I-protein
and B-O O
a B-O O
novel B-O O
TH B-O B-protein
protein B-O I-protein
. B-O O

The B-O O
human B-O B-DNA
interferon B-O I-DNA
beta B-O I-DNA
( B-O I-DNA
IFN-beta B-O I-DNA
) B-O I-DNA
regulatory B-O I-DNA
element B-O I-DNA
consists B-O O
of B-O O
multiple B-O O
enhanson B-O B-DNA
domains B-O I-DNA
which B-O O
are B-O O
targets B-O O
for B-O O
transcription B-O B-protein
factors B-O I-protein
involved B-O O
in B-O O
inducible B-O O
expression B-O O
of B-O O
the B-O O
promoter B-O B-DNA
. B-O O

To B-O O
further B-O O
characterize B-O O
the B-O O
protein-DNA B-O O
interactions B-O O
mediating B-O O
IFN-beta B-O B-protein
induction B-O O
, B-O O
positive B-O B-protein
regulatory B-O I-protein
domain B-O I-protein
( B-O I-protein
PRD B-O I-protein
) B-O I-protein
II B-O I-protein
binding B-O I-protein
proteins B-O I-protein
were B-O O
purified B-O O
from B-O O
phorbol B-O O
ester B-O O
induced B-O O
Jurkat B-O B-cell_line
T-cells B-O I-cell_line
and B-O O
from B-O O
IFN B-O B-protein
primed B-O O
, B-O O
cycloheximide/polyinosinic-polycytidylic B-O O
acid B-O O
treated B-O O
HeLa B-O B-cell_line
S3 B-O I-cell_line
cells B-O I-cell_line
. B-O O

From B-O O
HeLa B-O B-cell_line
cells B-O I-cell_line
, B-O O
two B-O O
major B-O B-protein
proteins B-O I-protein
of B-O O
52 B-O O
and B-O O
45 B-O O
kilodaltons B-O O
( B-O O
kD B-O O
) B-O O
copurified B-O O
with B-O O
DNA B-O O
binding B-O O
activity B-O O
, B-O O
whereas B-O O
from B-O O
T-cells B-O B-cell_type
, B-O O
four B-O O
proteins B-O O
-- B-O O
a B-O O
major B-O B-protein
protein B-O I-protein
of B-O O
52 B-O B-protein
kD B-O I-protein
and B-O O
three B-O O
minor B-O B-protein
proteins B-O I-protein
of B-O O
82 B-O O
, B-O O
67 B-O O
, B-O O
and B-O O
43-47 B-O B-protein
kD B-O I-protein
-- B-O O
were B-O O
purified B-O O
. B-O O

Also B-O O
, B-O O
an B-O O
induction B-O O
specific B-O O
DNA B-O B-protein
binding B-O I-protein
protein B-O I-protein
was B-O O
purified B-O O
from B-O O
HeLa B-O B-cell_line
cells B-O I-cell_line
that B-O O
interacted B-O O
with B-O O
the B-O O
( B-O O
AAGTGA B-O O
) B-O O
4 B-O O
tetrahexamer B-O B-DNA
sequence B-O I-DNA
and B-O O
the B-O O
PRDI B-O B-DNA
domain B-O I-DNA
. B-O O

This B-O O
protein B-O O
is B-O O
immunologically B-O O
distinct B-O O
from B-O O
IRF-1/ISGF2 B-O B-protein
. B-O O

Uninduced B-O O
or B-O O
Sendai B-O O
virus B-O O
induced B-O O
HeLa B-O O
extracts B-O O
were B-O O
used B-O O
to B-O O
examine B-O O
transcription B-O O
in B-O O
vitro B-O O
using B-O O
a B-O O
series B-O O
of B-O O
IFN B-O B-DNA
beta B-O I-DNA
promoter B-O I-DNA
deletions B-O I-DNA
. B-O O

Deletions B-O O
upstream B-O O
of B-O O
the B-O O
PRDII B-O B-DNA
element B-O I-DNA
increased B-O O
transcription B-O O
in B-O O
the B-O O
uninduced B-O O
extract B-O O
, B-O O
indicating B-O O
predominantly B-O O
negative B-O O
regulation B-O O
of B-O O
the B-O O
promoter B-O B-DNA
. B-O O

A B-O O
2-4-fold B-O O
increase B-O O
in B-O O
IFN-beta B-O B-DNA
promoter B-O I-DNA
transcription B-O O
was B-O O
observed B-O O
in B-O O
Sendai B-O O
virus B-O O
induced B-O O
extracts B-O O
, B-O O
and B-O O
deletion B-O O
of B-O O
PRDI B-O B-DNA
and B-O O
PRDII B-O B-DNA
elements B-O I-DNA
decreased B-O O
this B-O O
induced B-O O
level B-O O
of B-O O
transcription B-O O
. B-O O

When B-O O
purified B-O O
PRDII B-O B-protein
and B-O O
tetrahexamer B-O B-protein
binding B-O I-protein
proteins B-O I-protein
were B-O O
added B-O O
to B-O O
the B-O O
induced B-O O
extract B-O O
, B-O O
a B-O O
4-fold B-O O
increase B-O O
in B-O O
transcription B-O O
was B-O O
observed B-O O
. B-O O

These B-O O
experiments B-O O
demonstrate B-O O
that B-O O
it B-O O
is B-O O
possible B-O O
to B-O O
modulate B-O O
IFN-beta B-O B-protein
transcription B-O O
in B-O O
vitro B-O O
but B-O O
indicate B-O O
that B-O O
additional B-O O
proteins B-O O
may B-O O
be B-O O
required B-O O
to B-O O
fully B-O O
activate B-O O
IFN-beta B-O B-protein
transcription B-O O
. B-O O

The B-O O
rhombotin B-O B-protein
family B-O I-protein
of B-O O
cysteine B-O B-DNA
-rich B-O I-DNA
LIM-domain B-O I-DNA
oncogenes B-O I-DNA
: B-O O
distinct B-O O
members B-O O
are B-O O
involved B-O O
in B-O O
T-cell B-O B-DNA
translocations B-O I-DNA
to B-O O
human B-O B-DNA
chromosomes B-O I-DNA
11p15 B-O I-DNA
and B-O I-DNA
11p13 B-O I-DNA
. B-O O

A B-O O
chromosomal B-O O
translocation B-O O
in B-O O
a B-O O
T-cell B-O O
leukemia B-O O
involving B-O O
the B-O O
short B-O B-DNA
arm B-O I-DNA
of B-O O
human B-O B-DNA
chromosome B-O I-DNA
11 B-O I-DNA
at B-O O
band B-O B-DNA
11p15 B-O I-DNA
disrupts B-O O
the B-O O
rhombotin B-O B-DNA
gene B-O I-DNA
. B-O O

This B-O O
gene B-O O
encodes B-O O
a B-O O
protein B-O O
with B-O O
duplicated B-O O
cysteine B-O B-protein
-rich B-O I-protein
regions B-O I-protein
called B-O O
LIM B-O B-protein
domains B-O I-protein
, B-O O
which B-O O
show B-O O
homology B-O O
to B-O O
zinc-binding B-O B-protein
proteins B-O I-protein
and B-O O
to B-O O
iron-sulfur B-O B-protein
centers B-O I-protein
of B-O O
ferredoxins B-O B-protein
. B-O O

Two B-O O
homologues B-O O
of B-O O
the B-O O
rhombotin B-O B-DNA
gene B-O I-DNA
have B-O O
now B-O O
been B-O O
isolated B-O O
. B-O O

One B-O O
of B-O O
these B-O O
, B-O O
designated B-O O
Rhom-2 B-O B-DNA
, B-O O
is B-O O
located B-O O
on B-O O
human B-O B-DNA
chromosome B-O I-DNA
11 B-O I-DNA
at B-O O
band B-O B-DNA
11p13 B-O I-DNA
, B-O O
where B-O O
a B-O O
cluster B-O O
of B-O O
T-cell B-O B-DNA
leukemia-specific B-O I-DNA
translocations B-O I-DNA
occur B-O O
; B-O O
all B-O O
translocation B-O O
breakpoints B-O O
at B-O O
11p13 B-O B-DNA
are B-O O
upstream B-O O
of B-O O
the B-O O
Rhom-2 B-O B-DNA
gene B-O I-DNA
. B-O O

Human B-O B-DNA
and B-O I-DNA
mouse B-O I-DNA
Rhom-2 B-O I-DNA
are B-O O
highly B-O O
conserved B-O O
and B-O O
, B-O O
like B-O O
rhombotin B-O B-DNA
, B-O O
encode B-O O
two B-O O
tandem B-O B-DNA
cysteine B-O I-DNA
-rich B-O I-DNA
LIM B-O I-DNA
domains B-O I-DNA
. B-O O

Rhom-2 B-O B-RNA
mRNA B-O I-RNA
is B-O O
expressed B-O O
in B-O O
early B-O O
mouse B-O O
development B-O O
in B-O O
central B-O O
nervous B-O O
system B-O O
, B-O O
lung B-O O
, B-O O
kidney B-O O
, B-O O
liver B-O O
, B-O O
and B-O O
spleen B-O O
but B-O O
only B-O O
very B-O O
low B-O O
levels B-O O
occur B-O O
in B-O O
thymus B-O O
. B-O O

The B-O O
other B-O O
gene B-O O
, B-O O
designated B-O O
Rhom-3 B-O B-DNA
, B-O O
is B-O O
not B-O O
on B-O O
chromosome B-O B-DNA
11 B-O I-DNA
but B-O O
also B-O O
retains B-O O
homology B-O O
to B-O O
the B-O O
LIM B-O B-protein
domain B-O I-protein
of B-O O
rhombotin B-O B-DNA
. B-O O

Since B-O O
the B-O O
Rhom-2 B-O B-DNA
gene B-O I-DNA
is B-O O
such B-O O
a B-O O
common B-O O
site B-O O
of B-O O
chromosomal B-O O
damage B-O O
in B-O O
T-cell B-O B-cell_type
tumors B-O I-cell_type
, B-O O
the B-O O
consistency B-O O
of B-O O
translocations B-O O
near B-O O
the B-O O
rhombotin B-O B-DNA
gene B-O I-DNA
was B-O O
further B-O O
examined B-O O
. B-O O

A B-O O
second B-O O
translocation B-O O
adjacent B-O O
to B-O O
rhombotin B-O B-DNA
was B-O O
found B-O O
and B-O O
at B-O O
the B-O O
same B-O O
position B-O O
as B-O O
in B-O O
the B-O O
previous B-O O
example B-O O
. B-O O

Therefore B-O O
, B-O O
chromosome B-O B-DNA
bands B-O I-DNA
11p15 B-O I-DNA
( B-O O
rhombotin B-O B-DNA
) B-O O
and B-O O
11p13 B-O B-DNA
( B-O O
Rhom-2 B-O B-DNA
) B-O O
are B-O O
consistent B-O O
sites B-O O
of B-O O
chromosome B-O O
translocation B-O O
in B-O O
T-cell B-O O
leukemia B-O O
, B-O O
with B-O O
the B-O O
11p15 B-O B-DNA
target B-O I-DNA
more B-O O
rarely B-O O
involved B-O O
. B-O O

The B-O O
results B-O O
define B-O O
the B-O O
rhombotin B-O B-DNA
gene B-O I-DNA
family B-O I-DNA
as B-O O
a B-O O
class B-O O
of B-O O
T-cell B-O B-DNA
oncogenes B-O I-DNA
with B-O O
duplicated B-O O
cysteine B-O B-protein
-rich B-O I-protein
LIM B-O I-protein
domains B-O I-protein
. B-O O

NF-kappa B-O B-protein
B B-O I-protein
activation B-O O
by B-O O
tumor B-O B-protein
necrosis B-O I-protein
factor B-O I-protein
alpha B-O I-protein
in B-O O
the B-O O
Jurkat B-O B-cell_line
T B-O I-cell_line
cell B-O I-cell_line
line B-O I-cell_line
is B-O O
independent B-O O
of B-O O
protein B-O B-protein
kinase B-O I-protein
A B-O I-protein
, B-O O
protein B-O B-protein
kinase B-O I-protein
C B-O I-protein
, B-O O
and B-O O
Ca B-O B-protein
( B-O I-protein
2+ B-O I-protein
) B-O I-protein
-regulated B-O I-protein
kinases B-O I-protein
. B-O O

NF-kappa B-O B-protein
B B-O I-protein
is B-O O
a B-O O
DNA-binding B-O B-protein
regulatory B-O I-protein
factor B-O I-protein
able B-O O
to B-O O
control B-O O
transcription B-O O
of B-O O
a B-O O
number B-O O
of B-O O
genes B-O O
, B-O O
including B-O O
human B-O B-DNA
immunodeficiency B-O I-DNA
virus B-O I-DNA
( B-O I-DNA
HIV B-O I-DNA
) B-O I-DNA
genes B-O I-DNA
. B-O O

In B-O O
T B-O B-cell_type
cells B-O I-cell_type
, B-O O
NF-kappa B-O B-protein
B B-O I-protein
is B-O O
activated B-O O
upon B-O O
cellular B-O O
treatment B-O O
by B-O O
phorbol B-O O
esters B-O O
and B-O O
the B-O O
cytokine B-O B-protein
tumor B-O B-protein
necrosis B-O I-protein
factor B-O I-protein
alpha B-O I-protein
( B-O O
TNF B-O B-protein
alpha B-O I-protein
) B-O O
. B-O O

In B-O O
the B-O O
present B-O O
work B-O O
, B-O O
we B-O O
investigated B-O O
the B-O O
molecular B-O O
events B-O O
leading B-O O
to B-O O
NF-kappa B-O B-protein
B B-O I-protein
activation B-O O
by B-O O
TNF B-O B-protein
alpha B-O I-protein
in B-O O
a B-O O
human B-O B-cell_line
T B-O I-cell_line
cell B-O I-cell_line
line B-O I-cell_line
( B-O O
Jurkat B-O B-cell_line
) B-O O
and B-O O
its B-O O
subclone B-O O
JCT6 B-O B-protein
, B-O O
which B-O O
presents B-O O
a B-O O
deficiency B-O O
in B-O O
the B-O O
PKA B-O B-protein
transduction B-O O
pathway B-O O
. B-O O

We B-O O
found B-O O
that B-O O
in B-O O
both B-O O
cell B-O B-cell_line
lines B-O I-cell_line
, B-O O
both B-O O
phorbol B-O O
ester B-O O
and B-O O
TNF B-O B-protein
alpha B-O I-protein
were B-O O
able B-O O
to B-O O
activate B-O O
NF-kappa B-O B-protein
B B-O I-protein
. B-O O

Phorbol B-O O
activation B-O O
was B-O O
positively B-O O
modulated B-O O
by B-O O
Ca2+ B-O O
influx B-O O
while B-O O
TNF B-O B-protein
alpha B-O I-protein
activation B-O O
was B-O O
not B-O O
. B-O O

Furthermore B-O O
, B-O O
while B-O O
PMA B-O O
activation B-O O
was B-O O
inhibited B-O O
by B-O O
the B-O O
PKC B-O B-protein
inhibitor B-O O
staurosporin B-O O
, B-O O
the B-O O
TNF B-O B-protein
alpha B-O I-protein
effect B-O O
was B-O O
unchanged B-O O
. B-O O

TNF B-O B-protein
alpha B-O I-protein
did B-O O
not B-O O
activate B-O O
cAMP B-O O
production B-O O
and B-O O
its B-O O
signal B-O O
was B-O O
not B-O O
modulated B-O O
by B-O O
cAMP B-O O
activators B-O O
. B-O O

Moreover B-O O
, B-O O
cAMP B-O O
activators B-O O
did B-O O
not B-O O
activate B-O O
NF-kappa B-O B-protein
B B-O I-protein
in B-O O
Jurkat B-O B-cell_line
cells B-O I-cell_line
. B-O O

Thus B-O O
, B-O O
TNF B-O B-protein
alpha B-O I-protein
-induced B-O O
NF-kappa B-O B-protein
B B-O I-protein
activation B-O O
was B-O O
found B-O O
to B-O O
be B-O O
mediated B-O O
by B-O O
none B-O O
of B-O O
the B-O O
major B-O O
signal-mediating B-O B-protein
kinases B-O I-protein
such B-O O
as B-O O
protein B-O B-protein
kinase B-O I-protein
C B-O I-protein
( B-O O
PKC B-O B-protein
) B-O O
, B-O O
protein B-O B-protein
kinase B-O I-protein
A B-O I-protein
, B-O O
or B-O O
Ca B-O B-protein
( B-O I-protein
2+ B-O I-protein
) B-O I-protein
-regulated B-O I-protein
kinases B-O I-protein
. B-O O

Furthermore B-O O
, B-O O
we B-O O
found B-O O
that B-O O
cytoplasmic B-O O
acidification B-O O
facilitated B-O O
NF-kappa B-O B-protein
B B-O I-protein
activation B-O O
by B-O O
both B-O O
TNF B-O B-protein
alpha B-O I-protein
and B-O O
PKC B-O B-protein
, B-O O
by B-O O
a B-O O
mechanism B-O O
that B-O O
increases B-O O
NF-kappa B-O B-protein
B B-O I-protein
/I B-O B-protein
kappa B-O I-protein
B B-O I-protein
dissociation B-O O
without B-O O
affecting B-O O
the B-O O
NF-kappa B-O B-protein
B B-O I-protein
translocation B-O O
step B-O O
. B-O O

The B-O O
functional B-O B-protein
domains B-O I-protein
of B-O O
the B-O O
murine B-O B-DNA
Thy-1 B-O I-DNA
gene B-O I-DNA
promoter B-O I-DNA
. B-O O

The B-O O
Thy-1 B-O B-DNA
gene B-O I-DNA
promoter B-O I-DNA
resembles B-O O
a B-O O
`` B-O B-DNA
housekeeping B-O I-DNA
`` B-O I-DNA
promoter B-O I-DNA
in B-O O
that B-O O
it B-O O
is B-O O
located B-O O
within B-O O
a B-O O
methylation-free B-O B-DNA
island B-O I-DNA
, B-O O
lacks B-O O
a B-O O
canonical B-O B-DNA
TATA B-O I-DNA
box B-O I-DNA
, B-O O
and B-O O
displays B-O O
heterogeneity B-O O
in B-O O
the B-O O
5'-end B-O B-RNA
termini B-O I-RNA
of B-O O
the B-O O
mRNA B-O B-RNA
. B-O O

Using B-O O
transgenic B-O O
mice B-O O
, B-O O
we B-O O
show B-O O
that B-O O
this B-O O
promoter B-O B-DNA
does B-O O
not B-O O
confer B-O O
any B-O O
tissue B-O O
specificity B-O O
and B-O O
is B-O O
active B-O O
only B-O O
in B-O O
a B-O O
position-dependent B-O O
manner B-O O
. B-O O

It B-O O
can B-O O
only B-O O
be B-O O
activated B-O O
in B-O O
a B-O O
tissue-specific B-O O
manner B-O O
by B-O O
elements B-O O
that B-O O
lie B-O O
downstream B-O O
of B-O O
the B-O O
initiation B-O B-DNA
site B-O I-DNA
. B-O O

We B-O O
have B-O O
analyzed B-O O
the B-O O
functional B-O B-protein
domains B-O I-protein
of B-O O
the B-O O
minimal B-O B-DNA
Thy-1 B-O I-DNA
promoter B-O I-DNA
and B-O O
show B-O O
that B-O O
the B-O O
dominant B-O B-DNA
promoter B-O I-DNA
elements B-O I-DNA
consist B-O O
of B-O O
multiple B-O B-DNA
binding B-O I-DNA
sites B-O I-DNA
for B-O O
the B-O O
transcription B-O B-protein
factor B-O I-protein
Sp1 B-O B-protein
, B-O O
an B-O O
inverted B-O O
CCAAT B-O B-DNA
box B-O I-DNA
, B-O O
and B-O O
sequences B-O O
proximal B-O O
to B-O O
the B-O O
transcription B-O B-DNA
start B-O I-DNA
site B-O I-DNA
. B-O O

DNase B-O B-protein
I B-O I-protein
and B-O O
gel B-O O
mobility B-O O
shift B-O O
assays B-O O
show B-O O
the B-O O
binding B-O O
of B-O O
a B-O O
number B-O O
of B-O O
nuclear B-O B-protein
factors B-O I-protein
to B-O O
these B-O O
elements B-O B-DNA
, B-O O
including B-O O
Sp1 B-O B-protein
and B-O O
CP1 B-O B-protein
. B-O O

Our B-O O
results B-O O
show B-O O
that B-O O
the B-O O
structure B-O O
of B-O O
this B-O O
promoter B-O B-DNA
only B-O O
permits B-O O
productive B-O O
interactions B-O O
of B-O O
the B-O O
two B-O O
transcription B-O B-protein
factors B-O I-protein
Sp1 B-O B-protein
and B-O O
CP1 B-O B-protein
with B-O O
the B-O O
basal B-O O
transcription B-O O
machinery B-O O
in B-O O
the B-O O
presence B-O O
of B-O O
enhancer B-O B-DNA
sequences B-O I-DNA
. B-O O

Nuclear B-O B-protein
factor B-O I-protein
kappa B-O I-protein
B B-O I-protein
activates B-O O
proenkephalin B-O O
transcription B-O O
in B-O O
T B-O B-cell_type
lymphocytes B-O I-cell_type
. B-O O

Upon B-O O
activation B-O O
, B-O O
T B-O B-cell_type
lymphocytes B-O I-cell_type
accumulate B-O O
high B-O O
levels B-O O
of B-O O
the B-O O
neuropeptide B-O O
enkephalin B-O O
which B-O O
correlate B-O O
with B-O O
high B-O O
levels B-O O
of B-O O
proenkephalin B-O B-RNA
mRNA B-O I-RNA
in B-O O
the B-O O
cells B-O O
. B-O O

Here B-O O
we B-O O
investigated B-O O
the B-O O
transcriptional B-O O
basis B-O O
for B-O O
these B-O O
changes B-O O
. B-O O

The B-O O
proenkephalin B-O B-DNA
promoter B-O I-DNA
contains B-O O
a B-O O
sequence B-O O
GGGGACGTCCCC B-O O
, B-O O
named B-O O
B2 B-O B-protein
, B-O O
which B-O O
is B-O O
similar B-O O
to B-O O
the B-O O
kappa B-O B-DNA
B B-O I-DNA
sequence B-O I-DNA
GGGGACTTTCC B-O O
, B-O O
the B-O O
binding B-O B-DNA
site B-O I-DNA
of B-O O
the B-O O
transcription B-O B-protein
factor B-O I-protein
nuclear B-O B-protein
factor B-O I-protein
( B-O I-protein
NF B-O I-protein
) B-O I-protein
-kappa B-O I-protein
B B-O I-protein
. B-O O

Activation B-O O
of B-O O
T B-O B-cell_type
lymphocytes B-O I-cell_type
induces B-O O
an B-O O
NF-kappa B-O B-protein
B B-O I-protein
-like B-O O
binding B-O O
activity B-O O
to B-O O
the B-O O
B2 B-O B-DNA
site B-O O
, B-O O
concomitant B-O O
with B-O O
activation B-O O
of B-O O
the B-O O
proenkephalin B-O B-DNA
promoter B-O I-DNA
. B-O O

Mutations B-O O
at B-O O
the B-O O
B2 B-O B-DNA
site B-O O
abolish B-O O
this B-O O
transcriptional B-O O
activation B-O O
. B-O O

The B-O O
purified B-O O
homodimer B-O B-protein
( B-O O
two B-O O
p50s B-O B-protein
) B-O O
of B-O O
the B-O O
DNA-binding B-O B-protein
subunit B-O I-protein
of B-O O
NF-kappa B-O B-protein
B B-O I-protein
binds B-O O
the B-O O
B2 B-O B-DNA
site B-O O
of B-O O
proenkephalin B-O O
relatively B-O O
better B-O O
than B-O O
does B-O O
the B-O O
heterotetramer B-O B-protein
( B-O O
two B-O O
p65s B-O B-protein
plus B-O O
two B-O O
p50s B-O B-protein
) B-O O
form B-O O
of B-O O
the B-O O
factor B-O O
. B-O O

Thus B-O O
, B-O O
it B-O O
appears B-O O
that B-O O
the B-O O
T-cell-specific B-O O
activation B-O O
of B-O O
the B-O O
proenkephalin B-O B-DNA
promoter B-O I-DNA
is B-O O
mediated B-O O
by B-O O
NF-kappa B-O B-protein
B B-O I-protein
. B-O O

However B-O O
, B-O O
as B-O O
NF-kappa B-O B-protein
B B-O I-protein
is B-O O
ubiquitous B-O O
and B-O O
the B-O O
transcriptional B-O O
activation B-O O
through B-O O
the B-O O
B2 B-O B-DNA
site B-O I-DNA
is B-O O
T B-O O
cell B-O O
specific B-O O
, B-O O
yet B-O O
another B-O O
T-cell-specific B-O B-protein
factor B-O I-protein
which B-O O
synergizes B-O O
with B-O O
NF-kappa B-O B-protein
B B-O I-protein
should B-O O
be B-O O
considered B-O O
. B-O O

Induction B-O O
of B-O O
NF-KB B-O B-protein
during B-O O
monocyte B-O O
differentiation B-O O
by B-O O
HIV B-O O
type B-O O
1 B-O O
infection B-O O
. B-O O

The B-O O
production B-O O
of B-O O
human B-O O
immunodeficiency B-O O
virus B-O O
type B-O O
1 B-O O
( B-O O
HIV-1 B-O O
) B-O O
progeny B-O O
was B-O O
followed B-O O
in B-O O
the B-O O
U937 B-O B-cell_line
promonocytic B-O I-cell_line
cell B-O I-cell_line
line B-O I-cell_line
after B-O O
stimulation B-O O
either B-O O
with B-O O
retinoic B-O O
acid B-O O
or B-O O
PMA B-O O
, B-O O
and B-O O
in B-O O
purified B-O O
human B-O B-cell_type
monocytes B-O I-cell_type
and B-O O
macrophages B-O B-cell_type
. B-O O

Electrophoretic B-O O
mobility B-O O
shift B-O O
assays B-O O
and B-O O
Southwestern B-O O
blotting B-O O
experiments B-O O
were B-O O
used B-O O
to B-O O
detect B-O O
the B-O O
binding B-O O
of B-O O
cellular B-O B-protein
transactivation B-O I-protein
factor B-O I-protein
NF-KB B-O B-protein
to B-O O
the B-O O
double B-O B-DNA
repeat-KB B-O I-DNA
enhancer B-O I-DNA
sequence B-O I-DNA
located B-O O
in B-O O
the B-O O
long B-O B-DNA
terminal B-O I-DNA
repeat B-O I-DNA
. B-O O

PMA B-O O
treatment B-O O
, B-O O
and B-O O
not B-O O
retinoic B-O O
acid B-O O
treatment B-O O
of B-O O
the B-O O
U937 B-O B-cell_line
cells B-O I-cell_line
acts B-O O
in B-O O
inducing B-O O
NF-KB B-O B-protein
expression B-O O
in B-O O
the B-O O
nuclei B-O O
. B-O O

In B-O O
nuclear B-O O
extracts B-O O
from B-O O
monocytes B-O B-cell_type
or B-O O
macrophages B-O B-cell_type
, B-O O
induction B-O O
of B-O O
NF-KB B-O B-protein
occurred B-O O
only B-O O
if B-O O
the B-O O
cells B-O O
were B-O O
previously B-O O
infected B-O O
with B-O O
HIV-1 B-O O
. B-O O

When B-O O
U937 B-O B-cell_line
cells B-O I-cell_line
were B-O O
infected B-O O
with B-O O
HIV-1 B-O O
, B-O O
no B-O O
induction B-O O
of B-O O
NF-KB B-O B-protein
factor B-O I-protein
was B-O O
detected B-O O
, B-O O
whereas B-O O
high B-O O
level B-O O
of B-O O
progeny B-O O
virions B-O O
was B-O O
produced B-O O
, B-O O
suggesting B-O O
that B-O O
this B-O O
factor B-O O
was B-O O
not B-O O
required B-O O
for B-O O
viral B-O O
replication B-O O
. B-O O

These B-O O
results B-O O
indicate B-O O
that B-O O
in B-O O
monocytic B-O B-cell_type
cell B-O I-cell_type
lineage B-O I-cell_type
, B-O O
HIV-1 B-O O
could B-O O
mimic B-O O
some B-O O
differentiation/activation B-O O
stimuli B-O O
allowing B-O O
nuclear B-O O
NF-KB B-O B-protein
expression B-O O
. B-O O

Disruption B-O O
of B-O O
the B-O O
human B-O B-DNA
SCL B-O I-DNA
locus B-O I-DNA
by B-O O
`` B-O O
illegitimate B-O O
`` B-O O
V- B-O O
( B-O O
D B-O O
) B-O O
-J B-O O
recombinase B-O O
activity B-O O
. B-O O

A B-O O
fusion B-O B-DNA
complementary B-O I-DNA
DNA B-O I-DNA
in B-O O
the B-O O
T B-O B-cell_line
cell B-O I-cell_line
line B-O I-cell_line
HSB-2 B-O I-cell_line
elucidates B-O O
a B-O O
provocative B-O O
mechanism B-O O
for B-O O
the B-O O
disruption B-O O
of B-O O
the B-O O
putative B-O O
hematopoietic B-O B-protein
transcription B-O I-protein
factor B-O I-protein
SCL B-O B-protein
. B-O O

The B-O O
fusion B-O B-DNA
cDNA B-O I-DNA
results B-O O
from B-O O
an B-O O
interstitial B-O O
deletion B-O O
between B-O O
a B-O O
previously B-O O
unknown B-O B-DNA
locus B-O I-DNA
, B-O O
SIL B-O B-protein
( B-O O
SCL B-O B-DNA
interrupting B-O I-DNA
locus B-O I-DNA
) B-O O
, B-O O
and B-O O
the B-O O
5 B-O B-DNA
' B-O I-DNA
untranslated B-O I-DNA
region B-O I-DNA
of B-O O
SCL B-O B-protein
. B-O O

Similar B-O O
to B-O O
1 B-O O
; B-O O
14 B-O O
translocations B-O O
, B-O O
this B-O O
deletion B-O O
disrupts B-O O
the B-O O
SCL B-O B-DNA
5 B-O I-DNA
' B-O I-DNA
regulatory B-O I-DNA
region B-O I-DNA
. B-O O

This B-O O
event B-O O
is B-O O
probably B-O O
mediated B-O O
by B-O O
V- B-O B-protein
( B-O I-protein
D B-O I-protein
) B-O I-protein
-J B-O I-protein
recombinase B-O I-protein
activity B-O O
, B-O O
although B-O O
neither B-O O
locus B-O O
is B-O O
an B-O O
immunoglobulin B-O B-protein
or B-O O
a B-O O
T B-O B-protein
cell B-O I-protein
receptor B-O I-protein
. B-O O

Two B-O O
other B-O O
T B-O B-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
, B-O O
CEM B-O B-cell_line
and B-O O
RPMI B-O B-cell_line
8402 B-O I-cell_line
, B-O O
have B-O O
essentially B-O O
identical B-O O
deletions B-O O
. B-O O

Thus B-O O
, B-O O
in B-O O
lymphocytes B-O B-cell_type
, B-O O
growth-affecting B-O B-DNA
genes B-O I-DNA
other B-O O
than B-O O
immune B-O B-protein
receptors B-O I-protein
risk B-O O
rearrangements B-O O
. B-O O

Thyroid B-O B-protein
hormone B-O I-protein
receptors B-O I-protein
form B-O O
distinct B-O O
nuclear B-O B-protein
protein- B-O I-protein
dependent B-O O
and B-O O
independent B-O O
complexes B-O O
with B-O O
a B-O O
thyroid B-O B-DNA
hormone B-O I-DNA
response B-O I-DNA
element B-O I-DNA
. B-O O

We B-O O
have B-O O
examined B-O O
the B-O O
binding B-O O
of B-O O
nuclear B-O B-protein
proteins B-O I-protein
and B-O O
recombinant B-O B-protein
thyroid B-O I-protein
hormone B-O I-protein
receptors B-O I-protein
( B-O O
TRs B-O B-protein
) B-O O
to B-O O
the B-O O
palindromic B-O B-DNA
thyroid B-O I-DNA
hormone B-O I-DNA
responsive B-O I-DNA
element B-O I-DNA
AGGTCATGACCT B-O O
( B-O O
TREp B-O B-DNA
) B-O O
using B-O O
a B-O O
gel B-O O
electrophoretic B-O O
mobility B-O O
shift B-O O
assay B-O O
. B-O O

Four B-O O
specific B-O O
protein-DNA B-O B-protein
complexes B-O I-protein
were B-O O
detected B-O O
after B-O O
incubation B-O O
of B-O O
nuclear B-O O
extracts B-O O
( B-O O
NE B-O B-protein
) B-O O
from B-O O
T3-responsive B-O B-cell_line
pituitary B-O I-cell_line
( B-O I-cell_line
GH3 B-O I-cell_line
) B-O I-cell_line
cells B-O I-cell_line
with B-O O
a B-O O
TREp B-O B-DNA
-containing B-O I-DNA
DNA B-O I-DNA
fragment B-O I-DNA
. B-O O

This B-O O
was B-O O
compared B-O O
with B-O O
the B-O O
TREp B-O B-DNA
binding B-O O
of B-O O
reticulocyte B-O B-protein
lysate-synthesized B-O I-protein
TRs B-O I-protein
. B-O O

TR B-O B-protein
alpha B-O I-protein
1 B-O I-protein
and B-O O
TR B-O B-protein
beta B-O I-protein
2 B-O I-protein
each B-O O
formed B-O O
a B-O O
single B-O O
major B-O O
TR B-O B-protein
: B-O I-protein
TREp B-O I-protein
complex B-O I-protein
which B-O O
comigrated B-O O
with B-O O
the B-O O
least B-O O
retarded B-O O
complex B-O O
formed B-O O
by B-O O
GH3 B-O O
NE B-O O
, B-O O
while B-O O
TR B-O B-protein
beta B-O I-protein
1 B-O I-protein
formed B-O O
multiple B-O O
complexes B-O O
suggesting B-O O
that B-O O
it B-O O
can B-O O
bind B-O O
to B-O O
TREp B-O B-DNA
as B-O O
an B-O O
oligomer B-O B-protein
. B-O O

Interestingly B-O O
, B-O O
coincubation B-O O
of B-O O
35S- B-O B-protein
TR B-O I-protein
alpha B-O I-protein
1 B-O I-protein
, B-O O
GH3 B-O O
NE B-O O
, B-O O
and B-O O
unlabeled B-O O
TREp B-O B-DNA
resulted B-O O
in B-O O
not B-O O
only B-O O
the B-O O
35S-TR B-O B-protein
: B-O I-protein
TREp B-O I-protein
complex B-O I-protein
, B-O O
but B-O O
in B-O O
two B-O O
additional B-O O
more B-O O
greatly B-O O
retarded B-O O
complexes B-O O
containing B-O O
35S- B-O B-protein
TR B-O I-protein
alpha B-O I-protein
1 B-O I-protein
and B-O O
comigrating B-O O
with B-O O
those B-O O
formed B-O O
by B-O O
GH3 B-O O
extract B-O O
alone B-O O
. B-O O

Incubation B-O O
of B-O O
each B-O O
of B-O O
the B-O O
TRs B-O B-protein
with B-O O
NE B-O B-protein
from B-O O
COS-7 B-O B-cell_line
cells B-O I-cell_line
, B-O O
which B-O O
do B-O O
not B-O O
possess B-O O
sufficient B-O O
endogenous B-O O
TRs B-O B-protein
to B-O O
mediate B-O O
T3-responses B-O O
, B-O O
resulted B-O O
in B-O O
formation B-O O
of B-O O
a B-O O
new B-O O
, B-O O
more B-O O
greatly B-O B-protein
shifted B-O I-protein
complex B-O I-protein
. B-O O

A B-O O
similar B-O O
, B-O O
heat B-O O
labile B-O O
activity B-O O
which B-O O
altered B-O O
mobility B-O O
of B-O O
the B-O O
TR B-O B-protein
: B-O I-protein
TRE B-O I-protein
complex B-O I-protein
was B-O O
also B-O O
present B-O O
in B-O O
NE B-O O
from B-O O
T3-unresponsive B-O B-cell_line
JEG-3 B-O I-cell_line
cells B-O I-cell_line
. B-O O

At B-O O
high B-O O
concentration B-O O
of B-O O
NE B-O B-protein
, B-O O
all B-O O
of B-O O
the B-O O
TR B-O B-protein
bound B-O O
to B-O O
TREp B-O B-DNA
was B-O O
more B-O O
greatly B-O O
retarded B-O O
than B-O O
in B-O O
the B-O O
absence B-O O
of B-O O
NE B-O B-protein
. B-O O

Truncation B-O O
of B-O O
TR B-O B-protein
alpha B-O I-protein
1 B-O I-protein
at B-O O
amino B-O B-protein
acid B-O I-protein
210 B-O I-protein
prevented B-O I-protein
additional B-O I-protein
complex B-O I-protein
formation B-O O
in B-O O
the B-O O
presence B-O O
of B-O O
NE B-O B-protein
without B-O O
affecting B-O O
DNA B-O O
binding B-O O
, B-O O
suggesting B-O O
that B-O O
the B-O O
carboxyl-terminus B-O B-protein
of B-O O
the B-O O
TRs B-O B-protein
is B-O O
essential B-O O
for B-O O
interaction B-O O
with B-O O
nuclear B-O B-protein
proteins B-O I-protein
. B-O O

( B-O O
ABSTRACT B-O O
TRUNCATED B-O O
AT B-O O
250 B-O O
WORDS B-O O
) B-O O

Cell-specific B-O O
differences B-O O
in B-O O
activation B-O O
of B-O O
NF-kappa B-O B-DNA
B B-O I-DNA
regulatory B-O I-DNA
elements B-O I-DNA
of B-O O
human B-O B-DNA
immunodeficiency B-O I-DNA
virus B-O I-DNA
and B-O I-DNA
beta B-O I-DNA
interferon B-O I-DNA
promoters B-O I-DNA
by B-O O
tumor B-O B-protein
necrosis B-O I-protein
factor B-O I-protein
. B-O O

Three B-O O
aspects B-O O
of B-O O
the B-O O
involvement B-O O
of B-O O
tumor B-O B-protein
necrosis B-O I-protein
factor B-O I-protein
in B-O O
human B-O O
immunodeficiency B-O O
virus B-O O
( B-O O
HIV B-O O
) B-O O
pathogenesis B-O O
were B-O O
examined B-O O
. B-O O

Tumor B-O B-protein
necrosis B-O I-protein
factor B-O I-protein
alpha B-O I-protein
( B-O O
TNF-alpha B-O B-protein
) B-O O
mRNA B-O O
production B-O O
was B-O O
analyzed B-O O
by B-O O
polymerase B-O O
chain B-O O
reaction B-O O
amplification B-O O
in B-O O
monocytic B-O B-cell_line
U937 B-O I-cell_line
cells B-O I-cell_line
and B-O O
in B-O O
a B-O O
chronically B-O B-cell_line
HIV B-O I-cell_line
infected B-O I-cell_line
U937 B-O I-cell_line
cell B-O I-cell_line
line B-O I-cell_line
( B-O O
U9-IIIB B-O B-cell_line
) B-O O
. B-O O

TNF-alpha B-O B-RNA
RNA B-O I-RNA
was B-O O
undetectable B-O O
in B-O O
U937 B-O B-cell_line
cells B-O I-cell_line
, B-O O
whereas B-O O
a B-O O
low B-O O
constitutive B-O O
level B-O O
was B-O O
detected B-O O
in B-O O
U9-IIIB B-O B-cell_line
cells B-O I-cell_line
. B-O O

Paramyxovirus B-O O
infection B-O O
induced B-O O
a B-O O
5- B-O O
to B-O O
10-fold B-O O
increase B-O O
in B-O O
the B-O O
steady-state B-O O
level B-O O
of B-O O
TNF-alpha B-O B-RNA
RNA B-O I-RNA
in B-O O
U9-IIIB B-O B-cell_line
cells B-O I-cell_line
compared B-O O
with B-O O
U937 B-O B-cell_line
cells B-O I-cell_line
, B-O O
suggesting B-O O
that B-O O
HIV-infected B-O B-cell_type
monocytic B-O I-cell_type
cells B-O I-cell_type
produced B-O O
higher B-O O
levels B-O O
of B-O O
TNF-alpha B-O B-protein
than B-O O
did B-O O
normal B-O B-cell_type
cells B-O I-cell_type
after B-O O
a B-O O
secondary B-O O
virus B-O O
infection B-O O
. B-O O

The B-O O
effects B-O O
of B-O O
TNF-alpha B-O B-protein
on B-O O
gene B-O O
expression B-O O
were B-O O
examined B-O O
by B-O O
transient B-O O
expression B-O O
assays B-O O
using B-O O
reporter B-O B-DNA
chloramphenicol B-O I-DNA
acetyltransferase B-O I-DNA
plasmids B-O I-DNA
linked B-O O
to B-O O
regulatory B-O B-DNA
elements B-O I-DNA
from B-O O
the B-O O
HIV B-O B-DNA
long B-O I-DNA
terminal B-O I-DNA
repeat B-O I-DNA
( B-O O
LTR B-O B-DNA
) B-O O
and B-O O
the B-O O
beta B-O B-DNA
interferon B-O I-DNA
promoter B-O I-DNA
. B-O O

In B-O O
U937 B-O B-cell_line
and B-O O
Jurkat B-O B-cell_line
T B-O I-cell_line
lymphoid B-O I-cell_line
cells B-O I-cell_line
, B-O O
the B-O O
inducibility B-O O
of B-O O
the B-O O
different B-O O
hybrid B-O B-DNA
promoters B-O I-DNA
by B-O O
TNF-alpha B-O B-protein
or B-O O
phorbol B-O O
ester B-O O
varied B-O O
in B-O O
a B-O O
cell B-O O
type- B-O O
and B-O O
promoter B-O O
context-specific B-O O
manner B-O O
; B-O O
the B-O O
levels B-O O
of B-O O
gene B-O O
activity B-O O
of B-O O
NF-kappa B-O B-protein
B B-O I-protein
-containing B-O O
plasmids B-O O
correlated B-O O
directly B-O O
with B-O O
induction B-O O
of B-O O
NF-kappa B-O B-protein
B B-O I-protein
DNA-binding B-O O
activity B-O O
. B-O O

Although B-O O
the B-O O
intact B-O O
beta B-O B-DNA
interferon B-O I-DNA
promoter B-O I-DNA
was B-O O
only B-O O
weakly B-O O
stimulated B-O O
by B-O O
phorbol B-O O
ester B-O O
or B-O O
TNF-alpha B-O B-protein
, B-O O
multimers B-O O
of B-O O
the B-O O
PRDII B-O B-DNA
NF-kappa B-O I-DNA
B B-O I-DNA
-binding B-O I-DNA
domain B-O I-DNA
were B-O O
inducible B-O O
by B-O O
both B-O O
agents B-O O
. B-O O

TNF-alpha B-O B-protein
was B-O O
able B-O O
to B-O O
increase B-O O
expression B-O O
of B-O O
the B-O O
HIV B-O B-DNA
LTR B-O I-DNA
in B-O O
T B-O B-cell_type
cells B-O I-cell_type
, B-O O
but B-O O
in B-O O
monocytic B-O B-cell_type
cells B-O I-cell_type
, B-O O
TNF-alpha B-O B-protein
did B-O O
not B-O O
induce B-O O
the B-O O
HIV B-O B-DNA
LTR B-O I-DNA
above B-O O
a B-O O
constitutive B-O O
level B-O O
of B-O O
activity B-O O
. B-O O

This B-O O
level B-O O
of B-O O
NF-kappa B-O B-protein
B B-O I-protein
-independent B-O O
activity B-O O
appears B-O O
to B-O O
be B-O O
sufficient B-O O
for B-O O
virus B-O O
multiplication B-O O
, B-O O
since B-O O
TNF-alpha B-O B-protein
treatment B-O O
had B-O O
no B-O O
effect B-O O
on B-O O
the B-O O
kinetics B-O O
of B-O O
de B-O O
novo B-O O
HIV B-O O
type B-O O
1 B-O O
( B-O O
HIV-1 B-O O
) B-O O
infection B-O O
and B-O O
viral B-O B-RNA
RNA B-O I-RNA
production B-O O
in B-O O
U937 B-O B-cell_line
cells B-O I-cell_line
. B-O O

However B-O O
, B-O O
in B-O O
Jurkat B-O B-cell_line
cells B-O I-cell_line
, B-O O
TNF-alpha B-O B-protein
dramatically B-O O
enhanced B-O O
the B-O O
spread B-O O
of B-O O
HIV-1 B-O O
through B-O O
the B-O O
cell B-O O
population B-O O
and B-O O
increased B-O O
viral B-O B-RNA
RNA B-O I-RNA
synthesis B-O O
, B-O O
indicating B-O O
that B-O O
in B-O O
T B-O B-cell_type
cells B-O I-cell_type
HIV-1 B-O O
multiplication B-O O
was B-O O
stimulated B-O O
by B-O O
TNF-alpha B-O B-protein
treatment B-O O
. B-O O

Functional B-O O
analysis B-O O
of B-O O
cis-linked B-O B-DNA
regulatory B-O I-DNA
sequences B-O I-DNA
in B-O O
the B-O O
HLA B-O B-DNA
DRA B-O I-DNA
promoter B-O I-DNA
by B-O O
transcription B-O O
in B-O O
vitro B-O O
. B-O O

Two B-O O
consensus B-O B-DNA
sequences B-O I-DNA
, B-O O
called B-O O
X B-O B-DNA
and B-O I-DNA
Y B-O I-DNA
boxes B-O I-DNA
, B-O O
capable B-O O
of B-O O
binding B-O O
nuclear B-O B-protein
proteins B-O I-protein
and B-O O
regulating B-O O
expression B-O O
in B-O O
B B-O B-cell_type
cells B-O I-cell_type
have B-O O
been B-O O
defined B-O O
within B-O O
the B-O O
immediate B-O B-DNA
upstream B-O I-DNA
region B-O I-DNA
of B-O O
major B-O B-DNA
histocompatibility B-O I-DNA
complex B-O I-DNA
( B-O I-DNA
MHC B-O I-DNA
) B-O I-DNA
class B-O I-DNA
II B-O I-DNA
promoters B-O I-DNA
. B-O O

Unlike B-O O
other B-O O
class B-O B-DNA
II B-O I-DNA
promoters B-O I-DNA
, B-O O
the B-O O
HLA-DR B-O B-DNA
alpha B-O I-DNA
( B-O I-DNA
DRA B-O I-DNA
) B-O I-DNA
promoter B-O I-DNA
also B-O O
contains B-O O
one B-O O
element B-O O
identical B-O O
to B-O O
the B-O O
`` B-O B-DNA
octamer B-O I-DNA
`` B-O I-DNA
motif B-O I-DNA
of B-O O
immunoglobulin B-O B-DNA
variable B-O I-DNA
region B-O I-DNA
promoters B-O I-DNA
that B-O O
is B-O O
responsible B-O O
for B-O O
B B-O O
cell-specific B-O O
transcription B-O O
. B-O O

This B-O O
`` B-O O
octamer B-O B-DNA
`` B-O O
in B-O O
the B-O O
context B-O O
of B-O O
DRA B-O B-protein
appears B-O O
capable B-O O
of B-O O
binding B-O O
both B-O O
the B-O O
ubiquitous B-O O
( B-O O
OTF-1 B-O B-protein
) B-O O
and B-O O
lymphoid-specific B-O B-protein
( B-O I-protein
OTF-2 B-O I-protein
) B-O I-protein
`` B-O I-protein
octamer B-O I-protein
`` B-O I-protein
binding B-O I-protein
proteins B-O I-protein
, B-O O
but B-O O
at B-O O
least B-O O
one B-O O
other B-O O
distinct B-O O
`` B-O B-protein
octamer B-O I-protein
`` B-O I-protein
complex B-O I-protein
was B-O O
found B-O O
. B-O O

In B-O O
order B-O O
to B-O O
characterize B-O O
the B-O O
function B-O O
of B-O O
cis-acting B-O B-DNA
elements B-O I-DNA
, B-O O
we B-O O
have B-O O
developed B-O O
an B-O O
in B-O O
vitro B-O O
system B-O O
in B-O O
which B-O O
a B-O O
DRA B-O B-DNA
promoter B-O I-DNA
construct B-O I-DNA
is B-O O
transcribed B-O O
more B-O O
efficiently B-O O
in B-O O
extracts B-O O
from B-O O
B B-O B-cell_type
cells B-O I-cell_type
than B-O O
in B-O O
extracts B-O O
from B-O O
class B-O B-cell_line
II-negative B-O I-cell_line
HeLa B-O I-cell_line
cells B-O I-cell_line
. B-O O

5 B-O B-DNA
' B-O I-DNA
deletion B-O I-DNA
constructs B-O I-DNA
which B-O O
lacked B-O O
the B-O O
Y B-O B-DNA
box B-O I-DNA
, B-O O
but B-O O
retained B-O O
the B-O O
`` B-O B-DNA
octamer B-O I-DNA
`` B-O I-DNA
motif B-O I-DNA
and B-O O
TATA B-O B-DNA
box B-O I-DNA
were B-O O
completely B-O O
inactive B-O O
, B-O O
and B-O O
internal B-O O
deletion B-O O
of B-O O
the B-O O
Y B-O B-DNA
box B-O I-DNA
reduced B-O O
transcription B-O O
by B-O O
95 B-O O
% B-O O
. B-O O

Using B-O O
supercoiled B-O O
, B-O O
but B-O O
not B-O O
linear B-O O
templates B-O O
, B-O O
we B-O O
observed B-O O
differences B-O O
in B-O O
transcription B-O O
efficiencies B-O O
from B-O O
templates B-O O
lacking B-O O
or B-O O
disrupting B-O O
the B-O O
X B-O B-DNA
consensus B-O I-DNA
element B-O I-DNA
that B-O O
reflect B-O O
effects B-O O
of B-O O
random B-O O
replacement B-O O
of B-O O
X B-O B-DNA
box B-O I-DNA
sequences B-O I-DNA
in B-O O
transient B-O O
expression B-O O
assays B-O O
. B-O O

Demonstration B-O O
of B-O O
the B-O O
complete B-O O
dependence B-O O
on B-O O
the B-O O
Y B-O B-DNA
box B-O I-DNA
in B-O O
this B-O O
system B-O O
suggests B-O O
that B-O O
, B-O O
despite B-O O
its B-O O
demonstrated B-O O
importance B-O O
in B-O O
the B-O O
DRA B-O B-DNA
promoter B-O I-DNA
, B-O O
the B-O O
DRA B-O B-DNA
`` B-O I-DNA
octamer B-O I-DNA
`` B-O O
does B-O O
not B-O O
utilize B-O O
OTF-2 B-O B-protein
in B-O O
a B-O O
manner B-O O
analogous B-O O
to B-O O
immunoglobulin B-O B-DNA
promoters B-O I-DNA
in B-O O
B B-O B-cell_type
cells B-O I-cell_type
. B-O O

Lipopolysaccharide B-O O
is B-O O
a B-O O
potent B-O O
monocyte/macrophage-specific B-O O
stimulator B-O O
of B-O O
human B-O O
immunodeficiency B-O O
virus B-O O
type B-O O
1 B-O O
expression B-O O
. B-O O

Lipopolysaccharide B-O O
( B-O O
LPS B-O O
) B-O O
potently B-O O
stimulates B-O O
human B-O B-DNA
immunodeficiency B-O I-DNA
virus B-O I-DNA
type B-O I-DNA
1-long B-O I-DNA
terminal B-O I-DNA
repeat B-O I-DNA
( B-O I-DNA
HIV-1-LTR B-O I-DNA
) B-O I-DNA
CAT B-O I-DNA
constructs B-O I-DNA
transfected B-O O
into B-O O
monocyte/macrophage-like B-O B-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
but B-O O
not B-O O
a B-O O
T B-O B-cell_line
cell B-O I-cell_line
line B-O I-cell_line
. B-O O

This B-O O
effect B-O O
appears B-O O
to B-O O
be B-O O
mediated B-O O
through B-O O
the B-O O
induction B-O O
of B-O O
nuclear B-O B-protein
factor B-O I-protein
kappa B-O I-protein
B B-O I-protein
( B-O O
NF-kappa B-O B-protein
B B-O I-protein
) B-O O
. B-O O

Electrophoretic B-O O
mobility B-O O
shift B-O O
assays B-O O
demonstrate B-O O
that B-O O
LPS B-O O
induces B-O O
a B-O O
DNA B-O O
binding B-O O
activity B-O O
indistinguishable B-O O
from B-O O
NF-kappa B-O B-protein
B B-O I-protein
in B-O O
U937 B-O B-cell_line
and B-O O
THP-1 B-O B-cell_line
cells B-O I-cell_line
. B-O O

LPS B-O O
is B-O O
also B-O O
shown B-O O
to B-O O
dramatically B-O O
increase B-O O
HIV-1 B-O O
production B-O O
from B-O O
a B-O O
chronically B-O B-cell_line
infected B-O I-cell_line
monocyte/macrophage-like B-O I-cell_line
cloned B-O I-cell_line
cell B-O I-cell_line
line B-O I-cell_line
, B-O O
U1 B-O B-cell_line
, B-O O
which B-O O
produces B-O O
very B-O O
low B-O O
levels B-O O
of B-O O
HIV-1 B-O O
at B-O O
baseline B-O O
. B-O O

The B-O O
stimulation B-O O
of B-O O
viral B-O O
production B-O O
from B-O O
this B-O O
cell B-O O
line B-O O
occurs B-O O
only B-O O
if B-O O
these B-O O
cells B-O O
are B-O O
treated B-O O
with B-O O
granulocyte/macrophage B-O B-protein
colony-stimulating B-O I-protein
factor B-O I-protein
( B-O O
GM-CSF B-O B-protein
) B-O O
before B-O O
treatment B-O O
with B-O O
LPS B-O O
. B-O O

This B-O O
stimulation B-O O
of B-O O
HIV-1 B-O O
production B-O O
is B-O O
correlated B-O O
with B-O O
an B-O O
increase B-O O
in B-O O
the B-O O
level B-O O
of B-O O
HIV-1 B-O B-RNA
RNA B-O I-RNA
and B-O O
and B-O O
activation B-O O
of B-O O
NF-kappa B-O B-protein
B B-O I-protein
. B-O O

LPS B-O O
is B-O O
not B-O O
able B-O O
to B-O O
induce B-O O
HIV-1 B-O O
production B-O O
in B-O O
a B-O O
cloned B-O B-cell_line
T B-O I-cell_line
cell B-O I-cell_line
line B-O I-cell_line
. B-O O

The B-O O
effect B-O O
of B-O O
LPS B-O O
on B-O O
HIV-1 B-O O
replication B-O O
occurs B-O O
at B-O O
picogram B-O O
per B-O O
milliliter B-O O
concentrations B-O O
and B-O O
may B-O O
be B-O O
clinically B-O O
significant B-O O
in B-O O
understanding B-O O
the B-O O
variability B-O O
of B-O O
the B-O O
natural B-O O
history B-O O
of B-O O
HIV-1 B-O O
infection B-O O
. B-O O

Steroid B-O O
dose B-O O
sparing B-O O
: B-O O
pharmacodynamic B-O O
responses B-O O
to B-O O
single B-O O
versus B-O O
divided B-O O
doses B-O O
of B-O O
methylprednisolone B-O O
in B-O O
man B-O O
. B-O O

Inhibitory B-O O
drug B-O O
interactions B-O O
affecting B-O O
the B-O O
metabolism B-O O
of B-O O
methylprednisolone B-O O
( B-O O
MP B-O O
) B-O O
may B-O O
produce B-O O
either B-O O
steroid B-O O
sparing B-O O
or B-O O
adverse B-O O
effects B-O O
partly B-O O
by B-O O
increasing B-O O
the B-O O
exposure B-O O
time B-O O
to B-O O
the B-O O
steroid B-O O
. B-O O

This B-O O
phenomenon B-O O
can B-O O
be B-O O
mimicked B-O O
by B-O O
administering B-O O
MP B-O O
in B-O O
divided B-O O
doses B-O O
. B-O O

Two B-O O
types B-O O
of B-O O
responses B-O O
were B-O O
compared B-O O
after B-O O
a B-O O
single B-O O
MP B-O O
dose B-O O
( B-O O
40 B-O O
mg B-O O
bolus B-O O
) B-O O
and B-O O
a B-O O
divided B-O O
regimen B-O O
( B-O O
20 B-O O
mg B-O O
bolus B-O O
and B-O O
a B-O O
5 B-O O
mg B-O O
bolus B-O O
8 B-O O
hours B-O O
later B-O O
) B-O O
in B-O O
six B-O O
healthy B-O O
male B-O O
volunteers B-O O
. B-O O

The B-O O
suppression B-O O
of B-O O
basophils B-O B-cell_type
measured B-O O
as B-O O
whole B-O O
blood B-O O
histamine B-O O
and B-O O
plasma B-O O
cortisol B-O O
concentrations B-O O
was B-O O
assessed B-O O
during B-O O
32 B-O O
hours B-O O
. B-O O

The B-O O
37.5 B-O O
% B-O O
reduction B-O O
in B-O O
dose B-O O
produced B-O O
a B-O O
23 B-O O
% B-O O
overall B-O O
decreased B-O O
blood B-O O
histamine B-O O
response B-O O
. B-O O

A B-O O
pharmacodynamic B-O O
model B-O O
for B-O O
basophil B-O O
cell B-O O
distribution B-O O
to B-O O
and B-O O
from B-O O
an B-O O
extravascular B-O O
compartment B-O O
describes B-O O
the B-O O
effects B-O O
of B-O O
MP B-O O
after B-O O
both B-O O
regimens B-O O
. B-O O

A B-O O
slower B-O O
initial B-O O
decline B-O O
in B-O O
blood B-O O
histamine B-O O
after B-O O
the B-O O
divided B-O O
regimen B-O O
may B-O O
be B-O O
related B-O O
to B-O O
incomplete B-O O
suppression B-O O
of B-O O
basophil B-O B-cell_type
cell B-O I-cell_type
return B-O O
to B-O O
blood B-O O
. B-O O

The B-O O
50 B-O O
% B-O O
inhibitory B-O O
concentrations B-O O
of B-O O
MP B-O O
of B-O O
about B-O O
5 B-O O
ng/ml B-O O
were B-O O
similar B-O O
for B-O O
both B-O O
regimens B-O O
. B-O O

The B-O O
decline B-O O
and B-O O
return B-O O
of B-O O
cortisol B-O O
concentrations B-O O
were B-O O
similar B-O O
between B-O O
MP B-O O
treatments B-O O
with B-O O
suppression B-O O
continuing B-O O
for B-O O
24 B-O O
hours B-O O
. B-O O

The B-O O
50 B-O O
% B-O O
inhibitory B-O O
concentrations B-O O
of B-O O
MP B-O O
values B-O O
for B-O O
adrenal B-O O
suppression B-O O
were B-O O
about B-O O
1 B-O O
ng/ml B-O O
. B-O O

Pharmacodynamic B-O O
modeling B-O O
is B-O O
useful B-O O
in B-O O
quantitating B-O O
corticosteroid B-O O
responses B-O O
and B-O O
generally B-O O
predicted B-O O
the B-O O
`` B-O O
dose-sparing B-O O
`` B-O O
effects B-O O
that B-O O
were B-O O
achieved B-O O
by B-O O
prolonging B-O O
MP B-O O
plasma B-O O
concentrations B-O O
. B-O O

This B-O O
study B-O O
supports B-O O
previous B-O O
clinical B-O O
observations B-O O
that B-O O
patients B-O O
may B-O O
require B-O O
morning B-O O
through B-O O
evening B-O O
exposure B-O O
to B-O O
MP B-O O
to B-O O
optimize B-O O
efficacy B-O O
while B-O O
adrenal B-O O
suppression B-O O
is B-O O
being B-O O
minimized B-O O
. B-O O

1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D2 B-O O
production B-O O
by B-O O
T B-O B-cell_type
lymphocytes B-O I-cell_type
and B-O O
alveolar B-O B-cell_type
macrophages B-O I-cell_type
recovered B-O O
by B-O O
lavage B-O O
from B-O O
normocalcemic B-O O
patients B-O O
with B-O O
tuberculosis B-O O
. B-O O

To B-O O
compare B-O O
extra-renal B-O O
1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
production B-O O
in B-O O
different B-O O
types B-O O
of B-O O
granulomatous B-O O
disease B-O O
, B-O O
and B-O O
to B-O O
identify B-O O
the B-O O
cell B-O O
types B-O O
responsible B-O O
, B-O O
we B-O O
have B-O O
evaluated B-O O
the B-O O
conversion B-O O
of B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
D3 B-O O
in B-O O
1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
by B-O O
uncultured B-O B-cell_type
cells B-O I-cell_type
recovered B-O O
by B-O O
bronchoalveolar B-O O
lavage B-O O
and B-O O
blood B-O B-cell_type
mononuclear B-O I-cell_type
cells B-O I-cell_type
from B-O O
normocalcemic B-O O
patients B-O O
with B-O O
sarcoidosis B-O O
and B-O O
tuberculosis B-O O
. B-O O

1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
was B-O O
produced B-O O
both B-O O
by B-O O
lavage B-O B-cell_type
cells B-O I-cell_type
( B-O O
12/12 B-O O
tuberculosis B-O O
patients B-O O
, B-O O
2/6 B-O O
sarcoidosis B-O O
patients B-O O
) B-O O
and B-O O
blood B-O B-cell_type
mononuclear B-O I-cell_type
cells B-O I-cell_type
( B-O O
3/5 B-O O
tuberculosis B-O O
patients B-O O
, B-O O
0/3 B-O O
sarcoidosis B-O O
patients B-O O
) B-O O
from B-O O
patients B-O O
but B-O O
not B-O O
controls B-O O
, B-O O
but B-O O
significantly B-O O
greater B-O O
amounts B-O O
were B-O O
produced B-O O
by B-O O
lavage B-O B-cell_type
cells B-O I-cell_type
from B-O O
tuberculosis B-O O
patients B-O O
than B-O O
those B-O O
of B-O O
sarcoidosis B-O O
patients B-O O
( B-O O
P B-O O
less B-O O
than B-O O
0.001 B-O O
) B-O O
. B-O O

1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
production B-O O
by B-O O
lavage B-O B-cell_type
cells B-O I-cell_type
from B-O O
tuberculosis B-O O
patients B-O O
correlated B-O O
with B-O O
the B-O O
number B-O O
of B-O O
CD8+ B-O B-cell_type
T B-O I-cell_type
lymphocytes B-O I-cell_type
present B-O O
but B-O O
not B-O O
other B-O O
cell B-O O
types B-O O
. B-O O

T B-O B-cell_type
lymphocytes B-O I-cell_type
appeared B-O O
to B-O O
be B-O O
an B-O O
important B-O O
source B-O O
of B-O O
1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
production B-O O
, B-O O
since B-O O
purified B-O O
T B-O B-cell_type
lymphocytes B-O I-cell_type
from B-O O
all B-O O
patients B-O O
with B-O O
tuberculosis B-O O
produced B-O O
1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
, B-O O
and B-O O
1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
production B-O O
by B-O O
these B-O O
cells B-O O
correlated B-O O
closely B-O O
with B-O O
that B-O O
produced B-O O
by B-O O
unseparated B-O B-cell_type
lavage B-O I-cell_type
cells B-O I-cell_type
. B-O O

Because B-O O
1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
can B-O O
improve B-O O
the B-O O
capacity B-O O
of B-O O
macrophages B-O B-cell_type
to B-O O
kill B-O O
mycobacteria B-O O
, B-O O
our B-O O
results B-O O
support B-O O
the B-O O
conclusion B-O O
that B-O O
macrophage-lymphocyte B-O O
interactions B-O O
, B-O O
mediated B-O O
at B-O O
least B-O O
in B-O O
part B-O O
by B-O O
1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
, B-O O
may B-O O
be B-O O
an B-O O
important B-O O
component B-O O
of B-O O
a B-O O
successful B-O O
antituberculous B-O O
immune B-O O
response B-O O
. B-O O

Megakaryocytic B-O O
and B-O O
erythrocytic B-O B-cell_type
lineages B-O I-cell_type
share B-O O
specific B-O O
transcription B-O B-protein
factors B-O I-protein
. B-O O

Erythroid-specific B-O B-DNA
genes B-O I-DNA
contain B-O O
binding B-O B-DNA
sites B-O I-DNA
for B-O O
NF-E1 B-O B-protein
( B-O O
also B-O O
called B-O O
GF-1 B-O B-protein
and B-O O
Eryf-1 B-O B-protein
; B-O O
refs B-O O
1-3 B-O O
respectively B-O O
) B-O O
, B-O O
the B-O O
principal B-O O
DNA-binding B-O B-protein
protein B-O I-protein
of B-O O
the B-O O
erythrocytic B-O B-cell_type
lineage B-O I-cell_type
. B-O O

NF-E1 B-O B-protein
expression B-O O
seems B-O O
to B-O O
be B-O O
restricted B-O O
to B-O O
the B-O O
erythrocytic B-O B-cell_type
lineage B-O I-cell_type
. B-O O

A B-O O
closely B-O O
related B-O O
( B-O O
if B-O O
not B-O O
identical B-O O
) B-O O
protein B-O O
is B-O O
found B-O O
in B-O O
both B-O O
a B-O O
human B-O B-cell_line
megakaryocytic B-O I-cell_line
cell B-O I-cell_line
line B-O I-cell_line
and B-O O
purified B-O B-cell_type
human B-O I-cell_type
megakaryocytes B-O I-cell_type
; B-O O
it B-O O
binds B-O O
to B-O O
promoter B-O B-DNA
regions B-O I-DNA
of B-O O
two B-O O
megakaryocytic-specific B-O B-DNA
genes B-O I-DNA
. B-O O

The B-O O
binding B-O B-DNA
sites B-O I-DNA
and B-O O
partial B-O O
proteolysis B-O O
profile B-O O
of B-O O
this B-O O
protein B-O O
are B-O O
indistinguishable B-O O
from B-O O
those B-O O
of B-O O
the B-O O
erythroid B-O B-protein
protein B-O I-protein
; B-O O
also B-O O
, B-O O
NF-E1 B-O B-RNA
messenger B-O I-RNA
RNA B-O I-RNA
is B-O O
the B-O O
same B-O O
size B-O O
in B-O O
both B-O O
the B-O O
megakaryocytic B-O B-cell_line
and B-O I-cell_line
erythroid B-O I-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
. B-O O

Furthermore B-O O
, B-O O
point B-O O
mutations B-O O
that B-O O
abolish B-O O
binding B-O O
of B-O O
NF-E1 B-O B-protein
result B-O O
in B-O O
a B-O O
70 B-O O
% B-O O
decrease B-O O
in B-O O
the B-O O
transcriptional B-O O
activity B-O O
of B-O O
a B-O O
megakaryocytic-specific B-O B-DNA
promoter B-O I-DNA
. B-O O

We B-O O
also B-O O
find B-O O
that B-O O
NF-E2 B-O B-protein
, B-O O
another B-O O
trans-acting B-O B-protein
factor B-O I-protein
of B-O O
the B-O O
erythrocytic B-O B-cell_type
lineage B-O I-cell_type
, B-O O
is B-O O
present B-O O
in B-O O
megakaryocytes B-O B-cell_type
. B-O O

Transcriptional B-O O
effects B-O O
in B-O O
both B-O O
lineages B-O O
might B-O O
then B-O O
be B-O O
mediated B-O O
in B-O O
part B-O O
by B-O O
the B-O O
same B-O O
specific B-O O
trans-acting B-O B-protein
factors B-O I-protein
. B-O O

Our B-O O
data B-O O
strengthen B-O O
the B-O O
idea B-O O
of B-O O
a B-O O
close B-O O
association B-O O
between B-O O
the B-O O
erythrocytic B-O O
and B-O O
the B-O O
megakaryocytic B-O B-cell_type
lineages B-O I-cell_type
and B-O O
could B-O O
also B-O O
explain B-O O
the B-O O
expression B-O O
of B-O O
markers B-O O
specific B-O O
to B-O O
the B-O O
erythrocytic B-O B-cell_type
and B-O I-cell_type
megakaryocytic B-O I-cell_type
lineages B-O I-cell_type
in B-O O
most B-O O
erythroblastic B-O B-cell_line
and B-O I-cell_line
megakaryoblastic B-O I-cell_line
permanent B-O I-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
. B-O O

Transcriptional B-O O
down-regulation B-O O
of B-O O
c-myc B-O B-DNA
expression B-O O
by B-O O
protein B-O O
synthesis B-O O
-dependent B-O O
and B-O O
-independent B-O O
pathways B-O O
in B-O O
a B-O O
human B-O B-cell_line
T B-O I-cell_line
lymphoblastic B-O I-cell_line
tumor B-O I-cell_line
cell B-O I-cell_line
line B-O I-cell_line
. B-O O

We B-O O
show B-O O
that B-O O
in B-O O
the B-O O
human B-O B-cell_line
T B-O I-cell_line
lymphoblastic B-O I-cell_line
tumor B-O I-cell_line
cell B-O I-cell_line
line B-O I-cell_line
Molt4 B-O B-RNA
c-myc B-O I-RNA
mRNA B-O I-RNA
and B-O O
protein B-O O
expression B-O O
is B-O O
down-regulated B-O O
after B-O O
exposure B-O O
to B-O O
dimethyl B-O O
sulfoxide B-O O
, B-O O
to B-O O
phorbol B-O O
myristate B-O O
acetate B-O O
, B-O O
or B-O O
to B-O O
the B-O O
calcium B-O O
ionophore B-O O
A23187 B-O O
, B-O O
which B-O O
raises B-O O
the B-O O
intracellular B-O O
calcium B-O O
concentration B-O O
. B-O O

A B-O O
block B-O O
to B-O O
RNA B-O O
elongation B-O O
is B-O O
largely B-O O
responsible B-O O
for B-O O
decreased B-O O
c-myc B-O B-DNA
transcription B-O O
. B-O O

Although B-O O
negative B-O O
regulation B-O O
by B-O O
dimethyl B-O O
sulfoxide B-O O
takes B-O O
place B-O O
even B-O O
when B-O O
protein B-O O
synthesis B-O O
is B-O O
inhibited B-O O
by B-O O
cycloheximide B-O O
, B-O O
the B-O O
phorbol B-O O
myristate B-O O
acetate B-O O
effect B-O O
is B-O O
blocked B-O O
to B-O O
some B-O O
extent B-O O
only B-O O
by B-O O
cycloheximide B-O O
. B-O O

The B-O O
calcium B-O O
ionophore-induced B-O O
c-myc B-O B-DNA
suppression B-O O
, B-O O
however B-O O
, B-O O
strictly B-O O
requires B-O O
de B-O O
novo B-O O
protein B-O O
synthesis B-O O
. B-O O

Therefore B-O O
, B-O O
two B-O O
different B-O O
negative B-O O
regulatory B-O O
pathways B-O O
are B-O O
involved B-O O
in B-O O
c-myc B-O B-DNA
regulation B-O O
: B-O O
one B-O O
which B-O O
is B-O O
independent B-O O
and B-O O
one B-O O
which B-O O
depends B-O O
on B-O O
de B-O O
novo B-O O
protein B-O O
synthesis B-O O
. B-O O

The B-O O
latter B-O O
one B-O O
appears B-O O
to B-O O
be B-O O
mediated B-O O
by B-O O
a B-O O
rapidly B-O O
calcium B-O O
-dependent B-O O
induced B-O O
gene B-O O
product B-O O
. B-O O

Oestrogen B-O B-protein
receptor B-O I-protein
( B-O O
ER B-O B-protein
) B-O O
analysis B-O O
in B-O O
B-cell B-O O
chronic B-O O
lymphocytic B-O O
leukemia B-O O
: B-O O
correlation B-O O
of B-O O
biochemical B-O O
and B-O O
immunocytochemical B-O O
methods B-O O
. B-O O

Oestrogen B-O B-protein
receptors B-O I-protein
( B-O O
ER B-O B-protein
) B-O O
are B-O O
present B-O O
in B-O O
neoplastic B-O B-cell_type
lymphoid B-O I-cell_type
cells B-O I-cell_type
and B-O O
have B-O O
been B-O O
considered B-O O
a B-O O
physiological B-O O
marker B-O O
of B-O O
growth B-O O
rate B-O O
or B-O O
differentiation B-O O
. B-O O

Tamoxifen B-O O
, B-O O
an B-O O
oestrogen B-O O
antagonist B-O O
, B-O O
has B-O O
been B-O O
given B-O O
in B-O O
some B-O O
patients B-O O
with B-O O
CLL B-O O
and B-O O
Hodgkin B-O O
's B-O O
disease B-O O
, B-O O
with B-O O
dramatic B-O O
response B-O O
in B-O O
single B-O O
cases B-O O
. B-O O

Until B-O O
now B-O O
, B-O O
ER B-O B-protein
status B-O O
has B-O O
been B-O O
assessed B-O O
using B-O O
a B-O O
steroid B-O O
binding B-O O
assay B-O O
( B-O O
SBA B-O O
) B-O O
which B-O O
has B-O O
many B-O O
inherent B-O O
problems B-O O
. B-O O

Recently B-O O
, B-O O
the B-O O
development B-O O
of B-O O
monoclonal B-O B-protein
antibodies B-O I-protein
directed B-O O
against B-O O
ER B-O B-protein
has B-O O
been B-O O
applied B-O O
to B-O O
the B-O O
study B-O O
of B-O O
breast B-O O
carcinomas B-O O
and B-O O
results B-O O
obtained B-O O
show B-O O
good B-O O
correlation B-O O
with B-O O
the B-O O
quantitative B-O O
SBA B-O O
. B-O O

We B-O O
studied B-O O
49 B-O O
cases B-O O
of B-O O
B-cell B-O O
chronic B-O O
lymphocytic B-O O
leukemia B-O O
( B-O O
CLL B-O O
) B-O O
using B-O O
immunostaining B-O O
of B-O O
cytospin B-O O
preparations B-O O
. B-O O

In B-O O
30 B-O O
of B-O O
these B-O O
cases B-O O
ER B-O B-protein
enzyme B-O O
immunoassay B-O O
( B-O O
ER B-O B-protein
-EIA B-O O
) B-O O
was B-O O
also B-O O
performed B-O O
. B-O O

Cultured B-O B-cell_line
MCF-7 B-O I-cell_line
cells B-O I-cell_line
, B-O O
derived B-O O
from B-O O
a B-O O
pleural B-O O
effusion B-O O
of B-O O
a B-O O
breast B-O O
cancer B-O O
patient B-O O
, B-O O
known B-O O
to B-O O
contain B-O O
high B-O O
levels B-O O
of B-O O
ER B-O B-protein
were B-O O
used B-O O
as B-O O
a B-O O
positive B-O O
control B-O O
( B-O O
40-48 B-O O
% B-O O
ER B-O B-cell_type
positive B-O I-cell_type
cells B-O I-cell_type
by B-O O
immunocytochemistry B-O B-protein
; B-O I-protein
200 B-O I-protein
fmol/mg B-O I-protein
protein B-O I-protein
by B-O O
EIA B-O O
) B-O O
. B-O O

All B-O O
of B-O O
the B-O O
CLL B-O O
cases B-O O
except B-O O
two B-O O
( B-O O
96 B-O O
% B-O O
) B-O O
were B-O O
negative B-O O
for B-O O
ER B-O B-protein
( B-O O
less B-O O
than B-O O
1 B-O O
% B-O O
staining B-O O
; B-O O
less B-O O
than B-O O
4 B-O O
fmol/mg B-O O
protein B-O O
) B-O O
. B-O O

The B-O O
two B-O O
positive B-O O
cases B-O O
expressed B-O O
granular B-O O
ER B-O B-protein
staining B-O O
over B-O O
the B-O O
nucleus B-O O
( B-O O
9.2 B-O O
and B-O O
12.1 B-O O
% B-O O
positive B-O O
cells B-O O
) B-O O
and B-O O
were B-O O
positive B-O O
by B-O O
EIA B-O O
and B-O O
SBA B-O O
. B-O O

It B-O O
is B-O O
concluded B-O O
that B-O O
( B-O O
i B-O O
) B-O O
patients B-O O
with B-O O
CLL B-O O
rarely B-O O
express B-O O
ER B-O B-protein
and B-O O
( B-O O
ii B-O O
) B-O O
immunocytochemical B-O O
staining B-O O
of B-O O
cytospin B-O O
preparations B-O O
is B-O O
a B-O O
valid B-O O
technique B-O O
for B-O O
the B-O O
measurement B-O O
of B-O O
ER B-O B-protein
. B-O O

It B-O O
is B-O O
of B-O O
interest B-O O
that B-O O
one B-O O
of B-O O
the B-O O
positive B-O O
cases B-O O
was B-O O
diagnosed B-O O
as B-O O
CLL B-O O
with B-O O
Richter B-O O
's B-O O
transformation B-O O
confirming B-O O
earlier B-O O
findings B-O O
. B-O O

Type-II B-O B-protein
estrogen B-O I-protein
binding B-O I-protein
sites B-O I-protein
in B-O O
a B-O O
lymphoblastoid B-O B-cell_line
cell B-O I-cell_line
line B-O I-cell_line
and B-O O
growth-inhibitory B-O O
effect B-O O
of B-O O
estrogen B-O O
, B-O O
anti-estrogen B-O O
and B-O O
bioflavonoids B-O O
. B-O O

Type-II B-O B-protein
estrogen B-O I-protein
-binding B-O I-protein
sites B-O I-protein
( B-O O
type-II B-O B-protein
EBS B-O I-protein
) B-O O
have B-O O
been B-O O
demonstrated B-O O
in B-O O
the B-O O
human B-O B-cell_line
lymphoblastoid B-O I-cell_line
cell B-O I-cell_line
line B-O I-cell_line
IM-9 B-O B-cell_line
using B-O O
a B-O O
whole-cell B-O O
assay B-O O
with B-O O
( B-O O
6 B-O O
, B-O O
7-3H B-O O
) B-O O
estradiol B-O O
( B-O O
3H-E2 B-O O
) B-O O
as B-O O
tracer B-O O
. B-O O

Competition B-O O
analysis B-O O
showed B-O O
that B-O O
the B-O O
anti-estrogen B-O O
tamoxifen B-O O
and B-O O
the B-O O
flavonoids B-O O
quercetin B-O O
and B-O O
rutin B-O O
competed B-O O
for B-O O
( B-O O
3H B-O O
) B-O O
-E2 B-O O
binding B-O O
to B-O O
type-II B-O B-protein
EBS B-O I-protein
. B-O O

Growth B-O O
experiments B-O O
demonstrated B-O O
that B-O O
diethylstilbestrol B-O O
( B-O O
DES B-O O
) B-O O
tamoxifen B-O O
( B-O O
TAM B-O O
) B-O O
, B-O O
quercetin B-O O
and B-O O
rutin B-O O
exerted B-O O
a B-O O
reversible B-O O
dose-dependent B-O O
inhibition B-O O
of B-O O
cell B-O O
proliferation B-O O
in B-O O
the B-O O
range B-O O
of B-O O
concentrations B-O O
between B-O O
10 B-O O
nM B-O O
and B-O O
10 B-O O
microM B-O O
. B-O O

The B-O O
relative B-O O
binding B-O O
affinity B-O O
of B-O O
quercetin B-O O
, B-O O
rutin B-O O
, B-O O
DES B-O O
and B-O O
TAM B-O O
for B-O O
type-II B-O B-protein
EBS B-O I-protein
correlated B-O O
well B-O O
with B-O O
their B-O O
potency B-O O
as B-O O
cell B-O O
growth B-O O
inhibitors B-O O
. B-O O

Moreover B-O O
, B-O O
hesperidin B-O O
, B-O O
a B-O O
flavonoid B-O O
which B-O O
does B-O O
not B-O O
bind B-O O
to B-O O
type-II B-O B-protein
EBS B-O I-protein
, B-O O
was B-O O
ineffective B-O O
in B-O O
inhibiting B-O O
cell B-O O
growth B-O O
. B-O O

Cell-cycle B-O O
analysis B-O O
showed B-O O
that B-O O
the B-O O
growth-inhibitory B-O O
effect B-O O
of B-O O
DES B-O O
, B-O O
TAM B-O O
or B-O O
quercetin B-O O
was B-O O
due B-O O
to B-O O
a B-O O
blocking B-O O
effect B-O O
in B-O O
the B-O O
G0-G1 B-O O
phases B-O O
. B-O O

Our B-O O
results B-O O
suggest B-O O
that B-O O
high B-O O
estrogen B-O O
and B-O O
anti-estrogen B-O O
concentrations B-O O
and B-O O
flavonoids B-O O
may B-O O
regulate B-O O
IM-9 B-O O
cell B-O O
growth B-O O
through B-O O
a B-O O
common B-O O
mechanism B-O O
involving B-O O
a B-O O
binding B-O O
interaction B-O O
with B-O O
type-II B-O B-protein
EBS B-O I-protein
. B-O O

[ B-O O
Glucocorticoid B-O B-protein
receptors B-O I-protein
in B-O O
peripheral B-O B-cell_type
blood B-O I-cell_type
lymphocytes B-O I-cell_type
of B-O O
patients B-O O
with B-O O
bronchial B-O O
asthma B-O O
] B-O O

Quantitation B-O O
of B-O O
glucocorticoid B-O B-protein
receptors B-O I-protein
( B-O O
GCR B-O B-protein
) B-O O
and B-O O
the B-O O
study B-O O
of B-O O
their B-O O
affinity B-O O
for B-O O
glucocorticosteroids B-O O
( B-O O
GCS B-O O
) B-O O
were B-O O
made B-O O
in B-O O
peripheral B-O B-cell_type
blood B-O I-cell_type
lymphocytes B-O I-cell_type
of B-O O
bronchial B-O O
asthma B-O O
( B-O O
BA B-O O
) B-O O
patients B-O O
in B-O O
consideration B-O O
of B-O O
GCR B-O B-protein
treatment B-O O
and B-O O
serum B-O O
levels B-O O
of B-O O
endogenous B-O O
cortisol B-O O
. B-O O

It B-O O
is B-O O
stated B-O O
that B-O O
GCR B-O B-protein
of B-O O
healthy B-O O
controls B-O O
and B-O O
GCS B-O O
-untreated B-O O
patients B-O O
outnumbered B-O O
those B-O O
of B-O O
cortisol-dependent B-O O
BA B-O O
patients B-O O
on B-O O
hormone B-O O
therapy B-O O
. B-O O

Following B-O O
discontinuation B-O O
of B-O O
glucocorticoid B-O O
drugs B-O O
GCR B-O B-protein
count B-O O
in B-O O
cortisol B-O O
-dependent B-O O
BA B-O O
tends B-O O
to B-O O
rise B-O O
. B-O O

Endogenous B-O O
cortisol B-O O
has B-O O
no B-O O
effect B-O O
on B-O O
GCR B-O B-protein
level B-O O
estimated B-O O
by B-O O
3H-triamcinolone B-O O
acetonide B-O O
. B-O O

Two B-O O
glucocorticoid B-O B-protein
binding B-O I-protein
sites B-O I-protein
on B-O O
the B-O O
human B-O B-protein
glucocorticoid B-O I-protein
receptor B-O I-protein
. B-O O

Glucocorticoids B-O O
are B-O O
known B-O O
to B-O O
have B-O O
a B-O O
lytic B-O O
effect B-O O
in B-O O
leukemic B-O B-cell_type
cells B-O I-cell_type
via B-O O
interactions B-O O
with B-O O
the B-O O
glucocorticoid B-O B-protein
receptor B-O I-protein
( B-O O
GR B-O B-protein
) B-O O
. B-O O

Cortisol B-O O
and B-O O
various B-O O
synthetic B-O O
glucocorticoids B-O O
bind B-O O
to B-O O
the B-O O
GR B-O B-protein
with B-O O
one-site B-O O
kinetics B-O O
. B-O O

Cortivazol B-O O
( B-O O
CVZ B-O O
) B-O O
is B-O O
a B-O O
unique B-O O
, B-O O
high B-O O
potency B-O O
synthetic B-O O
glucocorticoid B-O O
, B-O O
which B-O O
has B-O O
a B-O O
phenylpyrazol B-O O
fused B-O O
to B-O O
the B-O O
A-ring B-O O
of B-O O
the B-O O
steroid B-O O
nucleus B-O O
and B-O O
displays B-O O
binding B-O O
consistent B-O O
with B-O O
two B-O O
or B-O O
more B-O O
sites B-O O
in B-O O
the B-O O
cytosol B-O O
from B-O O
CEM B-O B-cell_line
C7 B-O I-cell_line
cells B-O I-cell_line
( B-O O
a B-O O
human B-O B-cell_line
acute B-O I-cell_line
lymphoblastic B-O I-cell_line
T-cell B-O I-cell_line
line B-O I-cell_line
) B-O O
. B-O O

It B-O O
has B-O O
previously B-O O
been B-O O
shown B-O O
that B-O O
the B-O O
lower B-O O
affinity B-O O
class B-O O
of B-O O
sites B-O O
are B-O O
similar B-O O
in B-O O
affinity B-O O
and B-O O
site B-O O
molarity B-O O
to B-O O
those B-O O
recognized B-O O
by B-O O
dexamethasone B-O O
. B-O O

The B-O O
higher B-O B-DNA
affinity B-O I-DNA
sites B-O I-DNA
bind B-O O
CVZ B-O O
with B-O O
20- B-O O
to B-O O
50-fold B-O O
greater B-O O
affinity B-O O
, B-O O
consistent B-O O
with B-O O
CVZ B-O O
's B-O O
enhanced B-O O
biological B-O O
effects B-O O
. B-O O

In B-O O
mutant B-O B-cell_type
leukemic B-O I-cell_type
cells B-O I-cell_type
resistant B-O O
to B-O O
the B-O O
lytic B-O O
effects B-O O
of B-O O
dexamethasone B-O O
, B-O O
CVZ B-O O
both B-O O
lyses B-O O
the B-O O
cells B-O O
and B-O O
recognizes B-O O
a B-O O
single B-O O
class B-O O
of B-O O
sites B-O O
similar B-O O
to B-O O
the B-O O
high B-O B-DNA
affinity B-O I-DNA
site B-O I-DNA
in B-O O
CEM B-O B-cell_line
C7 B-O I-cell_line
cells B-O I-cell_line
. B-O O

We B-O O
have B-O O
carried B-O O
out B-O O
experiments B-O O
to B-O O
define B-O O
the B-O O
nature B-O O
of B-O O
the B-O O
higher B-O B-DNA
affinity B-O I-DNA
CVZ B-O I-DNA
binding B-O I-DNA
site B-O I-DNA
. B-O O

We B-O O
now B-O O
show B-O O
that B-O O
: B-O O
1 B-O O
) B-O O
CVZ B-O O
has B-O O
more B-O O
than B-O O
one B-O O
binding B-O B-DNA
site B-O I-DNA
in B-O O
a B-O O
second B-O O
, B-O O
independent B-O O
, B-O O
B-cell B-O B-cell_line
line B-O I-cell_line
, B-O O
IM-9 B-O B-cell_line
; B-O O
2 B-O O
) B-O O
the B-O O
antiglucocorticoid B-O O
RU B-O O
38486 B-O O
is B-O O
able B-O O
to B-O O
block B-O O
both B-O O
CVZ B-O O
's B-O O
higher B-O O
and B-O O
lower B-O O
affinity B-O O
sites B-O O
; B-O O
3 B-O O
) B-O O
all B-O O
of B-O O
CVZ B-O B-DNA
's B-O I-DNA
binding B-O I-DNA
sites B-O I-DNA
are B-O O
on B-O O
a B-O O
protein B-O O
immunologically B-O O
indistinguishable B-O O
from B-O O
the B-O O
human B-O O
GR B-O B-protein
; B-O O
and B-O O
4 B-O O
) B-O O
freshly B-O O
isolated B-O O
clones B-O O
of B-O O
CVZ B-O B-cell_line
-resistant B-O I-cell_line
cells B-O I-cell_line
have B-O O
lost B-O O
all B-O O
binding B-O B-DNA
sites B-O I-DNA
for B-O O
CVZ B-O O
. B-O O

These B-O O
data B-O O
indicate B-O O
that B-O O
CVZ B-O B-protein
is B-O O
recognizing B-O O
two B-O O
glucocorticoid B-O B-protein
binding B-O I-protein
sites B-O I-protein
on B-O O
the B-O O
human B-O O
GR B-O B-protein
or B-O O
a B-O O
protein B-O O
very B-O O
similar B-O O
to B-O O
it B-O O
. B-O O

Retroviral B-O O
mediated B-O O
transfer B-O O
and B-O O
expression B-O O
of B-O O
exogenous B-O B-DNA
genes B-O I-DNA
in B-O O
primary B-O B-cell_type
lymphoid B-O I-cell_type
cells B-O I-cell_type
: B-O O
assaying B-O O
for B-O O
a B-O O
viral B-O B-protein
transactivator B-O I-protein
activity B-O O
in B-O O
normal B-O B-cell_type
and B-O I-cell_type
malignant B-O I-cell_type
cells B-O I-cell_type
. B-O O

In B-O O
this B-O O
report B-O O
we B-O O
describe B-O O
the B-O O
use B-O O
of B-O O
recombinant B-O O
retroviruses B-O O
to B-O O
characterize B-O O
the B-O O
activity B-O O
of B-O O
an B-O O
exogenous B-O B-DNA
promoter B-O I-DNA
in B-O O
primary B-O B-cell_type
cells B-O I-cell_type
obtained B-O O
from B-O O
patients B-O O
with B-O O
lymphoproliferative B-O O
disorders B-O O
. B-O O

The B-O O
infection B-O O
of B-O O
a B-O O
variety B-O O
of B-O O
cultured B-O O
and B-O O
primary B-O B-cell_type
lymphoid B-O I-cell_type
cells B-O I-cell_type
with B-O O
a B-O O
recombinant B-O O
retrovirus B-O O
containing B-O O
a B-O O
histone B-O B-DNA
promoter-driven B-O I-DNA
beta-galactosidase B-O I-DNA
gene B-O I-DNA
is B-O O
shown B-O O
to B-O O
result B-O O
in B-O O
the B-O O
expression B-O O
of B-O O
beta-galactosidase B-O B-protein
in B-O O
50 B-O O
% B-O O
to B-O O
100 B-O O
% B-O O
of B-O O
the B-O O
cells B-O O
. B-O O

A B-O O
similar B-O O
infection B-O O
with B-O O
a B-O O
recombinant B-O O
retrovirus B-O O
containing B-O O
the B-O O
beta-galactosidase B-O B-DNA
gene B-O I-DNA
with B-O O
an B-O O
adenovirus B-O B-DNA
E2 B-O I-DNA
promoter B-O I-DNA
, B-O O
results B-O O
in B-O O
beta-galactosidase B-O B-protein
activity B-O O
in B-O O
a B-O O
limited B-O O
number B-O O
of B-O O
cultured B-O O
and B-O O
primary B-O B-cell_type
cells B-O I-cell_type
. B-O O

Since B-O O
the B-O O
adenovirus B-O B-DNA
E2 B-O I-DNA
promoter B-O I-DNA
has B-O O
been B-O O
well B-O O
characterized B-O O
and B-O O
is B-O O
known B-O O
to B-O O
be B-O O
regulated B-O O
by B-O O
transactivators B-O B-protein
encoded B-O O
by B-O O
many B-O O
viruses B-O O
, B-O O
the B-O O
activity B-O O
of B-O O
this B-O O
promoter B-O B-DNA
in B-O O
specific B-O O
cell B-O O
types B-O O
is B-O O
discussed B-O O
in B-O O
reference B-O O
to B-O O
both B-O O
the B-O O
biology B-O O
of B-O O
the B-O O
cell B-O O
and B-O O
the B-O O
possible B-O O
presence B-O O
of B-O O
as B-O O
yet B-O O
undetected B-O O
viral B-O B-protein
gene B-O I-protein
products B-O I-protein
. B-O O

[ B-O O
The B-O O
effect B-O O
of B-O O
24 B-O O
, B-O O
25-dihydroxyvitamin B-O O
D3 B-O O
( B-O O
dioxyvit B-O O
) B-O O
on B-O O
Ca B-O O
metabolism B-O O
and B-O O
immune B-O O
status B-O O
during B-O O
chronic B-O O
kidney B-O O
failure B-O O
] B-O O

Active B-O O
metabolite B-O O
of B-O O
vitamin B-O O
D3 B-O O
, B-O O
24R B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
( B-O O
dioxyvit B-O O
) B-O O
was B-O O
used B-O O
at B-O O
a B-O O
daily B-O O
dose B-O O
of B-O O
100 B-O O
micrograms B-O O
in B-O O
treatment B-O O
of B-O O
children B-O O
affected B-O O
with B-O O
tubulointerstitial B-O O
disease B-O O
of B-O O
kidney B-O O
and B-O O
with B-O O
chronic B-O O
glomerulonephritis B-O O
under B-O O
conditions B-O O
of B-O O
kidney B-O O
insufficiency B-O O
. B-O O

The B-O O
drug B-O O
exhibited B-O O
distinct B-O O
normalizing B-O O
effect B-O O
on B-O O
patterns B-O O
of B-O O
calcium B-O O
metabolism B-O O
: B-O O
increase B-O O
of B-O O
total B-O O
and B-O O
ionized B-O O
Ca2+ B-O O
and B-O O
of B-O O
25-OHD B-O O
, B-O O
decrease B-O O
in B-O O
concentration B-O O
of B-O O
parath B-O O
hormone B-O O
and B-O O
osteocalcine B-O O
in B-O O
blood B-O O
serum B-O O
as B-O O
well B-O O
as B-O O
on B-O O
immunological B-O O
parameters B-O O
: B-O O
restoration B-O O
of B-O O
decreased B-O O
content B-O O
of B-O O
T- B-O B-cell_type
and B-O I-cell_type
0- B-O I-cell_type
lymphocytes B-O I-cell_type
. B-O O

Concentration B-O O
of B-O O
receptors B-O O
of B-O O
hormonal B-O O
form B-O O
of B-O O
1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
was B-O O
found B-O O
to B-O O
be B-O O
minimal B-O O
in B-O O
lymphocytes B-O B-cell_type
under B-O O
conditions B-O O
of B-O O
chronic B-O O
kidney B-O O
insufficiency B-O O
, B-O O
while B-O O
their B-O O
expression B-O O
, B-O O
after B-O O
the B-O O
dioxyvit B-O O
action B-O O
, B-O O
was B-O O
detected B-O O
only B-O O
in B-O O
patients B-O O
with B-O O
glomerulonephritis B-O O
. B-O O

Specific B-O O
calcitropic B-O O
effect B-O O
of B-O O
dioxyvit B-O O
with B-O O
simultaneous B-O O
correction B-O O
of B-O O
vitamin B-O O
D B-O O
deficiency B-O O
were B-O O
apparently B-O O
responsible B-O O
for B-O O
high B-O O
efficacy B-O O
of B-O O
the B-O O
drug B-O O
in B-O O
treatment B-O O
of B-O O
calcium B-O O
metabolism B-O O
and B-O O
immunity B-O O
impairments B-O O
in B-O O
children B-O O
with B-O O
renal B-O O
deteriorations B-O O
at B-O O
the B-O O
step B-O O
of B-O O
chronic B-O O
kidney B-O O
insufficiency B-O O
. B-O O

[ B-O O
The B-O O
role B-O O
of B-O O
glucocorticoid B-O B-protein
receptors B-O I-protein
and B-O O
HLA B-O B-protein
antigens B-O I-protein
in B-O O
the B-O O
pathogenesis B-O O
of B-O O
Cushing B-O O
's B-O O
syndrome B-O O
] B-O O

Lymphocytic B-O O
levels B-O O
of B-O O
glucocorticoid B-O B-protein
receptors B-O I-protein
were B-O O
evaluated B-O O
in B-O O
114 B-O O
patients B-O O
suffering B-O O
from B-O O
Icenko- B-O O
Cushing B-O O
's B-O O
syndrome B-O O
. B-O O

Incidence B-O O
of B-O O
HLA B-O B-protein
antigens B-O I-protein
was B-O O
determined B-O O
in B-O O
94 B-O O
of B-O O
them B-O O
. B-O O

A B-O O
significant B-O O
rise B-O O
of B-O O
A10 B-O B-protein
and B-O O
B27 B-O B-protein
antigen B-O I-protein
incidence B-O O
compared B-O O
to B-O O
that B-O O
in B-O O
normal B-O O
subjects B-O O
allows B-O O
these B-O O
antigens B-O O
to B-O O
be B-O O
considered B-O O
genetic B-O O
markers B-O O
of B-O O
Icenko- B-O O
Cushing B-O O
's B-O O
syndrome B-O O
. B-O O

The B-O O
levels B-O O
of B-O O
glucocorticoid B-O B-protein
receptors B-O I-protein
in B-O O
lymphocytes B-O B-cell_type
of B-O O
the B-O O
patients B-O O
are B-O O
lower B-O O
than B-O O
in B-O O
normal B-O O
subjects B-O O
both B-O O
in B-O O
the B-O O
active B-O O
stage B-O O
of B-O O
the B-O O
disease B-O O
and B-O O
following B-O O
bilateral B-O O
total B-O O
adrenalectomy B-O O
. B-O O

The B-O O
patients B-O O
carrying B-O O
B27 B-O B-protein
antigen B-O I-protein
had B-O O
lymphocytic B-O O
receptor B-O O
concentrations B-O O
under B-O O
the B-O O
levels B-O O
of B-O O
such B-O O
in B-O O
patients B-O O
free B-O O
of B-O O
the B-O O
antigen B-O O
carriage B-O O
. B-O O

Antigen B-O B-protein
B27 B-O I-protein
seems B-O O
to B-O O
be B-O O
a B-O O
cause B-O O
of B-O O
lower B-O O
levels B-O O
of B-O O
glucocorticoid B-O B-protein
receptors B-O I-protein
in B-O O
blood B-O B-cell_type
lymphocytes B-O I-cell_type
. B-O O

Effects B-O O
of B-O O
1 B-O O
alpha B-O O
, B-O O
25-dihydroxyvitamin B-O O
D3 B-O O
on B-O O
the B-O O
human B-O B-cell_line
chronic B-O I-cell_line
myelogenous B-O I-cell_line
leukemia B-O I-cell_line
cell B-O I-cell_line
line B-O I-cell_line
RWLeu-4 B-O B-cell_line
. B-O O

The B-O O
effects B-O O
of B-O O
1 B-O O
alpha B-O O
, B-O O
25-dihydroxyvitamin B-O O
D3 B-O O
( B-O O
VD3 B-O O
) B-O O
on B-O O
proliferation B-O O
, B-O O
differentiation B-O O
, B-O O
and B-O O
macromolecular B-O O
synthesis B-O O
in B-O O
the B-O O
new B-O O
Philadelphia B-O B-cell_line
chromosome-positive B-O I-cell_line
chronic B-O I-cell_line
myelogenous B-O I-cell_line
leukemia B-O I-cell_line
cell B-O I-cell_line
line B-O I-cell_line
, B-O O
RWLeu-4 B-O B-cell_line
, B-O O
were B-O O
investigated B-O O
. B-O O

Binding B-O O
of B-O O
[ B-O O
3H B-O O
] B-O O
VD3 B-O O
was B-O O
saturable B-O O
, B-O O
with B-O O
approximately B-O O
2000-3000 B-O O
sites/cell B-O O
, B-O O
and B-O O
half-maximal B-O O
binding B-O O
occurring B-O O
at B-O O
0.21-0.33 B-O O
nM B-O O
. B-O O

Treatment B-O O
of B-O O
RWLeu-4 B-O B-cell_line
cells B-O I-cell_line
with B-O O
VD3 B-O B-protein
induced B-O O
24R-hydroxylase B-O B-protein
activity B-O O
, B-O O
a B-O O
marker B-O O
of B-O O
vitamin B-O O
D3 B-O O
responsiveness B-O O
in B-O O
many B-O O
tissues B-O O
. B-O O

Exposure B-O O
of B-O O
RWLeu-4 B-O B-cell_line
cells B-O I-cell_line
to B-O O
VD3 B-O O
also B-O O
inhibited B-O O
proliferation B-O O
and B-O O
DNA B-O O
synthesis B-O O
with B-O O
a B-O O
50 B-O O
% B-O O
effective B-O O
dose B-O O
of B-O O
3.5-10 B-O O
nM B-O O
within B-O O
72 B-O O
h B-O O
; B-O O
in B-O O
addition B-O O
, B-O O
protein B-O O
and B-O O
RNA B-O O
synthesis B-O O
were B-O O
inhibited B-O O
by B-O O
VD3 B-O O
treatment B-O O
. B-O O

Exposure B-O O
of B-O O
RWLeu-4 B-O B-cell_line
cells B-O I-cell_line
to B-O O
5 B-O O
nM B-O O
VD3 B-O O
for B-O O
72 B-O O
h B-O O
caused B-O O
50 B-O O
% B-O O
of B-O O
the B-O O
cells B-O O
to B-O O
differentiate B-O O
into B-O O
macrophage/monocyte B-O B-cell_type
type B-O I-cell_type
cells B-O I-cell_type
as B-O O
judged B-O O
by B-O O
nitroblue B-O O
tetrazolium B-O O
staining B-O O
and B-O O
adherence B-O O
to B-O O
plastic B-O O
. B-O O

Progressive B-O O
expression B-O O
of B-O O
cell B-O B-protein
surface B-O I-protein
maturation-specific B-O I-protein
antigens B-O I-protein
of B-O O
the B-O O
monocyte/macrophage B-O B-cell_type
lineage B-O I-cell_type
was B-O O
induced B-O O
by B-O O
treatment B-O O
of B-O O
RWLeu-4 B-O B-cell_line
cells B-O I-cell_line
with B-O O
VD3 B-O O
for B-O O
24 B-O O
to B-O O
72 B-O O
h B-O O
at B-O O
doses B-O O
that B-O O
inhibited B-O O
cellular B-O O
proliferation B-O O
. B-O O

c-myc B-O B-RNA
RNA B-O I-RNA
, B-O O
which B-O O
is B-O O
constitutively B-O O
expressed B-O O
in B-O O
RWLeu-4 B-O B-cell_line
cells B-O I-cell_line
, B-O O
increased B-O O
after B-O O
0.5 B-O O
h B-O O
of B-O O
treatment B-O O
with B-O O
50 B-O O
nM B-O O
VD3 B-O O
and B-O O
then B-O O
rapidly B-O O
decreased B-O O
to B-O O
barely B-O O
detectable B-O O
levels B-O O
after B-O O
4 B-O O
h B-O O
of B-O O
treatment B-O O
. B-O O

Finally B-O O
, B-O O
the B-O O
in B-O O
vitro B-O O
tyrosine B-O B-protein
kinase B-O I-protein
activity B-O O
associated B-O O
with B-O O
the B-O O
p210bcr-abl B-O B-protein
oncogene B-O I-protein
product B-O I-protein
was B-O O
decreased B-O O
approximately B-O O
50 B-O O
% B-O O
by B-O O
VD3 B-O O
treatment B-O O
. B-O O

Because B-O O
of B-O O
the B-O O
presence B-O O
of B-O O
a B-O O
functional B-O O
receptor-effector B-O O
system B-O O
for B-O O
VD3 B-O O
and B-O O
multiple B-O O
biological B-O O
responses B-O O
to B-O O
the B-O O
hormone B-O O
, B-O O
these B-O O
cells B-O O
provide B-O O
a B-O O
unique B-O O
model B-O O
system B-O O
with B-O O
which B-O O
to B-O O
probe B-O O
the B-O O
specific B-O O
effects B-O O
of B-O O
VD3 B-O O
on B-O O
cell B-O O
growth B-O O
and B-O O
differentiation B-O O
in B-O O
chronic B-O O
myelogenous B-O O
leukemia B-O O
. B-O O

A B-O O
new B-O O
member B-O O
of B-O O
the B-O O
leucine B-O B-protein
zipper B-O I-protein
class B-O I-protein
of B-O O
proteins B-O O
that B-O O
binds B-O O
to B-O O
the B-O O
HLA B-O B-DNA
DR B-O I-DNA
alpha B-O I-DNA
promoter B-O I-DNA
. B-O O

Several B-O O
mutants B-O O
derived B-O O
from B-O O
transformed B-O B-cell_line
human B-O I-cell_line
B B-O I-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
are B-O O
defective B-O O
in B-O O
expressing B-O O
major B-O B-DNA
histocompatibility B-O I-DNA
complex B-O I-DNA
( B-O I-DNA
MHC B-O I-DNA
) B-O I-DNA
class B-O I-DNA
II B-O I-DNA
genes B-O I-DNA
. B-O O

The B-O O
failure B-O O
to B-O O
express B-O O
a B-O O
class B-O B-DNA
II B-O I-DNA
gene B-O I-DNA
in B-O O
at B-O O
least B-O O
one B-O O
such B-O O
mutant B-O B-cell_line
line B-O I-cell_line
has B-O O
been B-O O
mapped B-O O
to B-O O
the B-O O
MHC B-O B-DNA
class B-O I-DNA
II B-O I-DNA
X B-O I-DNA
box B-O I-DNA
, B-O O
a B-O O
conserved B-O B-DNA
transcriptional B-O I-DNA
element B-O I-DNA
in B-O O
the B-O O
promoter B-O B-DNA
region B-O I-DNA
. B-O O

A B-O O
complementary B-O B-DNA
DNA B-O I-DNA
encoding B-O O
a B-O O
DNA-binding B-O B-protein
protein B-O I-protein
( B-O O
human B-O B-protein
X B-O I-protein
box B-O I-protein
binding B-O I-protein
protein B-O I-protein
, B-O O
hXBP-1 B-O B-protein
) B-O O
whose B-O O
target B-O O
is B-O O
the B-O O
human B-O B-DNA
DR B-O I-DNA
alpha B-O I-DNA
X B-O I-DNA
box B-O I-DNA
and B-O O
the B-O O
3 B-O B-DNA
' B-O I-DNA
flanking B-O I-DNA
region B-O I-DNA
has B-O O
now B-O O
been B-O O
cloned B-O O
. B-O O

This B-O O
complementary B-O B-DNA
DNA B-O I-DNA
encoded B-O O
a B-O O
protein B-O O
with B-O O
structural B-O O
similarities B-O O
to B-O O
the B-O O
c-jun B-O B-protein
proto-oncogene B-O I-protein
product B-O I-protein
, B-O O
and B-O O
its B-O O
target B-O O
sequence B-O O
was B-O O
closely B-O O
related B-O O
to B-O O
the B-O O
palindromic B-O B-DNA
target B-O I-DNA
sequence B-O I-DNA
of B-O O
c-jun B-O B-DNA
. B-O O

Mutation B-O O
of B-O O
the B-O O
hXBP-1 B-O B-DNA
DNA B-O I-DNA
target B-O I-DNA
sequence B-O I-DNA
decreased B-O O
DR B-O B-DNA
alpha B-O I-DNA
promoter B-O I-DNA
activity B-O O
in B-O O
vivo B-O O
. B-O O

These B-O O
studies B-O O
suggest B-O O
that B-O O
the B-O O
hXBP-1 B-O B-protein
protein B-O I-protein
acts B-O O
as B-O O
a B-O O
transcription B-O B-protein
factor B-O I-protein
in B-O O
B B-O B-cell_type
cells B-O I-cell_type
. B-O O

Pseudohypoaldosteronism B-O O
in B-O O
eight B-O O
families B-O O
: B-O O
different B-O O
forms B-O O
of B-O O
inheritance B-O O
are B-O O
evidence B-O O
for B-O O
various B-O O
genetic B-O O
defects B-O O
. B-O O

Pseudohypoaldosteronism B-O O
is B-O O
a B-O O
rare B-O O
hereditary B-O O
disorder B-O O
presenting B-O O
in B-O O
early B-O O
infancy B-O O
with B-O O
renal B-O O
salt B-O O
loss B-O O
leading B-O O
to B-O O
hyponatremia B-O O
and B-O O
hyperkalemia B-O O
despite B-O O
high B-O O
levels B-O O
of B-O O
plasma B-O O
aldosterone B-O O
. B-O O

The B-O O
patients B-O O
are B-O O
insensitive B-O O
to B-O O
mineralocorticoids B-O O
; B-O O
however B-O O
, B-O O
sodium B-O O
supplementation B-O O
is B-O O
able B-O O
to B-O O
correct B-O O
electrolyte B-O O
abnormalities B-O O
. B-O O

Absent B-O O
or B-O O
greatly B-O O
diminished B-O O
type B-O B-protein
I B-O I-protein
aldosterone B-O I-protein
receptors B-O I-protein
in B-O O
peripheral B-O B-cell_type
mononuclear B-O I-cell_type
leucocytes B-O I-cell_type
have B-O O
been B-O O
recently B-O O
demonstrated B-O O
and B-O O
explain B-O O
the B-O O
lack B-O O
of B-O O
response B-O O
to B-O O
mineralocorticoids B-O O
. B-O O

We B-O O
have B-O O
studied B-O O
the B-O O
mode B-O O
of B-O O
inheritance B-O O
in B-O O
eight B-O O
families B-O O
with B-O O
a B-O O
total B-O O
of B-O O
nine B-O O
patients B-O O
. B-O O

There B-O O
was B-O O
evidence B-O O
for B-O O
an B-O O
autosomal B-O O
recessive B-O O
form B-O O
of B-O O
inheritance B-O O
in B-O O
four B-O O
families B-O O
, B-O O
while B-O O
the B-O O
other B-O O
four B-O O
families B-O O
appeared B-O O
to B-O O
have B-O O
an B-O O
autosomal B-O O
dominant B-O O
mode B-O O
of B-O O
transmission B-O O
. B-O O

In B-O O
three B-O O
families B-O O
the B-O O
autosomal B-O O
recessive B-O O
form B-O O
was B-O O
characterized B-O O
by B-O O
normal B-O B-protein
receptor B-O I-protein
as B-O O
well B-O O
as B-O O
hormone B-O O
data B-O O
in B-O O
both B-O O
parents B-O O
, B-O O
while B-O O
in B-O O
one B-O O
family B-O O
receptor B-O O
levels B-O O
in B-O O
both B-O O
parents B-O O
were B-O O
greatly B-O O
reduced B-O O
, B-O O
but B-O O
hormone B-O O
levels B-O O
were B-O O
normal B-O O
. B-O O

In B-O O
the B-O O
four B-O O
families B-O O
with B-O O
an B-O O
autosomal B-O O
dominant B-O O
mode B-O O
of B-O O
transmission B-O O
there B-O O
was B-O O
always B-O O
one B-O O
parent B-O O
with B-O O
reduced B-O O
receptor B-O O
binding B-O O
in B-O O
peripheral B-O B-cell_type
mononuclear B-O I-cell_type
leucocytes B-O I-cell_type
and B-O O
elevated B-O O
serum B-O O
hormone B-O O
levels B-O O
. B-O O

These B-O O
parents B-O O
were B-O O
entirely B-O O
asymptomatic B-O O
. B-O O

In B-O O
an B-O O
extended B-O O
family B-O O
we B-O O
were B-O O
able B-O O
to B-O O
study B-O O
an B-O O
aunt B-O O
and B-O O
her B-O O
newborn B-O O
daughter B-O O
, B-O O
who B-O O
were B-O O
both B-O O
also B-O O
biochemically B-O O
affected B-O O
but B-O O
clinically B-O O
asymptomatic B-O O
. B-O O

It B-O O
, B-O O
therefore B-O O
, B-O O
appears B-O O
that B-O O
this B-O O
dual B-O O
pattern B-O O
of B-O O
genetic B-O O
transmission B-O O
may B-O O
indicate B-O O
differing B-O O
genetic B-O O
defects B-O O
which B-O O
cause B-O O
the B-O O
same B-O O
clinical B-O O
picture B-O O
of B-O O
pseudohypoaldosteronism B-O O
. B-O O

Perceived B-O O
social B-O O
support B-O O
and B-O O
tumor B-O O
estrogen/progesterone B-O B-protein
receptor B-O I-protein
status B-O O
as B-O O
predictors B-O O
of B-O O
natural B-O B-cell_type
killer B-O I-cell_type
cell B-O I-cell_type
activity B-O O
in B-O O
breast B-O O
cancer B-O O
patients B-O O
. B-O O

This B-O O
report B-O O
is B-O O
concerned B-O O
with B-O O
the B-O O
prediction B-O O
of B-O O
natural B-O B-cell_type
killer B-O I-cell_type
( B-O I-cell_type
NK B-O I-cell_type
) B-O I-cell_type
cell B-O I-cell_type
activity B-O O
in B-O O
61 B-O O
Stage B-O O
I B-O O
and B-O O
II B-O O
breast B-O O
cancer B-O O
patients B-O O
, B-O O
between B-O O
the B-O O
ages B-O O
of B-O O
25 B-O O
and B-O O
70 B-O O
, B-O O
who B-O O
were B-O O
accrued B-O O
to B-O O
this B-O O
project B-O O
. B-O O

All B-O O
baseline B-O O
interview B-O O
and B-O O
testing B-O O
data B-O O
were B-O O
obtained B-O O
either B-O O
just B-O O
before B-O O
patients B-O O
were B-O O
discharged B-O O
from B-O O
the B-O O
hospital B-O O
, B-O O
or B-O O
at B-O O
their B-O O
first B-O O
outpatient B-O O
visit B-O O
, B-O O
within B-O O
two B-O O
weeks B-O O
of B-O O
discharge B-O O
. B-O O

A B-O O
major B-O O
interest B-O O
of B-O O
this B-O O
project B-O O
is B-O O
the B-O O
predictive B-O O
value B-O O
of B-O O
perceived B-O O
social B-O O
support B-O O
, B-O O
as B-O O
a B-O O
potential B-O O
`` B-O O
stress B-O O
`` B-O O
buffer B-O O
, B-O O
related B-O O
to B-O O
NK B-O O
activity B-O O
. B-O O

In B-O O
the B-O O
main B-O O
model B-O O
reported B-O O
here B-O O
, B-O O
we B-O O
found B-O O
that B-O O
a B-O O
significant B-O O
amount B-O O
of B-O O
NK B-O O
activity B-O O
variance B-O O
could B-O O
be B-O O
explained B-O O
by B-O O
five B-O O
variables B-O O
. B-O O

Higher B-O O
NK B-O O
activity B-O O
could B-O O
be B-O O
predicted B-O O
by B-O O
the B-O O
perception B-O O
of B-O O
high B-O O
quality B-O O
emotional B-O O
support B-O O
from B-O O
a B-O O
spouse B-O O
or B-O O
intimate B-O O
other B-O O
, B-O O
perceived B-O O
social B-O O
support B-O O
from B-O O
the B-O O
patient B-O O
's B-O O
physician B-O O
, B-O O
estrogen B-O B-protein
receptor B-O I-protein
-negative B-O O
tumor B-O O
status B-O O
, B-O O
having B-O O
an B-O O
excisional B-O O
biopsy B-O O
as B-O O
surgical B-O O
treatment B-O O
, B-O O
and B-O O
actively B-O O
seeking B-O O
social B-O O
support B-O O
as B-O O
a B-O O
major B-O O
coping B-O O
strategy B-O O
( B-O O
R2 B-O O
= B-O O
0.33 B-O O
, B-O O
F B-O O
( B-O O
5 B-O O
, B-O O
55 B-O O
) B-O O
= B-O O
5.5 B-O O
, B-O O
p B-O O
less B-O O
than B-O O
0.0004 B-O O
) B-O O
. B-O O

Findings B-O O
are B-O O
discussed B-O O
in B-O O
terms B-O O
of B-O O
host B-O O
interaction B-O O
with B-O O
tumor B-O O
endocrine B-O O
status B-O O
, B-O O
and B-O O
the B-O O
role B-O O
that B-O O
social B-O O
support B-O O
might B-O O
play B-O O
in B-O O
modulating B-O O
such B-O O
activity B-O O
. B-O O

[ B-O O
Estrogen B-O B-protein
receptor B-O I-protein
content B-O O
of B-O O
peripheral B-O B-cell_type
blood B-O I-cell_type
lymphocytes B-O I-cell_type
in B-O O
patients B-O O
with B-O O
systemic B-O O
lupus B-O O
erythematosus B-O O
] B-O O

ER B-O B-protein
content B-O O
in B-O O
lymphocytes B-O B-cell_type
of B-O O
peripheral B-O O
blood B-O O
from B-O O
27 B-O O
SLE B-O O
patients B-O O
and B-O O
20 B-O O
healthy B-O O
controls B-O O
were B-O O
determined B-O O
by B-O O
dextran-coated B-O O
charcoal B-O O
assay B-O O
. B-O O

ER B-O B-protein
content B-O O
in B-O O
lymphocytes B-O B-cell_type
of B-O O
each B-O O
sample B-O O
was B-O O
expressed B-O O
by B-O O
both B-O O
fmol/mg B-O O
of B-O O
lymphocyte B-O B-protein
cytosolic B-O I-protein
protein B-O I-protein
and B-O O
fmol/micrograms B-O O
of B-O O
lymphocyte B-O B-DNA
DNA B-O I-DNA
. B-O O

The B-O O
results B-O O
showed B-O O
that B-O O
there B-O O
was B-O O
no B-O O
significant B-O O
difference B-O O
between B-O O
the B-O O
ER B-O B-protein
content B-O O
of B-O O
lymphocytes B-O B-cell_type
from B-O O
the B-O O
controls B-O O
and B-O O
that B-O O
from B-O O
patients B-O O
with B-O O
SLE B-O O
. B-O O

But B-O O
the B-O O
logarithmic B-O O
mean B-O O
of B-O O
ER B-O B-protein
content B-O O
in B-O O
lymphocytes B-O B-cell_type
, B-O O
expressed B-O O
by B-O O
fmol/mg B-O O
of B-O O
cytosolic B-O B-protein
protein B-O I-protein
, B-O O
in B-O O
14 B-O O
patients B-O O
with B-O O
active B-O O
SLE B-O O
( B-O O
0.9356 B-O O
+/- B-O O
0.31 B-O O
) B-O O
was B-O O
significantly B-O O
higher B-O O
than B-O O
that B-O O
in B-O O
13 B-O O
patients B-O O
with B-O O
inactive B-O O
SLE B-O O
( B-O O
0.2979 B-O O
+/- B-O O
0.23 B-O O
, B-O O
P B-O O
less B-O O
than B-O O
0.001 B-O O
) B-O O
and B-O O
in B-O O
the B-O O
controls B-O O
( B-O O
0.6204 B-O O
+/- B-O O
0.52 B-O O
, B-O O
P B-O O
less B-O O
than B-O O
0.001 B-O O
) B-O O
. B-O O

The B-O O
normal B-O O
upper B-O O
limit B-O O
of B-O O
ER B-O B-protein
content B-O O
in B-O O
lymphocytes B-O B-cell_type
, B-O O
expressed B-O O
by B-O O
fmol/micrograms B-O O
of B-O O
DNA B-O O
, B-O O
was B-O O
0.136 B-O O
. B-O O

The B-O O
elevated B-O O
rate B-O O
of B-O O
ER B-O B-protein
content B-O O
in B-O O
lymphocytes B-O B-cell_type
in B-O O
14 B-O O
active B-O O
SLE B-O O
( B-O O
92.9 B-O O
% B-O O
) B-O O
was B-O O
also B-O O
higher B-O O
than B-O O
that B-O O
in B-O O
quieiescent B-O O
patients B-O O
( B-O O
23.1 B-O O
% B-O O
, B-O O
P B-O O
less B-O O
than B-O O
0.001 B-O O
) B-O O
and B-O O
in B-O O
the B-O O
controls B-O O
( B-O O
10 B-O O
% B-O O
, B-O O
P B-O O
less B-O O
than B-O O
0.001 B-O O
) B-O O
. B-O O

Moreover B-O O
, B-O O
the B-O O
elevated B-O O
level B-O O
of B-O O
ER B-O B-protein
content B-O O
was B-O O
found B-O O
to B-O O
be B-O O
related B-O O
to B-O O
the B-O O
positive B-O O
antidsDNA B-O B-protein
antibody B-O I-protein
and B-O O
hypocomplementemia B-O O
. B-O O

An B-O O
in B-O O
vitro B-O O
globin B-O B-DNA
gene B-O I-DNA
switching B-O O
model B-O O
based B-O O
on B-O O
differentiated B-O B-cell_type
embryonic B-O I-cell_type
stem B-O I-cell_type
cells B-O I-cell_type
. B-O O

We B-O O
used B-O O
mouse B-O B-cell_type
embryonic B-O I-cell_type
stem B-O I-cell_type
( B-O I-cell_type
ES B-O I-cell_type
) B-O I-cell_type
cells B-O I-cell_type
to B-O O
study B-O O
globin B-O B-DNA
gene B-O I-DNA
expression B-O O
and B-O O
switching B-O O
in B-O O
vitro B-O O
. B-O O

We B-O O
show B-O O
that B-O O
ES-derived B-O B-cell_type
embryoid B-O I-cell_type
bodies B-O I-cell_type
express B-O O
the B-O O
full B-O O
complement B-O O
of B-O O
mouse B-O B-DNA
embryonic B-O I-DNA
globin B-O I-DNA
genes B-O I-DNA
in B-O O
the B-O O
correct B-O O
temporal B-O O
order B-O O
and B-O O
that B-O O
on B-O O
further B-O O
differentiation B-O O
, B-O O
a B-O O
switch B-O O
occurs B-O O
to B-O O
the B-O O
fetal/adult B-O B-DNA
genes B-O I-DNA
. B-O O

In B-O O
addition B-O O
, B-O O
the B-O O
erythroid-specific B-O B-protein
transcription B-O I-protein
factor B-O I-protein
NF-E1 B-O B-protein
was B-O O
shown B-O O
to B-O O
be B-O O
expressed B-O O
coordinately B-O O
with B-O O
that B-O O
of B-O O
globin B-O B-protein
in B-O O
embryoid B-O B-cell_type
bodies B-O I-cell_type
. B-O O

We B-O O
conclude B-O O
from B-O O
these B-O O
experiments B-O O
that B-O O
the B-O O
ES B-O O
cell B-O O
system B-O O
provides B-O O
a B-O O
good B-O O
model B-O O
to B-O O
study B-O O
hematopoietic B-O O
development B-O O
. B-O O

When B-O O
the B-O O
human B-O B-DNA
epsilon- B-O I-DNA
or B-O I-DNA
beta- B-O I-DNA
globin B-O I-DNA
genes B-O I-DNA
driven B-O O
by B-O O
the B-O O
dominant B-O B-DNA
control B-O I-DNA
region B-O I-DNA
( B-O O
DCR B-O B-DNA
) B-O O
are B-O O
introduced B-O O
into B-O O
this B-O O
system B-O O
, B-O O
the B-O O
human B-O B-DNA
epsilon- B-O I-DNA
globin B-O I-DNA
gene B-O I-DNA
, B-O O
in B-O O
contrast B-O O
to B-O O
the B-O O
beta- B-O B-DNA
globin B-O I-DNA
gene B-O I-DNA
, B-O O
is B-O O
not B-O O
deregulated B-O O
by B-O O
the B-O O
presence B-O O
of B-O O
the B-O O
DCR B-O B-DNA
and B-O O
is B-O O
expressed B-O O
strictly B-O O
as B-O O
an B-O O
embryonic B-O B-DNA
gene B-O I-DNA
. B-O O

We B-O O
conclude B-O O
from B-O O
this B-O O
that B-O O
the B-O O
epsilon- B-O B-DNA
globin B-O I-DNA
gene B-O I-DNA
is B-O O
not B-O O
regulated B-O O
by B-O O
competition B-O O
with B-O O
other B-O O
genes B-O O
in B-O O
the B-O O
human B-O B-DNA
beta-globin B-O I-DNA
locus B-O I-DNA
. B-O O

Cloning B-O O
of B-O O
a B-O O
mitogen-inducible B-O B-DNA
gene B-O I-DNA
encoding B-O O
a B-O O
kappa B-O B-protein
B B-O I-protein
DNA-binding B-O I-protein
protein B-O I-protein
with B-O O
homology B-O O
to B-O O
the B-O O
rel B-O B-DNA
oncogene B-O I-DNA
and B-O O
to B-O O
cell-cycle B-O B-DNA
motifs B-O I-DNA
. B-O O

We B-O O
have B-O O
cloned B-O O
and B-O O
characterized B-O O
a B-O O
mitogen-inducible B-O B-DNA
gene B-O I-DNA
isolated B-O O
from B-O O
human B-O B-cell_type
T B-O I-cell_type
cells B-O I-cell_type
that B-O O
predicts B-O O
a B-O O
protein B-O O
of B-O O
968 B-O B-protein
amino B-O I-protein
acids B-O I-protein
. B-O O

The B-O O
amino-terminal B-O B-protein
domain B-O I-protein
has B-O O
regions B-O O
homologous B-O O
to B-O O
the B-O O
oncogene B-O B-DNA
rel B-O I-DNA
and B-O O
to B-O O
the B-O O
developmentally B-O O
important B-O O
gene B-O O
dorsal B-O O
of B-O O
Drosophila B-O O
. B-O O

The B-O O
carboxy-terminal B-O B-protein
domain B-O I-protein
contains B-O O
repeat B-O O
structures B-O O
found B-O O
in B-O O
a B-O O
variety B-O O
of B-O O
proteins B-O O
that B-O O
are B-O O
involved B-O O
in B-O O
cell-cycle B-O O
control B-O O
of B-O O
yeast B-O O
and B-O O
in B-O O
tissue B-O O
differentiation B-O O
in B-O O
Drosophila B-O O
and B-O O
Ceanorhabditis B-O O
elegans B-O O
, B-O O
as B-O O
well B-O O
as B-O O
in B-O O
the B-O O
putative B-O B-DNA
human B-O I-DNA
oncogene B-O I-DNA
bcl-3 B-O I-DNA
and B-O O
in B-O O
the B-O O
ankyrin B-O B-protein
protein B-O I-protein
. B-O O

A B-O O
truncated B-O O
form B-O O
of B-O O
the B-O O
product B-O O
of B-O O
this B-O O
gene B-O O
translated B-O O
in B-O O
vitro B-O O
is B-O O
a B-O O
DNA-binding B-O B-protein
protein B-O I-protein
which B-O O
interacts B-O O
specifically B-O O
with B-O O
the B-O O
kappa B-O B-DNA
B B-O I-DNA
binding B-O I-DNA
site B-O I-DNA
found B-O O
in B-O O
many B-O O
inducible B-O B-DNA
genes B-O I-DNA
, B-O O
including B-O O
the B-O O
enhancer B-O B-DNA
in B-O O
human B-O O
immunodeficiency B-O O
virus B-O O
. B-O O

This B-O O
gene B-O O
is B-O O
yet B-O O
another B-O O
in B-O O
a B-O O
growing B-O O
list B-O O
of B-O O
important B-O O
regulatory B-O B-protein
molecules B-O I-protein
whose B-O O
expression B-O O
is B-O O
transcriptionally B-O O
induced B-O O
upon B-O O
cellular B-O O
activation B-O O
. B-O O

Extrarenal B-O O
receptor-effector-mechanisms B-O O
for B-O O
aldosterone B-O O
: B-O O
the B-O O
sequence B-O O
of B-O O
effects B-O O
on B-O O
the B-O O
cellular B-O O
electrolyte B-O O
transport B-O O
in B-O O
human B-O B-cell_type
lymphocytes B-O I-cell_type
and B-O O
their B-O O
implications B-O O
for B-O O
disorders B-O O
of B-O O
the B-O O
water B-O O
and B-O O
electrolyte B-O O
balances B-O O
. B-O O

High B-O O
affinity B-O O
aldosterone B-O O
binding B-O O
sites B-O O
have B-O O
not B-O O
only B-O O
been B-O O
described B-O O
in B-O O
the B-O O
classic B-O O
target B-O O
tissues B-O O
such B-O O
as B-O O
the B-O O
renal B-O O
tubules B-O O
, B-O O
but B-O O
also B-O O
in B-O O
non-classic B-O O
target B-O O
tissues B-O O
such B-O O
as B-O O
the B-O O
hippocampus B-O O
, B-O O
mammary B-O O
gland B-O O
, B-O O
endothelial B-O B-cell_type
cells B-O I-cell_type
and B-O O
, B-O O
recently B-O O
, B-O O
human B-O B-cell_type
mononuclear B-O I-cell_type
leukocytes B-O I-cell_type
. B-O O

An B-O O
in B-O O
vitro B-O O
effect B-O O
of B-O O
aldosterone B-O O
on B-O O
intracellular B-O O
sodium B-O O
, B-O O
potassium B-O O
and B-O O
calcium B-O O
concentrations B-O O
and B-O O
cell B-O O
volume B-O O
was B-O O
shown B-O O
in B-O O
human B-O B-cell_type
mononuclear B-O I-cell_type
leukocytes B-O I-cell_type
. B-O O

In B-O O
the B-O O
absence B-O O
of B-O O
aldosterone B-O O
, B-O O
the B-O O
intracellular B-O O
Na+ B-O O
, B-O O
K+ B-O O
and B-O O
Ca2+ B-O O
concentrations B-O O
and B-O O
the B-O O
cell B-O O
volume B-O O
decreased B-O O
significantly B-O O
, B-O O
but B-O O
remained B-O O
constant B-O O
when B-O O
aldosterone B-O O
( B-O O
1.4 B-O O
nmol/l B-O O
) B-O O
was B-O O
added B-O O
to B-O O
the B-O O
incubation B-O O
medium B-O O
. B-O O

These B-O O
effects B-O O
of B-O O
aldosterone B-O O
were B-O O
blocked B-O O
by B-O O
the B-O O
aldosterone B-O O
antagonist B-O O
canrenone B-O O
( B-O O
140 B-O O
nmol/l B-O O
) B-O O
. B-O O

The B-O O
sodium/proton B-O B-protein
exchanger B-O I-protein
of B-O O
the B-O O
cell B-O O
membrane B-O O
could B-O O
be B-O O
identified B-O O
as B-O O
the B-O O
primary B-O O
target B-O O
of B-O O
the B-O O
aldosterone B-O O
action B-O O
, B-O O
possibly B-O O
non-genomically B-O O
mediated B-O O
through B-O O
membrane B-O B-protein
receptors B-O I-protein
. B-O O

The B-O O
clinical B-O O
significance B-O O
of B-O O
this B-O O
model B-O O
was B-O O
underlined B-O O
by B-O O
the B-O O
demonstration B-O O
of B-O O
absent B-O O
or B-O O
a B-O O
decreased B-O O
number B-O O
of B-O O
mineralocorticoid B-O B-protein
receptors B-O I-protein
and B-O O
the B-O O
lack B-O O
of B-O O
electrolyte B-O O
response B-O O
to B-O O
aldosterone B-O O
in B-O O
human B-O B-cell_type
mononuclear B-O I-cell_type
leukocytes B-O I-cell_type
of B-O O
patients B-O O
with B-O O
pseudohypoaldosteronism B-O O
and B-O O
aldosteronism B-O O
. B-O O

Additionally B-O O
, B-O O
an B-O O
abnormal B-O O
effector B-O O
mechanism B-O O
could B-O O
be B-O O
demonstrated B-O O
in B-O O
human B-O B-cell_type
mononuclear B-O I-cell_type
leukocytes B-O I-cell_type
from B-O O
essential B-O O
hypertensives B-O O
. B-O O

These B-O O
studies B-O O
are B-O O
the B-O O
first B-O O
to B-O O
demonstrate B-O O
the B-O O
significance B-O O
of B-O O
extrarenal B-O B-protein
, B-O I-protein
nonepithelial B-O I-protein
mineralocorticoid B-O I-protein
receptors B-O I-protein
and B-O O
the B-O O
related B-O O
effector B-O O
mechanism B-O O
in B-O O
different B-O O
disorders B-O O
of B-O O
the B-O O
water B-O O
and B-O O
electrolyte B-O O
balance B-O O
in B-O O
man B-O O
. B-O O

Immunohistochemical B-O O
study B-O O
of B-O O
steroid B-O O
hormones B-O O
and B-O O
an B-O O
estrogen B-O O
binding B-O O
assay B-O O
in B-O O
malignant B-O B-cell_type
soft B-O I-cell_type
tissue B-O I-cell_type
tumors B-O I-cell_type
. B-O O

Immunohistochemically B-O O
, B-O O
the B-O O
immunoreaction B-O O
against B-O O
5 B-O O
steroid B-O O
hormone B-O O
anti-sera B-O O
( B-O O
estradiol B-O O
, B-O O
estriol B-O O
, B-O O
cortisol B-O O
, B-O O
progesterone B-O O
and B-O O
testosterone B-O O
) B-O O
was B-O O
examined B-O O
in B-O O
39 B-O O
cases B-O O
with B-O O
the B-O O
malignant B-O B-cell_type
soft B-O I-cell_type
tissue B-O I-cell_type
tumors B-O I-cell_type
( B-O O
fibrosarcoma B-O O
: B-O O
8 B-O O
, B-O O
malignant B-O O
fibrous B-O O
histiocytoma B-O O
: B-O O
6 B-O O
, B-O O
rhabdomyosarcoma B-O O
: B-O O
10 B-O O
, B-O O
leiomyosarcoma B-O O
: B-O O
10 B-O O
, B-O O
liposarcoma B-O O
: B-O O
5 B-O O
) B-O O
. B-O O

Seventeen B-O O
cases B-O O
revealed B-O O
distinct B-O O
immunostaining B-O O
against B-O O
at B-O O
least B-O O
1 B-O O
of B-O O
the B-O O
5 B-O O
steroid B-O O
hormones B-O O
. B-O O

Immunostained B-O B-cell_type
tumor B-O I-cell_type
cells B-O I-cell_type
were B-O O
more B-O O
frequently B-O O
distributed B-O O
in B-O O
the B-O O
area B-O O
where B-O O
tumor B-O O
cell B-O O
infiltration B-O O
was B-O O
more B-O O
invasive B-O O
. B-O O

The B-O O
majority B-O O
of B-O O
the B-O O
positive B-O O
cases B-O O
occurred B-O O
in B-O O
female B-O O
cases B-O O
. B-O O

Furthermore B-O O
, B-O O
the B-O O
existence B-O O
of B-O O
estrogen B-O B-protein
receptor B-O I-protein
( B-O O
estrogen B-O O
binding B-O O
activity B-O O
) B-O O
was B-O O
examined B-O O
histochemically B-O O
in B-O O
39 B-O O
cases B-O O
and B-O O
it B-O O
was B-O O
detected B-O O
in B-O O
8 B-O O
. B-O O

We B-O O
concluded B-O O
that B-O O
steroid B-O O
hormones B-O O
might B-O O
be B-O O
closely B-O O
related B-O O
to B-O O
tumor B-O O
cell B-O O
infiltration B-O O
of B-O O
some B-O O
malignant B-O B-cell_type
soft B-O I-cell_type
tissue B-O I-cell_type
tumors B-O I-cell_type
. B-O O

Involvement B-O O
of B-O O
cyclic B-O B-protein
AMP-dependent B-O I-protein
protein B-O I-protein
kinases B-O I-protein
in B-O O
the B-O O
signal B-O O
transduction B-O O
pathway B-O O
for B-O O
interleukin-1 B-O B-protein
. B-O O

Expression B-O O
of B-O O
a B-O O
highly B-O O
specific B-O O
protein B-O O
inhibitor B-O O
for B-O O
cyclic B-O B-protein
AMP-dependent B-O I-protein
protein B-O I-protein
kinases B-O I-protein
in B-O O
interleukin-1 B-O B-cell_line
( B-O I-cell_line
IL-1 B-O I-cell_line
) B-O I-cell_line
-responsive B-O I-cell_line
cells B-O I-cell_line
blocked B-O O
IL-1-induced B-O B-DNA
gene B-O I-DNA
transcription B-O O
that B-O O
was B-O O
driven B-O O
by B-O O
the B-O O
kappa B-O B-DNA
immunoglobulin B-O I-DNA
enhancer B-O I-DNA
or B-O O
the B-O O
human B-O B-DNA
immunodeficiency B-O I-DNA
virus B-O I-DNA
long B-O I-DNA
terminal B-O I-DNA
repeat B-O I-DNA
. B-O O

This B-O O
inhibitor B-O O
did B-O O
not B-O O
affect B-O O
protein B-O B-protein
kinase B-O I-protein
C B-O I-protein
-mediated B-O O
gene B-O O
transcription B-O O
, B-O O
suggesting B-O O
that B-O O
cyclic B-O B-protein
AMP-dependent B-O I-protein
protein B-O I-protein
kinases B-O I-protein
are B-O O
involved B-O O
in B-O O
the B-O O
signal B-O O
transduction B-O O
pathway B-O O
for B-O O
IL-1 B-O B-protein
in B-O O
a B-O O
number B-O O
of B-O O
responsive B-O B-cell_type
cell B-O I-cell_type
types B-O I-cell_type
. B-O O

The B-O O
Epstein-Barr B-O B-DNA
virus B-O I-DNA
( B-O I-DNA
EBV B-O I-DNA
) B-O I-DNA
ORI1yt B-O I-DNA
enhancer B-O I-DNA
is B-O O
not B-O O
B-cell B-O O
specific B-O O
and B-O O
does B-O O
not B-O O
respond B-O O
synergistically B-O O
to B-O O
the B-O O
EBV B-O B-protein
transcription B-O I-protein
factors B-O I-protein
R B-O B-protein
and B-O O
Z B-O B-protein
. B-O O

The B-O O
Epstein-Barr B-O B-DNA
virus B-O I-DNA
DR B-O I-DNA
promoter B-O I-DNA
is B-O O
located B-O O
upstream B-O O
of B-O O
the B-O O
PstI B-O B-DNA
repeats B-O I-DNA
, B-O O
and B-O O
in B-O O
addition B-O O
to B-O O
the B-O O
TATA B-O B-DNA
box B-O I-DNA
, B-O O
it B-O O
contains B-O O
an B-O O
upstream B-O B-DNA
region B-O I-DNA
( B-O O
positions B-O B-DNA
-69 B-O I-DNA
to B-O I-DNA
-220 B-O I-DNA
) B-O O
responsive B-O O
to B-O O
EB1 B-O B-protein
( B-O O
Z B-O B-protein
) B-O O
( B-O O
the B-O O
BZLF1-encoded B-O B-protein
transcription B-O I-protein
factor B-O I-protein
) B-O O
and B-O O
an B-O O
enhancer B-O B-DNA
with B-O O
two B-O O
functionally B-O O
distinct B-O O
domains B-O O
, B-O O
A B-O O
and B-O O
B B-O O
. B-O O

Domain B-O B-DNA
B B-O I-DNA
has B-O O
been B-O O
described B-O O
as B-O O
a B-O O
B-cell-specific B-O B-DNA
EB1 B-O I-DNA
-responsive B-O I-DNA
element B-O I-DNA
( B-O O
P.M.Lieberman B-O O
, B-O O
J.M.Hardwick B-O O
, B-O O
and B-O O
S.D.Hayward B-O O
, B-O O
J.Virol.63 B-O O
: B-O O
3040-3050 B-O O
, B-O O
1989 B-O O
) B-O O
activated B-O O
synergistically B-O O
by B-O O
EB1 B-O B-protein
and B-O O
R B-O B-protein
, B-O O
an B-O O
EBV B-O B-protein
early B-O I-protein
product B-O I-protein
encoded B-O O
by B-O O
the B-O O
open B-O B-DNA
reading B-O I-DNA
frame B-O I-DNA
BRLF1 B-O I-DNA
( B-O O
M.A. B-O O
Cox B-O O
, B-O O
J.Leahy B-O O
, B-O O
and B-O O
J.M.Hardwick B-O O
, B-O O
J.Virol.64 B-O O
: B-O O
313-321 B-O O
, B-O O
1990 B-O O
) B-O O
. B-O O

We B-O O
show B-O O
here B-O O
that B-O O
domain B-O B-DNA
B B-O I-DNA
is B-O O
an B-O O
R-responsive B-O B-DNA
element B-O I-DNA
in B-O O
HeLa B-O B-cell_line
cells B-O I-cell_line
and B-O O
is B-O O
therefore B-O O
not B-O O
an B-O O
EB1 B-O B-DNA
-responsive B-O I-DNA
B-cell-specific B-O I-DNA
element B-O I-DNA
. B-O O

However B-O O
, B-O O
there B-O O
is B-O O
an B-O O
EB1 B-O B-DNA
-binding B-O I-DNA
site B-O I-DNA
( B-O O
ZRE-B B-O B-DNA
) B-O O
located B-O O
within B-O O
the B-O O
R-responsive B-O B-DNA
enhancer B-O I-DNA
region B-O I-DNA
. B-O O

ZRE-B B-O B-DNA
can B-O O
be B-O O
deleted B-O O
without B-O O
affecting B-O O
the B-O O
R-dependent B-O B-DNA
enhancer B-O I-DNA
activity B-O O
. B-O O

Moreover B-O O
, B-O O
there B-O O
is B-O O
no B-O O
cooperation B-O O
or B-O O
synergy B-O O
between B-O O
R B-O B-protein
and B-O O
EB1 B-O B-protein
when B-O O
activating B-O O
the B-O O
B B-O B-DNA
domain B-O I-DNA
( B-O O
ZRE-B B-O B-DNA
plus B-O O
the B-O O
R-responsive B-O B-DNA
element B-O I-DNA
) B-O O
positioned B-O O
as B-O O
an B-O O
enhancer B-O B-DNA
. B-O O

ZRE-B B-O B-DNA
is B-O O
therefore B-O O
not B-O O
part B-O O
of B-O O
the B-O O
enhancer B-O I-DNA
. B-O O

We B-O O
have B-O O
tested B-O O
several B-O O
subregions B-O O
of B-O O
the B-O O
DR B-O B-DNA
enhancer B-O I-DNA
B B-O I-DNA
domain B-O I-DNA
, B-O O
either B-O O
alone B-O O
or B-O O
in B-O O
combination B-O O
, B-O O
for B-O O
their B-O O
capacity B-O O
to B-O O
transmit B-O O
the B-O O
R-activating B-O O
signal B-O O
to B-O O
the B-O O
rabbit B-O B-DNA
beta-globin B-O I-DNA
promoter B-O I-DNA
. B-O O

We B-O O
found B-O O
that B-O O
the B-O O
R-responsive B-O B-DNA
element B-O I-DNA
is B-O O
composed B-O O
of B-O O
four B-O O
protoenhancers B-O B-DNA
that B-O O
span B-O O
the B-O O
whole B-O O
B B-O B-DNA
domain B-O I-DNA
. B-O O

These B-O O
protoenhancers B-O B-DNA
alone B-O O
are B-O O
weakly B-O O
or B-O O
not B-O O
responsive B-O O
to B-O O
R B-O B-protein
. B-O O

One B-O O
of B-O O
the B-O O
protoenhancers B-O B-DNA
contains B-O O
the B-O O
overlapping B-O B-DNA
palindromes B-O I-DNA
5'-TTGTCCcgtGGACAAaTGTCC-3 B-O O
' B-O O
. B-O O

However B-O O
, B-O O
one B-O O
palindrome B-O B-DNA
, B-O O
either B-O O
alone B-O O
or B-O O
duplicated B-O O
, B-O O
or B-O O
the B-O O
overlapping B-O B-DNA
palindromes B-O I-DNA
did B-O O
not B-O O
respond B-O O
to B-O O
R B-O B-protein
. B-O O

Nuclear B-O O
3 B-O O
, B-O O
5 B-O O
, B-O O
3'-triiodothyronine B-O O
receptors B-O O
( B-O O
T3R B-O B-protein
) B-O O
of B-O O
circulating B-O B-cell_type
human B-O I-cell_type
lymphocytes B-O I-cell_type
in B-O O
hyper- B-O O
and B-O O
hypo B-O O
thyroidism B-O O
and B-O O
nonthyroidal B-O O
diseases B-O O
. B-O O

The B-O O
clinical B-O O
implications B-O O
of B-O O
nuclear B-O O
T3R B-O B-protein
alterations B-O O
of B-O O
circulating B-O B-cell_type
lymphocytes B-O I-cell_type
in B-O O
hyperthyroidism B-O O
, B-O O
hypothyroidism B-O O
and B-O O
nonthyroidal B-O O
diseases B-O O
were B-O O
investigated B-O O
. B-O O

Nuclear B-O B-protein
T3R B-O I-protein
in B-O O
lymphocytes B-O B-cell_type
was B-O O
determined B-O O
by B-O O
radio-ligand B-O O
binding B-O O
analysis B-O O
. B-O O

The B-O O
results B-O O
showed B-O O
that B-O O
in B-O O
hyper- B-O O
and B-O O
hypo B-O O
thyroid B-O O
patients B-O O
the B-O O
nuclear B-O O
affinity B-O O
( B-O O
Ka B-O O
) B-O O
for B-O O
T3 B-O O
was B-O O
similar B-O O
to B-O O
that B-O O
of B-O O
normal B-O O
subjects B-O O
. B-O O

In B-O O
hyperthyroidism B-O O
nuclear B-O O
T3 B-O O
maximal B-O O
binding B-O O
capacity B-O O
( B-O O
MBC B-O O
) B-O O
was B-O O
unaltered B-O O
, B-O O
whereas B-O O
in B-O O
hypothyroidism B-O O
the B-O O
MBC B-O O
was B-O O
significantly B-O O
increased B-O O
. B-O O

In B-O O
the B-O O
patients B-O O
with B-O O
diabetes B-O O
mellitus B-O O
, B-O O
chronic B-O O
renal B-O O
failure B-O O
and B-O O
hepatic B-O O
cirrhosis B-O O
, B-O O
the B-O O
nuclear B-O B-protein
T3R B-O I-protein
MBC B-O O
of B-O O
lymphocytes B-O B-cell_type
was B-O O
about B-O O
1.5-1.6 B-O O
times B-O O
of B-O O
the B-O O
normal B-O O
controls B-O O
. B-O O

It B-O O
was B-O O
concluded B-O O
that B-O O
there B-O O
existed B-O O
hormonal B-O O
regulation B-O O
of B-O O
nuclear B-O B-protein
T3R B-O I-protein
, B-O O
and B-O O
up-regulation B-O O
was B-O O
seen B-O O
in B-O O
hypothyroidism B-O O
and B-O O
low B-O O
T3 B-O O
syndrome B-O O
. B-O O

Lymphocyte B-O B-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
from B-O O
vitamin B-O O
D-dependent B-O O
rickets B-O O
type B-O O
II B-O O
show B-O O
functional B-O O
defects B-O O
in B-O O
the B-O O
1 B-O B-protein
alpha B-O I-protein
, B-O I-protein
25-dihydroxyvitamin B-O I-protein
D3 B-O I-protein
receptor B-O I-protein
. B-O O

Lymphocyte B-O B-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
were B-O O
established B-O O
from B-O O
five B-O O
patients B-O O
with B-O O
vitamin B-O O
D-dependent B-O O
rickets B-O O
, B-O O
type B-O O
II B-O O
( B-O O
VDDR-II B-O B-protein
) B-O O
. B-O O

These B-O O
lines B-O O
were B-O O
established B-O O
by B-O O
infection B-O O
with B-O O
human B-O O
T-lymphotrophic B-O O
virus B-O O
type B-O O
I B-O O
( B-O O
HTLV-I B-O O
) B-O O
. B-O O

Binding B-O O
of B-O O
[ B-O O
3H B-O O
] B-O O
1 B-O O
alpha B-O O
, B-O O
25-dihydroxyvitamin B-O O
D3 B-O O
( B-O O
1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
) B-O O
to B-O O
its B-O O
receptor B-O O
in B-O O
these B-O O
cell B-O B-cell_line
lines B-O I-cell_line
was B-O O
compared B-O O
to B-O O
binding B-O O
studies B-O O
using B-O O
a B-O O
T-lymphocyte B-O B-cell_line
cell B-O I-cell_line
line B-O I-cell_line
( B-O O
S-LB1 B-O B-cell_line
) B-O O
from B-O O
a B-O O
normal B-O O
individual B-O O
. B-O O

The B-O O
1 B-O B-protein
, B-O I-protein
25 B-O I-protein
( B-O I-protein
OH B-O I-protein
) B-O I-protein
2D3 B-O I-protein
receptor B-O I-protein
of B-O O
S-LB1 B-O B-cell_line
was B-O O
comparable B-O O
to B-O O
the B-O O
well-characterized B-O O
chick B-O B-protein
intestinal B-O I-protein
1 B-O I-protein
, B-O I-protein
25 B-O I-protein
( B-O I-protein
OH B-O I-protein
) B-O I-protein
2D3 B-O I-protein
receptor B-O I-protein
in B-O O
terms B-O O
of B-O O
its B-O O
ligand B-O O
binding B-O O
affinity B-O O
and B-O O
capacity B-O O
, B-O O
its B-O O
mobility B-O O
on B-O O
5-20 B-O O
% B-O O
sucrose B-O O
gradients B-O O
, B-O O
and B-O O
its B-O O
adsorption B-O O
to B-O O
and B-O O
elution B-O O
properties B-O O
from B-O O
DNA-cellulose B-O O
. B-O O

Three B-O O
cell B-O B-cell_line
lines B-O I-cell_line
established B-O O
from B-O O
patients B-O O
with B-O O
VDDR-II B-O O
( B-O O
Rh- B-O O
VDR B-O B-protein
, B-O O
Sh- B-O O
VDR B-O B-protein
, B-O O
and B-O O
Ab- B-O O
VDR B-O B-protein
) B-O O
showed B-O O
no B-O O
specific B-O O
binding B-O O
of B-O O
1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
to B-O O
a B-O O
receptor B-O O
and B-O O
treatment B-O O
of B-O O
the B-O O
cultured B-O B-cell_line
cells B-O I-cell_line
with B-O O
1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
did B-O O
not B-O O
stimulate B-O O
production B-O O
of B-O O
24 B-O O
, B-O O
25-dihydroxy-vitamin B-O O
D3 B-O O
( B-O O
24 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
) B-O O
, B-O O
a B-O O
response B-O O
which B-O O
is B-O O
diagnostic B-O O
of B-O O
the B-O O
presence B-O O
of B-O O
a B-O O
functional B-O O
1 B-O B-protein
, B-O I-protein
25 B-O I-protein
( B-O I-protein
OH B-O I-protein
) B-O I-protein
2D3 B-O I-protein
receptor B-O I-protein
. B-O O

In B-O O
a B-O O
fourth B-O B-cell_line
cell B-O I-cell_line
line B-O I-cell_line
, B-O O
A1-VDR B-O B-cell_line
, B-O O
the B-O O
receptor B-O O
for B-O O
1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
had B-O O
a B-O O
low B-O O
binding B-O O
capacity B-O O
and B-O O
25 B-O B-protein
( B-O I-protein
OH B-O I-protein
) B-O I-protein
D3-24-hydroxylase B-O I-protein
activity B-O O
was B-O O
not B-O O
detectable B-O O
. B-O O

Induction B-O O
of B-O O
24 B-O O
, B-O O
25- B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
synthesis B-O O
by B-O O
1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
was B-O O
observed B-O O
in B-O O
the B-O O
fifth B-O B-cell_line
cell B-O I-cell_line
line B-O I-cell_line
, B-O O
designated B-O O
Ro-VDR B-O B-cell_line
, B-O O
although B-O O
the B-O O
sensitivity B-O O
to B-O O
hormone B-O O
treatment B-O O
was B-O O
lower B-O O
than B-O O
in B-O O
the B-O O
control B-O B-cell_line
cell B-O I-cell_line
line B-O I-cell_line
from B-O O
a B-O O
normal B-O O
donor B-O O
. B-O O

The B-O O
capacity B-O O
of B-O O
the B-O O
receptor B-O O
for B-O O
1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
was B-O O
low B-O O
in B-O O
Ro-VDR B-O B-cell_line
. B-O O

In B-O O
all B-O O
cell B-O B-cell_line
lines B-O I-cell_line
where B-O O
1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
binding B-O O
to B-O O
a B-O O
receptor B-O O
was B-O O
detectable B-O O
, B-O O
the B-O O
receptor B-O B-protein
had B-O O
the B-O O
typical B-O O
sedimentation B-O O
coefficient B-O O
of B-O O
3.7 B-O O
S B-O O
on B-O O
sucrose B-O O
density B-O O
gradient B-O O
analysis B-O O
. B-O O

Binding B-O O
and B-O O
elution B-O O
properties B-O O
to B-O O
DNA-cellulose B-O O
, B-O O
however B-O O
, B-O O
differed B-O O
from B-O O
normal B-O O
in B-O O
both B-O O
Ro-VDR B-O B-cell_line
and B-O O
A1-VDR B-O B-cell_line
cells B-O I-cell_line
where B-O O
elution B-O O
from B-O O
DNA-cellulose B-O O
occurred B-O O
at B-O O
a B-O O
lower B-O O
salt B-O O
concentration B-O O
than B-O O
is B-O O
typical B-O O
of B-O O
the B-O O
1 B-O B-protein
, B-O I-protein
25 B-O I-protein
( B-O I-protein
OH B-O I-protein
) B-O I-protein
2D3 B-O I-protein
receptor B-O I-protein
. B-O O

While B-O O
Ro-VDR B-O B-cell_line
cells B-O I-cell_line
showed B-O O
typical B-O O
nuclear B-O O
localization B-O O
of B-O O
the B-O O
unoccupied B-O B-protein
1 B-O I-protein
, B-O I-protein
25 B-O I-protein
( B-O I-protein
OH B-O I-protein
) B-O I-protein
2D3 B-O I-protein
receptor B-O I-protein
, B-O O
neither B-O O
the B-O O
unoccupied B-O O
nor B-O O
the B-O O
occupied B-O B-protein
receptor B-O I-protein
from B-O O
A1-VDR B-O B-cell_line
cells B-O I-cell_line
was B-O O
completely B-O O
localized B-O O
in B-O O
the B-O O
nucleus B-O O
. B-O O

In B-O O
a B-O O
series B-O O
of B-O O
functional B-O O
studies B-O O
we B-O O
found B-O O
that B-O O
modulation B-O O
of B-O O
the B-O O
level B-O O
of B-O O
the B-O O
mRNAs B-O B-RNA
coding B-O O
for B-O O
both B-O O
the B-O O
c-myc B-O B-DNA
oncogene B-O I-DNA
and B-O O
the B-O O
growth B-O B-protein
factor B-O I-protein
known B-O O
as B-O O
granulocyte-monocyte B-O O
colony B-O O
stimulating B-O O
activity B-O O
by B-O O
1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
correlated B-O O
with B-O O
the B-O O
1 B-O B-protein
, B-O I-protein
25 B-O I-protein
( B-O I-protein
OH B-O I-protein
) B-O I-protein
2D3 B-O I-protein
receptor B-O I-protein
status B-O O
of B-O O
these B-O O
cells B-O O
. B-O O

Use B-O O
of B-O O
these B-O O
cell B-O B-cell_line
lines B-O I-cell_line
will B-O O
facilitate B-O O
further B-O O
study B-O O
of B-O O
the B-O O
molecular B-O O
defect B-O O
( B-O O
s B-O O
) B-O O
in B-O O
the B-O O
receptor B-O O
for B-O O
1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
in B-O O
vitamin B-O O
D-dependent B-O O
rickets B-O O
type B-O O
II B-O O
and B-O O
will B-O O
allow B-O O
a B-O O
correlation B-O O
with B-O O
impairment B-O O
of B-O O
cellular B-O O
functions B-O O
. B-O O

Transcriptional B-O O
and B-O O
post-transcriptional B-O O
regulation B-O O
of B-O O
c-jun B-O B-DNA
expression B-O O
during B-O O
monocytic B-O O
differentiation B-O O
of B-O O
human B-O B-cell_type
myeloid B-O I-cell_type
leukemic B-O I-cell_type
cells B-O I-cell_type
. B-O O

AP-1 B-O B-protein
, B-O O
the B-O O
polypeptide B-O O
product B-O O
of B-O O
c-jun B-O B-DNA
, B-O O
recognizes B-O O
and B-O O
binds B-O O
to B-O O
specific B-O O
DNA B-O B-DNA
sequences B-O I-DNA
and B-O O
stimulates B-O O
transcription B-O O
of B-O O
genes B-O O
responsive B-O O
to B-O O
certain B-O O
growth B-O B-protein
factors B-O I-protein
and B-O O
phorbol B-O O
esters B-O O
such B-O O
as B-O O
12-O-tetradecanoylphorbol-13-acetate B-O O
( B-O O
TPA B-O O
) B-O O
. B-O O

We B-O O
studied B-O O
the B-O O
effects B-O O
of B-O O
TPA B-O O
on B-O O
the B-O O
regulation B-O O
of B-O O
c-jun B-O B-DNA
gene B-O O
expression B-O O
in B-O O
HL-60 B-O B-cell_line
cells B-O I-cell_line
during B-O O
monocytic B-O O
differentiation B-O O
. B-O O

Low B-O O
levels B-O O
of B-O O
c-jun B-O B-RNA
transcripts B-O I-RNA
were B-O O
detectable B-O O
in B-O O
untreated B-O B-cell_line
HL-60 B-O I-cell_line
leukemic B-O I-cell_line
cells B-O I-cell_line
, B-O O
increased B-O O
significantly B-O O
by B-O O
6 B-O O
h B-O O
, B-O O
and B-O O
reached B-O O
near B-O O
maximal B-O O
levels B-O O
by B-O O
24 B-O O
h B-O O
of B-O O
exposure B-O O
to B-O O
32 B-O O
nM B-O O
TPA B-O O
. B-O O

Similar B-O O
kinetics B-O O
of B-O O
c-jun B-O B-DNA
induction B-O O
by B-O O
TPA B-O O
were B-O O
observed B-O O
in B-O O
human B-O B-cell_line
U-937 B-O I-cell_line
and B-O O
THP-1 B-O B-cell_line
monocytic B-O I-cell_line
leukemia B-O I-cell_line
cells B-O I-cell_line
. B-O O

Similar B-O O
findings B-O O
were B-O O
obtained B-O O
with B-O O
bryostatin B-O O
1 B-O O
( B-O O
10 B-O O
nM B-O O
) B-O O
, B-O O
another B-O O
activator B-O O
of B-O O
protein B-O B-protein
kinase B-O I-protein
C B-O I-protein
and B-O O
inducer B-O O
of B-O O
monocytic B-O O
differentiation B-O O
. B-O O

Furthermore B-O O
, B-O O
1 B-O O
, B-O O
25-dihydroxyvitamin B-O O
D3 B-O O
( B-O O
0.5 B-O O
microM B-O O
) B-O O
, B-O O
a B-O O
structurally B-O O
distinct B-O O
agent B-O O
which B-O O
also B-O O
induces B-O O
HL-60 B-O O
monocytic B-O O
differentiation B-O O
, B-O O
increased B-O O
c-jun B-O B-DNA
expression B-O O
. B-O O

TPA B-O O
treatment B-O O
of B-O O
HL-60 B-O B-cell_line
cells B-O I-cell_line
in B-O O
the B-O O
presence B-O O
of B-O O
cycloheximide B-O O
was B-O O
associated B-O O
with B-O O
superinduction B-O O
of B-O O
c-jun B-O B-RNA
transcripts B-O I-RNA
. B-O O

Run-on B-O O
analysis B-O O
demonstrated B-O O
detectable B-O O
levels B-O O
of B-O O
c-jun B-O B-DNA
gene B-O I-DNA
transcription B-O O
in B-O O
untreated B-O B-cell_line
HL-60 B-O I-cell_line
cells B-O I-cell_line
, B-O O
and B-O O
that B-O O
exposure B-O O
to B-O O
TPA B-O O
increases B-O O
this B-O O
rate B-O O
3.3-fold B-O O
. B-O O

Treatment B-O O
of B-O O
HL-60 B-O B-cell_line
cells B-O I-cell_line
with B-O O
both B-O O
TPA B-O O
and B-O O
cycloheximide B-O O
had B-O O
no B-O O
effect B-O O
on B-O O
the B-O O
rates B-O O
of B-O O
c-jun B-O B-DNA
transcription B-O O
. B-O O

The B-O O
half-life B-O O
of B-O O
c-jun B-O B-RNA
RNA B-O I-RNA
as B-O O
determined B-O O
by B-O O
treating B-O O
HL-60 B-O B-cell_line
cells B-O I-cell_line
with B-O O
TPA B-O O
and B-O O
actinomycin B-O O
D B-O O
was B-O O
30 B-O O
min B-O O
. B-O O

In B-O O
contrast B-O O
, B-O O
the B-O O
half-life B-O O
of B-O O
c-jun B-O B-RNA
RNA B-O I-RNA
in B-O O
TPA B-O B-cell_line
-treated B-O I-cell_line
HL-60 B-O I-cell_line
cells B-O I-cell_line
exposed B-O O
to B-O O
cycloheximide B-O O
and B-O O
actinomycin B-O O
D B-O O
was B-O O
greater B-O O
than B-O O
2 B-O O
h B-O O
. B-O O

These B-O O
findings B-O O
suggested B-O O
that B-O O
the B-O O
increase B-O O
in B-O O
c-jun B-O B-RNA
RNA B-O I-RNA
observed B-O O
during B-O O
TPA B-O O
-induced B-O O
monocytic B-O O
differentiation B-O O
is B-O O
mediated B-O O
by B-O O
both B-O O
transcriptional B-O O
and B-O O
post-transcriptional B-O O
mechanisms B-O O
. B-O O

[ B-O O
Hormonal B-O O
interactions B-O O
and B-O O
glucocorticoid B-O B-protein
receptors B-O I-protein
in B-O O
patients B-O O
with B-O O
the B-O O
nephrotic B-O O
syndrome B-O O
] B-O O

As B-O O
many B-O O
as B-O O
27 B-O O
children B-O O
aged B-O O
6 B-O O
to B-O O
15 B-O O
years B-O O
with B-O O
morphologically B-O O
verified B-O O
nephropathies B-O O
were B-O O
examined B-O O
. B-O O

Four B-O O
variants B-O O
of B-O O
changes B-O O
in B-O O
the B-O O
thyroid B-O O
status B-O O
, B-O O
characteristic B-O O
of B-O O
children B-O O
with B-O O
different B-O O
variants B-O O
of B-O O
nephrotic B-O O
syndrome B-O O
were B-O O
distinguished B-O O
: B-O O
1 B-O O
) B-O O
biochemical B-O O
signs B-O O
of B-O O
primary B-O O
hypothyroidism B-O O
, B-O O
2 B-O O
) B-O O
biochemical B-O O
signs B-O O
of B-O O
secondary B-O O
hypothyroidism B-O O
, B-O O
3 B-O O
) B-O O
low B-O O
content B-O O
of B-O O
T3 B-O O
, B-O O
4 B-O O
) B-O O
dysfunction B-O O
of B-O O
the B-O O
hypophyseal B-O O
and B-O O
thyroid B-O O
system B-O O
. B-O O

It B-O O
is B-O O
shown B-O O
that B-O O
the B-O O
low B-O O
level B-O O
of B-O O
steroid B-O B-protein
receptors B-O I-protein
, B-O O
thyroid B-O O
hormones B-O O
that B-O O
the B-O O
low B-O O
level B-O O
of B-O O
steroid B-O B-protein
receptors B-O I-protein
, B-O O
thyroid B-O O
hormones B-O O
( B-O O
T3 B-O O
and B-O O
T4 B-O O
) B-O O
and B-O O
cortisol B-O O
is B-O O
typical B-O O
of B-O O
children B-O O
with B-O O
the B-O O
signs B-O O
of B-O O
renal B-O O
dysplasia B-O O
. B-O O

It B-O O
is B-O O
assumed B-O O
that B-O O
superaddition B-O O
under B-O O
such B-O O
conditions B-O O
of B-O O
immune B-O O
glomerulopathy B-O O
( B-O O
glomerulonephritis B-O O
and B-O O
nephrotic B-O O
syndrome B-O O
) B-O O
gives B-O O
rise B-O O
to B-O O
the B-O O
resistance B-O O
to B-O O
the B-O O
treatment B-O O
with B-O O
glucocorticoids B-O O
. B-O O

Lymphoid B-O O
specific B-O O
gene B-O O
expression B-O O
of B-O O
the B-O O
adenovirus B-O B-DNA
early B-O I-DNA
region B-O I-DNA
3 B-O I-DNA
promoter B-O I-DNA
is B-O O
mediated B-O O
by B-O O
NF-kappa B-O B-protein
B B-O I-protein
binding B-O O
motifs B-O O
. B-O O

A B-O O
primary B-O O
site B-O O
of B-O O
infection B-O O
by B-O O
human B-O O
adenoviruses B-O O
is B-O O
lymphoid B-O B-cell_type
cells B-O I-cell_type
. B-O O

However B-O O
, B-O O
analysis B-O O
of B-O O
the B-O O
viral B-O B-DNA
control B-O I-DNA
elements B-O I-DNA
and B-O O
the B-O O
cellular B-O B-protein
factors B-O I-protein
that B-O O
regulate B-O O
adenoviral B-O O
gene B-O O
expression B-O O
in B-O O
lymphocytes B-O B-cell_type
has B-O O
not B-O O
been B-O O
reported B-O O
. B-O O

The B-O O
adenovirus B-O B-protein
early B-O I-protein
region B-O I-protein
3 B-O I-protein
( B-O I-protein
ES B-O I-protein
) B-O I-protein
gene B-O I-protein
products B-O I-protein
are B-O O
involved B-O O
in B-O O
the B-O O
maintenance B-O O
of B-O O
viral B-O O
persistence B-O O
by B-O O
complexing B-O O
with B-O O
the B-O O
class B-O B-protein
I B-O I-protein
MHC B-O I-protein
antigens B-O I-protein
, B-O O
thus B-O O
preventing B-O O
their B-O O
cell B-O O
surface B-O O
expression B-O O
with B-O O
a B-O O
resultant B-O O
decrease B-O O
in B-O O
host B-O O
immunologic B-O O
destruction B-O O
. B-O O

To B-O O
determine B-O O
whether B-O O
different B-O O
cellular B-O B-protein
factors B-O I-protein
were B-O O
involved B-O O
in B-O O
E3 B-O B-protein
regulation B-O O
in B-O O
lymphocytes B-O B-cell_type
as B-O O
compared B-O O
with B-O O
HeLa B-O B-cell_line
cells B-O I-cell_line
, B-O O
both B-O O
DNA B-O O
binding B-O O
and B-O O
transfection B-O O
analysis B-O O
with B-O O
the B-O O
E3 B-O B-DNA
promoter B-O I-DNA
in B-O O
both B-O O
cell B-O O
types B-O O
were B-O O
performed B-O O
. B-O O

These B-O O
studies B-O O
detected B-O O
two B-O O
novel B-O B-DNA
domains B-O I-DNA
referred B-O O
to B-O O
as B-O O
L1 B-O B-DNA
and B-O O
L2 B-O B-DNA
with B-O O
a B-O O
variety B-O O
of B-O O
lymphoid B-O O
but B-O O
not B-O O
HeLa B-O O
extracts B-O O
. B-O O

Each B-O O
of B-O O
these B-O O
domains B-O O
possessed B-O O
strong B-O O
homology B-O O
to B-O O
motifs B-O O
previously B-O O
found B-O O
to B-O O
bind B-O O
the B-O O
cellular B-O B-protein
factor B-O I-protein
NF-kappa B-O B-protein
B B-O I-protein
. B-O O

Transfections B-O O
of B-O O
E3 B-O B-DNA
constructs B-O I-DNA
linked B-O O
to B-O O
the B-O O
chloramphenicol B-O B-DNA
acetyltransferase B-O I-DNA
gene B-O I-DNA
revealed B-O O
that B-O O
mutagenesis B-O O
of B-O O
the B-O O
distal B-O B-DNA
NF-kappa B-O I-DNA
B B-O I-DNA
motif B-O I-DNA
( B-O O
L2 B-O B-DNA
) B-O O
had B-O O
minimal B-O O
effects B-O O
on B-O O
promoter B-O B-DNA
expression B-O O
in B-O O
HeLa B-O B-cell_line
cells B-O I-cell_line
, B-O O
but B-O O
resulted B-O O
in B-O O
dramatic B-O O
decreases B-O O
in B-O O
expression B-O O
by B-O O
lymphoid B-O B-cell_type
cells B-O I-cell_type
. B-O O

In B-O O
contrast B-O O
, B-O O
mutagenesis B-O O
of B-O O
proximal B-O B-DNA
NF-kappa B-O I-DNA
B B-O I-DNA
motif B-O I-DNA
( B-O O
L1 B-O B-DNA
) B-O O
had B-O O
minimal B-O O
effects B-O O
on B-O O
gene B-O O
expression B-O O
in B-O O
both B-O O
HeLa B-O B-cell_line
cells B-O I-cell_line
and B-O O
lymphoid B-O B-cell_type
cells B-O I-cell_type
but B-O O
resulted B-O O
in B-O O
a B-O O
small B-O O
, B-O O
but B-O O
reproducible B-O O
, B-O O
increase B-O O
in B-O O
gene B-O O
expression B-O O
in B-O O
lymphoid B-O B-cell_type
cells B-O I-cell_type
when B-O O
coupled B-O O
to B-O O
the B-O O
L2 B-O B-DNA
mutation B-O O
. B-O O

Reversing B-O O
the B-O O
position B-O O
and B-O O
subsequent B-O O
mutagenesis B-O O
of B-O O
the B-O O
L1 B-O B-DNA
and B-O O
L2 B-O B-DNA
domains B-O I-DNA
indicated B-O O
that B-O O
the B-O O
primary B-O B-DNA
sequence B-O I-DNA
of B-O O
these B-O O
motifs B-O O
rather B-O O
than B-O O
their B-O O
position B-O O
in B-O O
the B-O O
E3 B-O B-DNA
promoter B-O I-DNA
was B-O O
critical B-O O
for B-O O
regulating B-O O
gene B-O O
expression B-O O
. B-O O

( B-O O
ABSTRACT B-O O
TRUNCATED B-O O
AT B-O O
250 B-O O
WORDS B-O O
) B-O O

Characterization B-O O
of B-O O
defensin B-O B-protein
resistance B-O O
phenotypes B-O O
associated B-O O
with B-O O
mutations B-O O
in B-O O
the B-O O
phoP B-O B-DNA
virulence B-O I-DNA
regulon B-O I-DNA
of B-O O
Salmonella B-O O
typhimurium B-O O
. B-O O

The B-O O
defensin B-O B-protein
sensitivities B-O O
of B-O O
Salmonella B-O O
typhimurium B-O O
strains B-O O
with B-O O
mutations B-O O
in B-O O
the B-O O
phoP/phoQ B-O B-DNA
two-component B-O I-DNA
virulence B-O I-DNA
regulon B-O I-DNA
were B-O O
tested B-O O
by B-O O
using B-O O
purified B-O B-protein
defensins B-O I-protein
NP-1 B-O B-protein
and B-O O
NP-2 B-O B-protein
. B-O O

Strains B-O O
with B-O O
mutations B-O O
in B-O O
either B-O O
gene B-O O
of B-O O
the B-O O
regulatory B-O B-DNA
pair B-O I-DNA
( B-O O
phoP B-O B-DNA
[ B-O O
transcriptional B-O B-protein
activator B-O I-protein
] B-O O
or B-O O
phoQ B-O B-DNA
[ B-O O
membrane B-O B-protein
sensor B-O I-protein
kinase B-O I-protein
] B-O O
) B-O O
had B-O O
increased B-O O
sensitivities B-O O
to B-O O
defensin B-O B-protein
. B-O O

The B-O O
predicted B-O O
periplasmic B-O B-protein
domain B-O I-protein
of B-O O
the B-O O
PhoQ B-O B-protein
protein B-O I-protein
contained B-O O
a B-O O
markedly B-O O
anionic B-O O
domain B-O O
that B-O O
could B-O O
interact B-O O
with B-O O
cationic B-O B-protein
proteins B-O I-protein
and B-O O
that B-O O
could B-O O
be B-O O
responsible B-O O
for B-O O
resistance B-O O
to B-O O
defensin B-O B-protein
. B-O O

Because B-O O
insertion B-O O
mutations B-O O
in B-O O
phoP B-O B-DNA
are B-O O
polar B-O O
on B-O O
phoQ B-O B-DNA
, B-O O
we B-O O
constructed B-O O
strains B-O O
that B-O O
expressed B-O O
the B-O O
PhoQ B-O B-protein
protein B-O I-protein
in B-O O
the B-O O
absence B-O O
of B-O O
PhoP B-O B-protein
to B-O O
test B-O O
whether B-O O
resistance B-O O
to B-O O
defensin B-O B-protein
requires B-O O
only B-O O
the B-O O
phoQ B-O B-protein
gene B-O I-protein
product B-O I-protein
. B-O O

We B-O O
found B-O O
that B-O O
resistance B-O O
to B-O O
defensin B-O B-protein
requires B-O O
the B-O O
function B-O O
of B-O O
both B-O O
components B-O O
of B-O O
this B-O O
regulatory B-O O
system B-O O
, B-O O
because B-O O
strains B-O O
expressing B-O O
PhoQ B-O B-protein
without B-O O
PhoP B-O B-protein
were B-O O
still B-O O
markedly B-O O
sensitive B-O O
to B-O O
defensins B-O B-protein
. B-O O

This B-O O
implied B-O O
that B-O O
a B-O O
pag B-O B-protein
( B-O I-protein
phoP B-O I-protein
-activated B-O I-protein
gene B-O I-protein
) B-O I-protein
product B-O I-protein
is B-O O
responsible B-O O
for B-O O
defensin B-O B-protein
resistance B-O O
. B-O O

We B-O O
also B-O O
tested B-O O
for B-O O
the B-O O
ability B-O O
of B-O O
defensins B-O B-protein
NP-1 B-O B-protein
, B-O O
NP-5 B-O B-protein
, B-O O
and B-O O
HNP-1 B-O B-protein
to B-O O
activate B-O O
pag B-O B-DNA
expression B-O O
and B-O O
found B-O O
that B-O O
these B-O O
peptides B-O O
have B-O O
no B-O O
effect B-O O
. B-O O

Defensin B-O B-protein
resistance B-O O
is B-O O
not B-O O
the B-O O
only B-O O
virulence B-O O
characteristic B-O O
controlled B-O O
by B-O O
the B-O O
PhoP B-O B-protein
-PhoQ B-O I-protein
regulon B-O I-protein
because B-O O
mutations B-O O
in B-O O
pagC B-O B-DNA
, B-O O
as B-O O
well B-O O
as B-O O
ones B-O O
in B-O O
the B-O O
phoP B-O B-DNA
locus B-O I-DNA
that B-O O
resulted B-O O
in B-O O
constitutive B-O O
pag B-O B-DNA
activation B-O O
( B-O O
phenotype B-O O
PhoPc B-O O
) B-O O
, B-O O
had B-O O
no B-O O
effect B-O O
on B-O O
defensin B-O B-protein
resistance B-O O
, B-O O
even B-O O
though B-O O
they B-O O
rendered B-O O
the B-O O
organism B-O O
avirulent B-O O
and B-O O
deficient B-O O
in B-O O
survival B-O O
within B-O O
macrophages B-O B-cell_type
. B-O O

The B-O O
virulence B-O O
defect B-O O
conferred B-O O
by B-O O
mutations B-O O
in B-O O
the B-O O
phoP B-O B-DNA
-phoQ B-O O
two-component B-O O
regulatory B-O O
system B-O O
is B-O O
not B-O O
completely B-O O
explained B-O O
by B-O O
alterations B-O O
in B-O O
resistance B-O O
to B-O O
cationic B-O B-protein
proteins B-O I-protein
and B-O O
involves B-O O
the B-O O
control B-O O
of B-O O
other B-O O
proteins B-O O
necessary B-O O
for B-O O
S. B-O O
typhimurium B-O O
survival B-O O
within B-O O
macrophages B-O B-cell_type
. B-O O

Stimulation B-O O
of B-O O
a B-O O
human B-O B-cell_line
T-cell B-O I-cell_line
clone B-O I-cell_line
with B-O O
anti-CD3 B-O B-protein
or B-O O
tumor B-O B-protein
necrosis B-O I-protein
factor B-O I-protein
induces B-O O
NF-kappa B-O B-protein
B B-O I-protein
translocation B-O O
but B-O O
not B-O O
human B-O O
immunodeficiency B-O O
virus B-O O
1 B-O O
enhancer-dependent B-O O
transcription B-O O
. B-O O

The B-O O
expression B-O O
of B-O O
transiently B-O O
transfected B-O O
expression B-O O
vectors B-O O
under B-O O
the B-O O
control B-O O
of B-O O
the B-O O
long B-O B-DNA
terminal B-O I-DNA
repeat B-O I-DNA
( B-O O
LTR B-O B-DNA
) B-O O
of B-O O
the B-O O
human B-O O
immunodeficiency B-O O
virus B-O O
( B-O O
HIV B-O O
) B-O O
or B-O O
its B-O O
enhancer B-O B-DNA
sequence B-O I-DNA
and B-O O
the B-O O
translocation B-O O
of B-O O
the B-O O
HIV B-O B-protein
enhancer-binding B-O I-protein
protein B-O I-protein
NF-kappa B-O B-protein
B B-O I-protein
were B-O O
analyzed B-O O
in B-O O
two B-O O
human B-O B-cell_line
T-cell B-O I-cell_line
clones B-O I-cell_line
stimulated B-O O
through B-O O
their B-O O
T-cell B-O B-protein
receptor B-O I-protein
complex B-O I-protein
or B-O O
by B-O O
tumor B-O B-protein
necrosis B-O I-protein
factor B-O I-protein
or B-O O
phorbol B-O O
12-myristate B-O O
13-acetate B-O O
. B-O O

We B-O O
found B-O O
a B-O O
dissociation B-O O
of B-O O
NF-kappa B-O B-protein
B B-O I-protein
translocation B-O O
from B-O O
transactivation B-O O
of B-O O
either B-O O
the B-O O
HIV B-O B-DNA
LTR B-O I-DNA
or B-O O
the B-O O
HIV B-O B-DNA
enhancer B-O I-DNA
. B-O O

Interleukin B-O B-protein
2 B-O I-protein
induced B-O O
proliferation B-O O
but B-O O
not B-O O
NF-kappa B-O B-protein
B B-O I-protein
translocation B-O O
or B-O O
LTR B-O B-DNA
transactivation B-O O
. B-O O

Phorbol B-O O
ester B-O O
or B-O O
specific B-O O
antigen B-O O
recognition B-O O
induced B-O O
HIV B-O B-DNA
LTR B-O I-DNA
transactivation B-O O
, B-O O
whereas B-O O
stimulation B-O O
with B-O O
tumor B-O B-protein
necrosis B-O I-protein
factor B-O I-protein
or B-O O
antibody B-O O
to B-O O
CD3 B-O B-protein
did B-O O
not B-O O
. B-O O

The B-O O
two B-O O
latter B-O O
signals B-O O
were B-O O
nevertheless B-O O
able B-O O
to B-O O
induce B-O O
NF-kappa B-O B-protein
B B-O I-protein
translocation B-O O
with B-O O
a B-O O
pattern B-O O
in B-O O
the B-O O
band-shift B-O O
assay B-O O
indistinguishable B-O O
from B-O O
that B-O O
observed B-O O
using B-O O
phorbol B-O O
ester B-O O
. B-O O

Our B-O O
finding B-O O
that B-O O
induction B-O O
of B-O O
NF-kappa B-O B-protein
B B-O I-protein
by B-O O
tumor B-O B-protein
necrosis B-O I-protein
factor B-O I-protein
or B-O O
antibody B-O O
to B-O O
CD3 B-O B-protein
is B-O O
not B-O O
sufficient B-O O
to B-O O
induce B-O O
HIV B-O B-DNA
enhancer B-O I-DNA
-dependent B-O O
transcription B-O O
in B-O O
cloned B-O B-cell_line
T B-O I-cell_line
cells B-O I-cell_line
contrasts B-O O
with B-O O
results B-O O
obtained B-O O
in B-O O
most B-O O
lymphoblastoid B-O B-cell_line
T-cell B-O I-cell_line
lines B-O I-cell_line
and B-O O
indicates B-O O
that B-O O
normal B-O B-cell_type
T B-O I-cell_type
lymphocytes B-O I-cell_type
differ B-O O
from B-O O
tumoral B-O B-cell_type
T B-O I-cell_type
cells B-O I-cell_type
in B-O O
terms B-O O
of B-O O
requirements B-O O
for B-O O
HIV B-O B-DNA
LTR B-O I-DNA
activation B-O O
. B-O O

Furthermore B-O O
, B-O O
our B-O O
results B-O O
suggest B-O O
that B-O O
events B-O O
linked B-O O
to B-O O
T-cell B-O O
activation B-O O
, B-O O
in B-O O
addition B-O O
to B-O O
NF-kappa B-O B-protein
B B-O I-protein
translocation B-O O
per B-O O
se B-O O
, B-O O
induce B-O O
functional B-O O
interactions B-O O
of B-O O
the B-O O
NF-kappa B-O B-protein
B B-O I-protein
complex B-O I-protein
with B-O O
the B-O O
HIV B-O B-DNA
enhancer B-O I-DNA
. B-O O

Decreased B-O O
concentration B-O O
of B-O O
1 B-O B-protein
, B-O I-protein
25-dihydroxyvitamin B-O I-protein
D3 B-O I-protein
receptors B-O I-protein
in B-O O
peripheral B-O B-cell_type
mononuclear B-O I-cell_type
cells B-O I-cell_type
of B-O O
patients B-O O
with B-O O
X-linked B-O O
hypophosphatemic B-O O
rickets B-O O
: B-O O
effect B-O O
of B-O O
phosphate B-O O
supplementation B-O O
. B-O O

Abnormal B-O O
renal B-O O
tubular B-O O
phosphate B-O O
transport B-O O
is B-O O
considered B-O O
to B-O O
be B-O O
the B-O O
primary B-O O
defect B-O O
in B-O O
X-linked B-O O
hypophosphatemic B-O O
rickets B-O O
( B-O O
XLH B-O O
) B-O O
. B-O O

However B-O O
, B-O O
the B-O O
resistance B-O O
to B-O O
vitamin B-O O
D B-O O
treatment B-O O
in B-O O
XLH B-O O
can B-O O
not B-O O
be B-O O
explained B-O O
by B-O O
hypophosphatemia B-O O
alone B-O O
. B-O O

Since B-O O
most B-O O
of B-O O
the B-O O
actions B-O O
of B-O O
vitamin B-O O
D B-O O
are B-O O
mediated B-O O
by B-O O
its B-O O
receptors B-O O
( B-O O
VDR B-O B-protein
) B-O O
, B-O O
abnormalities B-O O
of B-O O
VDR B-O B-protein
have B-O O
been B-O O
postulated B-O O
in B-O O
XLH B-O O
. B-O O

In B-O O
order B-O O
to B-O O
investigate B-O O
this B-O O
possibility B-O O
, B-O O
we B-O O
measured B-O O
the B-O O
concentration B-O O
of B-O O
VDR B-O B-protein
in B-O O
PHA-activated B-O B-cell_line
peripheral B-O I-cell_line
mononuclear B-O I-cell_line
cells B-O I-cell_line
from B-O O
10 B-O O
XLH B-O O
patients B-O O
. B-O O

Patients B-O O
without B-O O
phosphate B-O O
supplementation B-O O
showed B-O O
significantly B-O O
lower B-O O
concentration B-O O
( B-O O
21.7 B-O O
+/- B-O O
5.1 B-O O
fmol/mg B-O O
protein B-O O
, B-O O
mean B-O O
+/- B-O O
SEM B-O O
) B-O O
compared B-O O
to B-O O
the B-O O
normal B-O O
controls B-O O
( B-O O
60.7 B-O O
+/- B-O O
4.0 B-O O
) B-O O
. B-O O

On B-O O
the B-O O
contrary B-O O
, B-O O
there B-O O
was B-O O
no B-O O
significant B-O O
difference B-O O
between B-O O
the B-O O
phosphate-supplemented B-O O
patients B-O O
( B-O O
58.3 B-O O
+/- B-O O
2.7 B-O O
) B-O O
and B-O O
controls B-O O
. B-O O

There B-O O
was B-O O
a B-O O
significant B-O O
positive B-O O
correlation B-O O
between B-O O
VDR B-O B-protein
concentration B-O O
and B-O O
serum B-O O
phosphate B-O O
( B-O O
P B-O O
less B-O O
than B-O O
0.05 B-O O
) B-O O
. B-O O

In B-O O
two B-O O
patients B-O O
, B-O O
VDR B-O B-protein
was B-O O
increased B-O O
after B-O O
daily B-O O
phosphate B-O O
supplementation B-O O
was B-O O
started B-O O
. B-O O

These B-O O
results B-O O
indicate B-O O
that B-O O
a B-O O
decreased B-O O
concentration B-O O
of B-O O
VDR B-O B-protein
secondary B-O O
to B-O O
persistent B-O O
hypophosphatemia B-O O
is B-O O
one B-O O
of B-O O
the B-O O
causes B-O O
of B-O O
vitamin B-O O
D B-O O
resistance B-O O
in B-O O
XLH B-O O
. B-O O

Two B-O O
distinct B-O O
forms B-O O
of B-O O
active B-O B-protein
transcription B-O I-protein
factor B-O I-protein
CREB B-O I-protein
( B-O O
cAMP B-O B-protein
response B-O I-protein
element B-O I-protein
binding B-O I-protein
protein B-O I-protein
) B-O O
. B-O O

Mammalian B-O B-cell_type
cells B-O I-cell_type
express B-O O
two B-O O
distinct B-O O
forms B-O O
of B-O O
transcription B-O B-protein
factor B-O I-protein
CREB B-O I-protein
( B-O O
cAMP B-O B-protein
response B-O I-protein
element B-O I-protein
binding B-O I-protein
protein B-O I-protein
) B-O O
that B-O O
are B-O O
apparently B-O O
the B-O O
products B-O O
of B-O O
alternative B-O O
splicing B-O O
of B-O O
the B-O O
CREB B-O B-RNA
gene B-O I-RNA
transcript B-O I-RNA
. B-O O

The B-O O
two B-O O
proteins B-O O
differ B-O O
by B-O O
a B-O O
14-amino B-O B-protein
acid B-O I-protein
serine-rich B-O I-protein
insertion B-O I-protein
present B-O O
in B-O O
one B-O O
of B-O O
the B-O O
CREB B-O B-protein
isoforms B-O I-protein
. B-O O

We B-O O
show B-O O
that B-O O
both B-O O
CREB B-O B-protein
isoforms B-O I-protein
are B-O O
expressed B-O O
in B-O O
many B-O O
cell B-O O
types B-O O
and B-O O
mammalian B-O B-protein
species B-O I-protein
. B-O O

Both B-O O
encode B-O O
proteins B-O O
that B-O O
bind B-O O
specifically B-O O
to B-O O
a B-O O
cAMP B-O B-DNA
response B-O I-DNA
element B-O I-DNA
in B-O O
vitro B-O O
. B-O O

As B-O O
expected B-O O
for B-O O
proteins B-O O
of B-O O
this B-O O
class B-O O
, B-O O
the B-O O
CREB B-O B-protein
proteins B-O I-protein
bind B-O O
DNA B-O O
as B-O O
dimers B-O B-protein
. B-O O

Both B-O O
proteins B-O O
impart B-O O
cAMP B-O O
-regulated B-O O
transcriptional B-O O
activity B-O O
to B-O O
a B-O O
heterologous B-O B-protein
DNA-binding B-O I-protein
domain B-O I-protein
, B-O O
showing B-O O
that B-O O
cAMP B-O O
directly B-O O
modulates B-O O
the B-O O
transcriptional B-O O
stimulatory B-O O
activity B-O O
of B-O O
CREB B-O B-protein
. B-O O

The B-O O
presence B-O O
of B-O O
multiple B-O O
CREB B-O B-protein
isoforms B-O I-protein
with B-O O
identical B-O O
DNA-binding B-O O
specificities B-O O
but B-O O
differences B-O O
in B-O O
the B-O O
presumed B-O O
regulatory B-O B-protein
domain B-O I-protein
raises B-O O
the B-O O
possibility B-O O
that B-O O
CREB B-O B-protein
proteins B-O I-protein
may B-O O
be B-O O
able B-O O
to B-O O
integrate B-O O
distinct B-O O
regulatory B-O O
signals B-O O
at B-O O
the B-O O
level B-O O
of B-O O
gene B-O O
transcription B-O O
. B-O O

Human B-O B-protein
immunodeficiency B-O I-protein
virus B-O I-protein
vpr B-O I-protein
product B-O I-protein
is B-O O
a B-O O
virion-associated B-O B-protein
regulatory B-O I-protein
protein B-O I-protein
. B-O O

The B-O O
vpr B-O B-protein
product B-O I-protein
of B-O O
the B-O O
human B-O O
immunodeficiency B-O O
virus B-O O
type B-O O
1 B-O O
( B-O O
HIV-1 B-O O
) B-O O
acts B-O O
in B-O O
trans B-O O
to B-O O
accelerate B-O O
virus B-O O
replication B-O O
and B-O O
cytopathic B-O O
effect B-O O
in B-O O
T B-O B-cell_type
cells B-O I-cell_type
. B-O O

Here B-O O
it B-O O
is B-O O
shown B-O O
that B-O O
the B-O O
HIV-1 B-O O
viral B-O O
particle B-O O
contains B-O O
multiple B-O O
copies B-O O
of B-O O
the B-O O
vpr B-O B-protein
protein B-O I-protein
. B-O O

The B-O O
vpr B-O B-protein
product B-O I-protein
is B-O O
the B-O O
first B-O B-protein
regulatory B-O I-protein
protein B-O I-protein
of B-O O
HIV-1 B-O O
to B-O O
be B-O O
found B-O O
in B-O O
the B-O O
virus B-O O
particle B-O O
. B-O O

This B-O O
observation B-O O
raises B-O O
the B-O O
possibility B-O O
that B-O O
vpr B-O B-protein
acts B-O O
to B-O O
facilitate B-O O
the B-O O
early B-O O
steps B-O O
of B-O O
infection B-O O
before B-O O
de B-O O
novo B-O O
viral B-O O
protein B-O O
synthesis B-O O
occurs B-O O
. B-O O

A B-O O
novel B-O O
B-cell B-O B-protein
lineage-specific B-O I-protein
transcription B-O I-protein
factor B-O I-protein
present B-O O
at B-O O
early B-O O
but B-O O
not B-O O
late B-O O
stages B-O O
of B-O O
differentiation B-O O
. B-O O

A B-O O
novel B-O O
B-cell-specific B-O B-protein
transcription B-O I-protein
factor B-O I-protein
, B-O O
BSAP B-O B-protein
, B-O O
was B-O O
identified B-O O
as B-O O
a B-O O
mammalian B-O B-protein
homolog B-O I-protein
of B-O O
the B-O O
sea B-O B-protein
urchin B-O I-protein
protein B-O I-protein
TSAP B-O B-protein
, B-O O
which B-O O
interacts B-O O
with B-O O
the B-O O
promoters B-O B-DNA
of B-O O
four B-O O
tissue-specific B-O B-DNA
late B-O I-DNA
histone B-O I-DNA
H2A-2 B-O I-DNA
and B-O I-DNA
H2B-2 B-O I-DNA
genes B-O I-DNA
. B-O O

As B-O O
shown B-O O
by B-O O
mobility-shift B-O O
, B-O O
methylation B-O O
interference B-O O
, B-O O
and B-O O
mutational B-O O
analyses B-O O
, B-O O
the B-O O
mammalian B-O B-protein
protein B-O I-protein
BSAP B-O B-protein
recognizes B-O O
all B-O O
four B-O O
sea B-O B-DNA
urchin B-O I-DNA
binding B-O I-DNA
sites B-O I-DNA
in B-O O
a B-O O
manner B-O O
indistinguishable B-O O
from B-O O
TSAP B-O B-protein
; B-O O
however B-O O
, B-O O
the B-O O
two B-O O
proteins B-O O
differ B-O O
in B-O O
molecular B-O O
weight B-O O
. B-O O

BSAP B-O B-protein
is B-O O
exclusively B-O O
restricted B-O O
to B-O O
the B-O O
B-cell B-O B-cell_type
lineage B-O I-cell_type
of B-O O
lymphoid B-O O
differentiation B-O O
. B-O O

Its B-O O
expression B-O O
appears B-O O
to B-O O
be B-O O
activated B-O O
during B-O O
pro-B-cell B-O O
development B-O O
, B-O O
is B-O O
abundant B-O O
at B-O O
the B-O O
pre-B- B-O O
and B-O O
mature B-O O
B- B-O O
cell B-O O
stages B-O O
, B-O O
but B-O O
is B-O O
absent B-O O
in B-O O
terminally B-O B-cell_type
differentiated B-O I-cell_type
plasma B-O I-cell_type
cells B-O I-cell_type
. B-O O

Moreover B-O O
, B-O O
BSAP B-O B-protein
is B-O O
clearly B-O O
a B-O O
B-cell-specific B-O B-protein
transcription B-O I-protein
factor B-O I-protein
, B-O O
as B-O O
a B-O O
wild-type B-O O
but B-O O
not B-O O
a B-O O
mutant B-O B-DNA
TSAP B-O I-DNA
-binding B-O I-DNA
site B-O I-DNA
of B-O O
the B-O O
sea B-O O
urchin B-O O
functions B-O O
only B-O O
in B-O O
transfected B-O B-cell_line
B B-O I-cell_line
cells B-O I-cell_line
as B-O O
an B-O O
upstream B-O B-DNA
promoter B-O I-DNA
element B-O I-DNA
. B-O O

Competition B-O O
experiments B-O O
did B-O O
not B-O O
reveal B-O O
any B-O O
high-affinity B-O B-DNA
binding B-O I-DNA
site B-O I-DNA
for B-O O
BSAP B-O B-protein
in B-O O
known B-O O
regulatory B-O B-DNA
regions B-O I-DNA
of B-O O
immunoglobulin B-O B-DNA
and B-O I-DNA
class B-O I-DNA
II B-O I-DNA
major B-O I-DNA
histocompatibility B-O I-DNA
( B-O I-DNA
MHC B-O I-DNA
) B-O I-DNA
genes B-O I-DNA
, B-O O
suggesting B-O O
that B-O O
BSAP B-O B-protein
is B-O O
a B-O O
regulator B-O O
of B-O O
a B-O O
different B-O O
set B-O O
of B-O O
B-lymphoid-specific B-O B-DNA
genes B-O I-DNA
. B-O O

Octamer B-O B-protein
transcription B-O I-protein
factors B-O I-protein
and B-O O
the B-O O
cell B-O O
type-specificity B-O O
of B-O O
immunoglobulin B-O B-DNA
gene B-O I-DNA
expression B-O O
. B-O O

Antibodies B-O B-protein
are B-O O
produced B-O O
exclusively B-O O
in B-O O
B B-O B-cell_type
lymphocytes B-O I-cell_type
. B-O O

The B-O O
expression B-O O
of B-O O
the B-O O
antibody-encoding B-O B-DNA
genes B-O I-DNA
, B-O O
the B-O O
immunoglobulin B-O B-DNA
( B-O I-DNA
Ig B-O I-DNA
) B-O I-DNA
genes B-O I-DNA
, B-O O
is B-O O
also B-O O
restricted B-O O
to B-O O
B B-O B-cell_type
cells B-O I-cell_type
. B-O O

The B-O O
octamer B-O B-DNA
sequence B-O I-DNA
ATGCAAAT B-O O
is B-O O
present B-O O
in B-O O
the B-O O
promoter B-O B-DNA
and B-O O
the B-O O
enhancer B-O B-DNA
of B-O O
Ig B-O B-DNA
genes B-O I-DNA
, B-O O
and B-O O
plays B-O O
an B-O O
important B-O O
role B-O O
in B-O O
its B-O O
tissue-specific B-O O
expression B-O O
. B-O O

This B-O O
sequence B-O B-DNA
motif B-O I-DNA
is B-O O
a B-O O
binding B-O B-DNA
site B-O I-DNA
for B-O O
nuclear B-O B-protein
proteins B-O I-protein
, B-O O
the B-O O
so-called B-O O
octamer B-O B-protein
transcription B-O I-protein
factors B-O I-protein
( B-O O
Oct B-O B-protein
or B-O O
OTF B-O B-protein
factors B-O I-protein
) B-O O
. B-O O

The B-O O
Oct-1 B-O B-protein
protein B-O I-protein
is B-O O
present B-O O
in B-O O
all B-O O
cell B-O O
types B-O O
analyzed B-O O
so B-O O
far B-O O
, B-O O
whereas B-O O
Oct-2A B-O B-protein
and B-O O
Oct-2B B-O B-protein
are B-O O
found B-O O
mainly B-O O
in B-O O
B B-O B-cell_type
lymphocytes B-O I-cell_type
. B-O O

All B-O O
three B-O O
proteins B-O O
show B-O O
the B-O O
same B-O O
sequence B-O O
specificity B-O O
and B-O O
binding B-O O
affinity B-O O
. B-O O

It B-O O
appears B-O O
that B-O O
the B-O O
B B-O O
cell-specific B-O O
expression B-O O
of B-O O
Ig B-O B-DNA
genes B-O I-DNA
is B-O O
mediated B-O O
at B-O O
least B-O O
in B-O O
part B-O O
by B-O O
cell B-O B-protein
type-specific B-O I-protein
Oct B-O I-protein
factors B-O I-protein
, B-O O
and B-O O
that B-O O
there B-O O
are B-O O
both B-O O
quantitative B-O O
and B-O O
qualitative B-O O
differences B-O O
between B-O O
Oct-1 B-O B-protein
and B-O O
Oct-2 B-O B-protein
factors B-O I-protein
. B-O O

Recently B-O O
, B-O O
a B-O O
number B-O O
of B-O O
other B-O O
octamer B-O B-protein
factor B-O I-protein
variants B-O I-protein
were B-O O
identified B-O O
. B-O O

Many B-O O
of B-O O
these B-O O
may B-O O
be B-O O
created B-O O
by B-O O
alternative B-O O
splicing B-O O
of B-O O
a B-O O
primary B-O B-RNA
transcript B-O I-RNA
of B-O O
one B-O O
Oct B-O B-DNA
factor B-O I-DNA
gene B-O I-DNA
and B-O O
may B-O O
serve B-O O
a B-O O
specific B-O O
function B-O O
in B-O O
the B-O O
fine B-O O
tuning B-O O
of B-O O
gene B-O O
expression B-O O
. B-O O

A B-O O
factor B-O O
known B-O O
to B-O O
bind B-O O
to B-O O
endogenous B-O B-DNA
Ig B-O I-DNA
heavy B-O I-DNA
chain B-O I-DNA
enhancer B-O I-DNA
only B-O O
in B-O O
lymphocytes B-O B-cell_type
is B-O O
a B-O O
ubiquitously B-O B-protein
active B-O I-protein
transcription B-O I-protein
factor B-O I-protein
. B-O O

The B-O O
transcriptional B-O B-DNA
enhancer B-O I-DNA
located B-O O
in B-O O
the B-O O
first B-O B-DNA
intron B-O I-DNA
of B-O O
the B-O O
immunoglobulin B-O B-DNA
heavy B-O I-DNA
chain B-O I-DNA
constant B-O I-DNA
region B-O I-DNA
is B-O O
a B-O O
major B-O O
determinant B-O O
of B-O O
B-cell-specific B-O O
expression B-O O
of B-O O
immunoglobulin B-O B-DNA
genes B-O I-DNA
. B-O O

Like B-O O
other B-O O
enhancers B-O B-DNA
, B-O O
the B-O O
Ig B-O B-DNA
heavy B-O I-DNA
chain B-O I-DNA
enhancer B-O I-DNA
contains B-O O
several B-O O
short B-O O
sequence B-O B-DNA
motifs B-O I-DNA
that B-O O
bind B-O O
specific B-O O
transcription B-O B-protein
factors B-O I-protein
. B-O O

Each B-O O
binding B-O B-DNA
site B-O I-DNA
contributes B-O O
to B-O O
the B-O O
overall B-O O
activity B-O O
of B-O O
the B-O O
enhancer B-O B-DNA
, B-O O
however B-O O
no B-O O
single B-O O
element B-O O
seems B-O O
absolutely B-O O
required B-O O
for B-O O
activity B-O O
. B-O O

For B-O O
a B-O O
better B-O O
understanding B-O O
of B-O O
the B-O O
Ig B-O B-protein
heavy B-O I-protein
chain B-O I-protein
enhancer B-O I-protein
components B-O I-protein
, B-O O
we B-O O
have B-O O
cloned B-O O
and B-O O
analyzed B-O O
individual B-O O
sequence B-O B-DNA
elements B-O I-DNA
. B-O O

We B-O O
find B-O O
that B-O O
the B-O O
factor B-O O
that B-O O
binds B-O O
to B-O O
the B-O O
E3 B-O B-DNA
enhancer B-O I-DNA
motif B-O I-DNA
, B-O O
CATGTGGC B-O O
, B-O O
is B-O O
a B-O O
ubiquitous B-O B-protein
transcription B-O I-protein
factor B-O I-protein
. B-O O

It B-O O
is B-O O
present B-O O
in B-O O
an B-O O
active B-O O
form B-O O
in B-O O
both B-O O
B B-O B-cell_type
cells B-O I-cell_type
and B-O O
non- B-O B-cell_type
B B-O I-cell_type
cells B-O I-cell_type
, B-O O
where B-O O
it B-O O
can B-O O
mediate B-O O
transcriptional B-O O
activation B-O O
in B-O O
vitro B-O O
and B-O O
in B-O O
vivo B-O O
. B-O O

However B-O O
, B-O O
despite B-O O
its B-O O
ability B-O O
to B-O O
activate B-O O
transcription B-O O
of B-O O
a B-O O
transfected B-O B-DNA
reporter B-O I-DNA
gene B-O I-DNA
, B-O O
the B-O O
factor B-O O
is B-O O
apparently B-O O
unable B-O O
to B-O O
bind B-O O
to B-O O
the B-O O
endogenous B-O B-DNA
Ig B-O I-DNA
heavy B-O I-DNA
chain B-O I-DNA
enhancer B-O I-DNA
in B-O O
non- B-O B-cell_type
lymphoid B-O I-cell_type
cells B-O I-cell_type
: B-O O
In B-O O
previous B-O O
experiments B-O O
by B-O O
others B-O O
, B-O O
the B-O O
characteristic B-O O
in B-O O
vivo B-O O
footprint B-O O
of B-O O
this B-O O
factor B-O O
, B-O O
designated B-O O
NF-muE3 B-O B-protein
, B-O O
was B-O O
detected B-O O
in B-O O
B B-O B-cell_type
cells B-O I-cell_type
but B-O O
not B-O O
in B-O O
non-B B-O B-cell_type
cells B-O I-cell_type
. B-O O

From B-O O
this B-O O
and B-O O
other B-O O
findings B-O O
the B-O O
picture B-O O
emerges B-O O
that B-O O
there B-O O
are B-O O
at B-O O
least B-O O
three B-O O
categories B-O O
of B-O O
factors B-O O
which B-O O
mediate B-O O
cell-type-specific B-O O
transcription B-O O
in B-O O
B B-O B-cell_type
lymphocytes B-O I-cell_type
: B-O O
( B-O O
a B-O O
) B-O O
cell-specific B-O B-protein
factors B-O I-protein
such B-O O
as B-O O
Oct-2A B-O B-protein
and B-O O
Oct-2B B-O B-protein
that B-O O
are B-O O
not B-O O
expressed B-O O
in B-O O
most B-O O
other B-O O
cell B-O O
types B-O O
: B-O O
( B-O O
b B-O O
) B-O O
ubiquitous B-O B-protein
factors B-O I-protein
such B-O O
as B-O O
NF-kappa B-O B-protein
B B-O I-protein
that B-O O
are B-O O
constitutively B-O O
active B-O O
in B-O O
B B-O B-cell_type
cells B-O I-cell_type
but B-O O
are B-O O
sequestered B-O O
in B-O O
an B-O O
inactive B-O O
form B-O O
in B-O O
other B-O O
cells B-O O
; B-O O
( B-O O
c B-O O
) B-O O
ubiquitously B-O B-protein
active B-O I-protein
factors B-O I-protein
, B-O O
exemplified B-O O
by B-O O
the B-O O
one B-O O
binding B-O O
to B-O O
the B-O O
E3 B-O B-DNA
sequence B-O I-DNA
motif B-O I-DNA
. B-O O

This B-O O
factor B-O O
is B-O O
present B-O O
in B-O O
an B-O O
active B-O O
form B-O O
in B-O O
a B-O O
variety B-O O
of B-O O
cell B-O O
types B-O O
but B-O O
is B-O O
apparently B-O O
unable B-O O
to B-O O
bind B-O O
to B-O O
the B-O O
endogenous B-O B-DNA
Ig B-O I-DNA
heavy B-O I-DNA
chain B-O I-DNA
enhancer B-O I-DNA
in B-O O
non-B B-O B-cell_type
cells B-O I-cell_type
, B-O O
perhaps B-O O
due B-O O
to B-O O
a B-O O
non-permissive B-O O
chromatin B-O B-DNA
structure B-O O
of B-O O
the B-O O
Ig B-O B-DNA
heavy B-O I-DNA
chain B-O I-DNA
locus B-O I-DNA
. B-O O

[ B-O O
Endocrine B-O O
status B-O O
changes B-O O
in B-O O
children B-O O
with B-O O
bronchial B-O O
asthma B-O O
] B-O O

A B-O O
study B-O O
was B-O O
made B-O O
of B-O O
adrenocortical B-O O
function B-O O
by B-O O
measuring B-O O
blood B-O O
plasma B-O O
cortisol B-O O
concentration B-O O
and B-O O
amount B-O O
of B-O O
glucocorticoid B-O B-protein
receptors B-O I-protein
in B-O O
lymphocytes B-O B-cell_type
as B-O O
well B-O O
as B-O O
thyroid B-O O
function B-O O
by B-O O
measuring B-O O
blood B-O O
plasma B-O O
triidothyronine B-O O
and B-O O
thyroxine B-O O
concentration B-O O
in B-O O
58 B-O O
bronchial B-O O
asthma B-O O
children B-O O
aged B-O O
1 B-O O
to B-O O
14 B-O O
years B-O O
. B-O O

The B-O O
authors B-O O
revealed B-O O
alterations B-O O
in B-O O
the B-O O
functional B-O O
activity B-O O
of B-O O
the B-O O
indicated B-O O
endocrine B-O O
glands B-O O
depending B-O O
on B-O O
the B-O O
intensity B-O O
of B-O O
bronchial B-O O
patency B-O O
disorders B-O O
and B-O O
the B-O O
nature B-O O
of B-O O
the B-O O
therapeutic B-O O
measures B-O O
carried B-O O
out B-O O
. B-O O

TAR B-O B-DNA
independent B-O O
activation B-O O
of B-O O
the B-O O
human B-O O
immunodeficiency B-O O
virus B-O O
in B-O O
phorbol B-O O
ester B-O O
stimulated B-O O
T B-O B-cell_type
lymphocytes B-O I-cell_type
. B-O O

Multiple B-O B-DNA
regulatory B-O I-DNA
elements B-O I-DNA
in B-O O
the B-O O
human B-O B-DNA
immunodeficiency B-O I-DNA
virus B-O I-DNA
long B-O I-DNA
terminal B-O I-DNA
repeat B-O I-DNA
( B-O O
HIV B-O B-DNA
LTR B-O I-DNA
) B-O O
are B-O O
required B-O O
for B-O O
activation B-O O
of B-O O
HIV B-O O
gene B-O O
expression B-O O
. B-O O

Previous B-O O
transfection B-O O
studies B-O O
of B-O O
HIV B-O B-DNA
LTR B-O I-DNA
constructs B-O I-DNA
linked B-O O
to B-O O
the B-O O
chloramphenicol B-O B-DNA
acetyltransferase B-O I-DNA
gene B-O I-DNA
indicated B-O O
that B-O O
multiple B-O O
regulatory B-O B-DNA
regions B-O I-DNA
including B-O O
the B-O O
enhancer B-O B-DNA
, B-O O
SP1 B-O B-protein
, B-O O
TATA B-O B-DNA
and B-O O
TAR B-O B-DNA
regions B-O I-DNA
were B-O O
important B-O O
for B-O O
HIV B-O O
gene B-O O
expression B-O O
. B-O O

To B-O O
characterize B-O O
these B-O O
regulatory B-O B-DNA
elements B-O I-DNA
further B-O O
, B-O O
mutations B-O O
in B-O O
these B-O O
regions B-O O
were B-O O
inserted B-O O
into B-O O
both B-O O
the B-O O
5 B-O B-DNA
' B-O I-DNA
and B-O I-DNA
3 B-O I-DNA
' B-O I-DNA
HIV B-O I-DNA
LTRs B-O I-DNA
and B-O O
infectious B-O O
proviral B-O O
constructs B-O O
were B-O O
assembled B-O O
. B-O O

These B-O O
constructs B-O O
were B-O O
transfected B-O O
into B-O O
either B-O O
HeLa B-O B-cell_line
cells B-O I-cell_line
, B-O O
Jurkat B-O B-cell_line
cells B-O I-cell_line
or B-O O
U937 B-O B-cell_line
cells B-O I-cell_line
in B-O O
both B-O O
the B-O O
presence B-O O
and B-O O
absence B-O O
of B-O O
phorbol B-O O
esters B-O O
which B-O O
have B-O O
previously B-O O
been B-O O
demonstrated B-O O
to B-O O
activate B-O O
HIV B-O O
gene B-O O
expression B-O O
. B-O O

Viral B-O O
gene B-O O
expression B-O O
was B-O O
assayed B-O O
by B-O O
the B-O O
level B-O O
of B-O O
p24 B-O B-protein
gag B-O I-protein
protein B-O I-protein
released B-O O
from B-O O
cultures B-O O
transfected B-O O
with B-O O
the B-O O
proviral B-O B-DNA
constructs B-O I-DNA
. B-O O

Results B-O O
in B-O O
all B-O O
cell B-O B-cell_line
lines B-O I-cell_line
indicated B-O O
that B-O O
mutations B-O O
of B-O O
the B-O O
SP1 B-O B-protein
, B-O O
TATA B-O B-DNA
and B-O O
the B-O O
TAR B-O O
loop B-O O
and B-O O
stem B-O O
secondary B-O O
structure B-O O
resulted B-O O
in B-O O
marked B-O O
decreases B-O O
in B-O O
gene B-O O
expression B-O O
while B-O O
mutations B-O O
of B-O O
the B-O O
enhancer B-O B-DNA
motif B-O I-DNA
or B-O O
TAR B-O B-DNA
primary B-O I-DNA
sequence B-O I-DNA
resulted B-O O
in B-O O
only B-O O
slight B-O O
decreases B-O O
. B-O O

However B-O O
, B-O O
viruses B-O O
containing B-O O
mutations B-O O
in B-O O
either B-O O
the B-O O
TAR B-O B-DNA
loop B-O I-DNA
sequences B-O I-DNA
or B-O O
stem B-O O
secondary B-O O
structure B-O O
which B-O O
were B-O O
very B-O O
defective B-O O
for B-O O
gene B-O O
expression B-O O
in B-O O
untreated B-O O
Jurkat B-O B-cell_line
cells B-O I-cell_line
, B-O O
gave B-O O
nearly B-O O
wild-type B-O O
levels B-O O
of B-O O
gene B-O O
expression B-O O
in B-O O
phorbol B-O B-cell_line
ester B-O I-cell_line
-treated B-O I-cell_line
Jurkat B-O I-cell_line
cells B-O I-cell_line
but B-O O
not B-O O
in B-O O
phorbol B-O B-cell_line
ester B-O I-cell_line
-treated B-O I-cell_line
HeLa B-O I-cell_line
or B-O O
U937 B-O B-cell_line
cells B-O I-cell_line
. B-O O

High B-O O
level B-O O
gene B-O O
expression B-O O
of B-O O
these B-O O
TAR B-O B-DNA
mutant B-O I-DNA
constructs B-O I-DNA
in B-O O
phorbol B-O B-cell_line
ester B-O I-cell_line
-treated B-O I-cell_line
Jurkat B-O I-cell_line
cells B-O I-cell_line
was B-O O
eliminated B-O O
by B-O O
second B-O O
site B-O O
mutations B-O O
in B-O O
the B-O O
enhancer B-O B-DNA
region B-O I-DNA
or B-O O
by B-O O
disruption B-O O
of B-O O
the B-O O
tat B-O B-DNA
gene B-O I-DNA
. B-O O

( B-O O
ABSTRACT B-O O
TRUNCATED B-O O
AT B-O O
250 B-O O
WORDS B-O O
) B-O O

A B-O O
case B-O O
of B-O O
hypersensitivity B-O O
to B-O O
thyroid B-O O
hormones B-O O
with B-O O
normally B-O O
functioning B-O O
thyroid B-O O
gland B-O O
and B-O O
increased B-O O
nuclear B-O B-protein
triiodothyronine B-O I-protein
receptors B-O I-protein
. B-O O

A B-O O
52-year-old B-O O
male B-O O
presented B-O O
himself B-O O
with B-O O
tachycardia B-O O
crises B-O O
which B-O O
appeared B-O O
first B-O O
during B-O O
childhood B-O O
, B-O O
increased B-O O
in B-O O
frequency B-O O
without B-O O
goiter B-O O
or B-O O
exophthalmos B-O O
. B-O O

Cardiac B-O O
and B-O O
adrenergic B-O O
diseases B-O O
were B-O O
excluded B-O O
. B-O O

The B-O O
thyroid B-O O
function B-O O
was B-O O
normal B-O O
regarding B-O O
T4 B-O O
, B-O O
free B-O O
T4 B-O O
and B-O O
T3 B-O B-DNA
, B-O O
TBG B-O B-protein
, B-O O
radioiodine B-O O
uptake B-O O
, B-O O
TSH B-O O
and B-O O
T3 B-O O
suppressibility B-O O
; B-O O
however B-O O
the B-O O
TSH B-O O
response B-O O
to B-O O
TRH B-O B-protein
was B-O O
decreased B-O O
. B-O O

The B-O O
lymphocyte B-O B-protein
nuclear B-O I-protein
T3 B-O I-protein
receptor B-O I-protein
was B-O O
found B-O O
with B-O O
an B-O O
affinity B-O O
close B-O O
to B-O O
that B-O O
of B-O O
normal B-O O
volunteers B-O O
( B-O O
Ka B-O O
: B-O O
1.42 B-O O
x B-O O
10 B-O O
( B-O O
10 B-O O
) B-O O
M-1 B-O O
vs B-O O
1.95 B-O O
+/- B-O O
0.35 B-O O
x B-O O
10 B-O O
( B-O O
10 B-O O
) B-O O
M-1 B-O O
) B-O O
and B-O O
a B-O O
binding B-O O
capacity B-O O
markedly B-O O
increased B-O O
( B-O O
9.9 B-O O
vs B-O O
3.7 B-O O
+/- B-O O
0.4 B-O O
fmol B-O O
T3 B-O O
/ B-O O
100 B-O O
micrograms B-O O
DNA B-O O
) B-O O
. B-O O

Pindolol B-O O
was B-O O
inefficient B-O O
on B-O O
the B-O O
dysrhythmia B-O O
which B-O O
disappeared B-O O
with B-O O
carbimazole B-O O
and B-O O
relapsed B-O O
after B-O O
withdrawal B-O O
of B-O O
the B-O O
antithyroid B-O O
drug B-O O
. B-O O

Under B-O O
carbimazole B-O O
, B-O O
the B-O O
plasma B-O O
T4 B-O O
markedly B-O O
decreased B-O O
( B-O O
27.7 B-O O
+/- B-O O
3.6 B-O O
nmol/l B-O O
) B-O O
but B-O O
the B-O O
patient B-O O
remained B-O O
euthyroid B-O O
. B-O O

The B-O O
clinical B-O O
course B-O O
and B-O O
the B-O O
laboratory B-O O
data B-O O
suggest B-O O
that B-O O
the B-O O
tachycardia B-O O
crises B-O O
are B-O O
the B-O O
consequence B-O O
of B-O O
a B-O O
hypersensitivity B-O O
of B-O O
the B-O O
heart B-O O
to B-O O
thyroid B-O O
hormones B-O O
, B-O O
associated B-O O
with B-O O
an B-O O
increased B-O O
number B-O O
of B-O O
T3 B-O B-protein
nuclear B-O I-protein
receptor B-O I-protein
sites B-O O
in B-O O
lymphocytes B-O B-cell_type
. B-O O

Induction B-O O
of B-O O
immediate B-O B-DNA
early B-O I-DNA
response B-O I-DNA
genes B-O I-DNA
by B-O O
macrophage B-O B-protein
colony-stimulating B-O I-protein
factor B-O I-protein
in B-O O
normal B-O B-cell_type
human B-O I-cell_type
monocytes B-O I-cell_type
. B-O O

A B-O O
group B-O O
of B-O O
coordinately B-O O
induced B-O O
protooncogenes B-O B-DNA
, B-O O
cytoskeletal B-O O
, B-O O
and B-O O
extracellular B-O B-DNA
matrix B-O I-DNA
genes B-O I-DNA
have B-O O
been B-O O
termed B-O O
immediate B-O B-DNA
early B-O I-DNA
response B-O I-DNA
genes B-O I-DNA
, B-O O
and B-O O
their B-O O
induction B-O O
has B-O O
been B-O O
associated B-O O
with B-O O
growth B-O B-protein
factor B-O I-protein
-stimulated B-O O
cell B-O O
proliferation B-O O
. B-O O

We B-O O
have B-O O
investigated B-O O
the B-O O
induction B-O O
of B-O O
these B-O O
genes B-O O
by B-O O
macrophage-CSF B-O B-protein
( B-O O
M-CSF B-O B-protein
) B-O O
in B-O O
human B-O B-cell_type
monocytes B-O I-cell_type
that B-O O
do B-O O
not B-O O
proliferate B-O O
in B-O O
response B-O O
to B-O O
M-CSF B-O B-protein
but B-O O
require B-O O
the B-O O
factor B-O O
for B-O O
optimal B-O O
cell B-O O
differentiation B-O O
. B-O O

Normal B-O O
human B-O B-cell_type
monocytes B-O I-cell_type
were B-O O
isolated B-O O
, B-O O
carefully B-O O
washed B-O O
, B-O O
and B-O O
incubated B-O O
for B-O O
36 B-O O
to B-O O
48 B-O O
h B-O O
in B-O O
fetal B-O O
bovine B-O O
serum-containing B-O O
medium B-O O
. B-O O

At B-O O
the B-O O
end B-O O
of B-O O
this B-O O
incubation B-O O
the B-O O
resting B-O B-cell_type
cells B-O I-cell_type
were B-O O
stimulated B-O O
with B-O O
M-CSF B-O B-protein
, B-O O
and B-O O
RNA B-O O
was B-O O
isolated B-O O
for B-O O
analysis B-O O
by B-O O
Northern B-O O
blotting B-O O
. B-O O

RNA B-O O
from B-O O
control B-O O
resting B-O B-cell_type
cells B-O I-cell_type
contained B-O O
low B-O O
to B-O O
undetectable B-O O
levels B-O O
of B-O O
c-jun B-O B-DNA
, B-O O
fibronectin B-O B-protein
receptor B-O I-protein
, B-O O
and B-O O
actin B-O B-RNA
mRNA B-O I-RNA
. B-O O

Within B-O O
15 B-O O
to B-O O
30 B-O O
min B-O O
of B-O O
addition B-O O
of B-O O
M-CSF B-O B-protein
, B-O O
however B-O O
, B-O O
there B-O O
was B-O O
a B-O O
dramatic B-O O
coordinate B-O O
induction B-O O
of B-O O
these B-O O
genes B-O O
. B-O O

The B-O O
c-jun B-O B-DNA
gene B-O I-DNA
expression B-O O
was B-O O
very B-O O
transient B-O O
and B-O O
was B-O O
not B-O O
detectable B-O O
by B-O O
60 B-O O
min B-O O
after B-O O
M-CSF B-O B-protein
addition B-O O
. B-O O

In B-O O
contrast B-O O
, B-O O
the B-O O
expression B-O O
of B-O O
actin B-O B-RNA
and B-O I-RNA
fibronectin B-O I-RNA
receptor B-O I-RNA
mRNA B-O I-RNA
was B-O O
more B-O O
sustained B-O O
, B-O O
and B-O O
the B-O O
expression B-O O
of B-O O
these B-O O
genes B-O O
remained B-O O
elevated B-O O
at B-O O
24 B-O O
to B-O O
48 B-O O
h B-O O
after B-O O
M-CSF B-O B-protein
addition B-O O
. B-O O

We B-O O
also B-O O
observed B-O O
the B-O O
induction B-O O
of B-O O
the B-O O
myelomonocytic B-O B-DNA
specific B-O I-DNA
tyrosine B-O I-DNA
kinase B-O I-DNA
hck B-O I-DNA
gene B-O I-DNA
simultaneously B-O O
with B-O O
the B-O O
other B-O O
immediate B-O B-DNA
early B-O I-DNA
response B-O I-DNA
genes B-O I-DNA
. B-O O

The B-O O
protein B-O O
synthesis B-O O
inhibitor B-O O
cycloheximide B-O O
did B-O O
not B-O O
block B-O O
the B-O O
induction B-O O
of B-O O
any B-O O
of B-O O
these B-O O
genes B-O O
, B-O O
and B-O O
in B-O O
fact B-O O
, B-O O
super-induced B-O O
the B-O O
expression B-O O
of B-O O
c-jun B-O B-DNA
and B-O O
hck B-O B-DNA
. B-O O

Nuclear B-O O
run B-O O
on B-O O
transcription B-O O
of B-O O
the B-O O
c-jun B-O B-DNA
, B-O O
hck B-O B-DNA
, B-O O
and B-O O
actin B-O B-DNA
genes B-O I-DNA
. B-O O

Therefore B-O O
, B-O O
in B-O O
normal B-O B-cell_type
human B-O I-cell_type
monocytes B-O I-cell_type
M-CSF B-O B-protein
induces B-O O
immediate B-O B-DNA
early B-O I-DNA
response B-O I-DNA
genes B-O I-DNA
without B-O O
inducing B-O O
cell B-O O
proliferation B-O O
. B-O O

These B-O O
genes B-O O
may B-O O
then B-O O
play B-O O
a B-O O
role B-O O
in B-O O
altering B-O O
the B-O O
physiologic B-O O
status B-O O
of B-O O
the B-O O
cells B-O O
in B-O O
response B-O O
to B-O O
CSF B-O B-protein
. B-O O

Inducible B-O O
nuclear B-O B-protein
factor B-O I-protein
binding B-O O
to B-O O
the B-O O
kappa B-O B-DNA
B B-O I-DNA
elements B-O I-DNA
of B-O O
the B-O O
human B-O B-DNA
immunodeficiency B-O I-DNA
virus B-O I-DNA
enhancer B-O I-DNA
in B-O O
T B-O B-cell_type
cells B-O I-cell_type
can B-O O
be B-O O
blocked B-O O
by B-O O
cyclosporin B-O O
A B-O O
in B-O O
a B-O O
signal-dependent B-O O
manner B-O O
. B-O O

Cyclosporin B-O O
A B-O O
( B-O O
CsA B-O O
) B-O O
is B-O O
thought B-O O
to B-O O
exert B-O O
its B-O O
immunosuppressive B-O O
effects B-O O
by B-O O
inhibiting B-O O
the B-O O
expression B-O O
of B-O O
a B-O O
distinct B-O O
set B-O O
of B-O O
lymphokine B-O B-DNA
genes B-O I-DNA
which B-O O
are B-O O
induced B-O O
upon B-O O
T-cell B-O O
activation B-O O
, B-O O
among B-O O
them B-O O
the B-O O
gene B-O O
coding B-O O
for B-O O
interleukin-2 B-O B-protein
. B-O O

In B-O O
addition B-O O
, B-O O
the B-O O
activation B-O O
of B-O O
the B-O O
human B-O O
immunodeficiency B-O O
virus B-O O
( B-O O
HIV B-O O
) B-O O
is B-O O
partially B-O O
suppressed B-O O
. B-O O

To B-O O
better B-O O
understand B-O O
the B-O O
molecular B-O O
mechanisms B-O O
underlying B-O O
suppression B-O O
by B-O O
CsA B-O O
, B-O O
we B-O O
have B-O O
investigated B-O O
the B-O O
effects B-O O
of B-O O
this B-O O
drug B-O O
on B-O O
transcription B-O B-protein
factors B-O I-protein
in B-O O
T B-O B-cell_type
cells B-O I-cell_type
. B-O O

Here B-O O
we B-O O
report B-O O
that B-O O
the B-O O
formation B-O O
of B-O O
two B-O O
distinct B-O O
mitogen-inducible B-O B-protein
DNA-binding B-O I-protein
complexes B-O I-protein
, B-O O
the B-O O
kappa B-O B-protein
B B-O I-protein
complex B-O I-protein
within B-O O
the B-O O
HIV B-O B-DNA
enhancer B-O I-DNA
and B-O O
the B-O O
NFAT-1 B-O B-protein
complex B-O I-protein
within B-O O
the B-O O
interleukin-2 B-O B-DNA
enhancer B-O I-DNA
, B-O O
is B-O O
inhibited B-O O
in B-O O
the B-O O
presence B-O O
of B-O O
CsA B-O O
. B-O O

The B-O O
kappa B-O O
B-binding B-O O
activity B-O O
with B-O O
the B-O O
HIV B-O B-DNA
enhancer B-O I-DNA
is B-O O
inhibited B-O O
only B-O O
if B-O O
it B-O O
is B-O O
activated B-O O
via B-O O
the B-O O
mitogen B-O B-protein
phytohemagglutinin B-O I-protein
whereas B-O O
phorbol B-O O
myristate B-O O
acetate B-O O
-mediated B-O O
activation B-O O
is B-O O
completely B-O O
insensitive B-O O
to B-O O
the B-O O
drug B-O O
. B-O O

This B-O O
suggests B-O O
a B-O O
model B-O O
in B-O O
which B-O O
functionally B-O O
indistinguishable B-O O
kappa B-O B-protein
B B-O I-protein
complexes B-O I-protein
can B-O O
be B-O O
activated B-O O
via B-O O
two B-O O
separate B-O O
pathways B-O O
of B-O O
signal B-O O
transduction B-O O
distinguishable B-O O
by B-O O
CsA B-O O
. B-O O

Purification B-O O
of B-O O
TCF-1 B-O B-protein
alpha B-O I-protein
, B-O O
a B-O O
T-cell-specific B-O B-protein
transcription B-O I-protein
factor B-O I-protein
that B-O O
activates B-O O
the B-O O
T-cell B-O B-DNA
receptor B-O I-DNA
C B-O I-DNA
alpha B-O I-DNA
gene B-O I-DNA
enhancer B-O I-DNA
in B-O O
a B-O O
context-dependent B-O O
manner B-O O
. B-O O

The B-O O
differentiation B-O O
of B-O O
T B-O B-cell_type
cells B-O I-cell_type
into B-O O
functionally B-O O
diverse B-O O
subpopulations B-O O
is B-O O
controlled B-O O
in B-O O
part B-O O
, B-O O
by B-O O
transcriptional B-O O
activation B-O O
and B-O O
silencing B-O O
; B-O O
however B-O O
, B-O O
little B-O O
is B-O O
known B-O O
in B-O O
detail B-O O
about B-O O
the B-O O
proteins B-O O
that B-O O
influence B-O O
this B-O O
developmental B-O O
process B-O O
. B-O O

We B-O O
have B-O O
purified B-O O
a B-O O
new B-O O
T-cell-specific B-O B-protein
factor B-O I-protein
, B-O O
TCF-1 B-O B-protein
alpha B-O I-protein
, B-O O
that B-O O
is B-O O
implicated B-O O
in B-O O
the B-O O
activation B-O O
of B-O O
genes B-O O
encoding B-O O
a B-O O
major B-O O
component B-O O
of B-O O
the B-O O
human B-O B-protein
T-cell B-O I-protein
receptor B-O I-protein
( B-O O
TCR B-O B-protein
) B-O O
. B-O O

TCF-1 B-O B-protein
alpha B-O I-protein
, B-O O
originally B-O O
identified B-O O
and B-O O
purified B-O O
through B-O O
its B-O O
binding B-O O
sites B-O O
on B-O O
the B-O O
HIV-1 B-O B-DNA
promoter B-O I-DNA
, B-O O
was B-O O
found B-O O
to B-O O
bind B-O O
to B-O O
the B-O O
TCR B-O B-DNA
alpha B-O I-DNA
enhancer B-O I-DNA
and B-O O
to B-O O
promoters B-O B-DNA
for B-O O
several B-O O
genes B-O B-DNA
expressed B-O O
at B-O O
significantly B-O O
earlier B-O O
stages B-O O
of B-O O
T-cell B-O O
development B-O O
than B-O O
the B-O O
TCR B-O B-DNA
alpha B-O I-DNA
gene B-O I-DNA
( B-O O
e.g. B-O O
, B-O O
p56lck B-O B-protein
and B-O O
CD3 B-O B-protein
delta B-O I-protein
) B-O O
. B-O O

Sequences B-O O
related B-O O
to B-O O
the B-O O
TCF-1 B-O B-DNA
alpha B-O I-DNA
binding B-O I-DNA
motif B-O I-DNA
( B-O O
5'-GGCACCCTTTGA-3 B-O O
' B-O O
) B-O O
are B-O O
also B-O O
found B-O O
in B-O O
the B-O O
human B-O B-DNA
TCR B-O I-DNA
delta B-O I-DNA
( B-O I-DNA
and B-O I-DNA
possibly B-O I-DNA
TCR B-O I-DNA
beta B-O I-DNA
) B-O I-DNA
enhancers B-O I-DNA
. B-O O

Southwestern B-O O
and B-O O
gel B-O O
renaturation B-O O
experiments B-O O
with B-O O
the B-O O
use B-O O
of B-O O
purified B-O O
protein B-O O
fractions B-O O
revealed B-O O
that B-O O
TCF-1 B-O B-protein
alpha B-O I-protein
activity B-O O
is B-O O
derived B-O O
from B-O O
a B-O O
family B-O O
of B-O O
57- B-O O
to B-O O
53-kD B-O B-protein
proteins B-O I-protein
that B-O O
are B-O O
abundantly B-O O
expressed B-O O
in B-O O
mature B-O B-cell_line
and B-O I-cell_line
immature B-O I-cell_line
T-cell B-O I-cell_line
lines B-O I-cell_line
( B-O O
Jurkat B-O B-cell_line
, B-O O
CCRF-CEM B-O B-cell_line
) B-O O
and B-O O
not B-O O
in B-O O
mature B-O B-cell_type
B B-O I-cell_type
cells B-O I-cell_type
( B-O O
JY B-O O
, B-O O
Namalwa B-O B-cell_line
) B-O O
or B-O O
nonlymphoid B-O B-cell_line
( B-O I-cell_line
HeLa B-O I-cell_line
) B-O I-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
. B-O O

A B-O O
small B-O O
95-bp B-O O
fragment B-O O
of B-O O
the B-O O
TCR B-O B-DNA
alpha B-O I-DNA
control B-O I-DNA
region B-O I-DNA
that B-O O
contains B-O O
the B-O O
TCF-1 B-O B-DNA
alpha B-O I-DNA
binding B-O I-DNA
site B-O I-DNA
juxtaposed B-O O
between B-O O
a B-O O
cAMP-response B-O B-DNA
element B-O I-DNA
( B-O O
the B-O O
CRE B-O B-DNA
or B-O O
T B-O B-DNA
alpha B-O I-DNA
1 B-O I-DNA
motif B-O I-DNA
) B-O O
and B-O O
the B-O O
binding B-O B-DNA
site B-O I-DNA
for B-O O
a B-O O
distinct B-O O
lymphoid-specific B-O B-protein
protein B-O I-protein
( B-O O
TCF-2 B-O B-protein
alpha B-O I-protein
) B-O O
behaved B-O O
as B-O O
a B-O O
potent B-O O
T-cell-specific B-O B-DNA
enhancer B-O I-DNA
in B-O O
vivo B-O O
. B-O O

Tandem B-O O
copies B-O O
of B-O O
this B-O O
enhancer B-O B-DNA
functioned B-O O
synergistically B-O O
in B-O O
mature B-O B-cell_line
( B-O I-cell_line
Jurkat B-O I-cell_line
) B-O I-cell_line
T-cell B-O I-cell_line
lines B-O I-cell_line
as B-O O
well B-O O
as B-O O
resting B-O O
and B-O O
activated B-O O
immature B-O B-cell_line
( B-O I-cell_line
CCRF-CEM B-O I-cell_line
) B-O I-cell_line
T-cell B-O I-cell_line
lines B-O I-cell_line
. B-O O

Mutation B-O O
of B-O O
the B-O O
TCF-1 B-O B-DNA
alpha B-O I-DNA
binding B-O I-DNA
site B-O I-DNA
diminished B-O O
enhancer B-O O
activity B-O O
and B-O O
disrupted B-O O
the B-O O
synergism B-O O
observed B-O O
in B-O O
vivo B-O O
between B-O O
tandem B-O B-DNA
enhancer B-O I-DNA
repeats B-O I-DNA
. B-O O

The B-O O
TCF-1 B-O B-DNA
alpha B-O I-DNA
binding B-O I-DNA
site B-O I-DNA
was B-O O
also B-O O
required B-O O
for B-O O
TCR B-O B-DNA
alpha B-O I-DNA
enhancer B-O I-DNA
activity B-O O
in B-O O
transcriptionally B-O O
active B-O O
extracts B-O O
from B-O O
Jurkat B-O B-cell_line
but B-O O
not B-O O
HeLa B-O B-cell_line
cells B-O I-cell_line
, B-O O
confirming B-O O
that B-O O
TCF-1 B-O B-protein
alpha B-O I-protein
is B-O O
a B-O O
T-cell-specific B-O B-protein
transcription B-O I-protein
factor B-O I-protein
. B-O O

Curiously B-O O
, B-O O
the B-O O
TCF-1 B-O B-DNA
alpha B-O I-DNA
binding B-O I-DNA
element B-O I-DNA
was B-O O
inactive B-O O
in B-O O
vivo B-O O
when B-O O
removed B-O O
from B-O O
its B-O O
neighboring B-O O
elements B-O O
on B-O O
the B-O O
TCR B-O B-DNA
alpha B-O I-DNA
enhancer B-O I-DNA
and B-O O
positioned B-O O
in B-O O
one B-O O
or B-O O
more B-O O
copies B-O O
upstream B-O O
of B-O O
a B-O O
heterologous B-O B-DNA
promoter B-O I-DNA
. B-O O

Thus B-O O
, B-O O
the B-O O
transcriptional B-O O
activity B-O O
of B-O O
TCF-1 B-O B-protein
alpha B-O I-protein
appears B-O O
to B-O O
depend B-O O
on B-O O
the B-O O
TCF-2 B-O B-protein
alpha B-O I-protein
and B-O O
T B-O B-protein
alpha B-O I-protein
1 B-O I-protein
( B-O O
CREB B-O B-protein
) B-O O
transcription B-O B-protein
factors B-O I-protein
and B-O O
the B-O O
context B-O O
of B-O O
its B-O O
binding B-O O
site B-O O
within B-O O
the B-O O
TCR B-O B-DNA
alpha B-O I-DNA
enhancer B-O I-DNA
. B-O O

Tandem B-O B-DNA
AP-1-binding B-O I-DNA
sites B-O I-DNA
within B-O O
the B-O O
human B-O B-DNA
beta-globin B-O I-DNA
dominant B-O I-DNA
control B-O I-DNA
region B-O I-DNA
function B-O O
as B-O O
an B-O O
inducible B-O B-DNA
enhancer B-O I-DNA
in B-O O
erythroid B-O B-cell_type
cells B-O I-cell_type
. B-O O

A B-O O
powerful B-O O
enhancer B-O B-DNA
has B-O O
been B-O O
mapped B-O O
to B-O O
an B-O O
18-bp B-O B-DNA
DNA B-O I-DNA
segment B-O I-DNA
located B-O O
11 B-O O
kb B-O O
5 B-O O
' B-O O
to B-O O
the B-O O
human B-O B-DNA
epsilon-globin B-O I-DNA
gene B-O I-DNA
within B-O O
the B-O O
dominant B-O O
control B-O O
or B-O O
locus-activating B-O B-DNA
region B-O I-DNA
. B-O O

This B-O O
enhancer B-O B-DNA
is B-O O
inducible B-O O
in B-O O
K562 B-O B-cell_line
human B-O I-cell_line
erythroleukemia B-O I-cell_line
cells B-O I-cell_line
, B-O O
increasing B-O O
linked B-O O
gamma-globin B-O B-DNA
promoter B-O I-DNA
/luciferase B-O B-protein
gene B-O O
expression B-O O
to B-O O
170-fold B-O O
over B-O O
an B-O O
enhancerless B-O B-DNA
construct B-O I-DNA
. B-O O

The B-O O
enhancer B-O B-DNA
consists B-O O
of B-O O
tandem B-O B-DNA
AP-1-binding B-O I-DNA
sites B-O I-DNA
, B-O O
phased B-O O
10 B-O O
bp B-O O
apart B-O O
, B-O O
which B-O O
are B-O O
both B-O O
required B-O O
for B-O O
full B-O O
activity B-O O
. B-O O

DNA-protein B-O O
binding B-O O
assays B-O O
with B-O O
nuclear B-O O
extracts B-O O
from B-O O
induced B-O O
cells B-O O
demonstrate B-O O
a B-O O
high B-O B-protein
molecular B-O I-protein
weight B-O I-protein
complex B-O I-protein
on B-O O
the B-O O
enhancer B-O B-DNA
. B-O O

The B-O O
formation B-O O
of B-O O
this B-O O
complex B-O O
also B-O O
requires B-O O
both B-O O
AP-1 B-O B-DNA
sites B-O I-DNA
and B-O O
correlates B-O O
with B-O O
maximal B-O O
enhancer B-O O
activity B-O O
. B-O O

Induction B-O O
of B-O O
the B-O O
enhancer B-O B-DNA
may B-O O
have B-O O
a B-O O
role B-O O
in B-O O
the B-O O
increase B-O O
in B-O O
globin B-O B-DNA
gene B-O I-DNA
transcription B-O O
that B-O O
characterizes B-O O
erythroid B-O O
maturation B-O O
. B-O O

Enhancer B-O O
activity B-O O
appears B-O O
to B-O O
be B-O O
mediated B-O O
by B-O O
the B-O O
binding B-O O
of B-O O
a B-O O
complex B-O O
of B-O O
proteins B-O O
from B-O O
the B-O O
jun B-O B-DNA
and B-O I-DNA
fos B-O I-DNA
families B-O I-DNA
to B-O O
tandem B-O B-DNA
AP-1 B-O I-DNA
consensus B-O I-DNA
sequences B-O I-DNA
. B-O O

Identification B-O O
of B-O O
a B-O O
novel B-O B-protein
factor B-O I-protein
that B-O O
interacts B-O O
with B-O O
an B-O O
immunoglobulin B-O B-DNA
heavy-chain B-O I-DNA
promoter B-O I-DNA
and B-O O
stimulates B-O O
transcription B-O O
in B-O O
conjunction B-O O
with B-O O
the B-O O
lymphoid B-O B-protein
cell-specific B-O I-protein
factor B-O I-protein
OTF2 B-O B-protein
. B-O O

The B-O O
tissue-specific B-O O
expression B-O O
of B-O O
the B-O O
MOPC B-O B-DNA
141 B-O I-DNA
immunoglobulin B-O I-DNA
heavy-chain B-O I-DNA
gene B-O I-DNA
was B-O O
studied B-O O
by B-O O
using B-O O
in B-O O
vitro B-O O
transcription B-O O
. B-O O

B-cell-specific B-O O
transcription B-O O
of B-O O
this B-O O
gene B-O O
was B-O O
dependent B-O O
on B-O O
the B-O O
octamer B-O B-DNA
element B-O I-DNA
5'-ATGCAAAG-3 B-O O
' B-O O
, B-O O
located B-O O
in B-O O
the B-O O
upstream B-O B-DNA
region B-O I-DNA
of B-O O
this B-O O
promoter B-O B-DNA
and B-O O
in B-O O
the B-O O
promoters B-O B-DNA
of B-O O
all B-O O
other B-O O
immunoglobulin B-O B-DNA
heavy- B-O I-DNA
and B-O I-DNA
light- B-O I-DNA
chain B-O I-DNA
genes B-O I-DNA
. B-O O

The B-O O
interaction B-O O
of B-O O
purified B-O O
octamer B-O B-protein
transcription B-O I-protein
factors B-O I-protein
1 B-O I-protein
and B-O I-protein
2 B-O I-protein
( B-O O
OTF1 B-O B-protein
and B-O O
OTF2 B-O B-protein
) B-O O
with B-O O
the B-O O
MOPC B-O B-DNA
141 B-O I-DNA
promoter B-O I-DNA
was B-O O
studied B-O O
by B-O O
using B-O O
electrophoretic B-O O
mobility B-O O
shift B-O O
assays B-O O
and B-O O
DNase B-O B-protein
I B-O I-protein
footprinting B-O O
. B-O O

Purified B-O O
OTF1 B-O B-protein
from B-O O
HeLa B-O B-cell_line
cells B-O I-cell_line
and B-O O
OTF1 B-O B-protein
and B-O O
OTF2 B-O B-protein
from B-O O
B B-O B-cell_type
cells B-O I-cell_type
bound B-O O
to B-O O
identical B-O O
sequences B-O O
within B-O O
the B-O O
heavy-chain B-O B-DNA
promoter B-O I-DNA
. B-O O

The B-O O
OTF B-O O
interactions B-O O
we B-O O
observed B-O O
extended B-O O
over B-O O
the B-O O
heptamer B-O B-DNA
element B-O I-DNA
5'-CTCAGGA-3 B-O O
' B-O O
, B-O O
and B-O O
it B-O O
seems B-O O
likely B-O O
that B-O O
the B-O O
binding B-O O
of B-O O
the B-O O
purified B-O B-protein
factors B-O I-protein
involves B-O O
cooperation B-O O
between B-O O
octamer B-O B-DNA
and B-O I-DNA
heptamer B-O I-DNA
sites B-O I-DNA
in B-O O
this B-O O
promoter B-O B-DNA
. B-O O

In B-O O
addition B-O O
to B-O O
these B-O O
elements B-O B-DNA
, B-O O
we B-O O
identified B-O O
a B-O O
second B-O O
regulatory B-O B-DNA
element B-O I-DNA
, B-O O
the B-O O
N B-O B-DNA
element B-O I-DNA
with B-O O
the B-O O
sequence B-O O
5'-GGAACCTCCCCC-3 B-O O
' B-O O
. B-O O

The B-O O
N B-O B-DNA
element B-O I-DNA
could B-O O
independently B-O O
mediate B-O O
low B-O O
levels B-O O
of B-O O
transcription B-O O
in B-O O
both B-O O
B-cell B-O B-cell_type
and B-O O
HeLa-cell B-O O
extracts B-O O
, B-O O
and B-O O
, B-O O
in B-O O
conjunction B-O O
with B-O O
the B-O O
octamer B-O B-DNA
element B-O I-DNA
, B-O O
it B-O O
can B-O O
promote B-O O
high B-O O
levels B-O O
of B-O O
transcription B-O O
in B-O O
B-cell B-O O
extracts B-O O
. B-O O

The B-O O
N B-O B-DNA
element B-O I-DNA
bound B-O O
a B-O O
transcription B-O B-protein
factor B-O I-protein
, B-O O
NTF B-O B-protein
, B-O O
that B-O O
is B-O O
ubiquitous B-O O
in B-O O
cell-type B-O O
distribution B-O O
, B-O O
and B-O O
NTF B-O B-protein
was B-O O
distinct B-O O
from B-O O
any B-O O
of B-O O
the B-O O
previously B-O O
described B-O O
proteins B-O O
that B-O O
bind B-O O
to B-O O
similar B-O O
sequences B-O O
. B-O O

Based B-O O
on B-O O
these B-O O
results B-O O
, B-O O
we B-O O
propose B-O O
that B-O O
NTF B-O B-protein
and B-O O
OTF2 B-O B-protein
interactions B-O O
( B-O O
both B-O O
with B-O O
their B-O O
cognate B-O B-DNA
DNA B-O I-DNA
elements B-O I-DNA
and B-O O
possibly B-O O
at B-O O
the B-O O
protein-protein B-O O
level B-O O
) B-O O
may B-O O
be B-O O
critical B-O O
to B-O O
B-cell-specific B-O O
expression B-O O
and B-O O
that B-O O
these B-O O
interactions B-O O
provide B-O O
additional B-O O
pathways B-O O
for B-O O
regulating B-O O
gene B-O O
expression B-O O
. B-O O

NF-kappa B-O B-protein
B B-O I-protein
as B-O O
inducible B-O O
transcriptional B-O B-protein
activator B-O I-protein
of B-O O
the B-O O
granulocyte-macrophage B-O B-DNA
colony-stimulating B-O I-DNA
factor B-O I-DNA
gene B-O I-DNA
. B-O O

The B-O O
expression B-O O
of B-O O
the B-O O
gene B-O O
encoding B-O O
the B-O O
granulocyte- B-O B-protein
macrophage B-O I-protein
colony-stimulating B-O I-protein
factor B-O I-protein
( B-O O
GM-CSF B-O B-protein
) B-O O
is B-O O
induced B-O O
upon B-O O
activation B-O O
of B-O O
T B-O B-cell_type
cells B-O I-cell_type
with B-O O
phytohemagglutinin B-O B-protein
and B-O O
active B-O O
phorbolester B-O O
and B-O O
upon B-O O
expression B-O O
of B-O O
tax1 B-O B-protein
, B-O O
a B-O O
transactivating B-O B-protein
protein B-O I-protein
of B-O O
the B-O O
human B-O O
T-cell B-O O
leukemia B-O O
virus B-O O
type B-O O
I B-O O
. B-O O

The B-O O
same B-O O
agents B-O O
induce B-O O
transcription B-O O
from B-O O
the B-O O
interleukin-2 B-O B-DNA
receptor B-O I-DNA
alpha-chain B-O I-DNA
and B-O I-DNA
interleukin-2 B-O I-DNA
genes B-O I-DNA
, B-O O
depending B-O O
on B-O O
promoter B-O B-DNA
elements B-O I-DNA
that B-O O
bind B-O O
the B-O O
inducible B-O B-protein
transcription B-O I-protein
factor B-O I-protein
NF-kappa B-O B-protein
B B-O I-protein
( B-O O
or B-O O
an B-O O
NF-kappa B-O B-protein
B B-O I-protein
-like B-O O
factor B-O O
) B-O O
. B-O O

We B-O O
therefore B-O O
tested B-O O
the B-O O
possibility B-O O
that B-O O
the B-O O
GM-CSF B-O B-DNA
gene B-O I-DNA
is B-O O
also B-O O
regulated B-O O
by B-O O
a B-O O
cognate B-O O
motif B-O O
for B-O O
the B-O O
NF-kappa B-O B-protein
B B-O I-protein
transcription B-O I-protein
factor B-O I-protein
. B-O O

A B-O O
recent B-O O
functional B-O O
analysis B-O O
by B-O O
Miyatake B-O O
et B-O O
al. B-O O
( B-O O
S. B-O O
Miyatake B-O O
, B-O O
M. B-O O
Seiki B-O O
, B-O O
M. B-O O
Yoshida B-O O
, B-O O
and B-O O
K. B-O O
Arai B-O O
, B-O O
Mol. B-O O
Cell. B-O O
Biol. B-O O
8 B-O O
: B-O O
5581-5587 B-O O
, B-O O
1988 B-O O
) B-O O
described B-O O
a B-O O
short B-O B-DNA
promoter B-O I-DNA
region B-O I-DNA
in B-O O
the B-O O
GM-CSF B-O B-DNA
gene B-O I-DNA
that B-O O
conferred B-O O
strong B-O O
inducibility B-O O
by B-O O
T-cell-activating B-O O
signals B-O O
and B-O O
tax1 B-O B-protein
, B-O O
but B-O O
no B-O O
NF-kappa B-O B-protein
B B-O I-protein
-binding B-O B-DNA
motifs B-O I-DNA
were B-O O
identified B-O O
. B-O O

Using B-O O
electrophoretic B-O O
mobility B-O O
shift B-O O
assays B-O O
, B-O O
we B-O O
showed B-O O
binding B-O O
of B-O O
purified B-O O
human B-O B-protein
NF-kappa B-O I-protein
B B-O I-protein
and B-O O
of B-O O
the B-O O
NF-kappa B-O B-protein
B B-O I-protein
activated B-O O
in B-O O
Jurkat B-O B-cell_line
T B-O I-cell_line
cells B-O I-cell_line
to B-O O
an B-O O
oligonucleotide B-O O
comprising B-O O
the B-O O
GM-CSF B-O B-DNA
promoter B-O I-DNA
element B-O I-DNA
responsible B-O O
for B-O O
mediating B-O O
responsiveness B-O O
to B-O O
T-cell-activating B-O O
signals B-O O
and B-O O
tax1 B-O B-protein
. B-O O

As B-O O
shown B-O O
by B-O O
a B-O O
methylation B-O O
interference B-O O
analysis B-O O
and B-O O
oligonucleotide B-O O
competition B-O O
experiments B-O O
, B-O O
purified B-O O
NF-kappa B-O B-protein
B B-O I-protein
binds B-O O
at B-O O
positions B-O B-DNA
-82 B-O I-DNA
to B-O I-DNA
-91 B-O I-DNA
( B-O O
GGGAACTACC B-O O
) B-O O
of B-O O
the B-O O
GM-CSF B-O B-DNA
promoter B-O I-DNA
sequence B-O I-DNA
with B-O O
an B-O O
affinity B-O O
similar B-O O
to B-O O
that B-O O
with B-O O
which B-O O
it B-O O
binds B-O O
to B-O O
the B-O O
biologically B-O B-DNA
functional B-O I-DNA
kappa B-O I-DNA
B B-O I-DNA
motif B-O I-DNA
in B-O O
the B-O O
beta B-O B-DNA
interferon B-O I-DNA
promoter B-O I-DNA
( B-O O
GGGAAATTCC B-O O
) B-O O
. B-O O

Two B-O O
kappa B-O B-DNA
B-like B-O I-DNA
motifs B-O I-DNA
at B-O O
positions B-O B-DNA
-98 B-O I-DNA
to B-O I-DNA
-108 B-O I-DNA
of B-O O
the B-O O
GM-CSF B-O B-DNA
promoter B-O I-DNA
were B-O O
also B-O O
recognized B-O O
but B-O O
with B-O O
much B-O O
lower B-O O
affinities B-O O
. B-O O

Our B-O O
data B-O O
provide B-O O
strong B-O O
evidence B-O O
that B-O O
the B-O O
expression B-O O
of B-O O
the B-O O
GM-CSF B-O B-DNA
gene B-O I-DNA
following B-O O
T-cell B-O O
activation B-O O
is B-O O
controlled B-O O
by B-O O
binding B-O O
of B-O O
the B-O O
NF-kappa B-O B-protein
B B-O I-protein
transcription B-O I-protein
factor B-O I-protein
to B-O O
a B-O O
high-affinity B-O B-DNA
binding B-O I-DNA
site B-O I-DNA
in B-O O
the B-O O
GM-CSF B-O B-DNA
promoter B-O I-DNA
. B-O O

Effects B-O O
of B-O O
mitogenic B-O O
agents B-O O
upon B-O O
glucocorticoid B-O O
action B-O O
in B-O O
human B-O B-cell_type
tonsillar B-O I-cell_type
T- B-O I-cell_type
lymphocytes B-O I-cell_type
. B-O O

The B-O O
treatment B-O O
of B-O O
human B-O B-cell_type
tonsillar B-O I-cell_type
T- B-O I-cell_type
lymphocytes B-O I-cell_type
with B-O O
4-phorbol B-O O
12-myristate B-O O
13-acetate B-O O
( B-O O
PMA B-O O
) B-O O
, B-O O
resulted B-O O
in B-O O
about B-O O
two B-O O
fold B-O O
increase B-O O
in B-O O
glucocorticoid B-O B-protein
receptor B-O I-protein
( B-O O
GR B-O B-protein
) B-O O
number B-O O
, B-O O
without B-O O
any B-O O
significant B-O O
change B-O O
in B-O O
the B-O O
receptor B-O O
affinity B-O O
. B-O O

This B-O O
increase B-O O
disappeared B-O O
in B-O O
the B-O O
presence B-O O
of B-O O
cycloheximide B-O O
. B-O O

Alone B-O O
, B-O O
PMA B-O O
and B-O O
calcium B-O O
ionophore B-O O
A23187 B-O O
did B-O O
not B-O O
affect B-O O
, B-O O
but B-O O
together B-O O
stimulated B-O O
, B-O O
like B-O O
phytohaemagglutinin B-O B-protein
( B-O O
PHA B-O B-protein
) B-O O
, B-O O
leucine B-O O
and B-O O
, B-O O
in B-O O
particular B-O O
, B-O O
thymidine B-O O
incorporation B-O O
. B-O O

PMA B-O O
enhanced B-O O
slightly B-O O
the B-O O
stimulatory B-O O
effect B-O O
of B-O O
PHA B-O B-protein
. B-O O

Alone B-O O
, B-O O
these B-O O
agents B-O O
failed B-O O
to B-O O
alter B-O O
the B-O O
suppressive B-O O
effect B-O O
of B-O O
dexamethasone B-O O
on B-O O
thymidine B-O O
and B-O O
leucine B-O O
incorporation B-O O
; B-O O
however B-O O
, B-O O
PMA B-O O
-A23187 B-O O
and B-O O
PMA B-O O
-PHA B-O B-protein
combinations B-O O
appeared B-O O
to B-O O
antagonize B-O O
the B-O O
suppression B-O O
by B-O O
dexamethasone B-O O
. B-O O

To B-O O
be B-O O
or B-O O
not B-O O
to B-O O
be B-O O
a B-O O
responder B-O O
in B-O O
T-cell B-O O
responses B-O O
: B-O O
ubiquitous B-O O
oligopeptides B-O O
in B-O O
all B-O O
proteins B-O O
. B-O O

Amino B-O B-protein
acid B-O I-protein
sequences B-O I-protein
of B-O O
all B-O O
proteins B-O O
are B-O O
essays B-O O
written B-O O
in B-O O
the B-O O
same B-O O
language B-O O
. B-O O

Accordingly B-O O
, B-O O
the B-O O
same B-O O
set B-O O
of B-O O
words B-O O
and B-O O
phrases B-O O
( B-O O
oligopeptides B-O O
) B-O O
appear B-O O
in B-O O
totally B-O O
unrelated B-O O
proteins B-O O
. B-O O

The B-O O
reason B-O O
that B-O O
only B-O O
certain B-O O
individuals B-O O
of B-O O
particular B-O O
major B-O B-protein
histocompatibility B-O I-protein
complex B-O I-protein
( B-O I-protein
MHC B-O I-protein
) B-O I-protein
haplotypes B-O I-protein
can B-O O
mount B-O O
T-cell B-O O
responses B-O O
against B-O O
a B-O O
given B-O O
antigen B-O O
of B-O O
pathogens B-O O
is B-O O
found B-O O
in B-O O
the B-O O
fact B-O O
that B-O O
T-cell B-O B-protein
receptors B-O I-protein
are B-O O
designed B-O O
to B-O O
recognize B-O O
18-20 B-O O
residue-long B-O O
peptide B-O O
fragments B-O O
sandwiched B-O O
between B-O O
two B-O O
alpha-helices B-O B-protein
of B-O O
class B-O B-protein
I B-O I-protein
or B-O O
class B-O B-protein
II B-O I-protein
MHC B-O I-protein
molecules B-O I-protein
. B-O O

At B-O O
this B-O O
range B-O O
of B-O O
peptide B-O O
lengths B-O O
, B-O O
most B-O O
would B-O O
appear B-O O
as B-O O
self B-O O
, B-O O
while B-O O
nonselfness B-O O
of B-O O
the B-O O
remainders B-O O
are B-O O
destined B-O O
to B-O O
be B-O O
quite B-O O
ambiguous B-O O
, B-O O
hence B-O O
creating B-O O
responders B-O O
and B-O O
nonresponders B-O O
. B-O O

Two B-O O
distinct B-O O
signal B-O O
transmission B-O O
pathways B-O O
in B-O O
T B-O B-cell_type
lymphocytes B-O I-cell_type
are B-O O
inhibited B-O O
by B-O O
complexes B-O O
formed B-O O
between B-O O
an B-O O
immunophilin B-O B-protein
and B-O O
either B-O O
FK506 B-O O
or B-O O
rapamycin B-O O
. B-O O

Proliferation B-O O
and B-O O
immunologic B-O O
function B-O O
of B-O O
T B-O B-cell_type
lymphocytes B-O I-cell_type
are B-O O
initiated B-O O
by B-O O
signals B-O O
from B-O O
the B-O O
antigen B-O B-protein
receptor B-O I-protein
that B-O O
are B-O O
inhibited B-O O
by B-O O
the B-O O
immunosuppressant B-O O
FK506 B-O O
but B-O O
not B-O O
by B-O O
its B-O O
structural B-O O
analog B-O O
, B-O O
rapamycin B-O O
. B-O O

On B-O O
the B-O O
other B-O O
hand B-O O
, B-O O
interleukin B-O B-protein
2 B-O I-protein
( B-O O
IL-2 B-O B-protein
) B-O O
-induced B-O O
signals B-O O
are B-O O
blocked B-O O
by B-O O
rapamycin B-O O
but B-O O
not B-O O
by B-O O
FK506 B-O O
. B-O O

Remarkably B-O O
, B-O O
these B-O O
two B-O O
drugs B-O O
inhibit B-O O
each B-O O
other B-O O
's B-O O
actions B-O O
, B-O O
raising B-O O
the B-O O
possibility B-O O
that B-O O
both B-O O
act B-O O
by B-O O
means B-O O
of B-O O
a B-O O
common B-O O
immunophilin B-O B-protein
( B-O O
immunosuppressant B-O B-protein
binding B-O I-protein
protein B-O I-protein
) B-O O
. B-O O

We B-O O
find B-O O
that B-O O
the B-O O
dissociation B-O O
constant B-O O
of B-O O
rapamycin B-O O
to B-O O
the B-O O
FK506 B-O B-protein
binding B-O I-protein
protein B-O I-protein
FKBP B-O B-protein
( B-O O
Kd B-O O
= B-O O
0.2 B-O O
nM B-O O
) B-O O
is B-O O
close B-O O
to B-O O
the B-O O
dissociation B-O O
constant B-O O
of B-O O
FK506 B-O O
to B-O O
FKBP B-O B-protein
( B-O O
Kd B-O O
= B-O O
0.4 B-O O
nM B-O O
) B-O O
and B-O O
to B-O O
their B-O O
effective B-O O
biologic B-O O
inhibitory B-O O
concentrations B-O O
. B-O O

However B-O O
, B-O O
an B-O O
excess B-O O
of B-O O
rapamycin B-O O
is B-O O
needed B-O O
to B-O O
revert B-O O
FK506 B-O O
-mediated B-O O
inhibition B-O O
of B-O O
IL-2 B-O B-protein
production B-O O
, B-O O
apoptosis B-O O
, B-O O
and B-O O
transcriptional B-O O
activation B-O O
of B-O O
NF-AT B-O B-protein
, B-O O
a B-O O
T-cell-specific B-O B-protein
transcription B-O I-protein
factor B-O I-protein
necessary B-O O
for B-O O
IL-2 B-O B-DNA
gene B-O I-DNA
activation B-O O
. B-O O

Similarly B-O O
, B-O O
an B-O O
excess B-O O
of B-O O
FK506 B-O O
is B-O O
needed B-O O
to B-O O
revert B-O O
rapamycin B-O O
-mediated B-O O
inhibition B-O O
of B-O O
IL-2 B-O B-protein
-induced B-O O
proliferation B-O O
. B-O O

The B-O O
drug B-O O
concentrations B-O O
required B-O O
for B-O O
antagonism B-O O
may B-O O
be B-O O
explained B-O O
by B-O O
the B-O O
relative B-O O
affinity B-O O
of B-O O
the B-O O
drugs B-O O
to B-O O
, B-O O
and B-O O
by B-O O
the B-O O
abundance B-O O
of B-O O
, B-O O
the B-O O
immunophilin B-O B-protein
FKBP B-O B-protein
. B-O O

FKBP B-O B-protein
has B-O O
been B-O O
shown B-O O
to B-O O
catalyze B-O O
the B-O O
interconversion B-O O
of B-O O
the B-O O
cis- B-O O
and B-O O
trans- B-O O
rotamers B-O O
of B-O O
the B-O O
peptidyl-prolyl B-O B-protein
amide B-O I-protein
bond B-O I-protein
of B-O O
peptide B-O O
substrates B-O O
; B-O O
here B-O O
we B-O O
show B-O O
that B-O O
rapamycin B-O O
, B-O O
like B-O O
FK506 B-O O
, B-O O
is B-O O
a B-O O
potent B-O O
inhibitor B-O O
of B-O O
the B-O O
rotamase B-O O
activity B-O O
of B-O O
FKBP B-O B-protein
( B-O O
Ki B-O O
= B-O O
0.2 B-O O
nM B-O O
) B-O O
. B-O O

Neither B-O O
FKBP B-O B-protein
binding B-O O
nor B-O O
inhibition B-O O
of B-O O
rotamase B-O O
activity B-O O
of B-O O
FKBP B-O B-protein
alone B-O O
is B-O O
sufficient B-O O
to B-O O
explain B-O O
the B-O O
biologic B-O O
actions B-O O
of B-O O
these B-O O
drugs B-O O
. B-O O

Rather B-O O
, B-O O
these B-O O
findings B-O O
suggest B-O O
that B-O O
immunophilin B-O B-protein
bound B-O O
to B-O O
FK506 B-O O
interferes B-O O
with B-O O
antigen B-O B-protein
receptor B-O I-protein
-induced B-O O
signals B-O O
, B-O O
while B-O O
rapamycin B-O O
bound B-O O
to B-O O
the B-O O
immunophilin B-O B-protein
interferes B-O O
with B-O O
IL-2 B-O B-protein
-induced B-O O
signals B-O O
. B-O O

Adherence-dependent B-O O
increase B-O O
in B-O O
human B-O B-RNA
monocyte B-O I-RNA
PDGF B-O I-RNA
( B-O I-RNA
B B-O I-RNA
) B-O I-RNA
mRNA B-O I-RNA
is B-O O
associated B-O O
with B-O O
increases B-O O
in B-O O
c-fos B-O B-RNA
, B-O I-RNA
c-jun B-O I-RNA
, B-O I-RNA
and B-O I-RNA
EGR2 B-O I-RNA
mRNA B-O I-RNA
. B-O O

Adherence B-O O
is B-O O
an B-O O
important B-O O
initial B-O O
step B-O O
in B-O O
the B-O O
transition B-O O
of B-O O
a B-O O
circulating B-O B-cell_type
monocyte B-O I-cell_type
to B-O O
a B-O O
tissue B-O B-cell_type
macrophage B-O I-cell_type
. B-O O

This B-O O
differentiation B-O O
is B-O O
accompanied B-O O
by B-O O
an B-O O
augmented B-O O
capacity B-O O
to B-O O
generate B-O O
growth B-O B-protein
factors B-O I-protein
. B-O O

We B-O O
hypothesized B-O O
that B-O O
adherence B-O O
itself B-O O
might B-O O
be B-O O
an B-O O
important B-O O
trigger B-O O
for B-O O
a B-O O
sequence B-O O
of B-O O
gene B-O O
activation B-O O
culminating B-O O
in B-O O
cells B-O O
with B-O O
increased B-O O
mRNA B-O B-RNA
encoding B-O O
profibrotic B-O O
growth B-O B-protein
factors B-O I-protein
such B-O O
as B-O O
platelet-derived B-O B-protein
growth B-O I-protein
factor B-O I-protein
B B-O I-protein
subunit B-O I-protein
( B-O O
PDGF B-O B-protein
[ B-O I-protein
B B-O I-protein
] B-O I-protein
) B-O O
and B-O O
transforming B-O B-protein
growth B-O I-protein
factor-beta B-O I-protein
( B-O O
TGF-beta B-O B-protein
) B-O O
. B-O O

After B-O O
in B-O O
vitro B-O O
adherence B-O O
, B-O O
human B-O B-cell_type
monocytes B-O I-cell_type
had B-O O
a B-O O
biphasic B-O O
increase B-O O
in B-O O
PDGF B-O B-RNA
( B-O I-RNA
B B-O I-RNA
) B-O I-RNA
mRNA B-O I-RNA
with B-O O
peaks B-O O
at B-O O
6 B-O O
h B-O O
and B-O O
13 B-O O
d B-O O
. B-O O

No B-O O
increase B-O O
in B-O O
TGF-beta B-O B-RNA
mRNA B-O I-RNA
was B-O O
observed B-O O
. B-O O

The B-O O
6-h B-O O
increase B-O O
in B-O O
PDGF B-O B-RNA
( B-O I-RNA
B B-O I-RNA
) B-O I-RNA
mRNA B-O I-RNA
was B-O O
adherence B-O O
dependent B-O O
, B-O O
and B-O O
in B-O O
addition B-O O
, B-O O
was B-O O
abrogated B-O O
when B-O O
the B-O O
cytoskeletal B-O O
integrity B-O O
was B-O O
compromised B-O O
by B-O O
cytochalasin B-O O
D B-O O
. B-O O

The B-O O
6-h B-O O
increase B-O O
in B-O O
PDGF B-O B-RNA
( B-O I-RNA
B B-O I-RNA
) B-O I-RNA
mRNA B-O I-RNA
was B-O O
unaltered B-O O
by B-O O
adherence B-O O
in B-O O
the B-O O
presence B-O O
of B-O O
the B-O O
monocyte B-O O
stimulus B-O O
lipopolysaccharide B-O O
. B-O O

Adherence B-O O
to B-O O
either B-O O
fibronectin B-O B-protein
or B-O O
collagen-coated B-O O
plastic B-O O
had B-O O
little B-O O
consistent B-O O
effect B-O O
on B-O O
PDGF B-O B-RNA
( B-O I-RNA
B B-O I-RNA
) B-O I-RNA
mRNA B-O I-RNA
accumulation B-O O
. B-O O

The B-O O
increased B-O O
PDGF B-O B-RNA
( B-O I-RNA
B B-O I-RNA
) B-O I-RNA
mRNA B-O I-RNA
observed B-O O
in B-O O
adherent B-O B-cell_type
monocytes B-O I-cell_type
was B-O O
accompanied B-O O
by B-O O
increases B-O O
in B-O O
mRNAs B-O B-RNA
of B-O O
the B-O O
early B-O B-DNA
growth B-O I-DNA
response B-O I-DNA
genes B-O I-DNA
c-fos B-O B-DNA
( B-O O
maximal B-O O
at B-O O
20 B-O O
min B-O O
) B-O O
, B-O O
c-jun B-O B-DNA
, B-O O
and B-O O
EGR2 B-O B-protein
( B-O O
maximal B-O O
at B-O O
6-24 B-O O
h B-O O
) B-O O
. B-O O

The B-O O
increase B-O O
in B-O O
c-jun B-O B-DNA
and B-O O
EGR2 B-O B-protein
, B-O O
but B-O O
not B-O O
c-fos B-O B-DNA
, B-O O
mRNA B-O B-RNA
was B-O O
also B-O O
abrogated B-O O
by B-O O
cytochalasin B-O O
D B-O O
. B-O O

These B-O O
observations B-O O
suggest B-O O
that B-O O
adherence B-O O
results B-O O
in B-O O
increases B-O O
of B-O O
c-fos B-O B-RNA
, B-O I-RNA
c-jun B-O I-RNA
, B-O I-RNA
EGR2 B-O I-RNA
, B-O I-RNA
and B-O I-RNA
PDGF B-O I-RNA
( B-O I-RNA
B B-O I-RNA
) B-O I-RNA
mRNA B-O I-RNA
. B-O O

In B-O O
addition B-O O
, B-O O
the B-O O
increases B-O O
in B-O O
c-jun B-O B-DNA
, B-O O
EGR2 B-O B-protein
, B-O O
and B-O O
PDGF B-O B-protein
( B-O I-protein
B B-O I-protein
) B-O I-protein
may B-O O
depend B-O O
on B-O O
cytoskeletal B-O O
rearrangement B-O O
. B-O O

Modulation B-O O
of B-O O
these B-O O
events B-O O
at B-O O
the B-O O
time B-O O
of B-O O
adherence B-O O
offers B-O O
a B-O O
mechanism B-O O
by B-O O
which B-O O
differential B-O O
priming B-O O
of B-O O
the B-O O
cells B-O O
may B-O O
be B-O O
accomplished B-O O
. B-O O

Single B-O O
cell B-O O
assay B-O O
of B-O O
a B-O O
transcription B-O B-protein
factor B-O I-protein
reveals B-O O
a B-O O
threshold B-O O
in B-O O
transcription B-O O
activated B-O O
by B-O O
signals B-O O
emanating B-O O
from B-O O
the B-O O
T-cell B-O B-protein
antigen B-O I-protein
receptor B-O I-protein
. B-O O

Stimulation B-O O
of B-O O
T B-O B-cell_type
lymphocytes B-O I-cell_type
through B-O O
their B-O O
antigen B-O B-protein
receptor B-O I-protein
leads B-O O
to B-O O
the B-O O
appearance B-O O
of B-O O
several B-O O
transcription B-O B-protein
factors B-O I-protein
, B-O O
including B-O O
NF-AT B-O B-protein
and B-O O
NF-kappa B-O B-protein
B B-O I-protein
, B-O O
which B-O O
are B-O O
involved B-O O
in B-O O
regulating B-O O
genes B-O O
required B-O O
for B-O O
immunologic B-O O
activation B-O O
. B-O O

To B-O O
investigate B-O O
the B-O O
activity B-O O
of B-O O
a B-O O
single B-O O
transcription B-O B-protein
factor B-O I-protein
in B-O O
individual B-O B-cell_type
viable B-O I-cell_type
cells B-O I-cell_type
, B-O O
we B-O O
have B-O O
applied B-O O
an B-O O
assay B-O O
that B-O O
uses B-O O
the B-O O
fluorescence-activated B-O O
cell B-O O
sorter B-O O
to B-O O
quantitate B-O O
beta-galactosidase B-O B-protein
( B-O O
beta-gal B-O B-protein
) B-O O
. B-O O

We B-O O
have B-O O
analyzed B-O O
the B-O O
distribution B-O O
of B-O O
NF-AT B-O B-protein
transcriptional B-O O
activity B-O O
among B-O O
T B-O B-cell_type
cells B-O I-cell_type
undergoing B-O O
activation B-O O
by B-O O
using B-O O
a B-O O
construct B-O O
in B-O O
which B-O O
three B-O O
tandem B-O O
copies B-O O
of B-O O
the B-O O
NF-AT B-O B-DNA
-binding B-O I-DNA
site B-O I-DNA
directs B-O O
transcription B-O O
of B-O O
the B-O O
lacZ B-O B-DNA
gene B-O I-DNA
. B-O O

Unexpectedly B-O O
, B-O O
stimulation B-O O
of B-O O
cloned B-O B-cell_line
stably B-O I-cell_line
transfected B-O I-cell_line
Jurkat B-O I-cell_line
T B-O I-cell_line
cells B-O I-cell_line
leads B-O O
to B-O O
a B-O O
bimodal B-O O
pattern B-O O
of B-O O
beta-gal B-O B-protein
expression B-O O
in B-O O
which B-O O
some B-O O
cells B-O O
express B-O O
no B-O O
beta-gal B-O B-protein
and B-O O
others B-O O
express B-O O
high B-O O
levels B-O O
. B-O O

This B-O O
expression B-O O
pattern B-O O
can B-O O
not B-O O
be B-O O
accounted B-O O
for B-O O
by B-O O
cell-cycle B-O O
position B-O O
or B-O O
heritable B-O O
variation B-O O
. B-O O

Further B-O O
results B-O O
, B-O O
in B-O O
which B-O O
beta-gal B-O B-protein
activity B-O O
is B-O O
correlated B-O O
with B-O O
NF-AT B-O B-protein
-binding B-O O
activity B-O O
, B-O O
indicate B-O O
that B-O O
the B-O O
concentration B-O O
of B-O O
NF-AT B-O B-protein
must B-O O
exceed B-O O
a B-O O
critical B-O O
threshold B-O O
before B-O O
transcription B-O O
initiates B-O O
. B-O O

This B-O O
threshold B-O O
likely B-O O
reflects B-O O
the B-O O
NF-AT B-O B-protein
concentration-dependent B-O O
assembly B-O O
of B-O O
transcription B-O B-protein
complexes B-O I-protein
at B-O O
the B-O O
promoter B-O B-DNA
. B-O O

Similar B-O O
constructs B-O O
controlled B-O O
by B-O O
NF-kappa B-O B-protein
B B-O I-protein
or B-O O
the B-O O
entire B-O O
interleukin-2 B-O B-DNA
enhancer B-O I-DNA
show B-O O
bimodal B-O O
expression B-O O
patterns B-O O
during B-O O
induction B-O O
, B-O O
suggesting B-O O
that B-O O
thresholds B-O O
set B-O O
by B-O O
the B-O O
concentration B-O O
of B-O O
transcription B-O B-protein
factors B-O I-protein
may B-O O
be B-O O
a B-O O
common B-O O
property B-O O
of B-O O
inducible B-O B-DNA
genes B-O I-DNA
. B-O O

The B-O O
Epstein-Barr B-O B-DNA
virus B-O I-DNA
( B-O I-DNA
EBV B-O I-DNA
) B-O I-DNA
BMRF1 B-O I-DNA
promoter B-O I-DNA
for B-O O
early B-O B-protein
antigen B-O I-protein
( B-O O
EA-D B-O B-protein
) B-O O
is B-O O
regulated B-O O
by B-O O
the B-O O
EBV B-O B-protein
transactivators B-O I-protein
, B-O O
BRLF1 B-O B-protein
and B-O O
BZLF1 B-O B-protein
, B-O O
in B-O O
a B-O O
cell-specific B-O O
manner B-O O
. B-O O

The B-O O
Epstein-Barr B-O B-protein
virus B-O I-protein
early B-O I-protein
antigen B-O I-protein
diffuse B-O I-protein
component B-O I-protein
( B-O O
EA-D B-O B-protein
) B-O O
is B-O O
essential B-O O
for B-O O
Epstein-Barr B-O B-protein
virus B-O I-protein
DNA B-O I-protein
polymerase B-O I-protein
activity B-O O
, B-O O
and B-O O
its B-O O
activity B-O O
is B-O O
suppressed B-O O
during B-O O
latent B-O O
infection B-O O
. B-O O

We B-O O
investigated B-O O
the B-O O
regulation B-O O
of B-O O
the B-O O
promoter B-O B-DNA
( B-O O
BMRF1 B-O B-DNA
) B-O O
for B-O O
this B-O O
early B-O B-DNA
gene B-O I-DNA
by B-O O
studying B-O O
its B-O O
responsiveness B-O O
in B-O O
vitro B-O O
to B-O O
two B-O O
immediate-early B-O B-protein
viral B-O I-protein
transactivators B-O I-protein
, B-O O
BZLF1 B-O B-protein
( B-O O
Z B-O B-protein
) B-O O
and B-O O
BRLF1 B-O B-protein
( B-O O
R B-O B-protein
) B-O O
, B-O O
focusing B-O O
on B-O O
the B-O O
differences B-O O
in B-O O
response B-O O
in B-O O
lymphoid B-O B-cell_type
cells B-O I-cell_type
and B-O O
epithelial B-O B-cell_type
cells B-O I-cell_type
. B-O O

In B-O O
lymphoid B-O B-cell_type
cells B-O I-cell_type
, B-O O
Z B-O B-protein
or B-O O
R B-O B-protein
alone B-O O
produced B-O O
only B-O O
small B-O O
increases B-O O
in B-O O
EA-D B-O B-DNA
promoter B-O I-DNA
activity B-O O
, B-O O
whereas B-O O
both B-O O
transactivators B-O B-protein
together B-O O
produced B-O O
a B-O O
large B-O O
stimulatory B-O O
effect B-O O
. B-O O

In B-O O
epithelial B-O B-cell_type
cells B-O I-cell_type
, B-O O
the B-O O
Z B-O B-protein
transactivator B-O I-protein
alone B-O O
produced B-O O
maximal B-O O
stimulation B-O O
of B-O O
the B-O O
EA-D B-O B-DNA
promoter B-O I-DNA
; B-O O
the B-O O
effect B-O O
of B-O O
R B-O B-protein
and B-O O
Z B-O B-protein
together B-O O
was B-O O
no B-O O
greater B-O O
than B-O O
that B-O O
of B-O O
Z B-O B-protein
alone B-O O
. B-O O

Deletional B-O O
analysis B-O O
and B-O O
site-directed B-O O
mutagenesis B-O O
of B-O O
the B-O O
EA-D B-O B-DNA
promoter B-O I-DNA
demonstrated B-O O
that B-O O
in B-O O
epithelial B-O B-cell_type
cells B-O I-cell_type
the B-O O
potential B-O O
AP-1 B-O B-DNA
binding B-O I-DNA
site B-O I-DNA
plays B-O O
an B-O O
essential B-O O
role B-O O
in B-O O
Z B-O B-protein
responsiveness B-O O
, B-O O
although B-O O
sequences B-O O
further B-O O
upstream B-O O
are B-O O
also B-O O
important B-O O
. B-O O

In B-O O
lymphoid B-O B-cell_type
cells B-O I-cell_type
, B-O O
only B-O O
the B-O O
upstream B-O B-DNA
sequences B-O I-DNA
are B-O O
required B-O O
for B-O O
transactivation B-O O
by B-O O
the B-O O
Z/R B-O B-protein
combination B-O O
, B-O O
and B-O O
the B-O O
AP-1 B-O B-DNA
site B-O I-DNA
is B-O O
dispensable B-O O
. B-O O

These B-O O
data B-O O
suggest B-O O
that B-O O
EA-D B-O B-DNA
( B-O I-DNA
BMRF1 B-O I-DNA
) B-O I-DNA
promoter B-O I-DNA
regulation B-O O
by B-O O
Z B-O B-protein
and B-O O
R B-O B-protein
is B-O O
cell B-O O
type B-O O
specific B-O O
and B-O O
appears B-O O
to B-O O
involve B-O O
different B-O O
mechanisms B-O O
in B-O O
each B-O O
cell B-O O
type B-O O
. B-O O

Complementary B-O B-DNA
DNA B-O I-DNA
encoding B-O O
the B-O O
human B-O B-protein
T-cell B-O I-protein
FK506 B-O I-protein
-binding B-O I-protein
protein B-O I-protein
, B-O O
a B-O O
peptidylprolyl B-O B-protein
cis-trans B-O I-protein
isomerase B-O I-protein
distinct B-O O
from B-O O
cyclophilin B-O B-protein
. B-O O

The B-O O
recently B-O O
discovered B-O O
macrolide B-O O
FK506 B-O O
has B-O O
been B-O O
demonstrated B-O O
to B-O O
have B-O O
potent B-O O
immunosuppressive B-O O
activity B-O O
at B-O O
concentrations B-O O
100-fold B-O O
lower B-O O
than B-O O
cyclosporin B-O O
A B-O O
, B-O O
a B-O O
cyclic B-O O
undecapeptide B-O O
that B-O O
is B-O O
used B-O O
to B-O O
prevent B-O O
rejection B-O O
after B-O O
transplantation B-O O
of B-O O
bone B-O O
marrow B-O O
and B-O O
organs B-O O
, B-O O
such B-O O
as B-O O
kidney B-O O
, B-O O
heart B-O O
, B-O O
and B-O O
liver B-O O
. B-O O

After B-O O
the B-O O
recent B-O O
discovery B-O O
that B-O O
the B-O O
cyclosporin B-O O
A B-O O
-binding B-O O
protein B-O O
cyclophilin B-O B-protein
is B-O O
identical B-O O
to B-O O
peptidylprolyl B-O B-protein
cis-trans B-O I-protein
isomerase B-O I-protein
, B-O O
a B-O O
cellular B-O B-protein
binding B-O I-protein
protein B-O I-protein
for B-O O
FK506 B-O O
was B-O O
found B-O O
to B-O O
be B-O O
distinct B-O O
from B-O O
cyclophilin B-O B-protein
but B-O O
to B-O O
have B-O O
the B-O O
same B-O O
enzymatic B-O O
activity B-O O
. B-O O

In B-O O
this B-O O
study B-O O
, B-O O
we B-O O
isolated B-O O
a B-O O
cDNA B-O B-DNA
coding B-O O
for B-O O
FK506 B-O B-protein
-binding B-O I-protein
protein B-O I-protein
( B-O O
FKBP B-O B-protein
) B-O O
from B-O O
human B-O B-cell_type
peripheral B-O I-cell_type
blood B-O I-cell_type
T B-O I-cell_type
cells B-O I-cell_type
by B-O O
using B-O O
mixed B-O O
20-mer B-O O
oligonucleotide B-O O
probes B-O O
synthesized B-O O
on B-O O
the B-O O
basis B-O O
of B-O O
the B-O O
sequence B-O O
, B-O O
Glu-Asp-Gly-Lys-Lys-Phe-Asp B-O O
, B-O O
reported B-O O
for B-O O
bovine B-O O
FKBP B-O B-protein
. B-O O

The B-O O
DNA B-O O
isolated B-O O
contained B-O O
an B-O O
open B-O B-DNA
reading B-O I-DNA
frame B-O I-DNA
encoding B-O O
108 B-O O
amino B-O O
acid B-O O
residues B-O O
. B-O O

The B-O O
first B-O O
40 B-O O
residues B-O O
of B-O O
the B-O O
deduced B-O O
amino B-O O
acid B-O O
sequence B-O O
were B-O O
identical B-O O
to B-O O
those B-O O
of B-O O
the B-O O
reported B-O O
amino-terminal B-O B-protein
sequence B-O I-protein
of B-O O
bovine B-O O
FKBP B-O B-protein
, B-O O
indicating B-O O
that B-O O
the B-O O
DNA B-O B-DNA
sequence B-O I-DNA
isolated B-O O
represents B-O O
the B-O O
gene B-O O
coding B-O O
for B-O O
FKBP B-O B-protein
. B-O O

Computer-assisted B-O O
analysis B-O O
of B-O O
the B-O O
deduced B-O O
amino B-O O
acid B-O O
sequence B-O O
indicates B-O O
that B-O O
FKBP B-O B-protein
exhibits B-O O
no B-O O
internal B-O O
homology B-O O
and B-O O
does B-O O
not B-O O
have B-O O
significant B-O O
sequence B-O O
similarity B-O O
to B-O O
any B-O O
other B-O O
amino B-O O
acid B-O O
sequences B-O O
of B-O O
known B-O O
proteins B-O O
, B-O O
including B-O O
cyclophilin B-O B-protein
. B-O O

This B-O O
result B-O O
suggests B-O O
that B-O O
two B-O O
catalytically B-O B-protein
similar B-O I-protein
proteins B-O I-protein
, B-O O
cyclophilin B-O B-protein
and B-O O
FKBP B-O B-protein
, B-O O
evolved B-O O
independently B-O O
. B-O O

In B-O O
Northern B-O O
blot B-O O
analysis B-O O
, B-O O
mRNA B-O B-RNA
species B-O I-RNA
of B-O O
approximately B-O O
1.8 B-O O
kilobases B-O O
that B-O O
hybridized B-O O
with B-O O
human B-O B-DNA
FKBP B-O I-DNA
cDNA B-O I-DNA
were B-O O
detected B-O O
in B-O O
poly B-O B-RNA
( B-O I-RNA
A B-O I-RNA
) B-O I-RNA
+ B-O I-RNA
RNAs B-O I-RNA
from B-O O
brain B-O O
, B-O O
lung B-O O
, B-O O
liver B-O O
, B-O O
and B-O O
placental B-O B-cell_type
cells B-O I-cell_type
and B-O O
leukocytes B-O B-cell_type
. B-O O

Induction B-O O
of B-O O
Jurkat B-O B-cell_line
leukemic B-O I-cell_line
T B-O I-cell_line
cells B-O I-cell_line
with B-O O
phorbol B-O O
12-myristate B-O O
13-acetate B-O O
and B-O O
ionomycin B-O O
did B-O O
not B-O O
affect B-O O
the B-O O
level B-O O
of B-O O
FKBP B-O B-RNA
mRNA B-O I-RNA
. B-O O

Southern B-O O
blot B-O O
analysis B-O O
of B-O O
human B-O B-DNA
genomic B-O I-DNA
DNA B-O I-DNA
digested B-O O
with B-O O
different B-O O
restriction B-O B-protein
enzymes B-O I-protein
suggests B-O O
the B-O O
existence B-O O
of B-O O
only B-O O
a B-O O
few B-O O
copies B-O O
of B-O O
the B-O O
DNA B-O B-DNA
sequence B-O I-DNA
encoding B-O O
FKBP B-O B-protein
. B-O O

This B-O O
is B-O O
in B-O O
contrast B-O O
to B-O O
the B-O O
result B-O O
that B-O O
as B-O O
many B-O O
as B-O O
20 B-O O
copies B-O O
of B-O O
the B-O O
cyclophilin B-O B-DNA
gene B-O I-DNA
and B-O O
possible B-O O
pseudogenes B-O O
may B-O O
be B-O O
present B-O O
in B-O O
the B-O O
mammalian B-O B-DNA
genome B-O I-DNA
. B-O O

Involvement B-O O
of B-O O
a B-O O
second B-O O
lymphoid-specific B-O B-DNA
enhancer B-O I-DNA
element B-O I-DNA
in B-O O
the B-O O
regulation B-O O
of B-O O
immunoglobulin B-O B-DNA
heavy-chain B-O I-DNA
gene B-O I-DNA
expression B-O O
. B-O O

To B-O O
determine B-O O
whether B-O O
enhancer B-O B-DNA
elements B-O I-DNA
in B-O O
addition B-O O
to B-O O
the B-O O
highly B-O O
conserved B-O O
octamer B-O B-DNA
( B-O I-DNA
OCTA B-O I-DNA
) B-O I-DNA
-nucleotide B-O I-DNA
motif B-O I-DNA
are B-O O
important B-O O
for B-O O
lymphoid-specific B-O O
expression B-O O
of B-O O
the B-O O
immunoglobulin B-O B-DNA
heavy-chain B-O I-DNA
( B-O I-DNA
IgH B-O I-DNA
) B-O I-DNA
gene B-O I-DNA
, B-O O
we B-O O
have B-O O
investigated B-O O
the B-O O
effect B-O O
of B-O O
mutating B-O O
the B-O O
binding B-O B-DNA
site B-O I-DNA
for B-O O
a B-O O
putative B-O B-protein
additional B-O I-protein
lymphoid-specific B-O I-protein
transcription B-O I-protein
factor B-O I-protein
, B-O O
designated B-O O
NF-microB B-O B-protein
, B-O O
in B-O O
the B-O O
murine B-O B-DNA
IgH B-O I-DNA
enhancer B-O I-DNA
. B-O O

We B-O O
demonstrate B-O O
that B-O O
the B-O O
NF-microB-binding B-O B-DNA
site B-O I-DNA
plays B-O O
a B-O O
critical B-O O
role B-O O
in B-O O
the B-O O
IgH B-O B-DNA
enhancer B-O I-DNA
, B-O O
because B-O O
mutation B-O O
of B-O O
the B-O O
microB B-O B-DNA
DNA B-O I-DNA
motif B-O I-DNA
decreased B-O O
transcriptional B-O O
activity B-O O
of B-O O
the B-O O
IgH B-O B-DNA
enhancer B-O I-DNA
in B-O O
cells B-O O
of B-O O
the B-O O
B-cell B-O B-cell_type
lineage B-O I-cell_type
but B-O O
not B-O O
in B-O O
nonlymphoid B-O B-cell_type
cells B-O I-cell_type
. B-O O

This B-O O
effect B-O O
was B-O O
comparable B-O O
to B-O O
or B-O O
even B-O O
stronger B-O O
than B-O O
the B-O O
effect B-O O
of B-O O
a B-O O
mutation B-O O
in B-O O
the B-O O
OCTA B-O B-DNA
site B-O I-DNA
. B-O O

Moreover B-O O
, B-O O
combined B-O O
mutation B-O O
of B-O O
both B-O O
microB B-O B-DNA
and B-O O
OCTA B-O B-DNA
sites B-O I-DNA
further B-O O
reduced B-O O
enhancer B-O O
activity B-O O
in B-O O
lymphoid B-O B-cell_type
cells B-O I-cell_type
. B-O O

Interestingly B-O O
, B-O O
alteration B-O O
of B-O O
either B-O O
the B-O O
microB B-O B-DNA
or B-O O
E3 B-O B-DNA
site B-O I-DNA
in B-O O
a B-O O
70-base-pair B-O B-DNA
fragment B-O I-DNA
of B-O O
the B-O O
IgH B-O B-DNA
enhancer B-O I-DNA
that B-O O
lacks B-O O
the B-O O
binding B-O B-DNA
site B-O I-DNA
for B-O O
OCTA B-O B-protein
abolished B-O O
enhancer B-O O
activity B-O O
in B-O O
lymphoid B-O B-cell_type
cells B-O I-cell_type
completely B-O O
. B-O O

Nevertheless B-O O
, B-O O
a B-O O
multimer B-O O
of B-O O
the B-O O
microB B-O B-DNA
motif B-O I-DNA
alone B-O O
showed B-O O
no B-O O
enhancer B-O O
activity B-O O
. B-O O

DNase B-O B-protein
footprinting B-O O
analysis B-O O
corroborated B-O O
the B-O O
functional B-O O
data B-O O
showing B-O O
that B-O O
a B-O O
lymphoid-specific B-O B-protein
protein B-O I-protein
binds B-O O
to B-O O
the B-O O
microB B-O B-DNA
DNA B-O I-DNA
motif B-O I-DNA
. B-O O

Our B-O O
results B-O O
suggest B-O O
that B-O O
the B-O O
microB B-O B-DNA
element B-O I-DNA
is B-O O
a B-O O
new B-O O
crucial B-O O
element B-O O
important B-O O
for B-O O
lymphoid-specific B-O O
expression B-O O
of B-O O
the B-O O
IgH B-O B-DNA
gene B-O I-DNA
but B-O O
that B-O O
interaction B-O O
with B-O O
another B-O O
enhancer B-O B-DNA
element B-O I-DNA
is B-O O
essential B-O O
for B-O O
its B-O O
activity B-O O
. B-O O

Stimulation B-O O
of B-O O
the B-O O
human B-O B-DNA
immunodeficiency B-O I-DNA
virus B-O I-DNA
type B-O I-DNA
2 B-O I-DNA
( B-O I-DNA
HIV-2 B-O I-DNA
) B-O I-DNA
gene B-O I-DNA
expression B-O O
by B-O O
the B-O O
cytomegalovirus B-O O
and B-O O
HIV-2 B-O B-DNA
transactivator B-O I-DNA
gene B-O I-DNA
. B-O O

Human B-O O
immunodeficiency B-O O
virus B-O O
( B-O O
HIV B-O O
) B-O O
often B-O O
causes B-O O
latent B-O O
infection B-O O
. B-O O

Transactivation B-O O
by B-O O
some B-O O
DNA B-O O
viruses B-O O
has B-O O
been B-O O
implicated B-O O
in B-O O
inducing B-O O
HIV-1 B-O O
replication B-O O
and B-O O
pathogenesis B-O O
. B-O O

The B-O O
transactivator B-O B-DNA
( B-O I-DNA
IE-2 B-O I-DNA
) B-O I-DNA
gene B-O I-DNA
of B-O O
the B-O O
human B-O O
cytomegalovirus B-O O
( B-O O
CMV B-O O
) B-O O
can B-O O
enhance B-O O
HIV-2 B-O O
as B-O O
well B-O O
as B-O O
HIV-1 B-O O
gene B-O O
expression B-O O
in B-O O
vitro B-O O
. B-O O

This B-O O
inducer B-O O
can B-O O
act B-O O
in B-O O
concert B-O O
with B-O O
the B-O O
HIV-2 B-O B-DNA
tat B-O I-DNA
gene B-O I-DNA
and B-O O
T-cell B-O O
activation B-O O
in B-O O
enhancing B-O O
gene B-O O
expression B-O O
in B-O O
human B-O B-cell_type
CD4+ B-O I-cell_type
lymphocytes B-O I-cell_type
. B-O O

While B-O O
the B-O O
HIV-2 B-O O
and B-O O
HIV-1 B-O B-DNA
tat B-O I-DNA
genes B-O I-DNA
and B-O O
T-cell B-O B-protein
activators B-O I-protein
apparently B-O O
employ B-O O
independent B-O O
modes B-O O
of B-O O
action B-O O
, B-O O
the B-O O
CMV B-O B-DNA
transactivator B-O I-DNA
in B-O O
combination B-O O
with B-O O
the B-O O
HIV-2 B-O B-protein
tat B-O I-protein
or B-O O
T-cell B-O B-protein
activators B-O I-protein
may B-O O
employ B-O O
a B-O O
gene B-O O
activation B-O O
pathway B-O O
with B-O O
some B-O O
common B-O O
and B-O O
some B-O O
distinct B-O O
components B-O O
. B-O O

Both B-O O
HIV-2 B-O O
and B-O O
CMV B-O B-DNA
transactivators B-O I-DNA
enhance B-O O
HIV-2 B-O O
gene B-O O
expression B-O O
by B-O O
transcriptional B-O O
activation B-O O
involving B-O O
transcript B-O O
initiation B-O O
as B-O O
well B-O O
as B-O O
elongation B-O O
, B-O O
with B-O O
CMV B-O B-DNA
transactivator B-O I-DNA
affecting B-O O
elongation B-O O
more B-O O
than B-O O
the B-O O
initiation B-O O
. B-O O

A B-O O
significant B-O O
proportion B-O O
of B-O O
transcripts B-O B-RNA
appear B-O O
to B-O O
terminate B-O O
prematurely B-O O
in B-O O
the B-O O
absence B-O O
of B-O O
transactivators B-O B-protein
. B-O O

Deletion B-O O
mutation B-O O
analysis B-O O
of B-O O
the B-O O
HIV-2 B-O B-DNA
long B-O I-DNA
terminal B-O I-DNA
repeat B-O I-DNA
( B-O O
LTR B-O B-DNA
) B-O O
suggests B-O O
that B-O O
the B-O O
element B-O O
that B-O O
responds B-O O
to B-O O
CMV B-O O
transactivation B-O O
in B-O O
human B-O B-cell_type
CD4+ B-O I-cell_type
lymphocytes B-O I-cell_type
is B-O O
either B-O O
a B-O O
diffuse B-O O
one B-O O
or B-O O
located B-O O
downstream B-O O
of B-O O
the B-O O
HIV-2 B-O B-DNA
enhancer B-O I-DNA
element B-O I-DNA
. B-O O

Quantitative B-O O
immunohistochemical B-O O
analysis B-O O
of B-O O
mononuclear B-O B-cell_type
infiltrates B-O I-cell_type
in B-O O
breast B-O O
carcinomas B-O O
-- B-O O
correlation B-O O
with B-O O
tumour B-O O
differentiation B-O O
. B-O O

Inflammatory B-O B-cell_type
infiltrates B-O I-cell_type
were B-O O
analysed B-O O
in B-O O
tissue B-O O
sections B-O O
of B-O O
76 B-O O
breast B-O O
carcinomas B-O O
by B-O O
counting B-O O
the B-O O
percentage B-O O
of B-O O
macrophages B-O B-cell_type
, B-O O
IgA+ B-O B-cell_type
and B-O I-cell_type
IgG+ B-O I-cell_type
plasma B-O I-cell_type
cells B-O I-cell_type
, B-O O
T B-O B-cell_type
cells B-O I-cell_type
with B-O O
their B-O O
subpopulations B-O O
, B-O O
and B-O O
natural B-O B-cell_type
killer B-O I-cell_type
cells B-O I-cell_type
, B-O O
and B-O O
by B-O O
measuring B-O O
postcapillary B-O O
venules B-O O
( B-O O
PCVs B-O O
, B-O O
found B-O O
in B-O O
12 B-O O
cases B-O O
) B-O O
within B-O O
the B-O O
infiltrates B-O O
. B-O O

These B-O O
parameters B-O O
were B-O O
correlated B-O O
with B-O O
nuclear B-O O
grade B-O O
and B-O O
biochemically B-O O
determined B-O O
hormone B-O O
receptor B-O O
status B-O O
, B-O O
known B-O O
markers B-O O
of B-O O
tumour B-O O
differentiation B-O O
. B-O O

A B-O O
direct B-O O
correlation B-O O
was B-O O
found B-O O
between B-O O
the B-O O
extent B-O O
of B-O O
inflammation B-O O
and B-O O
nuclear B-O O
grade B-O O
( B-O O
P B-O O
less B-O O
than B-O O
0.0001 B-O O
) B-O O
, B-O O
and B-O O
an B-O O
inverse B-O O
correlation B-O O
between B-O O
inflammation B-O O
and B-O O
oestrogen B-O B-protein
receptor B-O I-protein
( B-O O
OR B-O B-protein
) B-O O
positivity B-O O
( B-O O
P B-O O
less B-O O
than B-O O
0.05 B-O O
) B-O O
as B-O O
well B-O O
as B-O O
inflammation B-O O
and B-O O
progesterone B-O B-protein
receptor B-O I-protein
( B-O O
PR B-O B-protein
) B-O O
positivity B-O O
( B-O O
P B-O O
less B-O O
than B-O O
0.05 B-O O
) B-O O
. B-O O

The B-O O
percentage B-O O
of B-O O
the B-O O
OKT8+ B-O B-cell_line
suppressor/cytotoxic B-O I-cell_line
T B-O I-cell_line
cells B-O I-cell_line
increased B-O O
when B-O O
the B-O O
inflammation B-O O
expanded B-O O
from B-O O
scanty B-O O
to B-O O
moderate B-O O
( B-O O
P B-O O
less B-O O
than B-O O
0.02 B-O O
) B-O O
. B-O O

The B-O O
diameter B-O O
of B-O O
the B-O O
PCVs B-O O
also B-O O
increased B-O O
with B-O O
increasing B-O O
inflammatory B-O O
infiltrate B-O O
( B-O O
P B-O O
less B-O O
than B-O O
0.02 B-O O
) B-O O
. B-O O

In B-O O
addition B-O O
, B-O O
a B-O O
direct B-O O
correlation B-O O
exists B-O O
between B-O O
the B-O O
diameter B-O O
of B-O O
the B-O O
PCVs B-O O
and B-O O
both B-O O
the B-O O
percentage B-O O
of B-O O
the B-O O
OKT8+ B-O B-cell_line
T B-O I-cell_line
cells B-O I-cell_line
( B-O O
P B-O O
less B-O O
than B-O O
0.04 B-O O
) B-O O
and B-O O
the B-O O
Leu-7+ B-O O
natural B-O B-cell_type
killer B-O I-cell_type
cells B-O I-cell_type
( B-O O
P B-O O
less B-O O
than B-O O
0.03 B-O O
) B-O O
. B-O O

Reactivity B-O O
of B-O O
lymphocytes B-O B-cell_type
to B-O O
a B-O O
progesterone B-O B-protein
receptor-specific B-O I-protein
monoclonal B-O I-protein
antibody B-O I-protein
. B-O O

In B-O O
this B-O O
study B-O O
we B-O O
present B-O O
evidence B-O O
for B-O O
reactivity B-O O
of B-O O
pregnancy B-O B-cell_type
lymphocytes B-O I-cell_type
, B-O O
but B-O O
not B-O O
nonpregnancy B-O B-cell_type
lymphocytes B-O I-cell_type
, B-O O
with B-O O
the B-O O
progesterone B-O B-protein
receptor-specific B-O I-protein
monoclonal B-O I-protein
antibody B-O I-protein
mPRI B-O O
. B-O O

Using B-O O
an B-O O
avidin B-O B-protein
-biotin B-O B-protein
peroxidase B-O I-protein
detection B-O O
system B-O O
, B-O O
we B-O O
found B-O O
a B-O O
nuclear B-O O
staining B-O O
in B-O O
14.6 B-O O
+/- B-O O
3.7 B-O O
% B-O O
( B-O O
mean B-O O
+/- B-O O
SEM B-O O
, B-O O
N B-O O
= B-O O
27 B-O O
) B-O O
of B-O O
pregnancy B-O B-cell_type
lymphocytes B-O I-cell_type
, B-O O
while B-O O
only B-O O
0.47 B-O O
+/- B-O O
0.33 B-O O
% B-O O
( B-O O
mean B-O O
+/- B-O O
SEM B-O O
, B-O O
N B-O O
= B-O O
15 B-O O
) B-O O
of B-O O
nonpregnancy B-O B-cell_type
lymphocytes B-O I-cell_type
reacted B-O O
with B-O O
the B-O O
antibody B-O O
. B-O O

To B-O O
characterize B-O O
the B-O O
receptor-bearing B-O O
subset B-O O
, B-O O
CD8+ B-O B-cell_line
and B-O I-cell_line
CD4+ B-O I-cell_line
cells B-O I-cell_line
were B-O O
depleted B-O O
by B-O O
complement-dependent B-O O
lysis B-O O
. B-O O

Depletion B-O O
of B-O O
CD8+ B-O B-cell_line
cells B-O I-cell_line
was B-O O
accompanied B-O O
by B-O O
62 B-O O
+/- B-O O
18 B-O O
% B-O O
loss B-O O
of B-O O
progesterone B-O B-protein
receptor B-O I-protein
-bearing B-O O
cells B-O O
, B-O O
while B-O O
depletion B-O O
of B-O O
CD4+ B-O B-cell_line
cells B-O I-cell_line
resulted B-O O
in B-O O
a B-O O
twofold B-O O
increase B-O O
in B-O O
the B-O O
number B-O O
of B-O O
positively B-O O
staining B-O O
lymphocytes B-O B-cell_type
. B-O O

In B-O O
nonpregnancy B-O B-cell_type
lymphocytes B-O I-cell_type
a B-O O
3-day B-O O
PHA B-O B-protein
treatment B-O O
, B-O O
as B-O O
well B-O O
as B-O O
allogeneic B-O O
stimulation B-O O
, B-O O
resulted B-O O
in B-O O
a B-O O
significant B-O O
increase B-O O
in B-O O
the B-O O
number B-O O
of B-O O
receptor-containing B-O B-cell_type
cells B-O I-cell_type
. B-O O

These B-O O
results B-O O
suggest B-O O
that B-O O
pregnancy B-O O
, B-O O
but B-O O
not B-O O
nonpregnancy B-O O
, B-O O
lymphocytes B-O B-cell_type
contain B-O O
progesterone B-O B-protein
binding B-O I-protein
structures B-O I-protein
, B-O O
and B-O O
that B-O O
these B-O O
are B-O O
inducible B-O O
by B-O O
mitogenic B-O O
or B-O O
alloantigenic B-O O
stimuli B-O O
. B-O O

Activation B-O O
of B-O O
human B-O B-cell_type
CD4 B-O I-cell_type
T B-O I-cell_type
lymphocytes B-O I-cell_type
. B-O O

Interaction B-O O
of B-O O
fibronectin B-O B-protein
with B-O O
VLA-5 B-O B-protein
receptor B-O I-protein
on B-O O
CD4 B-O B-cell_line
cells B-O I-cell_line
induces B-O O
the B-O O
AP-1 B-O B-protein
transcription B-O I-protein
factor B-O I-protein
. B-O O

Fibronectin B-O B-protein
synergized B-O O
with B-O O
anti-CD3 B-O B-protein
antibody B-O I-protein
to B-O O
promote B-O O
CD4 B-O B-protein
cell B-O O
proliferation B-O O
in B-O O
a B-O O
serum-free B-O O
culture B-O O
system B-O O
whereas B-O O
no B-O O
proliferation B-O O
was B-O O
observed B-O O
when B-O O
CD4 B-O B-cell_line
cells B-O I-cell_line
were B-O O
cultured B-O O
with B-O O
anti-CD3 B-O B-protein
alone B-O O
or B-O O
fibronectin B-O B-protein
alone B-O O
. B-O O

In B-O O
addition B-O O
, B-O O
anti-CD29 B-O B-protein
( B-O O
integrin B-O B-protein
beta B-O I-protein
1 B-O I-protein
) B-O O
as B-O O
well B-O O
as B-O O
anti-VLA-5 B-O B-protein
( B-O O
human B-O B-protein
fibronectin B-O I-protein
receptor B-O I-protein
) B-O O
antibodies B-O O
blocked B-O O
this B-O O
CD4 B-O B-cell_line
cell B-O I-cell_line
activation B-O O
in B-O O
this B-O O
system B-O O
. B-O O

Although B-O O
anti-CD3 B-O B-protein
alone B-O O
or B-O O
fibronectin B-O B-protein
alone B-O O
can B-O O
not B-O O
induce B-O O
IL-2 B-O B-protein
message B-O O
by B-O O
CD4 B-O B-cell_line
cells B-O I-cell_line
, B-O O
the B-O O
combination B-O O
of B-O O
anti-CD3 B-O B-protein
plus B-O O
fibronectin B-O B-protein
induced B-O O
IL-2 B-O B-protein
message B-O O
by B-O O
CD4 B-O B-cell_line
cells B-O I-cell_line
. B-O O

In B-O O
an B-O O
analysis B-O O
of B-O O
the B-O O
molecular B-O O
mechanism B-O O
by B-O O
which B-O O
IL-2 B-O B-protein
message B-O O
was B-O O
generated B-O O
, B-O O
we B-O O
showed B-O O
that B-O O
a B-O O
fibronectin B-O B-protein
-VLA-5 B-O I-protein
fibronectin B-O I-protein
receptor B-O I-protein
interaction B-O O
may B-O O
contribute B-O O
an B-O O
independent B-O O
signal B-O O
distinct B-O O
from B-O O
the B-O O
CD3 B-O B-protein
pathway B-O O
of B-O O
activation B-O O
by B-O O
the B-O O
induction B-O O
of B-O O
an B-O O
AP-1 B-O B-protein
transcriptional B-O I-protein
factor B-O I-protein
. B-O O

Thus B-O O
the B-O O
VLA-5 B-O B-protein
fibronectin B-O I-protein
receptor B-O I-protein
on B-O O
CD4 B-O B-cell_line
cells B-O I-cell_line
can B-O O
play B-O O
a B-O O
complementary B-O O
role B-O O
in B-O O
CD3 B-O B-protein
- B-O O
TCR B-O B-protein
-mediated B-O O
signal B-O O
transduction B-O O
through B-O O
its B-O O
interaction B-O O
with B-O O
fibronectin B-O B-protein
. B-O O

Glucocorticoid B-O B-protein
receptors B-O I-protein
on B-O O
mononuclear B-O B-cell_type
leukocytes B-O I-cell_type
in B-O O
Alzheimer B-O O
's B-O O
disease B-O O
. B-O O

Several B-O O
lines B-O O
of B-O O
evidence B-O O
suggest B-O O
disturbances B-O O
of B-O O
the B-O O
hypothalamic-pituitary-adrenal B-O O
( B-O O
HPA B-O O
) B-O O
system B-O O
in B-O O
Alzheimer B-O O
's B-O O
disease B-O O
( B-O O
AD B-O O
) B-O O
. B-O O

In B-O O
an B-O O
exploration B-O O
of B-O O
the B-O O
potential B-O O
role B-O O
of B-O O
the B-O O
glucocorticoid B-O B-protein
receptor B-O I-protein
( B-O O
GR B-O B-protein
) B-O O
in B-O O
AD B-O O
, B-O O
GR B-O B-protein
density B-O O
and B-O O
affinity B-O O
were B-O O
assessed B-O O
on B-O O
mononuclear B-O B-cell_type
leukocytes B-O I-cell_type
of B-O O
12 B-O O
AD B-O O
patients B-O O
and B-O O
12 B-O O
healthy B-O O
controls B-O O
. B-O O

GR B-O B-protein
binding B-O O
characteristics B-O O
did B-O O
not B-O O
differ B-O O
between B-O O
patients B-O O
and B-O O
controls B-O O
or B-O O
between B-O O
patients B-O O
subdivided B-O O
according B-O O
to B-O O
diagnosis B-O O
or B-O O
associated B-O O
clinical B-O O
features B-O O
. B-O O

These B-O O
data B-O O
suggest B-O O
that B-O O
the B-O O
abnormalities B-O O
of B-O O
the B-O O
HPA B-O O
system B-O O
in B-O O
AD B-O O
are B-O O
not B-O O
related B-O O
to B-O O
a B-O O
GR B-O B-protein
deficiency B-O O
. B-O O

Oncogene B-O B-DNA
amplification B-O O
correlates B-O O
with B-O O
dense B-O O
lymphocyte B-O O
infiltration B-O O
in B-O O
human B-O O
breast B-O O
cancers B-O O
: B-O O
a B-O O
role B-O O
for B-O O
hematopoietic B-O B-protein
growth B-O I-protein
factor B-O I-protein
release B-O O
by B-O O
tumor B-O B-cell_type
cells B-O I-cell_type
? B-O O

One B-O O
hundred B-O O
six B-O O
primary B-O O
breast B-O O
cancer B-O O
samples B-O O
were B-O O
analysed B-O O
for B-O O
c-erbB2 B-O B-protein
, B-O O
int-2 B-O B-DNA
, B-O O
and B-O O
c-myc B-O O
gene B-O O
amplification B-O O
. B-O O

Surgically B-O O
confirmed B-O O
nodal B-O O
involvement B-O O
was B-O O
observed B-O O
in B-O O
42 B-O O
% B-O O
. B-O O

Level B-O O
of B-O O
gene B-O O
amplification B-O O
was B-O O
studied B-O O
by B-O O
Southern B-O O
and/or B-O O
slot B-O O
blot B-O O
techniques B-O O
. B-O O

Amplified B-O O
c-erbB2 B-O B-DNA
gene B-O I-DNA
sequences B-O I-DNA
were B-O O
present B-O O
in B-O O
21.5 B-O O
% B-O O
of B-O O
all B-O O
samples B-O O
. B-O O

Int-2 B-O B-protein
was B-O O
amplified B-O O
in B-O O
13.1 B-O O
% B-O O
and B-O O
c-myc B-O B-DNA
was B-O O
amplified B-O O
in B-O O
10.3 B-O O
% B-O O
. B-O O

In B-O O
a B-O O
non-parametric B-O O
test B-O O
( B-O O
Kruskal-Wallis B-O O
) B-O O
a B-O O
strong B-O O
negative B-O O
association B-O O
was B-O O
found B-O O
between B-O O
high B-O O
levels B-O O
of B-O O
c-erbB2 B-O B-DNA
amplification B-O O
and B-O O
absence B-O O
of B-O O
estrogen B-O B-protein
receptor B-O I-protein
( B-O O
ER B-O B-protein
) B-O O
( B-O O
P B-O O
= B-O O
.0009 B-O O
) B-O O
or B-O O
progesterone B-O B-protein
receptor B-O I-protein
( B-O O
PR B-O B-protein
) B-O O
( B-O O
P B-O O
= B-O O
.011 B-O O
) B-O O
expression B-O O
. B-O O

No B-O O
correlations B-O O
were B-O O
found B-O O
between B-O O
all B-O O
or B-O O
high B-O O
levels B-O O
of B-O O
amplification B-O O
of B-O O
each B-O O
oncogene B-O B-DNA
separately B-O O
or B-O O
combined B-O O
with B-O O
T B-O O
, B-O O
N B-O O
, B-O O
grade B-O O
, B-O O
multifocality B-O O
of B-O O
tumor B-O O
, B-O O
or B-O O
associated B-O O
carcinoma B-O O
in B-O O
situ B-O O
. B-O O

There B-O O
was B-O O
a B-O O
trend B-O O
approaching B-O O
statistical B-O O
significance B-O O
for B-O O
patients B-O O
with B-O O
c-erbB2 B-O B-DNA
amplifications B-O O
to B-O O
have B-O O
positive B-O O
lymph B-O O
nodes B-O O
at B-O O
surgery B-O O
( B-O O
P B-O O
= B-O O
0.09 B-O O
) B-O O
. B-O O

A B-O O
somewhat B-O O
surprising B-O O
finding B-O O
however B-O O
was B-O O
a B-O O
very B-O O
strong B-O O
association B-O O
between B-O O
oncogene B-O B-DNA
amplification B-O O
and B-O O
dense B-O O
lymphocyte B-O O
infiltration B-O O
of B-O O
the B-O O
tumor B-O O
( B-O O
P B-O O
= B-O O
.05 B-O O
) B-O O
. B-O O
This B-O O
correlation B-O O
is B-O O
even B-O O
stronger B-O O
when B-O O
only B-O O
high B-O O
levels B-O O
of B-O O
amplification B-O O
are B-O O
considered B-O O
, B-O O
either B-O O
for B-O O
each B-O O
oncogene B-O B-DNA
separately B-O O
( B-O O
P B-O O
= B-O O
.0048 B-O O
) B-O O
or B-O O
in B-O O
combination B-O O
( B-O O
P B-O O
= B-O O
.0007 B-O O
) B-O O
. B-O O

We B-O O
propose B-O O
that B-O O
malignant B-O O
cell B-O O
cytokine B-O B-protein
production B-O O
may B-O O
help B-O O
explain B-O O
this B-O O
observation B-O O
. B-O O

Suppression B-O O
of B-O O
signals B-O O
required B-O O
for B-O O
activation B-O O
of B-O O
transcription B-O B-protein
factor B-O I-protein
NF-kappa B-O B-protein
B B-O I-protein
in B-O O
cells B-O O
constitutively B-O O
expressing B-O O
the B-O O
HTLV-I B-O B-protein
Tax B-O I-protein
protein B-O I-protein
. B-O O

Transient B-O O
short-term B-O O
expression B-O O
of B-O O
the B-O O
Tax B-O B-protein
protein B-O I-protein
of B-O O
human B-O O
T-cell B-O O
leukemia B-O O
virus B-O O
type-I B-O O
( B-O O
HTLV-I B-O O
) B-O O
leads B-O O
to B-O O
activation B-O O
of B-O O
the B-O O
pleiotropic B-O B-protein
transcription B-O I-protein
factor B-O I-protein
NF-kappa B-O B-protein
B B-O I-protein
. B-O O

Consistent B-O O
with B-O O
findings B-O O
obtained B-O O
with B-O O
transient B-O O
expression B-O O
assays B-O O
, B-O O
we B-O O
observed B-O O
marked B-O O
accumulation B-O O
of B-O O
the B-O O
transcription B-O B-protein
factor B-O I-protein
NF-kappa B-O B-protein
B B-O I-protein
in B-O O
the B-O O
nucleus B-O O
of B-O O
Namalwa B-O B-cell_line
B B-O I-cell_line
lymphoid B-O I-cell_line
cells B-O I-cell_line
, B-O O
which B-O O
constitutively B-O O
express B-O O
Tax B-O B-protein
. B-O O

In B-O O
contrast B-O O
, B-O O
NF-kappa B-O B-protein
B B-O I-protein
activity B-O O
was B-O O
not B-O O
detected B-O O
in B-O O
the B-O O
nucleus B-O O
following B-O O
long-term B-O O
expression B-O O
of B-O O
Tax B-O B-protein
in B-O O
Jurkat B-O B-cell_line
T B-O I-cell_line
lymphocytes B-O I-cell_line
. B-O O

The B-O O
ability B-O O
of B-O O
both B-O O
mitogens B-O B-protein
and B-O O
cytokines B-O B-protein
to B-O O
activate B-O O
NF-kappa B-O B-protein
B B-O I-protein
was B-O O
also B-O O
blocked B-O O
in B-O O
Jurkat B-O B-cell_line
cells B-O I-cell_line
constitutively B-O O
expressing B-O O
Tax B-O B-protein
. B-O O

However B-O O
, B-O O
the B-O O
activation B-O O
of B-O O
other B-O O
mitogen-inducible B-O B-protein
transcription B-O I-protein
factors B-O I-protein
, B-O O
such B-O O
as B-O O
Fos B-O B-protein
and B-O O
Jun B-O B-protein
, B-O O
was B-O O
unaffected B-O O
. B-O O

Thus B-O O
, B-O O
depending B-O O
on B-O O
the B-O O
cellular B-O O
environment B-O O
, B-O O
the B-O O
short- B-O O
and B-O O
long-term B-O O
effects B-O O
of B-O O
Tax B-O B-protein
expression B-O O
can B-O O
be B-O O
quite B-O O
different B-O O
. B-O O

Consequently B-O O
, B-O O
one B-O O
function B-O O
of B-O O
Tax B-O B-protein
in B-O O
cells B-O O
infected B-O O
with B-O O
HTLV-I B-O O
might B-O O
involve B-O O
cell-type-specific B-O O
suppression B-O O
, B-O O
as B-O O
opposed B-O O
to B-O O
activation B-O O
, B-O O
of B-O O
distinct B-O O
signal B-O O
pathways B-O O
. B-O O

The B-O O
cells B-O B-cell_line
lines B-O I-cell_line
described B-O O
here B-O O
should B-O O
be B-O O
useful B-O O
for B-O O
the B-O O
delineation B-O O
of B-O O
signaling B-O O
pathways B-O O
utilized B-O O
in B-O O
the B-O O
selective B-O O
regulation B-O O
of B-O O
gene B-O O
expression B-O O
. B-O O

Interferon-gamma B-O B-protein
and B-O O
the B-O O
sexual B-O O
dimorphism B-O O
of B-O O
autoimmunity B-O O
. B-O O

The B-O O
sexual B-O O
difference B-O O
in B-O O
the B-O O
incidence B-O O
of B-O O
autoimmune B-O O
diseases B-O O
has B-O O
remained B-O O
an B-O O
enigma B-O O
for B-O O
many B-O O
years B-O O
. B-O O

In B-O O
the B-O O
examination B-O O
of B-O O
the B-O O
induction B-O O
of B-O O
autoimmunity B-O O
in B-O O
transgenic B-O O
mice B-O O
, B-O O
evidence B-O O
has B-O O
been B-O O
obtained B-O O
further B-O O
implicating B-O O
the B-O O
lymphokine B-O B-protein
interferon-gamma B-O B-protein
in B-O O
the B-O O
etiology B-O O
of B-O O
autoimmunity B-O O
. B-O O

Sex B-O O
steroid B-O O
regulation B-O O
of B-O O
the B-O O
production B-O O
of B-O O
this B-O O
molecule B-O O
, B-O O
as B-O O
well B-O O
as B-O O
other B-O O
cytokines B-O B-protein
, B-O O
may B-O O
help B-O O
explain B-O O
the B-O O
gender-specific B-O O
differences B-O O
in B-O O
the B-O O
immune B-O O
system B-O O
, B-O O
including B-O O
autoimmunity B-O O
. B-O O

Cloning B-O O
of B-O O
a B-O O
transcriptionally B-O B-protein
active B-O I-protein
human B-O I-protein
TATA B-O I-protein
binding B-O I-protein
factor B-O I-protein
. B-O O

Transcription B-O B-protein
factor B-O I-protein
IID B-O I-protein
( B-O O
TFIID B-O B-protein
) B-O O
binds B-O O
to B-O O
the B-O O
TATA B-O B-DNA
box B-O I-DNA
promoter B-O I-DNA
element B-O I-DNA
and B-O O
regulates B-O O
the B-O O
expression B-O O
of B-O O
most B-O O
eukaryotic B-O B-DNA
genes B-O I-DNA
transcribed B-O O
by B-O O
RNA B-O B-protein
polymerase B-O I-protein
II B-O I-protein
. B-O O

Complementary B-O B-DNA
DNA B-O I-DNA
( B-O O
cDNA B-O B-DNA
) B-O O
encoding B-O O
a B-O O
human B-O B-protein
TFIID B-O I-protein
protein B-O I-protein
has B-O O
been B-O O
cloned B-O O
. B-O O

The B-O O
human B-O B-protein
TFIID B-O I-protein
polypeptide B-O I-protein
has B-O O
339 B-O O
amino B-O O
acids B-O O
and B-O O
a B-O O
molecular B-O O
size B-O O
of B-O O
37 B-O O
, B-O O
745 B-O O
daltons B-O O
. B-O O

The B-O O
carboxyl-terminal B-O B-protein
181 B-O I-protein
amino B-O I-protein
acids B-O I-protein
of B-O O
the B-O O
human B-O B-protein
TFIID B-O I-protein
protein B-O I-protein
shares B-O O
80 B-O O
% B-O O
identity B-O O
with B-O O
the B-O O
TFIID B-O B-protein
protein B-O I-protein
from B-O O
Saccharomyces B-O O
cerevisiae B-O O
. B-O O

The B-O O
amino B-O B-protein
terminus B-O I-protein
contains B-O O
an B-O O
unusual B-O O
repeat B-O O
of B-O O
38 B-O O
consecutive B-O O
glutamine B-O O
residues B-O O
and B-O O
an B-O O
X-Thr-Pro B-O B-DNA
repeat B-O I-DNA
. B-O O

Expression B-O O
of B-O O
DNA B-O O
in B-O O
reticulocyte B-O O
lysates B-O O
or B-O O
in B-O O
Escherichia B-O O
coli B-O O
yielded B-O O
a B-O O
protein B-O O
that B-O O
was B-O O
competent B-O O
for B-O O
both B-O O
DNA B-O O
binding B-O O
and B-O O
transcription B-O O
activation B-O O
. B-O O

A B-O O
novel B-O O
T-cell B-O B-protein
trans-activator B-O I-protein
that B-O O
recognizes B-O O
a B-O O
phorbol B-O B-DNA
ester-inducible B-O I-DNA
element B-O I-DNA
of B-O O
the B-O O
interleukin-2 B-O B-DNA
promoter B-O I-DNA
. B-O O

The B-O O
interleukin B-O B-DNA
2 B-O I-DNA
( B-O I-DNA
IL-2 B-O I-DNA
) B-O I-DNA
gene B-O I-DNA
promoter B-O I-DNA
is B-O O
recognized B-O O
by B-O O
several B-O O
cell-type-specific B-O O
and B-O O
ubiquitous B-O B-protein
transcriptional B-O I-protein
regulators B-O I-protein
that B-O O
integrate B-O O
information B-O O
transmitted B-O O
by B-O O
various B-O O
signaling B-O O
systems B-O O
leading B-O O
to B-O O
IL-2 B-O B-protein
production B-O O
and B-O O
T-cell B-O B-cell_type
activation B-O O
. B-O O

Using B-O O
a B-O O
combination B-O O
of B-O O
transfection B-O O
, B-O O
protein-DNA B-O O
binding B-O O
, B-O O
and B-O O
in B-O O
vitro B-O O
transcription B-O O
methods B-O O
, B-O O
we B-O O
have B-O O
discovered B-O O
the B-O O
novel B-O B-protein
T-cell-specific B-O I-protein
transcriptional B-O I-protein
activator B-O I-protein
TCF-1 B-O B-protein
( B-O O
for B-O O
T-Cell B-O B-protein
Factor-1 B-O I-protein
) B-O O
, B-O O
which B-O O
recognizes B-O O
a B-O O
T-cell-specific B-O B-DNA
response B-O I-DNA
element B-O I-DNA
( B-O O
TCE B-O B-DNA
) B-O O
located B-O O
within B-O O
the B-O O
IL-2 B-O B-DNA
promoter B-O I-DNA
. B-O O

Although B-O O
the B-O O
TCE B-O B-DNA
is B-O O
similar B-O O
in B-O O
sequence B-O O
to B-O O
a B-O O
consensus B-O B-DNA
NF B-O I-DNA
kappa B-O I-DNA
B B-O I-DNA
site B-O I-DNA
, B-O O
several B-O O
criteria B-O O
indicate B-O O
that B-O O
TCF-1 B-O B-protein
is B-O O
distinct B-O O
from B-O O
NF B-O B-protein
kappa B-O I-protein
B B-O I-protein
. B-O O

However B-O O
, B-O O
like B-O O
NF B-O B-protein
kappa B-O I-protein
B B-O I-protein
, B-O O
TCF-1 B-O B-protein
activity B-O O
is B-O O
induced B-O O
by B-O O
phorbol B-O O
esters B-O O
and B-O O
other B-O O
T-cell B-O B-protein
activators B-O I-protein
. B-O O

Risk B-O O
factors B-O O
for B-O O
breast B-O O
recurrence B-O O
in B-O O
premenopausal B-O O
and B-O O
postmenopausal B-O O
patients B-O O
with B-O O
ductal B-O O
cancers B-O O
treated B-O O
by B-O O
conservation B-O O
therapy B-O O
. B-O O

Risk B-O O
factors B-O O
for B-O O
local B-O O
failure B-O O
were B-O O
evaluated B-O O
for B-O O
496 B-O O
clinical B-O O
Stage B-O O
I-II B-O O
patients B-O O
with B-O O
infiltrating B-O O
ductal B-O O
carcinomas B-O O
( B-O O
median B-O O
follow-up B-O O
, B-O O
71 B-O O
months B-O O
) B-O O
treated B-O O
by B-O O
conservative B-O O
surgery B-O O
and B-O O
radiotherapy B-O O
. B-O O

Monofactorial B-O O
analysis B-O O
identified B-O O
the B-O O
following B-O O
factors B-O O
to B-O O
be B-O O
correlated B-O O
with B-O O
increased B-O O
risk B-O O
: B-O O
moderate/marked B-O O
mononuclear B-O O
cell B-O O
reaction B-O O
( B-O O
MCR B-O B-protein
) B-O O
, B-O O
high B-O O
histologic B-O O
grade B-O O
( B-O O
G B-O O
) B-O O
, B-O O
extensive B-O O
intraductal B-O O
component B-O O
( B-O O
EIC B-O O
) B-O O
, B-O O
tumor B-O O
necrosis B-O O
, B-O O
macroscopic B-O O
multiplicity B-O O
, B-O O
estrogen B-O B-protein
receptor B-O I-protein
negativity B-O O
, B-O O
anatomic B-O O
tumor B-O O
size B-O O
, B-O O
age B-O O
younger B-O O
than B-O O
40 B-O O
years B-O O
, B-O O
and B-O O
vascular B-O O
invasion B-O O
. B-O O

Only B-O O
MCR B-O O
, B-O O
G B-O O
, B-O O
and B-O O
EIC B-O O
proved B-O O
significant B-O O
in B-O O
Cox B-O O
multivariate B-O O
analysis B-O O
. B-O O

These B-O O
risk B-O O
factors B-O O
were B-O O
highly B-O O
age B-O O
dependent B-O O
, B-O O
with B-O O
EIC B-O O
markedly B-O O
more B-O O
prevalent B-O O
in B-O O
women B-O O
younger B-O O
than B-O O
50 B-O O
, B-O O
MCR B-O O
and B-O O
G B-O O
in B-O O
women B-O O
younger B-O O
than B-O O
40 B-O O
. B-O O

Separate B-O O
Cox B-O O
analysis B-O O
for B-O O
premenopausal B-O O
patients B-O O
showed B-O O
that B-O O
MCR B-O O
/EIC B-O O
determined B-O O
risk B-O O
independent B-O O
of B-O O
resection B-O O
margins B-O O
: B-O O
tumors B-O O
with B-O O
MCR B-O O
had B-O O
a B-O O
28 B-O O
% B-O O
, B-O O
and B-O O
with B-O O
EIC B-O O
a B-O O
22 B-O O
% B-O O
probability B-O O
of B-O O
recurring B-O O
locally B-O O
by B-O O
5 B-O O
years B-O O
. B-O O

Premenopausal B-O O
patients B-O O
with B-O O
neither B-O O
risk B-O O
factor B-O O
had B-O O
a B-O O
very B-O O
low B-O O
failure B-O O
rate B-O O
( B-O O
2.6 B-O O
% B-O O
at B-O O
5 B-O O
years B-O O
) B-O O
, B-O O
regardless B-O O
of B-O O
age B-O O
. B-O O

For B-O O
postmenopausal B-O O
patients B-O O
risk B-O O
of B-O O
breast B-O O
recurrence B-O O
was B-O O
determined B-O O
both B-O O
by B-O O
adequacy B-O O
of B-O O
resection B-O O
margins B-O O
and B-O O
grade B-O O
, B-O O
with B-O O
a B-O O
high B-O O
local B-O O
failure B-O O
rate B-O O
for B-O O
patients B-O O
having B-O O
G3 B-O O
tumors B-O O
with B-O O
positive B-O O
or B-O O
indeterminate B-O O
margins B-O O
( B-O O
31 B-O O
% B-O O
at B-O O
5 B-O O
years B-O O
) B-O O
. B-O O

The B-O O
authors B-O O
conclude B-O O
that B-O O
the B-O O
microscopic B-O O
examination B-O O
is B-O O
the B-O O
only B-O O
useful B-O O
tool B-O O
for B-O O
assessing B-O O
the B-O O
risk B-O O
of B-O O
local B-O O
failure B-O O
, B-O O
which B-O O
is B-O O
quite B-O O
low B-O O
for B-O O
the B-O O
majority B-O O
of B-O O
patients B-O O
treated B-O O
with B-O O
breast B-O O
conservation B-O O
. B-O O

High-risk B-O O
patients B-O O
can B-O O
be B-O O
recognized B-O O
morphologically B-O O
. B-O O

The B-O O
age B-O O
dependence B-O O
of B-O O
morphologic B-O O
risk B-O O
factors B-O O
appears B-O O
to B-O O
explain B-O O
the B-O O
high B-O O
local B-O O
failure B-O O
rate B-O O
seen B-O O
in B-O O
patients B-O O
younger B-O O
than B-O O
40 B-O O
. B-O O

Tax B-O B-protein
-independent B-O O
binding B-O O
of B-O O
multiple B-O O
cellular B-O B-protein
factors B-O I-protein
to B-O O
Tax B-O B-protein
-response B-O O
element B-O O
DNA B-O O
of B-O O
HTLV-I B-O O
. B-O O

The B-O O
human B-O B-DNA
T-cell B-O I-DNA
leukemia B-O I-DNA
virus B-O I-DNA
type B-O I-DNA
I B-O I-DNA
( B-O I-DNA
HTLV-I B-O I-DNA
) B-O I-DNA
promoter B-O I-DNA
contains B-O O
three B-O O
copies B-O O
of B-O O
imperfect B-O O
repeats B-O O
of B-O O
a B-O O
21-base B-O B-DNA
pair B-O I-DNA
sequence B-O I-DNA
designated B-O O
here B-O O
as B-O O
TRE B-O B-DNA
( B-O O
Tax B-O B-DNA
-response B-O I-DNA
element B-O I-DNA
) B-O O
that B-O O
is B-O O
responsive B-O O
to B-O O
the B-O O
virally B-O B-protein
encoded B-O I-protein
transactivator B-O I-protein
protein B-O I-protein
Tax B-O B-protein
. B-O O

We B-O O
have B-O O
identified B-O O
and B-O O
separated B-O O
four B-O O
nuclear B-O B-protein
proteins B-O I-protein
from B-O O
C81-66-45 B-O B-cell_line
cells B-O I-cell_line
, B-O O
an B-O O
HTLV-I B-O B-cell_line
immortalized B-O I-cell_line
Tax B-O I-cell_line
-expressing B-O I-cell_line
human B-O I-cell_line
T-lymphocyte B-O I-cell_line
line B-O I-cell_line
( B-O O
Salahuddin B-O O
et B-O O
al. B-O O
, B-O O
1983 B-O O
) B-O O
, B-O O
that B-O O
interact B-O O
with B-O O
the B-O O
TRE B-O B-DNA
-DNA B-O I-DNA
, B-O O
none B-O O
of B-O O
which B-O O
are B-O O
identical B-O O
with B-O O
the B-O O
Tax B-O B-protein
-protein B-O I-protein
. B-O O

The B-O O
proteins B-O O
identified B-O O
have B-O O
molecular B-O O
weights B-O O
of B-O O
about B-O O
32 B-O O
, B-O O
36 B-O O
to B-O O
42 B-O O
, B-O O
50 B-O O
and B-O O
110 B-O O
kD B-O O
. B-O O

Four B-O O
different B-O O
methods B-O O
were B-O O
used B-O O
to B-O O
identify B-O O
the B-O O
proteins B-O O
. B-O O

First B-O O
, B-O O
from B-O O
different B-O O
cell B-O O
lines B-O O
three B-O O
or B-O O
all B-O O
four B-O O
of B-O O
the B-O O
nuclear B-O B-protein
proteins B-O I-protein
were B-O O
specifically B-O O
cross-linked B-O O
by B-O O
UV B-O O
irradiation B-O O
to B-O O
the B-O O
radioactively B-O O
labeled B-O O
TRE B-O B-DNA
-DNA B-O I-DNA
fragment B-O I-DNA
. B-O O

Second B-O O
, B-O O
TRE B-O B-protein
-DNA B-O I-protein
binding B-O I-protein
proteins B-O I-protein
sedimented B-O O
through B-O O
a B-O O
glycerol B-O O
density B-O O
gradient B-O O
at B-O O
rates B-O O
corresponding B-O O
to B-O O
proteins B-O O
of B-O O
native B-O O
molecular B-O O
weights B-O O
of B-O O
35 B-O O
to B-O O
50 B-O O
kD B-O O
and B-O O
110 B-O O
kD B-O O
. B-O O

Third B-O O
, B-O O
only B-O O
the B-O O
50 B-O B-protein
kD B-O I-protein
protein B-O I-protein
was B-O O
retained B-O O
on B-O O
a B-O O
biotinylated B-O O
DNA-streptavidin B-O O
matrix B-O O
when B-O O
the B-O O
DNA B-O B-DNA
fragment B-O I-DNA
contained B-O O
the B-O O
TRE B-O B-DNA
-DNA B-O I-DNA
. B-O O

Fourth B-O O
, B-O O
extensive B-O O
purification B-O O
by B-O O
several B-O O
cycles B-O O
of B-O O
TRE B-O B-DNA
-DNA B-O O
affinity B-O O
chromatography B-O O
resulted B-O O
in B-O O
the B-O O
32 B-O O
, B-O O
36 B-O O
to B-O O
42 B-O O
and B-O O
110 B-O O
kD B-O O
proteins B-O O
and B-O O
to B-O O
less B-O O
extent B-O O
the B-O O
50 B-O B-protein
kD B-O I-protein
factor B-O I-protein
. B-O O

Two B-O O
abundant B-O O
proteins B-O O
of B-O O
75 B-O O
and B-O O
80 B-O O
kD B-O O
were B-O O
competed B-O O
out B-O O
by B-O O
poly B-O O
[ B-O O
d B-O O
( B-O O
I-C B-O O
) B-O O
] B-O O
in B-O O
all B-O O
reactions B-O O
. B-O O

The B-O O
cAMP-response B-O B-DNA
element B-O I-DNA
CRE B-O B-DNA
, B-O O
TGACGTCA B-O O
, B-O O
present B-O O
in B-O O
the B-O O
21 B-O B-DNA
base-pair B-O I-DNA
sequence B-O I-DNA
, B-O O
appears B-O O
to B-O O
be B-O O
essential B-O O
for B-O O
specific B-O O
protein- B-O O
TRE B-O B-DNA
-DNA B-O O
interactions B-O O
because B-O O
mutation B-O O
of B-O O
the B-O O
two B-O O
G B-O O
's B-O O
destroys B-O O
this B-O O
complex B-O O
. B-O O

This B-O O
result B-O O
suggests B-O O
that B-O O
the B-O O
cAMP B-O B-protein
response B-O I-protein
element B-O I-protein
binding B-O I-protein
protein B-O I-protein
, B-O O
CREB B-O B-protein
, B-O O
is B-O O
involved B-O O
in B-O O
the B-O O
protein- B-O O
TRE B-O B-protein
-DNA B-O I-protein
complex B-O I-protein
and B-O O
in B-O O
mediating B-O O
the B-O O
Tax B-O B-protein
response B-O O
. B-O O

Two B-O O
distinct B-O O
transcription B-O B-protein
factors B-O I-protein
that B-O O
bind B-O O
the B-O O
immunoglobulin B-O B-DNA
enhancer B-O I-DNA
microE5/kappa B-O I-DNA
2 B-O I-DNA
motif B-O I-DNA
. B-O O

Activity B-O O
of B-O O
the B-O O
immunoglobulin B-O B-DNA
heavy B-O I-DNA
and B-O I-DNA
kappa B-O I-DNA
light B-O I-DNA
chain B-O I-DNA
gene B-O I-DNA
enhancers B-O I-DNA
depends B-O O
on B-O O
a B-O O
complex B-O O
interplay B-O O
of B-O O
ubiquitous B-O B-protein
and B-O I-protein
developmentally B-O I-protein
regulated B-O I-protein
proteins B-O I-protein
. B-O O

Two B-O O
complementary B-O B-DNA
DNAs B-O I-DNA
were B-O O
isolated B-O O
that B-O O
encode B-O B-protein
proteins B-O I-protein
, B-O O
denoted B-O O
ITF-1 B-O B-protein
and B-O O
ITF-2 B-O B-protein
, B-O O
that B-O O
are B-O O
expressed B-O O
in B-O O
a B-O O
variety B-O O
of B-O O
cell B-O O
types B-O O
and B-O O
bind B-O O
the B-O O
microE5/kappa B-O B-DNA
2 B-O I-DNA
motif B-O I-DNA
found B-O O
in B-O O
both B-O O
heavy B-O B-DNA
and B-O I-DNA
kappa B-O I-DNA
light B-O I-DNA
chain B-O I-DNA
enhancers B-O I-DNA
. B-O O

The B-O O
complementary B-O B-DNA
DNAs B-O I-DNA
are B-O O
the B-O O
products B-O O
of B-O O
distinct B-O O
genes B-O O
, B-O O
yet B-O O
both B-O O
ITF-1 B-O B-protein
and B-O O
ITF-2 B-O B-protein
are B-O O
structurally B-O O
and B-O O
functionally B-O O
similar B-O O
. B-O O

The B-O O
two B-O O
proteins B-O O
interact B-O O
with B-O O
one B-O O
another B-O O
through B-O O
their B-O O
putative B-O O
helix-loop-helix B-O B-protein
motifs B-O I-protein
and B-O O
each B-O O
possesses B-O O
a B-O O
distinct B-O O
domain B-O O
that B-O O
dictates B-O O
transcription B-O O
activation B-O O
. B-O O

Elevated B-O O
glucocorticoid B-O B-protein
receptor B-O I-protein
concentrations B-O O
before B-O O
and B-O O
after B-O O
glucocorticoid B-O O
therapy B-O O
in B-O O
peripheral B-O B-cell_type
mononuclear B-O I-cell_type
leukocytes B-O I-cell_type
of B-O O
patients B-O O
with B-O O
atopic B-O O
dermatitis B-O O
. B-O O

The B-O O
number B-O O
and B-O O
affinity B-O O
of B-O O
glucocorticoid B-O B-protein
binding B-O I-protein
sites B-O I-protein
in B-O O
peripheral B-O B-cell_type
mononuclear B-O I-cell_type
leukocytes B-O I-cell_type
of B-O O
patients B-O O
with B-O O
atopic B-O O
dermatitis B-O O
( B-O O
AD B-O O
) B-O O
and B-O O
healthy B-O O
controls B-O O
were B-O O
determined B-O O
under B-O O
baseline B-O O
conditions B-O O
and B-O O
after B-O O
a B-O O
defined B-O O
oral B-O O
glucocorticoid B-O O
treatment B-O O
. B-O O

Patients B-O O
with B-O O
AD B-O O
( B-O O
n B-O O
= B-O O
15 B-O O
) B-O O
exhibited B-O O
significantly B-O O
more B-O O
glucocorticoid B-O B-protein
receptors B-O I-protein
( B-O O
GR B-O B-protein
) B-O O
per B-O O
cell B-O O
than B-O O
the B-O O
control B-O O
group B-O O
( B-O O
n B-O O
= B-O O
22 B-O O
) B-O O
, B-O O
while B-O O
the B-O O
GR B-O B-protein
affinity B-O O
did B-O O
not B-O O
differ B-O O
. B-O O

Methylprednisolone B-O O
treatment B-O O
resulted B-O O
in B-O O
a B-O O
significant B-O O
reduction B-O O
of B-O O
the B-O O
GR B-O B-DNA
sites B-O I-DNA
per B-O O
cell B-O O
in B-O O
the B-O O
steroid-treated B-O O
control B-O O
group B-O O
( B-O O
n B-O O
= B-O O
10 B-O O
) B-O O
in B-O O
contrast B-O O
to B-O O
the B-O O
patients B-O O
. B-O O

The B-O O
dissociation B-O O
constant B-O O
was B-O O
not B-O O
affected B-O O
by B-O O
methylprednisolone B-O O
treatment B-O O
in B-O O
either B-O O
group B-O O
. B-O O

In B-O O
view B-O O
of B-O O
the B-O O
therapeutic B-O O
efficiency B-O O
of B-O O
glucocorticoids B-O O
in B-O O
AD B-O O
and B-O O
findings B-O O
of B-O O
abnormal B-O O
cAMP B-O O
and B-O O
cAMP-phosphodiesterase B-O B-protein
activity B-O O
, B-O O
the B-O O
elevated B-O O
GR B-O B-protein
concentrations B-O O
in B-O O
AD B-O O
lend B-O O
support B-O O
to B-O O
the B-O O
hypothesis B-O O
of B-O O
a B-O O
compensatory B-O O
GR B-O B-protein
upregulation B-O O
due B-O O
to B-O O
an B-O O
insufficient B-O O
action B-O O
of B-O O
endogenous B-O O
cortisol B-O O
or B-O O
to B-O O
altered B-O O
cAMP B-O O
-induced B-O O
GR B-O B-protein
expression B-O O
. B-O O

The B-O O
actions B-O O
of B-O O
cyclosporin B-O O
A B-O O
and B-O O
FK506 B-O O
suggest B-O O
a B-O O
novel B-O O
step B-O O
in B-O O
the B-O O
activation B-O O
of B-O O
T B-O B-cell_type
lymphocytes B-O I-cell_type
. B-O O

Cyclosporin B-O O
A B-O O
and B-O O
FK506 B-O O
are B-O O
immunosuppressive B-O O
compounds B-O O
that B-O O
have B-O O
similar B-O O
inhibitory B-O O
effects B-O O
on B-O O
the B-O O
expression B-O O
of B-O O
several B-O O
lymphokines B-O B-protein
produced B-O O
by B-O O
T B-O B-cell_type
lymphocytes B-O I-cell_type
. B-O O

Despite B-O O
their B-O O
similar B-O O
effects B-O O
the B-O O
drugs B-O O
bind B-O O
to B-O O
two B-O O
different B-O O
cytosolic B-O B-protein
protein B-O I-protein
, B-O O
cyclophilin B-O B-protein
and B-O O
FKBP B-O B-protein
respectively B-O O
, B-O O
which B-O O
raises B-O O
the B-O O
possibility B-O O
that B-O O
they B-O O
have B-O O
different B-O O
modes B-O O
of B-O O
action B-O O
. B-O O

Using B-O O
constructs B-O O
in B-O O
which B-O O
mRNA B-O B-RNA
production B-O O
controlled B-O O
by B-O O
a B-O O
specific B-O O
transcription B-O B-protein
factor B-O I-protein
could B-O O
be B-O O
readily B-O O
measured B-O O
we B-O O
found B-O O
that B-O O
both B-O O
cyclosporin B-O O
A B-O O
and B-O O
FK506 B-O O
completely B-O O
inhibited B-O O
transcription B-O O
activated B-O O
by B-O O
NF-AT B-O B-protein
, B-O O
NFIL2 B-O B-protein
A B-O I-protein
, B-O O
NFIL2 B-O B-protein
B B-O I-protein
and B-O O
partially B-O O
inhibited B-O O
transcription B-O O
activated B-O O
by B-O O
NF B-O B-protein
kappa B-O I-protein
B B-O I-protein
. B-O O

Cyclosporin B-O O
A B-O O
and B-O O
FK506 B-O O
inhibited B-O O
only B-O O
transcriptional B-O O
activation B-O O
that B-O O
was B-O O
dependent B-O O
on B-O O
Ca2+ B-O O
mobilization B-O O
. B-O O

However B-O O
, B-O O
cyclosporin B-O O
A B-O O
and B-O O
FK506 B-O O
did B-O O
not B-O O
inhibit B-O O
Ca2+ B-O O
mobilization B-O O
dependent B-O O
expression B-O O
of B-O O
c-fos B-O B-RNA
mRNA B-O I-RNA
indicating B-O O
that B-O O
only B-O O
a B-O O
subset B-O O
of B-O O
signalling B-O O
pathways B-O O
regulated B-O O
by B-O O
Ca2+ B-O O
is B-O O
sensitive B-O O
to B-O O
these B-O O
drugs B-O O
. B-O O

Furthermore B-O O
, B-O O
we B-O O
did B-O O
not B-O O
observe B-O O
any B-O O
qualitative B-O O
differences B-O O
between B-O O
the B-O O
effect B-O O
of B-O O
cyclosporin B-O O
A B-O O
and B-O O
FK506 B-O O
on B-O O
six B-O O
different B-O O
transcription B-O B-protein
factors B-O I-protein
which B-O O
suggests B-O O
that B-O O
these B-O O
drugs B-O O
may B-O O
interfere B-O O
with B-O O
the B-O O
activity B-O O
of B-O O
a B-O O
novel B-O O
Ca2+ B-O O
dependent B-O O
step B-O O
that B-O O
regulates B-O O
several B-O O
transcription B-O B-protein
factors B-O I-protein
. B-O O

The B-O O
internal B-O O
methionine B-O O
codons B-O O
of B-O O
human B-O B-DNA
T-cell B-O I-DNA
leukemia B-O I-DNA
virus B-O I-DNA
type B-O I-DNA
II B-O I-DNA
rex B-O I-DNA
gene B-O I-DNA
are B-O O
not B-O O
required B-O O
for B-O O
p24rex B-O B-protein
production B-O O
or B-O O
virus B-O O
replication B-O O
and B-O O
transformation B-O O
. B-O O

Human B-O O
T-cell B-O O
leukemia B-O O
virus B-O O
types B-O O
I B-O O
( B-O O
HTLV-I B-O O
) B-O O
and B-O O
II B-O O
( B-O O
HTLV-II B-O O
) B-O O
have B-O O
two B-O O
nonstructural B-O B-DNA
trans-acting B-O I-DNA
regulatory B-O I-DNA
genes B-O I-DNA
, B-O O
tax B-O B-protein
and B-O O
rex B-O B-protein
, B-O O
located B-O O
in B-O O
the B-O O
3 B-O B-DNA
' B-O I-DNA
region B-O I-DNA
of B-O O
the B-O O
viral B-O B-DNA
genome B-O I-DNA
. B-O O

The B-O O
tax B-O B-protein
gene B-O I-protein
product B-O I-protein
( B-O O
HTLV-I B-O B-protein
p40tax B-O I-protein
and B-O O
HTLV-II B-O B-protein
p37tax B-O I-protein
) B-O O
is B-O O
the B-O O
transcriptional B-O B-protein
activator B-O I-protein
of B-O O
the B-O O
viral B-O B-DNA
long B-O I-DNA
terminal B-O I-DNA
repeat B-O I-DNA
. B-O O

The B-O O
rex B-O B-DNA
gene B-O I-DNA
encodes B-O O
two B-O O
protein B-O B-protein
products B-O I-protein
, B-O O
p27rex B-O B-protein
/p21rex B-O I-protein
and B-O O
p26rex B-O B-protein
/p24rex B-O I-protein
in B-O O
HTLV-I B-O O
and B-O O
HTLV-II B-O O
, B-O O
respectively B-O O
. B-O O

Rex B-O B-protein
acts B-O O
posttranscriptionally B-O O
to B-O O
facilitate B-O O
accumulation B-O O
of B-O O
full-length B-O O
gag/pol B-O O
and B-O O
singly B-O O
spliced B-O O
env B-O B-RNA
mRNA B-O I-RNA
in B-O O
the B-O O
cytoplasm B-O O
of B-O O
HTLV-infected B-O B-cell_type
cells B-O I-cell_type
. B-O O

Previous B-O O
studies B-O O
showed B-O O
that B-O O
the B-O O
first B-O O
ATG B-O O
of B-O O
the B-O O
rex B-O B-DNA
gene B-O I-DNA
is B-O O
critical B-O O
for B-O O
Rex B-O B-protein
production B-O O
and B-O O
function B-O O
. B-O O

The B-O O
importance B-O O
of B-O O
the B-O O
internal B-O O
ATGs B-O O
to B-O O
Rex B-O B-protein
function B-O O
is B-O O
not B-O O
known B-O O
. B-O O

However B-O O
, B-O O
in B-O O
vitro B-O O
mutagenesis B-O O
of B-O O
the B-O O
HTLV-I B-O B-DNA
rex B-O I-DNA
gene B-O I-DNA
has B-O O
provided B-O O
indirect B-O O
evidence B-O O
which B-O O
suggests B-O O
that B-O O
p21rex B-O B-protein
, B-O O
and B-O O
by B-O O
analogy B-O O
HTLV-II B-O O
p24rex B-O B-protein
, B-O O
results B-O O
from B-O O
initiation B-O O
at B-O O
an B-O O
internal B-O O
AUG B-O O
of B-O O
the B-O O
tax B-O B-RNA
/rex B-O I-RNA
mRNA B-O I-RNA
. B-O O

By B-O O
using B-O O
an B-O O
infectious B-O O
molecular B-O O
clone B-O O
of B-O O
HTLV-II B-O O
, B-O O
we B-O O
investigated B-O O
the B-O O
importance B-O O
of B-O O
the B-O O
internal B-O O
ATGs B-O O
of B-O O
the B-O O
rex B-O B-DNA
gene B-O I-DNA
on B-O O
Rex B-O B-protein
protein B-O O
production B-O O
and B-O O
function B-O O
. B-O O

Our B-O O
results B-O O
indicate B-O O
that B-O O
p24rex B-O B-protein
of B-O O
HTLV-II B-O O
is B-O O
not B-O O
initiated B-O O
at B-O O
an B-O O
internal B-O O
AUG B-O O
and B-O O
that B-O O
the B-O O
internal B-O O
methionine B-O O
codons B-O O
are B-O O
not B-O O
crucial B-O O
to B-O O
the B-O O
function B-O O
of B-O O
the B-O O
rex B-O B-DNA
gene B-O I-DNA
and B-O O
, B-O O
ultimately B-O O
, B-O O
the B-O O
transforming B-O O
properties B-O O
of B-O O
the B-O O
virus B-O O
. B-O O

Astrocytes B-O B-cell_type
and B-O O
glioblastoma B-O B-cell_type
cells B-O I-cell_type
express B-O O
novel B-O O
octamer-DNA B-O B-protein
binding B-O I-protein
proteins B-O I-protein
distinct B-O O
from B-O O
the B-O O
ubiquitous B-O B-protein
Oct-1 B-O I-protein
and B-O I-protein
B B-O I-protein
cell B-O I-protein
type B-O I-protein
Oct-2 B-O I-protein
proteins B-O I-protein
. B-O O

The B-O O
' B-O B-DNA
octamer B-O I-DNA
' B-O I-DNA
sequence B-O I-DNA
, B-O O
ATGCAAAT B-O O
or B-O O
its B-O O
complement B-O O
ATTTGCAT B-O O
, B-O O
is B-O O
a B-O O
key B-O O
element B-O O
for B-O O
the B-O O
transcriptional B-O O
regulation B-O O
of B-O O
immunoglobulin B-O B-DNA
genes B-O I-DNA
in B-O O
B-lymphocytes B-O B-cell_type
as B-O O
well B-O O
as B-O O
a B-O O
number B-O O
of B-O O
housekeeping B-O B-DNA
genes B-O I-DNA
in B-O O
all B-O O
cell B-O O
types B-O O
. B-O O

In B-O O
lymphocytes B-O B-cell_type
, B-O O
the B-O O
octamer-binding B-O B-protein
protein B-O I-protein
Oct-2A B-O B-protein
and B-O O
variants B-O O
thereof B-O O
are B-O O
thought B-O O
to B-O O
contribute B-O O
to B-O O
the B-O O
B-cell B-O B-DNA
specific B-O I-DNA
gene B-O I-DNA
expression B-O O
, B-O O
while B-O O
the B-O O
ubiquitous B-O B-protein
protein B-O I-protein
Oct-1 B-O B-protein
seems B-O O
to B-O O
control B-O O
general B-O O
octamer B-O B-DNA
site B-O I-DNA
-dependent B-O O
transcription B-O O
. B-O O

Various B-O O
other B-O O
genes B-O O
, B-O O
for B-O O
example B-O O
interleukin-1 B-O O
and B-O O
MHC B-O B-DNA
class B-O I-DNA
II B-O I-DNA
genes B-O I-DNA
, B-O O
contain B-O O
an B-O O
octamer B-O B-DNA
sequence B-O I-DNA
in B-O O
the B-O O
promoter B-O B-DNA
and B-O O
are B-O O
expressed B-O O
in B-O O
cells B-O O
of B-O O
both B-O O
the B-O O
immune B-O O
and B-O O
nervous B-O O
systems B-O O
. B-O O

This B-O O
prompted B-O O
us B-O O
to B-O O
analyze B-O O
the B-O O
octamer-binding B-O B-protein
proteins B-O I-protein
in B-O O
the B-O O
latter B-O B-cell_type
cells B-O I-cell_type
. B-O O

Using B-O O
the B-O O
electrophoretic B-O O
mobility B-O O
shift B-O O
assay B-O O
, B-O O
at B-O O
least B-O O
six B-O O
novel B-O O
octamer B-O B-protein
binding B-O I-protein
proteins B-O I-protein
were B-O O
detected B-O O
in B-O O
nuclear B-O O
extracts B-O O
of B-O O
cultured B-O B-cell_type
mouse B-O I-cell_type
astrocytes B-O I-cell_type
. B-O O

These B-O O
proteins B-O O
are B-O O
differentially B-O O
expressed B-O O
in B-O O
human B-O B-cell_line
glioblastoma B-O I-cell_line
and B-O I-cell_line
neuroblastoma B-O I-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
. B-O O

The B-O O
nervous B-O B-protein
system-derived B-O I-protein
( B-O I-protein
N-Oct B-O I-protein
) B-O I-protein
proteins B-O I-protein
bound B-O O
to B-O O
the B-O O
octamer B-O B-DNA
DNA B-O I-DNA
sequence B-O I-DNA
in B-O O
a B-O O
manner B-O O
which B-O O
is B-O O
indistinguishable B-O O
from B-O O
the B-O O
Oct-1 B-O B-protein
and B-O O
Oct-2A B-O B-protein
proteins B-O I-protein
. B-O O

The B-O O
relationship B-O O
of B-O O
the B-O O
N-Oct B-O B-protein
proteins B-O I-protein
to B-O O
Oct-1 B-O B-protein
and B-O O
Oct-2A B-O B-protein
was B-O O
analyzed B-O O
by B-O O
proteolytic B-O O
clipping B-O O
bandshift B-O O
assays B-O O
and B-O O
by B-O O
their B-O O
reactivity B-O O
towards B-O O
antisera B-O O
raised B-O O
against B-O O
recombinant B-O O
Oct-1 B-O B-protein
and B-O O
Oct-2A B-O B-protein
proteins B-O I-protein
. B-O O

On B-O O
the B-O O
basis B-O O
of B-O O
these B-O O
assays B-O O
, B-O O
all B-O O
N-Oct-factors B-O B-protein
were B-O O
found B-O O
to B-O O
be B-O O
distinct B-O O
from B-O O
the B-O O
ubiquitous B-O O
Oct-1 B-O B-protein
and B-O O
the B-O O
lymphoid-specific B-O B-protein
Oct-2A B-O I-protein
proteins B-O I-protein
. B-O O

In B-O O
melanoma B-O B-cell_type
cells B-O I-cell_type
that B-O O
contain B-O O
the B-O O
N-Oct-3 B-O B-protein
factor B-O I-protein
, B-O O
a B-O O
transfected B-O B-DNA
lymphocyte-specific B-O I-DNA
promoter B-O I-DNA
was B-O O
neither B-O O
activated B-O O
nor B-O O
was B-O O
it B-O O
repressed B-O O
upon B-O O
contransfection B-O O
with B-O O
an B-O O
Oct-2A B-O B-DNA
expression B-O I-DNA
vector B-O I-DNA
. B-O O

We B-O O
therefore B-O O
speculate B-O O
that B-O O
N-Oct-3 B-O B-protein
and B-O O
other B-O O
N-Oct B-O B-protein
factors B-O I-protein
have B-O O
a B-O O
specific B-O O
role B-O O
in B-O O
gene B-O O
expression B-O O
in B-O O
cells B-O O
of B-O O
the B-O O
nervous B-O O
system B-O O
. B-O O

Detection B-O O
in B-O O
non-erythroid B-O B-cell_type
cells B-O I-cell_type
of B-O O
a B-O O
factor B-O O
with B-O O
the B-O O
binding B-O O
characteristics B-O O
of B-O O
the B-O O
erythroid B-O B-protein
cell B-O I-protein
transcription B-O I-protein
factor B-O I-protein
EF1 B-O B-protein
. B-O O

The B-O O
erythroid B-O B-protein
transcription B-O I-protein
factor B-O I-protein
erythroid B-O B-protein
factor-1 B-O I-protein
( B-O O
EF1 B-O B-protein
) B-O O
plays B-O O
a B-O O
critical B-O O
role B-O O
in B-O O
the B-O O
transcription B-O O
of B-O O
erythroid-specific B-O B-DNA
genes B-O I-DNA
. B-O O

Here B-O O
we B-O O
report B-O O
the B-O O
presence B-O O
of B-O O
a B-O O
factor B-O O
with B-O O
the B-O O
mobility B-O O
and B-O O
sequence-specific B-O O
DNA-binding B-O O
characteristics B-O O
of B-O O
EF1 B-O B-protein
at B-O O
low B-O O
abundance B-O O
in B-O O
a B-O O
wide B-O O
variety B-O O
of B-O O
non-erythroid B-O B-cell_type
cell B-O I-cell_type
types B-O I-cell_type
. B-O O

This B-O O
is B-O O
the B-O O
first B-O O
report B-O O
of B-O O
an B-O O
EF1 B-O B-protein
-like B-O O
activity B-O O
in B-O O
non-erythroid B-O B-cell_type
cells B-O I-cell_type
and B-O O
indicates B-O O
that B-O O
this B-O O
factor B-O O
may B-O O
play B-O O
a B-O O
role B-O O
in B-O O
the B-O O
regulation B-O O
of B-O O
genes B-O B-DNA
expressed B-O O
in B-O O
such B-O O
cells B-O O
. B-O O

Protein B-O O
kinase B-O O
inhibitor B-O O
H-7 B-O O
blocks B-O O
accumulation B-O O
of B-O O
unspliced B-O B-RNA
mRNA B-O I-RNA
of B-O O
human B-O O
T-cell B-O O
leukemia B-O O
virus B-O O
type B-O O
I B-O O
( B-O O
HTLV-I B-O O
) B-O O
. B-O O

Rex B-O B-protein
, B-O O
the B-O O
post-transcriptional B-O B-protein
regulator B-O I-protein
of B-O O
human B-O O
T-cell B-O O
leukemia B-O O
virus B-O O
type B-O O
I B-O O
( B-O O
HTLV-I B-O O
) B-O O
, B-O O
is B-O O
known B-O O
to B-O O
induce B-O O
accumulation B-O O
of B-O O
the B-O O
unspliced B-O B-RNA
viral B-O I-RNA
gag-pol B-O I-RNA
mRNA B-O I-RNA
. B-O O

Rex B-O B-protein
is B-O O
a B-O O
phosphoprotein B-O B-protein
found B-O O
in B-O O
the B-O O
cell B-O O
nucleolus B-O O
, B-O O
whose B-O O
function B-O O
may B-O O
be B-O O
regulated B-O O
by B-O O
its B-O O
localization B-O O
and B-O O
phosphorylation B-O O
. B-O O

We B-O O
have B-O O
examined B-O O
the B-O O
role B-O O
of B-O O
phosphorylation B-O O
on B-O O
Rex B-O B-protein
function B-O O
by B-O O
using B-O O
a B-O O
protein B-O O
kinase B-O O
inhibitor B-O O
, B-O O
H-7 B-O O
[ B-O O
1- B-O O
( B-O O
5-isoquinolinyl-sulfonyl B-O O
) B-O O
-2-methylpiperazine B-O O
] B-O O
. B-O O

Treatment B-O O
of B-O O
an B-O O
HTLV-I B-O B-cell_line
infected B-O I-cell_line
human B-O I-cell_line
T-cell B-O I-cell_line
line B-O I-cell_line
with B-O O
H-7 B-O O
blocked B-O O
specifically B-O O
accumulation B-O O
of B-O O
the B-O O
unspliced B-O B-RNA
gag-pol B-O I-RNA
mRNA B-O I-RNA
, B-O O
resulting B-O O
in B-O O
the B-O O
decreased B-O O
Gag B-O B-protein
protein B-O I-protein
synthesis B-O O
that B-O O
corresponds B-O O
with B-O O
the B-O O
decreased B-O O
in B-O O
vivo B-O O
phosphorylation B-O O
of B-O O
Rex B-O B-protein
. B-O O

In B-O O
contrast B-O O
, B-O O
other B-O O
viral B-O O
and B-O O
cellular B-O O
products B-O O
have B-O O
not B-O O
been B-O O
influenced B-O O
by B-O O
the B-O O
level B-O O
of B-O O
H-7 B-O B-protein
used B-O O
. B-O O

Therefore B-O O
, B-O O
the B-O O
phosphorylation B-O O
of B-O O
Rex B-O B-protein
is B-O O
required B-O O
for B-O O
the B-O O
viral B-O O
RNA B-O O
partition B-O O
of B-O O
HTLV-I B-O O
. B-O O

Increased B-O O
glucocorticoid B-O O
responsiveness B-O O
of B-O O
CD4+ B-O B-cell_line
T-cell B-O I-cell_line
clonal B-O I-cell_line
lines B-O I-cell_line
grown B-O O
in B-O O
serum-free B-O O
media B-O O
. B-O O

CEM-C7 B-O B-cell_line
, B-O O
a B-O O
human B-O B-cell_line
leukemic B-O I-cell_line
CD4+ B-O I-cell_line
T-lymphocyte B-O I-cell_line
cell B-O I-cell_line
line B-O I-cell_line
and B-O O
three B-O O
of B-O O
its B-O O
subclones B-O O
, B-O O
CEM-4R4 B-O B-cell_line
, B-O O
CEM-3R43 B-O B-cell_line
, B-O O
and B-O O
ICR-27 B-O B-protein
, B-O O
previously B-O O
cultured B-O O
in B-O O
a B-O O
medium B-O O
supplemented B-O O
with B-O O
5 B-O O
to B-O O
10 B-O O
% B-O O
fetal B-O O
bovine B-O O
serum B-O O
, B-O O
have B-O O
been B-O O
adapted B-O O
to B-O O
serum-free B-O O
media B-O O
. B-O O

The B-O O
best B-O O
medium B-O O
of B-O O
those B-O O
tested B-O O
was B-O O
RPMI B-O O
1640 B-O O
supplemented B-O O
with B-O O
5 B-O O
micrograms/ml B-O O
each B-O O
transferrin B-O B-protein
and B-O O
insulin B-O B-protein
+ B-O O
5 B-O O
ng/ml B-O O
sodium B-O O
selenite B-O O
+/- B-O O
0.1 B-O O
% B-O O
bovine B-O B-protein
serum B-O I-protein
albumin B-O I-protein
. B-O O

While B-O O
growing B-O O
either B-O O
with B-O O
or B-O O
without B-O O
albumin B-O O
, B-O O
the B-O O
several B-O O
clonal B-O B-cell_line
lines B-O I-cell_line
of B-O O
CEM B-O B-cell_line
cells B-O I-cell_line
displayed B-O O
growth B-O O
similar B-O O
to B-O O
serum-supplemented B-O B-cell_line
cultures B-O I-cell_line
. B-O O

Cell B-O O
proliferation B-O O
of B-O O
CEM-C7 B-O B-cell_line
cells B-O I-cell_line
cultured B-O O
in B-O O
both B-O O
serum-free B-O O
media B-O O
has B-O O
been B-O O
sustained B-O O
for B-O O
3 B-O O
mo B-O O
. B-O O

with B-O O
culture B-O O
doubling B-O O
times B-O O
of B-O O
about B-O O
25 B-O O
h B-O O
for B-O O
both B-O O
serum-supplemented B-O B-cell_line
and B-O I-cell_line
serum-free B-O I-cell_line
cultures B-O I-cell_line
( B-O O
viability B-O O
greater B-O O
than B-O O
or B-O O
equal B-O O
to B-O O
90 B-O O
% B-O O
) B-O O
. B-O O

Cell B-O O
morphology B-O O
remained B-O O
essentially B-O O
the B-O O
same B-O O
in B-O O
serum-free B-O O
or B-O O
serum B-O O
containing B-O O
media B-O O
. B-O O

The B-O O
expression B-O O
of B-O O
CD4 B-O B-protein
, B-O O
a B-O O
marker B-O O
for B-O O
T-derived B-O B-cell_type
lymphoid B-O I-cell_type
cells B-O I-cell_type
, B-O O
was B-O O
not B-O O
significantly B-O O
different B-O O
in B-O O
serum-free B-O O
medium B-O O
. B-O O

When B-O O
grown B-O O
in B-O O
serum-free B-O O
medium B-O O
, B-O O
CEM-C7 B-O B-cell_line
cells B-O I-cell_line
exhibited B-O O
increased B-O O
steroid B-O O
responsiveness B-O O
as B-O O
evidenced B-O O
by B-O O
increased B-O O
glucocorticoid B-O B-protein
receptor B-O I-protein
binding B-O O
sites B-O O
, B-O O
increased B-O O
induction B-O O
of B-O O
glutamine B-O B-protein
synthetase B-O I-protein
, B-O O
and B-O O
cell B-O O
lysis B-O O
at B-O O
lower B-O O
concentrations B-O O
of B-O O
steroid B-O O
. B-O O

Receptor B-O O
mutant B-O O
subclones B-O O
of B-O O
CEM-C7 B-O B-cell_line
, B-O O
which B-O O
are B-O O
proven B-O O
to B-O O
be B-O O
completely B-O O
unresponsive B-O O
to B-O O
micromolar B-O O
concentrations B-O O
of B-O O
dexamethasone B-O O
when B-O O
grown B-O O
in B-O O
serum-supplemented B-O O
medium B-O O
, B-O O
become B-O O
partially B-O O
sensitive B-O O
to B-O O
the B-O O
hormone B-O O
after B-O O
growth B-O O
in B-O O
defined B-O O
medium B-O O
. B-O O

The B-O O
increased B-O O
sensitivity B-O O
of B-O O
CEM-C7 B-O B-cell_line
cells B-O I-cell_line
and B-O O
its B-O O
subclones B-O O
to B-O O
dexamethasone B-O O
in B-O O
serum-free B-O O
medium B-O O
returned B-O O
to B-O O
previous B-O O
levels B-O O
when B-O O
these B-O O
cells B-O O
were B-O O
recultured B-O O
in B-O O
serum-containing B-O O
medium B-O O
. B-O O

Our B-O O
results B-O O
suggest B-O O
that B-O O
substances B-O O
in B-O O
serum B-O O
influence B-O O
steroid B-O O
effects B-O O
on B-O O
these B-O O
cells B-O O
and B-O O
that B-O O
the B-O O
molecular B-O O
details B-O O
of B-O O
glucocorticoid B-O O
hormone B-O O
action B-O O
may B-O O
be B-O O
pursued B-O O
more B-O O
precisely B-O O
in B-O O
a B-O O
clearly B-O O
defined B-O O
culture B-O O
medium B-O O
. B-O O

[ B-O O
Glucocorticoid B-O B-protein
receptors B-O I-protein
on B-O O
human B-O B-cell_type
peripheral B-O I-cell_type
mononuclear B-O I-cell_type
and B-O I-cell_type
polymorphonuclear B-O I-cell_type
leucocytes B-O I-cell_type
: B-O O
changes B-O O
in B-O O
patients B-O O
with B-O O
yang-deficiency B-O O
] B-O O

It B-O O
was B-O O
found B-O O
that B-O O
, B-O O
in B-O O
former B-O O
works B-O O
, B-O O
the B-O O
glucocorticoid B-O B-protein
receptors B-O I-protein
( B-O O
GCR B-O B-protein
) B-O O
on B-O O
peripheral B-O B-cell_type
mixed B-O I-cell_type
leucocytes B-O I-cell_type
in B-O O
patients B-O O
with B-O O
Yang-deficiency B-O O
were B-O O
decreased B-O O
. B-O O

In B-O O
this B-O O
work B-O O
, B-O O
the B-O O
mixed B-O B-cell_type
leucocytes B-O I-cell_type
were B-O O
further B-O O
separated B-O O
into B-O O
mononuclear B-O B-cell_type
( B-O I-cell_type
MNL B-O I-cell_type
) B-O I-cell_type
and B-O I-cell_type
polymorphonuclear B-O I-cell_type
( B-O I-cell_type
PML B-O I-cell_type
) B-O I-cell_type
leucocytes B-O I-cell_type
, B-O O
and B-O O
GCR B-O B-protein
were B-O O
determined B-O O
in B-O O
each B-O O
part B-O O
of B-O O
leucocytes B-O B-cell_type
. B-O O

GCR B-O B-protein
on B-O O
MNL B-O B-cell_type
and B-O O
PML B-O B-cell_type
in B-O O
6 B-O O
Yang B-O O
deficient B-O O
patients B-O O
were B-O O
3473 B-O O
+/- B-O O
413 B-O O
and B-O O
4433 B-O O
+/- B-O O
651 B-O O
sites/cell B-O O
respectively B-O O
, B-O O
statistically B-O O
significant B-O O
from B-O O
the B-O O
normal B-O O
control B-O O
group B-O O
( B-O O
4462 B-O O
+/- B-O O
962 B-O O
and B-O O
5622 B-O O
+/- B-O O
782 B-O O
sites/cell B-O O
respectively B-O O
, B-O O
P B-O O
less B-O O
than B-O O
0.05 B-O O
) B-O O
. B-O O

GCR B-O B-protein
on B-O O
MNL B-O B-cell_type
, B-O O
PML B-O B-cell_type
and B-O O
mixed B-O B-cell_type
leucocytes B-O I-cell_type
in B-O O
5 B-O O
patients B-O O
were B-O O
determined B-O O
simultaneously B-O O
, B-O O
and B-O O
all B-O O
lowered B-O O
from B-O O
the B-O O
control B-O O
group B-O O
. B-O O

The B-O O
results B-O O
were B-O O
3369 B-O O
+/- B-O O
370 B-O O
, B-O O
4986 B-O O
+/- B-O O
419 B-O O
and B-O O
4524 B-O O
+/- B-O O
852 B-O O
sites/cell B-O O
respectively B-O O
, B-O O
with B-O O
the B-O O
lowest B-O O
GCR B-O B-protein
on B-O O
MNL B-O B-cell_type
and B-O O
highest B-O O
on B-O O
PML B-O B-cell_type
. B-O O

The B-O O
ubiquitous B-O B-protein
octamer-binding B-O I-protein
protein B-O I-protein
( B-O O
s B-O O
) B-O O
is B-O O
sufficient B-O O
for B-O O
transcription B-O O
of B-O O
immunoglobulin B-O B-DNA
genes B-O I-DNA
. B-O O

All B-O O
immunoglobulin B-O B-DNA
genes B-O I-DNA
contain B-O O
a B-O O
conserved B-O O
octanucleotide B-O B-DNA
promoter B-O I-DNA
element B-O I-DNA
, B-O O
ATGCAAAT B-O O
, B-O O
which B-O O
has B-O O
been B-O O
shown B-O O
to B-O O
be B-O O
required B-O O
for B-O O
their B-O O
normal B-O O
B-cell-specific B-O O
transcription B-O O
. B-O O

Proteins B-O O
that B-O O
bind B-O O
this B-O O
octamer B-O O
have B-O O
been B-O O
purified B-O O
, B-O O
and B-O O
cDNAs B-O B-DNA
encoding B-O O
octamer-binding B-O B-protein
proteins B-O I-protein
have B-O O
been B-O O
cloned B-O O
. B-O O

Some B-O O
of B-O O
these B-O O
proteins B-O O
( B-O O
referred B-O O
to B-O O
as B-O O
OTF-2 B-O B-protein
) B-O O
are B-O O
lymphoid B-O O
specific B-O O
, B-O O
whereas B-O O
at B-O O
least B-O O
one B-O O
other B-O O
, B-O O
and B-O O
possibly B-O O
more B-O O
( B-O O
referred B-O O
to B-O O
as B-O O
OTF-1 B-O B-protein
) B-O O
, B-O O
is B-O O
found B-O O
ubiquitously B-O O
in B-O O
all B-O O
cell B-O O
types B-O O
. B-O O

The B-O O
exact B-O O
role B-O O
of B-O O
these B-O O
different B-O O
proteins B-O O
in B-O O
directing B-O O
the B-O O
tissue-specific B-O O
expression B-O O
of B-O O
immunoglobulin B-O B-DNA
genes B-O I-DNA
is B-O O
unclear B-O O
. B-O O

We B-O O
have B-O O
identified B-O O
two B-O O
human B-O B-cell_line
pre-B-cell B-O I-cell_line
lines B-O I-cell_line
that B-O O
contain B-O O
extremely B-O O
low B-O O
levels B-O O
of B-O O
OTF-2 B-O B-protein
yet B-O O
still B-O O
express B-O O
high B-O O
levels B-O O
of B-O O
steady-state B-O B-RNA
immunoglobulin B-O I-RNA
heavy-chain B-O I-RNA
mRNA B-O I-RNA
in B-O O
vivo B-O O
and B-O O
efficiently B-O O
transcribe B-O O
an B-O O
immunoglobulin B-O B-DNA
gene B-O I-DNA
in B-O O
vitro B-O O
. B-O O

Addition B-O O
of B-O O
a B-O O
highly B-O O
enriched B-O O
preparation B-O O
of B-O O
OTF-1 B-O B-protein
made B-O O
from B-O O
one B-O O
of B-O O
these B-O O
pre-B B-O B-cell_type
cells B-O I-cell_type
or B-O O
from B-O O
HeLa B-O B-cell_line
cells B-O I-cell_line
specifically B-O O
stimulated B-O O
in B-O O
vitro B-O O
transcription B-O O
of B-O O
an B-O O
immunoglobulin B-O B-DNA
gene B-O I-DNA
. B-O O

Furthermore B-O O
, B-O O
OFT-1 B-O O
appeared B-O O
to B-O O
have B-O O
approximately B-O O
the B-O O
same B-O O
transactivation B-O O
ability B-O O
as B-O O
OTF-2 B-O B-protein
when B-O O
normalized B-O O
for B-O O
binding B-O O
activity B-O O
. B-O O

These B-O O
results B-O O
suggest B-O O
that B-O O
OTF-1 B-O B-protein
, B-O O
without B-O O
OTF-2 B-O B-protein
, B-O O
is B-O O
sufficient B-O O
for B-O O
transcription B-O O
of B-O O
immunoglobulin B-O B-DNA
genes B-O I-DNA
and B-O O
that B-O O
OTF-2 B-O B-protein
alone B-O O
is B-O O
not B-O O
responsible B-O O
for B-O O
the B-O O
B-cell-specific B-O O
regulation B-O O
of B-O O
immunoglobulin B-O B-DNA
gene B-O I-DNA
expression B-O O
. B-O O

Effects B-O O
of B-O O
aldosterone B-O O
on B-O O
intralymphocytic B-O O
sodium B-O O
and B-O O
potassium B-O O
in B-O O
patients B-O O
with B-O O
essential B-O O
hypertension B-O O
. B-O O

In B-O O
vitro B-O O
binding B-O O
of B-O O
aldosterone B-O O
to B-O O
mineralocorticoid B-O B-protein
receptors B-O I-protein
on B-O O
human B-O B-cell_type
mononuclear B-O I-cell_type
leukocytes B-O I-cell_type
( B-O O
HML B-O B-cell_type
) B-O O
and B-O O
its B-O O
effects B-O O
on B-O O
the B-O O
intracellular B-O O
sodium B-O O
and B-O O
potassium B-O O
concentrations B-O O
of B-O O
HML B-O B-cell_type
have B-O O
already B-O O
been B-O O
described B-O O
. B-O O

In B-O O
the B-O O
present B-O O
paper B-O O
this B-O O
easily B-O O
accessible B-O O
human B-O O
cell B-O O
model B-O O
was B-O O
investigated B-O O
in B-O O
13 B-O O
patients B-O O
with B-O O
essential B-O O
hypertension B-O O
. B-O O

In B-O O
only B-O O
four B-O O
patients B-O O
sodium B-O O
in B-O O
HML B-O B-cell_type
without B-O O
incubation B-O O
was B-O O
elevated B-O O
compared B-O O
with B-O O
the B-O O
range B-O O
for B-O O
normal B-O O
persons B-O O
. B-O O

A B-O O
decrease B-O O
of B-O O
intracellular B-O O
sodium B-O O
or B-O O
potassium B-O O
occurred B-O O
during B-O O
incubation B-O O
without B-O O
aldosterone B-O O
( B-O O
P B-O O
less B-O O
than B-O O
0.02 B-O O
) B-O O
. B-O O

The B-O O
addition B-O O
of B-O O
1.4 B-O O
nM B-O O
aldosterone B-O O
did B-O O
not B-O O
prevent B-O O
this B-O O
loss B-O O
of B-O O
electrolytes B-O O
as B-O O
observed B-O O
in B-O O
normal B-O O
persons B-O O
. B-O O

Plasma B-O B-protein
renin B-O I-protein
activity B-O O
and B-O O
aldosterone B-O O
were B-O O
not B-O O
correlated B-O O
with B-O O
the B-O O
electrolyte B-O O
response B-O O
and B-O O
were B-O O
within B-O O
the B-O O
normal B-O O
limits B-O O
. B-O O

The B-O O
number B-O O
of B-O O
mineralocorticoid B-O B-protein
receptors B-O I-protein
/cell B-O O
were B-O O
within B-O O
or B-O O
close B-O O
to B-O O
the B-O O
normal B-O O
range B-O O
( B-O O
n B-O O
= B-O O
9 B-O O
) B-O O
. B-O O

The B-O O
independence B-O O
of B-O O
intracellular B-O O
electrolytes B-O O
from B-O O
aldosterone B-O O
despite B-O O
a B-O O
normal B-O O
number B-O O
of B-O O
mineralocorticoid B-O B-protein
receptors B-O I-protein
may B-O O
reflect B-O O
an B-O O
impairment B-O O
of B-O O
the B-O O
mineralocorticoid B-O O
effector B-O O
mechanism B-O O
in B-O O
the B-O O
HML B-O B-cell_type
of B-O O
patients B-O O
with B-O O
essential B-O O
hypertension B-O O
. B-O O

[ B-O O
Differential B-O O
diagnostic B-O O
value B-O O
of B-O O
receptors B-O O
of B-O O
1 B-O O
, B-O O
25-dihydroxyvitamin B-O O
D3 B-O O
( B-O O
calcitriol B-O O
) B-O O
determination B-O O
in B-O O
lymphocytes B-O B-cell_type
of B-O O
children B-O O
with B-O O
rickets B-O O
and B-O O
rickets B-O O
-like B-O O
diseases B-O O
] B-O O

The B-O O
authors B-O O
provide B-O O
the B-O O
results B-O O
of B-O O
studying B-O O
1 B-O O
, B-O O
25-dihydroxyvitamin B-O O
D3 B-O O
( B-O O
calcitriol B-O O
) B-O O
in B-O O
lymphocytes B-O B-cell_type
of B-O O
children B-O O
with B-O O
rickets B-O O
and B-O O
rickets B-O O
-like B-O O
diseases B-O O
. B-O O

It B-O O
is B-O O
proposed B-O O
that B-O O
the B-O O
character B-O O
of B-O O
their B-O O
expression B-O O
under B-O O
the B-O O
influence B-O O
of B-O O
vitamin B-O O
D B-O O
may B-O O
be B-O O
used B-O O
with B-O O
differential B-O O
diagnostic B-O O
purposes B-O O
in B-O O
view B-O O
. B-O O

Regulation B-O O
of B-O O
gene B-O O
expression B-O O
with B-O O
double-stranded B-O O
phosphorothioate B-O O
oligonucleotides B-O O
. B-O O

Alteration B-O O
of B-O O
gene B-O O
transcription B-O O
by B-O O
inhibition B-O O
of B-O O
specific B-O O
transcriptional B-O B-protein
regulatory B-O I-protein
proteins B-O I-protein
is B-O O
necessary B-O O
for B-O O
determining B-O O
how B-O O
these B-O O
factors B-O O
participate B-O O
in B-O O
cellular B-O O
differentiation B-O O
. B-O O

The B-O O
functions B-O O
of B-O O
these B-O O
proteins B-O O
can B-O O
be B-O O
antagonized B-O O
by B-O O
several B-O O
methods B-O O
, B-O O
each B-O O
with B-O O
specific B-O O
limitations B-O O
. B-O O

Inhibition B-O O
of B-O O
sequence-specific B-O B-protein
DNA-binding B-O I-protein
proteins B-O I-protein
was B-O O
achieved B-O O
with B-O O
double-stranded B-O O
( B-O O
ds B-O O
) B-O O
phosphorothioate B-O O
oligonucleotides B-O O
that B-O O
contained B-O O
octamer B-O B-DNA
or B-O I-DNA
kappa B-O I-DNA
B B-O I-DNA
consensus B-O I-DNA
sequences B-O I-DNA
. B-O O

The B-O O
phosphorothioate B-O O
oligonucleotides B-O O
specifically B-O O
bound B-O O
either B-O O
octamer B-O B-protein
transcription B-O I-protein
factor B-O I-protein
or B-O O
nuclear B-O B-protein
factor B-O I-protein
( B-O I-protein
NF B-O I-protein
) B-O I-protein
-kappa B-O I-protein
B B-O I-protein
. B-O O

The B-O O
modified B-O O
oligonucleotides B-O O
accumulated B-O O
in B-O O
cells B-O O
more B-O O
effectively B-O O
than B-O O
standard B-O O
ds B-O O
oligonucleotides B-O O
and B-O O
modulated B-O O
gene B-O O
expression B-O O
in B-O O
a B-O O
specific B-O O
manner B-O O
. B-O O

Octamer-dependent B-O O
activation B-O O
of B-O O
a B-O O
reporter B-O B-DNA
plasmid B-O I-DNA
or B-O O
NF-kappa B-O B-protein
B B-O I-protein
-dependent B-O O
activation B-O O
of B-O O
the B-O O
human B-O B-DNA
immunodeficiency B-O I-DNA
virus B-O I-DNA
( B-O I-DNA
HIV B-O I-DNA
) B-O I-DNA
enhancer B-O I-DNA
was B-O O
inhibited B-O O
when B-O O
the B-O O
appropriate B-O O
phosphorothioate B-O O
oligonucleotide B-O O
was B-O O
added B-O O
to B-O O
a B-O O
transiently B-O B-cell_line
transfected B-O I-cell_line
B B-O I-cell_line
cell B-O I-cell_line
line B-O I-cell_line
. B-O O

Addition B-O O
of B-O O
phosphorothioate B-O O
oligonucleotides B-O O
that B-O O
contained B-O O
the B-O O
octamer B-O B-DNA
consensus B-O I-DNA
to B-O O
Jurkat B-O B-cell_line
T B-O I-cell_line
leukemia B-O I-cell_line
cells B-O I-cell_line
inhibited B-O O
interleukin-2 B-O B-protein
( B-O O
IL-2 B-O B-protein
) B-O O
secretion B-O O
to B-O O
a B-O O
degree B-O O
similar B-O O
to B-O O
that B-O O
observed B-O O
with B-O O
a B-O O
mutated B-O B-DNA
octamer B-O I-DNA
site B-O I-DNA
in B-O O
the B-O O
IL-2 B-O B-DNA
enhancer B-O I-DNA
. B-O O

The B-O O
ds B-O O
phosphorothioate B-O O
oligonucleotides B-O O
probably B-O O
compete B-O O
for B-O O
binding B-O O
of B-O O
specific B-O O
transcription B-O B-protein
factors B-O I-protein
and B-O O
may B-O O
provide B-O O
anti-viral B-O O
, B-O O
immunosuppressive B-O O
, B-O O
or B-O O
other B-O O
therapeutic B-O O
effects B-O O
. B-O O

[ B-O O
Effect B-O O
of B-O O
the B-O O
regimen B-O O
of B-O O
kidney-tonifying B-O O
and B-O O
qi-invigorating B-O O
on B-O O
aging B-O O
changes B-O O
of B-O O
glucocorticoid B-O B-protein
receptor B-O I-protein
] B-O O

The B-O O
plasma B-O O
cortisol B-O O
concentration B-O O
and B-O O
the B-O O
sites B-O O
of B-O O
glucocorticoid B-O B-protein
receptor B-O I-protein
( B-O O
GCR B-O B-protein
) B-O O
in B-O O
the B-O O
peripheral B-O B-cell_type
lymphocytes B-O I-cell_type
were B-O O
measured B-O O
in B-O O
32 B-O O
healthy B-O O
aged B-O O
persons B-O O
and B-O O
13 B-O O
young B-O O
adults B-O O
. B-O O

In B-O O
animal B-O O
experiment B-O O
, B-O O
GCR B-O B-protein
of B-O O
spleen B-O B-cell_type
lymphocytic B-O I-cell_type
cell B-O I-cell_type
was B-O O
also B-O O
measured B-O O
in B-O O
18 B-O O
aged B-O O
rats B-O O
and B-O O
9 B-O O
young B-O O
rats B-O O
. B-O O

The B-O O
results B-O O
showed B-O O
that B-O O
GCR B-O B-protein
was B-O O
significantly B-O O
lower B-O O
in B-O O
the B-O O
aged B-O O
persons B-O O
or B-O O
rats B-O O
than B-O O
that B-O O
in B-O O
the B-O O
young B-O O
while B-O O
the B-O O
plasma B-O O
cortisol B-O O
level B-O O
did B-O O
n't B-O O
change B-O O
with B-O O
aging B-O O
. B-O O

So B-O O
we B-O O
think B-O O
that B-O O
GCR B-O B-protein
is B-O O
more B-O O
sensitive B-O O
than B-O O
the B-O O
plasma B-O O
cortisol B-O O
level B-O O
to B-O O
reflect B-O O
the B-O O
aging B-O O
change B-O O
of B-O O
the B-O O
adrenal B-O O
cortex B-O O
function B-O O
. B-O O

After B-O O
the B-O O
treatment B-O O
with B-O O
the B-O O
regimen B-O O
of B-O O
Kidney-tonifying B-O O
and B-O O
Qi-invigorating B-O O
, B-O O
the B-O O
GCR B-O B-protein
of B-O O
the B-O O
aged B-O O
persons B-O O
and B-O O
rats B-O O
was B-O O
enhanced B-O O
, B-O O
and B-O O
in B-O O
this B-O O
way B-O O
, B-O O
the B-O O
function B-O O
of B-O O
the B-O O
aged B-O O
adrenal B-O O
cortex B-O O
was B-O O
improved B-O O
. B-O O

Interferon B-O B-protein
affects B-O O
nuclear B-O B-protein
proteins B-O I-protein
in B-O O
cells B-O O
of B-O O
clinically B-O O
sensitive B-O O
chronic B-O O
myelogenous B-O O
leukemia B-O O
patients B-O O
. B-O O

Cytoplasmic B-O O
protein B-O O
extracts B-O O
from B-O O
chronic B-O B-cell_type
myelogenous B-O I-cell_type
leukemia B-O I-cell_type
( B-O I-cell_type
CML B-O I-cell_type
) B-O I-cell_type
cells B-O I-cell_type
contained B-O O
an B-O O
activity B-O O
that B-O O
altered B-O O
the B-O O
electrophoretic B-O O
mobility B-O O
of B-O O
complexes B-O O
formed B-O O
between B-O O
nuclear B-O B-protein
proteins B-O I-protein
and B-O O
the B-O O
transcriptional B-O B-DNA
enhancers B-O I-DNA
of B-O O
interferon B-O B-DNA
( B-O I-DNA
IFN B-O I-DNA
) B-O I-DNA
-inducible B-O I-DNA
genes B-O I-DNA
. B-O O

Exposure B-O O
of B-O O
CML B-O B-cell_type
cells B-O I-cell_type
to B-O O
IFN-alpha B-O B-protein
diminished B-O O
the B-O O
effect B-O O
of B-O O
the B-O O
CML B-O B-protein
cytoplasmic B-O I-protein
proteins B-O I-protein
on B-O O
these B-O O
nuclear B-O B-protein
protein-DNA B-O I-protein
complexes B-O I-protein
. B-O O

The B-O O
presence B-O O
of B-O O
clinical B-O O
responsiveness B-O O
to B-O O
IFN-alpha B-O B-protein
correlated B-O O
with B-O O
the B-O O
sensitivity B-O O
to B-O O
the B-O O
IFN B-O B-protein
-induced B-O O
change B-O O
in B-O O
the B-O O
electrophoretic B-O O
mobility B-O O
of B-O O
nuclear B-O B-protein
protein-DNA B-O I-protein
complexes B-O I-protein
. B-O O

These B-O O
data B-O O
suggest B-O O
that B-O O
the B-O O
action B-O O
of B-O O
IFN-alpha B-O B-protein
in B-O O
CML B-O O
may B-O O
be B-O O
linked B-O O
to B-O O
a B-O O
pathway B-O O
that B-O O
can B-O O
result B-O O
in B-O O
posttranslational B-O O
modification B-O O
of B-O O
nuclear B-O B-protein
proteins B-O I-protein
. B-O O

Epstein-Barr B-O B-protein
virus B-O I-protein
nuclear B-O I-protein
antigen B-O I-protein
2 B-O I-protein
transactivates B-O O
latent B-O B-protein
membrane B-O I-protein
protein B-O I-protein
LMP1 B-O B-protein
. B-O O

Several B-O O
lines B-O O
of B-O O
evidence B-O O
are B-O O
compatible B-O O
with B-O O
the B-O O
hypothesis B-O O
that B-O O
Epstein-Barr B-O B-protein
virus B-O I-protein
( B-O I-protein
EBV B-O I-protein
) B-O I-protein
nuclear B-O I-protein
antigen B-O I-protein
2 B-O I-protein
( B-O O
EBNA-2 B-O B-protein
) B-O O
or B-O O
leader B-O B-protein
protein B-O I-protein
( B-O O
EBNA-LP B-O B-protein
) B-O O
affects B-O O
expression B-O O
of B-O O
the B-O O
EBV B-O B-protein
latent B-O I-protein
infection B-O I-protein
membrane B-O I-protein
protein B-O I-protein
LMP1 B-O B-protein
. B-O O

We B-O O
now B-O O
demonstrate B-O O
the B-O O
following B-O O
. B-O O

( B-O O
i B-O O
) B-O O
Acute B-O O
transfection B-O O
and B-O O
expression B-O O
of B-O O
EBNA-2 B-O B-protein
under B-O O
control B-O O
of B-O O
simian B-O B-DNA
virus B-O I-DNA
40 B-O I-DNA
or B-O I-DNA
Moloney B-O I-DNA
murine B-O I-DNA
leukemia B-O I-DNA
virus B-O I-DNA
promoters B-O I-DNA
resulted B-O O
in B-O O
increased B-O O
LMP1 B-O B-protein
expression B-O O
in B-O O
P3HR-1-infected B-O B-cell_line
Burkitt B-O I-cell_line
's B-O I-cell_line
lymphoma B-O I-cell_line
cells B-O I-cell_line
and B-O O
the B-O O
P3HR-1 B-O B-cell_line
or B-O O
Daudi B-O B-cell_line
cell B-O I-cell_line
line B-O I-cell_line
. B-O O

( B-O O
ii B-O O
) B-O O
Transfection B-O O
and B-O O
expression B-O O
of B-O O
EBNA-LP B-O B-protein
alone B-O O
had B-O O
no B-O O
effect B-O O
on B-O O
LMP1 B-O B-protein
expression B-O O
and B-O O
did B-O O
not B-O O
act B-O O
synergistically B-O O
with B-O O
EBNA-2 B-O B-protein
to B-O O
affect B-O O
LMP1 B-O B-protein
expression B-O O
. B-O O

( B-O O
iii B-O O
) B-O O
LMP1 B-O B-protein
expression B-O O
in B-O O
Daudi B-O B-cell_line
and B-O O
P3HR-1-infected B-O B-cell_line
cells B-O I-cell_line
was B-O O
controlled B-O O
at B-O O
the B-O O
mRNA B-O B-RNA
level B-O O
, B-O O
and B-O O
EBNA-2 B-O B-protein
expression B-O O
in B-O O
Daudi B-O B-cell_line
cells B-O I-cell_line
increased B-O O
LMP1 B-O B-RNA
mRNA B-O I-RNA
. B-O O

( B-O O
iv B-O O
) B-O O
No B-O O
other B-O O
EBV B-O B-DNA
genes B-O I-DNA
were B-O O
required B-O O
for B-O O
EBNA-2 B-O B-protein
transactivation B-O O
of B-O O
LMP1 B-O B-protein
since B-O O
cotransfection B-O O
of B-O O
recombinant B-O B-DNA
EBNA-2 B-O I-DNA
expression B-O I-DNA
vectors B-O I-DNA
and B-O O
genomic B-O O
LMP1 B-O B-DNA
DNA B-O I-DNA
fragments B-O I-DNA
enhanced B-O O
LMP1 B-O B-protein
expression B-O O
in B-O O
the B-O O
EBV-negative B-O B-cell_line
B-lymphoma B-O I-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
BJAB B-O B-cell_line
, B-O O
Louckes B-O O
, B-O O
and B-O O
BL30 B-O B-cell_line
. B-O O

( B-O O
v B-O O
) B-O O
An B-O O
EBNA-2 B-O B-DNA
-responsive B-O I-DNA
element B-O I-DNA
was B-O O
found B-O O
within B-O O
the B-O O
-512 B-O B-DNA
to B-O I-DNA
+40 B-O I-DNA
LMP1 B-O I-DNA
DNA B-O I-DNA
since B-O O
this B-O O
DNA B-O O
linked B-O O
to B-O O
a B-O O
chloramphenicol B-O B-DNA
acetyltransferase B-O I-DNA
reporter B-O I-DNA
gene B-O I-DNA
was B-O O
transactivated B-O O
by B-O O
cotransfection B-O O
with B-O O
an B-O O
EBNA-2 B-O B-DNA
expression B-O I-DNA
vector B-O I-DNA
. B-O O

( B-O O
vi B-O O
) B-O O
The B-O O
EBV B-O O
type B-O O
2 B-O O
EBNA-2 B-O B-protein
transactivated B-O O
LMP1 B-O B-protein
as B-O O
well B-O O
as B-O O
the B-O O
EBV B-O B-protein
type B-O I-protein
1 B-O I-protein
EBNA-2 B-O I-protein
. B-O O

( B-O O
vii B-O O
) B-O O
Two B-O O
deletions B-O O
within B-O O
the B-O O
EBNA-2 B-O B-DNA
gene B-O I-DNA
which B-O O
rendered B-O O
EBV B-O O
transformation B-O O
incompetent B-O O
did B-O O
not B-O O
transactivate B-O O
LMP1 B-O B-protein
, B-O O
whereas B-O O
a B-O O
transformation-competent B-O B-DNA
EBNA-2 B-O I-DNA
deletion B-O I-DNA
mutant B-O I-DNA
did B-O O
transactivate B-O O
LMP1 B-O B-protein
. B-O O

LMP1 B-O B-protein
is B-O O
a B-O O
potent B-O O
effector B-O O
of B-O O
B-lymphocyte B-O B-cell_type
activation B-O O
and B-O O
can B-O O
act B-O O
synergistically B-O O
with B-O O
EBNA-2 B-O B-protein
to B-O O
induce B-O O
cellular B-O O
CD23 B-O B-protein
gene B-O O
expression B-O O
. B-O O

Thus B-O O
, B-O O
EBNA-2 B-O B-protein
transactivation B-O O
of B-O O
LMP1 B-O B-protein
amplifies B-O O
the B-O O
biological B-O O
impact B-O O
of B-O O
EBNA-2 B-O B-protein
and B-O O
underscores B-O O
its B-O O
central B-O O
role B-O O
in B-O O
EBV-induced B-O O
growth B-O O
transformation B-O O
. B-O O

The B-O O
expression B-O O
of B-O O
c-fos B-O B-DNA
, B-O O
c-jun B-O B-DNA
, B-O O
and B-O O
c-myc B-O B-DNA
genes B-O I-DNA
is B-O O
regulated B-O O
by B-O O
heat B-O O
shock B-O O
in B-O O
human B-O B-cell_type
lymphoid B-O I-cell_type
cells B-O I-cell_type
. B-O O

The B-O O
effect B-O O
of B-O O
heat B-O O
shock B-O O
on B-O O
the B-O O
expression B-O O
of B-O O
the B-O O
nuclear B-O B-DNA
protooncogenes B-O I-DNA
c-fos B-O B-DNA
, B-O O
c-jun B-O B-DNA
, B-O O
and B-O O
c-myc B-O B-DNA
was B-O O
studied B-O O
in B-O O
human B-O B-cell_type
lymphoid B-O I-cell_type
cells B-O I-cell_type
. B-O O

Heat B-O O
shock B-O O
caused B-O O
an B-O O
increase B-O O
in B-O O
c-fos B-O B-DNA
and B-O O
c-jun B-O O
mRNA B-O O
levels B-O O
and B-O O
a B-O O
decrease B-O O
in B-O O
c-myc B-O B-RNA
mRNA B-O I-RNA
levels B-O O
in B-O O
pre-B B-O B-cell_line
( B-O I-cell_line
Hyon B-O I-cell_line
) B-O I-cell_line
and B-O I-cell_line
T B-O I-cell_line
( B-O I-cell_line
DND-41 B-O I-cell_line
) B-O I-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
as B-O O
well B-O O
as B-O O
in B-O O
freshly B-O B-cell_type
isolated B-O I-cell_type
normal B-O I-cell_type
human B-O I-cell_type
thymocytes B-O I-cell_type
. B-O O

The B-O O
changes B-O O
in B-O O
the B-O O
mRNA B-O B-RNA
levels B-O O
of B-O O
these B-O O
protooncogenes B-O B-DNA
in B-O O
Hyon B-O B-cell_line
cells B-O I-cell_line
were B-O O
most B-O O
pronounced B-O O
at B-O O
42 B-O O
and B-O O
43 B-O O
degrees B-O O
C B-O O
; B-O O
kinetic B-O O
analysis B-O O
demonstrated B-O O
that B-O O
the B-O O
changes B-O O
could B-O O
be B-O O
detected B-O O
within B-O O
30 B-O O
min B-O O
of B-O O
heat B-O O
shock B-O O
. B-O O

Altered B-O O
transcription B-O O
of B-O O
c-fos B-O B-DNA
and B-O O
c-myc B-O B-DNA
genes B-O I-DNA
was B-O O
the B-O O
primary B-O O
effect B-O O
of B-O O
heat B-O O
shock B-O O
. B-O O

Secondarily B-O O
, B-O O
heat B-O O
shock B-O O
of B-O O
Hyon B-O B-cell_line
cells B-O I-cell_line
stabilized B-O O
the B-O O
c-myc B-O B-RNA
mRNA B-O I-RNA
level B-O O
by B-O O
increasing B-O O
its B-O O
half-life B-O O
from B-O O
24 B-O O
to B-O O
45 B-O O
min B-O O
. B-O O

The B-O O
overall B-O O
effect B-O O
of B-O O
heat B-O O
shock B-O O
on B-O O
c-myc B-O B-RNA
mRNA B-O I-RNA
level B-O O
, B-O O
however B-O O
, B-O O
was B-O O
a B-O O
marked B-O O
inhibition B-O O
of B-O O
its B-O O
transcription B-O O
. B-O O

These B-O O
results B-O O
demonstrate B-O O
that B-O O
the B-O O
transcription B-O O
of B-O O
nuclear B-O B-DNA
protooncogenes B-O I-DNA
is B-O O
regulated B-O O
by B-O O
heat B-O O
shock B-O O
indicating B-O O
a B-O O
role B-O O
for B-O O
nuclear B-O B-DNA
protooncogenes B-O I-DNA
in B-O O
the B-O O
stress B-O O
response B-O O
of B-O O
lymphoid B-O B-cell_type
cells B-O I-cell_type
. B-O O

Mapping B-O O
of B-O O
B-cell B-O B-protein
epitopes B-O I-protein
of B-O O
the B-O O
human B-O B-protein
hepatitis B-O I-protein
B B-O I-protein
virus B-O I-protein
X B-O I-protein
protein B-O I-protein
. B-O O

The B-O O
immune B-O O
response B-O O
to B-O O
the B-O O
X B-O B-protein
protein B-O I-protein
of B-O O
human B-O O
hepatitis B-O O
B B-O O
virus B-O O
( B-O O
HBV B-O O
) B-O O
was B-O O
studied B-O O
by B-O O
epitope B-O O
mapping B-O O
by B-O O
using B-O O
a B-O O
set B-O O
of B-O O
MS2-HBx B-O B-protein
fusion B-O I-protein
proteins B-O I-protein
and B-O O
synthetic B-O O
peptides B-O O
. B-O O

Antibodies B-O B-protein
in B-O O
sera B-O O
of B-O O
patients B-O O
with B-O O
acute B-O O
and B-O O
chronic B-O O
HBV B-O O
infection B-O O
showed B-O O
a B-O O
multispecific B-O O
immune B-O O
response B-O O
. B-O O

Each B-O O
serum B-O O
contained B-O O
antibodies B-O B-protein
to B-O O
a B-O O
different B-O O
set B-O O
of B-O O
epitopes B-O B-protein
, B-O O
which B-O O
taken B-O O
together B-O O
cover B-O O
most B-O O
of B-O O
the B-O O
HBx B-O B-DNA
sequence B-O I-DNA
. B-O O

Some B-O O
of B-O O
the B-O O
epitopes B-O B-protein
were B-O O
detectable B-O O
only B-O O
by B-O O
immunoblotting B-O O
with B-O O
fusion B-O B-protein
proteins B-O I-protein
; B-O O
others B-O O
were B-O O
detectable B-O O
only B-O O
by B-O O
an B-O O
enzyme-linked B-O O
immunosorbent B-O O
assay B-O O
( B-O O
ELISA B-O O
) B-O O
with B-O O
synthetic B-O O
peptides B-O O
. B-O O

The B-O O
carboxy-terminal B-O B-protein
half B-O I-protein
of B-O O
the B-O O
HBx B-O B-protein
protein B-O I-protein
was B-O O
preferentially B-O O
recognized B-O O
by B-O O
antibodies B-O B-protein
from B-O O
patients B-O O
with B-O O
chronic B-O O
hepatitis B-O O
and B-O O
contained B-O O
a B-O O
short B-O O
immunodominant B-O B-protein
antigenic B-O I-protein
region B-O I-protein
with B-O O
at B-O O
least B-O O
two B-O O
major B-O O
nonoverlapping B-O B-protein
epitopes B-O I-protein
. B-O O

Anti- B-O O
HBx B-O B-protein
antibody B-O O
titers B-O O
as B-O O
revealed B-O O
by B-O O
peptide B-O O
ELISAs B-O O
were B-O O
highest B-O O
and B-O O
most B-O O
frequent B-O O
in B-O O
patients B-O O
with B-O O
chronic B-O O
hepatitis B-O O
and B-O O
usually B-O O
low B-O O
in B-O O
acutely B-O O
infected B-O O
patients B-O O
and B-O O
asymptomatic B-O O
carriers B-O O
. B-O O

The B-O O
data B-O O
demonstrate B-O O
a B-O O
remarkable B-O O
qualitative B-O O
and B-O O
quantitative B-O O
heterogeneity B-O O
of B-O O
the B-O O
humoral B-O O
HBx B-O B-protein
immune B-O O
response B-O O
which B-O O
can B-O O
be B-O O
monitored B-O O
by B-O O
HBx B-O B-protein
-specific B-O O
peptide B-O O
ELISAs B-O O
. B-O O

Such B-O O
tests B-O O
may B-O O
become B-O O
useful B-O O
diagnostic B-O O
tools B-O O
. B-O O

[ B-O O
The B-O O
inhibitory B-O O
effect B-O O
of B-O O
hydrocortisone B-O O
on B-O O
the B-O O
chemotactic B-O O
migration B-O O
of B-O O
human B-O B-cell_type
leukocytes B-O I-cell_type
] B-O O

Random B-O O
migration B-O O
( B-O O
RM B-O O
) B-O O
and B-O O
chemotactic B-O O
migration B-O O
( B-O O
ChtM B-O O
) B-O O
of B-O O
human B-O B-cell_type
leukocytes B-O I-cell_type
to B-O O
yeast B-O O
activated B-O O
serum B-O O
were B-O O
studied B-O O
with B-O O
the B-O O
modified B-O O
Boyden B-O O
chamber B-O O
method B-O O
. B-O O

Both B-O O
RM B-O O
and B-O O
ChtM B-O O
showed B-O O
circadian B-O O
rhythm B-O O
. B-O O

Leukocytes B-O B-cell_type
migrated B-O O
most B-O O
rapidly B-O O
at B-O O
night B-O O
. B-O O

The B-O O
difference B-O O
between B-O O
the B-O O
peak B-O O
( B-O O
0 B-O O
: B-O O
00 B-O O
) B-O O
and B-O O
trough B-O O
values B-O O
( B-O O
8 B-O O
: B-O O
00 B-O O
) B-O O
of B-O O
RM B-O O
and B-O O
ChtM B-O O
was B-O O
significant B-O O
statistically B-O O
( B-O O
P B-O O
less B-O O
than B-O O
0.01 B-O O
) B-O O
. B-O O

ChtM B-O O
was B-O O
inhibited B-O O
by B-O O
hydrocortisone B-O O
( B-O O
F B-O O
) B-O O
of B-O O
physiological B-O O
concentration B-O O
( B-O O
10 B-O O
( B-O O
-9 B-O O
) B-O O
-10 B-O O
( B-O O
-7 B-O O
) B-O O
mol/L B-O O
) B-O O
which B-O O
was B-O O
dose-dependent B-O O
and B-O O
completely B-O O
antagonized B-O O
by B-O O
the B-O O
competitive B-O O
antagonist B-O O
, B-O O
RU38486 B-O O
. B-O O

The B-O O
inhibitory B-O O
effect B-O O
was B-O O
much B-O O
more B-O O
evident B-O O
with B-O O
higher B-O O
dose B-O O
( B-O O
more B-O O
than B-O O
10 B-O O
( B-O O
-5 B-O O
) B-O O
mol/L B-O O
) B-O O
and B-O O
it B-O O
was B-O O
also B-O O
reversed B-O O
by B-O O
RU38486 B-O O
, B-O O
but B-O O
only B-O O
partially B-O O
. B-O O

It B-O O
is B-O O
suggested B-O O
that B-O O
glucocorticoids B-O O
( B-O O
GC B-O O
) B-O O
may B-O O
be B-O O
a B-O O
physiological B-O O
regulator B-O O
of B-O O
the B-O O
activity B-O O
of B-O O
leukocytes B-O B-cell_type
and B-O O
its B-O O
inhibitory B-O O
action B-O O
on B-O O
ChtM B-O O
may B-O O
be B-O O
involved B-O O
in B-O O
antiinflammatory B-O O
mechanisms B-O O
of B-O O
GC B-O O
of B-O O
pharmacological B-O O
doses B-O O
. B-O O

The B-O O
action B-O O
of B-O O
physiological B-O O
and B-O O
pharmacological B-O O
concentration B-O O
of B-O O
GC B-O O
may B-O O
be B-O O
mediated B-O O
by B-O O
low B-O O
affinity B-O O
specific B-O O
binding B-O O
sites B-O O
of B-O O
glucocorticoid B-O B-protein
receptors B-O I-protein
. B-O O

Heterogeneity B-O O
of B-O O
antigen B-O B-protein
molecules B-O I-protein
recognized B-O O
by B-O O
anti-tax1 B-O B-protein
monoclonal B-O I-protein
antibody B-O I-protein
Lt-4 B-O B-protein
in B-O O
cell B-O B-cell_line
lines B-O I-cell_line
bearing B-O O
human B-O O
T B-O O
cell B-O O
leukemia B-O O
virus B-O O
type B-O O
I B-O O
and B-O O
related B-O O
retroviruses B-O O
. B-O O

Using B-O O
a B-O O
monoclonal B-O B-protein
antibody B-O I-protein
, B-O O
Lt-4 B-O B-protein
, B-O O
directed B-O O
against B-O O
human B-O B-protein
T B-O I-protein
cell B-O I-protein
leukemia B-O I-protein
virus B-O I-protein
type B-O I-protein
I B-O I-protein
( B-O I-protein
HTLV-I B-O I-protein
) B-O I-protein
trans-activator B-O I-protein
( B-O I-protein
tax1 B-O I-protein
) B-O I-protein
antigen B-O I-protein
, B-O O
we B-O O
examined B-O O
the B-O O
expression B-O O
of B-O O
tax1 B-O B-protein
and B-O O
related B-O O
antigens B-O O
in B-O O
a B-O O
variety B-O O
of B-O O
T B-O B-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
bearing B-O O
HTLV-I B-O O
and B-O O
related B-O O
retroviruses B-O O
, B-O O
simian B-O O
T B-O O
cell B-O O
leukemia B-O O
virus B-O O
type B-O O
I B-O O
( B-O O
STLV-I B-O O
) B-O O
and B-O O
HTLV-II B-O O
, B-O O
by B-O O
immunofluorescence B-O O
and B-O O
immunoblot B-O O
assays B-O O
. B-O O

Lt-4 B-O B-protein
reacted B-O O
with B-O O
all B-O O
HTLV-I B-O B-cell_line
-bearing B-O I-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
tested B-O O
and B-O O
five B-O O
out B-O O
of B-O O
eight B-O O
simian B-O B-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
bearing B-O O
STLV-I B-O O
, B-O O
but B-O O
not B-O O
with B-O O
an B-O O
HTLV-II B-O B-cell_line
-bearing B-O I-cell_line
cell B-O I-cell_line
line B-O I-cell_line
. B-O O

Lt-4 B-O B-protein
detected B-O O
40 B-O O
kd B-O O
tax1 B-O B-protein
antigen B-O I-protein
molecules B-O I-protein
in B-O O
most B-O O
HTLV-I B-O B-cell_line
-bearing B-O I-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
except B-O O
one B-O O
cell B-O O
line B-O O
that B-O O
expressed B-O O
39 B-O B-protein
kd B-O I-protein
tax1 B-O I-protein
antigen B-O I-protein
. B-O O

In B-O O
the B-O O
STLV-I B-O B-cell_line
-bearing B-O I-cell_line
T B-O I-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
, B-O O
tax1 B-O B-protein
-related B-O I-protein
antigen B-O I-protein
molecules B-O I-protein
detected B-O O
by B-O O
Lt-4 B-O B-protein
were B-O O
heterogeneous B-O O
, B-O O
having B-O O
molecular B-O O
weights B-O O
in B-O O
the B-O O
range B-O O
of B-O O
36-41 B-O O
kd B-O O
. B-O O

Characterization B-O O
of B-O O
the B-O O
human B-O B-protein
immunodeficiency B-O I-protein
virus B-O I-protein
type B-O I-protein
1 B-O I-protein
enhancer B-O I-protein
-binding B-O I-protein
proteins B-O I-protein
from B-O O
the B-O O
human B-O B-cell_line
T-cell B-O I-cell_line
line B-O I-cell_line
Jurkat B-O I-cell_line
. B-O O

The B-O O
transcription B-O O
of B-O O
the B-O O
human B-O O
immunodeficiency B-O O
virus B-O O
type B-O O
1 B-O O
( B-O O
HIV-1 B-O O
) B-O O
is B-O O
under B-O O
the B-O O
control B-O O
of B-O O
cellular B-O B-protein
proteins B-O I-protein
that B-O O
bind B-O O
to B-O O
the B-O O
viral B-O B-DNA
long B-O I-DNA
terminal B-O I-DNA
repeat B-O I-DNA
( B-O O
LTR B-O B-DNA
) B-O O
. B-O O

Among B-O O
the B-O O
protein-binding B-O B-DNA
regions B-O I-DNA
of B-O O
the B-O O
HIV-1 B-O B-DNA
LTR B-O I-DNA
is B-O O
the B-O O
transcription-enhancer B-O B-DNA
region B-O I-DNA
. B-O O

We B-O O
show B-O O
that B-O O
at B-O O
least B-O O
one B-O O
inducible B-O O
, B-O O
C1 B-O B-protein
, B-O O
and B-O O
one B-O O
constitutive B-O O
, B-O O
C2 B-O B-protein
, B-O O
protein B-O O
can B-O O
bind B-O O
to B-O O
the B-O O
HIV B-O B-DNA
enhancer B-O I-DNA
in B-O O
Jurkat B-O B-cell_line
cells B-O I-cell_line
. B-O O

The B-O O
two B-O O
proteins B-O O
differ B-O O
in B-O O
their B-O O
surface B-O O
charge B-O O
, B-O O
since B-O O
they B-O O
are B-O O
separable B-O O
by B-O O
anion-exchange B-O O
chromatography B-O O
. B-O O

Bivalent B-O O
cations B-O O
such B-O O
as B-O O
Mg2+ B-O O
and B-O O
Zn2+ B-O O
differentially B-O O
affect B-O O
their B-O O
binding B-O O
to B-O O
oligonucleotides B-O O
which B-O O
contain B-O O
the B-O O
HIV-enhancer B-O B-DNA
domain B-O I-DNA
. B-O O

Both B-O O
C1 B-O B-protein
and B-O O
C2 B-O B-protein
proteins B-O I-protein
also B-O O
bind B-O O
to B-O O
a B-O O
similar B-O O
sequence B-O O
found B-O O
in B-O O
the B-O O
interleukin-2 B-O B-DNA
-receptor B-O I-DNA
alpha-subunit B-O I-DNA
enhancer B-O I-DNA
. B-O O

The B-O O
inducible B-O B-protein
C1 B-O I-protein
protein B-O I-protein
was B-O O
partially B-O O
purified B-O O
by B-O O
three B-O O
chromatographic B-O O
steps B-O O
and B-O O
characterized B-O O
by B-O O
u.v. B-O O
cross-linking B-O O
as B-O O
a B-O O
47 B-O B-protein
kDa B-O I-protein
protein B-O I-protein
. B-O O

Differences B-O O
in B-O O
transcriptional B-O B-DNA
enhancers B-O I-DNA
of B-O O
HIV-1 B-O O
and B-O O
HIV-2 B-O O
. B-O O

Response B-O O
to B-O O
T B-O O
cell B-O O
activation B-O O
signals B-O O
. B-O O

T B-O O
cell B-O O
activation B-O O
results B-O O
in B-O O
high B-O O
levels B-O O
of B-O O
HIV B-O O
replication B-O O
and B-O O
is B-O O
thought B-O O
to B-O O
be B-O O
one B-O O
mechanism B-O O
leading B-O O
to B-O O
the B-O O
conversion B-O O
from B-O O
latent B-O O
to B-O O
active B-O O
viral B-O O
infection B-O O
. B-O O

In B-O O
HIV-1 B-O O
, B-O O
the B-O O
sequences B-O O
that B-O O
respond B-O O
to B-O O
these B-O O
signaling B-O O
events B-O O
are B-O O
found B-O O
in B-O O
the B-O O
long B-O B-DNA
terminal B-O I-DNA
repeat B-O I-DNA
( B-O O
LTR B-O B-DNA
) B-O O
and B-O O
comprise B-O O
the B-O O
transcriptional B-O B-DNA
enhancer B-O I-DNA
, B-O O
which B-O O
contains B-O O
two B-O O
conserved B-O B-DNA
binding B-O I-DNA
sites B-O I-DNA
for B-O O
the B-O O
nuclear B-O B-protein
factor B-O I-protein
kappa B-O I-protein
B B-O I-protein
( B-O O
NF B-O B-protein
kappa B-O I-protein
B B-O I-protein
) B-O O
. B-O O

The B-O O
corresponding B-O O
region B-O O
in B-O O
the B-O O
second B-O O
AIDS B-O O
retrovirus B-O O
, B-O O
HIV-2 B-O O
, B-O O
contains B-O O
a B-O O
conserved B-O O
and B-O O
a B-O O
divergent B-O B-DNA
NF B-O I-DNA
kappa B-O I-DNA
B B-O I-DNA
binding B-O I-DNA
site B-O I-DNA
. B-O O

We B-O O
demonstrate B-O O
that B-O O
the B-O O
HIV-1 B-O B-DNA
LTR B-O I-DNA
responds B-O O
better B-O O
than B-O O
the B-O O
HIV-2 B-O B-DNA
LTR B-O I-DNA
to B-O O
T B-O O
cell B-O O
activation B-O O
signals B-O O
. B-O O

These B-O O
qualitative B-O O
differences B-O O
in B-O O
the B-O O
response B-O O
to B-O O
T B-O O
cell B-O O
activation B-O O
are B-O O
reproduced B-O O
not B-O O
only B-O O
when B-O O
HIV-1 B-O B-DNA
or B-O I-DNA
HIV-2 B-O I-DNA
enhancers B-O I-DNA
are B-O O
placed B-O O
upstream B-O O
of B-O O
a B-O O
heterologous B-O B-DNA
promoter B-O I-DNA
but B-O O
also B-O O
when B-O O
these B-O O
enhancers B-O B-DNA
are B-O O
switched B-O O
between B-O O
their B-O O
respective B-O O
LTR B-O B-DNA
. B-O O

In B-O O
electrophoretic B-O O
mobility B-O O
shift B-O O
assays B-O O
, B-O O
NF B-O B-protein
kappa B-O I-protein
B B-O I-protein
binds B-O O
to B-O O
both B-O O
conserved B-O O
sites B-O O
in B-O O
the B-O O
HIV-1 B-O B-DNA
transcriptional B-O I-DNA
enhancer B-O I-DNA
and B-O O
only B-O O
to B-O O
the B-O O
single B-O O
conserved B-O O
site B-O O
in B-O O
the B-O O
HIV-2 B-O B-DNA
transcriptional B-O I-DNA
enhancer B-O I-DNA
. B-O O

Instead B-O O
of B-O O
NF B-O B-protein
kappa B-O I-protein
B B-O I-protein
, B-O O
the B-O O
activator B-O B-protein
protein B-O I-protein
3 B-O I-protein
binds B-O O
to B-O O
the B-O O
divergent B-O B-DNA
site B-O I-DNA
in B-O O
HIV-2 B-O O
. B-O O

In B-O O
conclusion B-O O
, B-O O
HIV-1 B-O O
and B-O O
HIV-2 B-O O
are B-O O
differentially B-O O
regulated B-O O
by B-O O
T B-O O
cell B-O O
activation B-O O
signals B-O O
, B-O O
and B-O O
this B-O O
difference B-O O
may B-O O
account B-O O
for B-O O
the B-O O
longer B-O O
period B-O O
of B-O O
viral B-O O
latency B-O O
observed B-O O
with B-O O
HIV-2 B-O O
than B-O O
with B-O O
HIV-1 B-O O
infection B-O O
. B-O O

NF-X2 B-O B-protein
that B-O O
binds B-O O
to B-O O
the B-O O
DRA B-O B-DNA
X2-box B-O I-DNA
is B-O O
activator B-O B-protein
protein B-O I-protein
1 B-O I-protein
. B-O O

Expression B-O O
cloning B-O O
of B-O O
c-Jun B-O B-protein
. B-O O

Human B-O B-protein
class B-O I-protein
II B-O I-protein
MHC B-O I-protein
Ag B-O I-protein
are B-O O
a B-O O
family B-O O
of B-O O
cell B-O B-protein
surface B-O I-protein
glycoproteins B-O I-protein
. B-O O

Their B-O O
constitutive B-O O
expression B-O O
is B-O O
limited B-O O
to B-O O
B B-O B-cell_type
lymphocytes B-O I-cell_type
and B-O O
thymic B-O B-cell_type
epithelial B-O I-cell_type
cells B-O I-cell_type
. B-O O

In B-O O
many B-O O
other B-O O
cells B-O O
their B-O O
expression B-O O
can B-O O
be B-O O
induced B-O O
by B-O O
IFN-gamma B-O B-protein
. B-O O

Conserved B-O O
upstream B-O B-DNA
promoter B-O I-DNA
sequences B-O I-DNA
regulate B-O O
this B-O O
tissue-specific B-O O
expression B-O O
of B-O O
class B-O B-DNA
II B-O I-DNA
genes B-O I-DNA
. B-O O

In B-O O
the B-O O
DRA B-O B-DNA
promoter B-O I-DNA
, B-O O
one B-O O
of B-O O
these B-O O
cis-acting B-O B-DNA
regulatory B-O I-DNA
motifs B-O I-DNA
is B-O O
the B-O O
X2-box B-O B-DNA
to B-O O
which B-O O
nuclear B-O B-protein
factor B-O I-protein
X2 B-O I-protein
( B-O O
NF-X2 B-O B-protein
) B-O O
binds B-O O
. B-O O

Here B-O O
, B-O O
we B-O O
present B-O O
the B-O O
isolation B-O O
and B-O O
characterization B-O O
of B-O O
the B-O O
full-length B-O B-DNA
cDNA B-O I-DNA
clone B-O I-DNA
encoding B-O O
NF-X2 B-O B-protein
. B-O O

This B-O O
cDNA B-O B-DNA
clone B-O I-DNA
was B-O O
isolated B-O O
by B-O O
expression B-O O
cDNA B-O O
cloning B-O O
, B-O O
and B-O O
encodes B-O O
the B-O O
human B-O B-protein
c-Jun B-O I-protein
protein B-O I-protein
, B-O O
which B-O O
together B-O O
with B-O O
c-Fos B-O B-protein
forms B-O O
the B-O O
heterodimeric B-O B-protein
activator B-O I-protein
protein-1 B-O I-protein
transcription B-O I-protein
complex B-O I-protein
. B-O O

Whereas B-O O
c-Fos B-O B-protein
/c-Jun B-O I-protein
heterodimers B-O I-protein
do B-O O
not B-O O
exist B-O O
in B-O O
B B-O B-cell_type
cells B-O I-cell_type
, B-O O
they B-O O
form B-O O
and B-O O
bind B-O O
to B-O O
the B-O O
X2-box B-O B-DNA
in B-O O
class B-O B-cell_line
II B-O I-cell_line
nonexpressing B-O I-cell_line
cells B-O I-cell_line
. B-O O

Thus B-O O
, B-O O
c-Fos B-O B-protein
/c-Jun B-O B-protein
heterodimers B-O I-protein
might B-O O
contribute B-O O
to B-O O
the B-O O
repression B-O O
of B-O O
DRA B-O B-DNA
gene B-O I-DNA
expression B-O O
. B-O O

Synthesis B-O O
of B-O O
4 B-O O
, B-O O
19-disubstituted B-O O
derivatives B-O O
of B-O O
DOC B-O O
. B-O O

Radioreceptor B-O O
assay B-O O
of B-O O
some B-O O
corticosteroid B-O O
derivatives B-O O
in B-O O
human B-O B-cell_type
mononuclear B-O I-cell_type
leukocytes B-O I-cell_type
. B-O O

Several B-O O
new B-O O
4 B-O O
, B-O O
19-substituted B-O O
steroids B-O O
and B-O O
previously B-O O
synthesized B-O O
corticosteroids B-O O
were B-O O
assayed B-O O
for B-O O
affinity B-O O
to B-O O
type B-O B-protein
1 B-O I-protein
receptors B-O I-protein
in B-O O
human B-O B-cell_type
mononuclear B-O I-cell_type
leukocytes B-O I-cell_type
. B-O O

11 B-O O
beta B-O O
, B-O O
19-epoxy-4 B-O O
, B-O O
21-dihydroxypregn-4-ene-3 B-O O
, B-O O
20-dione B-O O
( B-O O
2 B-O O
) B-O O
was B-O O
hydrogenated B-O O
with B-O O
Pd-C B-O O
to B-O O
yield B-O O
a B-O O
mixture B-O O
of B-O O
all B-O O
four B-O O
dihydro B-O O
derivatives B-O O
5 B-O O
, B-O O
accompanied B-O O
by B-O O
4 B-O O
, B-O O
21-diacetoxy-11 B-O O
beta B-O O
, B-O O
19-epoxy-3-hydroxypregnan-20-one B-O O
( B-O O
6 B-O O
) B-O O
and B-O O
21-acetoxy-11 B-O O
beta B-O O
, B-O O
19-epoxy-4-hydroxypregnane-3 B-O O
, B-O O
20-dione B-O O
( B-O O
7 B-O O
) B-O O
. B-O O

With B-O O
hot B-O O
acetic B-O O
+ B-O O
p-toluenesulfonic B-O O
acid B-O O
5 B-O O
underwent B-O O
rearrangement B-O O
to B-O O
21-acetoxy-11 B-O O
beta B-O O
, B-O O
19-epoxypregn-5-ene-4 B-O O
, B-O O
20-dione B-O O
( B-O O
8 B-O O
) B-O O
Pd-C B-O O
hydrogenation B-O O
of B-O O
3 B-O O
, B-O O
21-diacetoxy-5 B-O O
beta B-O O
, B-O O
19-cyclopregna-2 B-O O
, B-O O
9 B-O O
( B-O O
11 B-O O
) B-O O
-diene-4 B-O O
, B-O O
20-dione B-O O
( B-O O
10 B-O O
) B-O O
gave B-O O
3 B-O O
, B-O O
21-diacetoxy-5 B-O O
beta B-O O
, B-O O
19-cyclopregn-5-ene-4 B-O O
, B-O O
20-dione B-O O
( B-O O
11 B-O O
) B-O O
and B-O O
the B-O O
9 B-O O
, B-O O
11-dihydro B-O O
derivative B-O O
of B-O O
the B-O O
latter B-O O
. B-O O

Treatment B-O O
of B-O O
10 B-O O
with B-O O
warm B-O O
HCl B-O O
furnished B-O O
19-chloro-4 B-O O
, B-O O
21-dihydroxypregna-4 B-O O
, B-O O
9 B-O O
( B-O O
11 B-O O
) B-O O
-diene-3 B-O O
, B-O O
20-dione B-O O
( B-O O
13 B-O O
) B-O O
. B-O O

Pd-C B-O O
hydrogenation B-O O
of B-O O
its B-O O
diacetate B-O O
14 B-O O
afforded B-O O
the B-O O
4 B-O O
, B-O O
5-dihydro B-O O
derivative B-O O
18 B-O O
, B-O O
19-chloro-21-acetoxypregn-9 B-O O
( B-O O
11 B-O O
) B-O O
-en-20-one B-O O
( B-O O
15 B-O O
) B-O O
, B-O O
its B-O O
4-acetoxy B-O O
derivative B-O O
16 B-O O
and B-O O
the B-O O
3 B-O O
, B-O O
4-diacetoxy B-O O
derivative B-O O
17 B-O O
. B-O O

When B-O O
tested B-O O
in B-O O
a B-O O
radioreceptor B-O O
assay B-O O
in B-O O
human B-O B-cell_type
mononuclear B-O I-cell_type
leukocytes B-O I-cell_type
the B-O O
synthesized B-O O
compounds B-O O
showed B-O O
only B-O O
low B-O O
relative B-O O
binding B-O O
affinities B-O O
( B-O O
RBA B-O B-protein
) B-O O
to B-O O
type B-O B-protein
1 B-O I-protein
receptor B-O I-protein
, B-O O
the B-O O
highest B-O O
being B-O O
0.72 B-O O
% B-O O
for B-O O
13 B-O O
( B-O O
aldosterone B-O O
= B-O O
100 B-O O
% B-O O
) B-O O
. B-O O

For B-O O
comparison B-O O
, B-O O
other B-O O
RBA B-O O
in B-O O
this B-O O
system B-O O
were B-O O
: B-O O
19-noraldosterone B-O O
, B-O O
20 B-O O
% B-O O
; B-O O
18-deoxyaldosterone B-O O
, B-O O
5.8 B-O O
% B-O O
; B-O O
18-deoxy-19-noraldosterone B-O O
, B-O O
4.7 B-O O
% B-O O
; B-O O
18 B-O O
, B-O O
21-anhydroaldosterone B-O O
, B-O O
0.37 B-O O
% B-O O
; B-O O
17-isoaldosterone B-O O
, B-O O
7.6 B-O O
% B-O O
and B-O O
apoaldosterone B-O O
, B-O O
4.3 B-O O
% B-O O

Cell B-O O
type B-O O
specificity B-O O
and B-O O
activation B-O O
requirements B-O O
for B-O O
NFAT-1 B-O B-protein
( B-O O
nuclear B-O O
factor B-O O
of B-O O
activated B-O B-cell_type
T-cells B-O I-cell_type
) B-O O
transcriptional B-O O
activity B-O O
determined B-O O
by B-O O
a B-O O
new B-O O
method B-O O
using B-O O
transgenic B-O O
mice B-O O
to B-O O
assay B-O O
transcriptional B-O O
activity B-O O
of B-O O
an B-O O
individual B-O O
nuclear B-O B-protein
factor B-O I-protein
. B-O O

Nuclear B-O O
factor B-O O
of B-O O
activated B-O B-cell_type
T-cells B-O I-cell_type
( B-O O
NFAT-1 B-O B-protein
) B-O O
is B-O O
a B-O O
transcription B-O B-protein
factor B-O I-protein
which B-O O
is B-O O
considered B-O O
to B-O O
be B-O O
an B-O O
important B-O O
regulator B-O O
in B-O O
early B-O O
T-cell B-O O
activation B-O O
. B-O O

We B-O O
have B-O O
developed B-O O
a B-O O
system B-O O
to B-O O
monitor B-O O
the B-O O
transcriptional B-O O
activity B-O O
of B-O O
NFAT-1 B-O B-protein
at B-O O
the B-O O
single B-O O
cell B-O O
level B-O O
in B-O O
whole B-O O
animals B-O O
. B-O O

The B-O O
system B-O O
is B-O O
based B-O O
on B-O O
the B-O O
use B-O O
of B-O O
an B-O O
oligomerized B-O O
NFAT-1 B-O B-protein
binding B-O O
motif B-O O
that B-O O
directs B-O O
transcription B-O O
of B-O O
SV40 B-O B-protein
T-antigen B-O I-protein
in B-O O
transgenic B-O O
mice B-O O
. B-O O

This B-O O
report B-O O
represents B-O O
the B-O O
first B-O O
demonstration B-O O
that B-O O
a B-O O
multimerized B-O B-DNA
short B-O I-DNA
binding B-O I-DNA
motif B-O I-DNA
can B-O O
function B-O O
appropriately B-O O
in B-O O
transgenic B-O O
mice B-O O
. B-O O

NFAT-1 B-O B-protein
activity B-O O
had B-O O
previously B-O O
been B-O O
thought B-O O
to B-O O
be B-O O
confined B-O O
to B-O O
activated B-O B-cell_type
T-lymphocytes B-O I-cell_type
upon B-O O
release B-O O
of B-O O
intracellular B-O O
calcium B-O O
. B-O O

By B-O O
targeting B-O O
NFAT-1 B-O B-protein
-dependent B-O O
gene B-O O
expression B-O O
in B-O O
transgenic B-O O
mice B-O O
we B-O O
discovered B-O O
new B-O O
sites B-O O
of B-O O
NFAT-1 B-O B-protein
activity B-O O
. B-O O

Besides B-O O
in B-O O
T-lymphocytes B-O B-cell_type
NFAT-1 B-O B-protein
activity B-O O
could B-O O
also B-O O
be B-O O
induced B-O O
in B-O O
T-lymphocyte-depleted B-O B-cell_type
spleen B-O I-cell_type
cells B-O I-cell_type
and B-O O
purified B-O B-cell_type
B-lymphocytes B-O I-cell_type
and B-O O
requires B-O O
agents B-O O
that B-O O
both B-O O
release B-O O
intracellular B-O O
calcium B-O O
and B-O O
activate B-O O
protein B-O B-protein
kinase B-O I-protein
C B-O I-protein
. B-O O

A B-O O
difference B-O O
in B-O O
the B-O O
time B-O O
course B-O O
of B-O O
appearance B-O O
of B-O O
NFAT-1 B-O B-protein
activity B-O O
between B-O O
T-lymphocytes B-O B-cell_type
and B-O O
non-T-lymphocytes B-O B-cell_type
was B-O O
revealed B-O O
. B-O O

Constitutive B-O O
expression B-O O
was B-O O
observed B-O O
in B-O O
a B-O O
small B-O O
population B-O O
of B-O O
cells B-O O
in B-O O
the B-O O
dermis B-O O
and B-O O
some B-O O
mice B-O O
have B-O O
developed B-O O
skin B-O O
lesions B-O O
. B-O O

Interestingly B-O O
, B-O O
the B-O O
tissue B-O O
pattern B-O O
of B-O O
expression B-O O
of B-O O
the B-O O
NFAT-1 B-O B-protein
activity B-O O
resembles B-O O
the B-O O
expression B-O O
pattern B-O O
described B-O O
for B-O O
HIV-LTR/tat B-O O
transgenic B-O O
mice B-O O
( B-O O
Vogel B-O O
, B-O O
J. B-O O
, B-O O
Hinrichs B-O O
, B-O O
S. B-O O
H. B-O O
, B-O O
Reynolds B-O O
, B-O O
R. B-O O
K. B-O O
, B-O O
Luciw B-O O
, B-O O
P. B-O O
A. B-O O
, B-O O
and B-O O
Jay B-O O
, B-O O
G. B-O O
( B-O O
1988 B-O O
) B-O O
Nature B-O O
335 B-O O
, B-O O
606-611 B-O O
) B-O O
. B-O O

This B-O O
similarity B-O O
in B-O O
expression B-O O
and B-O O
the B-O O
fact B-O O
that B-O O
NFAT-1 B-O B-protein
has B-O O
been B-O O
shown B-O O
to B-O O
bind B-O O
functional B-O B-DNA
sequences B-O I-DNA
in B-O O
HIV-LTR B-O B-DNA
suggest B-O O
a B-O O
role B-O O
for B-O O
NFAT-1 B-O B-protein
in B-O O
dermal B-O O
activation B-O O
of B-O O
the B-O O
HIV-LTR B-O B-DNA
. B-O O

A B-O O
novel B-O O
T-cell B-O B-protein
protein B-O I-protein
which B-O O
recognizes B-O O
a B-O O
palindromic B-O B-DNA
sequence B-O I-DNA
in B-O O
the B-O O
negative B-O B-DNA
regulatory B-O I-DNA
element B-O I-DNA
of B-O O
the B-O O
human B-O B-DNA
immunodeficiency B-O I-DNA
virus B-O I-DNA
long B-O I-DNA
terminal B-O I-DNA
repeat B-O I-DNA
. B-O O

Two B-O O
major B-O B-DNA
protein-binding B-O I-DNA
sites B-O I-DNA
within B-O O
the B-O O
negative B-O B-DNA
regulatory B-O I-DNA
element B-O I-DNA
of B-O O
the B-O O
human B-O B-DNA
immunodeficiency B-O I-DNA
virus B-O I-DNA
type B-O I-DNA
1 B-O I-DNA
long B-O I-DNA
terminal B-O I-DNA
repeat B-O I-DNA
have B-O O
been B-O O
identified B-O O
. B-O O

One B-O O
( B-O O
site B-O B-DNA
B B-O I-DNA
) B-O O
contained B-O O
a B-O O
palindromic B-O B-DNA
sequence B-O I-DNA
with B-O O
homology B-O O
to B-O O
steroid/thyroid B-O B-DNA
hormone B-O I-DNA
response B-O I-DNA
elements B-O I-DNA
but B-O O
was B-O O
distinct B-O O
from B-O O
previously B-O O
described B-O O
binding B-O O
sites B-O O
of B-O O
this B-O O
class B-O O
. B-O O

A B-O O
novel B-O O
T-cell B-O B-protein
protein B-O I-protein
recognized B-O O
the B-O O
palindromic B-O B-DNA
sequence B-O I-DNA
within B-O O
site B-O B-DNA
B B-O I-DNA
and B-O O
also B-O O
bound B-O O
estrogen- B-O B-DNA
or B-O I-DNA
thyroid B-O I-DNA
hormone- B-O I-DNA
response B-O I-DNA
elements B-O I-DNA
with B-O O
lower B-O O
affinity B-O O
. B-O O

A B-O O
7-base-pair B-O O
mutation B-O O
in B-O O
the B-O O
site B-O B-DNA
B B-O I-DNA
palindrome B-O I-DNA
, B-O O
which B-O O
destroyed B-O O
protein B-O O
binding B-O O
, B-O O
resulted B-O O
in B-O O
increased B-O O
expression B-O O
from B-O O
the B-O O
human B-O B-DNA
immunodeficiency B-O I-DNA
virus B-O I-DNA
type B-O I-DNA
1 B-O I-DNA
long B-O I-DNA
terminal B-O I-DNA
repeat B-O I-DNA
in B-O O
T B-O B-cell_type
cells B-O I-cell_type
. B-O O

Progesterone B-O O
suppression B-O O
of B-O O
pregnancy B-O B-cell_type
lymphocytes B-O I-cell_type
is B-O O
not B-O O
mediated B-O O
by B-O O
glucocorticoid B-O O
effect B-O O
. B-O O

This B-O O
study B-O O
investigated B-O O
whether B-O O
the B-O O
suppressive B-O O
effect B-O O
of B-O O
progesterone B-O O
on B-O O
pregnancy B-O B-cell_type
lymphocytes B-O I-cell_type
is B-O O
mediated B-O O
by B-O O
specific B-O O
progesterone B-O B-protein
receptors B-O I-protein
. B-O O

The B-O O
effects B-O O
of B-O O
a B-O O
competitive B-O O
progesterone B-O O
antagonist B-O O
( B-O O
RU486 B-O O
) B-O O
and B-O O
a B-O O
specific B-O O
glucocorticoid B-O B-protein
receptor B-O I-protein
blocker B-O O
( B-O O
RU43044 B-O O
) B-O O
were B-O O
tested B-O O
on B-O O
the B-O O
release B-O O
of B-O O
a B-O O
blocking B-O B-protein
factor B-O I-protein
by B-O O
progesterone B-O B-cell_line
-treated B-O I-cell_line
pregnancy B-O I-cell_line
lymphocytes B-O I-cell_line
. B-O O

RU B-O O
486 B-O O
tested B-O O
at B-O O
an B-O O
equal B-O O
concentration B-O O
as B-O O
progesterone B-O O
significantly B-O O
inhibited B-O O
the B-O O
production B-O O
of B-O O
the B-O O
blocking B-O B-protein
factor B-O I-protein
, B-O O
while B-O O
RU B-O O
43044 B-O O
was B-O O
without B-O O
effect B-O O
. B-O O

These B-O O
data B-O O
suggest B-O O
that B-O O
in B-O O
pregnancy B-O O
, B-O O
lymphocyte B-O O
progesterone B-O O
acts B-O O
on B-O O
specific B-O O
progesterone B-O B-protein
receptors B-O I-protein
and B-O O
glucocorticoid B-O B-protein
binding B-O I-protein
sites B-O I-protein
are B-O O
not B-O O
involved B-O O
. B-O O

The B-O O
56-59-kilodalton B-O B-protein
protein B-O I-protein
identified B-O O
in B-O O
untransformed B-O B-protein
steroid B-O I-protein
receptor B-O I-protein
complexes B-O I-protein
is B-O O
a B-O O
unique B-O B-protein
protein B-O I-protein
that B-O O
exists B-O O
in B-O O
cytosol B-O O
in B-O O
a B-O O
complex B-O O
with B-O O
both B-O O
the B-O O
70- B-O B-protein
and B-O I-protein
90- B-O I-protein
kilodalton B-O I-protein
heat B-O I-protein
shock B-O I-protein
proteins B-O I-protein
. B-O O

It B-O O
has B-O O
previously B-O O
been B-O O
shown B-O O
that B-O O
9S B-O B-protein
, B-O O
untransformed B-O B-protein
progestin B-O I-protein
, B-O O
estrogen B-O O
, B-O O
androgen B-O O
, B-O O
and B-O O
glucocorticoid B-O B-protein
receptor B-O I-protein
complexes B-O I-protein
in B-O O
rabbit B-O O
uterine B-O O
and B-O O
liver B-O O
cytosols B-O O
contain B-O O
a B-O O
59-kDa B-O B-protein
protein B-O I-protein
[ B-O O
Tai B-O O
, B-O O
P.K. B-O O
, B-O O
Maeda B-O O
, B-O O
Y. B-O O
, B-O O
Nakao B-O O
, B-O O
K. B-O O
, B-O O
Wakim B-O O
, B-O O
N.G. B-O O
, B-O O
Duhring B-O O
, B-O O
J.L. B-O O
, B-O O
& B-O O
amp B-O O
; B-O O
Faber B-O O
, B-O O
L.E. B-O O
( B-O O
1986 B-O O
) B-O O
Biochemistry B-O O
25 B-O O
, B-O O
5269-5275 B-O O
] B-O O
. B-O O

In B-O O
this B-O O
work B-O O
we B-O O
show B-O O
that B-O O
the B-O O
monoclonal B-O B-protein
antibody B-O I-protein
KN B-O I-protein
382/EC1 B-O I-protein
raised B-O O
against B-O O
the B-O O
rabbit B-O B-protein
59-kDa B-O I-protein
protein B-O I-protein
reacts B-O O
with B-O O
9S B-O B-protein
, B-O O
untransformed B-O B-protein
glucocorticoid B-O I-protein
receptor B-O I-protein
complexes B-O I-protein
in B-O O
cytosol B-O O
prepared B-O O
from B-O O
human B-O B-cell_line
IM-9 B-O I-cell_line
lymphocytes B-O I-cell_line
but B-O O
not B-O O
with B-O O
4S B-O B-protein
salt-transformed B-O I-protein
receptors B-O I-protein
. B-O O

The B-O O
human B-O B-protein
protein B-O I-protein
recognized B-O O
by B-O O
the B-O O
EC1 B-O B-protein
antibody B-O I-protein
is B-O O
a B-O O
56-kDa B-O B-protein
protein B-O I-protein
( B-O O
p56 B-O B-protein
) B-O O
of B-O O
moderate B-O O
abundance B-O O
located B-O O
predominantly B-O O
in B-O O
the B-O O
cytoplasm B-O O
by B-O O
indirect B-O O
immunofluorescence B-O O
. B-O O

There B-O O
are B-O O
at B-O O
least B-O O
six B-O O
isomorphs B-O B-protein
of B-O O
p56 B-O B-protein
by B-O O
two-dimensional B-O O
gel B-O O
analysis B-O O
. B-O O

N-Terminal B-O O
sequencing B-O O
( B-O O
20 B-O O
amino B-O O
acids B-O O
) B-O O
shows B-O O
that B-O O
p56 B-O B-protein
is B-O O
a B-O O
unique B-O B-protein
human B-O I-protein
protein B-O I-protein
. B-O O

When B-O O
p56 B-O B-protein
is B-O O
immunoadsorbed B-O O
from B-O O
IM-9 B-O B-cell_line
cell B-O I-cell_line
cytosol B-O O
, B-O O
both B-O O
the B-O O
70- B-O B-protein
and B-O I-protein
90- B-O I-protein
kDa B-O I-protein
heat B-O I-protein
shock B-O I-protein
proteins B-O I-protein
are B-O O
coadsorbed B-O O
in B-O O
an B-O O
immune-specific B-O O
manner B-O O
. B-O O

Neither B-O O
heat B-O B-protein
shock B-O I-protein
protein B-O I-protein
reacts B-O O
directly B-O O
with B-O O
the B-O O
EC1 B-O B-protein
antibody B-O I-protein
. B-O O

We B-O O
conclude B-O O
that B-O O
p56 B-O B-protein
exists B-O O
in B-O O
cytosol B-O O
in B-O O
a B-O O
higher B-O O
order B-O O
complex B-O O
containing B-O O
hsp70 B-O B-protein
and B-O O
hsp90 B-O B-protein
, B-O O
both B-O O
of B-O O
which B-O O
in B-O O
turn B-O O
have B-O O
been B-O O
found B-O O
to B-O O
be B-O O
associated B-O O
with B-O O
untransformed B-O B-protein
steroid B-O I-protein
receptors B-O I-protein
. B-O O

Sequence-specific B-O O
DNA B-O O
binding B-O O
of B-O O
the B-O O
proto-oncoprotein B-O B-protein
ets-1 B-O B-protein
defines B-O O
a B-O O
transcriptional B-O B-DNA
activator B-O I-DNA
sequence B-O I-DNA
within B-O O
the B-O O
long B-O B-DNA
terminal B-O I-DNA
repeat B-O I-DNA
of B-O O
the B-O O
Moloney B-O O
murine B-O O
sarcoma B-O O
virus B-O O
. B-O O

The B-O O
ets B-O B-DNA
proto-oncogene B-O I-DNA
family B-O I-DNA
is B-O O
a B-O O
group B-O O
of B-O O
sequence-related B-O B-DNA
genes B-O I-DNA
whose B-O O
normal B-O O
cellular B-O O
function B-O O
is B-O O
unknown B-O O
. B-O O

In B-O O
a B-O O
study B-O O
of B-O O
cellular B-O B-protein
proteins B-O I-protein
involved B-O O
in B-O O
the B-O O
transcriptional B-O O
regulation B-O O
of B-O O
murine B-O O
retroviruses B-O O
in B-O O
T B-O B-cell_type
lymphocytes B-O I-cell_type
, B-O O
we B-O O
have B-O O
discovered B-O O
that B-O O
a B-O O
member B-O O
of B-O O
the B-O O
ets B-O B-DNA
gene B-O I-DNA
family B-O I-DNA
encodes B-O O
a B-O O
sequence-specific B-O B-protein
DNA-binding B-O I-protein
protein B-O I-protein
. B-O O

A B-O O
mouse B-O B-DNA
ets-1 B-O I-DNA
cDNA B-O I-DNA
clone B-O I-DNA
was B-O O
obtained B-O O
by B-O O
screening B-O O
a B-O O
mouse B-O B-DNA
thymus B-O I-DNA
cDNA B-O I-DNA
expression B-O I-DNA
library B-O I-DNA
with B-O O
a B-O O
double-stranded B-O B-DNA
oligonucleotide B-O I-DNA
probe B-O I-DNA
representing B-O O
20 B-O O
bp B-O O
of B-O O
the B-O O
Moloney B-O O
murine B-O B-DNA
sarcoma B-O I-DNA
virus B-O I-DNA
( B-O I-DNA
MSV B-O I-DNA
) B-O I-DNA
long B-O I-DNA
terminal B-O I-DNA
repeat B-O I-DNA
( B-O O
LTR B-O B-DNA
) B-O O
. B-O O

The B-O O
cDNA B-O B-DNA
sequence B-O I-DNA
has B-O O
an B-O O
813-bp B-O B-DNA
open B-O I-DNA
reading B-O I-DNA
frame B-O I-DNA
( B-O O
ORF B-O B-DNA
) B-O O
whose B-O O
predicted B-O O
amino B-O O
acid B-O O
sequence B-O O
is B-O O
97.6 B-O O
% B-O O
identical B-O O
to B-O O
the B-O O
272 B-O B-protein
carboxy-terminal B-O I-protein
amino B-O I-protein
acids B-O I-protein
of B-O O
the B-O O
human B-O B-protein
ets-1 B-O I-protein
protein B-O I-protein
. B-O O

The B-O O
ORF B-O B-DNA
was B-O O
expressed B-O O
in B-O O
bacteria B-O O
, B-O O
and B-O O
the B-O O
30-kD B-O B-protein
protein B-O I-protein
product B-O I-protein
was B-O O
shown B-O O
to B-O O
bind B-O O
DNA B-O O
in B-O O
a B-O O
sequence-specific B-O O
manner B-O O
by B-O O
mobility-shift B-O O
assays B-O O
, B-O O
Southwestern B-O O
blot B-O O
analysis B-O O
, B-O O
and B-O O
methylation B-O O
interference B-O O
. B-O O

A B-O O
mutant B-O B-DNA
LTR B-O I-DNA
containing B-O O
four B-O O
base B-O O
pair B-O O
substitutions B-O O
in B-O O
the B-O O
ets-1 B-O B-DNA
binding B-O I-DNA
site B-O I-DNA
was B-O O
constructed B-O O
and B-O O
was B-O O
shown B-O O
to B-O O
have B-O O
reduced B-O O
binding B-O O
in B-O O
vitro B-O O
. B-O O

Transcriptional B-O O
efficiency B-O O
of B-O O
the B-O O
MSV B-O B-DNA
LTR B-O I-DNA
promoter B-O I-DNA
containing B-O O
this B-O O
disrupted B-O O
ets-1 B-O B-DNA
binding B-O I-DNA
site B-O I-DNA
was B-O O
compared B-O O
to B-O O
the B-O O
activity B-O O
of B-O O
a B-O O
wild-type B-O B-DNA
promoter B-O I-DNA
in B-O O
mouse B-O B-cell_type
T B-O I-cell_type
lymphocytes B-O I-cell_type
in B-O O
culture B-O O
, B-O O
and B-O O
15- B-O O
to B-O O
20-fold B-O O
reduction B-O O
in B-O O
expression B-O O
of B-O O
a B-O O
reporter B-O B-DNA
gene B-O I-DNA
was B-O O
observed B-O O
. B-O O

We B-O O
propose B-O O
that B-O O
ets-1 B-O B-protein
functions B-O O
as B-O O
a B-O O
transcriptional B-O B-protein
activator B-O I-protein
of B-O O
mammalian B-O O
type-C B-O O
retroviruses B-O O
and B-O O
speculate B-O O
that B-O O
ets-related B-O B-DNA
genes B-O I-DNA
constitute B-O O
a B-O O
new B-O O
group B-O O
of B-O O
eukaryotic B-O B-protein
DNA-binding B-O I-protein
proteins B-O I-protein
. B-O O

Type B-O B-protein
II B-O I-protein
estrogen B-O I-protein
binding B-O I-protein
sites B-O I-protein
in B-O O
human B-O B-cell_type
peripheral B-O I-cell_type
blood B-O I-cell_type
mononuclear B-O I-cell_type
cells B-O I-cell_type
: B-O O
variations B-O O
during B-O O
the B-O O
menstrual B-O O
cycle B-O O
. B-O O

We B-O O
have B-O O
previously B-O O
reported B-O O
that B-O O
human B-O B-cell_type
peripheral B-O I-cell_type
blood B-O I-cell_type
mononuclear B-O I-cell_type
cells B-O I-cell_type
( B-O O
PBMC B-O B-cell_type
) B-O O
contain B-O O
type B-O B-protein
II B-O I-protein
estrogen B-O I-protein
binding B-O I-protein
sites B-O I-protein
( B-O O
type B-O B-protein
II B-O I-protein
EBS B-O I-protein
) B-O O
. B-O O

In B-O O
this B-O O
study B-O O
, B-O O
the B-O O
fluctuations B-O O
of B-O O
type B-O B-protein
II B-O I-protein
EBS B-O I-protein
during B-O O
the B-O O
menstrual B-O O
cycle B-O O
were B-O O
analyzed B-O O
in B-O O
6 B-O O
normally B-O O
menstruating B-O O
women B-O O
. B-O O

Approximately B-O O
3 B-O O
times B-O O
higher B-O O
levels B-O O
of B-O O
type B-O B-protein
II B-O I-protein
EBS B-O I-protein
were B-O O
found B-O O
in B-O O
the B-O O
periovulatory B-O O
period B-O O
with B-O O
respect B-O O
to B-O O
both B-O O
follicular B-O O
and B-O O
luteal B-O O
phases B-O O
. B-O O

In B-O O
postmenopausal B-O O
women B-O O
the B-O O
mean B-O O
type B-O B-protein
II B-O I-protein
EBS B-O I-protein
levels B-O O
were B-O O
similar B-O O
to B-O O
those B-O O
observed B-O O
in B-O O
the B-O O
follicular B-O O
phase B-O O
of B-O O
the B-O O
cycle B-O O
. B-O O

However B-O O
, B-O O
in B-O O
3 B-O O
postmenopausal B-O O
patients B-O O
a B-O O
short B-O O
course B-O O
of B-O O
estrogen B-O O
or B-O O
tamoxifen B-O O
resulted B-O O
in B-O O
a B-O O
marked B-O O
increase B-O O
of B-O O
type B-O B-protein
II B-O I-protein
EBS B-O I-protein
levels B-O O
. B-O O

Tamoxifen B-O O
was B-O O
also B-O O
found B-O O
to B-O O
compete B-O O
with B-O O
17 B-O O
beta-estradiol B-O O
for B-O O
type B-O B-protein
II B-O I-protein
EBS B-O I-protein
in B-O O
PBMC B-O B-cell_type
, B-O O
although B-O O
to B-O O
a B-O O
lesser B-O O
extent B-O O
than B-O O
diethylstilbestrol B-O O
. B-O O

Mononuclear B-O B-cell_type
leukocyte B-O I-cell_type
glucocorticoid B-O B-protein
receptor B-O I-protein
binding B-O O
characteristics B-O O
and B-O O
down-regulation B-O O
in B-O O
major B-O O
depression B-O O
. B-O O

Some B-O O
patients B-O O
with B-O O
major B-O O
depressive B-O O
disorder B-O O
( B-O O
MDD B-O O
) B-O O
have B-O O
elevated B-O O
plasma B-O O
cortisol B-O O
concentrations B-O O
and B-O O
show B-O O
failure B-O O
to B-O O
suppress B-O O
cortisol B-O O
secretion B-O O
upon B-O O
administration B-O O
of B-O O
dexamethasone B-O O
( B-O O
DEX B-O O
) B-O O
, B-O O
yet B-O O
they B-O O
do B-O O
not B-O O
have B-O O
Cushingoid B-O O
features B-O O
. B-O O

To B-O O
study B-O O
whether B-O O
this B-O O
represents B-O O
glucocorticoid B-O O
( B-O O
GC B-O O
) B-O O
resistance B-O O
, B-O O
[ B-O O
3H B-O O
] B-O O
-DEX-binding B-O O
assays B-O O
were B-O O
used B-O O
to B-O O
measure B-O O
, B-O O
in B-O O
vitro B-O O
, B-O O
the B-O O
GC B-O B-protein
receptor B-O I-protein
affinity B-O O
( B-O O
1/Kd B-O O
) B-O O
and B-O O
number B-O O
( B-O O
Bmax B-O O
) B-O O
in B-O O
mononuclear B-O B-cell_type
leukocytes B-O I-cell_type
of B-O O
11 B-O O
MDD B-O O
patients B-O O
and B-O O
15 B-O O
control B-O O
subjects B-O O
. B-O O

No B-O O
receptor B-O O
abnormalities B-O O
were B-O O
detected B-O O
in B-O O
the B-O O
MDD B-O O
group B-O O
; B-O O
thus B-O O
any B-O O
cellular B-O O
defect B-O O
leading B-O O
to B-O O
a B-O O
lack B-O O
of B-O O
responsiveness B-O O
to B-O O
GC B-O O
in B-O O
the B-O O
MDD B-O O
patients B-O O
, B-O O
if B-O O
present B-O O
, B-O O
probably B-O O
lies B-O O
beyond B-O O
the B-O O
initial B-O O
receptor B-O O
binding B-O O
. B-O O

DEX B-O O
( B-O O
1.0 B-O O
mg B-O O
orally B-O O
) B-O O
was B-O O
administered B-O O
to B-O O
study B-O O
in B-O O
vivo B-O O
GC B-O O
receptor B-O O
down-regulation B-O O
. B-O O

Compared B-O O
to B-O O
the B-O O
control B-O O
group B-O O
, B-O O
fewer B-O O
depressed B-O O
subjects B-O O
down-regulated B-O O
Bmax B-O O
after B-O O
DEX B-O O
. B-O O

By B-O O
paired B-O O
t-test B-O O
, B-O O
Bmax B-O O
decreased B-O O
significantly B-O O
in B-O O
the B-O O
control B-O O
group B-O O
but B-O O
not B-O O
in B-O O
the B-O O
depressed B-O O
group B-O O
. B-O O

Receptor B-O O
number B-O O
on B-O O
the B-O O
control B-O O
day B-O O
did B-O O
not B-O O
correlate B-O O
significantly B-O O
with B-O O
the B-O O
degree B-O O
of B-O O
receptor B-O O
down-regulation B-O O
, B-O O
severity B-O O
of B-O O
depression B-O O
or B-O O
cortisol B-O O
concentrations B-O O
across B-O O
all B-O O
the B-O O
subjects B-O O
. B-O O

These B-O O
results B-O O
do B-O O
not B-O O
lend B-O O
support B-O O
to B-O O
previous B-O O
reports B-O O
suggesting B-O O
that B-O O
GC B-O O
resistance B-O O
in B-O O
MDD B-O O
results B-O O
from B-O O
a B-O O
GC B-O O
receptor-binding B-O O
abnormality B-O O
, B-O O
and B-O O
they B-O O
emphasize B-O O
the B-O O
importance B-O O
of B-O O
considering B-O O
receptor B-O O
studies B-O O
in B-O O
the B-O O
context B-O O
of B-O O
GC B-O O
-mediated B-O O
cell B-O O
processes B-O O
in B-O O
order B-O O
to B-O O
identify B-O O
the B-O O
exact B-O O
cellular B-O O
defect B-O O
( B-O O
s B-O O
) B-O O
leading B-O O
to B-O O
GC B-O O
resistance B-O O
. B-O O

Ras-related B-O B-protein
GTP-binding B-O I-protein
proteins B-O I-protein
and B-O O
leukocyte B-O B-cell_type
signal B-O O
transduction B-O O
. B-O O

Many B-O O
aspects B-O O
of B-O O
leukocyte B-O B-cell_type
function B-O O
are B-O O
regulated B-O O
by B-O O
both B-O O
heterotrimeric B-O B-protein
and B-O O
Ras-related B-O B-protein
GTP-binding B-O I-protein
proteins B-O I-protein
, B-O O
but B-O O
there B-O O
is B-O O
little B-O O
definite B-O O
information B-O O
about B-O O
their B-O O
roles B-O O
in B-O O
the B-O O
specialized B-O O
processes B-O O
utilized B-O O
by B-O O
leukocytes B-O B-cell_type
for B-O O
cell B-O O
killing B-O O
. B-O O

Recent B-O O
progress B-O O
in B-O O
understanding B-O O
the B-O O
regulation B-O O
of B-O O
the B-O O
phagocyte B-O B-protein
NADPH B-O I-protein
oxidase B-O I-protein
by B-O O
the B-O O
Rac B-O B-protein
GTP-binding B-O I-protein
proteins B-O I-protein
provides B-O O
a B-O O
basis B-O O
for B-O O
defining B-O O
the B-O O
operational B-O O
characteristics B-O O
of B-O O
one B-O O
such B-O O
phagocyte B-O O
system B-O O
. B-O O

It B-O O
is B-O O
clear B-O O
from B-O O
various B-O O
studies B-O O
that B-O O
the B-O O
activity B-O O
of B-O O
the B-O O
NADPH B-O B-protein
oxidase B-O I-protein
can B-O O
be B-O O
modulated B-O O
through B-O O
the B-O O
regulation B-O O
of B-O O
the B-O O
GTP-GDP B-O O
state B-O O
of B-O O
Rac B-O B-protein
. B-O O

Proteins B-O O
exist B-O O
in B-O O
leukocytes B-O B-cell_type
able B-O O
to B-O O
modify B-O O
GTP-binding B-O B-protein
protein B-O I-protein
function B-O O
in B-O O
this B-O O
manner B-O O
, B-O O
and B-O O
their B-O O
activity B-O O
may B-O O
be B-O O
regulated B-O O
by B-O O
signals B-O O
generated B-O O
on B-O O
phagocyte B-O O
stimulation B-O O
. B-O O

Proteins B-O O
of B-O O
the B-O O
Ras B-O B-protein
superfamily B-O I-protein
are B-O O
likely B-O O
to B-O O
be B-O O
involved B-O O
in B-O O
a B-O O
variety B-O O
of B-O O
normal B-O O
phagocyte B-O O
functions B-O O
through B-O O
their B-O O
ability B-O O
to B-O O
modulate B-O O
the B-O O
assembly B-O O
of B-O O
actin B-O B-protein
filaments B-O I-protein
, B-O O
direct B-O O
vesicle B-O O
trafficking B-O O
and B-O O
fusion B-O O
, B-O O
and B-O O
so B-O O
forth B-O O
. B-O O

BSAP B-O B-protein
: B-O O
a B-O O
key B-O O
regulator B-O O
of B-O O
B-cell B-O B-cell_type
development B-O O
and B-O O
differentiation B-O O
. B-O O

B-cell-specific B-O B-protein
activator B-O I-protein
protein B-O I-protein
( B-O O
BSAP B-O B-protein
) B-O O
is B-O O
a B-O O
recently B-O O
identified B-O O
member B-O O
of B-O O
the B-O O
Pax-gene B-O B-protein
family B-O I-protein
of B-O O
transcription B-O B-protein
factors B-O I-protein
; B-O O
in B-O O
the B-O O
lymphoid B-O O
system B-O O
, B-O O
BSAP B-O B-protein
is B-O O
produced B-O O
only B-O O
in B-O O
B B-O B-cell_type
cells B-O I-cell_type
. B-O O

Here B-O O
, B-O O
Markus B-O O
Neurath B-O O
, B-O O
Eckhard B-O O
Stuber B-O O
and B-O O
Warren B-O O
Strober B-O O
describe B-O O
the B-O O
molecular B-O O
structure B-O O
of B-O O
BSAP B-O B-protein
and B-O O
focus B-O O
on B-O O
the B-O O
ability B-O O
of B-O O
this B-O O
protein B-O O
to B-O O
regulate B-O O
the B-O O
expression B-O O
of B-O O
B-cell-specific B-O B-DNA
genes B-O I-DNA
. B-O O

They B-O O
propose B-O O
that B-O O
BSAP B-O B-protein
is B-O O
a B-O O
key B-O B-protein
protein B-O I-protein
of B-O O
B B-O B-cell_type
cells B-O I-cell_type
and B-O O
that B-O O
it B-O O
not B-O O
only B-O O
influence B-O O
B-cell B-O O
development B-O O
but B-O O
also B-O O
influences B-O O
the B-O O
balance B-O O
between B-O O
B-cell B-O B-cell_type
proliferation B-O O
and B-O O
immunoglobulin B-O B-protein
secretion B-O O
at B-O O
later B-O O
stages B-O O
of B-O O
B-cell B-O O
differentiation B-O O
. B-O O

Down-regulation B-O O
of B-O O
NF-kappa B-O B-protein
B B-O I-protein
protein B-O O
levels B-O O
in B-O O
activated B-O O
human B-O B-cell_type
lymphocytes B-O I-cell_type
by B-O O
1 B-O O
, B-O O
25-dihydroxyvitamin B-O O
D3 B-O O
[ B-O O
published B-O O
erratum B-O O
appears B-O O
in B-O O
Proc B-O O
Natl B-O O
Acad B-O O
Sci B-O O
U B-O O
S B-O O
A B-O O
1996 B-O O
Jan B-O O
9 B-O O
; B-O O
93 B-O O
( B-O O
1 B-O O
) B-O O
: B-O O
524 B-O O
] B-O O

The B-O O
effect B-O O
of B-O O
1 B-O O
, B-O O
25-dihydroxyvitamin B-O O
D3 B-O O
[ B-O O
1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2 B-O O
) B-O O
D3 B-O O
] B-O O
, B-O O
a B-O O
steroid B-O O
hormone B-O O
with B-O O
immunomodulating B-O O
properties B-O O
, B-O O
on B-O O
nuclear B-O B-protein
factor B-O I-protein
kappa B-O I-protein
B B-O I-protein
( B-O O
NF-kappa B-O B-protein
B B-O I-protein
) B-O O
proteins B-O O
was B-O O
examined B-O O
in B-O O
in B-O O
vitro B-O O
activated B-O O
normal B-O O
human B-O O
lymphocytes B-O O
by B-O O
Western B-O O
blot B-O O
analysis B-O O
. B-O O

Over B-O O
a B-O O
72-hr B-O O
period B-O O
of B-O O
activation B-O O
, B-O O
the B-O O
expression B-O O
of B-O O
the B-O O
50-kDa B-O B-protein
NF-kappa B-O I-protein
B B-O I-protein
, B-O O
p50 B-O B-protein
, B-O O
and B-O O
its B-O O
precursor B-O O
, B-O O
p105 B-O B-protein
, B-O O
was B-O O
increased B-O O
progressively B-O O
. B-O O

When B-O O
cells B-O O
were B-O O
activated B-O O
in B-O O
the B-O O
presence B-O O
of B-O O
1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
, B-O O
the B-O O
levels B-O O
of B-O O
the B-O O
mature B-O B-protein
protein B-O I-protein
as B-O O
well B-O O
as B-O O
its B-O O
precursor B-O O
were B-O O
decreased B-O O
. B-O O

The B-O O
effect B-O O
of B-O O
the B-O O
hormone B-O O
on B-O O
the B-O O
levels B-O O
of B-O O
p50 B-O B-protein
was B-O O
demonstrable B-O O
in B-O O
the B-O O
cytosolic B-O O
and B-O O
nuclear B-O O
compartments B-O O
; B-O O
it B-O O
required B-O O
between B-O O
4 B-O O
and B-O O
8 B-O O
hr B-O O
and B-O O
was B-O O
specific B-O O
, B-O O
as B-O O
25-hydroxyvitamin B-O O
D3 B-O O
and B-O O
24 B-O O
, B-O O
25-dihydroxyvitamin B-O O
D3 B-O O
were B-O O
ineffective B-O O
. B-O O

Besides B-O O
p50 B-O B-protein
, B-O O
1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
decreased B-O O
the B-O O
levels B-O O
of B-O O
another B-O O
NF-kappa B-O B-protein
B B-O I-protein
protein B-O I-protein
, B-O O
namely B-O O
c-rel B-O B-protein
. B-O O

In B-O O
addition B-O O
, B-O O
1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
decreased B-O O
the B-O O
abundance B-O O
of B-O O
a B-O O
specific B-O O
DNA-protein B-O B-protein
complex B-O I-protein
formed B-O O
upon B-O O
incubation B-O O
of B-O O
nuclear B-O O
extracts B-O O
from B-O O
activated B-O B-cell_type
lymphocytes B-O I-cell_type
with B-O O
a B-O O
labeled B-O O
NF-kappa B-O B-protein
B B-O I-protein
DNA B-O O
binding B-O O
motif B-O O
. B-O O

Further B-O O
, B-O O
1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
inhibited B-O O
the B-O O
transcriptional B-O O
activity B-O O
of B-O O
NF-kappa B-O B-protein
B B-O I-protein
in B-O O
Jurkat B-O B-cell_line
cells B-O I-cell_line
transiently B-O O
transfected B-O O
with B-O O
a B-O O
construct B-O O
containing B-O O
four B-O O
tandem B-O B-DNA
repeats B-O I-DNA
of B-O O
the B-O O
NF-kappa B-O B-DNA
B B-O I-DNA
binding B-O I-DNA
sequence B-O I-DNA
of B-O O
the B-O O
immunoglobulin B-O B-DNA
kappa B-O I-DNA
light B-O I-DNA
chain B-O I-DNA
gene B-O I-DNA
linked B-O O
to B-O O
the B-O O
chloramphenicol B-O B-DNA
acetyltransferase B-O I-DNA
reporter B-O I-DNA
gene B-O I-DNA
. B-O O

These B-O O
observations B-O O
demonstrate B-O O
directly B-O O
that B-O O
there B-O O
is B-O O
de B-O O
novo B-O O
synthesis B-O O
of B-O O
NF-kappa B-O B-protein
B B-O I-protein
during B-O O
human B-O O
lymphocyte B-O O
activation B-O O
and B-O O
suggest B-O O
that B-O O
this B-O O
process B-O O
is B-O O
hormonally B-O O
regulated B-O O
. B-O O

The B-O O
myeloid B-O B-DNA
zinc B-O I-DNA
finger B-O I-DNA
gene B-O I-DNA
, B-O O
MZF-1 B-O B-DNA
, B-O O
regulates B-O O
the B-O O
CD34 B-O B-DNA
promoter B-O I-DNA
in B-O O
vitro B-O O
. B-O O

MZF-1 B-O B-DNA
is B-O O
a B-O O
C2H2 B-O B-DNA
zinc B-O I-DNA
finger B-O I-DNA
gene B-O I-DNA
encoding B-O O
a B-O O
putative B-O B-protein
transcriptional B-O I-protein
regulator B-O I-protein
of B-O O
myeloid B-O O
differentiation B-O O
. B-O O

The B-O O
MZF-1 B-O B-protein
protein B-O I-protein
contains B-O O
13 B-O O
C2H2 B-O B-protein
zinc B-O I-protein
fingers B-O I-protein
arranged B-O O
in B-O O
bipartite B-O B-protein
DNA B-O I-protein
binding B-O I-protein
domains B-O I-protein
containing B-O O
zinc B-O B-protein
fingers B-O I-protein
through B-O O
4 B-O O
and B-O O
, B-O O
in B-O O
the B-O O
carboxy-terminus B-O B-protein
, B-O O
5 B-O O
through B-O O
13 B-O O
. B-O O

We B-O O
previously B-O O
identified B-O O
the B-O O
DNA B-O B-DNA
consensus B-O I-DNA
binding B-O I-DNA
site B-O I-DNA
recognized B-O O
by B-O O
the B-O O
two B-O O
DNA B-O B-protein
binding B-O I-protein
domains B-O I-protein
. B-O O

To B-O O
assess B-O O
the B-O O
transcription B-O O
regulatory B-O O
function B-O O
of B-O O
MZF-1 B-O B-protein
, B-O O
the B-O O
full-length B-O O
MZF-1 B-O B-DNA
coding B-O O
region B-O O
was B-O O
fused B-O O
to B-O O
the B-O O
DNA B-O B-protein
binding B-O I-protein
domain B-O I-protein
of B-O O
the B-O O
yeast B-O B-protein
transactivator B-O I-protein
GAL4 B-O I-protein
. B-O O

The B-O O
expression B-O O
vector B-O O
was B-O O
cotransfected B-O O
with B-O O
the B-O O
chloramphenicol B-O B-DNA
acetyl B-O I-DNA
transferase B-O I-DNA
( B-O I-DNA
CAT B-O I-DNA
) B-O I-DNA
reporter B-O I-DNA
gene B-O I-DNA
regulated B-O O
by B-O O
the B-O O
thymidine B-O B-DNA
kinase B-O I-DNA
promoter B-O I-DNA
containing B-O O
GAL4 B-O B-DNA
DNA B-O I-DNA
binding B-O I-DNA
sites B-O I-DNA
into B-O O
NIH B-O B-cell_line
3T3 B-O I-cell_line
, B-O O
293 B-O O
, B-O O
K562 B-O B-cell_line
, B-O O
and B-O O
Jurkat B-O B-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
. B-O O

MZF-1 B-O B-DNA
represses B-O O
CAT B-O B-DNA
reporter B-O I-DNA
gene B-O I-DNA
expression B-O O
via B-O O
GAL4 B-O B-DNA
binding B-O I-DNA
sites B-O I-DNA
in B-O O
the B-O O
nonhematopoietic B-O B-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
NIH B-O B-cell_line
3T3 B-O I-cell_line
and B-O O
293 B-O O
. B-O O

In B-O O
contrast B-O O
, B-O O
MZF-1 B-O B-DNA
activates B-O O
CAT B-O B-DNA
reporter B-O I-DNA
gene B-O I-DNA
expression B-O O
in B-O O
the B-O O
hematopoietic B-O B-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
K562 B-O B-cell_line
and B-O O
Jurkat B-O B-cell_line
. B-O O

The B-O O
MZF-1 B-O B-DNA
binding B-O I-DNA
sites B-O I-DNA
are B-O O
present B-O O
in B-O O
the B-O O
promoters B-O B-DNA
of B-O O
several B-O O
genes B-O B-DNA
expressed B-O O
during B-O O
myeloid B-O O
differentiation B-O O
, B-O O
including B-O O
the B-O O
CD34 B-O B-DNA
promoter B-O I-DNA
. B-O O

MZF-1 B-O B-DNA
transcriptional B-O O
regulation B-O O
of B-O O
this B-O O
physiologically B-O B-DNA
relevant B-O I-DNA
promoter B-O I-DNA
was B-O O
assessed B-O O
in B-O O
both B-O O
hematopoietic B-O O
and B-O O
nonhematopoietic B-O B-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
. B-O O

Recombinant B-O B-protein
MZF-1 B-O I-protein
protein B-O I-protein
specifically B-O O
binds B-O O
to B-O O
the B-O O
consensus B-O B-DNA
binding B-O I-DNA
sites B-O I-DNA
in B-O O
the B-O O
CD34 B-O B-DNA
promoter B-O I-DNA
in B-O O
mobility B-O O
shift B-O O
assays B-O O
. B-O O

MZF-1 B-O B-DNA
expression B-O I-DNA
vectors B-O I-DNA
were B-O O
cotransfected B-O O
with B-O O
the B-O O
luciferase B-O B-DNA
reporter B-O I-DNA
plasmids B-O I-DNA
regulated B-O O
by B-O O
the B-O O
CD34 B-O B-DNA
promoter B-O I-DNA
into B-O O
both B-O O
nonhematopoietic B-O O
and B-O O
hematopoietic B-O B-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
. B-O O

As B-O O
with B-O O
the B-O O
heterologous B-O B-protein
DNA B-O I-protein
binding B-O I-protein
domain B-O I-protein
, B-O O
MZF-1 B-O B-DNA
represses B-O O
reporter B-O B-DNA
gene B-O I-DNA
expression B-O O
in B-O O
nonhematopoietic B-O B-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
and B-O O
activates B-O O
expression B-O O
in B-O O
hematopoietic B-O B-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
. B-O O

Activation B-O O
of B-O O
CD34 B-O B-protein
expression B-O O
in B-O O
hematopoietic B-O B-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
is B-O O
dependent B-O O
on B-O O
the B-O O
presence B-O O
of B-O O
intact B-O O
MZF-1 B-O B-DNA
binding B-O I-DNA
sites B-O I-DNA
. B-O O

The B-O O
cell B-O O
type-specific B-O O
regulation B-O O
of B-O O
the B-O O
CD34 B-O B-DNA
promoter B-O I-DNA
by B-O O
MZF-1 B-O B-DNA
suggests B-O O
the B-O O
presence B-O O
of B-O O
tissue-specific B-O O
regulators/adapters B-O O
or B-O O
differential B-O O
MZF-1 B-O B-DNA
modifications B-O O
that B-O O
determine B-O O
MZF-1 B-O B-DNA
transcriptional B-O O
regulatory B-O O
function B-O O
. B-O O

The B-O O
murine B-O B-DNA
BCL6 B-O I-DNA
gene B-O I-DNA
is B-O O
induced B-O O
in B-O O
activated B-O B-cell_type
lymphocytes B-O I-cell_type
as B-O O
an B-O O
immediate B-O B-DNA
early B-O I-DNA
gene B-O I-DNA
. B-O O

The B-O O
chromosomal B-O O
translocation B-O O
involving B-O O
3q27 B-O B-DNA
is B-O O
often B-O O
detected B-O O
in B-O O
human B-O B-cell_type
B-cell B-O I-cell_type
lymphomas B-O I-cell_type
, B-O O
especially B-O O
diffuse B-O O
lymphomas B-O O
with B-O O
a B-O O
large-cell B-O O
component B-O O
. B-O O

The B-O O
BCL6 B-O B-DNA
gene B-O I-DNA
has B-O O
been B-O O
isolated B-O O
from B-O O
the B-O O
chromosomal B-O O
breakpoint B-O O
in B-O O
these B-O O
lymphomas B-O O
. B-O O

Here B-O O
we B-O O
cloned B-O O
the B-O O
murine B-O B-DNA
BCL6 B-O I-DNA
( B-O I-DNA
mBCL6 B-O I-DNA
) B-O I-DNA
cDNA B-O I-DNA
from B-O O
the B-O O
muscle B-O B-DNA
cDNA B-O I-DNA
library B-O I-DNA
using B-O O
the B-O O
human B-O B-DNA
BCL6 B-O I-DNA
( B-O I-DNA
hBCL6 B-O I-DNA
) B-O I-DNA
cDNA B-O I-DNA
as B-O O
a B-O O
probe B-O O
. B-O O

The B-O O
predicted B-O O
amino B-O O
acid B-O O
sequence B-O O
was B-O O
95 B-O O
% B-O O
identical B-O O
to B-O O
that B-O O
of B-O O
hBCL6 B-O B-protein
. B-O O

It B-O O
contains B-O O
six B-O O
repeats B-O O
of B-O O
the B-O O
Kruppel-like B-O B-DNA
zinc-finger B-O I-DNA
motif B-O I-DNA
that B-O O
are B-O O
completely B-O O
identical B-O O
to B-O O
those B-O O
of B-O O
hBCL6 B-O B-protein
, B-O O
indicating B-O O
that B-O O
the B-O O
BCL6 B-O B-DNA
gene B-O I-DNA
is B-O O
well B-O O
conserved B-O O
between B-O O
humans B-O O
and B-O O
mice B-O O
. B-O O

Expression B-O O
of B-O O
the B-O O
mBCL6 B-O B-DNA
gene B-O I-DNA
was B-O O
ubiquitously B-O O
detected B-O O
in B-O O
adult B-O O
mouse B-O O
tissues B-O O
including B-O O
lymphatic B-O O
organs B-O O
. B-O O

Furthermore B-O O
, B-O O
it B-O O
was B-O O
induced B-O O
in B-O O
lymphocytes B-O B-cell_type
activated B-O O
with B-O O
phorbol B-O O
ester B-O O
and B-O O
Ca2+ B-O O
ionophore B-O O
within B-O O
30 B-O O
min B-O O
after B-O O
stimulation B-O O
. B-O O

This B-O O
induction B-O O
was B-O O
not B-O O
inhibited B-O O
by B-O O
treatment B-O O
of B-O O
the B-O O
cells B-O O
with B-O O
a B-O O
protein B-O O
synthesis B-O O
inhibitor B-O O
, B-O O
cycloheximide B-O O
. B-O O

These B-O O
results B-O O
suggest B-O O
that B-O O
BCL6 B-O B-protein
plays B-O O
a B-O O
role B-O O
in B-O O
activated B-O B-cell_type
lymphocytes B-O I-cell_type
as B-O O
an B-O O
immediate B-O B-DNA
early B-O I-DNA
gene B-O I-DNA
. B-O O

The B-O O
role B-O O
of B-O O
BSAP B-O B-protein
( B-O O
Pax-5 B-O B-protein
) B-O O
in B-O O
B-cell B-O O
development B-O O
. B-O O

The B-O O
hierarchy B-O O
of B-O O
transcriptional B-O O
control B-O O
in B-O O
B-cell B-O O
development B-O O
has B-O O
recently B-O O
been B-O O
analyzed B-O O
by B-O O
targeted B-O O
gene B-O O
inactivation B-O O
in B-O O
the B-O O
mouse B-O O
. B-O O

In B-O O
this B-O O
manner B-O O
, B-O O
the B-O O
paired B-O B-DNA
box B-O I-DNA
containing B-O O
gene B-O O
Pax-5 B-O B-DNA
, B-O O
encoding B-O O
the B-O O
B B-O B-protein
cell B-O I-protein
specific B-O I-protein
transcription B-O I-protein
factor B-O I-protein
BSAP B-O B-protein
, B-O O
has B-O O
been B-O O
shown B-O O
to B-O O
play B-O O
a B-O O
key B-O O
role B-O O
in B-O O
early B-O O
B B-O O
lymphopoiesis B-O O
. B-O O

Other B-O O
experimental B-O O
strategies B-O O
have B-O O
implicated B-O O
BSAP B-O B-protein
in B-O O
the B-O O
control B-O O
of B-O O
cell B-O O
proliferation B-O O
, B-O O
isotype B-O O
switching B-O O
and B-O O
transcription B-O O
of B-O O
the B-O O
immunoglobulin B-O B-DNA
heavy-chain B-O I-DNA
gene B-O I-DNA
at B-O O
late B-O O
stages B-O O
of B-O O
B-cell B-O O
differentiation B-O O
. B-O O

The B-O O
DNA-binding B-O O
properties B-O O
of B-O O
two B-O O
heat B-O B-protein
shock B-O I-protein
factors B-O I-protein
, B-O O
HSF1 B-O B-protein
and B-O O
HSF3 B-O B-protein
, B-O O
are B-O O
induced B-O O
in B-O O
the B-O O
avian B-O B-cell_line
erythroblast B-O I-cell_line
cell B-O I-cell_line
line B-O I-cell_line
HD6 B-O B-cell_line
. B-O O

Avian B-O B-cell_type
cells B-O I-cell_type
express B-O O
three B-O O
heat B-O B-DNA
shock B-O I-DNA
transcription B-O I-DNA
factor B-O I-DNA
( B-O I-DNA
HSF B-O I-DNA
) B-O I-DNA
genes B-O I-DNA
corresponding B-O O
to B-O O
a B-O O
novel B-O B-protein
factor B-O I-protein
, B-O O
HSF3 B-O B-protein
, B-O O
and B-O O
homologs B-O O
of B-O O
mouse B-O O
and B-O O
human B-O O
HSF1 B-O B-protein
and B-O O
HSF2 B-O B-protein
. B-O O

Analysis B-O O
of B-O O
the B-O O
biochemical B-O O
and B-O O
cell B-O O
biological B-O O
properties B-O O
of B-O O
these B-O O
HSFs B-O B-protein
reveals B-O O
that B-O O
HSF3 B-O B-protein
has B-O O
properties B-O O
in B-O O
common B-O O
with B-O O
both B-O O
HSF1 B-O B-protein
and B-O O
HSF2 B-O B-protein
and B-O O
yet B-O O
has B-O O
features B-O O
which B-O O
are B-O O
distinct B-O O
from B-O O
both B-O O
. B-O O

HSF3 B-O B-protein
is B-O O
constitutively B-O O
expressed B-O O
in B-O O
the B-O O
erythroblast B-O B-cell_line
cell B-O I-cell_line
line B-O I-cell_line
HD6 B-O I-cell_line
, B-O O
the B-O O
lymphoblast B-O B-cell_line
cell B-O I-cell_line
line B-O I-cell_line
MSB B-O I-cell_line
, B-O O
and B-O O
embryo B-O B-cell_type
fibroblasts B-O I-cell_type
, B-O O
and B-O O
yet B-O O
its B-O O
DNA-binding B-O O
activity B-O O
is B-O O
induced B-O O
only B-O O
upon B-O O
exposure B-O O
of B-O O
HD6 B-O B-cell_line
cells B-O I-cell_line
to B-O O
heat B-O O
shock B-O O
. B-O O

Acquisition B-O O
of B-O O
HSF3 B-O B-protein
DNA-binding B-O O
activity B-O O
in B-O O
HD6 B-O B-cell_line
cells B-O I-cell_line
is B-O O
accompanied B-O O
by B-O O
oligomerization B-O O
from B-O O
a B-O O
non-DNA-binding B-O B-protein
dimer B-O I-protein
to B-O O
a B-O O
DNA-binding B-O B-protein
trimer B-O I-protein
, B-O O
whereas B-O O
the B-O O
effect B-O O
of B-O O
heat B-O O
shock B-O O
on B-O O
HSF1 B-O B-protein
is B-O O
oligomerization B-O O
of B-O O
an B-O O
inert B-O B-protein
monomer B-O I-protein
to B-O O
a B-O O
DNA-binding B-O B-protein
trimer B-O I-protein
. B-O O

Induction B-O O
of B-O O
HSF3 B-O B-protein
DNA-binding B-O O
activity B-O O
is B-O O
delayed B-O O
compared B-O O
with B-O O
that B-O O
of B-O O
HSF1 B-O B-protein
. B-O O

As B-O O
occurs B-O O
for B-O O
HSF1 B-O B-protein
, B-O O
heat B-O O
shock B-O O
leads B-O O
to B-O O
the B-O O
translocation B-O O
of B-O O
HSF3 B-O B-protein
to B-O O
the B-O O
nucleus B-O O
. B-O O

HSF B-O B-protein
exhibits B-O O
the B-O O
properties B-O O
of B-O O
a B-O O
transcriptional B-O B-protein
activator B-O I-protein
, B-O O
as B-O O
judged B-O O
from B-O O
the B-O O
stimulatory B-O O
activity B-O O
of B-O O
transiently B-O O
overexpressed B-O O
HSF3 B-O B-protein
measured B-O O
by B-O O
using B-O O
a B-O O
heat B-O B-DNA
shock B-O I-DNA
element-containing B-O I-DNA
reporter B-O I-DNA
construct B-O I-DNA
and B-O O
as B-O O
independently B-O O
assayed B-O O
by B-O O
the B-O O
activity B-O O
of B-O O
a B-O O
chimeric B-O B-protein
GAL4 B-O I-protein
-HSF3 B-O I-protein
protein B-O I-protein
on B-O O
a B-O O
GAL4 B-O B-DNA
reporter B-O I-DNA
construct B-O I-DNA
. B-O O

These B-O O
results B-O O
reveal B-O O
that B-O O
HSF3 B-O B-protein
is B-O O
negatively B-O O
regulated B-O O
in B-O O
avian B-O B-cell_type
cells B-O I-cell_type
and B-O O
acquires B-O O
DNA-binding B-O O
activity B-O O
in B-O O
certain B-O O
cells B-O O
upon B-O O
heat B-O O
shock B-O O
. B-O O

Direct B-O O
demonstration B-O O
of B-O O
NFATp B-O B-protein
dephosphorylation B-O O
and B-O O
nuclear B-O O
localization B-O O
in B-O O
activated B-O B-cell_line
HT-2 B-O I-cell_line
cells B-O I-cell_line
using B-O O
a B-O O
specific B-O O
NFATp B-O B-protein
polyclonal B-O I-protein
antibody B-O I-protein
. B-O O

Nuclear B-O B-protein
factor B-O I-protein
of B-O I-protein
activated B-O I-protein
T B-O I-protein
cells B-O I-protein
( B-O O
NFAT B-O B-protein
) B-O O
regulates B-O O
transcription B-O O
of B-O O
a B-O O
number B-O O
of B-O O
cytokine B-O B-DNA
genes B-O I-DNA
, B-O O
and B-O O
NFAT B-O B-protein
DNA B-O O
binding B-O O
activity B-O O
is B-O O
stimulated B-O O
following B-O O
T B-O O
cell B-O O
activation B-O O
. B-O O

Several B-O O
lines B-O O
of B-O O
evidence B-O O
have B-O O
suggested B-O O
that B-O O
NFAT B-O B-protein
is B-O O
a B-O O
substrate B-O O
for B-O O
calcineurin B-O B-protein
, B-O O
a B-O O
serine/threonine B-O B-protein
phosphatase B-O I-protein
. B-O O

Using B-O O
a B-O O
polyclonal B-O O
antibody B-O O
to B-O O
murine B-O B-protein
NFATp B-O I-protein
, B-O O
Western B-O O
blot B-O O
analysis B-O O
of B-O O
various B-O O
mouse B-O O
tissues B-O O
demonstrated B-O O
that B-O O
the B-O O
110-130-kDa B-O O
NFATp B-O B-protein
protein B-O I-protein
was B-O O
highly B-O O
expressed B-O O
in B-O O
thymus B-O O
and B-O O
spleen B-O O
. B-O O

Treatment B-O O
of B-O O
immunoprecipitated B-O O
NFATp B-O B-protein
from B-O O
untreated B-O O
HT-2 B-O B-cell_line
cells B-O I-cell_line
with B-O O
calcineurin B-O B-protein
resulted B-O O
in B-O O
the B-O O
dephosphorylation B-O O
of B-O O
NFATp B-O B-protein
, B-O O
demonstrating B-O O
that B-O O
NFATp B-O B-protein
is B-O O
an B-O O
in B-O O
vitro B-O O
substrate B-O O
for B-O O
calcineurin B-O B-protein
. B-O O

NFATp B-O B-protein
immunoprecipitated B-O O
from B-O O
32P-labeled B-O B-cell_line
HT-2 B-O I-cell_line
cells B-O I-cell_line
migrated B-O O
as B-O O
an B-O O
approximately B-O O
120-kDa B-O B-protein
protein B-O I-protein
that B-O O
was B-O O
localized B-O O
to B-O O
the B-O O
cytosol B-O O
of B-O O
the B-O O
cells B-O O
. B-O O

Treatment B-O O
of B-O O
the B-O O
cells B-O O
with B-O O
ionomycin B-O O
resulted B-O O
in B-O O
a B-O O
decrease B-O O
in B-O O
the B-O O
molecular B-O O
weight B-O O
of B-O O
NFATp B-O B-protein
and B-O O
a B-O O
loss B-O O
of B-O O
32P B-O O
, B-O O
consistent B-O O
with B-O O
NFATp B-O B-protein
dephosphorylation B-O O
. B-O O

The B-O O
dephosphorylation B-O O
of B-O O
NFATp B-O B-protein
was B-O O
accompanied B-O O
by B-O O
localization B-O O
of B-O O
the B-O O
protein B-O O
to B-O O
the B-O O
nuclear B-O O
fraction B-O O
. B-O O

Both B-O O
of B-O O
these B-O O
events B-O O
were B-O O
blocked B-O O
by B-O O
preincubation B-O O
of B-O O
the B-O O
cells B-O O
with B-O O
FK506 B-O O
, B-O O
a B-O O
calcineurin B-O B-protein
inhibitor B-O O
, B-O O
consistent B-O O
with B-O O
the B-O O
hypothesis B-O O
that B-O O
NFATp B-O B-protein
is B-O O
a B-O O
calcineurin B-O B-protein
substrate B-O O
in B-O O
cells B-O O
. B-O O

Activation B-O O
and B-O O
expression B-O O
of B-O O
the B-O O
nuclear B-O B-protein
factors B-O I-protein
of B-O I-protein
activated B-O I-protein
T B-O I-protein
cells B-O I-protein
, B-O O
NFATp B-O B-protein
and B-O O
NFATc B-O B-protein
, B-O O
in B-O O
human B-O B-cell_type
natural B-O I-cell_type
killer B-O I-cell_type
cells B-O I-cell_type
: B-O O
regulation B-O O
upon B-O O
CD16 B-O B-protein
ligand B-O I-protein
binding B-O O
. B-O O

The B-O O
putative B-O B-protein
factors B-O I-protein
that B-O O
couple B-O O
the B-O O
signal B-O O
transduction B-O O
from B-O O
surface B-O B-protein
receptors B-O I-protein
to B-O O
the B-O O
activation B-O O
of B-O O
cytokine B-O B-protein
synthesis B-O O
in B-O O
natural B-O B-cell_type
killer B-O I-cell_type
( B-O I-cell_type
NK B-O I-cell_type
) B-O I-cell_type
cells B-O I-cell_type
have B-O O
not B-O O
been B-O O
elucidated B-O O
. B-O O

We B-O O
report B-O O
here B-O O
that B-O O
the B-O O
nuclear B-O B-protein
factor B-O I-protein
of B-O I-protein
activated B-O I-protein
T B-O I-protein
cells B-O I-protein
( B-O O
NFATp B-O B-protein
) B-O O
, B-O O
a B-O O
cyclosporin B-O B-protein
A B-O I-protein
( B-O I-protein
CsA B-O I-protein
) B-O I-protein
-sensitive B-O I-protein
factor B-O I-protein
that B-O O
regulates B-O O
the B-O O
transcription B-O O
of B-O O
several B-O O
cytokines B-O B-protein
, B-O O
mediates B-O O
CD16 B-O B-protein
-induced B-O O
activation B-O O
of B-O O
cytokine B-O B-DNA
genes B-O I-DNA
in B-O O
human B-O B-cell_type
NK B-O I-cell_type
cells B-O I-cell_type
. B-O O

CD16 B-O B-protein
( B-O O
Fc B-O B-protein
gamma B-O I-protein
RIIIA B-O I-protein
) B-O O
-induced B-O O
expression B-O O
of B-O O
cytokine B-O B-RNA
mRNA B-O I-RNA
in B-O O
NK B-O B-cell_type
cells B-O I-cell_type
occurs B-O O
via B-O O
a B-O O
CsA B-O O
-sensitive B-O O
and B-O O
Ca B-O O
( B-O O
2+ B-O O
) B-O O
-dependent B-O O
mechanism B-O O
. B-O O

Stimulation B-O O
of B-O O
NK B-O B-cell_type
cells B-O I-cell_type
with B-O O
CD16 B-O B-protein
ligands B-O I-protein
induces B-O O
NFAT B-O B-protein
-like B-O O
DNA B-O O
binding B-O O
activity B-O O
in B-O O
the B-O O
nuclear B-O O
extracts B-O O
from B-O O
these B-O O
cells B-O O
, B-O O
as B-O O
detected B-O O
in B-O O
electrophoretic B-O O
mobility B-O O
shift B-O O
assays B-O O
. B-O O

This B-O O
occurs B-O O
with B-O O
fast B-O O
kinetics B-O O
after B-O O
stimulation B-O O
, B-O O
via B-O O
a B-O O
CsA B-O O
-sensitive B-O O
and B-O O
Ca B-O O
( B-O O
2+ B-O O
) B-O O
-dependent B-O O
mechanism B-O O
that B-O O
does B-O O
not B-O O
require B-O O
de B-O O
novo B-O O
protein B-O O
synthesis B-O O
. B-O O

NK B-O B-protein
cell B-O I-protein
NFAT B-O I-protein
is B-O O
present B-O O
in B-O O
the B-O O
cytosol B-O O
of B-O O
nonstimulated B-O B-cell_type
cells B-O I-cell_type
, B-O O
migrates B-O O
to B-O O
the B-O O
nucleus B-O O
upon B-O O
stimulation B-O O
, B-O O
and B-O O
can B-O O
associate B-O O
with B-O O
AP-1 B-O B-protein
. B-O O

Two B-O O
distinct B-O O
molecules B-O O
, B-O O
NFATp B-O B-protein
and B-O O
NFATc B-O B-protein
, B-O O
have B-O O
been B-O O
reported B-O O
to B-O O
mediate B-O O
NFAT B-O B-protein
activity B-O O
. B-O O

The B-O O
results B-O O
of B-O O
supershift B-O O
assays B-O O
using B-O O
NFATp- B-O B-protein
and B-O I-protein
NFATc- B-O I-protein
specific B-O I-protein
antibodies B-O I-protein
indicate B-O O
that B-O O
NK B-O O
cell B-O O
activation B-O O
early B-O O
after B-O O
CD16 B-O B-protein
ligand B-O O
binding B-O O
involves B-O O
primarily B-O O
, B-O O
if B-O O
not B-O O
exclusively B-O O
, B-O O
NFATp B-O B-protein
, B-O O
and B-O O
Western B-O O
blot B-O O
analysis B-O O
shows B-O O
that B-O O
this B-O O
has B-O O
the B-O O
same B-O O
electrophoretic B-O O
mobility B-O O
( B-O O
approximately B-O O
120 B-O O
kD B-O O
) B-O O
as B-O O
that B-O O
of B-O O
T B-O B-cell_type
lymphocytes B-O I-cell_type
. B-O O

NK B-O B-cell_type
cells B-O I-cell_type
do B-O O
not B-O O
express B-O O
NFATc B-O B-protein
constitutively B-O O
, B-O O
but B-O O
NFATc B-O B-RNA
mRNA B-O I-RNA
accumulation B-O O
is B-O O
induced B-O O
in B-O O
these B-O O
cells B-O O
within B-O O
2 B-O O
h B-O O
of B-O O
stimulation B-O O
with B-O O
CD16 B-O B-protein
ligands B-O I-protein
. B-O O

However B-O O
, B-O O
supershift B-O O
assays B-O O
using B-O O
the B-O O
available B-O O
mAb B-O B-protein
recognizing B-O O
the B-O O
T B-O B-protein
cell B-O I-protein
NFATc B-O I-protein
revealed B-O O
no B-O O
detectable B-O O
NFATc B-O B-protein
protein B-O I-protein
in B-O O
nuclear B-O O
and B-O O
cytoplasmic B-O O
extracts B-O O
from B-O O
CD16- B-O O
or B-O O
phorbol B-O B-cell_line
ester B-O I-cell_line
-stimulated B-O I-cell_line
cells B-O I-cell_line
at B-O O
any B-O O
time B-O O
tested B-O O
, B-O O
up B-O O
to B-O O
4 B-O O
h B-O O
. B-O O

These B-O O
results B-O O
provide B-O O
the B-O O
first B-O O
direct B-O O
evidence B-O O
that B-O O
both B-O O
CsA B-O B-protein
-sensitive B-O I-protein
transcription B-O I-protein
factors B-O I-protein
, B-O O
NFATp B-O B-protein
and B-O O
NFATc B-O B-protein
, B-O O
are B-O O
expressed B-O O
in B-O O
human B-O B-cell_type
NK B-O I-cell_type
cells B-O I-cell_type
, B-O O
and B-O O
that B-O O
their B-O O
activation B-O O
and/or B-O O
expression B-O O
can B-O O
be B-O O
regulated B-O O
in B-O O
primary B-O B-cell_type
cells B-O I-cell_type
by B-O O
a B-O O
single B-O O
stimulus B-O O
, B-O O
that B-O O
, B-O O
in B-O O
the B-O O
case B-O O
of B-O O
CD16 B-O B-protein
in B-O O
NK B-O B-cell_type
cells B-O I-cell_type
, B-O O
results B-O O
in B-O O
early B-O O
activation B-O O
of B-O O
NFATp B-O B-protein
and B-O O
subsequently B-O O
induced B-O O
expression B-O O
of B-O O
NFATc B-O B-RNA
mRNA B-O I-RNA
. B-O O

Interleukin B-O B-protein
2 B-O I-protein
signaling B-O O
involves B-O O
the B-O O
phosphorylation B-O O
of B-O O
Stat B-O B-protein
proteins B-O I-protein
. B-O O

One B-O O
of B-O O
the B-O O
most B-O O
important B-O O
cytokines B-O B-protein
involved B-O O
in B-O O
immune B-O O
response B-O O
regulation B-O O
is B-O O
interleukin B-O B-protein
2 B-O I-protein
( B-O O
IL-2 B-O B-protein
) B-O O
, B-O O
a B-O O
potent B-O O
activator B-O O
of B-O O
the B-O O
proliferation B-O O
and B-O O
function B-O O
of B-O O
T B-O B-cell_type
lymphocytes B-O I-cell_type
and B-O O
natural B-O B-cell_type
killer B-O I-cell_type
cells B-O I-cell_type
. B-O O

The B-O O
mechanisms B-O O
by B-O O
which B-O O
the B-O O
effects B-O O
of B-O O
IL-2 B-O B-protein
are B-O O
propagated B-O O
within B-O O
cells B-O O
are B-O O
not B-O O
understood B-O O
. B-O O

While B-O O
the B-O O
binding B-O O
of B-O O
IL-2 B-O B-protein
to B-O O
its B-O O
receptor B-O O
was B-O O
recently B-O O
shown B-O O
to B-O O
lead B-O O
to B-O O
the B-O O
activation B-O O
of B-O O
two B-O O
kinases B-O O
, B-O O
Jak-1 B-O B-protein
and B-O O
Jak-3 B-O B-protein
, B-O O
subsequent B-O O
steps B-O O
in B-O O
the B-O O
signaling B-O O
pathway B-O O
to B-O O
the B-O O
nucleus B-O O
that B-O O
lead B-O O
to B-O O
the B-O O
activation B-O O
of B-O O
specific B-O O
genes B-O O
had B-O O
not B-O O
been B-O O
characterized B-O O
. B-O O

Since B-O O
many B-O O
cytokines B-O B-protein
that B-O O
activate B-O O
Jak B-O B-protein
kinases B-O I-protein
also B-O O
lead B-O O
to B-O O
the B-O O
tyrosine B-O O
phosphorylation B-O O
and B-O O
activation B-O O
of B-O O
members B-O O
of B-O O
the B-O O
Stat B-O B-protein
family B-O I-protein
of B-O O
transcription B-O B-protein
factors B-O I-protein
, B-O O
the B-O O
ability B-O O
of B-O O
IL-2 B-O B-protein
to B-O O
trigger B-O O
Stat B-O B-protein
phosphorylation B-O O
was B-O O
examined B-O O
. B-O O

Exposure B-O O
of B-O O
activated B-O B-cell_type
human B-O I-cell_type
T B-O I-cell_type
lymphocytes B-O I-cell_type
or B-O O
of B-O O
a B-O O
natural B-O B-cell_line
killer B-O I-cell_line
cell B-O I-cell_line
line B-O I-cell_line
( B-O O
NKL B-O B-cell_line
) B-O O
to B-O O
IL-2 B-O B-protein
leads B-O O
to B-O O
the B-O O
phosphorylation B-O O
of B-O O
Stat1 B-O B-protein
alpha B-O I-protein
, B-O O
Stat1 B-O B-protein
beta B-O I-protein
, B-O O
and B-O O
Stat3 B-O B-protein
, B-O O
as B-O O
well B-O O
as B-O O
of B-O O
two B-O O
Stat-related B-O B-protein
proteins B-O I-protein
, B-O O
p94 B-O B-protein
and B-O O
p95 B-O B-protein
. B-O O

p94 B-O B-protein
and B-O O
p95 B-O B-protein
share B-O O
homology B-O O
with B-O O
Stat1 B-O B-protein
at B-O O
the B-O O
phosphorylation B-O B-DNA
site B-O I-DNA
and B-O O
in B-O O
the B-O O
Src B-O B-protein
homology B-O I-protein
2 B-O I-protein
( B-O I-protein
SH2 B-O I-protein
) B-O I-protein
domain B-O I-protein
, B-O O
but B-O O
otherwise B-O O
are B-O O
immunologically B-O O
distinct B-O O
from B-O O
Stat1 B-O B-protein
. B-O O

These B-O O
Stat B-O B-protein
proteins B-O I-protein
were B-O O
found B-O O
to B-O O
translocate B-O O
to B-O O
the B-O O
nucleus B-O O
and B-O O
to B-O O
bind B-O O
to B-O O
a B-O O
specific B-O B-DNA
DNA B-O I-DNA
sequence B-O I-DNA
. B-O O

These B-O O
findings B-O O
suggest B-O O
a B-O O
mechanism B-O O
by B-O O
which B-O O
IL-2 B-O B-protein
binding B-O O
to B-O O
its B-O O
receptor B-O O
may B-O O
activate B-O O
specific B-O B-DNA
genes B-O I-DNA
involved B-O O
in B-O O
immune B-O B-cell_type
cell B-O I-cell_type
function B-O O
. B-O O

Expression B-O O
of B-O O
c-fos B-O B-DNA
correlates B-O O
with B-O O
IFN-alpha B-O B-protein
responsiveness B-O O
in B-O O
Philadelphia B-O O
chromosome B-O O
positive B-O O
chronic B-O O
myelogenous B-O O
leukemia B-O O
. B-O O

This B-O O
study B-O O
evaluates B-O O
( B-O O
i B-O O
) B-O O
constitutive B-O O
levels B-O O
of B-O O
oncogene B-O B-DNA
and B-O O
p53 B-O B-RNA
transcripts B-O I-RNA
in B-O O
chronic B-O O
phase B-O O
CML B-O O
patients B-O O
and B-O O
( B-O O
ii B-O O
) B-O O
their B-O O
modulations B-O O
subsequent B-O O
to B-O O
in B-O O
vivo B-O O
therapy B-O O
with B-O O
rIFN-alpha B-O B-protein
2c B-O I-protein
. B-O O

Peripheral B-O B-cell_type
blood B-O I-cell_type
mononuclear B-O I-cell_type
cells B-O I-cell_type
( B-O O
pbmc B-O B-cell_type
) B-O O
and B-O O
bone B-O B-cell_type
marrow B-O I-cell_type
cells B-O I-cell_type
of B-O O
26 B-O O
patients B-O O
were B-O O
examined B-O O
for B-O O
c-fos B-O B-DNA
, B-O O
c-myc B-O B-DNA
, B-O O
p53 B-O B-protein
and B-O O
the B-O O
hybrid B-O O
bcr/abl B-O O
mRNA B-O O
levels B-O O
. B-O O

Results B-O O
indicated B-O O
that B-O O
( B-O O
i B-O O
) B-O O
constitutive B-O O
c-fos B-O B-RNA
transcript B-O I-RNA
levels B-O O
are B-O O
significantly B-O O
higher B-O O
in B-O O
patients B-O O
subsequently B-O O
responding B-O O
to B-O O
IFN-alpha B-O B-protein
therapy B-O O
( B-O O
p B-O O
& B-O O
lt B-O O
; B-O O
0.01 B-O O
) B-O O
and B-O O
positively B-O O
correlated B-O O
with B-O O
the B-O O
proportion B-O O
of B-O O
lymphocytes B-O B-cell_type
( B-O O
r B-O O
= B-O O
0.6895 B-O O
, B-O O
p B-O O
& B-O O
lt B-O O
; B-O O
0.01 B-O O
) B-O O
and B-O O
negatively B-O O
with B-O O
the B-O O
proportion B-O O
of B-O O
immature B-O B-cell_type
cells B-O I-cell_type
( B-O O
r B-O O
= B-O O
-0.568 B-O O
, B-O O
p B-O O
& B-O O
lt B-O O
; B-O O
0.01 B-O O
) B-O O
contained B-O O
in B-O O
the B-O O
pbmc B-O B-cell_type
preparations B-O O
tested B-O O
, B-O O
( B-O O
ii B-O O
) B-O O
constitutive B-O B-RNA
mRNA B-O I-RNA
levels B-O O
of B-O O
the B-O O
hybrid B-O B-DNA
bcr/abl B-O I-DNA
, B-O O
c-myc B-O B-DNA
and B-O O
p53 B-O B-protein
are B-O O
positively B-O O
correlated B-O O
with B-O O
each B-O O
other B-O O
, B-O O
but B-O O
failed B-O O
to B-O O
relate B-O O
to B-O O
disease B-O O
parameters B-O O
, B-O O
and B-O O
( B-O O
iii B-O O
) B-O O
acute B-O O
and B-O O
chronic B-O O
in B-O O
vivo B-O O
exposure B-O O
to B-O O
IFN-alpha B-O B-protein
is B-O O
accompanied B-O O
by B-O O
upregulation B-O O
of B-O O
c-fos B-O B-DNA
and B-O O
downregulation B-O O
of B-O O
c-myc B-O B-RNA
mRNA B-O I-RNA
levels B-O O
in B-O O
responder B-O O
patients B-O O
. B-O O

Menopause B-O O
is B-O O
associated B-O O
with B-O O
a B-O O
significant B-O O
increase B-O O
in B-O O
blood B-O B-cell_type
monocyte B-O I-cell_type
number B-O O
and B-O O
a B-O O
relative B-O O
decrease B-O O
in B-O O
the B-O O
expression B-O O
of B-O O
estrogen B-O B-protein
receptors B-O I-protein
in B-O O
human B-O B-cell_type
peripheral B-O I-cell_type
monocytes B-O I-cell_type
. B-O O

PROBLEM B-O O
: B-O O
The B-O O
clinical B-O O
significance B-O O
of B-O O
the B-O O
differential B-O O
expression B-O O
of B-O O
estrogen B-O B-protein
receptor B-O I-protein
( B-O O
ER B-O B-protein
) B-O O
in B-O O
human B-O B-cell_type
monocytes B-O I-cell_type
was B-O O
evaluated B-O O
. B-O O

METHOD B-O O
: B-O O
Two B-O O
color B-O O
flow B-O O
cytometry B-O O
analysis B-O O
was B-O O
used B-O O
on B-O O
peripheral B-O O
blood B-O O
samples B-O O
of B-O O
young B-O O
and B-O O
postmenopausal B-O O
females B-O O
and B-O O
postmenopausal B-O O
females B-O O
treated B-O O
with B-O O
estrogen B-O O
replacement B-O O
therapy B-O O
. B-O O

In B-O O
addition B-O O
, B-O O
the B-O O
monocyte B-O B-cell_type
and B-O O
lymphocyte B-O O
counts B-O O
and B-O O
the B-O O
blood B-O O
estrogen B-O O
levels B-O O
of B-O O
each B-O O
patient B-O O
were B-O O
determine B-O O
. B-O O

RESULTS B-O O
: B-O O
During B-O O
menopause B-O O
there B-O O
is B-O O
a B-O O
significant B-O O
decrease B-O O
in B-O O
the B-O O
percentage B-O O
of B-O O
ER B-O B-cell_type
positive B-O I-cell_type
monocytes B-O I-cell_type
, B-O O
and B-O O
an B-O O
increase B-O O
in B-O O
blood B-O B-cell_type
monocyte B-O I-cell_type
number B-O O
, B-O O
which B-O O
declines B-O O
following B-O O
estrogen B-O O
replacement B-O O
therapy B-O O
to B-O O
values B-O O
of B-O O
the B-O O
young B-O O
. B-O O

CONCLUSIONS B-O O
: B-O O
These B-O O
findings B-O O
suggest B-O O
that B-O O
estrogen B-O O
modulates B-O O
the B-O O
monocyte B-O O
numbers B-O O
and B-O O
its B-O O
effects B-O O
may B-O O
be B-O O
mediated B-O O
through B-O O
the B-O O
ER B-O B-protein
in B-O O
the B-O O
monocytes B-O B-cell_type
. B-O O

Staphylococcal B-O B-protein
enterotoxins B-O I-protein
modulate B-O O
interleukin B-O B-protein
2 B-O I-protein
receptor B-O I-protein
expression B-O O
and B-O O
ligand-induced B-O O
tyrosine B-O O
phosphorylation B-O O
of B-O O
the B-O O
Janus B-O B-protein
protein- B-O I-protein
tyrosine B-O I-protein
kinase B-O I-protein
3 B-O I-protein
( B-O O
Jak3 B-O B-protein
) B-O O
and B-O O
signal B-O B-protein
transducers B-O I-protein
and B-O I-protein
activators B-O I-protein
of B-O I-protein
transcription B-O I-protein
( B-O O
Stat B-O B-protein
proteins B-O I-protein
) B-O O
. B-O O

Staphylococcal B-O B-protein
enterotoxins B-O I-protein
( B-O O
SE B-O B-protein
) B-O O
stimulate B-O O
T B-O B-cell_type
cells B-O I-cell_type
expressing B-O O
the B-O O
appropriate B-O O
variable B-O O
region B-O O
beta B-O O
chain B-O O
of B-O O
( B-O O
V B-O O
beta B-O O
) B-O O
T-cell B-O B-protein
receptors B-O I-protein
and B-O O
have B-O O
been B-O O
implicated B-O O
in B-O O
the B-O O
pathogenesis B-O O
of B-O O
several B-O O
autoimmune B-O O
diseases B-O O
. B-O O

Depending B-O O
on B-O O
costimulatory B-O O
signals B-O O
, B-O O
SE B-O B-protein
induce B-O O
either B-O O
proliferation B-O O
or B-O O
anergy B-O O
in B-O O
T B-O B-cell_type
cells B-O I-cell_type
. B-O O

In B-O O
addition B-O O
, B-O O
SE B-O B-protein
can B-O O
induce B-O O
an B-O O
interleukin-2 B-O B-protein
( B-O O
IL-2 B-O B-protein
) B-O O
nonresponsive B-O O
state B-O O
and B-O O
apoptosis B-O O
. B-O O

Here B-O O
, B-O O
we B-O O
show B-O O
that B-O O
SE B-O B-protein
induce B-O O
dynamic B-O O
changes B-O O
in B-O O
the B-O O
expression B-O O
of B-O O
and B-O O
signal B-O O
transduction B-O O
through B-O O
the B-O O
IL-2 B-O B-protein
receptor B-O I-protein
( B-O O
IL-2R B-O B-protein
) B-O O
beta B-O O
and B-O O
gamma B-O B-protein
chains B-O I-protein
( B-O O
IL-2R B-O B-protein
beta B-O I-protein
and B-O O
IL-2R B-O B-protein
gamma B-O I-protein
) B-O O
in B-O O
human B-O B-cell_line
antigen-specific B-O I-cell_line
CD4+ B-O I-cell_line
T-cell B-O I-cell_line
lines B-O I-cell_line
. B-O O

Thus B-O O
, B-O O
after B-O O
4 B-O O
hr B-O O
of B-O O
exposure B-O O
to B-O O
SEA B-O B-protein
and B-O O
SEB B-O B-protein
, B-O O
the B-O O
expression B-O O
of B-O O
IL-2R B-O B-protein
beta B-O I-protein
was B-O O
down-regulated B-O O
, B-O O
IL-2R B-O B-protein
gamma B-O I-protein
was B-O O
slightly B-O O
up-regulated B-O O
, B-O O
while B-O O
IL-2R B-O B-protein
alpha B-O I-protein
remained B-O O
largely B-O O
unaffected B-O O
. B-O O

The B-O O
changes B-O O
in B-O O
the B-O O
composition B-O O
of B-O O
IL-2Rs B-O B-protein
were B-O O
accompanied B-O O
by B-O O
inhibition B-O O
of B-O O
IL-2 B-O B-protein
-induced B-O O
tyrosine B-O O
phosphorylation B-O O
of B-O O
the B-O O
Janus B-O B-protein
protein- B-O I-protein
tyrosine B-O I-protein
kinase B-O I-protein
3 B-O I-protein
( B-O O
Jak3 B-O B-protein
) B-O O
and B-O O
signal B-O B-protein
transducers B-O I-protein
and B-O I-protein
activators B-O I-protein
of B-O I-protein
transcription B-O I-protein
called B-O O
Stat3 B-O B-protein
and B-O O
Stat5 B-O B-protein
. B-O O

In B-O O
parallel B-O O
experiments B-O O
, B-O O
IL-2 B-O B-protein
-driven B-O O
proliferation B-O O
was B-O O
inhibited B-O O
significantly B-O O
. B-O O

After B-O O
16 B-O O
hr B-O O
of B-O O
exposure B-O O
to B-O O
SE B-O B-protein
, B-O O
the B-O O
expression B-O O
of B-O O
IL-2R B-O B-protein
beta B-O I-protein
remained B-O O
low B-O O
, B-O O
while B-O O
that B-O O
of B-O O
IL2R B-O B-protein
alpha B-O I-protein
and B-O O
IL2R B-O B-protein
gamma B-O I-protein
was B-O O
further B-O O
up-regulated B-O O
, B-O O
and B-O O
ligand-induced B-O O
tyrosine B-O O
phosphorylation B-O O
of B-O O
Jak3 B-O B-protein
and B-O O
Stat B-O B-protein
proteins B-O I-protein
was B-O O
partly B-O O
normalized B-O O
. B-O O

Yet B-O O
, B-O O
IL-2 B-O B-protein
-driven B-O O
proliferation B-O O
remained B-O O
profoundly B-O O
inhibited B-O O
, B-O O
suggesting B-O O
that B-O O
signaling B-O O
events B-O O
other B-O O
than B-O O
Jak3 B-O B-protein
/Stat B-O B-protein
activation B-O O
had B-O O
also B-O O
been B-O O
changed B-O O
following B-O O
SE B-O B-protein
stimulation B-O O
. B-O O

In B-O O
conclusion B-O O
, B-O O
our B-O O
data B-O O
suggest B-O O
that B-O O
SE B-O B-protein
can B-O O
modulate B-O O
IL-2R B-O B-protein
expression B-O O
and B-O O
signal B-O O
transduction B-O O
involving B-O O
the B-O O
Jak/Stat B-O B-protein
pathway B-O O
in B-O O
CD4+ B-O B-cell_line
T-cell B-O I-cell_line
lines B-O I-cell_line
. B-O O

Constitutive B-O O
NF-kappa B-O B-protein
B B-O I-protein
activation B-O O
, B-O O
enhanced B-O O
granulopoiesis B-O O
, B-O O
and B-O O
neonatal B-O O
lethality B-O O
in B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
alpha B-O I-protein
-deficient B-O O
mice B-O O
. B-O O

Transcription B-O B-protein
factors B-O I-protein
belonging B-O O
to B-O O
the B-O O
NF-kappa B-O B-protein
B B-O I-protein
family B-O I-protein
are B-O O
controlled B-O O
by B-O O
inhibitory B-O B-protein
I B-O I-protein
kappa B-O I-protein
B B-O I-protein
proteins B-O I-protein
, B-O O
mainly B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
alpha B-O I-protein
and B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
beta B-O I-protein
. B-O O

Apparently B-O O
normal B-O O
at B-O O
birth B-O O
, B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
alpha B-O I-protein
-/- B-O O
mice B-O O
exhibit B-O O
severe B-O O
runting B-O O
, B-O O
skin B-O O
defects B-O O
, B-O O
and B-O O
extensive B-O O
granulopoiesis B-O O
postnatally B-O O
, B-O O
typically B-O O
dying B-O O
by B-O O
8 B-O O
days B-O O
. B-O O

Hematopoietic B-O O
tissues B-O O
from B-O O
these B-O O
mice B-O O
display B-O O
elevated B-O O
levels B-O O
of B-O O
both B-O O
nuclear B-O B-protein
NF-kappa B-O I-protein
B B-O I-protein
and B-O O
mRNAs B-O B-RNA
of B-O O
some B-O O
, B-O O
but B-O O
not B-O O
all B-O O
, B-O O
genes B-O O
thought B-O O
to B-O O
be B-O O
regulated B-O O
by B-O O
NF-kappa B-O B-protein
B B-O I-protein
. B-O O

NF-kappa B-O B-protein
B B-O I-protein
elevation B-O O
results B-O O
in B-O O
these B-O O
phenotypic B-O O
abnormalities B-O O
because B-O O
mice B-O O
lacking B-O O
both B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
alpha B-O I-protein
and B-O O
the B-O O
p50 B-O B-protein
subunit B-O I-protein
of B-O O
NF-kappa B-O B-protein
B B-O I-protein
show B-O O
a B-O O
dramatically B-O O
delayed B-O O
onset B-O O
of B-O O
abnormalities B-O O
. B-O O

In B-O O
contrast B-O O
to B-O O
hematopoietic B-O B-cell_type
cells B-O I-cell_type
, B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
alpha B-O I-protein
-/- B-O O
embryonic B-O B-cell_type
fibroblasts B-O I-cell_type
show B-O O
minimal B-O O
constitutive B-O O
NF-kappa B-O B-protein
B B-O I-protein
, B-O O
as B-O O
well B-O O
as B-O O
normal B-O O
signal-dependent B-O O
NF-kappa B-O B-protein
B B-O I-protein
activation B-O O
that B-O O
is B-O O
concomitant B-O O
with B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
beta B-O I-protein
degradation B-O O
. B-O O

Our B-O O
results B-O O
indicate B-O O
that B-O O
I B-O B-protein
kappa B-O I-protein
b B-O I-protein
beta B-O I-protein
, B-O O
but B-O O
not B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
alpha B-O I-protein
, B-O O
is B-O O
required B-O O
for B-O O
the B-O O
signal-dependent B-O O
activation B-O O
of B-O O
NF-kappa B-O B-protein
B B-O I-protein
in B-O O
fibroblasts B-O B-cell_type
. B-O O

However B-O O
, B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
alpha B-O I-protein
is B-O O
required B-O O
for B-O O
the B-O O
postinduction B-O O
repression B-O O
of B-O O
NF-kappa B-O B-protein
B B-O I-protein
in B-O O
fibroblasts B-O B-cell_type
. B-O O

These B-O O
results B-O O
define B-O O
distinct B-O O
roles B-O O
for B-O O
the B-O O
two B-O O
forms B-O O
of B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
and B-O O
demonstrate B-O O
the B-O O
necessity B-O O
for B-O O
stringent B-O O
control B-O O
of B-O O
NF-kappa B-O B-protein
B B-O I-protein
. B-O O

Interleukin-7 B-O B-protein
can B-O O
induce B-O O
the B-O O
activation B-O O
of B-O O
Jak B-O B-protein
1 B-O I-protein
, B-O O
Jak B-O B-protein
3 B-O I-protein
and B-O O
STAT B-O B-protein
5 B-O I-protein
proteins B-O I-protein
in B-O O
murine B-O B-cell_type
T B-O I-cell_type
cells B-O I-cell_type
. B-O O

The B-O O
activation B-O O
of B-O O
Janus B-O B-protein
protein B-O I-protein
tyrosine B-O I-protein
kinases B-O I-protein
( B-O O
Jak B-O B-protein
) B-O O
and B-O O
STAT B-O B-protein
( B-O O
signal B-O O
transducer B-O O
and B-O O
activator B-O O
of B-O O
transcription B-O O
) B-O O
proteins B-O O
has B-O O
recently B-O O
been B-O O
linked B-O O
to B-O O
the B-O O
signal B-O O
transduction B-O O
mechanism B-O O
of B-O O
several B-O O
cytokines B-O B-protein
. B-O O

IL-7 B-O B-protein
was B-O O
observed B-O O
to B-O O
induce B-O O
a B-O O
rapid B-O O
and B-O O
dose-dependent B-O O
tyrosine B-O O
phosphorylation B-O O
of B-O O
Jak B-O B-protein
1 B-O I-protein
and B-O O
Jak B-O B-protein
3 B-O I-protein
and B-O O
concomitantly B-O O
, B-O O
the B-O O
tyrosine B-O O
phosphorylation B-O O
and B-O O
DNA B-O O
binding B-O O
activity B-O O
of B-O O
multiple B-O O
STAT B-O B-protein
proteins B-O I-protein
. B-O O

The B-O O
STAT B-O B-protein
proteins B-O I-protein
utilized B-O O
by B-O O
IL-7 B-O B-protein
were B-O O
identical B-O O
to B-O O
those B-O O
induced B-O O
by B-O O
IL-2 B-O B-protein
and B-O O
could B-O O
be B-O O
identified B-O O
as B-O O
various B-O O
STAT B-O B-protein
5 B-O I-protein
isoforms B-O I-protein
. B-O O

Moreover B-O O
, B-O O
the B-O O
induction B-O O
of B-O O
both B-O O
Jak B-O B-protein
1 B-O I-protein
and B-O I-protein
3 B-O I-protein
, B-O O
and B-O O
STAT B-O B-protein
5 B-O I-protein
activity B-O O
strongly B-O O
correlated B-O O
with B-O O
the B-O O
growth-promoting B-O O
effects B-O O
of B-O O
IL-7 B-O B-protein
, B-O O
suggesting B-O O
that B-O O
this B-O O
signal B-O O
transduction B-O O
mechanism B-O O
may B-O O
play B-O O
a B-O O
key B-O O
role B-O O
in B-O O
IL-7 B-O B-protein
-induced B-O O
proliferation B-O O
. B-O O

Cytokine B-O B-protein
-modulating B-O O
activity B-O O
of B-O O
tepoxalin B-O O
, B-O O
a B-O O
new B-O O
potential B-O O
antirheumatic B-O O
. B-O O

Tepoxalin B-O O
is B-O O
a B-O O
new B-O O
dual B-O O
cyclooxygenase/5-lipoxygenase B-O O
anti-inflammatory B-O O
compound B-O O
currently B-O O
under B-O O
clinical B-O O
investigation B-O O
. B-O O

It B-O O
has B-O O
been B-O O
shown B-O O
to B-O O
possess B-O O
anti-inflammatory B-O O
activity B-O O
in B-O O
a B-O O
variety B-O O
of B-O O
animal B-O O
models B-O O
and B-O O
more B-O O
recently B-O O
to B-O O
inhibit B-O O
IL-2 B-O B-protein
induced B-O O
signal B-O O
transduction B-O O
. B-O O

The B-O O
current B-O O
study B-O O
was B-O O
conducted B-O O
to B-O O
evaluate B-O O
the B-O O
cytokine B-O B-protein
modulating B-O O
activity B-O O
of B-O O
tepoxalin B-O O
and B-O O
the B-O O
role B-O O
of B-O O
iron B-O O
in B-O O
these B-O O
effects B-O O
. B-O O

In B-O O
human B-O B-cell_type
peripheral B-O I-cell_type
blood B-O I-cell_type
mononuclear B-O I-cell_type
cells B-O I-cell_type
( B-O O
PBMC B-O B-cell_type
) B-O O
stimulated B-O O
with B-O O
OKT3/PMA B-O O
, B-O O
tepoxalin B-O O
inhibited B-O O
lymphocyte B-O B-cell_type
proliferation B-O O
with B-O O
an B-O O
IC50 B-O O
of B-O O
6 B-O O
microM B-O O
. B-O O

Additionally B-O O
, B-O O
it B-O O
inhibited B-O O
the B-O O
production B-O O
of B-O O
LTB4 B-O B-protein
( B-O O
IC50 B-O O
= B-O O
0.5 B-O O
microM B-O O
) B-O O
and B-O O
the B-O O
cytokines B-O B-protein
IL-2 B-O B-protein
, B-O O
IL-6 B-O B-protein
and B-O O
TNF B-O B-protein
alpha B-O I-protein
( B-O O
IC50 B-O O
= B-O O
10-12 B-O O
microM B-O O
) B-O O
. B-O O

Cytotoxicity B-O O
was B-O O
not B-O O
demonstrated B-O O
at B-O O
these B-O O
concentrations B-O O
. B-O O

Add-back B-O O
experiments B-O O
with B-O O
either B-O O
cytokines B-O B-protein
( B-O O
IL-2 B-O B-protein
or B-O O
IL-6 B-O B-protein
) B-O O
, B-O O
LTB4 B-O B-protein
or B-O O
conditioned B-O O
media B-O O
failed B-O O
to B-O O
restore B-O O
the B-O O
proliferative B-O O
response B-O O
in B-O O
the B-O O
presence B-O O
of B-O O
tepoxalin B-O O
. B-O O

However B-O O
, B-O O
the B-O O
concurrent B-O O
addition B-O O
of B-O O
iron B-O O
( B-O O
in B-O O
the B-O O
form B-O O
of B-O O
ferrous B-O O
or B-O O
ferric B-O O
chloride B-O O
and B-O O
other B-O O
iron B-O O
salts B-O O
) B-O O
reversed B-O O
the B-O O
inhibition B-O O
of B-O O
proliferation B-O O
caused B-O O
by B-O O
tepoxalin B-O O
. B-O O

Tepoxalin B-O O
also B-O O
inhibits B-O O
the B-O O
activation B-O O
of B-O O
NF B-O B-protein
kappa B-O I-protein
B B-O I-protein
, B-O O
a B-O O
transcription B-O B-protein
factor B-O I-protein
which B-O O
acts B-O O
on B-O O
several B-O O
cytokine B-O B-DNA
genes B-O I-DNA
. B-O O

Tepoxalin B-O O
's B-O O
effect B-O O
on B-O O
NF B-O B-protein
kappa B-O I-protein
B B-O I-protein
is B-O O
also B-O O
reversed B-O O
by B-O O
the B-O O
addition B-O O
of B-O O
iron B-O O
salts B-O O
. B-O O

These B-O O
data B-O O
suggest B-O O
that B-O O
the B-O O
action B-O O
of B-O O
tepoxalin B-O O
to B-O O
inhibit B-O O
proliferation B-O O
in B-O O
PBMC B-O B-cell_type
may B-O O
be B-O O
at B-O O
least B-O O
in B-O O
part B-O O
due B-O O
to B-O O
its B-O O
ability B-O O
to B-O O
reduce B-O O
the B-O O
amount B-O O
of B-O O
available B-O O
iron B-O O
resulting B-O O
in B-O O
decreased B-O O
activation B-O O
of B-O O
NF B-O B-protein
kappa B-O I-protein
B B-O I-protein
and B-O O
subsequent B-O O
inhibition B-O O
of B-O O
cytokine B-O B-protein
production B-O O
. B-O O

N- B-O O
and B-O O
C-terminal B-O B-protein
sequences B-O I-protein
control B-O O
degradation B-O O
of B-O O
MAD3/ B-O B-protein
I B-O I-protein
kappa B-O I-protein
B B-O I-protein
alpha B-O I-protein
in B-O O
response B-O O
to B-O O
inducers B-O O
of B-O O
NF-kappa B-O B-protein
B B-O I-protein
activity B-O O
. B-O O

The B-O O
proteolytic B-O O
degradation B-O O
of B-O O
the B-O O
inhibitory B-O B-protein
protein B-O I-protein
MAD3/ B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
alpha B-O I-protein
in B-O O
response B-O O
to B-O O
extracellular B-O O
stimulation B-O O
is B-O O
a B-O O
prerequisite B-O O
step B-O O
in B-O O
the B-O O
activation B-O O
of B-O O
the B-O O
transcription B-O B-protein
factor B-O I-protein
NF-kappa B-O B-protein
B B-O I-protein
. B-O O

Analysis B-O O
of B-O O
the B-O O
expression B-O O
of B-O O
human B-O B-protein
I B-O I-protein
kappa B-O I-protein
B B-O I-protein
alpha B-O I-protein
protein B-O I-protein
in B-O O
stable B-O O
transfectants B-O O
of B-O O
mouse B-O B-cell_line
70Z/3 B-O I-cell_line
cells B-O I-cell_line
shows B-O O
that B-O O
, B-O O
as B-O O
for B-O O
the B-O O
endogenous B-O B-protein
murine B-O I-protein
protein B-O I-protein
, B-O O
exogenous B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
alpha B-O I-protein
is B-O O
degraded B-O O
in B-O O
response B-O O
to B-O O
inducers B-O O
of B-O O
NF-kappa B-O B-protein
B B-O I-protein
activity B-O O
, B-O O
such B-O O
as B-O O
phorbol B-O O
myristate B-O O
acetate B-O O
or B-O O
lipopolysaccharide B-O O
. B-O O

In B-O O
addition B-O O
, B-O O
pretreatment B-O O
of B-O O
the B-O O
cells B-O O
with B-O O
the B-O O
proteasome B-O B-protein
inhibitor B-O O
N-Ac-Leu-Leu-norleucinal B-O O
inhibits B-O O
this B-O O
ligand-induced B-O O
degradation B-O O
and B-O O
, B-O O
in B-O O
agreement B-O O
with B-O O
previous B-O O
studies B-O O
, B-O O
stabilizes B-O O
a B-O O
hyperphosphorylated B-O O
form B-O O
of B-O O
the B-O O
human B-O B-protein
I B-O I-protein
kappa B-O I-protein
B B-O I-protein
alpha B-O I-protein
protein B-O I-protein
. B-O O

By B-O O
expressing B-O O
mutant B-O O
forms B-O O
of B-O O
the B-O O
human B-O B-protein
protein B-O I-protein
in B-O O
this B-O O
cell B-O O
line B-O O
, B-O O
we B-O O
have B-O O
been B-O O
able B-O O
to B-O O
delineate B-O O
the B-O O
sequences B-O O
responsible B-O O
for B-O O
both B-O O
the B-O O
ligand-induced B-O O
phosphorylation B-O O
and B-O O
the B-O O
degradation B-O O
of B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
alpha B-O I-protein
. B-O O

Our B-O O
results B-O O
show B-O O
that B-O O
deletion B-O O
of B-O O
the B-O O
C B-O B-protein
terminus B-O I-protein
of B-O O
the B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
alpha B-O I-protein
molecule B-O I-protein
up B-O O
to B-O O
amino B-O B-protein
acid B-O I-protein
279 B-O I-protein
abolishes B-O O
constitutive B-O O
but B-O O
not B-O O
ligand-inducible B-O O
phosphorylation B-O O
and B-O O
inhibits B-O O
ligand-inducible B-O O
degradation B-O O
. B-O O

Further B-O O
analysis B-O O
reveals B-O O
that B-O O
the B-O O
inducible B-O O
phosphorylation B-O O
of B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
alpha B-O I-protein
maps B-O O
to B-O O
two B-O O
serines B-O O
in B-O O
the B-O O
N B-O B-protein
terminus B-O I-protein
of B-O O
the B-O O
protein B-O O
( B-O O
residues B-O O
32 B-O O
and B-O O
36 B-O O
) B-O O
and B-O O
that B-O O
the B-O O
mutation B-O O
of B-O O
either B-O O
residue B-O O
is B-O O
sufficient B-O O
to B-O O
abolish B-O O
ligand-induced B-O O
degradation B-O O
, B-O O
whereas B-O O
both B-O O
residues B-O O
must B-O O
be B-O O
mutated B-O O
to B-O O
abolish B-O O
inducible B-O O
phosphorylation B-O O
of B-O O
the B-O O
protein B-O O
. B-O O

( B-O O
ABSTRACT B-O O
TRUNCATED B-O O
AT B-O O
250 B-O O
WORDS B-O O
) B-O O

Microtubules B-O B-protein
mediate B-O O
cellular B-O O
25-hydroxyvitamin B-O O
D3 B-O O
trafficking B-O O
and B-O O
the B-O O
genomic B-O O
response B-O O
to B-O O
1 B-O O
, B-O O
25-dihydroxyvitamin B-O O
D3 B-O O
in B-O O
normal B-O B-cell_type
human B-O I-cell_type
monocytes B-O I-cell_type
. B-O O

The B-O O
genomic B-O O
actions B-O O
of B-O O
1 B-O O
, B-O O
25-dihydroxyvitamin B-O O
D3 B-O O
( B-O O
1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
) B-O O
are B-O O
mediated B-O O
by B-O O
the B-O O
intracellular B-O B-protein
vitamin B-O I-protein
D B-O I-protein
receptor B-O I-protein
( B-O O
VDR B-O B-protein
) B-O O
. B-O O

Although B-O O
immunocytochemistry B-O O
has B-O O
shown B-O O
that B-O O
disruption B-O O
of B-O O
microtubular B-O O
assembly B-O O
prevents B-O O
nuclear B-O O
access B-O O
of B-O O
the B-O O
sterol- B-O B-protein
VDR B-O I-protein
complex B-O I-protein
, B-O O
the B-O O
role B-O O
of B-O O
microtubules B-O B-protein
in B-O O
the B-O O
response B-O O
to B-O O
1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
has B-O O
not B-O O
been B-O O
studied B-O O
in B-O O
viable B-O B-cell_type
cells B-O I-cell_type
. B-O O

Our B-O O
studies B-O O
examined B-O O
this B-O O
interaction B-O O
in B-O O
normal B-O B-cell_type
human B-O I-cell_type
monocytes B-O I-cell_type
. B-O O

Monocytes B-O B-cell_type
convert B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
D3 B-O O
to B-O O
1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
and B-O O
to B-O O
24-hydroxylated B-O O
metabolites B-O O
more B-O O
polar B-O O
than B-O O
1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
. B-O O

Microtubule B-O B-protein
disruption B-O O
totally B-O O
abolished B-O O
the B-O O
ability B-O O
of B-O O
exogenous B-O O
1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
to B-O O
suppress B-O O
its B-O O
own B-O O
synthesis B-O O
and B-O O
to B-O O
induce B-O O
24-hydroxylase B-O B-RNA
mRNA B-O I-RNA
and B-O O
activity B-O O
, B-O O
without B-O O
affecting B-O O
either B-O O
total B-O O
1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
uptake B-O O
or B-O O
maximal B-O O
1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
-VDR B-O B-protein
binding B-O O
. B-O O

Thus B-O O
, B-O O
intact B-O O
microtubules B-O B-protein
are B-O O
essential B-O O
for B-O O
1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
-dependent B-O O
modulation B-O O
of B-O O
gene B-O O
transcription B-O O
. B-O O

Interestingly B-O O
, B-O O
microtubule B-O B-protein
disruption B-O O
also B-O O
decreased B-O O
monocyte B-O B-cell_type
1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
synthesis B-O O
, B-O O
not B-O O
by B-O O
decreasing B-O O
the B-O O
Vmax B-O O
of B-O O
monocyte B-O B-protein
mitochondrial B-O I-protein
1 B-O I-protein
alpha-hydroxylase B-O I-protein
but B-O O
through B-O O
an B-O O
increase B-O O
in B-O O
the B-O O
Km B-O O
for B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
. B-O O

We B-O O
examined B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
D3 B-O O
transport B-O O
. B-O O

Microtubule B-O B-protein
disruption B-O O
did B-O O
not B-O O
affect B-O O
total B-O O
cellular B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
D3 B-O O
uptake B-O O
but B-O O
reduced B-O O
its B-O O
intracellular B-O O
trafficking B-O O
to B-O O
the B-O O
mitochondria B-O O
. B-O O

Thus B-O O
, B-O O
microtubules B-O B-protein
participate B-O O
in B-O O
intracellular B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
D3 B-O O
transport B-O O
, B-O O
and B-O O
their B-O O
integrity B-O O
determines B-O O
normal B-O O
1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
synthesis B-O O
. B-O O

Relationship B-O O
between B-O O
Rap1 B-O B-protein
protein B-O I-protein
phosphorylation B-O O
and B-O O
regulation B-O O
of B-O O
Ca2+ B-O O
transport B-O O
in B-O O
platelets B-O B-cell_type
: B-O O
a B-O O
new B-O O
approach B-O O
. B-O O

Although B-O O
the B-O O
interrelationship B-O O
between B-O O
the B-O O
two B-O O
messengers B-O O
Ca2+ B-O O
and B-O O
cyclic B-O O
AMP B-O O
in B-O O
platelet B-O O
function B-O O
is B-O O
well B-O O
documented B-O O
, B-O O
its B-O O
mechanism B-O O
of B-O O
action B-O O
still B-O O
remains B-O O
to B-O O
be B-O O
established B-O O
. B-O O

We B-O O
investigated B-O O
here B-O O
the B-O O
question B-O O
of B-O O
the B-O O
regulation B-O O
of B-O O
platelet B-O B-protein
Ca B-O I-protein
( B-O I-protein
2+ B-O I-protein
) B-O I-protein
-ATPases B-O I-protein
by B-O O
cyclic B-O O
AMP B-O O
through B-O O
the B-O O
phosphorylation B-O O
of B-O O
the B-O O
Rap1 B-O B-protein
protein B-O I-protein
using B-O O
a B-O O
pathological B-O O
model B-O O
. B-O O

We B-O O
first B-O O
found B-O O
experimental B-O O
conditions B-O O
where B-O O
Ca B-O O
( B-O O
2+ B-O O
) B-O O
-transport B-O O
by B-O O
platelet B-O O
membrane B-O O
vesicles B-O O
appeared B-O O
to B-O O
be B-O O
dependent B-O O
on B-O O
the B-O O
phosphorylation B-O O
of B-O O
the B-O O
Rap1 B-O B-protein
protein B-O I-protein
. B-O O

Then B-O O
, B-O O
we B-O O
studied B-O O
platelets B-O B-cell_type
of B-O O
patients B-O O
with B-O O
congestive B-O O
heart B-O O
failure B-O O
for B-O O
their B-O O
expression B-O O
of B-O O
the B-O O
potential B-O O
97 B-O B-protein
kDa B-O I-protein
Ca B-O I-protein
( B-O I-protein
2+ B-O I-protein
) B-O I-protein
-ATPase B-O I-protein
target B-O I-protein
of B-O O
regulation B-O O
through B-O O
the B-O O
Rap1 B-O B-protein
protein B-O I-protein
as B-O O
well B-O O
as B-O O
the B-O O
phosphorylation B-O O
of B-O O
the B-O O
Rap1 B-O B-protein
protein B-O I-protein
using B-O O
the B-O O
catalytic B-O B-protein
subunit B-O I-protein
of B-O O
the B-O O
cyclic B-O B-protein
AMP B-O I-protein
-dependent B-O I-protein
protein B-O I-protein
kinase B-O I-protein
( B-O O
C. B-O O
Sub. B-O O
) B-O O
. B-O O

In B-O O
the B-O O
first B-O O
patients B-O O
studied B-O O
, B-O O
we B-O O
found B-O O
no B-O O
significant B-O O
modification B-O O
in B-O O
the B-O O
expression B-O O
of B-O O
the B-O O
97 B-O B-protein
kDa B-O I-protein
Ca B-O I-protein
( B-O I-protein
2+ B-O I-protein
) B-O I-protein
-ATPase B-O I-protein
by B-O O
Western B-O O
blotting B-O O
using B-O O
the B-O O
PL/IM B-O B-protein
430 B-O I-protein
monoclonal B-O I-protein
antibody B-O I-protein
which B-O O
specifically B-O O
recognized B-O O
this B-O O
isoform B-O O
. B-O O

In B-O O
contrast B-O O
, B-O O
the B-O O
Rap1 B-O B-protein
protein B-O I-protein
was B-O O
differentially B-O O
phosphorylated B-O O
when B-O O
using B-O O
15 B-O O
micrograms/ml B-O O
of B-O O
the B-O O
C. B-O O
Sub B-O O
. B-O O

These B-O O
results B-O O
allowed B-O O
us B-O O
to B-O O
use B-O O
these B-O O
pathological B-O B-cell_type
platelets B-O I-cell_type
to B-O O
study B-O O
the B-O O
relationship B-O O
between B-O O
the B-O O
expression B-O O
of B-O O
Rap1 B-O B-protein
protein B-O I-protein
and B-O O
the B-O O
regulation B-O O
of B-O O
Ca2+ B-O O
transport B-O O
by B-O O
selecting B-O O
a B-O O
patient B-O O
with B-O O
severe B-O O
heart B-O O
failure B-O O
. B-O O

We B-O O
could B-O O
show B-O O
a B-O O
decrease B-O O
in B-O O
the B-O O
expression B-O O
as B-O O
well B-O O
as B-O O
in B-O O
the B-O O
phosphorylation B-O O
of B-O O
Rap1 B-O B-protein
protein B-O I-protein
and B-O O
demonstrate B-O O
a B-O O
lower B-O O
effect B-O O
of B-O O
C. B-O O
Sub. B-O O
on B-O O
Ca2+ B-O O
transport B-O O
. B-O O

Finally B-O O
, B-O O
by B-O O
studying B-O O
a B-O O
further B-O O
series B-O O
of B-O O
patients B-O O
, B-O O
we B-O O
could B-O O
confirm B-O O
that B-O O
the B-O O
decrease B-O O
in B-O O
Rap1 B-O B-protein
protein B-O I-protein
expression B-O O
in B-O O
heart B-O O
failure B-O O
, B-O O
whatever B-O O
its B-O O
extent B-O O
, B-O O
was B-O O
variable B-O O
, B-O O
and B-O O
could B-O O
strictly B-O O
correlate B-O O
the B-O O
expression B-O O
of B-O O
Rap1 B-O B-protein
protein B-O I-protein
with B-O O
the B-O O
stimulatory B-O O
effect B-O O
of B-O O
C. B-O O
Sub. B-O O
on B-O O
Ca2+ B-O O
transport B-O O
. B-O O

Besides B-O O
the B-O O
evidence B-O O
for B-O O
regulation B-O O
of B-O O
the B-O O
expression B-O O
of B-O O
the B-O O
Rap1 B-O B-protein
protein B-O I-protein
in B-O O
platelets B-O B-cell_type
from B-O O
patients B-O O
with B-O O
heart B-O O
failure B-O O
, B-O O
these B-O O
findings B-O O
constitute B-O O
a B-O O
new B-O O
approach B-O O
in B-O O
favour B-O O
of B-O O
the B-O O
regulation B-O O
of B-O O
platelet B-O O
Ca2+ B-O O
transport B-O O
through B-O O
the B-O O
phosphorylation B-O O
of B-O O
the B-O O
Rap1 B-O B-protein
protein B-O I-protein
. B-O O

An B-O O
IRF-1 B-O B-protein
-dependent B-O O
pathway B-O O
of B-O O
DNA B-O O
damage-induced B-O O
apoptosis B-O O
in B-O O
mitogen-activated B-O B-cell_line
T B-O I-cell_line
lymphocytes B-O I-cell_line
. B-O O

Lymphocytes B-O B-cell_type
are B-O O
particularly B-O O
susceptible B-O O
to B-O O
DNA B-O O
damage-induced B-O O
apoptosis B-O O
, B-O O
a B-O O
response B-O O
which B-O O
may B-O O
serve B-O O
as B-O O
a B-O O
form B-O O
of B-O O
' B-O O
altruistic B-O O
suicide B-O O
' B-O O
to B-O O
counter B-O O
their B-O O
intrinsic B-O O
high B-O O
potential B-O O
for B-O O
mutation B-O O
and B-O O
clonal B-O O
expansion B-O O
. B-O O

The B-O O
tumour B-O B-protein
suppressor B-O I-protein
p53 B-O I-protein
has B-O O
been B-O O
shown B-O O
to B-O O
regulate B-O O
this B-O O
type B-O O
of B-O O
apoptosis B-O O
in B-O O
thymocytes B-O B-cell_type
, B-O O
but B-O O
an B-O O
as B-O O
yet B-O O
unknown B-O O
, B-O O
p53 B-O B-protein
-independent B-O O
pathway B-O O
( B-O O
s B-O O
) B-O O
appears B-O O
to B-O O
mediate B-O O
the B-O O
same B-O O
event B-O O
in B-O O
mitogen-activated B-O B-cell_line
mature B-O I-cell_line
T B-O I-cell_line
lymphocytes B-O I-cell_line
. B-O O

Here B-O O
we B-O O
show B-O O
DNA B-O O
damage-induced B-O O
apoptosis B-O O
in B-O O
these B-O O
T B-O B-cell_type
lymphocytes B-O I-cell_type
is B-O O
dependent B-O O
on B-O O
the B-O O
antioncogenic B-O B-protein
transcription B-O I-protein
factor B-O I-protein
interferon B-O I-protein
regulatory B-O I-protein
factor B-O I-protein
( B-O O
IRF B-O O
) B-O O
-1 B-O O
. B-O O

Thus B-O O
two B-O O
different B-O O
anti-onco-genic B-O B-protein
transcription B-O I-protein
factors B-O I-protein
, B-O O
p53 B-O B-protein
and B-O O
IRF-1 B-O B-protein
, B-O O
are B-O O
required B-O O
for B-O O
distinct B-O O
apoptotic B-O O
pathways B-O O
in B-O O
T B-O B-cell_type
lymphocytes B-O I-cell_type
. B-O O

We B-O O
also B-O O
show B-O O
that B-O O
mitogen B-O B-protein
induction B-O O
of B-O O
the B-O O
interleukin-1 B-O B-DNA
beta B-O I-DNA
converting B-O I-DNA
enzyme B-O I-DNA
( B-O I-DNA
ICE B-O I-DNA
) B-O I-DNA
gene B-O I-DNA
, B-O O
a B-O O
mammalian B-O B-protein
homologue B-O I-protein
of B-O O
the B-O O
Caenorhabditis B-O B-DNA
elegans B-O I-DNA
cell B-O I-DNA
death B-O I-DNA
gene B-O I-DNA
ced-3 B-O B-DNA
, B-O O
is B-O O
IRF-1 B-O B-protein
-dependent B-O O
. B-O O

Ectopic B-O O
overexpression B-O O
of B-O O
IRF-1 B-O B-protein
results B-O O
in B-O O
the B-O O
activation B-O O
of B-O O
the B-O O
endogenous B-O B-DNA
gene B-O I-DNA
for B-O O
ICE B-O B-protein
and B-O O
enhances B-O O
the B-O O
sensitivity B-O O
of B-O O
cells B-O O
to B-O O
radiation-induced B-O O
apoptosis B-O O
. B-O O

Circadian B-O O
rhythm B-O O
of B-O O
glucocorticoid B-O B-protein
receptors B-O I-protein
in B-O O
human B-O B-cell_type
peripheral B-O I-cell_type
leukocytes B-O I-cell_type
and B-O O
their B-O O
reactivity B-O O
to B-O O
glucocorticoids B-O O
. B-O O

1 B-O O
) B-O O
There B-O O
exists B-O O
a B-O O
CR B-O O
of B-O O
GR B-O B-protein
in B-O O
human B-O B-cell_type
leukocytes B-O I-cell_type
, B-O O
PMN B-O B-cell_type
, B-O O
and B-O O
monocytes B-O B-cell_type
with B-O O
the B-O O
peak B-O O
values B-O O
from B-O O
0400 B-O O
to B-O O
0800 B-O O
hr B-O O
and B-O O
the B-O O
trough B-O O
values B-O O
between B-O O
2300 B-O O
and B-O O
0000 B-O O
hr B-O O
. B-O O

The B-O O
difference B-O O
between B-O O
them B-O O
was B-O O
significant B-O O
statistically B-O O
. B-O O

2 B-O O
) B-O O
The B-O O
FI B-O O
of B-O O
the B-O O
chemotactic B-O O
migration B-O O
rate B-O O
of B-O O
PMN B-O B-cell_type
by B-O O
cortisol B-O O
also B-O O
showed B-O O
diurnal B-O O
changes B-O O
which B-O O
were B-O O
synchronous B-O O
with B-O O
that B-O O
of B-O O
GR B-O B-protein
. B-O O

This B-O O
indicates B-O O
that B-O O
the B-O O
CR B-O O
of B-O O
GR B-O B-protein
may B-O O
be B-O O
of B-O O
functional B-O O
significance B-O O
. B-O O

3 B-O O
) B-O O
In B-O O
Cushing B-O O
's B-O O
syndrome B-O O
, B-O O
the B-O O
CR B-O O
of B-O O
GR B-O B-protein
was B-O O
normal B-O O
in B-O O
spite B-O O
of B-O O
the B-O O
fact B-O O
that B-O O
the B-O O
CR B-O O
of B-O O
plasma B-O O
cortisol B-O O
was B-O O
disturbed B-O O
. B-O O

This B-O O
indicates B-O O
the B-O O
independency B-O O
of B-O O
the B-O O
CR B-O O
of B-O O
GR B-O B-protein
from B-O O
that B-O O
of B-O O
cortisol B-O O
. B-O O

4 B-O O
) B-O O
In B-O O
apoplexy B-O O
caused B-O O
by B-O O
brain B-O O
ischemia B-O O
, B-O O
the B-O O
CR B-O O
of B-O O
GR B-O B-protein
was B-O O
abolished B-O O
in B-O O
patients B-O O
with B-O O
basal B-O O
lesions B-O O
but B-O O
preserved B-O O
when B-O O
the B-O O
lesions B-O O
were B-O O
located B-O O
in B-O O
the B-O O
cerebral B-O O
cortex B-O O
. B-O O

These B-O O
results B-O O
strongly B-O O
suggest B-O O
that B-O O
the B-O O
main B-O O
`` B-O O
circadian B-O O
pacemaker B-O O
`` B-O O
of B-O O
GR B-O B-protein
is B-O O
located B-O O
in B-O O
the B-O O
basal B-O O
brain B-O O
, B-O O
most B-O O
probably B-O O
in B-O O
the B-O O
suprachiasmatic B-O O
nuclei B-O O
as B-O O
has B-O O
been B-O O
suggested B-O O
for B-O O
rodents B-O O
. B-O O

B-lymphoblastoid B-O B-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
from B-O O
multiple B-O O
sclerosis B-O O
patients B-O O
and B-O O
a B-O O
healthy B-O O
control B-O O
producing B-O O
a B-O O
putative B-O O
new B-O O
human B-O O
retrovirus B-O O
and B-O O
Epstein-Barr B-O O
virus B-O O
. B-O O

On B-O O
several B-O O
occasions B-O O
we B-O O
have B-O O
observed B-O O
retrovirus-like B-O O
particles B-O O
( B-O O
RVLPs B-O O
) B-O O
by B-O O
transmission B-O O
electron B-O O
microscopy B-O O
( B-O O
EM B-O O
) B-O O
of B-O O
cultured B-O B-cell_line
T B-O I-cell_line
cells B-O I-cell_line
from B-O O
a B-O O
patient B-O O
with B-O O
MS B-O O
. B-O O

Later B-O O
we B-O O
established B-O O
spontaneously B-O O
formed B-O O
B-lymphoblastoid B-O B-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
( B-O O
LCLs B-O B-cell_line
) B-O O
from B-O O
a B-O O
patient B-O O
with B-O O
an B-O O
MS B-O O
-like B-O O
disease B-O O
and B-O O
from B-O O
another B-O O
patient B-O O
with B-O O
MS B-O O
who B-O O
had B-O O
a B-O O
reactivated B-O O
Epstein-Barr B-O O
virus B-O O
( B-O O
EBV B-O O
) B-O O
infection B-O O
. B-O O

Both B-O O
LCLs B-O B-cell_line
were B-O O
found B-O O
by B-O O
EM B-O O
to B-O O
produce B-O O
RVLP B-O O
and B-O O
EBV B-O O
particles B-O O
. B-O O

Reverse B-O B-protein
transcriptase B-O I-protein
( B-O O
RT B-O O
) B-O O
assays B-O O
were B-O O
positive B-O O
in B-O O
purified B-O O
viral B-O O
material B-O O
from B-O O
both B-O O
LCLs B-O B-cell_line
. B-O O

To B-O O
substantiate B-O O
these B-O O
findings B-O O
we B-O O
initiated B-O O
an B-O O
intensified B-O O
culturing B-O O
procedure B-O O
and B-O O
were B-O O
able B-O O
to B-O O
establish B-O O
LCLs B-O B-cell_line
from B-O O
5 B-O O
out B-O O
of B-O O
21 B-O O
consecutive B-O O
MS B-O O
patients B-O O
and B-O O
1 B-O O
out B-O O
of B-O O
13 B-O O
consecutive B-O O
healthy B-O O
controls B-O O
. B-O O

All B-O O
LCLs B-O B-cell_line
were B-O O
found B-O O
to B-O O
produce B-O O
both B-O O
RVLP B-O O
and B-O O
EBV B-O O
particles B-O O
by B-O O
EM B-O O
. B-O O

Whether B-O O
the B-O O
putative B-O O
new B-O O
retrovirus B-O O
( B-O O
es B-O O
) B-O O
and B-O O
EBV B-O O
have B-O O
any B-O O
causal B-O O
relationship B-O O
to B-O O
MS B-O O
is B-O O
still B-O O
not B-O O
known B-O O
, B-O O
but B-O O
the B-O O
findings B-O O
support B-O O
this B-O O
possibility B-O O
. B-O O

Identification B-O O
of B-O O
an B-O O
ionomycin B-O O
/cyclosporin B-O O
A B-O O
-responsive B-O O
element B-O O
within B-O O
the B-O O
human B-O B-DNA
T B-O I-DNA
cell B-O I-DNA
receptor B-O I-DNA
gamma B-O I-DNA
enhancer B-O I-DNA
. B-O O

Activation B-O O
through B-O O
the B-O O
Ca2+ B-O O
/ B-O O
calcineurin B-O B-protein
pathway B-O O
is B-O O
essential B-O O
to B-O O
the B-O O
transcription B-O O
of B-O O
many B-O O
cytokine B-O B-DNA
genes B-O I-DNA
. B-O O

The B-O O
conserved B-O B-DNA
cis-acting B-O I-DNA
sequence B-O I-DNA
, B-O O
GGAAAA B-O O
, B-O O
and B-O O
transcription B-O B-protein
factors B-O I-protein
binding B-O O
to B-O O
this B-O O
sequence B-O O
are B-O O
involved B-O O
in B-O O
the B-O O
response B-O O
to B-O O
increased B-O O
intracellular B-O O
Ca2+ B-O O
concentrations B-O O
. B-O O

Here B-O O
we B-O O
report B-O O
the B-O O
identification B-O O
and B-O O
importance B-O O
of B-O O
the B-O O
same B-O O
sequence B-O O
in B-O O
a B-O O
non-cytokine B-O B-DNA
gene B-O I-DNA
, B-O O
the B-O O
human B-O B-DNA
T B-O I-DNA
cell B-O I-DNA
receptor B-O I-DNA
gamma B-O I-DNA
( B-O I-DNA
TCRG B-O I-DNA
) B-O I-DNA
enhancer B-O I-DNA
. B-O O

Results B-O O
from B-O O
site-directed B-O O
mutations B-O O
and B-O O
electrophoretic B-O O
mobility B-O O
shift B-O O
assays B-O O
strongly B-O O
suggest B-O O
that B-O O
this B-O O
sequence B-O O
mediates B-O O
the B-O O
ionomycin B-O O
-induced B-O O
activation B-O O
of B-O O
the B-O O
TCRG B-O B-DNA
enhancer B-O I-DNA
. B-O O

Our B-O O
studies B-O O
provide B-O O
an B-O O
explanation B-O O
for B-O O
a B-O O
previous B-O O
observation B-O O
that B-O O
TCRG B-O B-RNA
mRNA B-O I-RNA
levels B-O O
, B-O O
but B-O O
not B-O O
mRNA B-O O
levels B-O O
for B-O O
T B-O B-protein
cell B-O I-protein
receptor B-O I-protein
alpha B-O I-protein
and B-O I-protein
-beta B-O I-protein
, B-O O
are B-O O
increased B-O O
by B-O O
ionomycin B-O O
treatment B-O O
. B-O O

Coexpression B-O O
of B-O O
NF-kappa B-O B-protein
B B-O I-protein
/Rel B-O B-protein
and B-O O
Sp1 B-O B-protein
transcription B-O B-protein
factors B-O I-protein
in B-O O
human B-O O
immunodeficiency B-O O
virus B-O O
1 B-O O
-induced B-O O
, B-O O
dendritic B-O O
cell-T-cell B-O O
syncytia B-O O
. B-O O

Productive B-O O
infection B-O O
of B-O O
T B-O B-cell_type
cells B-O I-cell_type
with B-O O
human B-O O
immunodeficiency B-O O
virus B-O O
1 B-O O
( B-O O
HIV-1 B-O O
) B-O O
typically B-O O
requires B-O O
that B-O O
the B-O O
T B-O B-cell_type
cells B-O I-cell_type
be B-O O
stimulated B-O O
with B-O O
antigens B-O O
or B-O O
mitogens B-O B-protein
. B-O O

This B-O O
requirement B-O O
has B-O O
been B-O O
attributed B-O O
to B-O O
the B-O O
activation B-O O
of B-O O
the B-O O
transcription B-O B-protein
factor B-O I-protein
NF-kappa B-O B-protein
B B-O I-protein
, B-O O
which B-O O
synergizes B-O O
with B-O O
the B-O O
constitutive B-O B-protein
transcription B-O I-protein
factor B-O I-protein
Sp1 B-O B-protein
to B-O O
drive B-O O
the B-O O
HIV-1 B-O B-DNA
promoter B-O I-DNA
. B-O O

Recently B-O O
, B-O O
we B-O O
have B-O O
found B-O O
that B-O O
vigorous B-O O
replication B-O O
of B-O O
HIV-1 B-O O
takes B-O O
place B-O O
in B-O O
nonactivated B-O B-cell_type
memory B-O I-cell_type
T B-O I-cell_type
cells B-O I-cell_type
after B-O O
syncytium B-O O
formation B-O O
with B-O O
dendritic B-O B-cell_type
cells B-O I-cell_type
( B-O O
DCs B-O B-cell_type
) B-O O
. B-O O

These B-O O
syncytia B-O O
lack B-O O
activated B-O O
cells B-O O
as B-O O
determined B-O O
by B-O O
an B-O O
absence B-O O
of B-O O
staining B-O O
for B-O O
Ki-67 B-O B-protein
cell B-O I-protein
cycle B-O I-protein
antigen B-O I-protein
. B-O O

The B-O O
expression B-O O
and B-O O
activity B-O O
of B-O O
NF-kappa B-O B-protein
B B-O I-protein
and B-O O
Sp1 B-O B-protein
were B-O O
, B-O O
therefore B-O O
, B-O O
analyzed B-O O
in B-O O
isolated B-O O
T B-O B-cell_type
cells B-O I-cell_type
and B-O O
DCs B-O B-cell_type
from B-O O
humans B-O O
and B-O O
mice B-O O
. B-O O

We B-O O
have B-O O
used B-O O
immunolabeling B-O O
, B-O O
Western B-O O
blot B-O O
analysis B-O O
, B-O O
and B-O O
electrophoretic B-O O
mobility B-O O
shift B-O O
and B-O O
supershift B-O O
assays B-O O
. B-O O

T B-O B-cell_type
cells B-O I-cell_type
lack B-O O
active B-O O
NF-kappa B-O B-protein
B B-O I-protein
but B-O O
express B-O O
Sp1 B-O B-protein
as B-O O
expected B-O O
. B-O O

DCs B-O B-cell_type
express B-O O
high B-O O
levels B-O O
of B-O O
all B-O O
known B-O O
NF-kappa B-O B-protein
B B-O I-protein
and B-O O
Rel B-O B-protein
proteins B-O I-protein
, B-O O
with B-O O
activity B-O O
residing B-O O
primarily B-O O
within B-O O
RelB B-O B-protein
, B-O O
p50 B-O B-protein
, B-O O
and B-O O
p65 B-O B-protein
. B-O O

However B-O O
, B-O O
DCs B-O B-cell_type
lack B-O O
Sp1 B-O B-protein
, B-O O
which B-O O
may B-O O
explain B-O O
the B-O O
failure B-O O
of B-O O
HIV-1 B-O O
to B-O O
replicate B-O O
in B-O O
purified B-O O
DCs B-O B-cell_type
. B-O O

Coexpression B-O O
of B-O O
NF-kappa B-O B-protein
B B-O I-protein
and B-O O
Sp1 B-O B-protein
occurs B-O O
in B-O O
the B-O O
heterologous B-O B-cell_type
DC-T-cell B-O I-cell_type
syncytia B-O I-cell_type
that B-O O
are B-O O
induced B-O O
by B-O O
HIV-1 B-O O
. B-O O

Therefore B-O O
, B-O O
HIV-1 B-O O
-induced B-O O
cell B-O O
fusion B-O O
brings B-O O
together B-O O
factors B-O O
that B-O O
upregulate B-O O
virus B-O O
transcription B-O O
. B-O O

Since B-O O
DCs B-O B-cell_type
and B-O O
memory B-O B-cell_type
T B-O I-cell_type
cells B-O I-cell_type
frequently B-O O
traffic B-O O
together B-O O
in B-O O
situ B-O O
, B-O O
these B-O O
unusual B-O O
heterologous B-O B-cell_type
syncytia B-O I-cell_type
could B-O O
develop B-O O
in B-O O
infected B-O O
individuals B-O O
and B-O O
lead B-O O
to B-O O
chronic B-O O
HIV-1 B-O O
replication B-O O
without B-O O
ostensible B-O O
immune B-O O
stimulation B-O O
. B-O O

Cupric B-O O
ion B-O O
blocks B-O O
NF B-O B-protein
kappa B-O I-protein
B B-O I-protein
activation B-O O
through B-O O
inhibiting B-O O
the B-O O
signal-induced B-O O
phosphorylation B-O O
of B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
alpha B-O I-protein
. B-O O

A B-O O
transcription B-O B-protein
factor B-O I-protein
NF B-O B-protein
kappa B-O I-protein
B B-O I-protein
, B-O O
which B-O O
regulates B-O O
expression B-O O
of B-O O
various B-O O
cellular B-O B-DNA
genes B-O I-DNA
involved B-O O
in B-O O
immune B-O O
responses B-O O
and B-O O
viral B-O B-DNA
genes B-O I-DNA
including B-O O
HIV B-O O
, B-O O
is B-O O
sequestered B-O O
in B-O O
the B-O O
cytoplasm B-O O
as B-O O
a B-O O
complex B-O O
with B-O O
an B-O O
inhibitory B-O O
protein B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
. B-O O

Various B-O O
extracellular B-O O
signals B-O O
induce B-O O
phosphorylation B-O O
and B-O O
rapid B-O O
degradation B-O O
of B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
alpha B-O I-protein
to B-O O
release B-O O
NF B-O B-protein
kappa B-O I-protein
B B-O I-protein
. B-O O

Cu2+ B-O O
was B-O O
found B-O O
to B-O O
inhibit B-O O
the B-O O
activation B-O O
of B-O O
NF B-O B-protein
kappa B-O I-protein
B B-O I-protein
induced B-O O
by B-O O
TNF-alpha B-O B-protein
, B-O O
TPA B-O O
, B-O O
or B-O O
H2O2 B-O O
. B-O O

Deoxycholate B-O O
treatment B-O O
of B-O O
the B-O O
cytoplasmic B-O O
extract B-O O
prepared B-O O
from B-O O
cells B-O O
stimulated B-O O
by B-O O
TNF-alpha B-O B-protein
in B-O O
the B-O O
presence B-O O
of B-O O
Cu2+ B-O O
resulted B-O O
in B-O O
the B-O O
release B-O O
of B-O O
NF B-O B-protein
kappa B-O I-protein
B B-O I-protein
from B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
alpha B-O I-protein
, B-O O
indicating B-O O
that B-O O
Cu2+ B-O O
interferes B-O O
with B-O O
the B-O O
dissociation B-O O
of B-O O
the B-O O
NF B-O B-protein
kappa B-O I-protein
B B-O I-protein
-I B-O I-protein
kappa B-O I-protein
B B-O I-protein
complex B-O I-protein
. B-O O

Neither B-O O
phosphorylation B-O O
nor B-O O
degradation B-O O
of B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
alpha B-O I-protein
was B-O O
observed B-O O
upon B-O O
TNF-alpha B-O B-protein
stimulation B-O O
in B-O O
the B-O O
presence B-O O
of B-O O
Cu2+ B-O O
. B-O O

These B-O O
results B-O O
indicate B-O O
that B-O O
Cu2+ B-O O
inhibits B-O O
the B-O O
release B-O O
of B-O O
NF B-O B-protein
kappa B-O I-protein
B B-O I-protein
by B-O O
blockade B-O O
of B-O O
a B-O O
signal B-O O
leading B-O O
to B-O O
the B-O O
phosphorylation B-O O
of B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
alpha B-O I-protein
. B-O O

Cloning B-O O
a B-O O
cDNA B-O B-DNA
from B-O O
human B-O B-cell_type
NK/ B-O I-cell_type
T B-O I-cell_type
cells B-O I-cell_type
which B-O O
codes B-O O
for B-O O
a B-O O
protein B-O O
with B-O O
high B-O O
proline B-O O
content B-O O
. B-O O

A B-O O
cDNA B-O B-DNA
clone B-O I-DNA
, B-O O
B4-2 B-O B-DNA
, B-O O
was B-O O
isolated B-O O
from B-O O
a B-O O
natural B-O B-DNA
killer B-O I-DNA
( B-O I-DNA
NK B-O I-DNA
) B-O I-DNA
minus B-O I-DNA
T B-O I-DNA
cell B-O I-DNA
subtractive B-O I-DNA
library B-O I-DNA
. B-O O

The B-O O
B4-2 B-O B-cell_line
clone B-O I-cell_line
coded B-O O
for B-O O
an B-O O
mRNA B-O B-RNA
of B-O O
2061 B-O O
bp B-O O
in B-O O
length B-O O
. B-O O

It B-O O
encodes B-O O
a B-O O
deduced B-O O
327 B-O B-protein
aa B-O I-protein
protein B-O I-protein
with B-O O
a B-O O
calculated B-O O
molecular B-O O
mass B-O O
of B-O O
35.2 B-O B-RNA
kDa B-O I-RNA
. B-O O

Searching B-O O
of B-O O
B4-2 B-O B-DNA
DNA B-O I-DNA
and B-O O
protein B-O O
sequences B-O O
against B-O O
various B-O O
databases B-O O
revealed B-O O
no B-O O
high B-O O
homology B-O O
to B-O O
other B-O O
sequences B-O O
. B-O O

However B-O O
, B-O O
B4-2 B-O B-DNA
has B-O O
an B-O O
unusually B-O O
high B-O O
proline B-O O
content B-O O
( B-O O
13 B-O O
% B-O O
) B-O O
, B-O O
contains B-O O
a B-O O
putative B-O B-DNA
nuclear B-O I-DNA
targeting B-O I-DNA
sequence B-O I-DNA
, B-O O
and B-O O
has B-O O
several B-O O
SPXX B-O B-protein
motifs B-O I-protein
which B-O O
are B-O O
frequently B-O O
found B-O O
in B-O O
gene B-O B-protein
regulatory B-O I-protein
proteins B-O I-protein
. B-O O

One B-O O
of B-O O
the B-O O
stretches B-O O
of B-O O
prolines B-O O
in B-O O
B4-2 B-O B-DNA
closely B-O O
resembles B-O O
the B-O O
ligand B-O O
for B-O O
proteins B-O O
with B-O O
SH3 B-O B-protein
domains B-O I-protein
. B-O O

Northern B-O O
hybridization B-O O
data B-O O
showed B-O O
that B-O O
B4-2 B-O B-protein
is B-O O
not B-O O
a B-O O
lymphoid B-O B-DNA
specific B-O I-DNA
gene B-O I-DNA
and B-O O
is B-O O
expressed B-O O
in B-O O
a B-O O
hepatoma B-O B-cell_line
cell B-O I-cell_line
line B-O I-cell_line
and B-O O
also B-O O
weakly B-O O
transcribed B-O O
or B-O O
absent B-O O
in B-O O
a B-O O
variety B-O O
of B-O O
other B-O O
cells B-O O
. B-O O

A B-O O
polyclonal B-O O
antiserum B-O O
raised B-O O
against B-O O
recombinant B-O B-protein
B4-2 B-O I-protein
recognizes B-O O
a B-O O
32-34 B-O B-protein
kDa B-O I-protein
protein B-O I-protein
in B-O O
lymphocytes B-O B-cell_type
. B-O O

Activation B-O O
of B-O O
JAK3 B-O B-protein
, B-O O
but B-O O
not B-O O
JAK1 B-O B-protein
, B-O O
is B-O O
critical B-O O
for B-O O
IL-2 B-O B-protein
-induced B-O O
proliferation B-O O
and B-O O
STAT5 B-O B-protein
recruitment B-O O
by B-O O
a B-O O
COOH-terminal B-O B-protein
region B-O I-protein
of B-O O
the B-O O
IL-2 B-O B-protein
receptor B-O I-protein
beta-chain B-O I-protein
. B-O O

A B-O O
number B-O O
of B-O O
cytokines B-O B-protein
and B-O O
growth B-O B-protein
factors B-O I-protein
use B-O O
the B-O O
JAK B-O B-protein
-STAT B-O B-protein
pathway B-O O
to B-O O
signal B-O O
from B-O O
the B-O O
cell B-O O
membrane B-O O
to B-O O
the B-O O
nucleus B-O O
. B-O O

While B-O O
homodimerizing B-O B-protein
cytokine B-O I-protein
receptors B-O I-protein
may B-O O
transmit B-O O
signal B-O O
via B-O O
a B-O O
single B-O O
form B-O O
of B-O O
JAK B-O B-protein
( B-O O
i.e. B-O O
growth B-O B-protein
hormone B-O I-protein
receptors B-O I-protein
) B-O O
, B-O O
several B-O O
multicomponent B-O B-protein
cytokine B-O I-protein
receptors B-O I-protein
have B-O O
been B-O O
shown B-O O
to B-O O
require B-O O
simultaneous B-O O
activation B-O O
of B-O O
pairs B-O O
of B-O O
different B-O O
JAK B-O B-protein
kinases B-O I-protein
( B-O O
i.e. B-O O
interferon B-O B-protein
receptors B-O I-protein
) B-O O
. B-O O

Recent B-O O
evidence B-O O
for B-O O
a B-O O
preferential B-O O
coupling B-O O
of B-O O
JAK3 B-O B-protein
to B-O O
interleukin-2 B-O B-protein
receptor-gamma B-O I-protein
( B-O O
IL-2R B-O B-protein
gamma B-O I-protein
) B-O O
and B-O O
JAK1 B-O B-protein
to B-O O
IL-2R B-O B-protein
beta B-O I-protein
supports B-O O
the B-O O
concept B-O O
of B-O O
heterotrans-activation B-O O
of B-O O
JAK1 B-O B-protein
and B-O O
JAK3 B-O B-protein
caused B-O O
by B-O O
IL-2 B-O B-protein
-induced B-O O
heterodimerization B-O O
of B-O O
their B-O O
receptor B-O O
partners B-O O
. B-O O

The B-O O
present B-O O
study B-O O
verified B-O O
the B-O O
ability B-O O
of B-O O
IL-2 B-O B-protein
to B-O O
cause B-O O
tyrosine B-O O
phosphorylation B-O O
and B-O O
activation B-O O
of B-O O
JAK1 B-O B-protein
and B-O O
JAK3 B-O B-protein
, B-O O
but B-O O
demonstrated B-O O
that B-O O
IL-2 B-O B-protein
stimulated B-O O
JAK3 B-O B-protein
to B-O O
a B-O O
significantly B-O O
larger B-O O
extent B-O O
than B-O O
JAK1 B-O B-protein
in B-O O
human B-O B-cell_type
T B-O I-cell_type
lymphocytes B-O I-cell_type
and B-O O
the B-O O
YT B-O B-cell_line
cell B-O I-cell_line
line B-O I-cell_line
. B-O O

This B-O O
conclusion B-O O
was B-O O
based B-O O
upon B-O O
several B-O O
independent B-O O
criteria B-O O
, B-O O
including B-O O
more B-O O
vigorous B-O O
tyrosine B-O O
phosphorylation B-O O
of B-O O
JAK3 B-O B-protein
, B-O O
more B-O O
marked B-O O
enzymatic B-O O
activation B-O O
of B-O O
JAK3 B-O B-protein
as B-O O
well B-O O
as B-O O
higher B-O O
abundance B-O O
of B-O O
JAK3 B-O B-protein
in B-O O
activated B-O O
IL-2 B-O B-protein
receptor B-O I-protein
complexes B-O I-protein
. B-O O

Furthermore B-O O
, B-O O
when B-O O
human B-O B-protein
IL-2R B-O I-protein
beta B-O I-protein
was B-O O
stably B-O O
expressed B-O O
in B-O O
murine B-O B-cell_line
BA/F3 B-O I-cell_line
cells B-O I-cell_line
, B-O O
robust B-O O
IL-2 B-O B-protein
-induced B-O O
proliferation B-O O
and B-O O
JAK3 B-O B-protein
activation B-O O
occurred B-O O
without B-O O
detectable B-O O
involvement B-O O
of B-O O
either B-O O
JAK1 B-O B-protein
, B-O O
JAK2 B-O B-protein
or B-O O
TYK2 B-O B-protein
. B-O O

We B-O O
therefore B-O O
propose B-O O
that B-O O
IL-2 B-O B-protein
receptor B-O I-protein
signal B-O O
transduction B-O O
does B-O O
not B-O O
depend B-O O
on B-O O
equimolar B-O O
heterodimerization B-O O
of B-O O
JAK1 B-O B-protein
and B-O O
JAK3 B-O B-protein
following B-O O
IL-2 B-O B-protein
-induced B-O O
heterodimerization B-O O
of B-O O
IL-2R B-O B-protein
beta B-O I-protein
and B-O O
IL-2R B-O B-protein
gamma B-O I-protein
. B-O O

Nonetheless B-O O
, B-O O
a B-O O
membrane-proximal B-O B-protein
region B-O I-protein
of B-O O
human B-O B-protein
IL-2R B-O I-protein
beta B-O I-protein
( B-O O
Asn240-Leu335 B-O B-protein
) B-O O
was B-O O
critical B-O O
for B-O O
JAK3 B-O B-protein
activation B-O O
, B-O O
and B-O O
the B-O O
amount B-O O
of B-O O
JAK3 B-O B-protein
present B-O O
in B-O O
activated B-O O
IL-2 B-O B-protein
receptor B-O I-protein
complexes B-O I-protein
increased B-O O
with B-O O
time B-O O
, B-O O
suggesting B-O O
that B-O O
stabilization B-O O
of B-O O
JAK3 B-O B-protein
binding B-O O
to B-O O
the B-O O
receptor B-O B-protein
complex B-O I-protein
relies B-O O
on B-O O
both B-O O
IL-2R B-O B-protein
beta B-O I-protein
and B-O O
IL-2R B-O B-protein
gamma B-O I-protein
. B-O O

Moreover B-O O
, B-O O
STAT5 B-O B-protein
was B-O O
found B-O O
to B-O O
be B-O O
the B-O O
predominant B-O O
STAT B-O B-protein
transcription B-O I-protein
factor B-O I-protein
used B-O O
by B-O O
IL-2 B-O B-protein
in B-O O
human B-O B-cell_type
T B-O I-cell_type
cells B-O I-cell_type
, B-O O
and B-O O
specifically B-O O
required B-O O
a B-O O
COOH-terminal B-O B-protein
region B-O I-protein
of B-O O
IL-2R B-O B-protein
beta B-O I-protein
( B-O O
Ser386-Val525 B-O B-protein
) B-O O
, B-O O
while B-O O
STAT5 B-O B-protein
recruitment B-O O
was B-O O
not B-O O
correlated B-O O
to B-O O
activation B-O O
of B-O O
IL-2R B-O B-protein
gamma B-O I-protein
or B-O O
JAK3 B-O B-protein
. B-O O

Up-regulation B-O O
of B-O O
high-affinity B-O O
dehydroepiandrosterone B-O O
binding B-O O
activity B-O O
by B-O O
dehydroepiandrosterone B-O O
in B-O O
activated B-O B-cell_type
human B-O I-cell_type
T B-O I-cell_type
lymphocytes B-O I-cell_type
. B-O O

Although B-O O
evidence B-O O
indicates B-O O
that B-O O
dehydroepiandrosterone B-O O
( B-O O
DHEA B-O O
) B-O O
exerts B-O O
direct B-O O
physiological B-O O
effects B-O O
, B-O O
its B-O O
mechanism B-O O
of B-O O
action B-O O
remains B-O O
unknown B-O O
. B-O O

DHEA B-O O
binding B-O O
sites B-O O
were B-O O
examined B-O O
using B-O O
a B-O O
whole-cell B-O O
binding B-O O
assay B-O O
in B-O O
a B-O O
human B-O B-cell_line
T B-O I-cell_line
lymphoid B-O I-cell_line
cell B-O I-cell_line
line B-O I-cell_line
, B-O O
PEER B-O B-cell_line
, B-O O
revealing B-O O
that B-O O
a B-O O
single B-O O
class B-O O
of B-O O
high-affinity B-O B-DNA
binding B-O I-DNA
sites B-O I-DNA
for B-O O
DHEA B-O O
( B-O O
dissociation B-O O
constant B-O O
= B-O O
7.4 B-O O
+/- B-O O
0.53 B-O O
nmol/L B-O O
, B-O O
mean B-O O
+/- B-O O
SE B-O O
, B-O O
n B-O O
= B-O O
4 B-O O
) B-O O
was B-O O
greatly B-O O
increased B-O O
when B-O O
treated B-O O
with B-O O
DHEA B-O O
, B-O O
phorbol-12-myristate-13-acetate B-O O
, B-O O
and B-O O
the B-O O
Ca2+ B-O O
ionophore B-O O
A23187 B-O O
. B-O O

Bound B-O O
[ B-O O
3H B-O O
] B-O O
DHEA B-O O
was B-O O
displaced B-O O
sensitively B-O O
by B-O O
DHEA B-O O
and B-O O
secondarily B-O O
by B-O O
dihydrotestosterone B-O O
, B-O O
but B-O O
not B-O O
effectively B-O O
by B-O O
other B-O O
steroids B-O O
, B-O O
including B-O O
DHEA B-O O
sulfate B-O O
. B-O O

These B-O O
results B-O O
not B-O O
only B-O O
indicate B-O O
the B-O O
existence B-O O
of B-O O
a B-O O
DHEA B-O B-protein
receptor B-O I-protein
, B-O O
but B-O O
also B-O O
suggest B-O O
that B-O O
T B-O B-cell_type
cells B-O I-cell_type
become B-O O
susceptible B-O O
to B-O O
regulation B-O O
by B-O O
DHEA B-O O
during B-O O
the B-O O
process B-O O
of B-O O
signal-induced B-O O
activation B-O O
. B-O O

Ubiquitin-mediated B-O O
processing B-O O
of B-O O
NF-kappa B-O B-protein
B B-O I-protein
transcriptional B-O O
activator B-O O
precursor B-O O
p105 B-O B-protein
. B-O O

Reconstitution B-O O
of B-O O
a B-O O
cell-free B-O O
system B-O O
and B-O O
identification B-O O
of B-O O
the B-O O
ubiquitin-carrier B-O B-protein
protein B-O I-protein
, B-O O
E2 B-O B-protein
, B-O O
and B-O O
a B-O O
novel B-O O
ubiquitin-protein B-O B-protein
ligase B-O I-protein
, B-O O
E3 B-O B-protein
, B-O O
involved B-O O
in B-O O
conjugation B-O O
. B-O O

In B-O O
most B-O O
cases B-O O
, B-O O
the B-O O
transcriptional B-O B-protein
factor B-O I-protein
NF-kappa B-O B-protein
B B-O I-protein
is B-O O
a B-O O
heterodimer B-O B-protein
consisting B-O O
of B-O O
two B-O O
subunits B-O O
, B-O O
p50 B-O B-protein
and B-O O
p65 B-O B-protein
, B-O O
which B-O O
are B-O O
encoded B-O O
by B-O O
two B-O O
distinct B-O O
genes B-O O
of B-O O
the B-O O
Rel B-O B-protein
family B-O I-protein
. B-O O

p50 B-O B-protein
is B-O O
translated B-O O
as B-O O
a B-O O
precursor B-O O
of B-O O
105 B-O B-protein
kDa B-O I-protein
. B-O O

The B-O O
C-terminal B-O B-protein
domain B-O I-protein
of B-O O
the B-O O
precursor B-O O
is B-O O
rapidly B-O O
degraded B-O O
, B-O O
forming B-O O
the B-O O
mature B-O B-protein
p50 B-O I-protein
subunit B-O I-protein
consisted B-O O
of B-O O
the B-O O
N-terminal B-O B-protein
region B-O I-protein
of B-O O
the B-O O
molecule B-O O
. B-O O

The B-O O
mechanism B-O O
of B-O O
generation B-O O
of B-O O
p50 B-O B-protein
is B-O O
not B-O O
known B-O O
. B-O O

It B-O O
has B-O O
been B-O O
suggested B-O O
that B-O O
the B-O O
ubiquitin B-O B-protein
-proteasome B-O B-protein
system B-O O
is B-O O
involved B-O O
in B-O O
the B-O O
process B-O O
; B-O O
however B-O O
, B-O O
the B-O O
specific B-O O
enzymes B-O B-protein
involved B-O O
and B-O O
the B-O O
mechanism B-O O
of B-O O
limited B-O O
proteolysis B-O O
, B-O O
in B-O O
which B-O O
half B-O O
of B-O O
the B-O O
molecule B-O O
is B-O O
spared B-O O
, B-O O
have B-O O
been B-O O
obscure B-O O
. B-O O

Palombella B-O O
and B-O O
colleagues B-O O
( B-O O
Palombella B-O O
, B-O O
V.J. B-O O
, B-O O
Rando B-O O
, B-O O
O.J. B-O O
, B-O O
Goldberg B-O O
, B-O O
A.L. B-O O
, B-O O
and B-O O
Maniatis B-O O
, B-O O
T. B-O O
( B-O O
1994 B-O O
) B-O O
Cell B-O O
78 B-O O
, B-O O
773-785 B-O O
) B-O O
have B-O O
shown B-O O
that B-O O
ubiquitin B-O B-protein
is B-O O
required B-O O
for B-O O
the B-O O
processing B-O O
in B-O O
a B-O O
cell-free B-O O
system B-O O
of B-O O
a B-O O
truncated B-O O
, B-O O
artificially B-O O
constructed B-O O
, B-O O
60-kDa B-O B-protein
precursor B-O I-protein
. B-O O

They B-O O
have B-O O
also B-O O
shown B-O O
that B-O O
proteasome B-O B-protein
inhibitors B-O O
block B-O O
the B-O O
processing B-O O
both B-O O
in B-O O
vitro B-O O
and B-O O
in B-O O
vivo B-O O
. B-O O

In B-O O
this B-O O
study B-O O
, B-O O
we B-O O
demonstrate B-O O
reconstitution B-O O
of B-O O
a B-O O
cell-free B-O O
processing B-O O
system B-O O
and B-O O
demonstrate B-O O
directly B-O O
that B-O O
: B-O O
( B-O O
a B-O O
) B-O O
the B-O O
ubiquitin B-O B-protein
-proteasome B-O B-protein
system B-O O
is B-O O
involved B-O O
in B-O O
processing B-O O
of B-O O
the B-O O
intact B-O O
p105 B-O B-protein
precursor B-O O
, B-O O
( B-O O
b B-O O
) B-O O
conjugation B-O O
of B-O O
ubiquitin B-O B-protein
to B-O O
the B-O O
precursor B-O O
is B-O O
an B-O O
essential B-O O
intermediate B-O O
step B-O O
in B-O O
the B-O O
processing B-O O
, B-O O
( B-O O
c B-O O
) B-O O
the B-O O
recently B-O O
discovered B-O O
novel B-O O
species B-O O
of B-O O
the B-O O
ubiquitin B-O B-protein
-carrier B-O I-protein
protein B-O I-protein
, B-O O
E2-F1 B-O B-protein
, B-O O
that B-O O
is B-O O
involved B-O O
in B-O O
the B-O O
conjugation B-O O
and B-O O
degradation B-O O
of B-O O
p53 B-O B-protein
, B-O O
is B-O O
also B-O O
required B-O O
for B-O O
the B-O O
limited B-O O
processing B-O O
of B-O O
the B-O O
p105 B-O B-protein
precursor B-O I-protein
, B-O O
and B-O O
( B-O O
d B-O O
) B-O O
a B-O O
novel B-O O
, B-O O
approximately B-O O
320-kDa B-O B-protein
species B-O I-protein
of B-O O
ubiquitin B-O B-protein
-protein B-O I-protein
ligase B-O I-protein
, B-O O
is B-O O
involved B-O O
in B-O O
the B-O O
process B-O O
. B-O O

This B-O O
novel B-O O
enzyme B-O O
is B-O O
distinct B-O O
from B-O O
E6-AP B-O B-protein
, B-O O
the B-O O
p53 B-O B-protein
-conjugating B-O I-protein
ligase B-O I-protein
, B-O O
and B-O O
from B-O O
E3 B-O B-protein
alpha B-O I-protein
, B-O O
the B-O O
`` B-O B-protein
N-end B-O I-protein
rule B-O I-protein
`` B-O I-protein
ligase B-O I-protein
. B-O O

Flutamide B-O O
in B-O O
the B-O O
treatment B-O O
of B-O O
hirsutism B-O O
: B-O O
long-term B-O O
clinical B-O O
effects B-O O
, B-O O
endocrine B-O O
changes B-O O
, B-O O
and B-O O
androgen B-O B-protein
receptor B-O I-protein
behavior B-O O
. B-O O

OBJECTIVE B-O O
: B-O O
To B-O O
investigate B-O O
the B-O O
long-term B-O O
effects B-O O
of B-O O
treatment B-O O
with B-O O
low B-O O
doses B-O O
of B-O O
flutamide B-O O
on B-O O
clinical B-O O
and B-O O
hormonal B-O O
parameters B-O O
, B-O O
as B-O O
well B-O O
as B-O O
on B-O O
the B-O O
androgen B-O B-protein
receptor B-O I-protein
status B-O O
, B-O O
in B-O O
hirsute B-O O
women B-O O
. B-O O

DESIGN B-O O
: B-O O
Eighteen B-O O
hirsute B-O O
patients B-O O
with B-O O
regular B-O O
menses B-O O
were B-O O
studied B-O O
basally B-O O
and B-O O
during B-O O
treatment B-O O
with B-O O
125 B-O O
mg B-O O
flutamide B-O O
, B-O O
three B-O O
times B-O O
per B-O O
day B-O O
for B-O O
12 B-O O
months B-O O
. B-O O

Barrier B-O O
or B-O O
intrauterine B-O O
contraception B-O O
was B-O O
used B-O O
during B-O O
the B-O O
study B-O O
in B-O O
sexually B-O O
active B-O O
women B-O O
. B-O O

Safety B-O O
parameters B-O O
were B-O O
assessed B-O O
throughout B-O O
the B-O O
study B-O O
. B-O O

Hirsutism B-O O
, B-O O
graded B-O O
by B-O O
the B-O O
modified B-O O
Ferriman-Gallwey B-O O
score B-O O
, B-O O
and B-O O
hormonal B-O O
parameters B-O O
were B-O O
evaluated B-O O
basally B-O O
and B-O O
at B-O O
4-month B-O O
intervals B-O O
during B-O O
treatment B-O O
. B-O O

Gonadotropin-releasing B-O O
hormone B-O O
and B-O O
ACTH B-O O
stimulation B-O O
tests B-O O
were B-O O
performed B-O O
before B-O O
and B-O O
after B-O O
3 B-O O
to B-O O
4 B-O O
months B-O O
of B-O O
therapy B-O O
. B-O O

In B-O O
addition B-O O
, B-O O
the B-O O
concentration B-O O
of B-O O
androgen B-O B-protein
receptors B-O I-protein
in B-O O
mononuclear B-O B-cell_type
leukocytes B-O I-cell_type
was B-O O
measured B-O O
, B-O O
in B-O O
both B-O O
the B-O O
follicular B-O O
and B-O O
luteal B-O O
phases B-O O
of B-O O
the B-O O
menstrual B-O O
cycle B-O O
, B-O O
basally B-O O
and B-O O
after B-O O
4 B-O O
months B-O O
of B-O O
flutamide B-O O
treatment B-O O
. B-O O

RESULTS B-O O
: B-O O
Flutamide B-O O
was B-O O
well B-O O
tolerated B-O O
in B-O O
all B-O O
women B-O O
, B-O O
with B-O O
the B-O O
noticeable B-O O
exception B-O O
of B-O O
one B-O O
patient B-O O
who B-O O
presented B-O O
increased B-O O
serum B-O B-protein
transaminase B-O I-protein
after B-O O
8 B-O O
months B-O O
of B-O O
therapy B-O O
. B-O O

Hirsutism B-O O
markedly B-O O
improved B-O O
in B-O O
all B-O O
women B-O O
during B-O O
the B-O O
treatment B-O O
( B-O O
Ferriman-Gallwey B-O O
score B-O O
after B-O O
1 B-O O
year B-O O
: B-O O
4.1 B-O O
+/- B-O O
0.5 B-O O
versus B-O O
14.1 B-O O
+/- B-O O
0.9 B-O O
) B-O O
. B-O O

A B-O O
reduction B-O O
of B-O O
serum B-O O
androgens B-O O
was B-O O
found B-O O
, B-O O
whereas B-O O
no B-O O
change B-O O
was B-O O
observed B-O O
in B-O O
either B-O O
basal B-O O
or B-O O
GnRH-stimulated B-O O
gonadotropins B-O O
or B-O O
in B-O O
the B-O O
cortisol B-O O
and B-O O
17 B-O O
alpha-hydroxyprogesterone B-O O
response B-O O
to B-O O
ACTH B-O B-protein
. B-O O

Cycles B-O O
remained B-O O
ovulatory B-O O
. B-O O

Before B-O O
treatment B-O O
, B-O O
the B-O O
number B-O O
of B-O O
androgen B-O B-protein
receptors B-O I-protein
was B-O O
higher B-O O
in B-O O
the B-O O
luteal B-O O
than B-O O
in B-O O
the B-O O
follicular B-O O
phase B-O O
. B-O O

This B-O O
rhythmic B-O O
differentiation B-O O
disappeared B-O O
after B-O O
the B-O O
patients B-O O
had B-O O
been B-O O
given B-O O
the B-O O
antiandrogen B-O O
drug B-O O
. B-O O

CONCLUSIONS B-O O
: B-O O
Flutamide B-O O
is B-O O
effective B-O O
in B-O O
the B-O O
treatment B-O O
of B-O O
hirsutism B-O O
but B-O O
requires B-O O
constant B-O O
surveillance B-O O
of B-O O
liver B-O O
function B-O O
. B-O O

Androgen B-O B-protein
receptor B-O I-protein
blockade B-O O
might B-O O
be B-O O
potentiated B-O O
by B-O O
a B-O O
reduction B-O O
of B-O O
serum B-O O
androgens B-O O
. B-O O

Flutamide B-O O
affects B-O O
androgen B-O B-protein
receptor B-O I-protein
behavior B-O O
during B-O O
the B-O O
menstrual B-O O
cycle B-O O
. B-O O

The B-O O
meaning B-O O
of B-O O
this B-O O
finding B-O O
remains B-O O
to B-O O
be B-O O
elucidated B-O O
. B-O O

Constitutive B-O O
expression B-O O
of B-O O
HIV-1 B-O B-protein
tat B-O I-protein
protein B-O I-protein
in B-O O
human B-O B-cell_line
Jurkat B-O I-cell_line
T B-O I-cell_line
cells B-O I-cell_line
using B-O O
a B-O O
BK B-O O
virus B-O O
vector B-O O
. B-O O

The B-O O
production B-O O
and B-O O
characterization B-O O
of B-O O
Jurkat B-O B-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
that B-O O
constitutively B-O O
express B-O O
functional B-O O
human B-O B-protein
immune B-O I-protein
deficiency B-O I-protein
virus B-O I-protein
type B-O I-protein
1 B-O I-protein
( B-O I-protein
HIV-1 B-O I-protein
) B-O I-protein
tat B-O I-protein
protein B-O I-protein
, B-O O
using B-O O
a B-O O
BK B-O B-DNA
virus B-O I-DNA
plasmid B-O I-DNA
expression B-O I-DNA
vector B-O I-DNA
and B-O O
HIV-1 B-O B-DNA
tat B-O I-DNA
cDNA B-O I-DNA
, B-O O
is B-O O
described B-O O
. B-O O

An B-O O
increased B-O O
growth B-O O
rate B-O O
of B-O O
these B-O O
Jurkat-tat B-O B-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
as B-O O
compared B-O O
with B-O O
control B-O B-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
was B-O O
observed B-O O
. B-O O

A B-O O
PEBP2 B-O B-protein
alpha/AML-1-related B-O I-protein
factor B-O I-protein
increases B-O O
osteocalcin B-O B-DNA
promoter B-O I-DNA
activity B-O O
through B-O O
its B-O O
binding B-O O
to B-O O
an B-O O
osteoblast-specific B-O B-DNA
cis-acting B-O I-DNA
element B-O I-DNA
. B-O O

To B-O O
identify B-O O
osteoblast-specific B-O B-DNA
cis-acting B-O I-DNA
elements B-O I-DNA
and B-O O
trans-acting B-O B-protein
factors B-O I-protein
, B-O O
we B-O O
initiated B-O O
an B-O O
analysis B-O O
of B-O O
the B-O O
promoter B-O B-DNA
of B-O O
a B-O O
mouse B-O B-DNA
osteocalcin B-O I-DNA
gene B-O I-DNA
, B-O O
an B-O O
osteoblast-specific B-O B-DNA
gene B-O I-DNA
. B-O O

In B-O O
this B-O O
promoter B-O B-DNA
, B-O O
we B-O O
identified B-O O
two B-O O
osteoblast-specific B-O B-DNA
cis-acting B-O I-DNA
elements B-O I-DNA
( B-O O
Ducy B-O O
, B-O O
P. B-O O
and B-O O
Karsenty B-O O
, B-O O
G. B-O O
( B-O O
1995 B-O O
) B-O O
Mol.Cell.Biol.15 B-O O
, B-O O
1858-1869 B-O O
) B-O O
. B-O O

The B-O O
sequence B-O O
of B-O O
one B-O O
of B-O O
these B-O O
elements B-O B-DNA
, B-O O
OSE2 B-O B-protein
, B-O O
is B-O O
identical B-O O
to B-O O
the B-O O
DNA-binding B-O B-DNA
site B-O I-DNA
of B-O O
the B-O O
PEBP2 B-O B-protein
alpha/AML-1 B-O I-protein
transcription B-O I-protein
factors B-O I-protein
, B-O O
the B-O O
mammalian B-O B-protein
homologues B-O I-protein
of B-O O
the B-O O
Drosophila B-O B-protein
Runt B-O I-protein
protein B-O I-protein
. B-O O

Here B-O O
we B-O O
show B-O O
, B-O O
using B-O O
nuclear B-O O
extracts B-O O
, B-O O
recombinant B-O B-protein
protein B-O I-protein
, B-O O
and B-O O
a B-O O
specific B-O O
antiserum B-O O
against B-O O
AML-1 B-O B-protein
proteins B-O I-protein
in B-O O
DNA-binding B-O O
assays B-O O
, B-O O
that B-O O
one B-O O
member B-O O
of B-O O
this B-O O
family B-O O
, B-O O
AML-1B B-O B-protein
, B-O O
binds B-O O
specifically B-O O
to B-O O
OSE2 B-O B-protein
and B-O O
is B-O O
immunologically B-O O
related B-O O
to B-O O
OSF2 B-O B-protein
, B-O O
the B-O O
factor B-O O
present B-O O
in B-O O
osteoblast B-O O
nuclear B-O O
extracts B-O O
that B-O O
binds B-O O
to B-O O
OSE2 B-O B-protein
. B-O O

By B-O O
DNA B-O O
cotransfection B-O O
experiments B-O O
, B-O O
we B-O O
also B-O O
demonstrate B-O O
that B-O O
AML-1B B-O B-protein
can B-O O
increase B-O O
the B-O O
activity B-O O
of B-O O
a B-O O
short B-O O
osteocalcin B-O B-DNA
promoter B-O I-DNA
through B-O O
its B-O O
binding B-O O
to B-O O
OSE2 B-O B-protein
. B-O O

Lastly B-O O
, B-O O
the B-O O
different B-O O
mobilities B-O O
of B-O O
osteoblast B-O B-protein
nuclear B-O I-protein
extract-DNA B-O I-protein
complexes B-O I-protein
compared B-O O
with B-O O
T-cell B-O B-protein
nuclear B-O I-protein
extract-DNA B-O I-protein
complexes B-O I-protein
, B-O O
along B-O O
with B-O O
the B-O O
inability B-O O
of B-O O
OSF2 B-O B-protein
to B-O O
be B-O O
upregulated B-O O
by B-O O
retinoic B-O O
acid B-O O
, B-O O
unlike B-O O
the B-O O
other B-O O
PEBP2 B-O B-protein
alpha B-O I-protein
factors B-O I-protein
, B-O O
suggest B-O O
that B-O O
OSF2 B-O B-protein
is B-O O
a B-O O
new B-O O
member B-O O
of B-O O
this B-O O
family B-O O
of B-O O
transcription B-O B-protein
factors B-O I-protein
. B-O O

Thus B-O O
, B-O O
this B-O O
study B-O O
demonstrates B-O O
that B-O O
AML-1B B-O B-protein
can B-O O
increase B-O O
gene B-O O
expression B-O O
of B-O O
an B-O O
osteoblast-specific B-O B-DNA
gene B-O I-DNA
through B-O O
its B-O O
binding B-O O
to B-O O
an B-O O
osteoblast-specific B-O B-DNA
cis-acting B-O I-DNA
element B-O I-DNA
and B-O O
presents B-O O
evidence B-O O
that B-O O
OSF2 B-O B-protein
is B-O O
a B-O O
member B-O O
of B-O O
the B-O O
PEBP2 B-O B-protein
alpha/AML-1 B-O I-protein
family B-O I-protein
of B-O O
transcription B-O B-protein
factors B-O I-protein
. B-O O

Initiation B-O B-protein
binding B-O I-protein
repressor B-O I-protein
, B-O O
a B-O O
factor B-O O
that B-O O
binds B-O O
to B-O O
the B-O O
transcription B-O B-DNA
initiation B-O I-DNA
site B-O I-DNA
of B-O O
the B-O O
histone B-O B-DNA
h5 B-O I-DNA
gene B-O I-DNA
, B-O O
is B-O O
a B-O O
glycosylated B-O B-protein
member B-O I-protein
of B-O O
a B-O O
family B-O O
of B-O O
cell B-O B-protein
growth B-O I-protein
regulators B-O I-protein
[ B-O O
corrected B-O O
] B-O O
[ B-O O
published B-O O
erratum B-O O
appears B-O O
in B-O O
Mol B-O O
Cell B-O O
Biol B-O O
1996 B-O O
Feb B-O O
; B-O O
16 B-O O
( B-O O
2 B-O O
) B-O O
: B-O O
735 B-O O
] B-O O

Initiation B-O B-protein
binding B-O I-protein
repressor B-O I-protein
[ B-O O
corrected B-O O
] B-O O
( B-O O
IBR B-O B-protein
) B-O O
is B-O O
a B-O O
chicken B-O B-protein
erythrocyte B-O I-protein
factor B-O I-protein
( B-O O
apparent B-O O
molecular B-O O
mass B-O O
, B-O O
70 B-O O
to B-O O
73 B-O O
kDa B-O O
) B-O O
that B-O O
binds B-O O
to B-O O
the B-O O
sequences B-O O
spanning B-O O
the B-O O
transcription B-O B-DNA
initiation B-O I-DNA
site B-O I-DNA
of B-O O
the B-O O
histone B-O B-DNA
h5 B-O I-DNA
gene B-O I-DNA
, B-O O
repressing B-O O
its B-O O
transcription B-O O
. B-O O

A B-O O
variety B-O O
of B-O O
other B-O O
cells B-O O
, B-O O
including B-O O
transformed B-O B-cell_type
erythroid B-O I-cell_type
precursors B-O I-cell_type
, B-O O
do B-O O
not B-O O
have B-O O
IBR B-O B-protein
but B-O O
a B-O O
factor B-O O
referred B-O O
to B-O O
as B-O O
IBF B-O B-protein
( B-O O
68 B-O O
to B-O O
70 B-O O
kDa B-O O
) B-O O
that B-O O
recognizes B-O O
the B-O O
same B-O O
IBR B-O B-DNA
sites B-O I-DNA
. B-O O

We B-O O
have B-O O
cloned B-O O
the B-O O
IBR B-O B-DNA
cDNA B-O I-DNA
and B-O O
studied B-O O
the B-O O
relationship B-O O
of B-O O
IBR B-O B-protein
and B-O O
IBF B-O B-protein
. B-O O

IBR B-O B-protein
is B-O O
a B-O O
503-amino-acid-long B-O B-protein
acidic B-O I-protein
protein B-O I-protein
which B-O O
is B-O O
99.0 B-O O
% B-O O
identical B-O O
to B-O O
the B-O O
recently B-O O
reported B-O O
human B-O B-protein
NRF-1/alpha-Pal B-O I-protein
factor B-O I-protein
and B-O O
highly B-O O
related B-O O
to B-O O
the B-O O
invertebrate B-O O
transcription B-O B-protein
factors B-O I-protein
P3A2 B-O B-protein
and B-O O
erected B-O B-protein
wing B-O I-protein
gene B-O I-protein
product B-O I-protein
( B-O O
EWG B-O B-protein
) B-O O
. B-O O

We B-O O
present B-O O
evidence B-O O
that B-O O
IBR B-O B-protein
and B-O O
IBF B-O B-protein
are B-O O
most B-O O
likely B-O O
identical B-O O
proteins B-O O
, B-O O
differing B-O O
in B-O O
their B-O O
degree B-O O
of B-O O
glycosylation B-O O
. B-O O

We B-O O
have B-O O
analyzed B-O O
several B-O O
molecular B-O O
aspects B-O O
of B-O O
IBR/F B-O B-protein
and B-O O
shown B-O O
that B-O O
the B-O O
factor B-O O
associates B-O O
as B-O O
stable B-O O
homodimers B-O B-protein
and B-O O
that B-O O
the B-O O
dimer B-O B-protein
is B-O O
the B-O O
relevant B-O B-protein
DNA-binding B-O I-protein
species B-O I-protein
. B-O O

The B-O O
evolutionarily B-O O
conserved B-O O
N-terminal B-O B-protein
half B-O I-protein
of B-O O
IBR/F B-O B-protein
harbors B-O O
the B-O O
DNA-binding/dimerization B-O B-protein
domain B-O I-protein
( B-O O
outer B-O O
limits B-O O
, B-O O
127 B-O B-DNA
to B-O I-DNA
283 B-O I-DNA
) B-O O
, B-O O
one B-O O
or B-O O
several B-O O
casein B-O B-protein
kinase B-O I-protein
II B-O I-protein
sites B-O I-protein
( B-O O
37 B-O B-DNA
to B-O I-DNA
67 B-O I-DNA
) B-O O
, B-O O
and B-O O
a B-O O
bipartite B-O B-protein
nuclear B-O I-protein
localization B-O I-protein
signal B-O I-protein
( B-O O
89 B-O O
to B-O O
106 B-O O
) B-O O
which B-O O
appears B-O O
to B-O O
be B-O O
necessary B-O O
for B-O O
nuclear B-O O
targeting B-O O
. B-O O

Binding B-O O
site B-O O
selection B-O O
revealed B-O O
that B-O O
the B-O O
alternating B-O B-protein
RCGCRYGCGY B-O I-protein
consensus B-O I-protein
constitutes B-O O
high-affinity B-O O
IBR/F B-O B-DNA
binding B-O I-DNA
sites B-O I-DNA
and B-O O
that B-O O
the B-O O
direct-repeat B-O B-DNA
palindrome B-O I-DNA
TGCGCATGCGCA B-O O
is B-O O
the B-O O
optimal B-O B-DNA
site B-O I-DNA
. B-O O

A B-O O
survey B-O O
of B-O O
genes B-O B-DNA
potentially B-O O
regulated B-O O
by B-O O
this B-O O
family B-O O
of B-O O
factors B-O O
primarily B-O O
revealed B-O O
genes B-O O
involved B-O O
in B-O O
growth-related B-O O
metabolism B-O O
. B-O O

Triggering B-O O
of B-O O
the B-O O
human B-O B-DNA
interleukin-6 B-O I-DNA
gene B-O I-DNA
by B-O O
interferon-gamma B-O B-protein
and B-O O
tumor B-O B-protein
necrosis B-O I-protein
factor-alpha B-O I-protein
in B-O O
monocytic B-O B-cell_type
cells B-O I-cell_type
involves B-O O
cooperation B-O O
between B-O O
interferon B-O B-protein
regulatory B-O I-protein
factor-1 B-O I-protein
, B-O O
NF B-O B-protein
kappa B-O I-protein
B B-O I-protein
, B-O O
and B-O O
Sp1 B-O B-protein
transcription B-O B-protein
factors B-O I-protein
. B-O O

We B-O O
investigated B-O O
the B-O O
molecular B-O O
basis B-O O
of B-O O
the B-O O
synergistic B-O O
induction B-O O
by B-O O
interferon-gamma B-O B-protein
( B-O O
IFN-gamma B-O B-protein
) B-O O
/ B-O O
tumor B-O B-protein
necrosis B-O I-protein
factor-alpha B-O I-protein
( B-O O
TNF-alpha B-O B-protein
) B-O O
of B-O O
human B-O B-DNA
interleukin-6 B-O I-DNA
( B-O I-DNA
IL-6 B-O I-DNA
) B-O I-DNA
gene B-O I-DNA
in B-O O
THP-1 B-O B-cell_line
monocytic B-O I-cell_line
cells B-O I-cell_line
, B-O O
and B-O O
compared B-O O
it B-O O
with B-O O
the B-O O
basis B-O O
of B-O O
this B-O O
induction B-O O
by B-O O
lipopolysaccharide B-O O
( B-O O
LPS B-O O
) B-O O
. B-O O

Functional B-O O
studies B-O O
with B-O O
IL-6 B-O B-DNA
promoter B-O I-DNA
demonstrated B-O O
that B-O O
three B-O O
regions B-O O
are B-O O
the B-O O
targets B-O O
of B-O O
the B-O O
IFN-gamma B-O B-protein
and/or B-O O
TNF-alpha B-O B-protein
action B-O O
, B-O O
whereas B-O O
only B-O O
one B-O O
of B-O O
these B-O O
regions B-O O
seemed B-O O
to B-O O
be B-O O
implicated B-O O
in B-O O
LPS B-O O
activation B-O O
. B-O O

The B-O O
three B-O O
regions B-O O
concerned B-O O
are B-O O
: B-O O
1 B-O O
) B-O O
a B-O O
region B-O O
between B-O O
-73 B-O B-DNA
and B-O I-DNA
-36 B-O I-DNA
, B-O O
which B-O O
is B-O O
the B-O O
minimal B-O B-DNA
element B-O I-DNA
inducible B-O O
by B-O O
LPS B-O O
or B-O O
TNF-alpha B-O B-protein
; B-O O
2 B-O O
) B-O O
an B-O O
element B-O O
located B-O O
between B-O O
-181 B-O B-DNA
and B-O I-DNA
-73 B-O I-DNA
, B-O O
which B-O O
appeared B-O O
to B-O O
regulate B-O O
the B-O O
response B-O O
to B-O O
IFN-gamma B-O B-protein
and B-O O
TNF-alpha B-O B-protein
negatively B-O O
; B-O O
and B-O O
3 B-O O
) B-O O
a B-O O
distal B-O B-DNA
element B-O I-DNA
upstream B-O O
of B-O O
-224 B-O O
, B-O O
which B-O O
was B-O O
inducible B-O O
by B-O O
IFN-gamma B-O B-protein
alone B-O O
. B-O O

LPS B-O O
signaling B-O O
was B-O O
found B-O O
to B-O O
involve B-O O
NF B-O B-protein
kappa B-O I-protein
B B-O I-protein
activation B-O O
by B-O O
the B-O O
p50 B-O B-protein
/p65 B-O I-protein
heterodimers B-O I-protein
. B-O O

Synergistic B-O O
induction B-O O
of B-O O
the B-O O
IL-6 B-O B-DNA
gene B-O I-DNA
by B-O O
IFN-gamma B-O B-protein
and B-O O
TNF-alpha B-O B-protein
, B-O O
in B-O O
monocytic B-O B-cell_type
cells B-O I-cell_type
, B-O O
involved B-O O
cooperation B-O O
between B-O O
the B-O O
IRF-1 B-O B-protein
and B-O O
NF B-O B-protein
kappa B-O I-protein
B B-O I-protein
p65 B-O I-protein
homodimers B-O I-protein
with B-O O
concomitant B-O O
removal B-O O
of B-O O
the B-O O
negative B-O O
effect B-O O
of B-O O
the B-O O
retinoblastoma B-O B-DNA
control B-O I-DNA
element B-O I-DNA
present B-O O
in B-O O
the B-O O
IL-6 B-O B-DNA
promoter B-O I-DNA
. B-O O

This B-O O
removal B-O O
occurred B-O O
by B-O O
activation B-O O
of B-O O
the B-O O
constitutive B-O B-protein
Sp1 B-O I-protein
factor B-O I-protein
, B-O O
whose B-O O
increased B-O O
binding B-O O
activity B-O O
and B-O O
phosphorylation B-O O
were B-O O
mediated B-O O
by B-O O
IFN-gamma B-O B-protein
. B-O O

Mutation B-O O
of B-O O
Jak3 B-O B-protein
in B-O O
a B-O O
patient B-O O
with B-O O
SCID B-O O
: B-O O
essential B-O O
role B-O O
of B-O O
Jak3 B-O B-protein
in B-O O
lymphoid B-O O
development B-O O
. B-O O

Males B-O O
with B-O O
X-linked B-O O
severe B-O O
combined B-O O
immunodeficiency B-O O
( B-O O
XSCID B-O O
) B-O O
have B-O O
defects B-O O
in B-O O
the B-O O
common B-O O
cytokine B-O B-DNA
receptor B-O I-DNA
gamma B-O I-DNA
chain B-O I-DNA
( B-O I-DNA
gamma B-O I-DNA
c B-O I-DNA
) B-O I-DNA
gene B-O I-DNA
that B-O O
encodes B-O O
a B-O O
shared B-O O
, B-O O
essential B-O O
component B-O O
of B-O O
the B-O O
receptors B-O O
of B-O O
interleukin-2 B-O B-protein
( B-O O
IL-2 B-O B-protein
) B-O O
, B-O O
IL-4 B-O B-protein
, B-O O
IL-7 B-O B-protein
, B-O O
IL-9 B-O B-protein
, B-O O
and B-O O
IL-15 B-O B-protein
. B-O O

The B-O O
Janus B-O B-protein
family B-O I-protein
tyrosine B-O I-protein
kinase B-O I-protein
Jak3 B-O B-protein
is B-O O
the B-O O
only B-O O
signaling B-O B-protein
molecule B-O I-protein
known B-O O
to B-O O
be B-O O
associated B-O O
with B-O O
gamma B-O B-protein
c B-O I-protein
, B-O O
so B-O O
it B-O O
was B-O O
hypothesized B-O O
that B-O O
defects B-O O
in B-O O
Jak3 B-O B-protein
might B-O O
cause B-O O
an B-O O
XSCID B-O O
-like B-O O
phenotype B-O O
. B-O O

A B-O O
girl B-O O
with B-O O
immunological B-O O
features B-O O
indistinguishable B-O O
from B-O O
those B-O O
of B-O O
XSCID B-O O
was B-O O
therefore B-O O
selected B-O O
for B-O O
analysis B-O O
. B-O O

An B-O O
Epstein-Barr B-O B-cell_line
virus B-O I-cell_line
( B-O I-cell_line
EBV B-O I-cell_line
) B-O I-cell_line
-transformed B-O I-cell_line
cell B-O I-cell_line
line B-O I-cell_line
derived B-O O
from B-O O
her B-O O
lymphocytes B-O B-cell_type
had B-O O
normal B-O O
gamma B-O B-protein
c B-O I-protein
expression B-O O
but B-O O
lacked B-O O
Jak3 B-O B-protein
protein B-O I-protein
and B-O O
had B-O O
greatly B-O O
diminished B-O O
Jak3 B-O B-RNA
messenger B-O I-RNA
RNA B-O I-RNA
. B-O O

Sequencing B-O O
revealed B-O O
a B-O O
different B-O O
mutation B-O O
on B-O O
each B-O O
allele B-O B-DNA
: B-O O
a B-O O
single B-O O
nucleotide B-O O
insertion B-O O
resulting B-O O
in B-O O
a B-O O
frame B-O O
shift B-O O
and B-O O
premature B-O O
termination B-O O
in B-O O
the B-O O
Jak3 B-O B-protein
JH4 B-O I-protein
domain B-O I-protein
and B-O O
a B-O O
nonsense B-O O
mutation B-O O
in B-O O
the B-O O
Jak3 B-O B-protein
JH2 B-O I-protein
domain B-O I-protein
. B-O O

The B-O O
lack B-O O
of B-O O
Jak3 B-O B-protein
expression B-O O
correlated B-O O
with B-O O
impaired B-O O
B B-O O
cell B-O O
signaling B-O O
, B-O O
as B-O O
demonstrated B-O O
by B-O O
the B-O O
inability B-O O
of B-O O
IL-4 B-O B-protein
to B-O O
activate B-O O
Stat6 B-O B-protein
in B-O O
the B-O O
EBV B-O B-cell_line
-transformed B-O I-cell_line
cell B-O I-cell_line
line B-O I-cell_line
from B-O O
the B-O O
patient B-O O
. B-O O
These B-O O
observations B-O O
indicate B-O O
that B-O O
the B-O O
functions B-O O
of B-O O
gamma B-O B-protein
c B-O I-protein
are B-O O
dependent B-O O
on B-O O
Jak3 B-O B-protein
and B-O O
that B-O O
Jak3 B-O B-protein
is B-O O
essential B-O O
for B-O O
lymphoid B-O O
development B-O O
and B-O O
signaling B-O O
. B-O O

Constitutive B-O O
overexpression B-O O
of B-O O
the B-O O
L-selectin B-O B-DNA
gene B-O I-DNA
in B-O O
fresh B-O O
leukemic B-O B-cell_type
cells B-O I-cell_type
of B-O O
adult B-O O
T-cell B-O O
leukemia B-O O
that B-O O
can B-O O
be B-O O
transactivated B-O O
by B-O O
human B-O B-protein
T-cell B-O I-protein
lymphotropic B-O I-protein
virus B-O I-protein
type B-O I-protein
1 B-O I-protein
Tax B-O I-protein
. B-O O

L-selectin B-O B-protein
is B-O O
an B-O O
adhesion B-O B-protein
molecule B-O I-protein
of B-O O
the B-O O
selectin B-O B-protein
family B-O I-protein
that B-O O
mediates B-O O
the B-O O
initial B-O O
step B-O O
of B-O O
leukocyte B-O O
adhesion B-O O
to B-O O
vascular B-O O
endothelium B-O O
. B-O O

Upon B-O O
cellular B-O O
activation B-O O
, B-O O
expression B-O O
of B-O O
the B-O O
L-selectin B-O B-DNA
gene B-O I-DNA
is B-O O
downregulated B-O O
at B-O O
both B-O O
the B-O O
protein B-O O
and B-O O
mRNA B-O O
levels B-O O
. B-O O

To B-O O
understand B-O O
the B-O O
mechanism B-O O
of B-O O
leukemic B-O B-cell_type
cell B-O I-cell_type
infiltration B-O O
into B-O O
organs B-O O
, B-O O
we B-O O
studied B-O O
the B-O O
expression B-O O
and B-O O
regulation B-O O
of B-O O
L-selectin B-O B-RNA
mRNA B-O I-RNA
in B-O O
fresh B-O O
leukemic B-O B-cell_type
cells B-O I-cell_type
of B-O O
adult B-O O
T-cell B-O O
leukemia B-O O
( B-O O
ATL B-O O
) B-O O
patients B-O O
and B-O O
investigated B-O O
the B-O O
response B-O O
of B-O O
the B-O O
L-selectin B-O B-DNA
promoter B-O I-DNA
to B-O O
human B-O B-protein
T-cell B-O I-protein
lymphotropic B-O I-protein
virus B-O I-protein
type B-O I-protein
1 B-O I-protein
( B-O I-protein
HTLV-1 B-O I-protein
) B-O I-protein
Tax B-O I-protein
, B-O O
which B-O O
is B-O O
a B-O O
viral B-O B-protein
transcriptional B-O I-protein
transactivator B-O I-protein
. B-O O

Flow B-O O
cytometry B-O O
showed B-O O
that B-O O
L-selectin B-O B-protein
was B-O O
expressed B-O O
on B-O O
fresh B-O O
ATL B-O B-cell_line
cells B-O I-cell_line
along B-O O
with B-O O
other B-O O
activation B-O O
antigens B-O O
. B-O O

Northern B-O O
blot B-O O
analysis B-O O
showed B-O O
that B-O O
ATL B-O B-cell_line
cells B-O I-cell_line
overexpressed B-O O
that B-O O
L-selectin B-O B-RNA
mRNA B-O I-RNA
and B-O O
that B-O O
the B-O O
level B-O O
was B-O O
aberrantly B-O O
upregulated B-O O
after B-O O
PMA B-O O
stimulation B-O O
. B-O O

Studies B-O O
using B-O O
in B-O O
situ B-O O
hybridization B-O O
showed B-O O
expression B-O O
of B-O O
the B-O O
L-selectin B-O B-RNA
mRNA B-O I-RNA
in B-O O
the B-O O
infiltrating B-O O
leukemic B-O B-cell_type
cells B-O I-cell_type
in B-O O
the B-O O
liver B-O O
of B-O O
two B-O O
ATL B-O O
patients B-O O
. B-O O

Intravenous B-O O
injection B-O O
of B-O O
a B-O O
rat B-O B-cell_line
T-cell B-O I-cell_line
line B-O I-cell_line
that B-O O
overexpresses B-O O
L-selectin B-O B-protein
showed B-O O
increased B-O O
organ B-O O
infiltration B-O O
. B-O O

The B-O O
induction B-O O
of B-O O
Tax B-O B-protein
expression B-O O
in B-O O
JPX9 B-O B-cell_line
cells B-O I-cell_line
resulted B-O O
in B-O O
about B-O O
a B-O O
twofold B-O O
increase B-O O
in B-O O
the B-O O
mRNA B-O B-RNA
expression B-O O
levels B-O O
compared B-O O
with B-O O
the B-O O
basal B-O O
level B-O O
. B-O O

Chloramphenicol B-O B-protein
acetyltransferase B-O I-protein
( B-O O
CAT B-O B-protein
) B-O O
assay B-O O
after B-O O
transient B-O O
cotransfection B-O O
showed B-O O
about B-O O
a B-O O
fivefold B-O O
transactivation B-O O
of B-O O
the B-O O
L-selectin B-O B-DNA
promoter B-O I-DNA
by B-O O
Tax B-O B-protein
. B-O O

The B-O O
serum B-O O
level B-O O
of B-O O
the B-O O
shed B-O O
form B-O O
of B-O O
L-selectin B-O B-protein
was B-O O
significantly B-O O
increased B-O O
in B-O O
ATL B-O O
patients B-O O
( B-O O
mean B-O O
+/- B-O O
SD B-O O
, B-O O
4 B-O O
, B-O O
215.4 B-O O
+/- B-O O
4 B-O O
, B-O O
111 B-O O
ng/mL B-O O
) B-O O
compared B-O O
with B-O O
those B-O O
of B-O O
asymptomatic B-O O
carriers B-O O
and B-O O
healthy B-O O
blood B-O O
donors B-O O
( B-O O
mean B-O O
+/- B-O O
SD B-O O
, B-O O
1 B-O O
, B-O O
148.0 B-O O
+/- B-O O
269.0 B-O O
ng/mL B-O O
and B-O O
991.9 B-O O
+/- B-O O
224 B-O O
ng/mL B-O O
, B-O O
respectively B-O O
) B-O O
. B-O O

These B-O O
results B-O O
indicated B-O O
that B-O O
ATL B-O B-cell_line
cells B-O I-cell_line
constitutively B-O O
overexpress B-O O
the B-O O
L-selectin B-O B-DNA
gene B-O I-DNA
that B-O O
can B-O O
be B-O O
transactivated B-O O
by B-O O
HTLV-1 B-O O
Tax B-O B-protein
. B-O O

The B-O O
overexpression B-O O
of B-O O
L-selectin B-O B-protein
, B-O O
as B-O O
well B-O O
as B-O O
of B-O O
inflammatory B-O B-protein
cytokines B-O I-protein
, B-O O
by B-O O
ATL B-O B-cell_line
cells B-O I-cell_line
may B-O O
provide B-O O
a B-O O
basis B-O O
for B-O O
ATL B-O B-cell_line
cells B-O I-cell_line
to B-O O
attach B-O O
the B-O O
vascular B-O O
endothelium B-O O
, B-O O
leading B-O O
to B-O O
transmigration B-O O
and B-O O
organ B-O O
infitration B-O O
. B-O O

Human B-O O
herpesvirus B-O O
6 B-O O
variant B-O O
A B-O O
, B-O O
but B-O O
not B-O O
variant B-O O
B B-O O
, B-O O
infects B-O O
EBV B-O B-cell_line
-positive B-O I-cell_line
B B-O I-cell_line
lymphoid B-O I-cell_line
cells B-O I-cell_line
, B-O O
activating B-O O
the B-O O
latent B-O B-DNA
EBV B-O I-DNA
genome B-O I-DNA
through B-O O
a B-O O
BZLF-1 B-O B-protein
-dependent B-O O
mechanism B-O O
. B-O O

Human B-O O
herpesvirus B-O O
6 B-O O
, B-O O
a B-O O
predominantly B-O O
T B-O O
lymphotropic B-O O
virus B-O O
, B-O O
has B-O O
been B-O O
recently B-O O
shown B-O O
to B-O O
infect B-O O
some B-O O
EBV B-O B-cell_line
-positive B-O I-cell_line
B B-O I-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
, B-O O
and B-O O
to B-O O
induce B-O O
in B-O O
them B-O O
the B-O O
activation B-O O
of B-O O
the B-O O
EBV B-O O
lytic B-O O
cycle B-O O
. B-O O

Here B-O O
we B-O O
have B-O O
confirmed B-O O
and B-O O
extended B-O O
such B-O O
observations B-O O
, B-O O
showing B-O O
that B-O O
( B-O O
1 B-O O
) B-O O
this B-O O
phenomenon B-O O
is B-O O
restricted B-O O
to B-O O
the B-O O
variant B-O O
A B-O O
of B-O O
HHV-6 B-O O
: B-O O
in B-O O
fact B-O O
two B-O O
isolates B-O O
belonging B-O O
to B-O O
the B-O O
HHV-6 B-O O
variant B-O O
B B-O O
( B-O O
BA92 B-O B-protein
and B-O O
Z29 B-O B-protein
) B-O O
were B-O O
neither B-O O
able B-O O
to B-O O
infect B-O O
any B-O O
B B-O B-cell_line
cell B-O I-cell_line
line B-O I-cell_line
, B-O O
independently B-O O
of B-O O
the B-O O
EBV B-O O
status B-O O
, B-O O
nor B-O O
to B-O O
induce B-O O
the B-O O
EBV B-O B-DNA
genome B-O I-DNA
expression B-O O
. B-O O

The B-O O
only B-O O
exception B-O O
is B-O O
represented B-O O
by B-O O
the B-O O
P3HR1 B-O B-cell_line
cells B-O I-cell_line
, B-O O
in B-O O
which B-O O
, B-O O
however B-O O
, B-O O
the B-O O
infection B-O O
by B-O O
the B-O O
variant B-O O
B B-O O
does B-O O
not B-O O
determine B-O O
induction B-O O
of B-O O
EBV B-O B-protein
antigens B-O I-protein
; B-O O
( B-O O
2 B-O O
) B-O O
the B-O O
presence B-O O
of B-O O
the B-O O
EBV B-O B-DNA
genome B-O I-DNA
contributes B-O O
to B-O O
the B-O O
susceptibility B-O O
of B-O O
the B-O O
B B-O B-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
to B-O O
HHV-6 B-O O
infection B-O O
, B-O O
increasing B-O O
the B-O O
binding B-O B-DNA
sites B-O I-DNA
and B-O O
the B-O O
percentage B-O O
of B-O O
infectable B-O B-cell_type
cells B-O I-cell_type
, B-O O
as B-O O
detected B-O O
by B-O O
immunoelectron B-O O
microscopy B-O O
; B-O O
and B-O O
( B-O O
3 B-O O
) B-O O
HHV-6 B-O B-cell_line
infected B-O I-cell_line
T B-O I-cell_line
cells B-O I-cell_line
, B-O O
transfected B-O O
with B-O O
plasmids B-O B-DNA
bearing B-O O
the B-O O
promoter B-O B-DNA
regions B-O I-DNA
of B-O O
the B-O O
EBV B-O B-DNA
early B-O I-DNA
genes B-O I-DNA
BZLF1 B-O B-protein
and B-O O
BMRF1 B-O B-DNA
, B-O O
show B-O O
a B-O O
strong B-O O
transactivation B-O O
of B-O O
these B-O O
promoters B-O B-DNA
. B-O O

Evidence B-O O
for B-O O
normal B-O O
vitamin B-O B-RNA
D B-O I-RNA
receptor B-O I-RNA
messenger B-O I-RNA
ribonucleic B-O I-RNA
acid B-O I-RNA
and B-O O
genotype B-O O
in B-O O
absorptive B-O O
hypercalciuria B-O O
. B-O O

Absorptive B-O O
hypercalciuria B-O O
( B-O O
a B-O O
stone-forming B-O O
condition B-O O
) B-O O
is B-O O
characterized B-O O
by B-O O
gut B-O O
hyperabsorption B-O O
of B-O O
calcium B-O O
, B-O O
hypercalciuria B-O O
, B-O O
and B-O O
reduced B-O O
bone B-O O
density B-O O
. B-O O

Inasmuch B-O O
as B-O O
these B-O O
features B-O O
implicate B-O O
enhanced B-O O
calcitriol B-O O
action B-O O
in B-O O
gut B-O O
and B-O O
bone B-O O
, B-O O
we B-O O
analyzed B-O O
the B-O O
vitamin B-O B-DNA
D B-O I-DNA
receptor B-O I-DNA
( B-O I-DNA
VDR B-O I-DNA
) B-O I-DNA
gene B-O I-DNA
to B-O O
ascertain B-O O
whether B-O O
an B-O O
abnormality B-O O
of B-O O
this B-O O
gene B-O O
marks B-O O
patients B-O O
with B-O O
intestinal B-O O
hyperabsorption B-O O
of B-O O
calcium B-O O
. B-O O

We B-O O
have B-O O
compared B-O O
the B-O O
frequency B-O O
of B-O O
a B-O O
restriction B-O B-DNA
fragment B-O I-DNA
length B-O I-DNA
polymorphism B-O I-DNA
( B-O O
Bsm B-O O
I B-O O
) B-O O
associated B-O O
with B-O O
different B-O O
alleles B-O B-DNA
of B-O O
the B-O O
VDR B-O B-DNA
gene B-O I-DNA
in B-O O
a B-O O
group B-O O
of B-O O
33 B-O O
well B-O O
characterized B-O O
absorptive B-O O
hypercalciuric B-O O
patients B-O O
and B-O O
a B-O O
group B-O O
of B-O O
36 B-O O
normal B-O O
race- B-O O
and B-O O
age-matched B-O O
control B-O O
subjects B-O O
. B-O O

There B-O O
was B-O O
no B-O O
difference B-O O
between B-O O
the B-O O
distribution B-O O
of B-O O
the B-O O
VDR B-O B-DNA
alleles B-O I-DNA
in B-O O
the B-O O
patient B-O O
population B-O O
when B-O O
compared B-O O
with B-O O
the B-O O
normal B-O B-cell_type
population B-O I-cell_type
. B-O O

The B-O O
coding B-O O
region B-O O
of B-O O
VDR B-O B-RNA
messenger B-O I-RNA
RNA B-O I-RNA
was B-O O
also B-O O
normal B-O O
, B-O O
as B-O O
determined B-O O
by B-O O
both B-O O
DNA B-O B-DNA
sequence B-O I-DNA
analysis B-O O
and B-O O
chemical B-O O
mismatch B-O O
cleavage B-O O
analysis B-O O
of B-O O
copy B-O O
DNA B-O O
from B-O O
11 B-O O
index B-O O
absorptive B-O O
hypercalciuric B-O O
patients B-O O
. B-O O

On B-O O
the B-O O
basis B-O O
of B-O O
these B-O O
results B-O O
, B-O O
we B-O O
propose B-O O
that B-O O
the B-O O
enhanced B-O O
intestinal B-O O
calcium B-O O
absorption B-O O
invariably B-O O
seen B-O O
in B-O O
absorptive B-O O
hypercalciuria B-O O
and B-O O
attendant B-O O
symptoms B-O O
of B-O O
this B-O O
disorder B-O O
are B-O O
not B-O O
attributable B-O O
to B-O O
mutations B-O O
of B-O O
the B-O O
VDR B-O B-protein
and B-O O
are B-O O
not B-O O
linked B-O O
to B-O O
a B-O O
common B-O O
VDR B-O B-protein
genotype B-O O
. B-O O

Transcriptional B-O O
regulation B-O O
of B-O O
the B-O O
gene B-O O
encoding B-O O
the B-O O
human B-O B-protein
C-type B-O I-protein
lectin B-O I-protein
leukocyte B-O I-protein
receptor B-O I-protein
AIM/CD69 B-O B-protein
and B-O O
functional B-O O
characterization B-O O
of B-O O
its B-O O
tumor B-O B-DNA
necrosis B-O I-DNA
factor-alpha B-O I-DNA
-responsive B-O I-DNA
elements B-O I-DNA
. B-O O

The B-O O
human B-O B-protein
activation B-O I-protein
antigen B-O I-protein
CD69 B-O B-protein
is B-O O
a B-O O
member B-O O
of B-O O
the B-O O
C-type B-O B-protein
animal B-O I-protein
lectin B-O I-protein
superfamily B-O I-protein
that B-O O
functions B-O O
as B-O O
a B-O O
signal-transmitting B-O B-protein
receptor B-O I-protein
. B-O O

Although B-O O
the B-O O
expression B-O O
of B-O O
CD69 B-O B-protein
can B-O O
be B-O O
induced B-O O
in B-O O
vitro B-O O
on B-O O
cells B-O O
of B-O O
most B-O O
hematopoietic B-O B-cell_type
lineages B-O I-cell_type
with B-O O
a B-O O
wide B-O O
variety B-O O
of B-O O
stimuli B-O O
, B-O O
in B-O O
vivo B-O O
it B-O O
is B-O O
mainly B-O O
expressed B-O O
by B-O O
T- B-O B-cell_type
lymphocytes B-O I-cell_type
located B-O O
in B-O O
the B-O O
inflammatory B-O B-cell_type
infiltrates B-O I-cell_type
of B-O O
several B-O O
human B-O O
diseases B-O O
. B-O O

To B-O O
elucidate B-O O
the B-O O
mechanisms B-O O
that B-O O
regulate B-O O
the B-O O
constitutive B-O O
and B-O O
inducible B-O O
expression B-O O
of B-O O
CD69 B-O B-protein
by B-O O
leukocytes B-O B-cell_type
, B-O O
we B-O O
isolated B-O O
the B-O O
promoter B-O B-DNA
region B-O I-DNA
of B-O O
the B-O O
CD69 B-O B-DNA
gene B-O I-DNA
and B-O O
carried B-O O
out B-O O
its B-O O
functional B-O O
characterization B-O O
. B-O O

Sequence B-O O
analysis B-O O
of B-O O
the B-O O
5'-flanking B-O B-DNA
region B-O I-DNA
of B-O O
the B-O O
CD69 B-O B-DNA
gene B-O I-DNA
revealed B-O O
the B-O O
presence B-O O
of B-O O
a B-O O
potential B-O O
TATA B-O B-DNA
element B-O I-DNA
30 B-O B-DNA
base B-O I-DNA
pairs B-O I-DNA
upstream B-O I-DNA
of B-O O
the B-O O
major B-O O
transcription B-O B-DNA
initiation B-O I-DNA
site B-O I-DNA
and B-O O
several B-O O
putative B-O O
binding B-O O
sequences B-O O
for B-O O
inducible B-O O
transcription B-O B-protein
factors B-O I-protein
( B-O O
NF-kappa B-O B-protein
B B-O I-protein
, B-O O
Egr-1 B-O B-protein
, B-O O
AP-1 B-O B-protein
) B-O O
, B-O O
which B-O O
might B-O O
mediate B-O O
the B-O O
inducible B-O O
expression B-O O
of B-O O
this B-O O
gene B-O O
. B-O O

Transient B-O O
expression B-O O
of B-O O
CD69 B-O B-DNA
promoter-based B-O I-DNA
reporter B-O I-DNA
gene B-O I-DNA
constructs B-O I-DNA
in B-O O
K562 B-O B-cell_line
cells B-O I-cell_line
indicated B-O O
that B-O O
the B-O O
proximal B-O B-DNA
promoter B-O I-DNA
region B-O I-DNA
spanning B-O O
positions B-O O
-78 B-O O
to B-O O
+16 B-O O
contained B-O O
the B-O O
cis-acting B-O B-DNA
sequences B-O I-DNA
necessary B-O O
for B-O O
basal B-O O
and B-O O
phorbol B-O O
12-myristate B-O O
13-acetate B-O O
-inducible B-O O
transcription B-O O
of B-O O
the B-O O
CD69 B-O B-DNA
gene B-O I-DNA
. B-O O

Removal B-O O
of B-O O
the B-O O
upstream B-O B-DNA
sequences B-O I-DNA
located B-O O
between B-O O
positions B-O O
-78 B-O O
and B-O O
-38 B-O O
resulted B-O O
in B-O O
decreased B-O O
promoter B-O O
strength B-O O
and B-O O
abolished B-O O
the B-O O
response B-O O
to B-O O
phorbol B-O O
12-myristate B-O O
13-acetate B-O O
. B-O O

We B-O O
also B-O O
found B-O O
that B-O O
tumor B-O B-protein
necrosis B-O I-protein
factor-alpha B-O I-protein
( B-O O
TNF-alpha B-O B-protein
) B-O O
is B-O O
capable B-O O
of B-O O
inducing B-O O
the B-O O
surface B-O O
expression B-O O
of B-O O
the B-O O
CD69 B-O B-protein
molecule B-O I-protein
as B-O O
well B-O O
as B-O O
the B-O O
promoter B-O O
activity B-O O
of B-O O
fusion B-O B-DNA
plasmids B-O I-DNA
that B-O O
contain B-O O
5'-flanking B-O B-DNA
sequences B-O I-DNA
of B-O O
the B-O O
CD69 B-O B-DNA
gene B-O I-DNA
, B-O O
suggesting B-O O
that B-O O
this B-O O
cytokine B-O B-protein
may B-O O
regulate B-O O
in B-O O
vivo B-O O
the B-O O
expression B-O O
of B-O O
CD69 B-O B-protein
. B-O O

( B-O O
ABSTRACT B-O O
TRUNCATED B-O O
AT B-O O
250 B-O O
WORDS B-O O
) B-O O

Characterization B-O O
of B-O O
5 B-O B-DNA
' B-O I-DNA
end B-O I-DNA
of B-O O
human B-O B-DNA
thromboxane B-O I-DNA
receptor B-O I-DNA
gene B-O I-DNA
. B-O O

Organizational B-O O
analysis B-O O
and B-O O
mapping B-O O
of B-O O
protein B-O B-protein
kinase B-O I-protein
C B-O I-protein
-- B-O O
responsive B-O B-DNA
elements B-O I-DNA
regulating B-O O
expression B-O O
in B-O O
platelets B-O B-cell_type
. B-O O

Platelet B-O B-protein
thromboxane B-O I-protein
receptors B-O I-protein
are B-O O
acutely B-O O
and B-O O
reversibly B-O O
upregulated B-O O
after B-O O
acute B-O O
myocardial B-O O
infarction B-O O
. B-O O

To B-O O
determine B-O O
if B-O O
platelet B-O B-protein
thromboxane B-O I-protein
receptors B-O I-protein
are B-O O
under B-O O
transcriptional B-O O
control B-O O
, B-O O
we B-O O
isolated B-O O
and B-O O
characterized B-O O
human B-O B-DNA
genomic B-O I-DNA
DNA B-O I-DNA
clones B-O I-DNA
containing B-O O
the B-O O
5 B-O B-DNA
' B-O I-DNA
flanking B-O I-DNA
region B-O I-DNA
of B-O O
the B-O O
thromboxane B-O B-DNA
receptor B-O I-DNA
gene B-O I-DNA
. B-O O

The B-O O
exon-intron B-O B-DNA
structure B-O I-DNA
of B-O O
the B-O O
5 B-O B-DNA
' B-O I-DNA
portion B-O I-DNA
of B-O O
the B-O O
thromboxane B-O B-DNA
receptor B-O I-DNA
gene B-O I-DNA
was B-O O
determined B-O O
initially B-O O
by B-O O
comparing B-O O
the B-O O
nucleotide B-O B-DNA
sequence B-O I-DNA
of B-O O
the B-O O
5 B-O B-DNA
' B-O I-DNA
flanking B-O I-DNA
genomic B-O I-DNA
clone B-O I-DNA
with B-O O
that B-O O
of B-O O
a B-O O
novel B-O B-DNA
human B-O I-DNA
uterine B-O I-DNA
thromboxane B-O I-DNA
receptor B-O I-DNA
cDNA B-O I-DNA
that B-O O
extended B-O O
the B-O O
mRNA B-O B-RNA
141 B-O B-DNA
bp B-O I-DNA
further B-O I-DNA
upstream B-O I-DNA
than B-O O
the B-O O
previously B-O O
identified B-O O
human B-O B-DNA
placental B-O I-DNA
cDNA B-O I-DNA
. B-O O

A B-O O
major B-O B-DNA
transcription B-O I-DNA
initiation B-O I-DNA
site B-O I-DNA
was B-O O
located B-O O
in B-O O
three B-O O
human B-O O
tissues B-O O
approximately B-O O
560 B-O B-DNA
bp B-O I-DNA
upstream B-O I-DNA
from B-O O
the B-O O
translation B-O B-DNA
initiation B-O I-DNA
codon B-O I-DNA
and B-O O
380 B-O B-DNA
bp B-O I-DNA
upstream B-O I-DNA
from B-O O
any B-O O
previously B-O O
identified B-O O
transcription B-O B-DNA
initiation B-O I-DNA
site B-O I-DNA
. B-O O

The B-O O
thromboxane B-O B-DNA
receptor B-O I-DNA
gene B-O I-DNA
has B-O O
neither B-O O
a B-O O
TATA B-O B-DNA
nor B-O O
a B-O O
CAAT B-O B-DNA
consensus B-O I-DNA
site B-O I-DNA
. B-O O

Promoter B-O O
function B-O O
of B-O O
the B-O O
5 B-O B-DNA
' B-O I-DNA
flanking B-O I-DNA
region B-O I-DNA
of B-O O
the B-O O
thromboxane B-O B-DNA
receptor B-O I-DNA
gene B-O I-DNA
was B-O O
evaluated B-O O
by B-O O
transfection B-O O
of B-O O
thromboxane B-O B-DNA
receptor B-O I-DNA
gene B-O I-DNA
promoter/ B-O I-DNA
chloramphenicol B-O I-DNA
acetyltransferase B-O I-DNA
( B-O I-DNA
CAT B-O I-DNA
) B-O I-DNA
chimera B-O I-DNA
plasmids B-O I-DNA
into B-O O
platelet-like B-O O
K562 B-O B-cell_line
cells B-O I-cell_line
. B-O O

Thromboxane B-O O
receptor B-O O
promoter B-O O
activity B-O O
, B-O O
as B-O O
assessed B-O O
by B-O O
CAT B-O B-protein
expression B-O O
, B-O O
was B-O O
relatively B-O O
weak B-O O
but B-O O
was B-O O
significantly B-O O
enhanced B-O O
by B-O O
phorbol B-O O
ester B-O O
treatment B-O O
. B-O O

Functional B-O O
analysis B-O O
of B-O O
5 B-O B-DNA
' B-O I-DNA
deletion B-O I-DNA
constructs B-O I-DNA
in B-O O
transfected B-O O
K562 B-O B-cell_line
cells B-O I-cell_line
and B-O O
gel B-O O
mobility B-O O
shift B-O O
localized B-O O
the B-O O
major B-O B-DNA
phorbol B-O I-DNA
ester B-O I-DNA
-responsive B-O I-DNA
motifs B-O I-DNA
in B-O O
the B-O O
thromboxane B-O B-DNA
receptor B-O I-DNA
gene B-O I-DNA
promoter B-O I-DNA
to B-O O
a B-O O
cluster B-O O
of B-O O
activator B-O B-DNA
protein-2 B-O I-DNA
( B-O I-DNA
AP-2 B-O I-DNA
) B-O I-DNA
binding B-O I-DNA
consensus B-O I-DNA
sites B-O I-DNA
located B-O O
approximately B-O O
1.8 B-O O
kb B-O O
5 B-O O
' B-O O
from B-O O
the B-O O
transcription B-O B-DNA
initiation B-O I-DNA
site B-O I-DNA
. B-O O

These B-O O
studies B-O O
are B-O O
the B-O O
first B-O O
to B-O O
determine B-O O
the B-O O
structure B-O O
and B-O O
organization B-O O
of B-O O
the B-O O
5 B-O B-DNA
' B-O I-DNA
end B-O I-DNA
of B-O O
the B-O O
thromboxane B-O B-DNA
receptor B-O I-DNA
gene B-O I-DNA
and B-O O
demonstrate B-O O
that B-O O
thromboxane B-O B-DNA
receptor B-O I-DNA
gene B-O I-DNA
expression B-O O
can B-O O
be B-O O
regulated B-O O
by B-O O
activation B-O O
of B-O O
protein B-O B-protein
kinase B-O I-protein
C B-O I-protein
via B-O O
induction B-O O
of B-O O
an B-O O
AP-2 B-O B-protein
-like B-O O
nuclear B-O O
factor B-O O
binding B-O O
to B-O O
upstream B-O B-DNA
promoter B-O I-DNA
elements B-O I-DNA
. B-O O

These B-O O
findings B-O O
strongly B-O O
suggest B-O O
that B-O O
the B-O O
mechanism B-O O
for B-O O
previously B-O O
described B-O O
upregulation B-O O
of B-O O
platelet B-O B-protein
thromboxane B-O I-protein
receptors B-O I-protein
after B-O O
acute B-O O
myocardial B-O O
infarction B-O O
is B-O O
increased B-O O
thromboxane B-O B-DNA
receptor B-O I-DNA
gene B-O I-DNA
transcription B-O O
in B-O O
platelet-progenitor B-O B-cell_type
cells B-O I-cell_type
. B-O O

Estrogen B-O B-protein
receptor B-O I-protein
concentration B-O O
and B-O O
social B-O O
factors B-O O
as B-O O
predictors B-O O
of B-O O
natural B-O B-cell_type
killer B-O I-cell_type
cell B-O I-cell_type
activity B-O O
in B-O O
early-stage B-O O
breast B-O O
cancer B-O O
patients B-O O
. B-O O

Confirmation B-O O
of B-O O
a B-O O
model B-O O
. B-O O

Previous B-O O
work B-O O
of B-O O
ours B-O O
has B-O O
demonstrated B-O O
that B-O O
a B-O O
significant B-O O
amount B-O O
of B-O O
natural B-O O
killer B-O O
( B-O O
NK B-O O
) B-O O
activity B-O O
variance B-O O
after B-O O
surgery B-O O
in B-O O
stage B-O O
I B-O O
and B-O O
II B-O O
breast B-O O
cancer B-O O
patients B-O O
could B-O O
be B-O O
accounted B-O O
for B-O O
by B-O O
both B-O O
the B-O O
estrogen B-O B-protein
receptor B-O I-protein
( B-O O
ER B-O B-protein
) B-O O
status B-O O
of B-O O
the B-O O
tumor B-O O
and B-O O
by B-O O
social B-O B-protein
factors B-O I-protein
, B-O O
namely B-O O
, B-O O
perceived B-O O
social B-O O
support B-O O
and B-O O
seeking B-O O
social B-O O
support B-O O
as B-O O
a B-O O
general B-O O
coping B-O O
strategy B-O O
. B-O O

As B-O O
considerable B-O O
evidence B-O O
has B-O O
accumulated B-O O
that B-O O
social B-O O
support B-O O
in B-O O
both B-O O
animal B-O O
and B-O O
human B-O B-cell_type
populations B-O I-cell_type
may B-O O
have B-O O
survival B-O O
value B-O O
, B-O O
we B-O O
sought B-O O
to B-O O
test B-O O
the B-O O
reliability B-O O
of B-O O
this B-O O
regression B-O O
model B-O O
, B-O O
using B-O O
coping B-O O
and B-O O
perceived B-O O
support B-O O
factor B-O O
values B-O O
obtained B-O O
at B-O O
3 B-O O
months B-O O
after B-O O
surgery B-O O
to B-O O
account B-O O
for B-O O
concurrent B-O O
follow-up B-O O
NK B-O O
activity B-O O
in B-O O
this B-O O
serially B-O O
assessed B-O O
group B-O O
of B-O O
patients B-O O
. B-O O

It B-O O
was B-O O
found B-O O
that B-O O
the B-O O
most B-O O
significant B-O O
variable B-O O
predicting B-O O
NK B-O O
activity B-O O
at B-O O
follow-up B-O O
was B-O O
tumor B-O O
ER B-O B-protein
concentration B-O O
, B-O O
with B-O O
higher B-O O
NK B-O O
activity B-O O
associated B-O O
with B-O O
ER B-O B-protein
- B-O O
status B-O O
. B-O O

In B-O O
addition B-O O
, B-O O
seeking B-O O
social B-O O
support B-O O
as B-O O
a B-O O
coping B-O O
strategy B-O O
, B-O O
as B-O O
well B-O O
as B-O O
the B-O O
perceived B-O O
quality B-O O
of B-O O
support B-O O
, B-O O
also B-O O
entered B-O O
the B-O O
model B-O O
to B-O O
account B-O O
for B-O O
a B-O O
significant B-O O
amount B-O O
of B-O O
NK B-O O
activity B-O O
variance B-O O
( B-O O
multivariate B-O O
F B-O O
= B-O O
5.25 B-O O
, B-O O
p B-O O
less B-O O
than B-O O
0.001 B-O O
) B-O O
. B-O O

If B-O O
, B-O O
as B-O O
the B-O O
literature B-O O
suggests B-O O
, B-O O
NK B-O O
activity B-O O
is B-O O
relevant B-O O
to B-O O
breast B-O O
cancer B-O O
control B-O O
, B-O O
and B-O O
since B-O O
ER B-O B-protein
- B-O O
tumors B-O O
have B-O O
a B-O O
worse B-O O
prognosis B-O O
, B-O O
we B-O O
suggest B-O O
here B-O O
that B-O O
perhaps B-O O
such B-O O
tumors B-O O
are B-O O
resistant B-O O
to B-O O
control B-O O
by B-O O
NK B-O B-cell_type
cells B-O I-cell_type
because B-O O
they B-O O
lack B-O O
the B-O O
ability B-O O
to B-O O
attract B-O O
an B-O O
accumulation B-O O
of B-O O
effector B-O B-cell_type
cells B-O I-cell_type
to B-O O
the B-O O
tumor B-O B-DNA
site B-O I-DNA
, B-O O
or B-O O
because B-O O
blocking B-O B-protein
factors B-O I-protein
at B-O O
the B-O O
site B-O O
of B-O O
the B-O O
tumor B-O O
prevent B-O O
local B-O O
tumor B-O O
control B-O O
at B-O O
the B-O O
site B-O O
of B-O O
action B-O O
. B-O O

The B-O O
finding B-O O
related B-O O
to B-O O
social B-O O
support B-O O
also B-O O
replicates B-O O
results B-O O
from B-O O
an B-O O
independent B-O O
sample B-O O
of B-O O
breast B-O O
cancer B-O O
patients B-O O
. B-O O

This B-O O
finding B-O O
, B-O O
taken B-O O
together B-O O
with B-O O
other B-O O
evidence B-O O
that B-O O
this B-O O
social B-O O
variable B-O O
is B-O O
associated B-O O
with B-O O
longer B-O O
survival B-O O
in B-O O
breast B-O B-cell_type
cancer B-O I-cell_type
populations B-O I-cell_type
, B-O O
underscores B-O O
the B-O O
potential B-O O
importance B-O O
of B-O O
this B-O O
social B-O O
support B-O O
variable B-O O
. B-O O

Our B-O O
findings B-O O
also B-O O
suggest B-O O
one B-O O
possible B-O O
immunological B-O O
variable B-O O
involved B-O O
, B-O O
with B-O O
potential B-O O
clinical B-O O
significance B-O O
, B-O O
for B-O O
this B-O O
patient B-O O
population B-O O
. B-O O

Solution B-O O
structure B-O O
of B-O O
the B-O O
sequence-specific B-O B-DNA
HMG B-O I-DNA
box B-O I-DNA
of B-O O
the B-O O
lymphocyte B-O B-protein
transcriptional B-O I-protein
activator B-O I-protein
Sox-4 B-O B-protein
. B-O O

Two B-O O
groups B-O O
of B-O O
HMG B-O B-protein
box B-O I-protein
proteins B-O I-protein
are B-O O
distinguished B-O O
. B-O O

Proteins B-O O
in B-O O
the B-O O
first B-O O
group B-O O
contain B-O O
multiple B-O O
HMG B-O B-protein
boxes B-O I-protein
, B-O O
are B-O O
non-sequence-specific B-O O
, B-O O
and B-O O
recognize B-O O
structural B-O O
features B-O O
as B-O O
found B-O O
in B-O O
cruciform B-O B-DNA
DNA B-O I-DNA
and B-O O
cross-over B-O B-DNA
DNA B-O I-DNA
. B-O O

The B-O O
abundant B-O O
chromosomal B-O O
protein B-O O
HMG-1 B-O B-protein
belongs B-O O
to B-O O
this B-O O
subgroup B-O O
. B-O O

Proteins B-O O
in B-O O
the B-O O
second B-O O
group B-O O
carry B-O O
a B-O O
single B-O B-protein
HMG B-O I-protein
box B-O I-protein
with B-O O
affinity B-O O
for B-O O
the B-O O
minor B-O O
groove B-O O
of B-O O
the B-O O
heptamer B-O B-DNA
motif B-O I-DNA
AACAAAG B-O O
or B-O O
variations B-O O
thereof B-O O
. B-O O

A B-O O
solution B-O O
structure B-O O
for B-O O
the B-O O
non-sequence-specific B-O O
C-terminal B-O B-protein
HMG B-O I-protein
box B-O I-protein
of B-O O
HMG-1 B-O B-protein
has B-O O
recently B-O O
been B-O O
proposed B-O O
. B-O O

Now B-O O
, B-O O
we B-O O
report B-O O
the B-O O
solution B-O O
structure B-O O
of B-O O
the B-O O
sequence-specific B-O B-protein
HMG-box B-O I-protein
of B-O O
the B-O O
SRY-related B-O B-protein
protein B-O I-protein
Sox-4 B-O B-protein
. B-O O

NMR B-O O
analysis B-O O
demonstrated B-O O
the B-O O
presence B-O O
of B-O O
three B-O O
alpha-helices B-O B-protein
( B-O O
Val10-Gln22 B-O B-protein
, B-O O
Glu30-Leu41 B-O B-protein
and B-O O
Phe50-Tyr65 B-O B-protein
) B-O O
connected B-O O
by B-O O
loop B-O B-protein
regions B-O I-protein
( B-O O
Ser23-Ala49 B-O B-protein
and B-O O
Leu42-Pro49 B-O B-protein
) B-O O
. B-O O

Helices B-O B-protein
I B-O I-protein
and B-O I-protein
II B-O I-protein
are B-O O
positioned B-O O
in B-O O
an B-O O
antiparallel B-O B-protein
mode B-O I-protein
and B-O O
form B-O O
one B-O O
arm B-O O
of B-O O
the B-O O
HMG B-O B-protein
box B-O I-protein
. B-O O

Helix B-O B-protein
III B-O I-protein
is B-O O
less B-O O
rigid B-O O
, B-O O
makes B-O O
an B-O O
average B-O O
angle B-O O
of B-O O
about B-O O
90 B-O O
degrees B-O O
with B-O O
helices B-O B-protein
I B-O I-protein
and B-O I-protein
II B-O I-protein
, B-O O
and B-O O
constitutes B-O O
the B-O O
other B-O O
arm B-O O
of B-O O
the B-O O
molecule B-O O
. B-O O

As B-O O
in B-O O
HMG1B B-O B-protein
, B-O O
the B-O O
overall B-O O
structure B-O O
of B-O O
the B-O O
Sox-4 B-O B-protein
HMG B-O B-protein
box B-O I-protein
is B-O O
L-shaped B-O O
and B-O O
is B-O O
maintained B-O O
by B-O O
a B-O O
cluster B-O O
of B-O O
conserved B-O O
, B-O O
mainly B-O O
aromatic B-O O
residues B-O O
. B-O O

Nuclear B-O B-protein
factor-IL6 B-O I-protein
activates B-O O
the B-O O
human B-O B-DNA
IL-4 B-O I-DNA
promoter B-O I-DNA
in B-O O
T B-O B-cell_type
cells B-O I-cell_type
. B-O O

Positive B-O B-DNA
regulatory B-O I-DNA
element B-O I-DNA
I B-O I-DNA
( B-O O
PRE-I B-O B-DNA
) B-O O
is B-O O
a B-O O
strong B-O O
enhancer B-O B-DNA
element B-O I-DNA
essential B-O O
for B-O O
expression B-O O
of B-O O
the B-O O
human B-O B-DNA
IL-4 B-O I-DNA
gene B-O I-DNA
. B-O O

To B-O O
identify B-O O
transcription B-O B-protein
factors B-O I-protein
binding B-O O
to B-O O
PRE-I B-O B-DNA
, B-O O
we B-O O
screened B-O O
a B-O O
cDNA B-O B-DNA
expression B-O I-DNA
library B-O I-DNA
from B-O O
Jurkat B-O B-cell_line
T B-O I-cell_line
cells B-O I-cell_line
and B-O O
isolated B-O O
a B-O O
cDNA B-O B-DNA
encoding B-O O
nuclear B-O B-protein
factor B-O I-protein
( B-O O
NF B-O O
) B-O O
-IL6 B-O O
( B-O O
also B-O O
known B-O O
as B-O O
C/EBP B-O B-protein
beta B-O I-protein
) B-O O
. B-O O

NF-IL6 B-O B-RNA
mRNA B-O I-RNA
was B-O O
found B-O O
in B-O O
human B-O B-cell_line
Jurkat B-O I-cell_line
T B-O I-cell_line
cells B-O I-cell_line
and B-O O
in B-O O
the B-O O
mouse B-O B-cell_line
Th2 B-O I-cell_line
clone B-O I-cell_line
D10 B-O O
, B-O O
but B-O O
not B-O O
in B-O O
Th1 B-O B-cell_line
clone B-O I-cell_line
29 B-O I-cell_line
. B-O O

rNF-IL6 B-O B-protein
expressed B-O O
in B-O O
bacteria B-O O
was B-O O
shown B-O O
to B-O O
specifically B-O O
bind B-O O
to B-O O
PRE-I B-O B-DNA
. B-O O

PRE-I B-O B-DNA
forms B-O O
multiple B-O B-protein
DNA-protein B-O I-protein
complexes B-O I-protein
with B-O O
nuclear B-O O
extracts B-O O
from B-O O
Jurkat B-O B-cell_line
cells B-O I-cell_line
. B-O O

Some B-O O
of B-O O
these B-O O
complexes B-O O
were B-O O
demonstrated B-O O
to B-O O
contain B-O O
NF-IL6 B-O B-protein
by B-O O
using B-O O
anti- B-O O
C/EBP B-O B-protein
beta B-O I-protein
Abs B-O I-protein
. B-O O

Overexpression B-O O
of B-O O
NF-IL6 B-O B-protein
enhanced B-O O
expression B-O O
of B-O O
the B-O O
chloramphenicol B-O B-DNA
acetyl B-O I-DNA
transferase B-O I-DNA
reporter B-O I-DNA
gene B-O I-DNA
linked B-O O
to B-O O
the B-O O
PRE-I B-O B-protein
-thymidine B-O I-protein
kinase B-O I-protein
or B-O O
the B-O O
human B-O B-DNA
IL-4 B-O I-DNA
promoter B-O I-DNA
more B-O O
than B-O O
10-fold B-O O
in B-O O
Jurkat B-O B-cell_line
cells B-O I-cell_line
. B-O O

Promoter B-O O
deletion B-O O
studies B-O O
revealed B-O O
two B-O O
additional B-O O
NF-IL6 B-O B-DNA
binding B-O I-DNA
sites B-O I-DNA
located B-O O
at B-O O
positions B-O O
-44 B-O O
to B-O O
-36 B-O O
( B-O O
C/EBP B-O B-protein
proximal B-O I-protein
) B-O O
and B-O O
-87 B-O B-DNA
to B-O I-DNA
-79 B-O I-DNA
( B-O O
C/EBP B-O B-protein
medial B-O I-protein
) B-O O
, B-O O
respectively B-O O
. B-O O

Our B-O O
results B-O O
demonstrate B-O O
that B-O O
NF-IL6 B-O B-protein
is B-O O
involved B-O O
in B-O O
transcriptional B-O O
activation B-O O
of B-O O
the B-O O
human B-O B-DNA
IL-4 B-O I-DNA
promoter B-O I-DNA
in B-O O
T B-O B-cell_type
cells B-O I-cell_type
. B-O O

Identification B-O O
of B-O O
an B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
alpha-associated B-O I-protein
protein B-O I-protein
kinase B-O I-protein
in B-O O
a B-O O
human B-O B-cell_line
monocytic B-O I-cell_line
cell B-O I-cell_line
line B-O I-cell_line
and B-O O
determination B-O O
of B-O O
its B-O O
phosphorylation B-O B-protein
sites B-O I-protein
on B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
alpha B-O I-protein
. B-O O

Nuclear B-O B-protein
factor B-O I-protein
kappa B-O I-protein
B B-O I-protein
( B-O O
NF-kappa B-O B-protein
B B-O I-protein
) B-O O
is B-O O
stored B-O O
in B-O O
the B-O O
cytoplasm B-O O
as B-O O
an B-O O
inactive B-O O
form B-O O
through B-O O
interaction B-O O
with B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
. B-O O

Stimulation B-O O
of B-O O
cells B-O O
leads B-O O
to B-O O
a B-O O
rapid B-O O
phosphorylation B-O O
of B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
alpha B-O I-protein
, B-O O
which B-O O
is B-O O
presumed B-O O
to B-O O
be B-O O
important B-O O
for B-O O
the B-O O
subsequent B-O O
degradation B-O O
. B-O O

We B-O O
have B-O O
recently B-O O
reported B-O O
the B-O O
establishment B-O O
of B-O O
a B-O O
lipopolysaccharide B-O O
( B-O O
LPS B-O O
) B-O O
-dependent B-O O
cell-free B-O O
activation B-O O
system B-O O
of B-O O
NF-kappa B-O B-protein
B B-O I-protein
in B-O O
association B-O O
with B-O O
the B-O O
induction B-O O
of B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
alpha B-O I-protein
phosphorylation B-O O
. B-O O

In B-O O
this B-O O
study B-O O
, B-O O
we B-O O
have B-O O
identified B-O O
a B-O O
kinase B-O B-protein
in B-O O
cell B-O O
extracts B-O O
from B-O O
the B-O O
LPS B-O B-cell_line
-stimulated B-O I-cell_line
human B-O I-cell_line
monocytic B-O I-cell_line
cell B-O I-cell_line
line B-O I-cell_line
, B-O O
THP-1 B-O B-cell_line
, B-O O
that B-O O
specifically B-O O
binds B-O O
and B-O O
phosphorylates B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
alpha B-O I-protein
. B-O O

LPS B-O O
stimulation B-O O
transiently B-O O
enhanced B-O O
the B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
alpha B-O I-protein
-bound B-O B-protein
kinase B-O I-protein
activity B-O O
in B-O O
THP-1 B-O B-cell_line
cells B-O I-cell_line
. B-O O

Mutational B-O O
analyses B-O O
of B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
alpha B-O I-protein
and B-O O
competition B-O O
experiments B-O O
with B-O O
the B-O O
synthetic B-O O
peptides B-O O
identified B-O O
major B-O O
phosphorylation B-O B-protein
sites B-O I-protein
by B-O O
the B-O O
bound B-O B-protein
kinase B-O I-protein
as B-O O
Ser B-O B-protein
and B-O O
Thr B-O O
residues B-O O
in B-O O
the B-O O
C-terminal B-O B-protein
acidic B-O I-protein
domain B-O I-protein
of B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
alpha B-O I-protein
. B-O O

Moreover B-O O
, B-O O
we B-O O
show B-O O
that B-O O
the B-O O
peptide B-O O
, B-O O
corresponding B-O O
to B-O O
the B-O O
C-terminal B-O B-protein
acidic B-O I-protein
domain B-O I-protein
of B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
alpha B-O I-protein
, B-O O
blocked B-O O
the B-O O
LPS B-O O
-induced B-O O
NF-kappa B-O B-protein
B B-O I-protein
activation B-O O
as B-O O
well B-O O
as B-O O
inducible B-O O
phosphorylation B-O O
of B-O O
endogenous B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
alpha B-O I-protein
in B-O O
a B-O O
cell-free B-O O
system B-O O
using B-O O
THP-1 B-O B-cell_line
cells B-O I-cell_line
. B-O O

These B-O O
results B-O O
suggested B-O O
that B-O O
the B-O O
bound B-O B-protein
kinase B-O I-protein
is B-O O
involved B-O O
in B-O O
the B-O O
signaling B-O O
pathway B-O O
of B-O O
LPS B-O O
by B-O O
inducing B-O O
the B-O O
phosphorylation B-O O
of B-O O
the B-O O
C-terminal B-O B-protein
region B-O I-protein
of B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
alpha B-O I-protein
and B-O O
subsequent B-O O
dissociation B-O O
of B-O O
the B-O O
NF-kappa B-O B-protein
B B-O I-protein
. B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
alpha B-O I-protein
complex B-O I-protein
. B-O O

Bik B-O B-protein
, B-O O
a B-O O
novel B-O O
death-inducing B-O B-protein
protein B-O I-protein
shares B-O O
a B-O O
distinct B-O O
sequence B-O O
motif B-O O
with B-O O
Bcl-2 B-O B-protein
family B-O I-protein
proteins B-O I-protein
and B-O O
interacts B-O O
with B-O O
viral B-O O
and B-O O
cellular B-O B-protein
survival-promoting B-O I-protein
proteins B-O I-protein
. B-O O

The B-O O
survival-promoting B-O O
activity B-O O
of B-O O
the B-O O
Bcl-2 B-O B-protein
family B-O I-protein
of B-O O
proteins B-O O
appears B-O O
to B-O O
be B-O O
modulated B-O O
by B-O O
interactions B-O O
between B-O O
various B-O O
cellular B-O B-protein
proteins B-O I-protein
. B-O O

We B-O O
have B-O O
identified B-O O
a B-O O
novel B-O O
cellular B-O B-protein
protein B-O I-protein
, B-O O
Bik B-O B-protein
, B-O O
that B-O O
interacts B-O O
with B-O O
the B-O O
cellular B-O B-protein
survival-promoting B-O I-protein
proteins B-O I-protein
, B-O O
Bcl-2 B-O B-protein
and B-O O
Bcl-xL B-O B-protein
, B-O O
as B-O O
well B-O O
as B-O O
the B-O O
viral B-O B-protein
survival-promoting B-O I-protein
proteins B-O I-protein
, B-O O
Epstein B-O B-protein
Barr B-O I-protein
virus B-O I-protein
-BHRF1 B-O I-protein
and B-O O
adenovirus B-O B-protein
E1B-19 B-O I-protein
kDa B-O I-protein
. B-O O

In B-O O
transient B-O O
transfection B-O O
assays B-O O
, B-O O
Bik B-O B-protein
promotes B-O O
cell B-O O
death B-O O
in B-O O
a B-O O
manner B-O O
similar B-O O
to B-O O
the B-O O
death-promoting B-O B-protein
members B-O I-protein
of B-O O
the B-O O
Bcl-2 B-O B-protein
family B-O I-protein
, B-O O
Bax B-O B-protein
and B-O O
Bak B-O B-protein
. B-O O

This B-O O
death-promoting B-O O
activity B-O O
of B-O O
Bik B-O B-protein
can B-O O
be B-O O
suppressed B-O O
by B-O O
coexpression B-O O
of B-O O
Bcl-2 B-O B-protein
, B-O O
Bcl-XL B-O B-protein
, B-O O
EBV-BHRF1 B-O B-protein
and B-O O
E1B-19 B-O B-protein
kDa B-O I-protein
proteins B-O I-protein
suggesting B-O O
that B-O O
Bik B-O B-protein
may B-O O
be B-O O
a B-O O
common B-O O
target B-O O
for B-O O
both B-O O
cellular B-O B-protein
and B-O I-protein
viral B-O I-protein
anti-apoptotic B-O I-protein
proteins B-O I-protein
. B-O O

While B-O O
Bik B-O B-protein
does B-O O
not B-O O
show B-O O
overt B-O O
homology B-O O
to B-O O
the B-O O
BH1 B-O B-protein
and B-O O
BH2 B-O B-protein
conserved B-O O
domains B-O O
characteristic B-O O
of B-O O
the B-O O
Bcl-2 B-O B-protein
family B-O I-protein
, B-O O
it B-O O
does B-O O
share B-O O
a B-O O
9 B-O O
amino B-O B-protein
acid B-O I-protein
domain B-O I-protein
( B-O O
BH3 B-O B-protein
) B-O O
with B-O O
Bax B-O B-protein
and B-O O
Bak B-O B-protein
which B-O O
may B-O O
be B-O O
a B-O O
critical B-O O
determinant B-O O
for B-O O
the B-O O
death-promoting B-O O
activity B-O O
of B-O O
these B-O O
proteins B-O O
. B-O O

The B-O O
human B-O B-DNA
TCF-1 B-O I-DNA
gene B-O I-DNA
encodes B-O O
a B-O O
nuclear B-O B-protein
DNA-binding B-O I-protein
protein B-O I-protein
uniquely B-O O
expressed B-O O
in B-O O
normal B-O B-cell_type
and B-O I-cell_type
neoplastic B-O I-cell_type
T-lineage B-O I-cell_type
lymphocytes B-O I-cell_type
. B-O O

The B-O O
TCF-1 B-O B-DNA
gene B-O I-DNA
encodes B-O O
a B-O O
putative B-O O
transcription B-O B-protein
factor B-O I-protein
with B-O O
affinity B-O O
for B-O O
a B-O O
sequence B-O O
motif B-O O
occurring B-O O
in B-O O
a B-O O
number B-O O
of B-O O
T-cell B-O B-DNA
enhancers B-O I-DNA
. B-O O

TCF-1 B-O B-RNA
mRNA B-O I-RNA
was B-O O
originally B-O O
found B-O O
to B-O O
be B-O O
expressed B-O O
in B-O O
a B-O O
T B-O O
cell-specific B-O O
fashion B-O O
within B-O O
a B-O O
set B-O O
of B-O O
human B-O B-cell_line
and B-O I-cell_line
mouse B-O I-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
. B-O O

In B-O O
contrast B-O O
, B-O O
expression B-O O
reportedly B-O O
occurs B-O O
in B-O O
multiple B-O O
nonlymphoid B-O O
tissues B-O O
during B-O O
murine B-O O
embryogenesis B-O O
. B-O O

We B-O O
have B-O O
now B-O O
raised B-O O
a B-O O
monoclonal B-O B-protein
antibody B-O I-protein
to B-O O
document B-O O
expression B-O O
and B-O O
biochemistry B-O O
of B-O O
the B-O O
human B-O B-protein
TCF-1 B-O I-protein
protein B-O I-protein
. B-O O

As B-O O
expected B-O O
, B-O O
the B-O O
TCF-1 B-O B-protein
protein B-O I-protein
was B-O O
detectable B-O O
only B-O O
in B-O O
cell B-O B-cell_line
lines B-O I-cell_line
of B-O O
T B-O B-cell_type
lineage B-O I-cell_type
. B-O O

Its B-O O
expression B-O O
was B-O O
always B-O O
restricted B-O O
to B-O O
the B-O O
nucleus B-O O
. B-O O

Immunohistochemistry B-O O
on B-O O
a B-O O
panel B-O O
of B-O O
human B-O O
tissues B-O O
revealed B-O O
that B-O O
the B-O O
TCF-1 B-O B-protein
protein B-O I-protein
was B-O O
found B-O O
exclusively B-O O
in B-O O
thymocytes B-O B-cell_type
and B-O O
in B-O O
CD3+ B-O B-cell_type
T B-O I-cell_type
cells B-O I-cell_type
in B-O O
peripheral B-O O
lymphoid B-O O
tissues B-O O
. B-O O

Western B-O O
blotting B-O O
yielded B-O O
a B-O O
set B-O O
of B-O O
bands B-O O
ranging B-O O
from B-O O
25 B-O O
kD B-O O
to B-O O
55 B-O O
kD B-O O
, B-O O
resulting B-O O
from B-O O
extensive B-O O
alternative B-O O
splicing B-O O
. B-O O

The B-O O
TCF-1 B-O B-protein
protein B-O I-protein
was B-O O
detectable B-O O
in B-O O
all B-O O
samples B-O O
of B-O O
a B-O O
set B-O O
of B-O O
22 B-O O
T-cell B-O O
malignancies B-O O
of B-O O
various B-O O
stages B-O O
of B-O O
maturation B-O O
, B-O O
but B-O O
was B-O O
absent B-O O
from B-O O
a B-O O
large B-O O
number B-O O
of B-O O
other B-O O
hematologic B-O B-cell_type
neoplasms B-O I-cell_type
. B-O O

These B-O O
observations B-O O
imply B-O O
a B-O O
T B-O O
cell-specific B-O O
function B-O O
for B-O O
TCF-1 B-O B-protein
, B-O O
a B-O O
notion B-O O
corroborated B-O O
by B-O O
recent B-O O
observations B-O O
on B-O O
Tcf-1 B-O B-protein
knock-out B-O O
mice B-O O
. B-O O

In B-O O
addition B-O O
, B-O O
these B-O O
results B-O O
indicate B-O O
that B-O O
nuclear B-O O
TCF-1 B-O B-protein
expression B-O O
can B-O O
serve B-O O
as B-O O
a B-O O
pan-T-lineage B-O O
marker B-O O
in B-O O
the B-O O
diagnosis B-O O
of B-O O
lymphoid B-O O
malignancies B-O O
. B-O O

Cross-linking B-O O
of B-O O
Fc B-O B-protein
gamma B-O I-protein
receptors B-O I-protein
activates B-O O
HIV-1 B-O B-DNA
long B-O I-DNA
terminal B-O I-DNA
repeat B-O I-DNA
-driven B-O O
transcription B-O O
in B-O O
human B-O B-cell_type
monocytes B-O I-cell_type
. B-O O

Elevation B-O O
of B-O O
the B-O O
levels B-O O
of B-O O
circulating B-O B-protein
immune B-O I-protein
complexes B-O I-protein
frequently B-O O
accompanies B-O O
HIV-1 B-O O
infection B-O O
and B-O O
is B-O O
a B-O O
prognostic B-O O
indicator B-O O
of B-O O
clinical B-O O
progression B-O O
from B-O O
asymptomatic B-O O
infection B-O O
to B-O O
AIDS B-O O
. B-O O

Here B-O O
we B-O O
report B-O O
that B-O O
cross-linking B-O O
of B-O O
Fc B-O B-protein
gamma B-O I-protein
RI B-O I-protein
or B-O O
Fc B-O B-protein
gamma B-O I-protein
RII B-O I-protein
by B-O O
adherent B-O B-protein
human B-O I-protein
IgG B-O I-protein
or B-O O
by B-O O
specific B-O O
anti-Fc B-O B-protein
gamma B-O I-protein
R B-O I-protein
mAb B-O I-protein
activates B-O O
HIV-1 B-O B-DNA
gene B-O I-DNA
expression B-O O
in B-O O
the B-O O
human B-O B-cell_line
monocytic B-O I-cell_line
cell B-O I-cell_line
line B-O I-cell_line
BF24 B-O B-cell_line
and B-O O
increased B-O O
HIV B-O B-RNA
RNA B-O I-RNA
expression B-O O
in B-O O
monocytes B-O B-cell_type
from B-O O
HIV B-O O
infected B-O O
patients B-O O
as B-O O
assayed B-O O
by B-O O
reverse B-O O
transcription-PCR B-O O
. B-O O

In B-O O
THP-1 B-O B-cell_line
cells B-O I-cell_line
, B-O O
Fc B-O B-protein
gamma B-O I-protein
R B-O I-protein
cross-linking B-O O
induced B-O O
NF-kappa B-O B-protein
B B-O I-protein
, B-O O
which B-O O
is B-O O
known B-O O
to B-O O
bind B-O O
to B-O O
the B-O O
regulatory B-O B-DNA
region B-O I-DNA
of B-O O
the B-O O
long B-O B-DNA
terminal B-O I-DNA
repeat B-O I-DNA
( B-O O
LTR B-O B-DNA
) B-O O
of B-O O
HIV-1 B-O O
and B-O O
to B-O O
activate B-O O
HIV-1 B-O O
transcription B-O O
. B-O O
Anti-TNF-alpha B-O B-protein
antibody B-O I-protein
but B-O O
not B-O O
anti-IL-1 B-O B-protein
beta B-O I-protein
antibody B-O I-protein
strongly B-O O
inhibited B-O O
both B-O O
the B-O O
induction B-O O
of B-O O
HIV-1 B-O O
- B-O O
LTR B-O B-DNA
-driven B-O O
transcription B-O O
and B-O O
the B-O O
induction B-O O
of B-O O
NF-kappa B-O B-protein
B B-O I-protein
by B-O O
Fc B-O B-protein
gamma B-O I-protein
R B-O I-protein
cross-linking B-O O
. B-O O

These B-O O
results B-O O
indicate B-O O
that B-O O
Fc B-O B-protein
gamma B-O I-protein
R B-O I-protein
can B-O O
mediate B-O O
a B-O O
TNF-alpha B-O B-protein
-dependent B-O O
induction B-O O
of B-O O
HIV-1 B-O B-DNA
gene B-O I-DNA
transcription B-O O
and B-O O
suggest B-O O
that B-O O
immune B-O B-protein
complexes B-O I-protein
may B-O O
contribute B-O O
to B-O O
the B-O O
pathophysiology B-O O
of B-O O
HIV-1 B-O O
infection B-O O
by B-O O
augmenting B-O O
viral B-O O
replication B-O O
in B-O O
monocytes B-O B-cell_type
. B-O O

Signalling B-O O
via B-O O
CD28 B-O B-protein
of B-O O
human B-O B-cell_type
naive B-O I-cell_type
neonatal B-O I-cell_type
T B-O I-cell_type
lymphocytes B-O I-cell_type
. B-O O

Accessory B-O B-protein
molecules B-O I-protein
play B-O O
a B-O O
crucial B-O O
role B-O O
in B-O O
the B-O O
development B-O O
of B-O O
the B-O O
T B-O O
cell B-O O
response B-O O
to B-O O
antigenic B-O O
challenge B-O O
. B-O O

We B-O O
have B-O O
examined B-O O
the B-O O
role B-O O
of B-O O
CD28 B-O B-protein
in B-O O
modulating B-O O
the B-O O
' B-O O
naive B-O O
' B-O O
neonatal B-O B-cell_type
T B-O I-cell_type
cell B-O I-cell_type
response B-O O
to B-O O
anti-CD2 B-O B-protein
-mediated B-O O
activation B-O O
. B-O O

To B-O O
compare B-O O
the B-O O
role B-O O
of B-O O
CD28 B-O B-protein
, B-O O
neonatal B-O B-cell_type
and B-O I-cell_type
adult B-O I-cell_type
T B-O I-cell_type
cells B-O I-cell_type
were B-O O
stimulated B-O O
with B-O O
a B-O O
pair B-O O
of B-O O
mitogenic B-O B-protein
anti-CD2 B-O I-protein
antibodies B-O I-protein
in B-O O
the B-O O
presence B-O O
or B-O O
absence B-O O
of B-O O
anti- B-O B-protein
CD28 B-O I-protein
MoAb B-O I-protein
. B-O O

With B-O O
anti-CD2 B-O B-protein
alone B-O O
, B-O O
neonatal B-O B-cell_type
T B-O I-cell_type
cells B-O I-cell_type
proliferated B-O O
slightly B-O O
but B-O O
produced B-O O
no B-O O
detectable B-O O
IL-2 B-O B-protein
, B-O O
whereas B-O O
adult B-O B-cell_type
T B-O I-cell_type
cells B-O I-cell_type
proliferated B-O O
vigorously B-O O
, B-O O
with B-O O
significant B-O O
IL-2 B-O B-protein
production B-O O
. B-O O

Costimulation B-O O
with B-O O
anti- B-O B-protein
CD28 B-O I-protein
MoAb B-O I-protein
greatly B-O O
enhanced B-O O
the B-O O
proliferative B-O O
response B-O O
of B-O O
neonatal B-O B-cell_type
T B-O I-cell_type
cells B-O I-cell_type
to B-O O
levels B-O O
equivalent B-O O
to B-O O
those B-O O
of B-O O
adult B-O B-cell_type
T B-O I-cell_type
cells B-O I-cell_type
, B-O O
whereas B-O O
adult B-O B-cell_type
T B-O I-cell_type
cells B-O I-cell_type
showed B-O O
only B-O O
slight B-O O
increases B-O O
. B-O O

Although B-O O
IL-2 B-O B-protein
secretion B-O O
was B-O O
increased B-O O
in B-O O
the B-O O
presence B-O O
of B-O O
anti- B-O B-protein
CD28 B-O I-protein
MoAb B-O I-protein
, B-O O
neonatal B-O B-cell_type
T B-O I-cell_type
cell B-O I-cell_type
IL-2 B-O B-protein
production B-O O
remained B-O O
lower B-O O
than B-O O
in B-O O
adults B-O O
. B-O O

In B-O O
contrast B-O O
, B-O O
enhancement B-O O
of B-O O
IL-2 B-O B-RNA
mRNA B-O I-RNA
expression B-O O
in B-O O
neonates B-O O
was B-O O
similar B-O O
to B-O O
adult B-O O
levels B-O O
. B-O O

Anti- B-O O
CD28 B-O B-protein
MoAb B-O I-protein
costimulation B-O O
increased B-O O
NF B-O B-protein
kappa B-O I-protein
B B-O I-protein
levels B-O O
in B-O O
neonates B-O O
, B-O O
albeit B-O O
to B-O O
levels B-O O
lower B-O O
than B-O O
that B-O O
of B-O O
adults B-O O
. B-O O

The B-O O
cellular B-O O
mechanism B-O O
governing B-O O
the B-O O
diminished B-O O
proliferative B-O O
response B-O O
of B-O O
neonatal B-O B-cell_type
T B-O I-cell_type
lymphocytes B-O I-cell_type
to B-O O
anti-CD2 B-O B-protein
may B-O O
therefore B-O O
be B-O O
due B-O O
to B-O O
decreased B-O O
NF B-O B-protein
kappa B-O I-protein
B B-O I-protein
induction B-O O
, B-O O
reduced B-O O
IL-2 B-O B-RNA
mRNA B-O I-RNA
expression B-O O
and B-O O
deficient B-O O
IL-2 B-O B-protein
production B-O O
. B-O O

Although B-O O
anti- B-O B-protein
CD28 B-O I-protein
MoAb B-O I-protein
costimulation B-O O
enhances B-O O
all B-O O
of B-O O
the B-O O
above B-O O
signals B-O O
, B-O O
NF B-O B-protein
kappa B-O I-protein
B B-O I-protein
and B-O O
IL-2 B-O B-protein
levels B-O O
remain B-O O
lower B-O O
than B-O O
in B-O O
adults B-O O
, B-O O
suggesting B-O O
the B-O O
need B-O O
for B-O O
further B-O O
activation B-O O
requirements B-O O
in B-O O
the B-O O
neonate B-O O
. B-O O

TCL1 B-O B-DNA
oncogene B-O I-DNA
activation B-O O
in B-O O
preleukemic B-O B-cell_type
T B-O I-cell_type
cells B-O I-cell_type
from B-O O
a B-O O
case B-O O
of B-O O
ataxia-telangiectasia B-O O
. B-O O

The B-O O
TCL1 B-O B-DNA
oncogene B-O I-DNA
on B-O O
human B-O B-DNA
chromosome B-O I-DNA
14q32.1 B-O I-DNA
is B-O O
involved B-O O
in B-O O
chromosome B-O O
translocations B-O O
[ B-O O
t B-O B-DNA
( B-O I-DNA
14 B-O I-DNA
; B-O I-DNA
14 B-O I-DNA
) B-O I-DNA
( B-O I-DNA
q11 B-O I-DNA
; B-O I-DNA
q32.1 B-O I-DNA
) B-O I-DNA
and B-O O
t B-O B-DNA
( B-O I-DNA
7 B-O I-DNA
; B-O I-DNA
14 B-O I-DNA
) B-O I-DNA
( B-O I-DNA
q35 B-O I-DNA
; B-O I-DNA
q32.1 B-O I-DNA
) B-O I-DNA
] B-O O
and B-O O
inversions B-O O
[ B-O O
inv14 B-O B-DNA
( B-O I-DNA
q11 B-O I-DNA
; B-O I-DNA
q32.1 B-O I-DNA
) B-O I-DNA
] B-O O
with B-O O
TCR B-O B-DNA
alpha/beta B-O I-DNA
loci B-O I-DNA
in B-O O
T-cell B-O O
leukemias B-O O
, B-O O
such B-O O
as B-O O
T-prolymphocytic B-O O
( B-O O
T-PLL B-O O
) B-O O
. B-O O

It B-O O
is B-O O
also B-O O
involved B-O O
in B-O O
T- B-O O
acute B-O O
and B-O O
- B-O O
chronic B-O O
leukemias B-O O
arising B-O O
in B-O O
cases B-O O
of B-O O
ataxia-telangiectasia B-O O
( B-O O
AT B-O O
) B-O O
, B-O O
an B-O O
immunodeficiency B-O O
syndrome B-O O
. B-O O

Similar B-O O
chromosomal B-O O
rearrangements B-O O
occur B-O O
also B-O O
in B-O O
the B-O O
clonally B-O O
expanded B-O O
T B-O B-cell_type
cells B-O I-cell_type
in B-O O
AT B-O O
patients B-O O
before B-O O
the B-O O
appearance B-O O
of B-O O
the B-O O
overt B-O O
leukemia B-O O
. B-O O

We B-O O
have B-O O
analyzed B-O O
the B-O O
expression B-O O
of B-O O
TCL1 B-O B-RNA
mRNA B-O I-RNA
and B-O O
protein B-O O
in B-O O
peripheral B-O B-cell_type
blood B-O I-cell_type
lymphocytes B-O I-cell_type
( B-O O
PBLs B-O B-cell_type
) B-O O
from B-O O
four B-O O
AT B-O O
cases B-O O
and B-O O
from B-O O
healthy B-O O
controls B-O O
. B-O O

We B-O O
found B-O O
that B-O O
the B-O O
TCL1 B-O B-DNA
gene B-O I-DNA
was B-O O
overexpressed B-O O
in B-O O
the B-O O
PBLs B-O B-cell_type
of B-O O
an B-O O
AT B-O O
patient B-O O
with B-O O
a B-O O
large B-O B-cell_line
clonal B-O I-cell_line
T-cell B-O I-cell_line
population B-O I-cell_line
exhibiting B-O O
the B-O O
t B-O B-DNA
( B-O I-DNA
14 B-O I-DNA
; B-O I-DNA
14 B-O I-DNA
) B-O I-DNA
translocation B-O I-DNA
but B-O O
not B-O O
in B-O O
the B-O O
lymphocytes B-O B-cell_type
of B-O O
the B-O O
other B-O O
cases B-O O
. B-O O

Fluorescence B-O O
in B-O O
situ B-O O
hybridization B-O O
of B-O O
the B-O O
TCL1 B-O B-DNA
genomic B-O I-DNA
locus B-O I-DNA
to B-O O
lymphocyte B-O O
metaphases B-O O
from B-O O
the B-O O
AT B-O O
patient B-O O
with B-O O
the B-O O
T-cell B-O O
clonal B-O O
expansion B-O O
showed B-O O
that B-O O
the B-O O
breakpoint B-O O
of B-O O
the B-O O
t B-O B-DNA
( B-O I-DNA
14 B-O I-DNA
; B-O I-DNA
14 B-O I-DNA
) B-O I-DNA
translocation B-O I-DNA
lies B-O O
within B-O O
the B-O O
TCL1 B-O B-DNA
locus B-O I-DNA
and B-O O
is B-O O
accompanied B-O O
by B-O O
an B-O O
inverted B-O O
duplication B-O O
of B-O O
the B-O O
distal B-O B-DNA
part B-O I-DNA
of B-O O
chromosome B-O B-DNA
14 B-O I-DNA
. B-O O

These B-O O
data B-O O
indicate B-O O
that B-O O
TCL1 B-O B-protein
is B-O O
activated B-O O
in B-O O
preleukemic B-O B-cell_line
clonal B-O I-cell_line
cells B-O I-cell_line
as B-O O
a B-O O
consequence B-O O
of B-O O
chromosome B-O B-DNA
translocation B-O I-DNA
involving B-O I-DNA
sequences B-O I-DNA
from B-O O
the B-O O
TCR B-O B-DNA
locus B-O I-DNA
at B-O O
14q11 B-O B-DNA
. B-O O

Deregulation B-O O
of B-O O
TCL1 B-O B-protein
is B-O O
the B-O O
first B-O O
event B-O O
in B-O O
the B-O O
initiation B-O O
of B-O O
malignancy B-O O
in B-O O
these B-O O
types B-O O
of B-O O
leukemias B-O O
and B-O O
represents B-O O
a B-O O
potential B-O O
tool B-O O
for B-O O
clinical B-O O
evaluation B-O O
. B-O O

C/EBP B-O B-protein
proteins B-O I-protein
activate B-O O
transcription B-O O
from B-O O
the B-O O
human B-O B-DNA
immunodeficiency B-O I-DNA
virus B-O I-DNA
type B-O I-DNA
1 B-O I-DNA
long B-O I-DNA
terminal B-O I-DNA
repeat B-O I-DNA
in B-O O
macrophages/ B-O B-cell_type
monocytes B-O I-cell_type
. B-O O

Three B-O O
binding B-O B-DNA
sites B-O I-DNA
for B-O O
C/EBP B-O B-protein
proteins B-O I-protein
are B-O O
found B-O O
in B-O O
the B-O O
human B-O B-DNA
immunodeficiency B-O I-DNA
virus B-O I-DNA
type B-O I-DNA
1 B-O I-DNA
( B-O I-DNA
HIV-1 B-O I-DNA
) B-O I-DNA
long B-O I-DNA
terminal B-O I-DNA
repeat B-O I-DNA
( B-O O
LTR B-O B-DNA
) B-O O
( B-O O
V.M. B-O O
Tesmer B-O O
, B-O O
A.Rajadhyaksha B-O O
, B-O O
J.Babin B-O O
, B-O O
and B-O O
M.Bina B-O O
, B-O O
Proc.Natl.Acad.Sci. B-O O
USA B-O O
90 B-O O
: B-O O
7298-7302 B-O O
, B-O O
1993 B-O O
) B-O O
. B-O O

We B-O O
have B-O O
determined B-O O
the B-O O
functional B-O O
role B-O O
of B-O O
C/EBP B-O B-protein
proteins B-O I-protein
and B-O O
C/EBP B-O B-DNA
sites B-O I-DNA
in B-O O
regulating B-O O
transcription B-O O
from B-O O
the B-O O
LTR B-O I-DNA
in B-O O
monocytes B-O B-cell_type
/macrophages B-O B-cell_type
. B-O O

Inhibition B-O O
of B-O O
endogenous B-O B-protein
C/EBP B-O I-protein
proteins B-O I-protein
, B-O O
using B-O O
either B-O O
an B-O O
excess B-O O
of B-O O
C/EBP B-O B-DNA
binding B-O I-DNA
sites B-O I-DNA
or B-O O
a B-O O
negative B-O O
inhibitor B-O O
, B-O O
demonstrated B-O O
that B-O O
C/EBP B-O B-protein
proteins B-O I-protein
are B-O O
required B-O O
for B-O O
basal B-O O
and B-O O
activated B-O O
levels B-O O
of B-O O
HIV-1 B-O B-DNA
LTR B-O I-DNA
transcription B-O O
in B-O O
the B-O O
promonocytic B-O B-cell_line
cell B-O I-cell_line
line B-O I-cell_line
U937 B-O I-cell_line
. B-O O

Northern B-O O
( B-O O
RNA B-O O
) B-O O
blots B-O O
and B-O O
binding B-O O
assays B-O O
showed B-O O
that B-O O
NF-IL6 B-O B-protein
is B-O O
the B-O O
only B-O O
known B-O O
C/EBP B-O B-protein
family B-O I-protein
member B-O I-protein
which B-O O
is B-O O
increased B-O O
when B-O O
U937 B-O B-cell_line
cells B-O I-cell_line
are B-O O
activated B-O O
. B-O O

Mutational B-O O
analyses B-O O
of B-O O
the B-O O
HIV-1 B-O B-DNA
LTR B-O I-DNA
showed B-O O
that B-O O
one B-O O
C/EBP B-O B-DNA
site B-O I-DNA
is B-O O
required B-O O
for B-O O
normal B-O O
LTR B-O B-DNA
transcription B-O O
both B-O O
before B-O O
and B-O O
after B-O O
cellular B-O O
activation B-O O
and B-O O
that B-O O
the B-O O
two B-O O
3 B-O O
' B-O O
C/EBP B-O B-DNA
sites B-O I-DNA
are B-O O
functionally B-O O
equivalent B-O O
. B-O O

However B-O O
, B-O O
transcription B-O O
from B-O O
crippled B-O B-DNA
HIV-1 B-O I-DNA
LTRs B-O I-DNA
lacking B-O O
C/EBP B-O B-DNA
sites B-O I-DNA
can B-O O
still B-O O
be B-O O
induced B-O O
following B-O O
activation B-O O
of B-O O
U937 B-O B-cell_line
cells B-O I-cell_line
. B-O O

Several B-O O
models B-O O
are B-O O
suggested B-O O
for B-O O
how B-O O
elevated B-O O
NF-IL6 B-O B-protein
may B-O O
participate B-O O
in B-O O
an B-O O
autostimulatory B-O O
loop B-O O
involving B-O O
HIV B-O O
infection B-O O
, B-O O
macrophage B-O O
activation B-O O
, B-O O
cytokine B-O B-protein
expression B-O O
, B-O O
and B-O O
HIV B-O O
replication B-O O
. B-O O

Human B-O O
immunodeficiency B-O O
virus B-O O
type-2 B-O O
gene B-O O
expression B-O O
: B-O O
two B-O O
enhancers B-O B-DNA
and B-O O
their B-O O
activation B-O O
by B-O O
T-cell B-O B-protein
activators B-O I-protein
. B-O O

The B-O O
human B-O O
immunodeficiency B-O O
viruses B-O O
( B-O O
HIVs B-O O
) B-O O
may B-O O
include B-O O
a B-O O
spectrum B-O O
of B-O O
retroviruses B-O O
with B-O O
varying B-O O
potential B-O O
to B-O O
infect B-O O
their B-O O
host B-O O
, B-O O
undergo B-O O
long B-O O
periods B-O O
of B-O O
latent B-O O
infection B-O O
, B-O O
and B-O O
induce B-O O
pathology B-O O
. B-O O

Since B-O O
expression B-O O
of B-O O
the B-O O
viruses B-O O
is B-O O
in B-O O
large B-O O
part B-O O
regulated B-O O
by B-O O
the B-O O
sequence B-O B-DNA
elements B-O I-DNA
in B-O O
their B-O O
long B-O B-DNA
terminal B-O I-DNA
repeats B-O I-DNA
( B-O O
LTRs B-O B-DNA
) B-O O
, B-O O
this B-O O
study B-O O
was B-O O
directed B-O O
to B-O O
an B-O O
analysis B-O O
of B-O O
the B-O O
regulatory B-O B-DNA
elements B-O I-DNA
in B-O O
the B-O O
HIV-2 B-O B-DNA
LTR B-O I-DNA
. B-O O

The B-O O
HIV-2 B-O B-DNA
LTR B-O I-DNA
was B-O O
found B-O O
to B-O O
contain B-O O
two B-O O
enhancers B-O B-DNA
. B-O O

One B-O O
of B-O O
these B-O O
enhancers B-O B-DNA
is B-O O
, B-O O
in B-O O
part B-O O
, B-O O
identical B-O O
to B-O O
the B-O O
HIV-1 B-O B-DNA
enhancer B-O I-DNA
. B-O O

This B-O O
enhancer B-O B-DNA
in B-O O
HIV-1 B-O O
is B-O O
the B-O O
T-cell B-O B-DNA
activation B-O I-DNA
response B-O I-DNA
element B-O I-DNA
; B-O O
in B-O O
HIV-2 B-O O
, B-O O
however B-O O
, B-O O
it B-O O
is B-O O
the B-O O
second B-O B-DNA
enhancer B-O I-DNA
that B-O O
is B-O O
mainly B-O O
responsible B-O O
for B-O O
activation B-O O
in B-O O
response B-O O
to B-O O
T-cell B-O B-protein
activators B-O I-protein
. B-O O

The B-O O
second B-O O
enhancer B-O B-DNA
interacts B-O O
with B-O O
two B-O O
nuclear B-O B-protein
binding B-O I-protein
proteins B-O I-protein
( B-O O
85 B-O O
kD B-O O
and B-O O
27 B-O O
kD B-O O
mobility B-O O
) B-O O
that B-O O
appear B-O O
to B-O O
be B-O O
required B-O O
for B-O O
optimal B-O O
enhancer B-O O
function B-O O
and B-O O
activation B-O O
. B-O O

Observations B-O O
such B-O O
as B-O O
these B-O O
encourage B-O O
the B-O O
speculation B-O O
that B-O O
there B-O O
may B-O O
be B-O O
subtle B-O O
differences B-O O
in B-O O
the B-O O
regulation B-O O
of B-O O
HIV-1 B-O O
and B-O O
HIV-2 B-O O
expression B-O O
that B-O O
may B-O O
be B-O O
relevant B-O O
to B-O O
the B-O O
possible B-O O
longer B-O O
latency B-O O
and B-O O
reduced B-O O
pathogenicity B-O O
of B-O O
HIV-2 B-O O
. B-O O

NF-M B-O B-protein
( B-O O
chicken B-O B-protein
C/EBP B-O I-protein
beta B-O I-protein
) B-O O
induces B-O O
eosinophilic B-O O
differentiation B-O O
and B-O O
apoptosis B-O O
in B-O O
a B-O O
hematopoietic B-O B-cell_line
progenitor B-O I-cell_line
cell B-O I-cell_line
line B-O I-cell_line
. B-O O

CAAT/enhancer B-O B-protein
binding B-O I-protein
proteins B-O I-protein
( B-O O
C/EBPs B-O B-protein
) B-O O
are B-O O
transcriptional B-O B-protein
activators B-O I-protein
implicated B-O O
in B-O O
the B-O O
differentiation B-O O
processes B-O O
of B-O O
various B-O O
cell B-O B-cell_type
lineages B-O I-cell_type
. B-O O

We B-O O
have B-O O
shown B-O O
earlier B-O O
that B-O O
NF-M B-O B-protein
, B-O O
the B-O O
chicken B-O B-protein
homolog B-O I-protein
of B-O O
C/EBP B-O B-protein
beta B-O I-protein
, B-O O
is B-O O
specifically B-O O
expressed B-O O
in B-O O
myelomonocytic B-O B-cell_type
and B-O I-cell_type
eosinophilic B-O I-cell_type
cells B-O I-cell_type
of B-O O
the B-O O
hematopoietic B-O O
system B-O O
. B-O O

To B-O O
investigate B-O O
the B-O O
role B-O O
of B-O O
NF-M B-O B-protein
in B-O O
hematopoietic B-O B-cell_type
cell B-O I-cell_type
lineage B-O I-cell_type
commitment B-O O
, B-O O
we B-O O
constructed B-O O
a B-O O
conditional B-O O
form B-O O
of B-O O
the B-O O
protein B-O O
by B-O O
fusing B-O O
it B-O O
to B-O O
the B-O O
hormone B-O B-protein
binding B-O I-protein
domain B-O I-protein
of B-O O
the B-O O
human B-O B-protein
estrogen B-O I-protein
receptor B-O I-protein
. B-O O

This B-O O
construct B-O O
was B-O O
stably B-O O
expressed B-O O
in B-O O
a B-O O
multipotent B-O B-cell_line
progenitor B-O I-cell_line
cell B-O I-cell_line
line B-O I-cell_line
transformed B-O O
by B-O O
the B-O O
Myb-Ets B-O B-protein
oncoprotein B-O I-protein
. B-O O

We B-O O
report B-O O
here B-O O
that B-O O
both B-O O
NF-M B-O B-protein
-dependent B-O O
promoter B-O O
constructs B-O O
and B-O O
resident B-O O
genes B-O O
could B-O O
be B-O O
activated B-O O
by B-O O
addition B-O O
of B-O O
beta-estradiol B-O O
to B-O O
the B-O O
NF-M B-O B-protein
-estrogen B-O I-protein
receptor B-O I-protein
expressing B-O O
progenitors B-O O
. B-O O

At B-O O
the B-O O
same B-O O
time B-O O
, B-O O
we B-O O
observed B-O O
a B-O O
down-regulation B-O O
of B-O O
progenitor-specific B-O B-protein
surface B-O I-protein
markers B-O I-protein
and B-O O
the B-O O
up-regulation B-O O
of B-O O
differentiation B-O O
markers B-O O
restricted B-O O
to B-O O
the B-O O
eosinophil B-O B-cell_type
and B-O O
myeloid B-O B-cell_type
lineages B-O I-cell_type
. B-O O

In B-O O
addition B-O O
to B-O O
the B-O O
onset B-O O
of B-O O
differentiation B-O O
, B-O O
cell B-O O
death B-O O
was B-O O
induced B-O O
with B-O O
typical B-O O
apoptotic B-O O
features B-O O
. B-O O

Our B-O O
results B-O O
suggest B-O O
that B-O O
NF-M B-O B-protein
plays B-O O
an B-O O
important B-O O
role B-O O
in B-O O
commitment B-O O
along B-O O
the B-O O
eosinophil B-O B-cell_type
lineage B-O I-cell_type
and B-O O
in B-O O
the B-O O
induction B-O O
of B-O O
apoptosis B-O O
. B-O O

Prolactin B-O O
and B-O O
interleukin-2 B-O B-protein
receptors B-O I-protein
in B-O O
T B-O B-cell_type
lymphocytes B-O I-cell_type
signal B-O O
through B-O O
a B-O O
MGF-STAT5-like B-O B-protein
transcription B-O I-protein
factor B-O I-protein
. B-O O

The B-O O
cell B-O B-protein
surface B-O I-protein
receptors B-O I-protein
for B-O O
PRL B-O B-protein
and B-O O
interleukin-2 B-O B-protein
( B-O O
IL-2 B-O B-protein
) B-O O
are B-O O
structurally B-O O
distinct B-O O
, B-O O
but B-O O
share B-O O
regulatory B-O O
tasks B-O O
in B-O O
T B-O B-cell_type
lymphocytes B-O I-cell_type
. B-O O

They B-O O
can B-O O
stimulate B-O O
proliferation B-O O
and B-O O
activate B-O O
transcription B-O O
of B-O O
over-lapping B-O O
sets B-O O
of B-O O
genes B-O O
of B-O O
T B-O B-cell_type
cells B-O I-cell_type
. B-O O

PRL B-O B-protein
and B-O O
IL-2 B-O B-protein
receptor B-O O
activation B-O O
are B-O O
both B-O O
linked B-O O
to B-O O
the B-O O
Jak/Stat B-O B-protein
( B-O O
signal B-O B-protein
transducer B-O I-protein
and B-O I-protein
activator B-O I-protein
of B-O I-protein
transcription B-O I-protein
) B-O O
pathway B-O O
. B-O O

We B-O O
investigated B-O O
the B-O O
ability B-O O
of B-O O
PRL B-O B-protein
and B-O O
IL-2 B-O B-protein
to B-O O
activate B-O O
Stat B-O B-protein
proteins B-O I-protein
in B-O O
different B-O O
T B-O B-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
. B-O O

The B-O O
DNA B-O O
binding B-O O
specificities B-O O
, B-O O
the B-O O
reactivities B-O O
toward B-O O
Stat-specific B-O O
antisera B-O O
, B-O O
and B-O O
the B-O O
mol B-O O
wt B-O O
of B-O O
IL-2 B-O B-protein
- B-O O
and B-O O
PRL B-O B-protein
-induced B-O O
DNA-binding B-O B-protein
proteins B-O I-protein
in B-O O
Nb2 B-O B-cell_line
and B-O I-cell_line
C196 B-O I-cell_line
T B-O I-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
were B-O O
investigated B-O O
. B-O O

A B-O O
comparison B-O O
with B-O O
the B-O O
Stat B-O B-protein
proteins B-O I-protein
induced B-O O
by B-O O
interferon-gamma B-O B-protein
, B-O O
PRL B-O B-protein
, B-O O
and B-O O
IL-6 B-O B-protein
in B-O O
T47D B-O B-cell_line
mammary B-O I-cell_line
tumor B-O I-cell_line
cells B-O I-cell_line
was B-O O
made B-O O
. B-O O

We B-O O
found B-O O
that B-O O
these B-O O
parameters B-O O
were B-O O
indistinguishable B-O O
for B-O O
one B-O O
of B-O O
the B-O O
PRL- B-O O
and B-O O
IL-2- B-O B-protein
induced B-O O
factors B-O O
. B-O O

A B-O O
transcription B-O B-protein
factor B-O I-protein
closely B-O O
related B-O O
to B-O O
mammary B-O B-protein
gland B-O I-protein
factor-Stat5 B-O I-protein
is B-O O
rapidly B-O O
activated B-O O
upon B-O O
interaction B-O O
of B-O O
IL-2 B-O B-protein
and B-O O
PRL B-O B-protein
with B-O O
their B-O O
respective B-O O
receptors B-O O
. B-O O

Activation B-O O
of B-O O
a B-O O
second B-O O
protein B-O O
related B-O O
to B-O O
Stat1 B-O B-protein
was B-O O
also B-O O
observed B-O O
. B-O O

Our B-O O
results B-O O
emphasize B-O O
the B-O O
role B-O O
of B-O O
PRL B-O B-protein
as B-O O
a B-O O
regulator B-O O
of B-O O
the B-O O
immune B-O O
response B-O O
and B-O O
indicate B-O O
that B-O O
the B-O O
Stat B-O B-protein
factors B-O I-protein
mammary B-O B-protein
gland B-O I-protein
factor-Stat5 B-O I-protein
and B-O O
Stat1 B-O B-protein
play B-O O
a B-O O
role B-O O
in B-O O
the B-O O
regulation B-O O
of B-O O
gene B-O O
expression B-O O
during B-O O
T B-O O
cell B-O O
development B-O O
. B-O O

ETS1 B-O B-protein
transactivates B-O O
the B-O O
human B-O B-DNA
GM-CSF B-O I-DNA
promoter B-O I-DNA
in B-O O
Jurkat B-O B-cell_line
T B-O I-cell_line
cells B-O I-cell_line
stimulated B-O O
with B-O O
PMA B-O O
and B-O O
ionomycin B-O O
. B-O O

Activation B-O O
of B-O O
T B-O B-cell_type
helper B-O I-cell_type
cells B-O I-cell_type
results B-O O
in B-O O
coordinate B-O O
expression B-O O
of B-O O
a B-O O
number B-O O
of B-O O
cytokines B-O B-protein
involved B-O O
in B-O O
differentiation B-O O
, B-O O
proliferation B-O O
and B-O O
activation B-O O
of B-O O
the B-O O
haematopoietic B-O O
system B-O O
. B-O O

Granulocyte-macrophage B-O B-protein
colony-stimulating B-O I-protein
factor B-O I-protein
( B-O O
GM-CSF B-O B-protein
) B-O O
is B-O O
one B-O O
such B-O O
cytokine B-O B-protein
whose B-O O
increased B-O O
expression B-O O
results B-O O
partly B-O O
from B-O O
increases B-O O
in B-O O
transcription B-O O
. B-O O

Cis-acting B-O B-DNA
elements B-O I-DNA
with B-O O
NF B-O B-protein
kappa B-O I-protein
B B-O I-protein
, B-O O
AP-1 B-O B-protein
and B-O O
ETS-like B-O B-DNA
motifs B-O I-DNA
have B-O O
been B-O O
identified B-O O
in B-O O
the B-O O
promoter B-O B-DNA
region B-O I-DNA
of B-O O
the B-O O
GM-CSF B-O B-DNA
gene B-O I-DNA
, B-O O
which B-O O
are B-O O
important B-O O
for B-O O
transcriptional B-O O
activity B-O O
following B-O O
PMA B-O O
and B-O O
ionomycin B-O O
stimulation B-O O
. B-O O

A B-O O
number B-O O
of B-O O
the B-O O
ETS B-O B-protein
family B-O I-protein
of B-O O
transcription B-O B-protein
factors B-O I-protein
are B-O O
expressed B-O O
in B-O O
T B-O B-cell_type
cells B-O I-cell_type
, B-O O
including B-O O
ETS1 B-O B-protein
and B-O O
ELF1 B-O B-protein
. B-O O

Here B-O O
we B-O O
describe B-O O
the B-O O
ability B-O O
of B-O O
these B-O O
factors B-O O
to B-O O
interact B-O O
with B-O O
a B-O O
site B-O O
( B-O O
GM5 B-O B-DNA
) B-O O
, B-O O
located B-O O
within B-O O
the B-O O
CLE0 B-O B-DNA
element B-O I-DNA
, B-O O
-47 B-O B-DNA
to B-O I-DNA
-40 B-O I-DNA
upstream B-O I-DNA
of B-O O
the B-O O
GM-CSF B-O B-DNA
transcription B-O I-DNA
initiation B-O I-DNA
site B-O I-DNA
. B-O O

Exogenous B-O O
ETS1 B-O B-protein
, B-O O
but B-O O
not B-O O
ELF1 B-O B-protein
, B-O O
can B-O O
transactivate B-O O
GM-CSF B-O B-protein
, B-O O
through B-O O
the B-O O
GM5 B-O B-DNA
site B-O I-DNA
, B-O O
in B-O O
a B-O O
PMA B-O O
/ B-O O
ionomycin B-O O
dependent B-O O
manner B-O O
. B-O O

Other B-O O
unidentified B-O O
ETS-like B-O B-protein
factors B-O I-protein
present B-O O
in B-O O
Jurkat B-O B-cell_line
cells B-O I-cell_line
are B-O O
also B-O O
capable B-O O
of B-O O
binding B-O O
GM5 B-O B-DNA
. B-O O

Mutation B-O O
of B-O O
the B-O O
core B-O O
ETS B-O B-DNA
binding B-O I-DNA
site B-O I-DNA
from B-O O
-GGAA- B-O B-DNA
to B-O I-DNA
-GGAT- B-O I-DNA
prevents B-O O
the B-O O
binding B-O O
of B-O O
ETS-like B-O B-protein
factors B-O I-protein
with B-O O
the B-O O
exception B-O O
of B-O O
ETS1 B-O B-protein
. B-O O

The B-O O
GM-CSF B-O B-DNA
promoter B-O I-DNA
, B-O O
modified B-O O
in B-O O
this B-O O
way B-O O
to B-O O
be B-O O
ETS1 B-O B-protein
specific B-O O
, B-O O
is B-O O
fully B-O O
responsive B-O O
to B-O O
PMA B-O O
/ B-O O
ionomycin B-O O
induction B-O O
, B-O O
in B-O O
addition B-O O
to B-O O
ETS1 B-O B-protein
transactivation B-O O
in B-O O
the B-O O
presence B-O O
of B-O O
PMA B-O O
and B-O O
ionomycin B-O O
. B-O O

Together B-O O
these B-O O
data B-O O
suggest B-O O
that B-O O
ETS1 B-O B-protein
may B-O O
be B-O O
involved B-O O
in B-O O
mediating B-O O
the B-O O
increased B-O O
GM-CSF B-O B-protein
production B-O O
associated B-O O
with B-O O
T B-O O
cell B-O O
activation B-O O
. B-O O

Quantitation B-O O
of B-O O
beta B-O B-RNA
1 B-O I-RNA
triiodothyronine B-O I-RNA
receptor B-O I-RNA
mRNA B-O I-RNA
in B-O O
human B-O O
tissues B-O O
by B-O O
competitive B-O O
reverse B-O O
transcription B-O O
polymerase B-O O
chain B-O O
reaction B-O O
. B-O O

Thyroid B-O O
hormones B-O O
act B-O O
by B-O O
binding B-O O
to B-O O
nuclear B-O B-protein
receptor B-O I-protein
proteins B-O I-protein
, B-O O
the B-O O
thyroid B-O B-protein
hormone B-O I-protein
receptors B-O I-protein
( B-O O
TR B-O B-protein
) B-O O
alpha B-O O
and B-O O
beta B-O O
. B-O O

Data B-O O
from B-O O
cell B-O O
culture B-O O
and B-O O
animal B-O O
studies B-O O
indicate B-O O
that B-O O
TR B-O B-protein
expression B-O O
may B-O O
be B-O O
regulated B-O O
to B-O O
modulate B-O O
target B-O O
organ B-O O
responsiveness B-O O
to B-O O
thyroid B-O O
hormone B-O O
. B-O O

To B-O O
investigate B-O O
whether B-O O
such B-O O
adaptive B-O O
changes B-O O
in B-O O
TR B-O B-protein
expression B-O O
occur B-O O
in B-O O
humans B-O O
, B-O O
we B-O O
determined B-O O
the B-O O
mRNA B-O B-RNA
levels B-O O
of B-O O
the B-O O
hTR B-O B-protein
beta B-O I-protein
1 B-O I-protein
in B-O O
various B-O O
thyroid B-O O
states B-O O
. B-O O

Patients B-O O
with B-O O
overt B-O O
hypo B-O O
- B-O O
or B-O O
hyper B-O O
thyroidism B-O O
were B-O O
enrolled B-O O
in B-O O
the B-O O
study B-O O
. B-O O

Total B-O O
RNA B-O O
was B-O O
isolated B-O O
from B-O O
peripheral B-O B-cell_type
blood B-O I-cell_type
mononuclear B-O I-cell_type
cells B-O I-cell_type
and B-O O
hTR B-O B-RNA
beta B-O I-RNA
1 B-O I-RNA
mRNA B-O I-RNA
levels B-O O
determined B-O O
by B-O O
quantitative B-O O
competitive B-O O
reverse B-O O
transcription B-O O
PCR B-O O
. B-O O

For B-O O
comparison B-O O
, B-O O
hTR B-O B-RNA
beta B-O I-RNA
1 B-O I-RNA
mRNA B-O I-RNA
levels B-O O
were B-O O
determined B-O O
in B-O O
lymphocytes B-O B-cell_type
and B-O O
normal B-O O
thyroid B-O O
tissue B-O O
of B-O O
euthyroid B-O O
patients B-O O
. B-O O

Human B-O B-RNA
TR B-O I-RNA
beta B-O I-RNA
1 B-O I-RNA
mRNA B-O I-RNA
levels B-O O
in B-O O
lymphocytes B-O B-cell_type
were B-O O
1.8 B-O O
+/- B-O O
0.4 B-O O
, B-O O
1.9 B-O O
+/- B-O O
0.5 B-O O
, B-O O
1.1 B-O O
+/- B-O O
0.4 B-O O
10 B-O O
( B-O O
-18 B-O O
) B-O O
mol/microgram B-O O
RNA B-O O
in B-O O
hypo B-O O
- B-O O
, B-O O
eu B-O O
- B-O O
and B-O O
hyper B-O O
thyroid B-O O
patients B-O O
, B-O O
respectively B-O O
, B-O O
corresponding B-O O
to B-O O
an B-O O
estimated B-O O
0.5 B-O O
-2 B-O O
molecules B-O O
per B-O O
cell B-O O
. B-O O

Although B-O O
the B-O O
mean B-O O
hTR B-O B-RNA
beta B-O I-RNA
1 B-O I-RNA
mRNA B-O I-RNA
levels B-O O
were B-O O
40 B-O O
% B-O O
lower B-O O
in B-O O
hyperthyroid B-O O
than B-O O
in B-O O
euthyroid B-O O
subjects B-O O
, B-O O
this B-O O
difference B-O O
did B-O O
not B-O O
reach B-O O
statistical B-O O
significance B-O O
. B-O O

Similar B-O O
levels B-O O
of B-O O
hTR B-O B-RNA
beta B-O I-RNA
1 B-O I-RNA
mRNA B-O I-RNA
levels B-O O
were B-O O
detected B-O O
in B-O O
thyroid B-O O
gland B-O O
from B-O O
euthyroid B-O O
patients B-O O
. B-O O

In B-O O
summary B-O O
, B-O O
we B-O O
developed B-O O
an B-O O
assay B-O O
for B-O O
the B-O O
quantitative B-O O
determination B-O O
of B-O O
hTR B-O B-RNA
beta B-O I-RNA
1 B-O I-RNA
mRNA B-O I-RNA
levels B-O O
in B-O O
small B-O O
human B-O O
tissue B-O O
samples B-O O
, B-O O
containing B-O O
as B-O O
little B-O O
as B-O O
50 B-O O
ng B-O O
of B-O O
total B-O O
RNA B-O O
. B-O O

Absolute B-O O
hTR B-O B-RNA
beta B-O I-RNA
1 B-O I-RNA
mRNA B-O I-RNA
levels B-O O
are B-O O
very B-O O
low B-O O
with B-O O
an B-O O
estimated B-O O
one B-O O
molecule B-O O
of B-O O
mRNA B-O B-RNA
being B-O O
present B-O O
in B-O O
a B-O O
mononuclear B-O B-cell_type
blood B-O I-cell_type
cell B-O I-cell_type
or B-O O
thyrocyte B-O B-cell_type
. B-O O

No B-O O
up-regulation B-O O
of B-O O
hTR B-O B-protein
beta B-O I-protein
1 B-O I-protein
was B-O O
seen B-O O
in B-O O
hypothyroid B-O O
relative B-O O
to B-O O
euthyroid B-O O
patients B-O O
. B-O O

However B-O O
, B-O O
there B-O O
is B-O O
a B-O O
non-significant B-O O
trend B-O O
towards B-O O
a B-O O
down-regulation B-O O
of B-O O
hTR B-O B-RNA
beta B-O I-RNA
1 B-O I-RNA
mRNA B-O I-RNA
levels B-O O
in B-O O
hyperthyroid B-O O
patients B-O O
. B-O O

Multiple B-O O
proteins B-O O
interact B-O O
with B-O O
the B-O O
nuclear B-O B-DNA
inhibitory B-O I-DNA
protein B-O I-DNA
repressor B-O I-DNA
element B-O I-DNA
in B-O O
the B-O O
human B-O B-DNA
interleukin-3 B-O I-DNA
promoter B-O I-DNA
. B-O O

T B-O O
cell B-O O
expression B-O O
of B-O O
interleukin B-O B-protein
3 B-O I-protein
( B-O O
IL-3 B-O B-protein
) B-O O
is B-O O
directed B-O O
by B-O O
positive B-O B-DNA
and B-O I-DNA
negative B-O I-DNA
cis-acting B-O I-DNA
DNA B-O I-DNA
elements B-O I-DNA
clustered B-O O
within B-O O
300 B-O O
base B-O O
pairs B-O O
of B-O O
the B-O O
transcriptional B-O B-DNA
start B-O I-DNA
site B-O I-DNA
. B-O O

A B-O O
strong B-O B-DNA
repressor B-O I-DNA
element B-O I-DNA
, B-O O
termed B-O O
nuclear B-O B-protein
inhibitory B-O I-protein
protein B-O I-protein
( B-O O
NIP B-O B-protein
) B-O O
, B-O O
was B-O O
previously B-O O
mapped B-O O
to B-O O
a B-O O
segment B-O O
of B-O O
the B-O O
IL-3 B-O B-DNA
promoter B-O I-DNA
between B-O O
nucleotides B-O B-DNA
-271 B-O I-DNA
and B-O I-DNA
-250 B-O I-DNA
. B-O O

Functional B-O O
characterization B-O O
of B-O O
this B-O O
element B-O O
demonstrates B-O O
that B-O O
it B-O O
can B-O O
mediate B-O O
repression B-O O
when B-O O
linked B-O O
in B-O O
cis B-O O
to B-O O
a B-O O
heterologous B-O B-DNA
promoter B-O I-DNA
. B-O O

DNA B-O O
binding B-O O
experiments B-O O
were B-O O
carried B-O O
out B-O O
to B-O O
characterize B-O O
the B-O O
repressor B-O O
activity B-O O
. B-O O

Using B-O O
varying B-O O
conditions B-O O
, B-O O
three B-O O
distinct B-O O
complexes B-O O
were B-O O
shown B-O O
to B-O O
interact B-O O
specifically B-O O
with B-O O
the B-O O
NIP B-O B-DNA
region B-O I-DNA
, B-O O
although B-O O
only B-O O
one B-O O
correlates B-O O
with B-O O
repressor B-O O
activity B-O O
. B-O O

Complex B-O B-protein
1 B-O I-protein
results B-O O
from B-O O
binding B-O O
of B-O O
a B-O O
ubiquitous B-O B-protein
polypeptide B-O I-protein
that B-O O
recognizes B-O O
the B-O O
3 B-O B-DNA
' B-O I-DNA
portion B-O I-DNA
of B-O O
this B-O O
sequence B-O O
and B-O O
is B-O O
not B-O O
required B-O O
for B-O O
repression B-O O
. B-O O

Complex B-O B-protein
2 B-O I-protein
corresponds B-O O
to B-O O
binding B-O O
of B-O O
transcription B-O B-protein
factor B-O I-protein
( B-O O
upstream B-O B-protein
stimulatory B-O I-protein
factor B-O I-protein
) B-O O
to B-O O
an B-O O
E-box B-O B-DNA
motif B-O I-DNA
in B-O O
the B-O O
5 B-O B-DNA
' B-O I-DNA
portion B-O I-DNA
of B-O O
the B-O O
NIP B-O B-DNA
region B-O I-DNA
. B-O O

DNA B-O O
binding B-O O
specificity B-O O
of B-O O
complex B-O B-protein
3 B-O I-protein
overlaps B-O I-protein
with B-O O
that B-O O
of B-O O
upstream B-O B-protein
stimulatory B-O I-protein
factor B-O I-protein
but B-O O
is B-O O
clearly B-O O
distinct B-O O
. B-O O

To B-O O
determine B-O O
which B-O O
of B-O O
the B-O O
latter B-O O
two B-O O
complexes B-O O
represents B-O O
NIP B-O B-protein
activity B-O O
, B-O O
we B-O O
incorporated B-O O
small B-O O
alterations B-O O
into B-O O
the B-O O
NIP B-O B-DNA
site B-O I-DNA
of B-O O
an B-O O
IL-3 B-O B-DNA
promoter B-O I-DNA
-linked B-O I-DNA
reporter B-O I-DNA
construct B-O I-DNA
and B-O O
examined B-O O
their B-O O
effects B-O O
on B-O O
NIP B-O B-protein
-mediated B-O O
repression B-O O
. B-O O

Functional B-O O
specificity B-O O
for B-O O
repression B-O O
matches B-O O
the B-O O
DNA B-O O
binding B-O O
specificity B-O O
of B-O O
complex B-O B-protein
3 B-O I-protein
; B-O O
both B-O O
repressor B-O O
activity B-O O
and B-O O
complex B-O B-protein
3 B-O I-protein
binding B-O O
require B-O O
the B-O O
consensus B-O B-DNA
sequence B-O I-DNA
CTCACNTNC B-O O
. B-O O

The B-O O
hematopoietic B-O B-protein
transcription B-O I-protein
factor B-O I-protein
PU.1 B-O B-protein
is B-O O
downregulated B-O O
in B-O O
human B-O B-cell_line
multiple B-O I-cell_line
myeloma B-O I-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
. B-O O

PU.1 B-O B-protein
is B-O O
a B-O O
hematopoietic B-O B-protein
transcription B-O I-protein
factor B-O I-protein
belonging B-O O
to B-O O
the B-O O
Ets-family B-O B-protein
. B-O O

It B-O O
is B-O O
identical B-O O
to B-O O
the B-O O
Spi-1 B-O B-DNA
oncogene B-O I-DNA
, B-O O
which B-O O
is B-O O
implicated B-O O
in B-O O
spleen B-O O
focus-forming B-O O
virus-induced B-O O
murine B-O O
erythroleukemias B-O O
. B-O O

PU.1 B-O B-protein
seems B-O O
to B-O O
be B-O O
required B-O O
for B-O O
early B-O O
development B-O O
of B-O O
multiple B-O B-cell_type
hematopoietic B-O I-cell_type
lineages B-O I-cell_type
, B-O O
but B-O O
its B-O O
expression B-O O
in B-O O
mature B-O B-cell_type
cells B-O I-cell_type
is B-O O
preferentially B-O O
observed B-O O
in B-O O
cells B-O O
of B-O O
the B-O O
B-cell-and B-O B-cell_type
monocyte/macrophage- B-O I-cell_type
differentiation B-O I-cell_type
lineage B-O I-cell_type
. B-O O

It B-O O
binds B-O O
the B-O O
so-called B-O O
Pu B-O B-DNA
box B-O I-DNA
, B-O O
an B-O O
important B-O O
tissue-specific B-O B-DNA
regulatory B-O I-DNA
DNA B-O I-DNA
element B-O I-DNA
present B-O O
in B-O O
a B-O O
number B-O O
of B-O O
genes B-O B-DNA
expressed B-O O
in B-O O
these B-O O
cell B-O B-cell_type
lineages B-O I-cell_type
. B-O O

We B-O O
have B-O O
analyzed B-O O
the B-O O
expression B-O O
and B-O O
activity B-O O
of B-O O
PU.1 B-O B-protein
during B-O O
human B-O O
B-cell B-O O
development B-O O
using B-O O
a B-O O
panel B-O O
of B-O O
B-cell B-O B-cell_line
lines B-O I-cell_line
representing B-O O
different B-O O
stages B-O O
of B-O O
maturation B-O O
, B-O O
from B-O O
early B-O B-cell_line
precursors B-O I-cell_line
to B-O O
differentiated B-O B-cell_type
plasma B-O I-cell_type
cells B-O I-cell_type
. B-O O

PU.1 B-O B-RNA
mRNA B-O I-RNA
expression B-O O
and B-O O
PU.1 B-O B-protein
DNA B-O O
binding B-O O
activity B-O O
, B-O O
as B-O O
measured B-O O
by B-O O
Northern B-O O
blot B-O O
analysis B-O O
and B-O O
electrophoretic B-O O
mobility B-O O
shift B-O O
assay B-O O
, B-O O
respectively B-O O
, B-O O
were B-O O
evident B-O O
in B-O O
cell B-O B-cell_line
lines B-O I-cell_line
representing B-O O
pro-B B-O B-protein
, B-O O
pre-B B-O O
, B-O O
and B-O O
mature B-O B-cell_type
B B-O I-cell_type
cells B-O I-cell_type
. B-O O

We B-O O
could B-O O
also B-O O
show B-O O
Pu B-O B-DNA
box B-O I-DNA
-dependent B-O O
transactivation B-O O
of B-O O
a B-O O
reporter B-O B-DNA
gene B-O I-DNA
in B-O O
transient B-O O
transfections B-O O
in B-O O
these B-O O
cell B-O B-cell_line
lines B-O I-cell_line
. B-O O

In B-O O
contrast B-O O
, B-O O
in B-O O
a B-O O
number B-O O
of B-O O
multiple B-O B-cell_line
myeloma B-O I-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
, B-O O
representing B-O O
differentiated B-O O
, B-O O
plasma B-O B-cell_type
cell-like B-O I-cell_type
B B-O I-cell_type
cells B-O I-cell_type
, B-O O
PU.1 B-O B-protein
DNA B-O O
binding B-O O
activity B-O O
, B-O O
mRNA B-O B-RNA
expression B-O O
, B-O O
and B-O O
Pu B-O B-DNA
box B-O I-DNA
-dependent B-O O
transactivation B-O O
were B-O O
absent B-O O
or B-O O
detectable B-O O
at B-O O
a B-O O
very B-O O
low B-O O
level B-O O
. B-O O

In B-O O
lymphoblastoid B-O B-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
, B-O O
which B-O O
exemplify B-O O
an B-O O
intermediate B-O O
stage B-O O
of B-O O
B-cell B-O B-cell_type
differentiation B-O O
, B-O O
a B-O O
reduced B-O O
expression B-O O
and B-O O
activity B-O O
were B-O O
observed B-O O
. B-O O

The B-O O
findings B-O O
in B-O O
the B-O O
human B-O B-cell_line
multiple B-O I-cell_line
myeloma B-O I-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
represent B-O O
the B-O O
first B-O O
examples B-O O
of B-O O
B B-O B-cell_type
cells B-O I-cell_type
with B-O O
downregulated B-O O
PU.1 B-O B-protein
expression B-O O
and B-O O
apparently B-O O
contradict B-O O
observations B-O O
in B-O O
the B-O O
murine B-O O
system B-O O
in B-O O
which B-O O
PU.1 B-O B-protein
is B-O O
expressed B-O O
and B-O O
active B-O O
in B-O O
plasmacytoma B-O B-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
. B-O O

At B-O O
present B-O O
, B-O O
it B-O O
is B-O O
unclear B-O O
whether B-O O
the B-O O
lack B-O O
of B-O O
PU.1 B-O B-protein
expression B-O O
and B-O O
activity B-O O
in B-O O
human B-O B-cell_line
multiple B-O I-cell_line
myeloma B-O I-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
represents B-O O
a B-O O
malignancy-associated B-O O
defect B-O O
in B-O O
these B-O O
cells B-O O
or B-O O
exemplifies B-O O
a B-O O
normal B-O O
developmental B-O O
regulation B-O O
in B-O O
terminally B-O B-cell_type
differentiated B-O I-cell_type
B B-O I-cell_type
cells B-O I-cell_type
. B-O O

Regulation B-O O
of B-O O
granulocyte-macrophage B-O B-protein
colony-stimulating B-O I-protein
factor B-O I-protein
and B-O O
E-selectin B-O B-protein
expression B-O O
in B-O O
endothelial B-O B-cell_type
cells B-O I-cell_type
by B-O O
cyclosporin B-O O
A B-O O
and B-O O
the B-O O
T-cell B-O B-protein
transcription B-O I-protein
factor B-O I-protein
NFAT B-O B-protein
. B-O O

Nuclear B-O B-protein
factor B-O I-protein
of B-O I-protein
activated B-O I-protein
T B-O I-protein
cells B-O I-protein
( B-O O
NFAT B-O B-protein
) B-O O
was B-O O
originally B-O O
described B-O O
as B-O O
a B-O O
T-cell-specific B-O B-protein
transcription B-O I-protein
factor B-O I-protein
athat B-O O
supported B-O O
the B-O O
activation B-O O
of B-O O
cytokine B-O B-DNA
gene B-O I-DNA
expression B-O O
and B-O O
mediated B-O O
the B-O O
immunoregulatory B-O B-protein
effects B-O O
of B-O O
cyclosporin B-O O
A B-O O
( B-O O
CsA B-O O
) B-O O
. B-O O

As B-O O
we B-O O
observed B-O O
that B-O O
activated B-O B-cell_type
endothelial B-O I-cell_type
cells B-O I-cell_type
also B-O O
expressed B-O O
NFAT B-O B-protein
, B-O O
we B-O O
tested B-O O
the B-O O
antiinflammatory B-O O
properties B-O O
of B-O O
CsA B-O O
in B-O O
endothelial B-O B-cell_type
cells B-O I-cell_type
. B-O O

Significantly B-O O
, B-O O
CsA B-O O
completely B-O O
suppressed B-O O
the B-O O
induction B-O O
of B-O O
NFAT B-O B-protein
in B-O O
endothelial B-O B-cell_type
cells B-O I-cell_type
and B-O O
inhibited B-O O
the B-O O
activity B-O O
of B-O O
granulocyte-macrophage B-O B-DNA
colony-stimulating B-O I-DNA
factor B-O I-DNA
( B-O I-DNA
GM-CSF B-O I-DNA
) B-O I-DNA
gene B-O I-DNA
regulatory B-O I-DNA
elements B-O I-DNA
that B-O O
use B-O O
NFAT B-O B-protein
by B-O O
60 B-O O
% B-O O
. B-O O

CsA B-O O
similarly B-O O
mediated B-O O
a B-O O
reduction B-O O
of B-O O
up B-O O
to B-O O
65 B-O O
% B-O O
in B-O O
GM-CSF B-O B-RNA
mRNA B-O I-RNA
and B-O O
protein B-O O
expression B-O O
in B-O O
activated B-O B-cell_type
endothelial B-O I-cell_type
cells B-O I-cell_type
. B-O O

CsA B-O O
also B-O O
suppressed B-O O
E-selectin B-O B-protein
, B-O O
but B-O O
not B-O O
vascular B-O B-protein
cell B-O I-protein
adhesion B-O I-protein
molecule-1 B-O I-protein
( B-O O
VCAM-1 B-O B-protein
) B-O O
expression B-O O
in B-O O
endothelial B-O B-cell_type
cells B-O I-cell_type
, B-O O
even B-O O
though B-O O
the B-O O
E-selectin B-O B-DNA
promoter B-O I-DNA
is B-O O
activated B-O O
by B-O O
NF-kappa B-O B-protein
B B-O I-protein
rather B-O O
than B-O O
NFAT B-O B-protein
. B-O O

Hence B-O O
, B-O O
induction B-O O
of B-O O
cell B-O O
surface B-O O
expression B-O O
of B-O O
this B-O O
leukocyte B-O B-protein
adhesion B-O I-protein
molecule B-O I-protein
by B-O O
tumor B-O B-protein
necrosis B-O I-protein
factor B-O I-protein
( B-O I-protein
TNF B-O I-protein
) B-O I-protein
-alpha B-O I-protein
was B-O O
reduced B-O O
by B-O O
40 B-O O
% B-O O
in B-O O
the B-O O
presence B-O O
of B-O O
CsA B-O O
, B-O O
and B-O O
this B-O O
was B-O O
reflected B-O O
by B-O O
a B-O O
29 B-O O
% B-O O
decrease B-O O
in B-O O
neutrophil B-O B-cell_type
adhesion B-O O
. B-O O

The B-O O
effects B-O O
of B-O O
CsA B-O O
on B-O O
endothelial B-O B-cell_type
cells B-O I-cell_type
were B-O O
also B-O O
detected B-O O
at B-O O
the B-O O
chromatin B-O B-DNA
structure B-O O
level B-O O
, B-O O
as B-O O
DNasel B-O B-DNA
hypersensitive B-O I-DNA
sites B-O I-DNA
within B-O O
both B-O O
the B-O O
GM-CSF B-O B-DNA
enhancer B-O I-DNA
and B-O O
the B-O O
E-selectin B-O B-DNA
promoter B-O I-DNA
were B-O O
suppressed B-O O
by B-O O
CsA B-O O
. B-O O

This B-O O
represents B-O O
the B-O O
first B-O O
report B-O O
of B-O O
NFAT B-O B-protein
in B-O O
endothelial B-O B-cell_type
cells B-O I-cell_type
and B-O O
suggests B-O O
mechanisms B-O O
by B-O O
which B-O O
CsA B-O O
could B-O O
function B-O O
as B-O O
an B-O O
antiinflammatory B-O O
agent B-O O
. B-O O

Costimulation B-O O
requirement B-O O
for B-O O
AP-1 B-O B-protein
and B-O O
NF-kappa B-O B-protein
B B-O I-protein
transcription B-O O
factor B-O O
activation B-O O
in B-O O
T B-O B-cell_type
cells B-O I-cell_type
. B-O O

The B-O O
transcriptional B-O O
activity B-O O
of B-O O
the B-O O
IL-2 B-O B-DNA
promoter B-O I-DNA
requires B-O O
T-cell B-O B-cell_type
costimulation B-O O
delivered B-O O
by B-O O
the B-O O
TCR B-O B-protein
and B-O O
the B-O O
auxiliary B-O B-protein
receptor B-O I-protein
CD28 B-O I-protein
. B-O O

Several B-O O
transcription B-O B-protein
factors B-O I-protein
participate B-O O
in B-O O
IL-2 B-O B-DNA
promoter B-O I-DNA
activation B-O O
, B-O O
among B-O O
which B-O O
are B-O O
AP-1 B-O B-protein
-like B-O O
factors B-O O
and B-O O
NF-kappa B-O B-protein
B B-O I-protein
. B-O O

Protein B-O O
phosphorylation B-O O
has B-O O
an B-O O
important B-O O
role B-O O
in B-O O
the B-O O
regulation B-O O
of B-O O
these B-O O
two B-O O
factors B-O O
: B-O O
( B-O O
1 B-O O
) B-O O
it B-O O
induces B-O O
the B-O O
transactivating B-O O
capacity B-O O
of B-O O
the B-O O
AP-1 B-O B-protein
protein B-O I-protein
c-Jun B-O B-protein
; B-O O
and B-O O
( B-O O
2 B-O O
) B-O O
it B-O O
is B-O O
involved B-O O
in B-O O
the B-O O
release B-O O
of B-O O
the B-O O
cytoplasmic B-O B-protein
inhibitor B-O I-protein
, B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
, B-O O
from B-O O
NF-kappa B-O B-protein
B B-O I-protein
, B-O O
allowing B-O O
translocation B-O O
of B-O O
the B-O O
latter B-O O
into B-O O
the B-O O
nucleus B-O O
. B-O O

We B-O O
have B-O O
recently B-O O
shown B-O O
that B-O O
both B-O O
phosphorylation B-O O
processes B-O O
require B-O O
T-cell B-O O
costimulation B-O O
. B-O O

Furthermore B-O O
, B-O O
in B-O O
activated B-O B-cell_type
T B-O I-cell_type
cells B-O I-cell_type
, B-O O
the B-O O
kinetics B-O O
of B-O O
the B-O O
two B-O O
phosphorylation B-O O
events B-O O
are B-O O
essentially B-O O
similar B-O O
. B-O O

According B-O O
to B-O O
our B-O O
results B-O O
, B-O O
however B-O O
, B-O O
the B-O O
kinases B-O B-protein
responsible B-O O
for B-O O
the B-O O
two B-O O
processes B-O O
are B-O O
distinct B-O O
entities B-O O
. B-O O

Whereas B-O O
TPCK B-O B-protein
inhibits B-O O
phosphorylation B-O O
of B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
and B-O O
, B-O O
consequently B-O O
, B-O O
activation B-O O
of B-O O
NF-kappa B-O B-protein
B B-O I-protein
, B-O O
it B-O O
markedly B-O O
enhances B-O O
the B-O O
activity B-O O
of B-O O
JNK B-O B-protein
, B-O O
the B-O O
MAP B-O B-protein
kinase-related B-O I-protein
kinase B-O I-protein
that B-O O
phosphorylates B-O O
the B-O O
transactivation B-O B-protein
domain B-O I-protein
of B-O O
c-Jun B-O B-protein
. B-O O

We B-O O
, B-O O
therefore B-O O
, B-O O
propose B-O O
the B-O O
activation B-O O
scheme B-O O
presented B-O O
in B-O O
FIGURE B-O O
3 B-O O
for B-O O
T-cell B-O O
costimulation B-O O
. B-O O

Costimulation B-O O
results B-O O
in B-O O
the B-O O
activation B-O O
of B-O O
a B-O O
signaling B-O O
pathway B-O O
that B-O O
leads B-O O
to B-O O
the B-O O
simultaneous B-O O
induction B-O O
of B-O O
the B-O O
two B-O O
transcription B-O B-protein
factors B-O I-protein
, B-O O
AP-1 B-O B-protein
and B-O O
NF-kappa B-O B-protein
B B-O I-protein
. B-O O

Integration B-O O
of B-O O
the B-O O
signals B-O O
generated B-O O
by B-O O
TCR B-O B-protein
and B-O O
CD28 B-O B-protein
engagement B-O O
occurs B-O O
along B-O O
this B-O O
pathway B-O O
, B-O O
which B-O O
then B-O O
bifurcates B-O O
to B-O O
induce B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
phosphorylation B-O O
and B-O O
NF-kappa B-O B-protein
B B-O I-protein
activation B-O O
on B-O O
the B-O O
one B-O O
hand B-O O
, B-O O
and B-O O
JNK B-O B-protein
activation B-O O
and B-O O
c-Jun B-O B-protein
phosphorylation B-O O
on B-O O
the B-O O
other B-O O
. B-O O

We B-O O
are B-O O
currently B-O O
engaged B-O O
in B-O O
defining B-O O
where B-O O
the B-O O
two B-O O
signals B-O O
integrate B-O O
along B-O O
the B-O O
AP-1 B-O B-protein
/ B-O O
NF-kappa B-O B-protein
B B-O I-protein
pathway B-O O
. B-O O

Regulation B-O O
of B-O O
human B-O O
immunodeficiency B-O O
virus B-O O
type B-O O
1 B-O O
and B-O O
cytokine B-O O
gene B-O O
expression B-O O
in B-O O
myeloid B-O B-cell_type
cells B-O I-cell_type
by B-O O
NF-kappa B-O B-protein
B B-O I-protein
/Rel B-O I-protein
transcription B-O I-protein
factors B-O I-protein
. B-O O

CD4+ B-O B-cell_type
macrophages B-O I-cell_type
in B-O O
tissues B-O O
such B-O O
as B-O O
lung B-O O
, B-O O
skin B-O O
, B-O O
and B-O O
lymph B-O O
nodes B-O O
, B-O O
promyelocytic B-O B-cell_type
cells B-O I-cell_type
in B-O O
bone B-O O
marrow B-O O
, B-O O
and B-O O
peripheral B-O B-cell_type
blood B-O I-cell_type
monocytes B-O I-cell_type
serve B-O O
as B-O O
important B-O O
targets B-O O
and B-O O
reservoirs B-O O
for B-O O
human B-O O
immunodeficiency B-O O
virus B-O O
type B-O O
1 B-O O
( B-O O
HIV-1 B-O O
) B-O O
replication B-O O
. B-O O

HIV-1 B-O B-cell_type
-infected B-O I-cell_type
myeloid B-O I-cell_type
cells B-O I-cell_type
are B-O O
often B-O O
diminished B-O O
in B-O O
their B-O O
ability B-O O
to B-O O
participate B-O O
in B-O O
chemotaxis B-O O
, B-O O
phagocytosis B-O O
, B-O O
and B-O O
intracellular B-O O
killing B-O O
. B-O O

HIV-1 B-O O
infection B-O O
of B-O O
myeloid B-O B-cell_type
cells B-O I-cell_type
can B-O O
lead B-O O
to B-O O
the B-O O
expression B-O O
of B-O O
surface B-O B-protein
receptors B-O I-protein
associated B-O O
with B-O O
cellular B-O O
activation B-O O
and/or B-O O
differentiation B-O O
that B-O O
increase B-O O
the B-O O
responsiveness B-O O
of B-O O
these B-O O
cells B-O O
to B-O O
cytokines B-O B-protein
secreted B-O O
by B-O O
neighboring B-O O
cells B-O O
as B-O O
well B-O O
as B-O O
to B-O O
bacteria B-O O
or B-O O
other B-O O
pathogens B-O O
. B-O O

Enhancement B-O O
of B-O O
HIV-1 B-O O
replication B-O O
is B-O O
related B-O O
in B-O O
part B-O O
to B-O O
increased B-O O
DNA-binding B-O O
activity B-O O
of B-O O
cellular B-O B-protein
transcription B-O I-protein
factors B-O I-protein
such B-O O
as B-O O
NF-kappa B-O B-protein
B B-O I-protein
. B-O O

NF-kappa B-O B-protein
B B-O I-protein
binds B-O O
to B-O O
the B-O O
HIV-1 B-O B-DNA
enhancer B-O I-DNA
region B-O I-DNA
of B-O O
the B-O O
long B-O B-DNA
terminal B-O I-DNA
repeat B-O I-DNA
and B-O O
contributes B-O O
to B-O O
the B-O O
inducibility B-O O
of B-O O
HIV-1 B-O B-DNA
gene B-O I-DNA
expression B-O O
in B-O O
response B-O O
to B-O O
multiple B-O O
activating B-O O
agents B-O O
. B-O O

Phosphorylation B-O O
and B-O O
degradation B-O O
of B-O O
the B-O O
cytoplasmic B-O B-protein
inhibitor B-O I-protein
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
alpha B-O I-protein
are B-O O
crucial B-O O
regulatory B-O O
events B-O O
in B-O O
the B-O O
activation B-O O
of B-O O
NF-kappa B-O B-protein
B B-O I-protein
DNA-binding B-O O
activity B-O O
. B-O O

Both B-O O
N- B-O O
and B-O O
C- B-O O
terminal B-O O
residues B-O O
of B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
alpha B-O I-protein
are B-O O
required B-O O
for B-O O
inducer-mediated B-O O
degradation B-O O
. B-O O

Chronic B-O O
HIV-1 B-O O
infection B-O O
of B-O O
myeloid B-O B-cell_type
cells B-O I-cell_type
leads B-O O
to B-O O
constitutive B-O O
NF-kappa B-O B-protein
B B-O I-protein
DNA-binding B-O O
activity B-O O
and B-O O
provides B-O O
an B-O O
intranuclear B-O O
environment B-O O
capable B-O O
of B-O O
perpetuating B-O O
HIV-1 B-O O
replication B-O O
. B-O O

Increased B-O O
intracellular B-O O
stores B-O O
of B-O O
latent B-O B-protein
NF-kappa B-O I-protein
B B-O I-protein
may B-O O
also B-O O
result B-O O
in B-O O
rapid B-O O
inducibility B-O O
of B-O O
NF-kappa B-O B-protein
B B-O I-protein
-dependent B-O O
cytokine B-O B-DNA
gene B-O I-DNA
expression B-O O
. B-O O

In B-O O
response B-O O
to B-O O
secondary B-O O
pathogenic B-O O
infections B-O O
or B-O O
antigenic B-O O
challenge B-O O
, B-O O
cytokine B-O B-protein
gene B-O O
expression B-O O
is B-O O
rapidly B-O O
induced B-O O
, B-O O
enhanced B-O O
, B-O O
and B-O O
sustained B-O O
over B-O O
prolonged B-O O
periods B-O O
in B-O O
HIV-1 B-O B-cell_type
-infected B-O I-cell_type
myeloid B-O I-cell_type
cells B-O I-cell_type
compared B-O O
with B-O O
uninfected B-O B-cell_type
cells B-O I-cell_type
. B-O O

Elevated B-O O
levels B-O O
of B-O O
several B-O O
inflammatory B-O B-protein
cytokines B-O I-protein
have B-O O
been B-O O
detected B-O O
in B-O O
the B-O O
sera B-O O
of B-O O
HIV-1 B-O O
-infected B-O O
individuals B-O O
. B-O O

Secretion B-O O
of B-O O
myeloid B-O B-protein
cell-derived B-O I-protein
cytokines B-O I-protein
may B-O O
both B-O O
increase B-O O
virus B-O O
production B-O O
and B-O O
contribute B-O O
to B-O O
AIDS-associated B-O O
disorders B-O O
. B-O O

Steroid B-O O
mediated B-O O
lysis B-O O
of B-O O
lymphoblasts B-O B-cell_type
requires B-O O
the B-O O
DNA B-O B-protein
binding B-O I-protein
region B-O I-protein
of B-O O
the B-O O
steroid B-O B-protein
hormone B-O I-protein
receptor B-O I-protein
. B-O O

Glucocorticoids B-O O
kill B-O O
certain B-O O
types B-O O
of B-O O
lymphoblasts B-O B-cell_type
, B-O O
but B-O O
the B-O O
mechanisms B-O O
are B-O O
unknown B-O O
. B-O O

It B-O O
is B-O O
clear B-O O
that B-O O
sufficient B-O O
numbers B-O O
of B-O O
functional B-O O
glucocorticoid B-O B-protein
receptors B-O I-protein
are B-O O
required B-O O
to B-O O
mediate B-O O
lysis B-O O
, B-O O
but B-O O
whether B-O O
they B-O O
do B-O O
so B-O O
through B-O O
the B-O O
classical B-O O
model B-O O
of B-O O
steroid B-O O
hormone B-O O
activation B-O O
and B-O O
modulation B-O O
of B-O O
gene B-O O
expression B-O O
has B-O O
not B-O O
been B-O O
established B-O O
. B-O O

In B-O O
this B-O O
report B-O O
we B-O O
have B-O O
asked B-O O
which B-O O
region B-O O
( B-O O
s B-O O
) B-O O
of B-O O
the B-O O
steroid B-O B-protein
receptor B-O I-protein
are B-O O
important B-O O
for B-O O
mediating B-O O
lysis B-O O
in B-O O
leukemic B-O B-cell_type
T B-O I-cell_type
lymphoblasts B-O I-cell_type
. B-O O

CEM-ICR B-O B-cell_line
27 B-O I-cell_line
leukemic B-O I-cell_line
lymphoblasts B-O I-cell_line
, B-O O
a B-O O
clone B-O O
of B-O O
CEM B-O B-cell_line
cells B-O I-cell_line
which B-O O
lack B-O O
functional B-O O
glucocorticoid B-O B-protein
receptors B-O I-protein
and B-O O
therefore B-O O
are B-O O
neither B-O O
lysed B-O O
by B-O O
dexamethasone B-O O
nor B-O O
capable B-O O
of B-O O
showing B-O O
glutamine B-O B-protein
synthetase B-O I-protein
induction B-O O
, B-O O
were B-O O
provided B-O O
with B-O O
steroid B-O B-protein
receptors B-O I-protein
by B-O O
DNA B-O O
transfections B-O O
of B-O O
various B-O O
receptor B-O O
gene B-O O
constructs B-O O
. B-O O

We B-O O
measured B-O O
steroid B-O O
mediated B-O O
lysis B-O O
, B-O O
receptor B-O O
number B-O O
and B-O O
induction B-O O
of B-O O
glutamine B-O B-protein
synthetase B-O I-protein
in B-O O
the B-O O
transfected B-O B-cell_line
cells B-O I-cell_line
. B-O O

Our B-O O
results B-O O
provide B-O O
evidence B-O O
that B-O O
the B-O O
lysis B-O O
mechanism B-O O
in B-O O
the B-O O
ICR27 B-O B-cell_line
lymphoblasts B-O I-cell_line
is B-O O
restored B-O O
when B-O O
functional B-O O
receptor B-O O
number B-O O
is B-O O
restored B-O O
. B-O O

The B-O O
DNA B-O B-protein
binding B-O I-protein
region B-O I-protein
specifying B-O O
high B-O O
affinity B-O O
for B-O O
GRE B-O B-DNA
sites B-O I-DNA
is B-O O
required B-O O
. B-O O

Lysis B-O O
is B-O O
mediated B-O O
by B-O O
any B-O O
steroid B-O O
that B-O O
allows B-O O
for B-O O
activation B-O O
of B-O O
the B-O O
receptor B-O O
containing B-O O
such B-O O
a B-O O
region B-O O
. B-O O

Our B-O O
data B-O O
support B-O O
the B-O O
view B-O O
that B-O O
steroid B-O O
-mediated B-O O
cell B-O O
death B-O O
occurs B-O O
by B-O O
a B-O O
process B-O O
requiring B-O O
direct B-O O
interaction B-O O
of B-O O
steroid B-O B-protein
-receptor B-O I-protein
complexes B-O I-protein
with B-O O
the B-O O
genome B-O O
. B-O O

Functional B-O O
characterization B-O O
of B-O O
the B-O O
murine B-O B-protein
homolog B-O I-protein
of B-O O
the B-O O
B B-O B-protein
cell-specific B-O I-protein
coactivator B-O I-protein
BOB.1/OBF.1 B-O B-protein
. B-O O

B B-O B-DNA
cell-specific B-O I-DNA
transcriptional B-O I-DNA
promoter B-O I-DNA
activity B-O O
mediated B-O O
by B-O O
the B-O O
octamer B-O B-DNA
motif B-O I-DNA
requires B-O O
the B-O O
Oct1 B-O B-protein
or B-O O
Oct2 B-O B-protein
protein B-O I-protein
and B-O O
additional B-O O
B B-O B-protein
cell-restricted B-O I-protein
cofactors B-O I-protein
. B-O O

One B-O O
such B-O O
cofactor B-O B-protein
, B-O O
BOB.1/OBF.1 B-O B-protein
, B-O O
was B-O O
recently B-O O
isolated B-O O
from B-O O
human B-O B-cell_type
B B-O I-cell_type
cells B-O I-cell_type
. B-O O

Here B-O O
, B-O O
we B-O O
describe B-O O
the B-O O
isolation B-O O
and B-O O
detailed B-O O
characterization B-O O
of B-O O
the B-O O
murine B-O B-protein
homolog B-O I-protein
. B-O O

Full-length B-O O
cDNAs B-O B-DNA
and B-O O
genomic B-O B-DNA
clones B-O I-DNA
were B-O O
isolated B-O O
, B-O O
and B-O O
the B-O O
gene B-O O
structure B-O O
was B-O O
determined B-O O
. B-O O
Comparison B-O O
of B-O O
the B-O O
deduced B-O O
amino B-O O
acids B-O O
shows B-O O
88 B-O O
% B-O O
sequence B-O O
identity B-O O
between B-O O
mouse B-O O
and B-O O
human B-O B-protein
BOB.1/OBF.1 B-O I-protein
. B-O O

The B-O O
NH2-terminal B-O B-protein
126 B-O I-protein
amino B-O I-protein
acids B-O I-protein
of B-O O
BOB.1/OBF.1 B-O B-protein
are B-O O
both B-O O
essential B-O O
and B-O O
sufficient B-O O
for B-O O
interaction B-O O
with B-O O
the B-O O
POU B-O B-protein
domains B-O I-protein
of B-O O
either B-O O
Oct1 B-O B-protein
or B-O O
Oct2 B-O B-protein
. B-O O

This B-O O
protein-protein B-O O
interaction B-O O
does B-O O
not B-O O
require B-O O
the B-O O
simultaneous B-O O
binding B-O O
of B-O O
Oct B-O B-protein
proteins B-O I-protein
to B-O O
DNA B-O O
, B-O O
and B-O O
high B-O O
resolution B-O O
footprinting B-O O
of B-O O
the B-O O
Oct B-O B-DNA
-DNA B-O O
interaction B-O O
reveals B-O O
that B-O O
binding B-O O
of B-O O
BOB.1/OBF.1 B-O B-protein
to B-O O
Oct1 B-O B-protein
or B-O O
Oct2 B-O B-protein
does B-O O
not B-O O
alter B-O O
the B-O O
interaction B-O O
with B-O O
DNA B-O O
. B-O O

BOB.1/OBF.1 B-O B-protein
can B-O O
efficiently B-O O
activate B-O O
octamer-dependent B-O B-DNA
promoters B-O I-DNA
in B-O O
fibroblasts B-O B-cell_type
; B-O O
however B-O O
, B-O O
it B-O O
fails B-O O
to B-O O
stimulate B-O O
octamer-dependent B-O B-DNA
enhancer B-O I-DNA
activity B-O O
. B-O O

Fusion B-O O
of B-O O
subdomains B-O O
of B-O O
BOB.1/OBF.1 B-O B-protein
with B-O O
the B-O O
GAL4 B-O B-protein
DNA B-O I-protein
binding B-O I-protein
domain B-O I-protein
reveals B-O O
that B-O O
both B-O O
NH2- B-O B-protein
and B-O O
COOH- B-O B-protein
terminal B-O I-protein
domains B-O I-protein
of B-O O
BOB.1/OBF.1 B-O B-protein
contribute B-O O
to B-O O
full B-O O
transactivation B-O O
function B-O O
, B-O O
the B-O O
COOH-terminal B-O B-protein
domain B-O I-protein
is B-O O
more B-O O
efficient B-O O
in B-O O
this B-O O
transactivation B-O O
assay B-O O
. B-O O

Consistent B-O O
with B-O O
the B-O O
failure B-O O
of B-O O
full-length B-O B-protein
BOB.1/OBF.1 B-O I-protein
to B-O O
stimulate B-O O
octamer-dependent B-O B-DNA
enhancer B-O I-DNA
elements B-O I-DNA
in B-O O
non B-O B-cell_type
B B-O I-cell_type
cells B-O I-cell_type
, B-O O
the B-O O
GAL4 B-O B-protein
fusions B-O I-protein
likewise B-O O
only B-O O
stimulate B-O O
from B-O O
a B-O O
promoter-proximal B-O O
position B-O O
. B-O O

Anti-immunoglobulin B-O B-protein
M B-O I-protein
activates B-O O
nuclear B-O B-protein
calcium B-O I-protein
/calmodulin-dependent B-O I-protein
protein B-O I-protein
kinase B-O I-protein
II B-O I-protein
in B-O O
human B-O B-cell_type
B B-O I-cell_type
lymphocytes B-O I-cell_type
. B-O O

We B-O O
and B-O O
others B-O O
have B-O O
previously B-O O
shown B-O O
that B-O O
the B-O O
nuclear B-O B-protein
protein B-O I-protein
, B-O O
Ets-1 B-O B-protein
, B-O O
is B-O O
phosphorylated B-O O
in B-O O
a B-O O
calcium-dependent B-O O
manner B-O O
after B-O O
ligation B-O O
of B-O O
immunoglobulin B-O O
( B-O O
Ig B-O O
) B-O O
M B-O O
on B-O O
B B-O B-cell_type
lymphocytes B-O I-cell_type
. B-O O

As B-O O
this B-O O
phosphorylation B-O O
was B-O O
independent B-O O
of B-O O
protein B-O B-protein
kinase B-O I-protein
C B-O I-protein
activity B-O O
, B-O O
we B-O O
tested B-O O
whether B-O O
a B-O O
calcium B-O B-protein
/calmodulin-dependent B-O I-protein
protein B-O I-protein
kinase B-O I-protein
( B-O O
CaM B-O B-protein
kinase B-O I-protein
) B-O O
might B-O O
phosphorylate B-O O
the B-O O
Ets-1 B-O B-protein
protein B-O I-protein
after B-O O
elevation B-O O
of B-O O
intracellular B-O O
free B-O O
calcium B-O O
concentrations B-O O
. B-O O

The B-O O
dephosphorylated B-O O
form B-O O
of B-O O
Ets-1 B-O B-protein
has B-O O
been B-O O
shown B-O O
to B-O O
bind B-O O
to B-O O
chromatin B-O B-DNA
, B-O O
suggesting B-O O
that B-O O
the B-O O
operative B-O B-protein
kinase B-O I-protein
should B-O O
be B-O O
detectable B-O O
in B-O O
the B-O O
nucleus B-O O
. B-O O

We B-O O
prepared B-O O
nuclear B-O O
extracts B-O O
from B-O O
two B-O O
human B-O B-cell_line
B B-O I-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
in B-O O
which B-O O
increased B-O O
intracellular B-O O
free B-O O
calcium B-O O
levels B-O O
correlated B-O O
with B-O O
increased B-O O
phosphorylation B-O O
of B-O O
the B-O O
Ets-1 B-O B-protein
protein B-O I-protein
. B-O O

Activity B-O O
of B-O O
the B-O O
CaM B-O B-protein
kinases B-O I-protein
was B-O O
determined B-O O
using B-O O
a B-O O
synthetic B-O O
peptide B-O O
substrate B-O O
both B-O O
in B-O O
the B-O O
absence B-O O
and B-O O
presence B-O O
of B-O O
an B-O O
inhibitor B-O O
specific B-O O
for B-O O
the B-O O
CaM B-O B-protein
kinase B-O I-protein
family B-O I-protein
, B-O O
KN-62 B-O B-protein
. B-O O

Stimulation B-O O
of B-O O
cells B-O O
with B-O O
anti-IgM B-O B-protein
led B-O O
to B-O O
increased B-O O
activity B-O O
of B-O O
a B-O O
nuclear B-O B-protein
kinase B-O I-protein
that B-O O
could B-O O
phosphorylate B-O O
the B-O O
peptide B-O O
, B-O O
and B-O O
this B-O O
activity B-O O
was B-O O
reduced B-O O
by B-O O
10 B-O O
microM B-O O
KN-62 B-O O
. B-O O

Kinase B-O B-protein
activity B-O O
was B-O O
reduced B-O O
in B-O O
lysates B-O O
preadsorbed B-O O
using B-O O
an B-O O
antibody B-O B-protein
specific B-O O
for B-O O
CaM B-O B-protein
kinase B-O I-protein
II B-O I-protein
. B-O O

Two-dimensional B-O O
phosphopeptide B-O O
maps B-O O
of B-O O
the B-O O
Ets-1 B-O B-protein
protein B-O O
from B-O O
cells B-O O
incubated B-O O
with B-O O
ionomycin B-O O
or B-O O
anti-IgM B-O B-protein
contained B-O O
two B-O O
unique B-O O
phosphopeptides B-O O
that B-O O
were B-O O
absent B-O O
in B-O O
untreated B-O B-cell_type
cells B-O I-cell_type
. B-O O

Incubation B-O O
of B-O O
isolated B-O B-protein
Ets-1 B-O I-protein
protein B-O I-protein
with B-O O
purified B-O O
CaM B-O B-protein
kinase B-O I-protein
II B-O I-protein
produced B-O O
phosphorylation B-O O
of B-O O
peptides B-O O
that B-O O
migrated B-O O
identically B-O O
to B-O O
those B-O O
found B-O O
in B-O O
cells B-O O
incubated B-O O
with B-O O
either B-O O
anti-IgM B-O B-protein
or B-O O
ionomycin B-O O
. B-O O

These B-O O
data B-O O
suggest B-O O
a B-O O
model B-O O
of B-O O
signal B-O O
transduction B-O O
by B-O O
the B-O O
antigen B-O B-protein
receptor B-O I-protein
on B-O O
B B-O B-cell_type
lymphocytes B-O I-cell_type
in B-O O
which B-O O
increased B-O O
intracellular B-O O
free B-O O
calcium B-O O
can B-O O
rapidly B-O O
activate B-O O
nuclear B-O B-protein
CaM B-O I-protein
kinase B-O I-protein
II B-O I-protein
, B-O O
potentially B-O O
resulting B-O O
in B-O O
phosphorylation B-O O
and B-O O
regulation B-O O
of B-O O
DNA-binding B-O B-protein
proteins B-O I-protein
. B-O O

Transcriptional B-O O
activation B-O O
and B-O O
repression B-O O
, B-O O
two B-O O
properties B-O O
of B-O O
the B-O O
lymphoid-specific B-O B-protein
transcription B-O I-protein
factor B-O I-protein
Oct-2a B-O B-protein
. B-O O

The B-O O
lymphoid-specific B-O B-protein
transcription B-O I-protein
factor B-O I-protein
Oct-2a B-O B-protein
contains B-O O
two B-O O
transcriptional B-O B-protein
activation B-O I-protein
domains B-O I-protein
which B-O O
are B-O O
located B-O O
within B-O O
the B-O O
N-terminal B-O O
and B-O O
C-terminal B-O B-protein
regions B-O I-protein
. B-O O

To B-O O
study B-O O
their B-O O
differential B-O O
activation B-O O
properties B-O O
, B-O O
we B-O O
linked B-O O
the B-O O
isolated B-O O
effector B-O B-protein
domains B-O I-protein
to B-O O
the B-O O
GAL4 B-O B-protein
DNA-binding B-O I-protein
domain B-O I-protein
. B-O O

We B-O O
have B-O O
shown B-O O
that B-O O
both B-O O
activating B-O O
regions B-O O
of B-O O
Oct-2a B-O B-protein
, B-O O
isolated B-O O
from B-O O
their B-O O
natural B-O O
context B-O O
, B-O O
can B-O O
activate B-O O
transcription B-O O
as B-O O
promoter B-O B-protein
factors B-O I-protein
. B-O O

In B-O O
contrast B-O O
to B-O O
the B-O O
C-terminus B-O B-protein
, B-O O
activation B-O O
by B-O O
the B-O O
N-terminal B-O B-protein
domain B-O I-protein
is B-O O
dependent B-O O
on B-O O
a B-O O
yet B-O O
unidentified B-O O
factor B-O O
( B-O O
s B-O O
) B-O O
binding B-O O
to B-O O
the B-O O
simian B-O B-DNA
virus B-O I-DNA
40 B-O I-DNA
enhancer B-O I-DNA
. B-O O

The B-O O
results B-O O
obtained B-O O
by B-O O
duplication B-O O
of B-O O
activation B-O O
domains B-O O
or B-O O
their B-O O
mixed B-O O
combination B-O O
suggest B-O O
that B-O O
the B-O O
domains B-O O
are B-O O
functionally B-O O
independent B-O O
. B-O O

However B-O O
, B-O O
activation B-O O
from B-O O
a B-O O
remote B-O O
position B-O O
could B-O O
only B-O O
be B-O O
achieved B-O O
with B-O O
the B-O O
C-terminus B-O B-protein
of B-O O
Oct-2a B-O B-protein
in B-O O
B B-O B-cell_type
cells B-O I-cell_type
. B-O O

In B-O O
lymphoid B-O B-cell_type
cells B-O I-cell_type
, B-O O
higher B-O O
activation B-O O
levels B-O O
were B-O O
observed B-O O
, B-O O
suggesting B-O O
that B-O O
distinct B-O O
B-cell-specific B-O B-protein
cofactors B-O I-protein
in B-O O
concert B-O O
with B-O O
the B-O O
effector B-O B-protein
domains B-O I-protein
of B-O O
Oct-2a B-O B-protein
might B-O O
be B-O O
involved B-O O
in B-O O
mediating B-O O
transcription B-O O
from B-O O
proximal B-O O
and B-O O
remote B-O O
positions B-O O
. B-O O

Furthermore B-O O
, B-O O
we B-O O
identified B-O O
a B-O O
repression B-O B-protein
domain B-O I-protein
at B-O O
the B-O O
N-terminus B-O B-protein
of B-O O
Oct-2a B-O B-protein
. B-O O

When B-O O
transferred B-O O
to B-O O
a B-O O
potent B-O O
activator B-O O
, B-O O
transcriptional B-O O
stimulation B-O O
was B-O O
inhibited B-O O
efficiently B-O O
. B-O O

These B-O O
results B-O O
underscore B-O O
the B-O O
modular B-O O
structure B-O O
of B-O O
Oct-2a B-O B-protein
with B-O O
separable B-O O
domains B-O O
for B-O O
activation B-O O
and B-O O
repression B-O O
and B-O O
suggest B-O O
that B-O O
Oct-2a B-O B-protein
might B-O O
have B-O O
complex B-O O
regulatory B-O O
functions B-O O
in B-O O
vivo B-O O
. B-O O

Nonopsonic B-O O
phagocytosis B-O O
of B-O O
Pseudomonas B-O O
aeruginosa B-O O
by B-O O
macrophages B-O B-cell_type
and B-O O
polymorphonuclear B-O B-cell_type
leukocytes B-O I-cell_type
requires B-O O
the B-O O
presence B-O O
of B-O O
the B-O O
bacterial B-O O
flagellum B-O O
. B-O O

Whereas B-O O
the B-O O
mechanism B-O O
of B-O O
nonopsonic B-O O
phagocytosis B-O O
of B-O O
Pseudomonas B-O O
aeruginosa B-O O
has B-O O
been B-O O
described B-O O
, B-O O
the B-O O
bacterial B-O O
ligands B-O O
required B-O O
are B-O O
poorly B-O O
understood B-O O
. B-O O

To B-O O
identify B-O O
the B-O O
requisite B-O O
bacterial B-O O
ligands B-O O
, B-O O
studies B-O O
with B-O O
isogenic B-O O
mutants B-O O
of B-O O
P. B-O O
aeruginosa B-O O
PAK B-O O
lacking B-O O
pili B-O O
, B-O O
flagella B-O O
, B-O O
and B-O O
the B-O O
RpoN B-O B-protein
sigma B-O I-protein
factor B-O I-protein
were B-O O
undertaken B-O O
. B-O O

The B-O O
RpoN B-O B-protein
mutant B-O I-protein
, B-O O
lacking B-O O
pili B-O O
, B-O O
flagella B-O O
, B-O O
and B-O O
nonpilus B-O B-protein
adhesins B-O I-protein
, B-O O
bound B-O O
poorly B-O O
and B-O O
was B-O O
resistant B-O O
to B-O O
ingestion B-O O
by B-O O
both B-O O
macrophages B-O B-cell_type
and B-O O
neutrophils B-O B-cell_type
. B-O O

Pili B-O O
were B-O O
not B-O O
absolutely B-O O
required B-O O
for B-O O
binding B-O O
or B-O O
phagocytosis B-O O
of B-O O
P. B-O O
aeruginosa B-O O
. B-O O

The B-O O
presence B-O O
of B-O O
a B-O O
flagellum B-O O
was B-O O
not B-O O
required B-O O
for B-O O
binding B-O O
of B-O O
P. B-O O
aeruginosa B-O O
to B-O O
macrophages B-O B-cell_type
but B-O O
was B-O O
critical B-O O
for B-O O
the B-O O
subsequent B-O O
internalization B-O O
of B-O O
the B-O O
bacterium B-O O
, B-O O
suggesting B-O O
that B-O O
this B-O O
factor B-O O
or B-O O
a B-O O
surface B-O O
ligand B-O O
associated B-O O
with B-O O
its B-O O
assembly B-O O
was B-O O
responsible B-O O
for B-O O
stimulation B-O O
of B-O O
nonopsonic B-O O
phagocytosis B-O O
. B-O O

Identification B-O O
of B-O O
essential B-O O
GATA B-O B-DNA
and B-O O
Ets B-O B-DNA
binding B-O I-DNA
motifs B-O I-DNA
within B-O O
the B-O O
promoter B-O B-DNA
of B-O O
the B-O O
platelet B-O B-DNA
glycoprotein B-O I-DNA
Ib B-O I-DNA
alpha B-O I-DNA
gene B-O I-DNA
. B-O O

Platelet B-O B-protein
glycoprotein B-O I-protein
( B-O O
GP B-O B-protein
) B-O O
Ib-IX-V B-O B-protein
is B-O O
a B-O O
multisubunit B-O B-protein
adhesion B-O I-protein
receptor B-O I-protein
that B-O O
supports B-O O
platelet B-O O
attachment B-O O
to B-O O
thrombogenic B-O O
surfaces B-O O
at B-O O
sites B-O O
of B-O O
vascular B-O O
injury B-O O
. B-O O

The B-O O
congenital B-O O
absence B-O O
of B-O O
the B-O O
receptor B-O O
results B-O O
in B-O O
a B-O O
bleeding B-O O
disorder B-O O
associated B-O O
with B-O O
`` B-O B-cell_type
giant B-O I-cell_type
`` B-O I-cell_type
platelets B-O I-cell_type
, B-O O
a B-O O
condition B-O O
linking B-O O
the B-O O
expression B-O O
of B-O O
the B-O O
complex B-O O
to B-O O
platelet B-O O
morphogenesis B-O O
. B-O O

To B-O O
understand B-O O
better B-O O
the B-O O
expression B-O O
of B-O O
the B-O O
GP B-O B-protein
Ib-IX-V B-O I-protein
complex B-O I-protein
, B-O O
studies B-O O
were B-O O
undertaken B-O O
to B-O O
define B-O O
the B-O O
essential B-O B-DNA
genetic B-O I-DNA
elements B-O I-DNA
supporting B-O O
the B-O O
expression B-O O
of B-O O
the B-O O
alpha-subunit B-O B-protein
of B-O O
the B-O O
complex B-O O
( B-O O
GP B-O B-protein
Ib B-O I-protein
alpha B-O I-protein
) B-O O
. B-O O

GP B-O B-DNA
Ib B-O I-DNA
alpha B-O I-DNA
promoter B-O I-DNA
activity B-O O
was B-O O
evaluated B-O O
by B-O O
transfection B-O O
of B-O O
human B-O B-cell_type
erythroleukemia B-O I-cell_type
cells B-O I-cell_type
with B-O O
reporter B-O B-DNA
plasmids B-O I-DNA
coding B-O O
for B-O O
the B-O O
enzyme B-O B-protein
, B-O O
luciferase B-O B-protein
. B-O O

Studies B-O O
were B-O O
initiated B-O O
with B-O O
a B-O O
fragment B-O O
extending B-O O
2 B-O O
, B-O O
738 B-O O
nucleotides B-O O
5 B-O O
' B-O O
to B-O O
the B-O O
transcription B-O B-DNA
start B-O I-DNA
site B-O I-DNA
and B-O O
lead B-O O
to B-O O
the B-O O
identification B-O O
of B-O O
253 B-O B-DNA
nucleotides B-O I-DNA
retaining B-O I-DNA
full B-O I-DNA
promoter B-O I-DNA
activity B-O O
in B-O O
human B-O B-cell_type
erythroleukemia B-O I-cell_type
cells B-O I-cell_type
. B-O O

In B-O O
cells B-O O
of B-O O
nonhematopoietic B-O B-cell_type
lineage B-O I-cell_type
, B-O O
human B-O B-cell_type
endothelial B-O I-cell_type
and B-O O
HeLa B-O B-cell_line
cells B-O I-cell_line
, B-O O
the B-O O
GP B-O B-DNA
Ib B-O I-DNA
alpha B-O I-DNA
promoter B-O I-DNA
activity B-O O
was B-O O
no B-O O
greater B-O O
than B-O O
background B-O O
levels B-O O
obtained B-O O
with B-O O
promoterless B-O B-DNA
constructs B-O I-DNA
. B-O O

Gel B-O O
shift B-O O
assays B-O O
and B-O O
site-directed B-O O
mutagenesis B-O O
studies B-O O
defined B-O O
essential B-O O
GATA B-O B-DNA
and B-O O
Ets B-O B-DNA
binding B-O I-DNA
motifs B-O I-DNA
93 B-O B-DNA
and B-O I-DNA
150 B-O I-DNA
nucleotides B-O I-DNA
upstream B-O I-DNA
of B-O O
the B-O O
transcription B-O B-DNA
start B-O I-DNA
site B-O I-DNA
, B-O O
a B-O O
finding B-O O
which B-O O
further B-O O
substantiates B-O O
these B-O O
elements B-O O
as B-O O
important B-O O
determinants B-O O
of B-O O
megakaryocytic B-O B-DNA
gene B-O I-DNA
expression B-O O
. B-O O

The B-O O
results B-O O
define B-O O
essential B-O O
cis-acting B-O B-DNA
elements B-O I-DNA
responsible B-O O
for B-O O
the B-O O
expression B-O O
of B-O O
GP B-O B-protein
Ib B-O I-protein
alpha B-O I-protein
and B-O O
provide B-O O
insights B-O O
into B-O O
molecular B-O O
events B-O O
coinciding B-O O
with B-O O
the B-O O
release B-O O
of B-O O
normal B-O B-cell_type
platelets B-O I-cell_type
into B-O O
the B-O O
bloodstream B-O O
. B-O O

CD30 B-O B-protein
ligation B-O O
induces B-O O
nuclear B-O B-protein
factor-kappa B-O I-protein
B B-O I-protein
activation B-O O
in B-O O
human B-O B-cell_line
T B-O I-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
. B-O O

CD30 B-O B-protein
is B-O O
a B-O O
recently B-O O
described B-O O
member B-O O
of B-O O
the B-O O
tumor B-O B-protein
necrosis B-O I-protein
factor B-O I-protein
/nerve B-O O
growth B-O B-protein
factor B-O I-protein
receptor B-O I-protein
superfamily B-O I-protein
. B-O O

In B-O O
this B-O O
report B-O O
, B-O O
we B-O O
show B-O O
that B-O O
following B-O O
incubation B-O O
of B-O O
L540 B-O B-cell_line
cells B-O I-cell_line
( B-O O
Hodgkin B-O O
's B-O O
disease B-O O
-derived B-O O
, B-O O
T B-O O
cell-like B-O O
, B-O O
CD30 B-O B-protein
+ B-O O
cells B-O O
) B-O O
with B-O O
the B-O O
agonistic B-O B-protein
anti- B-O I-protein
CD30 B-O I-protein
monoclonal B-O I-protein
antibodies B-O I-protein
( B-O O
mAb B-O B-protein
) B-O O
M44 B-O B-protein
and B-O O
M67 B-O B-protein
, B-O O
two B-O O
nuclear B-O B-protein
factor B-O I-protein
( B-O I-protein
NF B-O I-protein
) B-O I-protein
-kappa B-O I-protein
B B-O I-protein
DNA B-O O
binding B-O O
activities B-O O
were B-O O
induced B-O O
in B-O O
nuclear B-O O
extracts B-O O
, B-O O
as B-O O
determined B-O O
in B-O O
gel B-O O
retardation B-O O
assays B-O O
. B-O O

The B-O O
effect B-O O
of B-O O
the B-O O
mAb B-O B-protein
towards B-O O
NF-kappa B-O B-protein
B B-O I-protein
activation B-O O
was B-O O
rapid B-O O
, B-O O
as B-O O
it B-O O
occurred B-O O
within B-O O
20 B-O O
min B-O O
, B-O O
and B-O O
was B-O O
sustained B-O O
for B-O O
up B-O O
to B-O O
6 B-O O
h B-O O
. B-O O

By B-O O
comparison B-O O
, B-O O
an B-O O
isotype-matched B-O B-protein
antibody B-O I-protein
had B-O O
no B-O O
effect B-O O
on B-O O
NF-kappa B-O B-protein
B B-O I-protein
activation B-O O
. B-O O

Moreover B-O O
, B-O O
in B-O O
human B-O B-cell_line
T B-O I-cell_line
helper B-O I-cell_line
( B-O I-cell_line
Th B-O I-cell_line
) B-O I-cell_line
clones B-O I-cell_line
functionally B-O O
characterized B-O O
as B-O O
being B-O O
of B-O O
the B-O O
type B-O O
0 B-O O
, B-O O
type B-O O
1 B-O O
and B-O O
type B-O O
2 B-O O
( B-O O
28 B-O O
% B-O O
, B-O O
& B-O O
lt B-O O
; B-O O
1 B-O O
% B-O O
und B-O O
93 B-O O
% B-O O
CD30+ B-O O
, B-O O
respectively B-O O
) B-O O
, B-O O
the B-O O
extent B-O O
of B-O O
CD30 B-O B-protein
-mediated B-O O
NF-kappa B-O B-protein
B B-O I-protein
activation B-O O
correlated B-O O
with B-O O
the B-O O
proportion B-O O
of B-O O
CD30+ B-O B-cell_type
cells B-O I-cell_type
. B-O O

In B-O O
all B-O O
cell B-O B-cell_line
lines B-O I-cell_line
investigated B-O O
, B-O O
the B-O O
NF-kappa B-O B-protein
B B-O I-protein
complexes B-O I-protein
induced B-O O
following B-O O
CD30 B-O B-protein
engagement B-O O
were B-O O
shown B-O O
to B-O O
contain B-O O
p50 B-O B-protein
NF-kappa B-O I-protein
B1 B-O I-protein
, B-O O
p65 B-O B-protein
RelA B-O I-protein
, B-O O
and B-O O
possibly B-O O
other B-O O
transcription B-O B-protein
factors B-O I-protein
. B-O O

Collectively B-O O
, B-O O
our B-O O
results B-O O
demonstrate B-O O
that B-O O
nuclear B-O O
translocation B-O O
and B-O O
activation B-O O
of B-O O
NF-kappa B-O B-protein
B B-O I-protein
rank B-O O
among B-O O
the B-O O
short-term B-O O
cellular B-O O
responses B-O O
elicited B-O O
following B-O O
CD30 B-O B-protein
ligation B-O O
. B-O O

Pathogenesis B-O O
of B-O O
atherosclerosis B-O O
. B-O O

The B-O O
earliest B-O O
lesion B-O O
in B-O O
the B-O O
development B-O O
of B-O O
an B-O O
atherosclerotic B-O O
plaque B-O O
is B-O O
the B-O O
fatty B-O O
streak B-O O
. B-O O

This B-O O
chronic B-O O
inflammatory B-O O
reaction B-O O
results B-O O
from B-O O
a B-O O
sequence B-O O
of B-O O
events B-O O
that B-O O
begins B-O O
with B-O O
the B-O O
trapping B-O O
of B-O O
low B-O B-protein
density B-O I-protein
lipoprotein B-O I-protein
( B-O O
LDL B-O B-protein
) B-O O
in B-O O
the B-O O
subendothelial B-O O
space B-O O
of B-O O
the B-O O
artery B-O O
wall B-O O
. B-O O

The B-O O
trapped B-O O
LDL B-O B-protein
is B-O O
seeded B-O O
with B-O O
oxidative B-O O
species B-O O
released B-O O
by B-O O
the B-O O
overlying B-O O
endothelium B-O O
, B-O O
and B-O O
lipid B-O O
oxidation B-O O
is B-O O
initiated B-O O
within B-O O
the B-O O
LDL B-O O
particle B-O O
. B-O O
Some B-O O
of B-O O
the B-O O
lipids B-O O
that B-O O
result B-O O
lead B-O O
to B-O O
the B-O O
activation B-O O
of B-O O
NFkB-like B-O B-protein
transcription B-O I-protein
factors B-O I-protein
that B-O O
cause B-O O
the B-O O
expression B-O O
of B-O O
genes B-O B-DNA
whose B-O O
protein B-O B-protein
products B-O I-protein
mediate B-O O
monocyte B-O O
binding B-O O
, B-O O
monocyte B-O B-cell_type
chemotaxis B-O O
into B-O O
the B-O O
subendothelial B-O O
space B-O O
, B-O O
and B-O O
conversion B-O O
into B-O O
macrophages B-O B-cell_type
. B-O O

At B-O O
least B-O O
1 B-O O
major B-O B-DNA
gene B-O I-DNA
modulates B-O O
the B-O O
oxidation B-O O
of B-O O
LDL B-O O
lipids B-O O
and/or B-O O
the B-O O
biologic B-O O
response B-O O
to B-O O
these B-O O
lipids B-O O
. B-O O

The B-O O
inverse B-O O
relation B-O O
between B-O O
high B-O O
density B-O O
lipoprotein B-O O
( B-O O
HDL B-O B-protein
) B-O O
and B-O O
atherosclerotic B-O O
events B-O O
may B-O O
in B-O O
part B-O O
be B-O O
due B-O O
to B-O O
enzymes B-O B-protein
associated B-O O
with B-O O
HDL B-O B-protein
that B-O O
destroy B-O O
the B-O O
biologically B-O O
active B-O O
lipids B-O O
generated B-O O
in B-O O
LDL B-O B-protein
. B-O O

Estrogen B-O O
and B-O O
progesterone B-O B-protein
receptors B-O I-protein
in B-O O
vernal B-O O
keratoconjunctivitis B-O O
. B-O O

PURPOSE B-O O
: B-O O
Sex-related B-O O
influences B-O O
have B-O O
been B-O O
implicated B-O O
in B-O O
the B-O O
pathogenesis B-O O
of B-O O
vernal B-O O
keratoconjunctivitis B-O O
( B-O O
VKC B-O B-protein
) B-O O
, B-O O
an B-O O
allergic B-O O
eosinophilic B-O O
disease B-O O
. B-O O

METHODS B-O O
: B-O O
The B-O O
authors B-O O
evaluated B-O O
tarsal B-O O
and B-O O
bulbar B-O O
conjunctival B-O O
biopsies B-O O
from B-O O
seven B-O O
patients B-O O
with B-O O
severe B-O O
and B-O O
symptomatic B-O O
VKC B-O O
for B-O O
the B-O O
presence B-O O
of B-O O
estrogen B-O B-protein
and B-O O
progesterone B-O B-protein
receptors B-O I-protein
by B-O O
using B-O O
monoclonal B-O B-protein
antibodies B-O I-protein
with B-O O
a B-O O
peroxidase-antiperoxidase B-O O
technique B-O O
. B-O O

RESULTS B-O O
: B-O O
Both B-O O
the B-O O
epithelium B-O O
and B-O O
subepithelium B-O O
of B-O O
the B-O O
tarsal B-O O
and B-O O
bulbar B-O O
conjunctiva B-O O
of B-O O
patients B-O O
with B-O O
VKC B-O O
, B-O O
but B-O O
not B-O O
those B-O O
of B-O O
four B-O O
nonatopic B-O O
control B-O O
subjects B-O O
, B-O O
showed B-O O
intense B-O O
positive B-O O
staining B-O O
for B-O O
estrogen B-O O
and B-O O
progesterone B-O B-protein
receptors B-O I-protein
. B-O O

Immunofluorescence B-O O
colocalization B-O O
of B-O O
both B-O O
estrogen B-O B-protein
and B-O O
progesterone B-O B-protein
receptors B-O I-protein
with B-O O
eosinophil B-O B-protein
cationic B-O I-protein
protein B-O I-protein
showed B-O O
that B-O O
approximately B-O O
70 B-O O
% B-O O
of B-O O
positive B-O B-cell_type
cells B-O I-cell_type
were B-O O
eosinophils B-O B-cell_type
. B-O O

CONCLUSIONS B-O O
: B-O O
Sexual B-O O
hormones B-O O
, B-O O
through B-O O
their B-O O
receptors B-O B-protein
, B-O O
may B-O O
influence B-O O
the B-O O
activity B-O O
of B-O O
eosinophils B-O B-cell_type
in B-O O
patients B-O O
with B-O O
VKC B-O O
. B-O O

CIITA B-O B-protein
activates B-O O
the B-O O
expression B-O O
of B-O O
MHC B-O B-DNA
class B-O I-DNA
II B-O I-DNA
genes B-O I-DNA
in B-O O
mouse B-O B-cell_type
T B-O I-cell_type
cells B-O I-cell_type
. B-O O

It B-O O
has B-O O
long B-O O
been B-O O
a B-O O
puzzle B-O O
that B-O O
MHC B-O B-protein
class B-O I-protein
II B-O I-protein
molecules B-O I-protein
are B-O O
expressed B-O O
in B-O O
human B-O B-cell_type
T B-O I-cell_type
cells B-O I-cell_type
after B-O O
activation B-O O
but B-O O
not B-O O
in B-O O
mouse B-O B-cell_type
T B-O I-cell_type
cells B-O I-cell_type
; B-O O
this B-O O
expression B-O O
is B-O O
believed B-O O
to B-O O
play B-O O
a B-O O
role B-O O
in B-O O
the B-O O
cell B-O O
mediated B-O O
immune B-O O
response B-O O
. B-O O

Recently B-O O
the B-O O
MHC B-O B-protein
class B-O I-protein
II B-O I-protein
transactivator B-O I-protein
( B-O O
CIITA B-O B-protein
) B-O O
has B-O O
been B-O O
reported B-O O
to B-O O
be B-O O
a B-O O
major B-O B-protein
regulatory B-O I-protein
factor B-O I-protein
for B-O O
both B-O O
the B-O O
constitutive B-O O
and B-O O
IFN B-O B-protein
inducible B-O O
expression B-O O
of B-O O
MHC B-O B-DNA
class B-O I-DNA
II B-O I-DNA
genes B-O I-DNA
. B-O O

Here B-O O
we B-O O
show B-O O
that B-O O
human B-O B-cell_type
T B-O I-cell_type
cells B-O I-cell_type
expressing B-O O
MHC B-O B-protein
class B-O I-protein
II B-O I-protein
have B-O O
CIITA B-O B-protein
transcripts B-O O
while B-O O
MHC B-O B-cell_type
class B-O I-cell_type
II-negative B-O I-cell_type
human B-O I-cell_type
T B-O I-cell_type
cells B-O I-cell_type
and B-O O
mouse B-O B-cell_type
T B-O I-cell_type
cells B-O I-cell_type
do B-O O
not B-O O
. B-O O

The B-O O
expression B-O O
of B-O O
MHC B-O B-DNA
class B-O I-DNA
II B-O I-DNA
genes B-O I-DNA
in B-O O
mouse B-O B-cell_type
T B-O I-cell_type
cells B-O I-cell_type
can B-O O
be B-O O
reconstituted B-O O
upon B-O O
transfection B-O O
with B-O O
the B-O O
human B-O B-DNA
CIITA B-O I-DNA
cDNA B-O I-DNA
. B-O O

These B-O O
data B-O O
indicate B-O O
that B-O O
the B-O O
expression B-O O
of B-O O
CIITA B-O B-protein
explains B-O O
the B-O O
expression B-O O
or B-O O
lack B-O O
of B-O O
expression B-O O
of B-O O
MHC B-O B-protein
class B-O I-protein
II B-O I-protein
in B-O O
human B-O B-cell_type
and B-O I-cell_type
mouse B-O I-cell_type
T B-O I-cell_type
cells B-O I-cell_type
respectively B-O O
. B-O O

Anti-Ro B-O B-protein
( B-O I-protein
SSA B-O I-protein
) B-O I-protein
autoantibodies B-O I-protein
are B-O O
associated B-O O
with B-O O
T B-O B-DNA
cell B-O I-DNA
receptor B-O I-DNA
beta B-O I-DNA
genes B-O I-DNA
in B-O O
systemic B-O O
lupus B-O O
erythematosus B-O O
patients B-O O
. B-O O

Several B-O O
of B-O O
the B-O O
heterogeneous B-O O
clinical B-O O
manifestations B-O O
of B-O O
systemic B-O O
lupus B-O O
erythematosus B-O O
have B-O O
been B-O O
associated B-O O
with B-O O
specific B-O O
autoantibodies B-O B-protein
. B-O O

Associations B-O O
between B-O O
HLA B-O B-protein
class B-O I-protein
II B-O I-protein
antigens B-O I-protein
and B-O O
autoantibodies B-O B-protein
to B-O O
the B-O O
ribonucleoproteins B-O B-protein
Ro B-O B-protein
( B-O I-protein
SSA B-O I-protein
) B-O I-protein
and B-O O
La B-O B-protein
( B-O I-protein
SSB B-O I-protein
) B-O I-protein
have B-O O
been B-O O
reported B-O O
in B-O O
these B-O O
patients B-O O
. B-O O

Because B-O O
HLA B-O B-protein
class B-O I-protein
II B-O I-protein
molecules B-O I-protein
present B-O O
antigen B-O O
to B-O O
T B-O B-protein
cell B-O I-protein
receptors B-O I-protein
( B-O O
TCRs B-O B-protein
) B-O O
, B-O O
we B-O O
have B-O O
searched B-O O
for B-O O
a B-O O
TCR B-O B-DNA
gene B-O I-DNA
associated B-O O
with B-O O
the B-O O
production B-O O
of B-O O
anti- B-O B-protein
Ro B-O I-protein
( B-O I-protein
SSA B-O I-protein
) B-O I-protein
antibodies B-O I-protein
. B-O O

A B-O O
pair B-O O
of B-O O
restriction B-O B-DNA
fragment B-O I-DNA
length B-O I-DNA
polymorphisms B-O I-DNA
( B-O O
RFLPs B-O B-DNA
) B-O O
, B-O O
one B-O O
of B-O O
which B-O O
hybridizes B-O O
to B-O O
the B-O O
TCR B-O B-DNA
constant B-O I-DNA
region B-O I-DNA
C B-O I-DNA
beta B-O I-DNA
1 B-O I-DNA
and B-O O
the B-O O
other B-O O
to B-O O
the B-O O
C B-O B-DNA
beta B-O I-DNA
2 B-O I-DNA
gene B-O I-DNA
, B-O O
has B-O O
been B-O O
identified B-O O
, B-O O
suggesting B-O O
these B-O O
may B-O O
be B-O O
genotypic B-O O
markers B-O O
for B-O O
an B-O O
extended B-O O
region B-O O
of B-O O
the B-O O
TCR B-O B-DNA
beta B-O I-DNA
locus B-O I-DNA
. B-O O

This B-O O
RFLP B-O B-DNA
pair B-O I-DNA
occurs B-O O
in B-O O
76 B-O O
% B-O O
of B-O O
patients B-O O
with B-O O
Ro B-O B-protein
( B-O I-protein
SSA B-O I-protein
) B-O I-protein
precipitins B-O O
, B-O O
84 B-O O
% B-O O
of B-O O
anti- B-O O
Ro B-O B-protein
( B-O I-protein
SSA B-O I-protein
) B-O I-protein
-positive B-O O
patients B-O O
lacking B-O O
La B-O B-protein
( B-O I-protein
SSB B-O I-protein
) B-O I-protein
precipitins B-O O
, B-O O
but B-O O
only B-O O
41 B-O O
% B-O O
of B-O O
the B-O O
patients B-O O
lacking B-O O
both B-O O
precipitins B-O B-protein
( B-O O
P B-O O
= B-O O
0.0004 B-O O
) B-O O
. B-O O

This B-O O
disproportionate B-O O
occurrence B-O O
in B-O O
a B-O O
subset B-O O
of B-O O
lupus B-O O
patients B-O O
indicates B-O O
that B-O O
these B-O O
RFLPs B-O B-DNA
are B-O O
not B-O O
disease B-O O
susceptibility B-O O
markers B-O O
, B-O O
but B-O O
rather B-O O
are B-O O
important B-O O
markers B-O O
for B-O O
TCR B-O B-DNA
genes B-O I-DNA
whose B-O O
products B-O O
are B-O O
involved B-O O
in B-O O
the B-O O
production B-O O
of B-O O
anti- B-O B-protein
Ro B-O I-protein
( B-O I-protein
SSA B-O I-protein
) B-O I-protein
antibodies B-O I-protein
. B-O O

The B-O O
majority B-O O
of B-O O
patients B-O O
who B-O O
have B-O O
these B-O O
RFLPs B-O B-DNA
and B-O O
HLA B-O B-protein
class B-O I-protein
II B-O I-protein
antigens B-O I-protein
previously B-O O
associated B-O O
with B-O O
the B-O O
anti- B-O O
Ro B-O B-protein
( B-O I-protein
SSA B-O I-protein
) B-O I-protein
response B-O O
make B-O O
this B-O O
antibody B-O O
, B-O O
suggesting B-O O
that B-O O
interactions B-O O
between B-O O
products B-O O
of B-O O
these B-O O
loci B-O O
occur B-O O
in B-O O
response B-O O
to B-O O
Ro B-O B-protein
( B-O I-protein
SSA B-O I-protein
) B-O I-protein
. B-O O

Inhibition B-O O
of B-O O
NF-AT B-O B-protein
-dependent B-O O
transcription B-O O
by B-O O
NF-kappa B-O B-protein
B B-O I-protein
: B-O O
implications B-O O
for B-O O
differential B-O O
gene B-O O
expression B-O O
in B-O O
T B-O B-cell_type
helper B-O I-cell_type
cell B-O I-cell_type
subsets B-O I-cell_type
. B-O O

Activation B-O O
of B-O O
individual B-O O
CD4+ B-O B-cell_line
T B-O I-cell_line
cells B-O I-cell_line
results B-O O
in B-O O
differential B-O O
lymphokine B-O B-protein
expression B-O O
: B-O O
interleukin B-O B-protein
2 B-O I-protein
( B-O O
IL-2 B-O B-protein
) B-O O
is B-O O
preferentially B-O O
produced B-O O
by B-O O
T B-O B-cell_type
helper B-O I-cell_type
type B-O I-cell_type
1 B-O I-cell_type
( B-O I-cell_type
TH1 B-O I-cell_type
) B-O I-cell_type
cells B-O I-cell_type
, B-O O
which B-O O
are B-O O
involved B-O O
in B-O O
cell-mediated B-O O
immune B-O O
responses B-O O
, B-O O
whereas B-O O
IL-4 B-O B-protein
is B-O O
synthesized B-O O
by B-O O
TH2 B-O B-cell_line
cells B-O I-cell_line
, B-O O
which B-O O
are B-O O
essential B-O O
for B-O O
humoral B-O O
immunity B-O O
. B-O O

The B-O O
Ca B-O B-protein
( B-O I-protein
2+ B-O I-protein
) B-O I-protein
-dependent B-O I-protein
factor B-O I-protein
NF-ATp B-O B-protein
plays B-O O
a B-O O
key B-O O
role B-O O
in B-O O
the B-O O
inducible B-O O
transcription B-O O
of B-O O
both B-O O
these B-O O
lymphokine B-O B-DNA
genes B-O I-DNA
. B-O O

However B-O O
, B-O O
while B-O O
IL2 B-O B-protein
expression B-O O
requires B-O O
the B-O O
contribution B-O O
of B-O O
Ca B-O O
( B-O O
2+ B-O O
) B-O O
- B-O O
and B-O O
protein B-O B-protein
kinase B-O I-protein
C B-O I-protein
-dependent B-O O
signals B-O O
, B-O O
we B-O O
report B-O O
that B-O O
activation B-O O
of B-O O
human B-O B-protein
IL4 B-O I-protein
transcription B-O O
through B-O O
the B-O O
Ca B-O O
( B-O O
2+ B-O O
) B-O O
-dependent B-O O
pathway B-O O
is B-O O
diminished B-O O
by B-O O
protein B-O B-protein
kinase B-O I-protein
C B-O I-protein
stimulation B-O O
in B-O O
Jurkat B-O B-cell_line
T B-O I-cell_line
cells B-O I-cell_line
. B-O O

This B-O O
phenomenon B-O O
is B-O O
due B-O O
to B-O O
mutually B-O O
exclusive B-O O
binding B-O O
of B-O O
NF-ATp B-O B-protein
and B-O O
NF-kappa B-O B-protein
B B-O I-protein
to B-O O
the B-O O
P B-O B-DNA
sequence B-O I-DNA
, B-O O
an B-O O
element B-O O
located B-O O
69 B-O B-DNA
bp B-O I-DNA
upstream B-O I-DNA
of B-O O
the B-O O
IL4 B-O B-DNA
transcription B-O I-DNA
initiation B-O I-DNA
site B-O I-DNA
. B-O O

Human B-O B-DNA
IL4 B-O I-DNA
promoter B-O I-DNA
-mediated B-O O
transcription B-O O
is B-O O
downregulated B-O O
in B-O O
Jurkat B-O B-cell_line
cells B-O I-cell_line
stimulated B-O O
with B-O O
the B-O O
NF-kappa B-O B-protein
B B-O I-protein
-activating B-O O
cytokine B-O O
tumor B-O B-protein
necrosis B-O I-protein
factor B-O I-protein
alpha B-O I-protein
and B-O O
suppressed B-O O
in B-O O
RelA B-O B-cell_line
-overexpressing B-O I-cell_line
cells B-O I-cell_line
. B-O O

In B-O O
contrast B-O O
, B-O O
protein B-O B-protein
kinase B-O I-protein
C B-O I-protein
stimulation B-O O
or B-O O
RelA B-O B-protein
overexpression B-O O
does B-O O
not B-O O
affect B-O O
the B-O O
activity B-O O
of B-O O
a B-O O
human B-O B-DNA
IL4 B-O I-DNA
promoter B-O I-DNA
containing B-O O
a B-O O
mouse B-O B-DNA
P B-O I-DNA
sequence B-O I-DNA
, B-O O
which B-O O
is B-O O
a B-O O
higher-affinity B-O B-DNA
site B-O I-DNA
for B-O O
NF-ATp B-O B-protein
and B-O O
a B-O O
lower-affinity B-O B-DNA
site B-O I-DNA
for B-O O
RelA B-O B-protein
. B-O O

Thus B-O O
, B-O O
competition B-O O
between B-O O
two B-O O
general B-O O
transcriptional B-O B-protein
activators B-O I-protein
, B-O O
RelA B-O B-protein
and B-O O
NF-ATp B-O B-protein
, B-O O
mediates B-O O
the B-O O
inhibitory B-O O
effect B-O O
of B-O O
protein B-O B-protein
kinase B-O I-protein
C B-O I-protein
stimulation B-O O
on B-O O
IL4 B-O B-protein
expression B-O O
and B-O O
may B-O O
contribute B-O O
to B-O O
differential B-O O
gene B-O O
expression B-O O
in B-O O
TH B-O B-cell_type
cells B-O I-cell_type
. B-O O

Regulation B-O O
of B-O O
the B-O O
balance B-O O
of B-O O
cytokine B-O B-protein
production B-O O
and B-O O
the B-O O
signal B-O O
transducer B-O O
and B-O O
activator B-O O
of B-O O
transcription B-O O
( B-O O
STAT B-O B-protein
) B-O O
transcription B-O B-protein
factor B-O I-protein
activity B-O O
by B-O O
cytokines B-O B-protein
and B-O O
inflammatory B-O O
synovial B-O O
fluids B-O O
. B-O O

The B-O O
balance B-O O
between B-O O
type B-O O
1 B-O O
and B-O O
2 B-O O
T B-O O
helper B-O O
cell B-O O
cytokine B-O B-protein
production B-O O
plays B-O O
an B-O O
important B-O O
role B-O O
in B-O O
several B-O O
animal B-O O
models B-O O
of B-O O
autoimmunity B-O O
, B-O O
and B-O O
skewed B-O O
patterns B-O O
of B-O O
cytokine B-O B-protein
expression B-O O
have B-O O
been B-O O
described B-O O
in B-O O
human B-O O
inflammatory B-O O
diseases B-O O
. B-O O

Many B-O O
cytokines B-O B-protein
activate B-O O
signal B-O O
transducer B-O O
and B-O O
activation B-O O
of B-O O
transcription B-O B-protein
( B-O I-protein
STAT B-O I-protein
) B-O I-protein
transcription B-O I-protein
factors B-O I-protein
, B-O O
which B-O O
, B-O O
in B-O O
turn B-O O
, B-O O
activate B-O O
transcription B-O O
of B-O O
inflammatory B-O B-DNA
effector B-O I-DNA
genes B-O I-DNA
. B-O O

We B-O O
used B-O O
mononuclear B-O B-cell_line
cell B-O I-cell_line
priming B-O I-cell_line
cultures B-O I-cell_line
and B-O O
inflammatory B-O B-cell_type
synovial B-O I-cell_type
fluids B-O I-cell_type
( B-O O
SFs B-O B-cell_type
) B-O O
derived B-O O
from B-O O
arthritis B-O O
patients B-O O
to B-O O
examine B-O O
the B-O O
regulation B-O O
of B-O O
cytokine B-O B-protein
production B-O O
and B-O O
STAT B-O B-protein
activity B-O O
by B-O O
an B-O O
inflammatory B-O O
synovial B-O O
microenvironment B-O O
. B-O O

Exposure B-O O
to B-O O
SFs B-O B-cell_type
during B-O O
priming B-O O
resulted B-O O
in B-O O
an B-O O
81 B-O O
% B-O O
inhibition B-O O
of B-O O
interferon B-O B-protein
( B-O I-protein
IFN B-O I-protein
) B-O I-protein
-gamma B-O I-protein
, B-O O
but B-O O
not B-O O
interleukin B-O B-protein
( B-O I-protein
IL B-O I-protein
) B-O I-protein
4 B-O I-protein
, B-O O
production B-O O
by B-O O
effector B-O B-cell_type
cells B-O I-cell_type
generated B-O O
in B-O O
priming B-O B-cell_line
cultures B-O I-cell_line
. B-O O

SF B-O O
suppression B-O O
was B-O O
mediated B-O O
by B-O O
IL-4 B-O B-protein
and B-O O
IL-10 B-O B-protein
and B-O O
inhibition B-O O
of B-O O
IL-12 B-O B-protein
expression B-O O
, B-O O
and B-O O
it B-O O
was B-O O
reversed B-O O
in B-O O
a B-O O
dominant B-O O
fashion B-O O
by B-O O
exogenous B-O O
IL-12 B-O B-protein
. B-O O

SFs B-O B-protein
blocked B-O O
the B-O O
sustained B-O O
activity B-O O
of B-O O
transcription B-O B-protein
factor B-O I-protein
Stat1 B-O B-protein
, B-O O
but B-O O
not B-O O
Stat3 B-O B-protein
, B-O O
during B-O O
the B-O O
priming B-O O
period B-O O
, B-O O
and B-O O
Stat1 B-O B-protein
activity B-O O
was B-O O
differentially B-O O
regulated B-O O
by B-O O
cytokines B-O B-protein
in B-O O
parallel B-O O
with B-O O
their B-O O
positive B-O O
or B-O O
negative B-O O
regulation B-O O
of B-O O
IFN-gamma B-O B-protein
production B-O O
. B-O O

Active B-O O
Stat3 B-O B-protein
, B-O O
but B-O O
not B-O O
Stat1 B-O B-protein
, B-O O
was B-O O
detected B-O O
in B-O O
cells B-O O
from B-O O
inflamed B-O O
joints B-O O
. B-O O

These B-O O
results B-O O
suggest B-O O
a B-O O
role B-O O
for B-O O
altered B-O O
balance B-O O
of B-O O
Stat1 B-O B-protein
and B-O O
Stat3 B-O B-protein
transcriptional B-O O
activity B-O O
in B-O O
the B-O O
regulation B-O O
of B-O O
T B-O B-cell_type
cell B-O I-cell_type
differentiation B-O O
and B-O O
in B-O O
the B-O O
pathogenesis B-O O
of B-O O
inflammatory B-O O
synovitis B-O O
. B-O O

Triggering B-O O
of B-O O
complement B-O B-protein
receptors B-O I-protein
CR1 B-O B-protein
( B-O O
CD35 B-O B-protein
) B-O O
and B-O O
CR3 B-O B-protein
( B-O O
CD11b/CD18 B-O B-protein
) B-O O
induces B-O O
nuclear B-O O
translocation B-O O
of B-O O
NF-kappa B-O B-protein
B B-O I-protein
( B-O O
p50 B-O O
/p65 B-O B-protein
) B-O O
in B-O O
human B-O B-cell_type
monocytes B-O I-cell_type
and B-O O
enhances B-O O
viral B-O O
replication B-O O
in B-O O
HIV-infected B-O B-cell_type
monocytic B-O I-cell_type
cells B-O I-cell_type
. B-O O

Monocyte/macrophages B-O B-cell_type
may B-O O
harbor B-O O
HIV B-O O
in B-O O
a B-O O
nonproductive B-O O
fashion B-O O
for B-O O
prolonged B-O O
periods B-O O
of B-O O
time B-O O
. B-O O

Viral B-O O
gene B-O O
expression B-O O
may B-O O
be B-O O
reactivated B-O O
by B-O O
stimulation B-O O
of B-O O
the B-O O
cells B-O O
with B-O O
LPS B-O O
or B-O O
cytokines B-O B-protein
such B-O O
as B-O O
TNF-alpha B-O B-protein
in B-O O
vitro B-O O
. B-O O

The B-O O
effect B-O O
of B-O O
LPS B-O O
and B-O O
TNF-alpha B-O B-protein
is B-O O
mediated B-O O
by B-O O
their B-O O
ability B-O O
to B-O O
induce B-O O
nuclear B-O O
translocation B-O O
of B-O O
the B-O O
DNA-binding B-O B-protein
heterodimer B-O I-protein
NF-kappa B-O B-protein
B B-O I-protein
( B-O O
p50 B-O O
/p65 B-O B-protein
) B-O O
, B-O O
which B-O O
binds B-O O
to B-O O
a B-O O
specific B-O O
sequence B-O O
in B-O O
the B-O O
HIV-long B-O B-DNA
terminal B-O I-DNA
repeat B-O I-DNA
. B-O O

The B-O O
present B-O O
study B-O O
demonstrates B-O O
that B-O O
triggering B-O O
of B-O O
complement B-O B-protein
receptors B-O I-protein
CR1 B-O B-protein
( B-O O
CD35 B-O B-protein
) B-O O
and B-O O
CR3 B-O B-protein
( B-O O
CD11b/CD18 B-O B-protein
) B-O O
enhances B-O O
viral B-O O
replication B-O O
in B-O O
HIV-infected B-O B-cell_type
human B-O I-cell_type
monocytic B-O I-cell_type
cells B-O I-cell_type
. B-O O

Monocytic B-O B-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
and B-O O
normal B-O B-cell_type
peripheral B-O I-cell_type
blood B-O I-cell_type
monocytes B-O I-cell_type
were B-O O
infected B-O O
with B-O O
HIV-1 B-O O
in B-O O
vitro B-O O
and B-O O
cultured B-O O
in B-O O
the B-O O
presence B-O O
or B-O O
absence B-O O
of B-O O
F B-O B-protein
( B-O I-protein
ab B-O I-protein
' B-O I-protein
) B-O I-protein
2 B-O I-protein
fragments B-O I-protein
of B-O O
monoclonal B-O B-protein
anti- B-O I-protein
CR1 B-O I-protein
or B-O O
anti- B-O B-protein
CR3 B-O I-protein
Abs B-O I-protein
or B-O O
with B-O O
C3 B-O B-protein
fragments B-O I-protein
. B-O O

Stimulation B-O O
of B-O O
CR1 B-O B-protein
or B-O O
CR3 B-O B-protein
induces B-O O
a B-O O
two- B-O O
to B-O O
fourfold B-O O
increase B-O O
in B-O O
the B-O O
amount B-O O
of B-O O
cell-associated B-O O
and B-O O
released B-O O
p24 B-O B-protein
Ag B-O I-protein
in B-O O
cell B-O B-cell_line
cultures B-O I-cell_line
that B-O O
was B-O O
equivalent B-O O
to B-O O
that B-O O
observed B-O O
in B-O O
control B-O B-cell_line
cultures B-O I-cell_line
triggered B-O O
with B-O O
LPS B-O O
. B-O O

We B-O O
further B-O O
observed B-O O
that B-O O
stimulation B-O O
of B-O O
CR1 B-O B-protein
or B-O O
CR3 B-O B-protein
induces B-O O
the B-O O
nuclear B-O O
translocation B-O O
of B-O O
NF-kappa B-O B-protein
B B-O I-protein
p50 B-O I-protein
/p65 B-O B-protein
in B-O O
infected B-O B-cell_type
cells B-O I-cell_type
. B-O O

Translocation B-O O
of B-O O
NF-kappa B-O B-protein
B B-O I-protein
p50 B-O I-protein
/p65 B-O B-protein
was B-O O
also B-O O
observed B-O O
following B-O O
stimulation B-O O
of B-O O
CR1 B-O B-protein
or B-O O
CR3 B-O B-protein
of B-O O
uninfected B-O B-cell_type
peripheral B-O I-cell_type
blood B-O I-cell_type
monocytes B-O I-cell_type
from B-O O
HIV-seronegative B-O O
donors B-O O
. B-O O

The B-O O
amount B-O O
of B-O O
protein B-O O
translocated B-O O
was B-O O
similar B-O O
to B-O O
that B-O O
observed B-O O
when B-O O
cells B-O O
were B-O O
stimulated B-O O
with B-O O
rhTNF-alpha B-O B-protein
. B-O O

TNF-alpha B-O B-protein
did B-O O
not B-O O
mediate B-O O
the B-O O
translocation B-O O
of B-O O
NF-kappa B-O B-protein
B B-O I-protein
p50 B-O I-protein
/p65 B-O B-protein
induced B-O O
by B-O O
triggering B-O O
of B-O O
complement B-O B-protein
receptors B-O I-protein
. B-O O

Taken B-O O
together B-O O
, B-O O
these B-O O
observations B-O O
suggest B-O O
that B-O O
HIV B-O O
gene B-O O
expression B-O O
may B-O O
be B-O O
activated B-O O
in B-O O
infected B-O B-cell_type
monocytes B-O I-cell_type
through B-O O
interaction B-O O
of B-O O
the B-O O
cells B-O O
with B-O O
complement-opsonized B-O B-protein
particles B-O I-protein
and B-O O
that B-O O
enhanced B-O O
viral B-O O
replication B-O O
is B-O O
associated B-O O
with B-O O
C3 B-O B-protein
receptor B-O I-protein
-mediated B-O O
nuclear B-O O
translocation B-O O
of B-O O
the B-O O
NF-kappa B-O B-protein
B B-O I-protein
complex B-O I-protein
. B-O O

Attenuation B-O O
of B-O O
gamma B-O B-protein
interferon B-O I-protein
-induced B-O O
tyrosine B-O O
phosphorylation B-O O
in B-O O
mononuclear B-O B-cell_type
phagocytes B-O I-cell_type
infected B-O O
with B-O O
Leishmania B-O O
donovani B-O O
: B-O O
selective B-O O
inhibition B-O O
of B-O O
signaling B-O O
through B-O O
Janus B-O B-protein
kinases B-O I-protein
and B-O O
Stat1 B-O B-protein
. B-O O

The B-O O
induction B-O O
of B-O O
gene B-O O
transcription B-O O
in B-O O
response B-O O
to B-O O
gamma B-O B-protein
interferon B-O I-protein
is B-O O
impaired B-O O
in B-O O
mononuclear B-O B-cell_type
phagocytes B-O I-cell_type
infected B-O O
with B-O O
Leishmania B-O O
donovani B-O O
, B-O O
and B-O O
the B-O O
mechanisms B-O O
involved B-O O
are B-O O
not B-O O
fully B-O O
understood B-O O
. B-O O

The B-O O
changes B-O O
in B-O O
gene B-O O
expression B-O O
brought B-O O
about B-O O
by B-O O
gamma B-O B-protein
interferon B-O I-protein
are B-O O
thought B-O O
to B-O O
involve B-O O
transient B-O O
increases B-O O
in B-O O
the B-O O
activities B-O O
of B-O O
cellular B-O B-protein
protein B-O I-protein
tyrosine B-O I-protein
kinases B-O I-protein
, B-O O
including B-O O
the B-O O
Janus B-O B-protein
kinases B-O I-protein
Jak1 B-O B-protein
and B-O O
Jak2 B-O B-protein
, B-O O
leading B-O O
to B-O O
tyrosine B-O O
phosphorylation B-O O
of B-O O
the B-O O
transcription B-O B-protein
factor B-O I-protein
Stat1 B-O B-protein
. B-O O

To B-O O
investigate B-O O
the B-O O
mechanisms B-O O
accounting B-O O
for B-O O
the B-O O
impaired B-O O
responses B-O O
to B-O O
gamma B-O B-protein
interferon B-O I-protein
, B-O O
a B-O O
model B-O O
system B-O O
for B-O O
examining B-O O
overall B-O O
changes B-O O
in B-O O
protein B-O O
tyrosine B-O O
phosphorylation B-O O
, B-O O
activation B-O O
of B-O O
Jak1 B-O B-protein
and B-O O
Jak2 B-O B-protein
and B-O O
phosphorylation B-O O
of B-O O
Stat1 B-O B-protein
was B-O O
developed B-O O
in B-O O
phorbol B-O B-cell_line
12-myristate B-O I-cell_line
13-acetate B-O I-cell_line
-differentiated B-O I-cell_line
U-937 B-O I-cell_line
cells B-O I-cell_line
. B-O O

Analysis B-O O
of B-O O
whole-cell B-O O
lysates B-O O
by B-O O
antiphosphotyrosine B-O O
immunoblotting B-O O
showed B-O O
that B-O O
incubation B-O O
with B-O O
gamma B-O B-protein
interferon B-O I-protein
brought B-O O
about B-O O
specific B-O O
increases B-O O
in B-O O
phosphotyrosine B-O O
labeling B-O O
of B-O O
several B-O O
proteins B-O O
. B-O O

Increased B-O O
labeling B-O O
of B-O O
these B-O O
proteins B-O O
occurred B-O O
to B-O O
similar B-O O
extents B-O O
in B-O O
control B-O B-cell_type
cells B-O I-cell_type
and B-O O
in B-O O
cells B-O O
that B-O O
had B-O O
been B-O O
infected B-O O
with B-O O
L. B-O O
donovani B-O O
for B-O O
16 B-O O
h B-O O
. B-O O

Jak1 B-O B-protein
, B-O O
Jak2 B-O B-protein
, B-O O
and B-O O
Stat1 B-O B-protein
were B-O O
immunoprecipitated B-O O
from B-O O
control B-O O
and B-O O
interferon-treated B-O B-cell_line
cells B-O I-cell_line
, B-O O
and B-O O
tyrosine B-O O
phosphorylation B-O O
of B-O O
these B-O O
proteins B-O O
, B-O O
detected B-O O
by B-O O
antiphosphotyrosine B-O O
immunoblotting B-O O
was B-O O
used B-O O
to B-O O
measured B-O O
their B-O O
activation B-O O
. B-O O

Tyrosine B-O O
phosphorylation B-O O
of B-O O
Jak1 B-O B-protein
, B-O O
Jak2 B-O B-protein
, B-O O
and B-O O
Stat1 B-O B-protein
increased B-O O
markedly B-O O
, B-O O
in B-O O
a B-O O
dose-dependent B-O O
manner B-O O
, B-O O
in B-O O
U-937 B-O B-cell_line
cells B-O I-cell_line
incubated B-O O
with B-O O
gamma B-O B-protein
interferon B-O I-protein
. B-O O

In B-O O
contrast B-O O
, B-O O
in B-O O
cells B-O O
infected B-O O
with B-O O
L. B-O O
donovani B-O O
, B-O O
tyrosine B-O O
phosphorylation B-O O
of B-O O
Jak1 B-O B-protein
, B-O O
Jak2 B-O B-protein
, B-O O
and B-O O
Stat1 B-O B-protein
was B-O O
markedly B-O O
impaired B-O O
. B-O O

This B-O O
effect B-O O
was B-O O
dependent B-O O
upon B-O O
the B-O O
duration B-O O
of B-O O
exposure B-O O
to B-O O
L. B-O O
donovani B-O O
and B-O O
was B-O O
maximal B-O O
and B-O O
complete B-O O
at B-O O
16 B-O O
h B-O O
. B-O O

Results B-O O
similar B-O O
to B-O O
those B-O O
observed B-O O
with B-O O
U-937 B-O B-cell_line
cells B-O I-cell_line
were B-O O
also B-O O
obtained B-O O
with B-O O
human B-O B-cell_type
peripheral B-O I-cell_type
blood B-O I-cell_type
monocytes B-O I-cell_type
. B-O O

These B-O O
findings B-O O
indicate B-O O
that B-O O
infection B-O O
of B-O O
human B-O B-cell_type
mononuclear B-O I-cell_type
phagocytes B-O I-cell_type
with B-O O
L. B-O O
donovani B-O O
leads B-O O
to B-O O
impaired B-O O
gamma B-O B-protein
interferon B-O I-protein
-mediated B-O O
tyrosine B-O O
phosphorylation B-O O
and B-O O
selective B-O O
effects B-O O
on B-O O
the B-O O
Jak- B-O O
Stat1 B-O B-protein
pathway B-O O
. B-O O

Unresponsiveness B-O O
to B-O O
gamma B-O B-protein
interferon B-O I-protein
for B-O O
activation B-O O
of B-O O
this B-O O
pathway B-O O
may B-O O
explain B-O O
impaired B-O O
transcriptional B-O O
responses B-O O
in B-O O
leishmania-infected B-O B-cell_type
cells B-O I-cell_type
. B-O O

Mutually B-O O
exclusive B-O O
interaction B-O O
of B-O O
a B-O O
novel B-O O
matrix B-O B-protein
attachment B-O I-protein
region B-O I-protein
binding B-O I-protein
protein B-O I-protein
and B-O O
the B-O O
NF-muNR B-O B-protein
enhancer B-O I-protein
repressor B-O I-protein
. B-O O

Implications B-O O
for B-O O
regulation B-O O
of B-O O
immunoglobulin B-O B-protein
heavy B-O I-protein
chain B-O I-protein
expression B-O O
. B-O O

The B-O O
immunoglobulin B-O B-DNA
heavy B-O I-DNA
chain B-O I-DNA
( B-O I-DNA
IgH B-O I-DNA
) B-O I-DNA
intronic B-O I-DNA
enhancer B-O I-DNA
stimulates B-O O
transcription B-O O
from B-O O
functional B-O O
promoters B-O O
in B-O O
B B-O B-cell_type
lymphocytes B-O I-cell_type
but B-O O
not B-O O
other B-O O
cell B-O O
types B-O O
. B-O O

The B-O O
observation B-O O
that B-O O
binding B-O B-DNA
sites B-O I-DNA
for B-O O
the B-O O
nuclear B-O B-protein
factor-mu B-O I-protein
negative B-O I-protein
regulator B-O I-protein
( B-O O
NF-muNR B-O B-protein
) B-O O
enhancer B-O O
repressor B-O O
overlap B-O O
nuclear B-O O
matrix B-O O
attachment B-O O
regions B-O O
( B-O O
MARs B-O B-protein
) B-O O
in B-O O
this B-O O
enhancer B-O B-DNA
has B-O O
lead B-O O
to B-O O
the B-O O
hypothesis B-O O
that B-O O
the B-O O
cell B-O O
type B-O O
specificity B-O O
of B-O O
the B-O O
enhancer B-O B-DNA
might B-O O
be B-O O
controlled B-O O
by B-O O
regulating B-O O
nuclear B-O O
matrix B-O O
attachment B-O O
( B-O O
Scheuermann B-O O
, B-O O
R. B-O O
H. B-O O
, B-O O
and B-O O
Chen B-O O
, B-O O
U. B-O B-DNA
( B-O I-DNA
1989 B-O I-DNA
) B-O I-DNA
Genes B-O I-DNA
& B-O O
amp B-O O
; B-O O
Dev. B-O O
3 B-O O
, B-O O
1255-1266 B-O O
) B-O O
. B-O O

To B-O O
understand B-O O
the B-O O
role B-O O
of B-O O
MARs B-O B-protein
in B-O O
IgH B-O B-DNA
enhancer B-O I-DNA
regulation B-O O
, B-O O
we B-O O
have B-O O
identified B-O O
a B-O O
novel B-O O
MAR-binding B-O B-protein
protein B-O I-protein
, B-O O
MAR-BP1 B-O B-protein
, B-O O
from B-O O
soluble B-O O
nuclear B-O O
matrix B-O O
preparations B-O O
based B-O O
on B-O O
its B-O O
ability B-O O
to B-O O
bind B-O O
to B-O O
the B-O O
MARs B-O B-protein
associated B-O O
with B-O O
the B-O O
IgH B-O B-DNA
enhancer B-O I-DNA
. B-O O

Purified B-O O
MAR-BP1 B-O B-protein
migrates B-O O
as B-O O
a B-O O
33-kDa B-O B-protein
protein B-O I-protein
, B-O O
and B-O O
it B-O O
can B-O O
be B-O O
found B-O O
in B-O O
nuclear B-O O
matrix B-O O
preparations B-O O
from B-O O
a B-O O
number B-O O
of B-O O
different B-O O
types B-O O
of B-O O
lymphoid B-O B-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
. B-O O

Although B-O O
specific B-O O
binding B-O O
sites B-O O
have B-O O
been B-O O
difficult B-O O
to B-O O
localize B-O O
by B-O O
chemical B-O O
or B-O O
enzymatic B-O O
footprinting B-O O
procedures B-O O
, B-O O
NF-muNR B-O B-protein
binding B-O O
sites B-O O
are B-O O
critical B-O O
for B-O O
efficient B-O O
MAR-BP1 B-O B-protein
binding B-O O
. B-O O

Indeed B-O O
, B-O O
binding B-O O
of B-O O
the B-O O
IgH B-O B-DNA
enhancer B-O I-DNA
to B-O O
either B-O O
intact B-O O
nuclear B-O O
matrix B-O O
preparations B-O O
or B-O O
to B-O O
MAR-BP1 B-O B-protein
is B-O O
mutually B-O O
exclusive B-O O
to B-O O
NF-muNR B-O B-protein
binding B-O O
. B-O O

These B-O O
results B-O O
are B-O O
consistent B-O O
with B-O O
a B-O O
model B-O O
for B-O O
cell-type B-O O
specific B-O O
regulation B-O O
in B-O O
which B-O O
binding B-O O
of B-O O
the B-O O
NF-muNR B-O B-protein
repressor B-O I-protein
to B-O O
the B-O O
IgH B-O B-DNA
enhancer B-O I-DNA
prevents B-O O
nuclear B-O O
matrix B-O O
attachment B-O O
in B-O O
inappropriate B-O B-cell_type
cells B-O I-cell_type
by B-O O
interfering B-O O
with B-O O
MAR-BP1 B-O B-protein
/enhancer B-O B-DNA
interaction B-O O
. B-O O

PU.1 B-O B-protein
( B-O O
Spi-1 B-O B-protein
) B-O O
and B-O O
C/EBP B-O B-protein
alpha B-O I-protein
regulate B-O O
expression B-O O
of B-O O
the B-O O
granulocyte-macrophage B-O B-DNA
colony-stimulating B-O I-DNA
factor B-O I-DNA
receptor B-O I-DNA
alpha B-O I-DNA
gene B-O I-DNA
. B-O O

Growth B-O B-protein
factor B-O I-protein
receptors B-O I-protein
play B-O O
an B-O O
important B-O O
role B-O O
in B-O O
hematopoiesis B-O O
. B-O O

In B-O O
order B-O O
to B-O O
further B-O O
understand B-O O
the B-O O
mechanisms B-O O
directing B-O O
the B-O O
expression B-O O
of B-O O
these B-O O
key B-O O
regulators B-O O
of B-O O
hematopoiesis B-O O
, B-O O
we B-O O
initiated B-O O
a B-O O
study B-O O
investigating B-O O
the B-O O
transcription B-O B-protein
factors B-O I-protein
activating B-O O
the B-O O
expression B-O O
of B-O O
the B-O O
granulocyte-macrophage B-O B-DNA
colony-stimulating B-O I-DNA
factor B-O I-DNA
( B-O I-DNA
GM-CSF B-O I-DNA
) B-O I-DNA
receptor B-O I-DNA
alpha B-O I-DNA
gene B-O I-DNA
. B-O O

Here B-O O
, B-O O
we B-O O
demonstrate B-O O
that B-O O
the B-O O
human B-O B-DNA
GM-CSF B-O I-DNA
receptor B-O I-DNA
alpha B-O I-DNA
promoter B-O I-DNA
directs B-O O
reporter B-O B-DNA
gene B-O I-DNA
activity B-O O
in B-O O
a B-O O
tissue-specific B-O O
fashion B-O O
in B-O O
myelomonocytic B-O B-cell_type
cells B-O I-cell_type
, B-O O
which B-O O
correlates B-O O
with B-O O
its B-O O
expression B-O O
pattern B-O O
as B-O O
analyzed B-O O
by B-O O
reverse B-O O
transcription B-O O
PCR B-O O
. B-O O

The B-O O
GM-CSF B-O B-DNA
receptor B-O I-DNA
alpha B-O I-DNA
promoter B-O I-DNA
contains B-O O
an B-O O
important B-O O
functional B-O O
site B-O O
between B-O O
positions B-O O
-53 B-O O
and B-O O
-41 B-O O
as B-O O
identified B-O O
by B-O O
deletion B-O O
analysis B-O O
of B-O O
reporter B-O B-DNA
constructs B-O I-DNA
. B-O O

We B-O O
show B-O O
that B-O O
the B-O O
myeloid B-O O
and B-O O
B B-O B-protein
cell B-O I-protein
transcription B-O I-protein
factor B-O I-protein
PU.1 B-O B-protein
binds B-O O
specifically B-O O
to B-O O
this B-O O
site B-O O
. B-O O

Furthermore B-O O
, B-O O
we B-O O
demonstrate B-O O
that B-O O
a B-O O
CCAAT B-O B-DNA
site B-O I-DNA
located B-O O
upstream B-O O
of B-O O
the B-O O
PU.1 B-O B-DNA
site B-O I-DNA
between B-O O
positions B-O O
-70 B-O B-DNA
and B-O I-DNA
-54 B-O I-DNA
is B-O O
involved B-O O
in B-O O
positive-negative B-O O
regulation B-O O
of B-O O
the B-O O
GM-CSF B-O B-DNA
receptor B-O I-DNA
alpha B-O I-DNA
promoter B-O I-DNA
activity B-O O
. B-O O

C/EBP B-O B-protein
alpha B-O I-protein
is B-O O
the B-O O
major B-O B-protein
CCAAT/enhancer B-O I-protein
-binding B-O I-protein
protein B-O I-protein
( B-O O
C/EBP B-O B-protein
) B-O O
form B-O O
binding B-O O
to B-O O
this B-O O
site B-O O
in B-O O
nuclear B-O O
extracts B-O O
of B-O O
U937 B-O B-cell_line
cells B-O I-cell_line
. B-O O

Point B-O O
mutations B-O O
of B-O O
either B-O O
the B-O O
PU.1 B-O B-DNA
site B-O I-DNA
or B-O O
the B-O O
C/EBP B-O B-DNA
site B-O I-DNA
that B-O O
abolish B-O O
the B-O O
binding B-O O
of B-O O
the B-O O
respective B-O O
factors B-O O
result B-O O
in B-O O
a B-O O
significant B-O O
decrease B-O O
of B-O O
GM-CSF B-O B-DNA
receptor B-O I-DNA
alpha B-O I-DNA
promoter B-O I-DNA
activity B-O O
in B-O O
myelomonocytic B-O B-cell_type
cells B-O I-cell_type
only B-O O
. B-O O

Furthermore B-O O
, B-O O
we B-O O
demonstrate B-O O
that B-O O
in B-O O
myeloid B-O O
and B-O O
B B-O O
cell B-O O
extracts B-O O
, B-O O
PU.1 B-O B-protein
forms B-O O
a B-O O
novel B-O O
, B-O O
specific B-O O
, B-O O
more B-O O
slowly B-O O
migrating B-O O
complex B-O O
( B-O O
PU-SF B-O B-protein
) B-O O
when B-O O
binding B-O O
the B-O O
GM-CSF B-O B-DNA
receptor B-O I-DNA
alpha B-O I-DNA
promoter B-O I-DNA
PU.1 B-O I-DNA
site B-O I-DNA
. B-O O

This B-O O
is B-O O
the B-O O
first B-O O
demonstration B-O O
of B-O O
a B-O O
specific B-O O
interaction B-O O
with B-O O
PU.1 B-O B-protein
on B-O O
a B-O O
myeloid B-O B-DNA
PU.1 B-O I-DNA
binding B-O I-DNA
site B-O I-DNA
. B-O O

The B-O O
novel B-O O
complex B-O O
is B-O O
distinct B-O O
from B-O O
that B-O O
described B-O O
previously B-O O
as B-O O
binding B-O O
to B-O O
B B-O B-DNA
cell B-O I-DNA
enhancer B-O I-DNA
sites B-O I-DNA
and B-O O
can B-O O
be B-O O
formed B-O O
by B-O O
addition B-O O
of B-O O
PU.1 B-O B-protein
to B-O O
extracts B-O O
from B-O O
certain B-O O
nonmyeloid B-O B-cell_type
cell B-O I-cell_type
types B-O I-cell_type
which B-O O
do B-O O
not B-O O
express B-O O
PU.1 B-O B-protein
, B-O O
including B-O O
T B-O B-cell_type
cells B-O I-cell_type
and B-O O
epithelial B-O B-cell_type
cells B-O I-cell_type
, B-O O
but B-O O
not B-O O
from B-O O
erythroid B-O B-cell_type
cells B-O I-cell_type
. B-O O

Furthermore B-O O
, B-O O
we B-O O
demonstrate B-O O
that B-O O
the B-O O
PU-SF B-O B-protein
complex B-O I-protein
binds B-O O
to B-O O
PU.1 B-O B-DNA
sites B-O I-DNA
found B-O O
on B-O O
a B-O O
number B-O O
of B-O O
myeloid B-O B-DNA
promoters B-O I-DNA
, B-O O
and B-O O
its B-O O
formation B-O O
requires B-O O
an B-O O
intact B-O O
PU.1 B-O B-DNA
site B-O I-DNA
adjacent B-O O
to B-O O
a B-O O
single-stranded B-O B-DNA
region B-O I-DNA
. B-O O

Expression B-O O
of B-O O
PU.1 B-O B-protein
in B-O O
nonmyeloid B-O B-cell_type
cells B-O I-cell_type
can B-O O
activate B-O O
the B-O O
GM-CSF B-O B-DNA
receptor B-O I-DNA
alpha B-O I-DNA
promoter B-O I-DNA
. B-O O

Deletion B-O O
of B-O O
the B-O O
amino-terminal B-O B-protein
region B-O I-protein
of B-O O
PU.1 B-O B-protein
results B-O O
in B-O O
a B-O O
failure B-O O
to B-O O
form B-O O
the B-O O
PU-SF B-O B-protein
complex B-O I-protein
and B-O O
in B-O O
a B-O O
concomitant B-O O
loss B-O O
of B-O O
transactivation B-O O
, B-O O
suggesting B-O O
that B-O O
formation B-O O
of B-O O
the B-O O
PU-SF B-O B-protein
complex B-O I-protein
is B-O O
of B-O O
functional B-O O
importance B-O O
for B-O O
the B-O O
activity B-O O
of B-O O
the B-O O
GM-CSF B-O B-DNA
receptor B-O I-DNA
alpha B-O I-DNA
promoter B-O I-DNA
. B-O O

Finally B-O O
, B-O O
we B-O O
demonstrate B-O O
that B-O O
C/EBP B-O B-protein
alpha B-O I-protein
can B-O O
also B-O O
active B-O O
the B-O O
GM-CSF B-O B-DNA
receptor B-O I-DNA
alpha B-O I-DNA
promoter B-O I-DNA
in B-O O
nonmyeloid B-O B-cell_type
cells B-O I-cell_type
. B-O O

( B-O O
ABSTRACT B-O O
TRUNCATED B-O O
AT B-O O
400 B-O O
WORDS B-O O
) B-O O

HMG-I B-O B-protein
binds B-O O
to B-O O
GATA B-O B-DNA
motifs B-O I-DNA
: B-O O
implications B-O O
for B-O O
an B-O O
HPFH B-O O
syndrome B-O O
. B-O O

We B-O O
have B-O O
examined B-O O
binding B-O O
of B-O O
the B-O O
nuclear B-O B-protein
protein B-O I-protein
HMG-I B-O B-protein
to B-O O
the B-O O
human B-O B-DNA
gamma-globin B-O I-DNA
promoter B-O I-DNA
. B-O O

We B-O O
find B-O O
that B-O O
HMG-I B-O B-protein
binds B-O O
preferentially B-O O
to B-O O
the B-O O
more B-O O
3 B-O O
' B-O O
of B-O O
a B-O O
pair B-O O
of B-O O
GATA B-O B-DNA
motifs B-O I-DNA
in B-O O
the B-O O
gamma-globin B-O B-DNA
promoter B-O I-DNA
; B-O O
this B-O O
paired B-O B-DNA
motif B-O I-DNA
is B-O O
bound B-O O
by B-O O
the B-O O
erythroid B-O B-protein
factor B-O I-protein
GATA-1 B-O I-protein
. B-O O

A B-O O
naturally B-O O
occurring B-O O
mutation B-O O
( B-O O
-175 B-O O
T-C B-O O
) B-O O
in B-O O
the B-O O
area B-O O
bound B-O O
by B-O O
HMG-I B-O B-protein
results B-O O
in B-O O
overexpression B-O O
of B-O O
gamma-globin B-O B-protein
in B-O O
adult B-O B-cell_type
red B-O I-cell_type
blood B-O I-cell_type
cells B-O I-cell_type
( B-O O
HPFH B-O B-cell_type
) B-O O
and B-O O
up-regulation B-O O
of B-O O
the B-O O
gamma-globin B-O B-DNA
promoter B-O I-DNA
in B-O O
in B-O O
vitro B-O O
expression B-O O
assays B-O O
; B-O O
HMG-I B-O B-protein
does B-O O
not B-O O
bind B-O O
to B-O O
this B-O O
mutant B-O B-DNA
sequence B-O I-DNA
. B-O O

A B-O O
survey B-O O
of B-O O
GATA B-O B-DNA
motifs B-O I-DNA
from B-O O
other B-O O
globin B-O B-DNA
cis-elements B-O I-DNA
demonstrates B-O O
HMG-I B-O B-protein
binding B-O O
to B-O O
most B-O O
of B-O O
them B-O O
. B-O O

These B-O O
findings B-O O
implicate B-O O
HMG-I B-O B-protein
in B-O O
the B-O O
HPFH B-O B-cell_type
phenotype B-O O
; B-O O
we B-O O
speculate B-O O
that B-O O
it B-O O
may B-O O
participate B-O O
in B-O O
the B-O O
formation B-O O
of B-O O
multiprotein B-O B-protein
complexes B-O I-protein
that B-O O
regulate B-O O
globin B-O B-DNA
gene B-O I-DNA
expression B-O O
. B-O O

Constitutive B-O O
activation B-O O
of B-O O
different B-O O
Jak B-O B-protein
tyrosine B-O I-protein
kinases B-O I-protein
in B-O O
human B-O B-protein
T B-O I-protein
cell B-O I-protein
leukemia B-O I-protein
virus B-O I-protein
type B-O I-protein
1 B-O I-protein
( B-O I-protein
HTLV-1 B-O I-protein
) B-O I-protein
tax B-O I-protein
protein B-O I-protein
or B-O O
virus-transformed B-O B-cell_line
cells B-O I-cell_line
. B-O O

HTLV-1 B-O O
infection B-O O
causes B-O O
an B-O O
adult B-O O
T B-O O
cell B-O O
leukemia B-O O
in B-O O
humans B-O O
. B-O O

The B-O O
viral B-O B-protein
encoded B-O I-protein
protein B-O I-protein
tax B-O B-protein
, B-O O
is B-O O
thought B-O O
to B-O O
play B-O O
an B-O O
important B-O O
role B-O O
in B-O O
oncogenesis B-O O
. B-O O

Our B-O O
previous B-O O
data B-O O
obtained B-O O
from B-O O
a B-O O
tax B-O B-protein
transgenic B-O O
mouse B-O O
model B-O O
revealed B-O O
that B-O O
tax B-O B-protein
transforms B-O O
mouse B-O B-cell_type
fibroblasts B-O I-cell_type
but B-O O
not B-O O
thymocytes B-O B-cell_type
, B-O O
despite B-O O
comparable B-O O
levels B-O O
of B-O O
tax B-O B-protein
expression B-O O
in B-O O
both B-O O
tissues B-O O
. B-O O

Constitutive B-O O
tyrosine B-O O
phosphorylation B-O O
of B-O O
a B-O O
130-kD B-O B-protein
protein B-O I-protein
( B-O O
s B-O O
) B-O O
was B-O O
observed B-O O
in B-O O
the B-O O
tax B-O B-protein
transformed B-O O
fibroblast B-O O
B B-O O
line B-O O
and B-O O
in B-O O
HTLV-1 B-O B-cell_line
transformed B-O I-cell_line
human B-O I-cell_line
lymphoid B-O I-cell_line
lines B-O I-cell_line
, B-O O
but B-O O
not B-O O
in B-O O
thymocytes B-O B-cell_type
from B-O O
Thy-tax B-O O
transgenic B-O O
mice B-O O
. B-O O

Phosphotyrosine B-O O
immunoprecipitation B-O O
followed B-O O
by B-O O
Western B-O O
blot B-O O
analysis B-O O
with B-O O
a B-O O
set B-O O
of B-O O
Jak B-O B-protein
kinase B-O I-protein
specific B-O I-protein
antibodies B-O I-protein
, B-O O
identified B-O O
p130 B-O B-protein
as B-O O
Jak2 B-O B-protein
in B-O O
the B-O O
tax B-O B-protein
transformed B-O O
mouse B-O B-cell_line
fibroblastic B-O I-cell_line
cell B-O I-cell_line
line B-O I-cell_line
and B-O O
Jak3 B-O B-protein
in B-O O
HTLV-1 B-O B-cell_line
transformed B-O I-cell_line
human B-O I-cell_line
T B-O I-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
. B-O O

Phosphorylation B-O O
of B-O O
Jak2 B-O B-protein
in B-O O
tax B-O B-cell_line
transformed B-O I-cell_line
cells B-O I-cell_line
resulted B-O O
from B-O O
high B-O O
expression B-O O
of B-O O
IL-6 B-O B-protein
. B-O O

Tyrosine B-O O
phosphorylation B-O O
of B-O O
this B-O O
protein B-O O
could B-O O
also B-O O
be B-O O
induced B-O O
in B-O O
Balb/c3T3 B-O B-cell_line
cells B-O I-cell_line
using B-O O
a B-O O
supernatant B-O O
from B-O O
the B-O O
B B-O B-cell_line
line B-O I-cell_line
, B-O O
which B-O O
was B-O O
associated B-O O
with B-O O
induction B-O O
of B-O O
cell B-O O
proliferation B-O O
. B-O O

Both B-O O
phosphorylation B-O O
and B-O O
proliferation B-O O
were B-O O
inhibited B-O O
by B-O O
IL-6 B-O B-protein
neutralizing B-O O
antibodies B-O O
. B-O O

Constitutive B-O O
phosphorylation B-O O
of B-O O
Jak B-O B-protein
kinases B-O I-protein
may B-O O
facilitate B-O O
tumor B-O O
growth B-O O
in B-O O
both B-O O
HTLV-1 B-O B-cell_type
infected B-O I-cell_type
human B-O I-cell_type
T B-O I-cell_type
cells B-O I-cell_type
and B-O O
the B-O O
transgenic B-O O
mouse B-O O
model B-O O
. B-O O

Regulation B-O O
of B-O O
c-jun B-O B-RNA
mRNA B-O I-RNA
expression B-O O
by B-O O
hydroxyurea B-O O
in B-O O
human B-O B-cell_line
K562 B-O I-cell_line
cells B-O I-cell_line
during B-O O
erythroid B-O O
differentiation B-O O
[ B-O O
published B-O O
erratum B-O O
appears B-O O
in B-O O
Biochim B-O O
Biophys B-O O
Acta B-O O
1995 B-O O
Dec B-O O
27 B-O O
; B-O O
1264 B-O O
( B-O O
3 B-O O
) B-O O
: B-O O
409 B-O O
] B-O O

Hydroxyurea B-O O
( B-O O
HU B-O O
) B-O O
is B-O O
an B-O O
antitumor B-O O
agent B-O O
which B-O O
also B-O O
induces B-O O
hemoglobinization B-O O
during B-O O
erythroid B-O O
differentiation B-O O
. B-O O

In B-O O
addition B-O O
, B-O O
HU B-O O
stimulates B-O O
the B-O O
synthesis B-O O
of B-O O
fetal B-O B-protein
hemoglobin B-O I-protein
in B-O O
sickle B-O O
cell B-O O
anemia B-O O
patients B-O O
. B-O O

To B-O O
further B-O O
understand B-O O
its B-O O
mechanism B-O O
of B-O O
action B-O O
, B-O O
we B-O O
investigated B-O O
the B-O O
effects B-O O
of B-O O
HU B-O O
on B-O O
regulation B-O O
of B-O O
c-jun B-O B-DNA
expression B-O O
prior B-O O
to B-O O
the B-O O
onset B-O O
of B-O O
erythroid B-O O
differentiation B-O O
of B-O O
K562 B-O B-cell_line
cells B-O I-cell_line
. B-O O

HU B-O O
induced B-O O
a B-O O
dose-dependent B-O O
stimulation B-O O
of B-O O
c-jun B-O B-DNA
synthesis B-O O
. B-O O

The B-O O
levels B-O O
of B-O O
c-jun B-O B-RNA
mRNA B-O I-RNA
was B-O O
elevated B-O O
4 B-O O
to B-O O
7.5-fold B-O O
by B-O O
HU B-O O
within B-O O
2 B-O O
h B-O O
. B-O O

This B-O O
was B-O O
followed B-O O
by B-O O
a B-O O
gradual B-O O
decline B-O O
to B-O O
the B-O O
basal B-O O
level B-O O
by B-O O
24 B-O O
h B-O O
. B-O O

Both B-O O
nuclear B-O O
run-on B-O O
and B-O O
actinomycin B-O O
D B-O O
pulse B-O O
experiments B-O O
strongly B-O O
indicate B-O O
that B-O O
HU B-O O
regulates B-O O
c-jun B-O B-RNA
mRNA B-O I-RNA
expression B-O O
by B-O O
increasing B-O O
the B-O O
rate B-O O
of B-O O
synthesis B-O O
as B-O O
well B-O O
as B-O O
stabilizing B-O O
the B-O O
c-jun B-O B-RNA
mRNA B-O I-RNA
. B-O O

In B-O O
addition B-O O
, B-O O
the B-O O
level B-O O
of B-O O
jun B-O B-protein
protein B-O I-protein
was B-O O
elevated B-O O
by B-O O
2 B-O O
to B-O O
5-fold B-O O
within B-O O
4 B-O O
h B-O O
in B-O O
HU B-O B-cell_line
treated B-O I-cell_line
cells B-O I-cell_line
. B-O O

Furthermore B-O O
, B-O O
concentrations B-O O
of B-O O
HU B-O O
below B-O O
250 B-O O
microM B-O O
slightly B-O O
increased B-O O
the B-O O
5X B-O O
AP-1 B-O B-protein
/CAT B-O B-protein
activity B-O O
. B-O O

These B-O O
results B-O O
strongly B-O O
suggest B-O O
that B-O O
HU B-O O
induces B-O O
both B-O O
transcriptional B-O O
and B-O O
post-transcription B-O O
regulation B-O O
of B-O O
c-jun B-O B-DNA
during B-O O
erythroid B-O O
differentiation B-O O
. B-O O

In B-O O
vivo B-O O
and B-O O
in B-O O
vitro B-O O
effects B-O O
of B-O O
glucocorticoids B-O O
on B-O O
lymphocyte B-O B-cell_type
proliferation B-O O
in B-O O
man B-O O
: B-O O
relationship B-O O
to B-O O
glucocorticoid B-O B-protein
receptors B-O I-protein
. B-O O

Interrelations B-O O
between B-O O
the B-O O
hypothalamic-pituitary-adrenal B-O O
system B-O O
( B-O O
HPA B-O O
) B-O O
and B-O O
the B-O O
immune B-O O
system B-O O
represent B-O O
a B-O O
well-documented B-O O
biological B-O O
phenomenon B-O O
. B-O O

While B-O O
in B-O O
vitro B-O O
administration B-O O
of B-O O
glucocorticoids B-O O
may B-O O
inhibit B-O O
concanavalin B-O O
A B-O O
( B-O O
Con B-O O
A B-O O
) B-O O
- B-O O
and B-O O
phytohemagglutinin B-O B-protein
( B-O O
PHA B-O B-protein
) B-O O
- B-O O
induced B-O O
T-cell B-O O
proliferation B-O O
, B-O O
pokeweed B-O B-protein
mitogen B-O I-protein
( B-O O
PWM B-O B-protein
) B-O O
-driven B-O O
B-cell B-O O
mitogenesis B-O O
is B-O O
relatively B-O O
resistant B-O O
to B-O O
glucocorticoids B-O O
. B-O O

To B-O O
further B-O O
explore B-O O
the B-O O
link B-O O
between B-O O
the B-O O
HPA B-O O
and B-O O
the B-O O
immune B-O O
system B-O O
in B-O O
relation B-O O
to B-O O
glucocorticoid B-O B-protein
receptor B-O I-protein
function B-O O
, B-O O
dose-response B-O O
curves B-O O
were B-O O
obtained B-O O
for B-O O
Con B-O B-protein
A B-O I-protein
- B-O O
and B-O O
PHA B-O B-protein
-induced B-O O
T-cell B-O O
mitogenesis B-O O
, B-O O
PWM B-O B-protein
-generated B-O O
B-cell B-O O
mitogenesis B-O O
and B-O O
spontaneous B-O O
lymphocyte B-O O
proliferation B-O O
in B-O O
13 B-O O
healthy B-O O
controls B-O O
. B-O O

Glucocorticoid B-O O
effects B-O O
were B-O O
assessed B-O O
in B-O O
vivo B-O O
by B-O O
depletion B-O O
of B-O O
endogenous B-O O
glucocorticoids B-O O
after B-O O
oral B-O O
administration B-O O
of B-O O
1.5 B-O O
g B-O O
metyrapone B-O O
( B-O O
MET B-O O
) B-O O
and B-O O
subsequent B-O O
glucocorticoid B-O O
replacement B-O O
, B-O O
and B-O O
in B-O O
vitro B-O O
by B-O O
incubation B-O O
of B-O O
the B-O O
cells B-O O
with B-O O
different B-O O
doses B-O O
of B-O O
dexamethasone B-O O
( B-O O
DEX B-O O
) B-O O
. B-O O

There B-O O
was B-O O
a B-O O
significant B-O O
decrease B-O O
in B-O O
PWM B-O B-protein
-induced B-O O
B-cell B-O O
mitogenesis B-O O
and B-O O
a B-O O
more B-O O
pronounced B-O O
effect B-O O
of B-O O
DEX B-O O
administered B-O O
in B-O O
vitro B-O O
on B-O O
spontaneous B-O O
lymphocyte B-O O
proliferation B-O O
after B-O O
MET B-O O
treatment B-O O
when B-O O
compared B-O O
with B-O O
the B-O O
DEX B-O O
plus B-O O
MET B-O O
pretreated B-O O
condition B-O O
in B-O O
vivo B-O O
. B-O O

These B-O O
data B-O O
suggest B-O O
that B-O O
the B-O O
inhibition B-O O
of B-O O
spontaneous B-O O
lymphocyte B-O O
proliferation B-O O
by B-O O
glucocorticoids B-O O
in B-O O
vitro B-O O
is B-O O
related B-O O
to B-O O
glucocorticoid B-O B-protein
receptor B-O I-protein
function B-O O
. B-O O

The B-O O
decrease B-O O
in B-O O
PWM B-O B-protein
-generated B-O O
B-cell B-O O
proliferation B-O O
following B-O O
cortisol B-O O
depletion B-O O
by B-O O
MET B-O O
may B-O O
be B-O O
seen B-O O
in B-O O
connection B-O O
with B-O O
impaired B-O O
glucocorticoid B-O O
-mediated B-O O
induction B-O O
of B-O O
interleukin-1 B-O B-protein
receptor B-O I-protein
synthesis B-O O
. B-O O

Transcription B-O O
specific B-O O
differences B-O O
visualized B-O O
by B-O O
fluorescence B-O O
in B-O O
situ B-O O
hybridization B-O O
pattern B-O O
on B-O O
interphase B-O O
nuclei B-O O
of B-O O
different B-O O
cell B-O O
types B-O O
. B-O O

Application B-O O
of B-O O
a B-O O
`` B-O O
formamide B-O O
free B-O O
`` B-O O
and B-O O
thus B-O O
`` B-O O
material B-O O
preserving B-O O
`` B-O O
in B-O O
situ B-O O
hybridization B-O O
technique B-O O
using B-O O
the B-O O
cDNA B-O B-DNA
of B-O O
the B-O O
myf3 B-O B-DNA
gene B-O I-DNA
revealed B-O O
the B-O O
following B-O O
results B-O O
: B-O O
Human B-O B-cell_type
rhabdomyosarcoma B-O I-cell_type
cells B-O I-cell_type
, B-O O
characterized B-O O
by B-O O
a B-O O
high B-O O
expression B-O O
of B-O O
myf3 B-O B-protein
show B-O O
intensive B-O O
hybridization B-O O
signals B-O O
in B-O O
their B-O O
interphase B-O O
. B-O O

RNase B-O B-protein
treatment B-O O
prior B-O O
to B-O O
hybridization B-O O
considerably B-O O
reduces B-O O
the B-O O
size B-O O
of B-O O
this B-O O
signals B-O O
. B-O O

In B-O O
comparison B-O O
, B-O O
isolated B-O O
nuclei B-O O
of B-O O
human B-O B-cell_type
lymphocytes B-O I-cell_type
in B-O O
which B-O O
no B-O O
need B-O O
for B-O O
the B-O O
expression B-O O
of B-O O
this B-O O
gene B-O O
exists B-O O
, B-O O
show B-O O
barely B-O O
hybridization B-O O
signals B-O O
. B-O O

Correspondingly B-O O
, B-O O
RNase B-O B-protein
treatment B-O O
had B-O O
no B-O O
effect B-O O
on B-O O
hybridization B-O O
pattern B-O O
at B-O O
all B-O O
. B-O O

In B-O O
conclusion B-O O
an B-O O
increased B-O O
transcription B-O O
efficiency B-O O
of B-O O
a B-O O
cell B-O B-DNA
type B-O I-DNA
specific B-O I-DNA
gene B-O I-DNA
is B-O O
accompanied B-O O
by B-O O
a B-O O
higher B-O O
hybridization B-O O
accessibility B-O O
in B-O O
the B-O O
corresponding B-O O
cell B-O O
nuclei B-O O
. B-O O

Oncogenicity B-O O
of B-O O
human B-O B-cell_line
papillomavirus- B-O I-cell_line
or B-O I-cell_line
adenovirus- B-O I-cell_line
transformed B-O I-cell_line
cells B-O I-cell_line
correlates B-O O
with B-O O
resistance B-O O
to B-O O
lysis B-O O
by B-O O
natural B-O B-cell_type
killer B-O I-cell_type
cells B-O I-cell_type
. B-O O

The B-O O
reasons B-O O
for B-O O
the B-O O
dissimilar B-O O
oncogenicities B-O O
of B-O O
human B-O O
adenoviruses B-O O
and B-O O
human B-O O
papillomaviruses B-O O
( B-O O
HPV B-O O
) B-O O
in B-O O
humans B-O O
are B-O O
unknown B-O O
but B-O O
may B-O O
relate B-O O
to B-O O
differences B-O O
in B-O O
the B-O O
capacities B-O O
of B-O O
the B-O O
E1A B-O B-protein
and B-O O
E7 B-O B-protein
proteins B-O I-protein
to B-O O
target B-O B-cell_type
cells B-O I-cell_type
for B-O O
rejection B-O O
by B-O O
the B-O O
host B-O B-cell_type
natural B-O I-cell_type
killer B-O I-cell_type
( B-O I-cell_type
NK B-O I-cell_type
) B-O I-cell_type
cell B-O I-cell_type
response B-O O
. B-O O

As B-O O
one B-O O
test B-O O
of B-O O
this B-O O
hypothesis B-O O
, B-O O
we B-O O
compared B-O O
the B-O O
abilities B-O O
of B-O O
E1A B-O B-protein
- B-O O
and B-O O
E7 B-O B-protein
-expressing B-O O
human B-O O
fibroblastic B-O O
or B-O O
keratinocyte-derived B-O B-cell_line
human B-O I-cell_line
cells B-O I-cell_line
to B-O O
be B-O O
selectively B-O O
killed B-O O
by B-O O
either B-O O
unstimulated B-O O
or B-O O
interferon B-O B-cell_line
( B-O I-cell_line
IFN B-O I-cell_line
) B-O I-cell_line
-activated B-O I-cell_line
NK B-O I-cell_line
cells B-O I-cell_line
. B-O O

Cells B-O O
expressing B-O O
the B-O O
E1A B-O B-protein
oncoprotein B-O I-protein
were B-O O
selectively B-O O
killed B-O O
by B-O O
unstimulated B-O B-cell_type
NK B-O I-cell_type
cells B-O I-cell_type
, B-O O
while B-O O
the B-O O
same B-O O
parental B-O B-cell_type
cells B-O I-cell_type
but B-O O
expressing B-O O
the B-O O
HPV B-O O
type B-O O
16 B-O O
( B-O O
HPV-16 B-O B-protein
) B-O O
or B-O O
HPV-18 B-O O
E7 B-O B-protein
oncoprotein B-O I-protein
were B-O O
resistant B-O O
to B-O O
NK B-O O
cell B-O O
lysis B-O O
. B-O O

The B-O O
ability B-O O
of B-O O
IFN-activated B-O B-cell_line
NK B-O I-cell_line
cells B-O I-cell_line
to B-O O
selectively B-O O
kill B-O O
virally B-O B-cell_line
transformed B-O I-cell_line
cells B-O I-cell_line
depends B-O O
on B-O O
IFN B-O B-protein
's B-O O
ability B-O O
to B-O O
induce B-O O
resistance B-O O
to B-O O
NK B-O O
cell B-O O
lysis B-O O
in B-O O
normal B-O O
( B-O O
i.e. B-O O
, B-O O
non-viral B-O O
oncogene-expressing B-O O
) B-O O
but B-O O
not B-O O
virally B-O B-cell_line
transformed B-O I-cell_line
cells B-O I-cell_line
. B-O O

E1A B-O B-protein
blocked B-O O
IFN B-O B-protein
's B-O O
induction B-O O
of B-O O
cytolytic B-O O
resistance B-O O
, B-O O
resulting B-O O
in B-O O
the B-O O
selective B-O O
lysis B-O O
of B-O O
adenovirus-transformed B-O B-cell_line
cells B-O I-cell_line
by B-O O
IFN B-O B-cell_line
-activated B-O I-cell_line
NK B-O I-cell_line
cells B-O I-cell_line
. B-O O

The B-O O
extent B-O O
of B-O O
IFN B-O B-protein
-induced B-O O
NK B-O O
cell B-O O
killing B-O O
of B-O O
E1A B-O B-cell_line
-expressing B-O I-cell_line
cells B-O I-cell_line
was B-O O
proportional B-O O
to B-O O
the B-O O
level B-O O
of B-O O
E1A B-O B-protein
expression B-O O
and B-O O
correlated B-O O
with B-O O
the B-O O
ability B-O O
of B-O O
E1A B-O B-protein
to B-O O
block B-O O
IFN B-O B-protein
-stimulated B-O O
gene B-O O
expression B-O O
in B-O O
target B-O B-cell_type
cells B-O I-cell_type
. B-O O

In B-O O
contrast B-O O
, B-O O
E7 B-O B-protein
blocked B-O O
neither B-O O
IFN B-O B-protein
-stimulated B-O O
gene B-O O
expression B-O O
nor B-O O
IFN B-O B-protein
's B-O O
induction B-O O
of B-O O
cytolytic B-O O
resistance B-O O
, B-O O
thereby B-O O
precluding B-O O
the B-O O
selective B-O O
lysis B-O O
of B-O O
HPV B-O B-cell_line
-transformed B-O I-cell_line
cells B-O I-cell_line
by B-O O
IFN B-O B-cell_line
-activated B-O I-cell_line
NK B-O I-cell_line
cells B-O I-cell_line
. B-O O

In B-O O
conclusion B-O O
, B-O O
E1A B-O B-protein
expression B-O O
marks B-O O
cells B-O O
for B-O O
destruction B-O O
by B-O O
the B-O O
host B-O O
NK B-O O
cell B-O O
response B-O O
, B-O O
whereas B-O O
the B-O O
E7 B-O B-protein
oncoprotein B-O I-protein
lacks B-O O
this B-O O
activity B-O O
. B-O O

Regulation B-O O
of B-O O
IkB B-O B-protein
alpha B-O I-protein
phosphorylation B-O O
by B-O O
PKC- B-O B-protein
and B-O O
Ca B-O O
( B-O O
2+ B-O O
) B-O O
- B-O O
dependent B-O O
signal B-O O
transduction B-O O
pathways B-O O
. B-O O

The B-O O
Ca B-O B-protein
( B-O I-protein
2+ B-O I-protein
) B-O I-protein
-dependent B-O I-protein
phosphatase B-O I-protein
calcineurin B-O B-protein
, B-O O
a B-O O
target B-O O
of B-O O
FK506 B-O O
and B-O O
CsA B-O O
, B-O O
synergizes B-O O
with B-O O
PKC B-O B-protein
-induced B-O O
activation B-O O
of B-O O
nuclear B-O B-protein
factor B-O I-protein
( B-O I-protein
NF B-O I-protein
) B-O I-protein
-kappa B-O I-protein
B B-O I-protein
in B-O O
T B-O B-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
. B-O O

We B-O O
have B-O O
investigated B-O O
whether B-O O
this B-O O
synergy B-O O
is B-O O
present B-O O
in B-O O
other B-O O
cell B-O O
types B-O O
and B-O O
the B-O O
mechanism B-O O
( B-O O
s B-O O
) B-O O
by B-O O
which B-O O
these B-O O
two B-O O
pathways B-O O
lead B-O O
to B-O O
NF-kappa B-O B-protein
B B-O I-protein
activation B-O O
. B-O O

While B-O O
this B-O O
synergy B-O O
is B-O O
present B-O O
in B-O O
other B-O O
cell B-O O
types B-O O
, B-O O
in B-O O
the B-O O
monocytic B-O B-cell_line
cell B-O I-cell_line
line B-O I-cell_line
U937 B-O I-cell_line
calcineurin B-O B-protein
is B-O O
also B-O O
sufficient B-O O
to B-O O
activate B-O O
NF-kappa B-O B-protein
B B-O I-protein
. B-O O

Having B-O O
previously B-O O
shown B-O O
that B-O O
Ca B-O O
( B-O O
2+ B-O O
) B-O O
- B-O O
and B-O O
PKC- B-O B-protein
dependent B-O O
pathways B-O O
synergize B-O O
by B-O O
accelerating B-O O
the B-O O
degradation B-O O
of B-O O
IkB B-O B-protein
alpha B-O I-protein
, B-O O
we B-O O
focused B-O O
on B-O O
the B-O O
regulation B-O O
of B-O O
IkB B-O B-protein
alpha B-O I-protein
phosphorylation B-O O
. B-O O

While B-O O
PKC B-O B-protein
-dependent B-O O
pathways B-O O
sequentially B-O O
result B-O O
in B-O O
the B-O O
phosphorylation B-O O
and B-O O
in B-O O
an B-O O
incomplete B-O O
degradation B-O O
of B-O O
IkB B-O B-protein
alpha B-O I-protein
in B-O O
T B-O B-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
, B-O O
co-activation B-O O
of B-O O
Ca B-O O
( B-O O
2+ B-O O
) B-O O
-dependent B-O O
pathways B-O O
accelerates B-O O
the B-O O
rate B-O O
of B-O O
IkB B-O B-protein
alpha B-O I-protein
phosphorylation B-O O
and B-O O
results B-O O
in B-O O
its B-O O
complete B-O O
degradation B-O O
. B-O O

Activation B-O O
of B-O O
Ca B-O O
( B-O O
2+ B-O O
) B-O O
-dependent B-O O
pathways B-O O
alone B-O O
do B-O O
not B-O O
result B-O O
in B-O O
the B-O O
phosphorylation B-O O
and/or B-O O
degradation B-O O
of B-O O
IkB B-O B-protein
alpha B-O I-protein
in B-O O
Jurkat B-O B-cell_line
T B-O I-cell_line
or B-O O
in B-O O
U937 B-O B-cell_line
cells B-O I-cell_line
. B-O O

Treatment B-O O
of B-O O
T B-O B-cell_type
cells B-O I-cell_type
with B-O O
the B-O O
selective B-O O
PKC B-O B-protein
inhibitor B-O O
GF109203X B-O O
abrogates B-O O
the B-O O
PMA B-O O
-induced B-O O
IkB B-O B-protein
alpha B-O I-protein
phosphorylation B-O O
/degradation B-O O
irrespective B-O O
of B-O O
activation B-O O
of B-O O
Ca B-O O
( B-O O
2+ B-O O
) B-O O
-dependent B-O O
pathways B-O O
, B-O O
but B-O O
not B-O O
the B-O O
phosphorylation B-O O
and B-O O
degradation B-O O
of B-O O
IkB B-O B-protein
alpha B-O I-protein
induced B-O O
by B-O O
TNF-alpha B-O B-protein
, B-O O
a B-O O
PKC B-O B-protein
-independent B-O O
stimulus B-O O
. B-O O

Contrary B-O O
to B-O O
the B-O O
interaction B-O O
with B-O O
PKC B-O B-protein
, B-O O
Ca B-O O
( B-O O
2+ B-O O
) B-O O
-dependent B-O O
pathways B-O O
synergize B-O O
with B-O O
TNF-alpha B-O B-protein
not B-O O
at B-O O
the B-O O
level B-O O
of B-O O
IkB B-O B-protein
alpha B-O I-protein
phosphorylation B-O O
, B-O O
but B-O O
at B-O O
the B-O O
level B-O O
of B-O O
its B-O O
degradation B-O O
. B-O O

These B-O O
results B-O O
indicate B-O O
that B-O O
Ca B-O O
( B-O O
2+ B-O O
) B-O O
-dependent B-O O
pathways B-O O
, B-O O
including B-O O
the B-O O
phosphatase B-O B-protein
calcineurin B-O B-protein
, B-O O
participate B-O O
in B-O O
the B-O O
regulation B-O O
of B-O O
NF-kappa B-O B-protein
B B-O I-protein
in B-O O
a B-O O
cell B-O O
specific B-O O
fashion B-O O
and B-O O
synergize B-O O
with B-O O
PKC B-O B-protein
-dependent B-O O
and B-O O
-independent B-O O
pathways B-O O
at B-O O
the B-O O
level B-O O
of B-O O
IkB B-O B-protein
alpha B-O I-protein
phosphorylation B-O O
and B-O O
degradation B-O O
. B-O O

Vitamin B-O O
E B-O O
therapy B-O O
of B-O O
acute B-O O
CCl4 B-O O
-induced B-O O
hepatic B-O O
injury B-O O
in B-O O
mice B-O O
is B-O O
associated B-O O
with B-O O
inhibition B-O O
of B-O O
nuclear B-O B-protein
factor B-O I-protein
kappa B-O I-protein
B B-O I-protein
binding B-O O
. B-O O

Oxidative B-O O
stress B-O O
, B-O O
with B-O O
reactive B-O O
oxygen B-O O
intermediate B-O O
formation B-O O
, B-O O
may B-O O
represent B-O O
a B-O O
common B-O O
mechanism B-O O
by B-O O
which B-O O
liver B-O O
injury B-O O
is B-O O
induced B-O O
by B-O O
diverse B-O O
etiologies B-O O
. B-O O

Oxidative B-O O
stress B-O O
enhances B-O O
nuclear B-O B-protein
factor B-O I-protein
kappa B-O I-protein
B B-O I-protein
( B-O O
NF-kappa B-O B-protein
B B-O I-protein
) B-O O
activity B-O O
, B-O O
and B-O O
NF-kappa B-O B-protein
B B-O I-protein
activity B-O O
has B-O O
been B-O O
shown B-O O
to B-O O
enhance B-O O
the B-O O
expression B-O O
of B-O O
cytotoxic B-O B-protein
cytokines B-O I-protein
. B-O O

Acute B-O O
hepatic B-O O
injury B-O O
caused B-O O
by B-O O
reactive B-O O
oxygen B-O O
intermediate B-O O
production B-O O
was B-O O
induced B-O O
by B-O O
an B-O O
intraperitoneal B-O O
injection B-O O
of B-O O
CCl4 B-O B-protein
in B-O O
mice B-O O
. B-O O

This B-O O
injury B-O O
was B-O O
significantly B-O O
inhibited B-O O
by B-O O
intravenous B-O O
pretreatment B-O O
of B-O O
the B-O O
mice B-O O
with B-O O
a B-O O
water-soluble B-O O
emulsion B-O O
of B-O O
alpha-tocopherol B-O O
. B-O O

Alpha-tocopherol B-O O
treatment B-O O
of B-O O
the B-O O
mice B-O O
given B-O O
the B-O O
CCl4 B-O O
also B-O O
reduced B-O O
the B-O O
NF-kappa B-O B-protein
B B-O I-protein
binding B-O O
to B-O O
levels B-O O
approaching B-O O
those B-O O
found B-O O
in B-O O
normal B-O O
mice B-O O
. B-O O

In B-O O
vitro B-O O
treatment B-O O
of B-O O
a B-O O
monocyte/macrophage B-O B-cell_line
cell B-O I-cell_line
line B-O I-cell_line
with B-O O
CCl4 B-O O
led B-O O
to B-O O
enhanced B-O O
NF-kappa B-O B-protein
B B-O I-protein
binding B-O O
and B-O O
an B-O O
increase B-O O
in B-O O
tumor B-O B-protein
necrosis B-O I-protein
factor-alpha B-O I-protein
( B-O O
TNF-alpha B-O B-protein
) B-O O
messenger B-O O
RNA B-O O
levels B-O O
. B-O O

Liver B-O O
specimens B-O O
taken B-O O
from B-O O
patients B-O O
with B-O O
acute B-O O
fulminant B-O O
hepatitis B-O O
had B-O O
markedly B-O O
increased B-O O
NF-kappa B-O B-protein
B B-O I-protein
binding B-O O
activity B-O O
in B-O O
comparison B-O O
with B-O O
the B-O O
binding B-O O
of B-O O
normal B-O O
livers B-O O
. B-O O

These B-O O
data B-O O
demonstrate B-O O
that B-O O
abolishing B-O O
acute B-O O
hepatic B-O O
injury B-O O
with B-O O
alpha-tocopherol B-O O
, B-O O
a B-O O
free B-O O
radical B-O O
scavenger B-O O
, B-O O
also B-O O
eliminated B-O O
increased B-O O
NF-kappa B-O B-protein
B B-O I-protein
binding B-O O
. B-O O

It B-O O
is B-O O
tempting B-O O
to B-O O
speculate B-O O
that B-O O
enhanced B-O O
NF-kappa B-O B-protein
B B-O I-protein
expression B-O O
caused B-O O
by B-O O
free B-O O
radical B-O O
production/oxidative B-O O
stress B-O O
may B-O O
modulate B-O O
liver B-O O
injury B-O O
, B-O O
perhaps B-O O
through B-O O
an B-O O
effect B-O O
on B-O O
cytotoxic B-O B-protein
cytokine B-O I-protein
synthesis B-O O
. B-O O

Immunosuppression B-O O
by B-O O
glucocorticoids B-O O
: B-O O
inhibition B-O O
of B-O O
NF-kappa B-O B-protein
B B-O I-protein
activity B-O O
through B-O O
induction B-O O
of B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
synthesis B-O O
[ B-O O
see B-O O
comments B-O O
] B-O O

Glucocorticoids B-O O
are B-O O
among B-O O
the B-O O
most B-O O
potent B-O O
anti-inflammatory B-O O
and B-O O
immunosuppressive B-O O
agents B-O O
. B-O O

They B-O O
inhibit B-O O
synthesis B-O O
of B-O O
almost B-O O
all B-O O
known B-O O
cytokines B-O B-protein
and B-O O
of B-O O
several B-O O
cell B-O B-protein
surface B-O I-protein
molecules B-O I-protein
required B-O O
for B-O O
immune B-O O
function B-O O
, B-O O
but B-O O
the B-O O
mechanism B-O O
underlying B-O O
this B-O O
activity B-O O
has B-O O
been B-O O
unclear B-O O
. B-O O
Here B-O O
it B-O O
is B-O O
shown B-O O
that B-O O
glucocorticoids B-O O
are B-O O
potent B-O O
inhibitors B-O O
of B-O O
nuclear B-O B-protein
factor B-O I-protein
kappa B-O I-protein
B B-O I-protein
( B-O O
NF-kappa B-O B-protein
B B-O I-protein
) B-O O
activation B-O O
in B-O O
mice B-O O
and B-O O
cultured B-O B-cell_line
cells B-O I-cell_line
. B-O O

This B-O O
inhibition B-O O
is B-O O
mediated B-O O
by B-O O
induction B-O O
of B-O O
the B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
alpha B-O I-protein
inhibitory B-O I-protein
protein B-O I-protein
, B-O O
which B-O O
traps B-O O
activated B-O O
NF-kappa B-O B-protein
B B-O I-protein
in B-O O
inactive B-O B-protein
cytoplasmic B-O I-protein
complexes B-O I-protein
. B-O O

Because B-O O
NF-kappa B-O B-protein
B B-O I-protein
activates B-O O
many B-O O
immunoregulatory B-O B-DNA
genes B-O I-DNA
in B-O O
response B-O O
to B-O O
pro-inflammatory B-O O
stimuli B-O O
, B-O O
the B-O O
inhibition B-O O
of B-O O
its B-O O
activity B-O O
can B-O O
be B-O O
a B-O O
major B-O O
component B-O O
of B-O O
the B-O O
anti-inflammatory B-O O
activity B-O O
of B-O O
glucocorticoids B-O O
. B-O O

Transcriptional B-O O
repression B-O O
of B-O O
the B-O O
interleukin-2 B-O B-DNA
gene B-O I-DNA
by B-O O
vitamin B-O O
D3 B-O O
: B-O O
direct B-O O
inhibition B-O O
of B-O O
NFATp B-O B-protein
/AP-1 B-O B-protein
complex B-O I-protein
formation B-O O
by B-O O
a B-O O
nuclear B-O B-protein
hormone B-O I-protein
receptor B-O I-protein
. B-O O

T- B-O B-cell_type
lymphocyte B-O I-cell_type
proliferation B-O O
is B-O O
suppressed B-O O
by B-O O
1 B-O O
, B-O O
25-dihydroxyvitamin B-O O
D3 B-O O
[ B-O O
1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
] B-O O
, B-O O
the B-O O
active B-O O
metabolite B-O O
of B-O O
vitamin B-O O
D3 B-O O
, B-O O
and B-O O
is B-O O
associated B-O O
with B-O O
a B-O O
decrease B-O O
in B-O O
interleukin B-O B-protein
2 B-O I-protein
( B-O O
IL-2 B-O B-protein
) B-O O
, B-O O
gamma B-O B-protein
interferon B-O I-protein
, B-O O
and B-O O
granulocyte-macrophage B-O O
colony-stimulating B-O O
factor B-O O
mRNA B-O O
levels B-O O
. B-O O

We B-O O
report B-O O
here B-O O
that B-O O
1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
-mediated B-O O
repression B-O O
in B-O O
Jurkat B-O B-cell_line
cells B-O I-cell_line
is B-O O
cycloheximide B-O O
resistant B-O O
, B-O O
suggesting B-O O
that B-O O
it B-O O
is B-O O
a B-O O
direct B-O O
transcriptional B-O O
repressive B-O O
effect B-O O
on B-O O
IL-2 B-O B-protein
expression B-O O
by B-O O
the B-O O
vitamin B-O B-protein
D3 B-O I-protein
receptor B-O I-protein
( B-O O
VDR B-O B-protein
) B-O O
. B-O O

We B-O O
therefore B-O O
examined B-O O
vitamin B-O O
D3 B-O O
-mediated B-O O
repression B-O O
of B-O O
activated B-O O
IL-2 B-O B-protein
expression B-O O
by B-O O
cotransfecting B-O O
Jurkat B-O B-cell_line
cells B-O I-cell_line
with B-O O
IL-2 B-O B-DNA
promoter B-O I-DNA
/reporter B-O I-DNA
constructs B-O I-DNA
and B-O O
a B-O O
VDR B-O B-DNA
overexpression B-O I-DNA
vector B-O I-DNA
and B-O O
by B-O O
DNA B-O O
binding B-O O
. B-O O

We B-O O
delineated B-O O
an B-O O
element B-O O
conferring B-O O
both B-O O
DNA B-O O
binding B-O O
by B-O O
the B-O O
receptor B-O O
in B-O O
vitro B-O O
and B-O O
1 B-O O
, B-O O
25 B-O O
( B-O O
OH B-O O
) B-O O
2D3 B-O O
-mediated B-O O
repression B-O O
in B-O O
vivo B-O O
to B-O O
a B-O O
short B-O O
40-bp B-O B-DNA
region B-O I-DNA
encompassing B-O O
an B-O O
important B-O O
positive B-O B-DNA
regulatory B-O I-DNA
element B-O I-DNA
, B-O O
NF-AT-1 B-O B-protein
, B-O O
which B-O O
is B-O O
bound B-O O
by B-O O
a B-O O
T-cell-specific B-O B-protein
transcription B-O I-protein
factor B-O I-protein
, B-O O
NFATp B-O B-protein
, B-O O
as B-O O
well B-O O
as B-O O
by B-O O
AP-1 B-O B-protein
. B-O O

VDR B-O B-protein
DNA-binding B-O I-protein
mutants B-O I-protein
were B-O O
unable B-O O
to B-O O
either B-O O
bind B-O O
to B-O O
this B-O O
element B-O O
in B-O O
vitro B-O O
or B-O O
repress B-O O
in B-O O
vivo B-O O
; B-O O
the B-O O
VDR B-O B-protein
DNA-binding B-O I-protein
domain B-O I-protein
alone B-O O
, B-O O
however B-O O
, B-O O
bound B-O O
the B-O O
element B-O O
but B-O O
also B-O O
could B-O O
not B-O O
repress B-O O
IL-2 B-O B-protein
expression B-O O
. B-O O

These B-O O
results B-O O
indicate B-O O
that B-O O
DNA B-O O
binding B-O O
by B-O O
VDR B-O B-protein
is B-O O
necessary B-O O
but B-O O
not B-O O
sufficient B-O O
to B-O O
mediate B-O O
IL-2 B-O B-protein
repression B-O O
. B-O O

By B-O O
combining B-O O
partially B-O B-protein
purified B-O I-protein
proteins B-O I-protein
in B-O O
vitro B-O O
, B-O O
we B-O O
observed B-O O
the B-O O
loss B-O O
of B-O O
the B-O O
bound B-O O
NFATp B-O B-protein
/AP-1-DNA B-O I-protein
complex B-O I-protein
upon B-O O
inclusion B-O O
of B-O O
VDR B-O B-protein
or B-O O
VDR B-O B-protein
-retinoid B-O I-protein
X B-O I-protein
receptor B-O I-protein
. B-O O

Order B-O O
of B-O O
addition B-O O
and B-O O
off-rate B-O O
experiments B-O O
indicate B-O O
that B-O O
the B-O O
VDR B-O B-protein
-retinoid B-O I-protein
X B-O I-protein
receptor B-O I-protein
heterodimer B-O I-protein
blocks B-O O
NFATp B-O B-protein
/ B-O O
AP-1 B-O B-protein
complex B-O I-protein
formation B-O O
and B-O O
then B-O O
stably B-O O
associates B-O O
with B-O O
the B-O O
NF-AT-1 B-O B-DNA
element B-O I-DNA
. B-O O

This B-O O
direct B-O O
inhibition B-O O
by B-O O
a B-O O
nuclear B-O B-protein
hormone B-O I-protein
receptor B-O I-protein
of B-O O
transcriptional B-O B-protein
activators B-O I-protein
of B-O O
the B-O O
IL-2 B-O B-DNA
gene B-O I-DNA
may B-O O
provide B-O O
a B-O O
mechanistic B-O O
explanation B-O O
of B-O O
how B-O O
vitamin B-O O
derivatives B-O O
can B-O O
act B-O O
as B-O O
potent B-O O
immunosuppressive B-O O
agents B-O O
. B-O O

Tissue-specific B-O O
regulation B-O O
of B-O O
the B-O O
rabbit B-O B-DNA
15-lipoxygenase B-O I-DNA
gene B-O I-DNA
in B-O O
erythroid B-O B-cell_type
cells B-O I-cell_type
by B-O O
a B-O O
transcriptional B-O B-DNA
silencer B-O I-DNA
. B-O O

The B-O O
15-lipoxygenase B-O B-DNA
( B-O I-DNA
lox B-O I-DNA
) B-O I-DNA
gene B-O I-DNA
is B-O O
expressed B-O O
in B-O O
a B-O O
tissue-specific B-O O
manner B-O O
, B-O O
predominantly B-O O
in B-O O
erythroid B-O B-cell_type
cells B-O I-cell_type
but B-O O
also B-O O
in B-O O
airway B-O B-cell_type
epithelial B-O I-cell_type
cells B-O I-cell_type
and B-O O
eosinophils B-O B-cell_type
. B-O O

We B-O O
demonstrate B-O O
in B-O O
this B-O O
report B-O O
that B-O O
the B-O O
5 B-O B-DNA
' B-O I-DNA
flanking B-O I-DNA
DNA B-O I-DNA
of B-O O
the B-O O
15-lox B-O B-DNA
gene B-O I-DNA
contains B-O O
sequences B-O O
which B-O O
down-regulate B-O O
its B-O O
activity B-O O
in B-O O
a B-O O
variety B-O O
of B-O O
non-erythroid B-O B-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
but B-O O
not B-O O
in B-O O
two B-O O
erythroid B-O B-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
. B-O O

The B-O O
element B-O O
has B-O O
characteristics B-O O
of B-O O
a B-O O
transcriptional B-O B-DNA
' B-O I-DNA
silencer B-O I-DNA
' B-O I-DNA
since B-O O
it B-O O
functions B-O O
in B-O O
both B-O O
orientations B-O O
. B-O O

The B-O O
main B-O O
activity B-O O
of B-O O
the B-O O
silencer B-O B-DNA
has B-O O
been B-O O
mapped B-O O
to B-O O
the B-O O
first B-O O
900 B-O O
bp B-O O
of B-O O
5 B-O B-DNA
' B-O I-DNA
flanking B-O I-DNA
DNA B-O I-DNA
, B-O O
which B-O O
contains B-O O
nine B-O O
binding B-O O
sites B-O O
for B-O O
a B-O O
nuclear B-O B-protein
factor B-O I-protein
present B-O O
in B-O O
non- B-O O
erythroid B-O B-cell_type
cells B-O I-cell_type
but B-O O
not B-O O
in B-O O
erythroid B-O B-cell_type
cells B-O I-cell_type
. B-O O

These B-O O
binding B-O B-DNA
sites B-O I-DNA
have B-O O
similar B-O O
sequences B-O O
and B-O O
multiple B-O O
copies B-O O
of B-O O
the B-O O
binding B-O B-DNA
sites B-O I-DNA
confer B-O O
tissue-specific B-O O
down-regulation B-O O
when B-O O
attached B-O O
to B-O O
a B-O O
minimal B-O B-DNA
lox B-O I-DNA
promoter B-O I-DNA
fragment B-O I-DNA
. B-O O

The B-O O
5 B-O B-DNA
' B-O I-DNA
flanking B-O I-DNA
DNA B-O I-DNA
also B-O O
contains B-O O
a B-O O
cluster B-O O
of B-O O
three B-O O
binding B-O B-DNA
sites B-O I-DNA
for B-O O
the B-O O
GATA B-O B-protein
family B-O I-protein
of B-O O
transcription B-O B-protein
factors B-O I-protein
. B-O O

Phosphorylation B-O O
of B-O O
the B-O O
transcription B-O B-protein
factor B-O I-protein
NFATp B-O B-protein
inhibits B-O O
its B-O O
DNA B-O O
binding B-O O
activity B-O O
in B-O O
cyclosporin B-O B-cell_line
A-treated B-O I-cell_line
human B-O I-cell_line
B B-O I-cell_line
and B-O O
T B-O B-cell_type
cells B-O I-cell_type
. B-O O

Cyclosporin B-O O
A B-O O
( B-O O
CsA B-O O
) B-O O
exerts B-O O
its B-O O
immunosuppressive B-O O
effect B-O O
by B-O O
inhibiting B-O O
the B-O O
activity B-O O
of B-O O
nuclear B-O B-protein
factor B-O I-protein
of B-O I-protein
activated B-O I-protein
T B-O I-protein
cells B-O I-protein
( B-O O
NFAT B-O B-protein
) B-O O
, B-O O
thus B-O O
preventing B-O O
transcriptional B-O O
induction B-O O
of B-O O
several B-O O
cytokine B-O B-DNA
genes B-O I-DNA
. B-O O

This B-O O
effect B-O O
is B-O O
thought B-O O
to B-O O
be B-O O
largely B-O O
mediated B-O O
through B-O O
inactivation B-O O
of B-O O
the B-O O
phosphatase B-O B-protein
calcineurin B-O B-protein
, B-O O
which B-O O
in B-O O
turn B-O O
inhibits B-O O
translocation B-O O
of B-O O
an B-O O
NFAT B-O B-protein
component B-O O
to B-O O
the B-O O
nucleus B-O O
. B-O O

Here B-O O
we B-O O
report B-O O
that B-O O
CsA B-O O
treatment B-O O
of B-O O
Raji B-O B-protein
B B-O I-protein
and B-O O
Jurkat B-O B-cell_line
T B-O I-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
yields B-O O
a B-O O
phosphorylated B-O O
form B-O O
of B-O O
NFATp B-O B-protein
that B-O O
is B-O O
inhibited B-O O
in B-O O
DNA-binding B-O O
and B-O O
in B-O O
its B-O O
ability B-O O
to B-O O
form B-O O
an B-O O
NFAT B-O B-protein
complex B-O I-protein
with B-O O
Fos B-O B-protein
and B-O O
Jun B-O B-protein
. B-O O

Immunoblot B-O O
analyses B-O O
and B-O O
metabolic B-O O
labeling B-O O
with B-O O
[ B-O O
32P B-O O
] B-O O
orthophosphate B-O O
show B-O O
that B-O O
CsA B-O O
alters B-O O
NFATp B-O B-protein
migration B-O O
on B-O O
SDS-polyacrylamide B-O O
gel B-O O
electrophoresis B-O O
by B-O O
increasing B-O O
its B-O O
phosphorylation B-O O
level B-O O
without B-O O
affecting B-O O
subcellular B-O O
distribution B-O O
. B-O O

Dephosphorylation B-O O
by B-O O
in B-O O
vitro B-O O
treatment B-O O
with B-O O
calcineurin B-O B-protein
or B-O O
alkaline B-O B-protein
phosphatase B-O I-protein
restores B-O O
NFATp B-O B-protein
DNA B-O O
binding B-O O
activity B-O O
and B-O O
its B-O O
ability B-O O
to B-O O
reconstitute B-O O
an B-O O
NFAT B-O B-protein
complex B-O I-protein
with B-O O
Fos B-O B-protein
and B-O O
Jun B-O B-protein
proteins B-O I-protein
. B-O O

These B-O O
data B-O O
point B-O O
to B-O O
a B-O O
new B-O O
mechanism B-O O
for B-O O
CsA B-O O
-sensitive B-O O
regulation B-O O
of B-O O
NFATp B-O B-protein
in B-O O
which B-O O
dephosphorylation B-O O
is B-O O
critical B-O O
for B-O O
DNA B-O O
binding B-O O
. B-O O

Transcription B-O B-protein
factors B-O I-protein
as B-O O
targets B-O O
for B-O O
oxidative B-O O
signalling B-O O
during B-O O
lymphocyte B-O O
activation B-O O
. B-O O

We B-O O
previously B-O O
have B-O O
demonstrated B-O O
a B-O O
requirement B-O O
for B-O O
oxidative B-O O
events B-O O
during B-O O
cell B-O O
cycle B-O O
entry B-O O
in B-O O
T B-O B-cell_type
lymphocytes B-O I-cell_type
and B-O O
have B-O O
hypothesised B-O O
that B-O O
reactive B-O O
oxygen B-O O
species B-O O
may B-O O
act B-O O
as B-O O
intracellular B-O O
signalling B-O O
agents B-O O
during B-O O
lymphocyte B-O O
activation B-O O
. B-O O

In B-O O
the B-O O
current B-O O
study B-O O
, B-O O
cysteamine B-O O
, B-O O
an B-O O
aminothiol B-O O
compound B-O O
with B-O O
antioxidant B-O O
activity B-O O
, B-O O
has B-O O
been B-O O
used B-O O
to B-O O
further B-O O
investigate B-O O
the B-O O
role B-O O
of B-O O
oxidative B-O O
signalling B-O O
during B-O O
lymphocyte B-O O
activation B-O O
. B-O O

Treatment B-O O
of B-O O
normal B-O B-cell_type
human B-O I-cell_type
peripheral B-O I-cell_type
blood B-O I-cell_type
lymphocytes B-O I-cell_type
with B-O O
cysteamine B-O O
in B-O O
vitro B-O O
was B-O O
found B-O O
to B-O O
inhibit B-O O
proliferation B-O O
in B-O O
a B-O O
dose-dependent B-O O
manner B-O O
, B-O O
with B-O O
essentially B-O O
complete B-O O
inhibition B-O O
occurring B-O O
at B-O O
a B-O O
dose B-O O
of B-O O
400 B-O O
microM B-O O
. B-O O

This B-O O
inhibitory B-O O
effect B-O O
was B-O O
limited B-O O
to B-O O
the B-O O
first B-O O
2 B-O O
h B-O O
after B-O O
mitogenic B-O O
activation B-O O
, B-O O
localizing B-O O
the B-O O
time-frame B-O O
of B-O O
action B-O O
of B-O O
cysteamine B-O O
to B-O O
within B-O O
the B-O O
commitment B-O O
period B-O O
. B-O O

It B-O O
therefore B-O O
was B-O O
of B-O O
interest B-O O
to B-O O
establish B-O O
which B-O O
, B-O O
if B-O O
any B-O O
, B-O O
commitment B-O O
events B-O O
were B-O O
affected B-O O
by B-O O
oxidative B-O O
signalling B-O O
during B-O O
cell B-O O
cycle B-O O
entry B-O O
. B-O O

Taking B-O O
the B-O O
IL-2 B-O B-DNA
gene B-O I-DNA
as B-O O
a B-O O
candidate B-O O
, B-O O
we B-O O
examined B-O O
the B-O O
effect B-O O
of B-O O
cysteamine B-O O
treatment B-O O
on B-O O
early B-O B-DNA
gene B-O I-DNA
expression B-O O
during B-O O
lymphocyte B-O O
activation B-O O
, B-O O
and B-O O
on B-O O
the B-O O
activity B-O O
of B-O O
transcription B-O B-protein
factors B-O I-protein
AP-1 B-O B-protein
, B-O O
NF-kappa B-O B-protein
B B-O I-protein
, B-O O
NF-AT B-O B-protein
and B-O O
Oct1 B-O B-protein
, B-O O
whose B-O O
functions B-O O
are B-O O
required B-O O
for B-O O
expression B-O O
of B-O O
the B-O O
IL-2 B-O B-RNA
mRNA B-O I-RNA
. B-O O

Cysteamine B-O O
treatment B-O O
inhibited B-O O
both B-O O
expression B-O O
of B-O O
the B-O O
IL-2 B-O B-RNA
mRNA B-O I-RNA
and B-O O
secretion B-O O
of B-O O
IL-2 B-O B-protein
into B-O O
the B-O O
culture B-O O
medium B-O O
. B-O O

The B-O O
inhibitory B-O O
effect B-O O
of B-O O
cysteamine B-O O
may B-O O
be B-O O
mediated B-O O
at B-O O
least B-O O
in B-O O
part B-O O
by B-O O
an B-O O
effect B-O O
on B-O O
transcription B-O B-protein
factor B-O I-protein
function B-O O
, B-O O
as B-O O
the B-O O
DNA B-O O
binding B-O O
activities B-O O
of B-O O
AP-1 B-O B-protein
and B-O O
NF-kappa B-O B-protein
B B-O I-protein
extracted B-O O
from B-O O
mitogen-stimulated B-O B-cell_type
cells B-O I-cell_type
were B-O O
significantly B-O O
inhibited B-O O
by B-O O
cysteamine B-O O
treatment B-O O
. B-O O

Interestingly B-O O
, B-O O
Oct1 B-O B-protein
and B-O O
NF-AT B-O B-protein
DNA B-O O
binding B-O O
activity B-O O
were B-O O
not B-O O
affected B-O O
by B-O O
cysteamine B-O O
treatment B-O O
, B-O O
suggesting B-O O
that B-O O
oxidative B-O O
signalling B-O O
processes B-O O
operate B-O O
in B-O O
a B-O O
selective B-O O
manner B-O O
. B-O O

The B-O O
identification B-O O
of B-O O
regulatory B-O B-protein
proteins B-O I-protein
, B-O O
such B-O O
as B-O O
transcription B-O B-protein
factors B-O I-protein
, B-O O
as B-O O
molecular B-O O
targets B-O O
for B-O O
oxidative B-O O
signalling B-O O
provides B-O O
further B-O O
evidence B-O O
to B-O O
implicate B-O O
oxidative B-O O
signalling B-O O
as B-O O
being B-O O
intimately B-O O
involved B-O O
in B-O O
the B-O O
G0 B-O O
to B-O O
G1 B-O O
phase B-O O
transition B-O O
in B-O O
T B-O B-cell_type
lymphocytes B-O I-cell_type
. B-O O

Sex B-O B-protein
and B-O O
age B-O O
distribution B-O O
of B-O O
1 B-O B-protein
, B-O I-protein
25 B-O I-protein
( B-O I-protein
OH B-O I-protein
) B-O I-protein
2D3 B-O I-protein
receptors B-O I-protein
in B-O O
peripheral B-O B-cell_type
blood B-O I-cell_type
mononuclear B-O I-cell_type
cells B-O I-cell_type
from B-O O
normal B-O O
human B-O O
subjects B-O O
. B-O O

Specific B-O O
receptors B-O O
for B-O O
1 B-O O
, B-O O
25 B-O O
Dihydroxyvitamin B-O O
D3 B-O O
have B-O O
been B-O O
described B-O O
in B-O O
human B-O B-cell_type
peripheral B-O I-cell_type
blood B-O I-cell_type
mononuclear B-O I-cell_type
cells B-O I-cell_type
( B-O O
PBMC B-O B-cell_type
) B-O O
. B-O O

We B-O O
have B-O O
tried B-O O
to B-O O
find B-O O
out B-O O
whether B-O O
these B-O O
receptors B-O O
could B-O O
show B-O O
any B-O O
difference B-O O
in B-O O
sex B-O O
or B-O O
age B-O O
distribution B-O O
. B-O O

Twenty B-O O
two B-O O
healthy B-O O
men B-O O
aged B-O O
21-66 B-O O
yr B-O O
( B-O O
mean B-O O
+/- B-O O
SD B-O O
41.0 B-O O
+/- B-O O
13.6 B-O O
) B-O O
and B-O O
nineteen B-O O
healthy B-O O
women B-O O
aged B-O O
22-60 B-O O
yr B-O O
( B-O O
38.9 B-O O
+/- B-O O
13.9 B-O O
) B-O O
have B-O O
been B-O O
studied B-O O
. B-O O

The B-O O
mean B-O O
dissociation B-O O
constant B-O O
( B-O O
Kd B-O O
) B-O O
was B-O O
similar B-O O
in B-O O
both B-O O
sexes B-O O
( B-O O
1.35 B-O O
+/- B-O O
0.70 B-O O
x B-O O
10 B-O O
( B-O O
-10 B-O O
) B-O O
M B-O O
in B-O O
males B-O O
, B-O O
1.13 B-O O
+/- B-O O
0.66 B-O O
x B-O O
10 B-O O
( B-O O
-10 B-O O
) B-O O
M B-O O
in B-O O
females B-O O
) B-O O
, B-O O
but B-O O
the B-O O
concentration B-O O
of B-O O
binding B-O O
sites B-O O
( B-O O
Nmax B-O O
) B-O O
was B-O O
significantly B-O O
lower B-O O
in B-O O
females B-O O
( B-O O
2.32 B-O O
+/- B-O O
0.92 B-O O
fmol/10 B-O O
( B-O O
7 B-O O
) B-O O
PBMC B-O B-cell_type
vs B-O O
4.43 B-O O
+/- B-O O
1.38 B-O O
fmol/10 B-O O
( B-O O
7 B-O O
) B-O O
PBMC B-O B-cell_type
in B-O O
males B-O O
; B-O O
p B-O O
= B-O O
0.0001 B-O O
) B-O O
. B-O O

Neither B-O O
Kd B-O O
nor B-O O
Nmax B-O O
were B-O O
significantly B-O O
correlated B-O O
with B-O O
age B-O O
. B-O O

No B-O O
difference B-O O
was B-O O
found B-O O
between B-O O
pre B-O B-DNA
and B-O O
post B-O O
menopausal B-O O
women B-O O
. B-O O

Further B-O O
studies B-O O
are B-O O
needed B-O O
to B-O O
elucidate B-O O
if B-O O
this B-O O
sex B-O O
difference B-O O
in B-O O
PBMC B-O B-protein
receptors B-O I-protein
for B-O O
1.25 B-O O
Dihydroxyvitamin B-O O
D3 B-O O
is B-O O
of B-O O
any B-O O
pathophysiological B-O O
relevance B-O O
. B-O O

Expression B-O O
of B-O O
Id2 B-O B-protein
and B-O O
Id3 B-O B-RNA
mRNA B-O I-RNA
in B-O O
human B-O B-cell_type
lymphocytes B-O I-cell_type
. B-O O

Helix-loop-helix B-O B-protein
( B-O I-protein
HLH B-O I-protein
) B-O I-protein
transcription B-O I-protein
factors B-O I-protein
are B-O O
involved B-O O
in B-O O
cellular B-O O
growth B-O O
and B-O O
differentiation B-O O
. B-O O

The B-O O
Id B-O O
( B-O O
inhibitor B-O O
of B-O O
DNA B-O O
binding B-O O
and B-O O
differentiation B-O O
) B-O O
HLH B-O O
proteins B-O O
, B-O O
in B-O O
a B-O O
dominantly B-O O
negative B-O O
fashion B-O O
, B-O O
regulate B-O O
transcriptional B-O O
activities B-O O
of B-O O
basic B-O B-protein
HLH B-O I-protein
proteins B-O I-protein
. B-O O

We B-O O
examined B-O O
by B-O O
northern B-O O
hybridization B-O O
the B-O O
expression B-O O
of B-O O
Id2 B-O B-protein
and B-O O
Id3 B-O B-RNA
mRNA B-O I-RNA
in B-O O
human B-O B-cell_line
leukemia/lymphoma B-O I-cell_line
lines B-O I-cell_line
and B-O O
patient B-O O
samples B-O O
, B-O O
as B-O O
well B-O O
as B-O O
resting B-O O
and B-O O
activated B-O B-cell_type
normal B-O I-cell_type
human B-O I-cell_type
lymphocytes B-O I-cell_type
from B-O O
peripheral B-O O
blood B-O O
( B-O O
PBL B-O B-cell_type
) B-O O
. B-O O

The B-O O
Id2 B-O B-RNA
mRNA B-O I-RNA
was B-O O
abundantly B-O O
expressed B-O O
in B-O O
5/12 B-O B-cell_line
T-cell B-O I-cell_line
and B-O O
3/4 B-O B-cell_line
B-cell B-O I-cell_line
lines B-O I-cell_line
, B-O O
and B-O O
Id3 B-O B-RNA
mRNA B-O I-RNA
was B-O O
detected B-O O
in B-O O
4/12 B-O B-cell_line
T-cell B-O I-cell_line
and B-O O
3/4 B-O B-cell_line
B-cell B-O I-cell_line
lines B-O I-cell_line
. B-O O

Interestingly B-O O
, B-O O
Id2 B-O B-protein
, B-O O
but B-O O
not B-O O
Id3 B-O B-protein
, B-O O
mRNA B-O B-RNA
was B-O O
strongly B-O O
expressed B-O O
in B-O O
4/5 B-O B-cell_line
T-cell B-O I-cell_line
lines B-O I-cell_line
infected B-O O
with B-O O
human B-O O
T-cell B-O O
leukemia B-O O
virus B-O O
type B-O O
I B-O O
( B-O O
HTLV-I B-O O
) B-O O
( B-O O
ATL-1k B-O B-cell_line
, B-O O
MT-2 B-O B-cell_line
, B-O O
S-LB1 B-O B-cell_line
) B-O O
and B-O O
type B-O O
II B-O O
( B-O O
Mo B-O B-cell_line
) B-O O
. B-O O

Another B-O O
unexpected B-O O
finding B-O O
was B-O O
that B-O O
T-cell B-O O
leukemias B-O O
and B-O O
T-cell B-O B-cell_line
lines B-O I-cell_line
often B-O O
expressed B-O O
either B-O O
Id2 B-O B-protein
or B-O O
Id3 B-O B-RNA
mRNA B-O I-RNA
. B-O O

In B-O O
addition B-O O
, B-O O
resting B-O B-cell_type
PBL B-O I-cell_type
constitutively B-O O
expressed B-O O
prominent B-O O
levels B-O O
of B-O O
Id2 B-O B-RNA
mRNA B-O I-RNA
, B-O O
but B-O O
not B-O O
Id3 B-O B-RNA
mRNA B-O I-RNA
. B-O O

Upon B-O O
PHA B-O B-protein
-stimulation B-O O
, B-O O
Id2 B-O B-protein
expression B-O O
decreased B-O O
and B-O O
Id3 B-O B-protein
levels B-O O
increased B-O O
with B-O O
biphasic B-O O
kinetics B-O O
. B-O O

Taken B-O O
together B-O O
, B-O O
our B-O O
studies B-O O
revealed B-O O
three B-O O
unexpected B-O O
findings B-O O
which B-O O
require B-O O
further B-O O
analysis B-O O
: B-O O
( B-O O
1 B-O O
) B-O O
expression B-O O
of B-O O
Id2 B-O B-RNA
mRNA B-O I-RNA
is B-O O
often B-O O
associated B-O O
with B-O O
lymphocytic B-O O
transformation B-O O
by B-O O
HTLV-I B-O O
or B-O O
-II B-O O
; B-O O
( B-O O
2 B-O O
) B-O O
T-cells B-O O
usually B-O O
express B-O O
either B-O O
Id2 B-O B-protein
or B-O O
Id3 B-O B-RNA
mRNA B-O I-RNA
, B-O O
but B-O O
B-cells B-O B-cell_type
often B-O O
express B-O O
both B-O O
simultaneously B-O O
; B-O O
( B-O O
3 B-O O
) B-O O
non-dividing B-O O
, B-O O
normal B-O O
PBL B-O B-cell_type
express B-O O
high B-O O
levels B-O O
of B-O O
Id2 B-O B-protein
and B-O O
no B-O O
Id3 B-O B-RNA
mRNA B-O I-RNA
; B-O O
and B-O O
with B-O O
the B-O O
onset B-O O
of B-O O
cellular B-O O
proliferation B-O O
, B-O O
levels B-O O
of B-O O
Id2 B-O B-RNA
mRNA B-O I-RNA
decrease B-O O
while B-O O
levels B-O O
of B-O O
Id3 B-O B-RNA
mRNA B-O I-RNA
increase B-O O
, B-O O
suggesting B-O O
that B-O O
regulation B-O O
of B-O O
expression B-O O
of B-O O
these B-O O
closely B-O O
related B-O O
genes B-O O
is B-O O
disparate B-O O
. B-O O

Salicylates B-O O
inhibit B-O O
lipopolysaccharide B-O O
-induced B-O O
transcriptional B-O O
activation B-O O
of B-O O
the B-O O
tissue B-O B-DNA
factor B-O I-DNA
gene B-O I-DNA
in B-O O
human B-O B-cell_type
monocytic B-O I-cell_type
cells B-O I-cell_type
. B-O O

Binding B-O O
of B-O O
plasma B-O B-protein
Factor B-O I-protein
VII/VIIa B-O I-protein
to B-O O
the B-O O
tissue B-O B-protein
factor B-O I-protein
( B-O I-protein
TF B-O I-protein
) B-O I-protein
receptor B-O I-protein
initiates B-O O
the B-O O
coagulation B-O B-protein
protease B-O I-protein
cascades B-O O
. B-O O

TF B-O B-protein
expression B-O O
by B-O O
circulating B-O B-cell_type
monocytes B-O I-cell_type
is B-O O
associated B-O O
with B-O O
thrombotic B-O O
and B-O O
inflammatory B-O O
complications B-O O
in B-O O
a B-O O
variety B-O O
of B-O O
diseases B-O O
. B-O O

Transcriptional B-O O
activation B-O O
of B-O O
the B-O O
human B-O B-DNA
TF B-O I-DNA
gene B-O I-DNA
in B-O O
monocytic B-O B-cell_type
cells B-O I-cell_type
exposed B-O O
to B-O O
bacterial B-O O
lipopolysaccharide B-O O
( B-O O
LPS B-O O
) B-O O
is B-O O
mediated B-O O
by B-O O
binding B-O O
of B-O O
c-Rel B-O B-protein
/p65 B-O I-protein
heterodimers B-O I-protein
to B-O O
a B-O O
kappa B-O B-DNA
B B-O I-DNA
site B-O I-DNA
in B-O O
the B-O O
TF B-O B-DNA
promoter B-O I-DNA
. B-O O

Here B-O O
, B-O O
we B-O O
report B-O O
that B-O O
a B-O O
family B-O O
of B-O O
anti-inflammatory B-O O
agents B-O O
, B-O O
known B-O O
as B-O O
the B-O O
salicylates B-O O
, B-O O
inhibited B-O O
LPS B-O O
induction B-O O
of B-O O
TF B-O B-protein
activity B-O O
and B-O O
TF B-O B-DNA
gene B-O I-DNA
transcription B-O O
in B-O O
human B-O B-cell_type
monocytes B-O I-cell_type
and B-O O
monocytic B-O B-cell_line
THP-1 B-O I-cell_line
cells B-O I-cell_line
at B-O O
clinically B-O O
relevant B-O O
doses B-O O
. B-O O

Furthermore B-O O
, B-O O
sodium B-O O
salicylate B-O O
blocked B-O O
the B-O O
LPS B-O O
-induced B-O O
proteolytic B-O O
degradation B-O O
of B-O O
I B-O B-protein
kappa B-O I-protein
B B-O I-protein
alpha B-O I-protein
, B-O O
which B-O O
prevented B-O O
the B-O O
nuclear B-O O
translocation B-O O
of B-O O
c-Rel B-O B-protein
/p65 B-O I-protein
heterodimers B-O I-protein
. B-O O

In B-O O
contrast B-O O
, B-O O
two B-O O
other B-O O
nonsteroidal B-O O
anti-inflammatory B-O O
drugs B-O O
, B-O O
ibuprofen B-O O
and B-O O
indomethacin B-O O
, B-O O
did B-O O
not B-O O
inhibit B-O O
LPS B-O O
induction B-O O
of B-O O
the B-O O
TF B-O B-DNA
gene B-O I-DNA
. B-O O

These B-O O
results B-O O
indicated B-O O
that B-O O
salicylates B-O O
inhibited B-O O
LPS B-O O
induction B-O O
of B-O O
TF B-O B-DNA
gene B-O I-DNA
transcription B-O O
in B-O O
monocytic B-O B-cell_type
cells B-O I-cell_type
by B-O O
preventing B-O O
nuclear B-O O
translocation B-O O
of B-O O
c-Rel B-O B-protein
/p65 B-O I-protein
heterodimers B-O I-protein
. B-O O

The B-O O
clinical B-O O
benefits B-O O
of B-O O
salicylates B-O O
in B-O O
the B-O O
treatment B-O O
of B-O O
several B-O O
diseases B-O O
, B-O O
including B-O O
atherosclerosis B-O O
and B-O O
rheumatoid B-O O
arthritis B-O O
, B-O O
may B-O O
be B-O O
related B-O O
to B-O O
their B-O O
ability B-O O
to B-O O
reduce B-O O
monocyte B-O O
gene B-O O
expression B-O O
. B-O O

Activation B-O O
of B-O O
the B-O O
signal B-O B-protein
transducer B-O I-protein
and B-O I-protein
transcription B-O I-protein
( B-O O
STAT B-O B-protein
) B-O O
signaling B-O O
pathway B-O O
in B-O O
a B-O O
primary B-O O
T B-O O
cell B-O O
response B-O O
. B-O O

Critical B-O O
role B-O O
for B-O O
IL-6 B-O B-protein
. B-O O

The B-O O
T B-O O
cell B-O O
activation B-O O
is B-O O
initiated B-O O
by B-O O
interaction B-O O
of B-O O
specific B-O O
Ags B-O B-protein
with B-O O
TCR B-O B-protein
, B-O O
followed B-O O
by B-O O
activation B-O O
of B-O O
intracellular B-O O
biochemical B-O O
events B-O O
leading B-O O
to B-O O
activation B-O O
of B-O O
several B-O O
genes B-O O
. B-O O

The B-O O
activation B-O O
of B-O O
signal B-O B-protein
transducer B-O I-protein
and B-O I-protein
activator B-O I-protein
of B-O I-protein
transcription B-O I-protein
( B-O I-protein
STAT B-O I-protein
) B-O I-protein
proteins B-O I-protein
in B-O O
a B-O O
primary B-O O
TCR B-O B-protein
-mediated B-O O
activation B-O O
of B-O O
T B-O B-cell_type
cells B-O I-cell_type
have B-O O
been B-O O
explored B-O O
. B-O O

In B-O O
purified B-O B-cell_type
human B-O I-cell_type
peripheral B-O I-cell_type
blood B-O I-cell_type
T B-O I-cell_type
cells B-O I-cell_type
, B-O O
nuclear B-O B-protein
STAT B-O I-protein
proteins B-O I-protein
were B-O O
activated B-O O
approximately B-O O
3 B-O O
h B-O O
after B-O O
activation B-O O
by B-O O
cross-linked B-O O
anti-CD3 B-O B-protein
Abs B-O I-protein
. B-O O

These B-O O
STAT B-O B-protein
proteins B-O I-protein
were B-O O
detected B-O O
by B-O O
using B-O O
the B-O O
IFN-gamma-activated B-O B-DNA
sequence B-O I-DNA
( B-O O
GAS B-O B-DNA
) B-O O
and B-O O
related B-O O
oligonucleotides B-O O
as B-O O
probes B-O O
in B-O O
electrophoretic B-O O
mobility B-O O
shift B-O O
assay B-O O
. B-O O

Analysis B-O O
of B-O O
the B-O O
nuclear B-O O
extracts B-O O
with B-O O
anti-STAT B-O B-protein
Abs B-O I-protein
indicated B-O O
that B-O O
they B-O O
contained B-O O
STAT-3 B-O B-protein
and B-O O
additional B-O O
proteins B-O O
crossreactive B-O O
with B-O O
the B-O O
STAT B-O B-protein
family B-O I-protein
. B-O O

The B-O O
induction B-O O
of B-O O
STAT B-O B-protein
activity B-O O
was B-O O
inhibited B-O O
completely B-O O
by B-O O
pretreatment B-O O
with B-O O
either B-O O
cycloheximide B-O O
or B-O O
cyclosporin B-O O
A B-O O
, B-O O
thus B-O O
indicating B-O O
that B-O O
the B-O O
induction B-O O
was B-O O
due B-O O
to B-O O
a B-O O
secondary B-O B-protein
factor B-O I-protein
produced B-O O
by B-O O
the B-O O
activated B-O B-cell_type
T B-O I-cell_type
cells B-O I-cell_type
. B-O O

As B-O O
neutralizing B-O O
anti- B-O O
IL-6 B-O B-protein
Abs B-O I-protein
effectively B-O O
down-regulated B-O O
the B-O O
early B-O O
induction B-O O
of B-O O
STAT B-O B-protein
proteins B-O I-protein
and B-O O
as B-O O
exogenously B-O O
added B-O O
IL-6 B-O B-protein
rapidly B-O O
activated B-O O
DNA B-O O
binding B-O O
similar B-O O
to B-O O
TCR B-O B-protein
-mediated B-O O
bindings B-O O
, B-O O
it B-O O
can B-O O
be B-O O
concluded B-O O
that B-O O
IL-6 B-O B-protein
is B-O O
the B-O O
factor B-O O
responsible B-O O
for B-O O
the B-O O
activation B-O O
of B-O O
STAT B-O B-protein
proteins B-O I-protein
in B-O O
a B-O O
primary B-O O
T B-O O
cell B-O O
response B-O O
. B-O O

The B-O O
normal B-O O
cell B-O O
cycle B-O O
activation B-O O
program B-O O
is B-O O
exploited B-O O
during B-O O
the B-O O
infection B-O O
of B-O O
quiescent B-O B-cell_type
B B-O I-cell_type
lymphocytes B-O I-cell_type
by B-O O
Epstein-Barr B-O O
virus B-O O
. B-O O

B B-O B-cell_type
lymphocytes B-O I-cell_type
in B-O O
the B-O O
peripheral B-O O
circulation B-O O
are B-O O
maintained B-O O
in B-O O
a B-O O
non-proliferative B-O O
state B-O O
. B-O O

Antigen B-O O
recognition B-O O
stimulates B-O O
limited B-O O
proliferation B-O O
, B-O O
whereas B-O O
infection B-O O
with B-O O
Epstein-Barr B-O O
virus B-O O
( B-O O
EBV B-O O
) B-O O
results B-O O
in B-O O
continual B-O O
proliferation B-O O
and B-O O
the B-O O
outgrowth B-O O
of B-O O
immortal B-O B-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
. B-O O

Because B-O O
it B-O O
is B-O O
not B-O O
clear B-O O
at B-O O
which B-O O
point B-O O
in B-O O
cell B-O O
cycle B-O O
the B-O O
peripheral B-O B-cell_type
B B-O I-cell_type
lymphocytes B-O I-cell_type
are B-O O
arrested B-O O
, B-O O
we B-O O
characterized B-O O
the B-O O
expression B-O O
of B-O O
several B-O O
cell B-O B-DNA
cycle-associated B-O I-DNA
genes B-O I-DNA
in B-O O
quiescent B-O B-cell_type
and B-O I-cell_type
stimulated B-O I-cell_type
cells B-O I-cell_type
. B-O O

We B-O O
show B-O O
that B-O O
the B-O O
expression B-O O
of B-O O
four B-O O
cell B-O B-DNA
genes B-O I-DNA
, B-O O
cdc-2 B-O B-DNA
, B-O O
cyclin B-O B-DNA
E B-O I-DNA
, B-O O
CD23 B-O B-protein
, B-O O
and B-O O
cyclin B-O B-protein
D2 B-O I-protein
, B-O O
are B-O O
up-regulated B-O O
approximately B-O O
100-fold B-O O
as B-O O
a B-O O
result B-O O
of B-O O
EBV B-O O
-mediated B-O O
immortalization B-O O
. B-O O

Because B-O O
these B-O O
genes B-O O
play B-O O
a B-O O
positive B-O O
role B-O O
in B-O O
cell B-O O
proliferation B-O O
, B-O O
we B-O O
suggest B-O O
that B-O O
this B-O O
regulatory B-O O
switch B-O O
contributes B-O O
to B-O O
controlling B-O O
entry B-O O
into B-O O
the B-O O
cell B-O O
cycle B-O O
. B-O O

Transient B-O O
stimulation B-O O
of B-O O
quiescent B-O B-cell_type
B B-O I-cell_type
lymphocytes B-O I-cell_type
with B-O O
either B-O O
a B-O O
cocktail B-O O
of B-O O
anti-CD40 B-O B-protein
, B-O O
anti-IgM B-O B-protein
, B-O O
and B-O O
IL4 B-O B-protein
, B-O O
or B-O O
EBV B-O O
results B-O O
in B-O O
the B-O O
rapid B-O O
expression B-O O
of B-O O
the B-O O
same B-O O
four B-O O
genes B-O O
, B-O O
suggesting B-O O
that B-O O
, B-O O
after B-O O
infection B-O O
, B-O O
EBV B-O O
exploits B-O O
the B-O O
normal B-O O
program B-O O
of B-O O
B-lymphocyte B-O B-cell_type
cell B-O O
cycle B-O O
activation B-O O
. B-O O

Expression B-O O
of B-O O
the B-O O
chemokine B-O B-protein
receptor B-O I-protein
BLR2/EBI1 B-O B-protein
is B-O O
specifically B-O O
transactivated B-O O
by B-O O
Epstein-Barr B-O B-protein
virus B-O I-protein
nuclear B-O I-protein
antigen B-O I-protein
2 B-O I-protein
. B-O O

In B-O O
our B-O O
attempt B-O O
to B-O O
identify B-O O
chemokine B-O B-protein
receptors B-O I-protein
that B-O O
are B-O O
related B-O O
to B-O O
Burkitt B-O B-protein
's B-O I-protein
lymphoma B-O I-protein
receptor B-O I-protein
1 B-O I-protein
( B-O O
BLR1 B-O B-protein
) B-O O
and B-O O
are B-O O
expressed B-O O
in B-O O
activated B-O B-cell_type
lymphocytes B-O I-cell_type
we B-O O
used B-O O
RT-PCR B-O O
resulting B-O O
in B-O O
the B-O O
isolation B-O O
of B-O O
a B-O O
cDNA B-O B-DNA
encoding B-O O
a B-O O
seven B-O B-protein
transmembrane B-O I-protein
receptor B-O I-protein
termed B-O O
BLR2 B-O B-protein
. B-O O

The B-O O
protein B-O O
shows B-O O
significant B-O O
sequence B-O O
similarities B-O O
to B-O O
the B-O O
family B-O O
of B-O O
G-protein B-O B-protein
coupled B-O I-protein
chemokine B-O I-protein
receptors B-O I-protein
and B-O O
turned B-O O
out B-O O
to B-O O
be B-O O
identical B-O O
to B-O O
the B-O O
recently B-O O
described B-O O
receptor B-O B-protein
EBI1 B-O I-protein
. B-O O

Northern B-O O
blot B-O O
analysis B-O O
revealed B-O O
that B-O O
BLR2 B-O B-RNA
mRNA B-O I-RNA
could B-O O
be B-O O
highly B-O O
stimulated B-O O
in B-O O
mitogen- B-O B-cell_line
and B-O I-cell_line
anti-CD3- B-O I-cell_line
treated B-O I-cell_line
peripheral B-O I-cell_line
blood B-O I-cell_line
lymphocytes B-O I-cell_line
. B-O O

BLR2 B-O B-RNA
-specific B-O I-RNA
mRNA B-O I-RNA
could B-O O
be B-O O
detected B-O O
in B-O O
all B-O O
Epstein-Barr B-O B-cell_line
virus B-O I-cell_line
positive B-O I-cell_line
B B-O I-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
. B-O O

We B-O O
show B-O O
that B-O O
transcription B-O O
of B-O O
the B-O O
BLR2 B-O B-DNA
gene B-O I-DNA
could B-O O
be B-O O
specifically B-O O
induced B-O O
in B-O O
Epstein-Barr B-O B-cell_line
virus B-O I-cell_line
negative B-O I-cell_line
BL B-O I-cell_line
41 B-O I-cell_line
cells B-O I-cell_line
via B-O O
estrogen-mediated B-O O
activation B-O O
of B-O O
Epstein-Barr B-O B-protein
virus B-O I-protein
nuclear B-O I-protein
antigen B-O I-protein
2 B-O I-protein
, B-O O
a B-O O
key B-O O
regulator B-O O
of B-O O
viral B-O B-DNA
and B-O I-DNA
cellular B-O I-DNA
genes B-O I-DNA
in B-O O
immortalized B-O B-cell_line
B B-O I-cell_line
cells B-O I-cell_line
. B-O O

Our B-O O
data B-O O
suggest B-O O
an B-O O
involvement B-O O
of B-O O
BLR2 B-O B-protein
in B-O O
the B-O O
regulation B-O O
of B-O O
migration B-O O
in B-O O
activated B-O B-cell_type
lymphocytes B-O I-cell_type
and B-O O
in B-O O
viral B-O O
pathogenesis B-O O
. B-O O

A B-O O
central B-O O
role B-O O
for B-O O
a B-O O
single B-O O
c-Myb B-O B-DNA
binding B-O I-DNA
site B-O I-DNA
in B-O O
a B-O O
thymic B-O B-DNA
locus B-O I-DNA
control B-O I-DNA
region B-O I-DNA
. B-O O

Locus B-O B-DNA
control B-O I-DNA
regions B-O I-DNA
( B-O O
LCRs B-O B-DNA
) B-O O
are B-O O
powerful B-O O
assemblies B-O O
of B-O O
cis B-O B-DNA
elements B-O I-DNA
that B-O O
organize B-O O
the B-O O
actions B-O O
of B-O O
cell-type-specific B-O B-protein
trans-acting B-O I-protein
factors B-O I-protein
. B-O O

A B-O O
2.3-kb B-O B-protein
LCR B-O I-protein
in B-O O
the B-O O
human B-O B-DNA
adenosine B-O I-DNA
deaminase B-O I-DNA
( B-O I-DNA
ADA B-O I-DNA
) B-O I-DNA
gene B-O I-DNA
first B-O I-DNA
intron B-O I-DNA
, B-O O
which B-O O
controls B-O O
expression B-O O
in B-O O
thymocytes B-O B-cell_type
, B-O O
is B-O O
composed B-O O
of B-O O
a B-O O
200-bp B-O B-DNA
enhancer B-O I-DNA
domain B-O I-DNA
and B-O O
extended B-O O
flanking B-O O
sequences B-O O
that B-O O
facilitate B-O O
activation B-O O
from B-O O
within B-O O
chromatin B-O B-DNA
. B-O O

Prior B-O O
analyses B-O O
have B-O O
demonstrated B-O O
that B-O O
the B-O O
enhancer B-O B-DNA
contains B-O O
a B-O O
28-bp B-O B-DNA
core B-O I-DNA
region B-O I-DNA
and B-O O
local B-O O
adjacent B-O O
augmentative B-O O
cis B-O B-DNA
elements B-O I-DNA
. B-O O

We B-O O
now B-O O
show B-O O
that B-O O
the B-O O
core B-O O
contains B-O O
a B-O O
single B-O O
critical B-O O
c-Myb B-O B-DNA
binding B-O I-DNA
site B-O I-DNA
. B-O O

In B-O O
both B-O O
transiently B-O B-cell_line
cotransfected B-O I-cell_line
human B-O I-cell_line
cells B-O I-cell_line
and B-O O
stable B-O O
chromatin-integrated B-O B-cell_line
yeast B-O I-cell_line
cells B-O I-cell_line
, B-O O
c-Myb B-O B-protein
strongly B-O O
transactivated B-O B-DNA
reporter B-O I-DNA
constructs B-O I-DNA
that B-O O
contained B-O O
polymerized B-O B-DNA
core B-O I-DNA
sequences B-O I-DNA
. B-O O

c-Myb B-O B-protein
protein B-O I-protein
was B-O O
strongly B-O O
evident B-O O
in B-O O
T B-O B-cell_type
lymphoblasts B-O I-cell_type
in B-O O
which B-O O
the B-O O
enhancer B-O B-DNA
was B-O O
active B-O O
and B-O O
was B-O O
localized B-O O
within B-O O
discrete B-O O
nuclear B-O O
structures B-O O
. B-O O

Fetal B-O O
murine B-O O
thymus B-O O
exhibited B-O O
a B-O O
striking B-O O
concordance B-O O
of B-O O
endogenous B-O O
c-myb B-O B-DNA
expression B-O O
with B-O O
that B-O O
of B-O O
mouse B-O B-DNA
ADA B-O I-DNA
and B-O O
human B-O B-DNA
ADA B-O I-DNA
LCR B-O I-DNA
-directed B-O O
transgene B-O O
expression B-O O
. B-O O

Point B-O O
mutation B-O O
of B-O O
the B-O O
c-Myb B-O B-DNA
site B-O I-DNA
within B-O O
the B-O O
intact B-O O
2.3-kb B-O B-protein
LCR B-O I-protein
severely B-O O
attenuated B-O O
enhancer B-O O
activity B-O O
in B-O O
transfections B-O O
and B-O O
LCR B-O B-DNA
activity B-O O
in B-O O
transgenic B-O B-cell_type
thymocytes B-O I-cell_type
. B-O O

Within B-O O
the B-O O
context B-O O
of B-O O
a B-O O
complex B-O B-DNA
enhancer B-O I-DNA
and B-O O
LCR B-O B-DNA
, B-O O
c-Myb B-O B-protein
can B-O O
act B-O O
as B-O O
an B-O O
organizer B-O O
of B-O O
thymocyte-specific B-O B-DNA
gene B-O I-DNA
expression B-O O
via B-O O
a B-O O
single B-O O
binding B-O O
site B-O O
. B-O O

A B-O O
regulatory B-O B-DNA
element B-O I-DNA
in B-O O
the B-O O
human B-O B-DNA
interleukin B-O I-DNA
2 B-O I-DNA
gene B-O I-DNA
promoter B-O I-DNA
is B-O O
a B-O O
binding B-O B-DNA
site B-O I-DNA
for B-O O
the B-O O
zinc B-O B-protein
finger B-O I-protein
proteins B-O I-protein
Sp1 B-O B-protein
and B-O O
EGR-1 B-O B-protein
. B-O O

Activation B-O O
of B-O O
the B-O O
interleukin B-O B-DNA
2 B-O I-DNA
( B-O I-DNA
IL-2 B-O I-DNA
) B-O I-DNA
gene B-O I-DNA
after B-O O
antigen B-O O
recognition B-O O
is B-O O
a B-O O
critical B-O O
event B-O O
for B-O O
T B-O B-cell_type
cell B-O I-cell_type
proliferation B-O O
and B-O O
effector B-O O
function B-O O
. B-O O

Prior B-O O
studies B-O O
have B-O O
identified B-O O
several B-O O
transcription B-O B-protein
factors B-O I-protein
that B-O O
contribute B-O O
to B-O O
the B-O O
activity B-O O
of B-O O
the B-O O
IL-2 B-O B-DNA
promoter B-O I-DNA
in B-O O
stimulated B-O B-cell_type
T B-O I-cell_type
lymphocytes B-O I-cell_type
. B-O O

Here B-O O
we B-O O
describe B-O O
a B-O O
novel B-O O
regulatory B-O B-DNA
element B-O I-DNA
within B-O O
the B-O O
IL-2 B-O B-DNA
promoter B-O I-DNA
located B-O O
immediately B-O O
upstream B-O O
of B-O O
the B-O O
nuclear B-O B-protein
factor B-O I-protein
of B-O I-protein
activated B-O I-protein
T B-O I-protein
cell B-O I-protein
( B-O O
NFAT B-O B-protein
) B-O O
domain B-O O
. B-O O

This B-O O
region B-O O
( B-O O
termed B-O O
the B-O O
zinc B-O B-protein
finger B-O I-protein
protein B-O I-protein
binding B-O O
region B-O O
( B-O O
ZIP B-O B-protein
) B-O O
) B-O O
serves B-O O
as B-O O
binding B-O B-DNA
site B-O I-DNA
for B-O O
two B-O O
differently B-O O
regulated B-O O
zinc B-O B-protein
finger B-O I-protein
proteins B-O I-protein
: B-O O
the B-O O
constitutively B-O O
expressed B-O O
transcription B-O B-protein
factor B-O I-protein
Sp1 B-O B-protein
and B-O O
the B-O O
inducible B-O O
early B-O O
growth B-O O
response B-O O
protein B-O O
EGR-1 B-O B-protein
. B-O O

In B-O O
unstimulated B-O B-cell_type
cells B-O I-cell_type
which B-O O
do B-O O
not B-O O
secrete B-O O
IL-2 B-O B-protein
, B-O O
only B-O O
Sp1 B-O B-protein
binds B-O O
to B-O O
this B-O O
region B-O O
, B-O O
while B-O O
in B-O O
stimulated B-O O
IL-2 B-O B-protein
secreting B-O O
cells B-O O
the B-O O
inducible B-O O
EGR-1 B-O B-protein
protein B-O I-protein
recognizes B-O O
this B-O O
element B-O O
. B-O O

In B-O O
Jurkat B-O B-cell_line
T B-O I-cell_line
cells B-O I-cell_line
, B-O O
the B-O O
ZIP B-O B-DNA
site B-O I-DNA
serves B-O O
as B-O O
an B-O O
activator B-O O
for B-O O
IL-2 B-O B-DNA
gene B-O I-DNA
expression B-O O
, B-O O
and B-O O
a B-O O
combination B-O O
of B-O O
ZIP B-O B-protein
and B-O O
NFAT B-O B-DNA
binding B-O I-DNA
sites B-O I-DNA
is B-O O
required B-O O
for B-O O
maximal B-O O
IL-2 B-O B-DNA
promoter B-O I-DNA
activity B-O O
. B-O O

These B-O O
results B-O O
suggest B-O O
a B-O O
critical B-O O
role B-O O
of B-O O
the B-O O
ZIP B-O B-DNA
site B-O I-DNA
for B-O O
IL-2 B-O B-DNA
promoter B-O I-DNA
activity B-O O
. B-O O

Activation B-O O
of B-O O
the B-O O
HIV-1 B-O B-DNA
enhancer B-O I-DNA
by B-O O
the B-O O
LEF-1 B-O B-protein
HMG B-O I-protein
protein B-O I-protein
on B-O O
nucleosome-assembled B-O O
DNA B-O O
in B-O O
vitro B-O O
. B-O O

Lymphoid B-O B-protein
enhancer-binding B-O I-protein
factor B-O I-protein
1 B-O I-protein
( B-O O
LEF-1 B-O B-protein
) B-O O
is B-O O
a B-O O
regulatory B-O B-protein
high B-O I-protein
mobility B-O I-protein
group B-O I-protein
( B-O I-protein
HMG B-O I-protein
) B-O I-protein
protein B-O I-protein
that B-O O
activates B-O O
the B-O O
T B-O B-DNA
cell B-O I-DNA
receptor B-O I-DNA
alpha B-O I-DNA
( B-O I-DNA
TCR B-O I-DNA
alpha B-O I-DNA
) B-O I-DNA
enhancer B-O I-DNA
in B-O O
a B-O O
context-restricted B-O O
manner B-O O
in B-O O
T B-O B-cell_type
cells B-O I-cell_type
. B-O O

In B-O O
this B-O O
paper B-O O
we B-O O
demonstrate B-O O
that B-O O
the B-O O
distal B-O B-DNA
region B-O I-DNA
of B-O O
the B-O O
human B-O B-DNA
immunodeficiency B-O I-DNA
virus-1 B-O I-DNA
( B-O I-DNA
HIV-1 B-O I-DNA
) B-O I-DNA
enhancer B-O I-DNA
, B-O O
which B-O O
contains B-O O
DNA-binding B-O B-DNA
sites B-O I-DNA
for B-O O
LEF-1 B-O B-protein
and B-O O
Ets-1 B-O B-protein
, B-O O
also B-O O
provides B-O O
a B-O O
functional B-O O
context B-O O
for B-O O
activation B-O O
by B-O O
LEF-1 B-O B-protein
. B-O O

First B-O O
, B-O O
we B-O O
show B-O O
that B-O O
mutations B-O O
in B-O O
the B-O O
LEF-1 B-O B-DNA
-binding B-O I-DNA
site B-O I-DNA
inhibit B-O O
the B-O O
activity B-O O
of B-O O
multimerized B-O O
copies B-O O
of B-O O
the B-O O
HIV-1 B-O B-DNA
enhancer B-O I-DNA
in B-O O
Jurkat B-O B-cell_line
T B-O I-cell_line
cells B-O I-cell_line
, B-O O
and B-O O
that B-O O
LEF-1 B-O B-protein
/GAL4 B-O B-protein
can B-O O
activate B-O O
a B-O O
GAL4-substituted B-O O
HIV-1 B-O O
enhancer B-O O
80- B-O O
to B-O O
100-fold B-O O
in B-O O
vivo B-O O
. B-O O

Second B-O O
, B-O O
recombinant B-O O
LEF-1 B-O B-protein
is B-O O
shown B-O O
to B-O O
activate B-O O
HIV-1 B-O O
transcription B-O O
on B-O O
chromatin-assembled B-O B-DNA
DNA B-O I-DNA
in B-O O
vitro B-O O
. B-O O

By B-O O
using B-O O
a B-O O
nucleosome B-O O
-assembly B-O O
system B-O O
derived B-O O
from B-O O
Drosophila B-O O
embryos B-O O
, B-O O
we B-O O
find B-O O
that B-O O
the B-O O
packaging B-O O
of B-O O
DNA B-O O
into B-O O
chromatin B-O B-DNA
in B-O O
vitro B-O O
strongly B-O O
represses B-O O
HIV-1 B-O O
transcription B-O O
and B-O O
that B-O O
repression B-O O
can B-O O
be B-O O
counteracted B-O O
efficiently B-O O
by B-O O
preincubation B-O O
of B-O O
the B-O O
DNA B-O O
with B-O O
LEF-1 B-O B-protein
( B-O O
or B-O O
LEF-1 B-O B-protein
and B-O O
Ets-1 B-O B-protein
) B-O O
supplemented B-O O
with B-O O
fractions B-O O
containing B-O O
the B-O O
promoter-binding B-O B-protein
protein B-O I-protein
, B-O O
Sp1 B-O B-protein
. B-O O

Addition B-O O
of B-O O
TFE-3 B-O B-protein
, B-O O
which B-O O
binds B-O O
to B-O O
an B-O O
E-box B-O B-DNA
motif B-O I-DNA
upstream B-O O
of B-O O
the B-O O
LEF-1 B-O B-protein
and B-O O
Ets-1 B-O B-DNA
sites B-O I-DNA
, B-O O
further B-O O
augments B-O O
transcription B-O O
in B-O O
this B-O O
system B-O O
. B-O O

Individually B-O O
or B-O O
collectively B-O O
, B-O O
none B-O O
of B-O O
the B-O O
three B-O O
enhancer-binding B-O B-protein
proteins B-O I-protein
( B-O O
LEF-1 B-O B-protein
, B-O O
Ets-1 B-O B-protein
, B-O O
and B-O O
TFE-3 B-O B-protein
) B-O O
could B-O O
activate B-O O
transcription B-O O
in B-O O
the B-O O
absence B-O O
of B-O O
Sp1 B-O B-protein
. B-O O

A B-O O
truncation B-O O
mutant B-O O
of B-O O
LEF-1 B-O B-protein
( B-O O
HMG-88 B-O B-protein
) B-O O
, B-O O
which B-O O
contains B-O O
the B-O O
HMG B-O B-protein
box B-O I-protein
but B-O O
lacks B-O O
the B-O O
trans-activation B-O B-protein
domain B-O I-protein
, B-O O
did B-O O
not B-O O
activate B-O O
transcription B-O O
from B-O O
nucleosomal B-O B-DNA
DNA B-O I-DNA
, B-O O
indicating B-O O
that B-O O
bending B-O O
of B-O O
DNA B-O O
by B-O O
the B-O O
HMG B-O B-protein
domain B-O I-protein
is B-O O
not B-O O
sufficient B-O O
to B-O O
activate B-O O
transcription B-O O
in B-O O
vitro B-O O
. B-O O

We B-O O
conclude B-O O
that B-O O
transcription B-O O
activation B-O O
by B-O O
LEF-1 B-O B-protein
in B-O O
vitro B-O O
is B-O O
a B-O O
chromatin B-O B-DNA
-dependent B-O O
process B-O O
that B-O O
requires B-O O
a B-O O
functional B-O O
trans-activation B-O B-protein
domain B-O I-protein
in B-O O
addition B-O O
to B-O O
the B-O O
HMG B-O B-protein
domain B-O I-protein
. B-O O

HIV-1 B-O B-protein
envelope B-O I-protein
glycoproteins B-O I-protein
induce B-O O
activation B-O O
of B-O O
activated B-O B-protein
protein-1 B-O I-protein
in B-O O
CD4+ B-O B-cell_type
T B-O I-cell_type
cells B-O I-cell_type
[ B-O O
published B-O O
erratum B-O O
appears B-O O
in B-O O
J B-O O
Biol B-O O
Chem B-O O
1995 B-O O
Dec B-O O
1 B-O O
; B-O O
270 B-O O
( B-O O
48 B-O O
) B-O O
: B-O O
29038 B-O O
] B-O O

Activation B-O O
of B-O O
CD4 B-O B-cell_type
positive B-O I-cell_type
T B-O I-cell_type
cells B-O I-cell_type
is B-O O
a B-O O
primary B-O O
requirement B-O O
for B-O O
human B-O O
immunodeficiency B-O O
virus B-O O
( B-O O
HIV B-O O
) B-O O
entry B-O O
, B-O O
efficient B-O O
HIV B-O O
replication B-O O
, B-O O
and B-O O
progression B-O O
to B-O O
AIDS B-O O
, B-O O
Utilizing B-O B-cell_line
CD4 B-O I-cell_line
positive B-O I-cell_line
T B-O I-cell_line
cell B-O I-cell_line
lines B-O I-cell_line
and B-O O
purified B-O O
T B-O B-cell_type
cells B-O I-cell_type
from B-O O
normal B-O O
individuals B-O O
, B-O O
we B-O O
have B-O O
demonstrated B-O O
that B-O O
native B-O B-protein
envelope B-O I-protein
glycoproteins B-O I-protein
of B-O O
HIV B-O O
, B-O O
gp B-O B-protein
160 B-O I-protein
, B-O O
can B-O O
induce B-O O
activation B-O O
of B-O O
transcription B-O B-protein
factor B-O I-protein
, B-O O
activated B-O B-protein
protein-1 B-O I-protein
( B-O O
AP-1 B-O B-protein
) B-O O
. B-O O

The B-O O
stimulatory B-O O
effects B-O O
of B-O O
gp160 B-O B-protein
are B-O O
mediated B-O O
through B-O O
the B-O O
CD4 B-O B-protein
molecule B-O I-protein
, B-O O
since B-O O
treatment B-O O
of B-O O
gp160 B-O B-protein
with B-O O
soluble B-O O
CD4-IgG B-O O
abrogates B-O O
its B-O O
activity B-O O
, B-O O
and B-O O
CD4 B-O B-protein
negative B-O O
T B-O O
cell B-O O
lines B-O O
fail B-O O
to B-O O
be B-O O
stimulated B-O O
with B-O O
gp160 B-O B-protein
. B-O O

Immunoprecipitation B-O O
of B-O O
the B-O O
gp B-O B-protein
160 B-O I-protein
-induced B-O O
nuclear B-O O
extracts B-O O
with B-O O
polyclonal B-O B-protein
antibodies B-O I-protein
to B-O O
Fos B-O B-protein
and B-O O
Jun B-O B-protein
proteins B-O I-protein
indicates B-O O
that B-O O
AP-1 B-O B-protein
complex B-O I-protein
is B-O O
comprised B-O O
of B-O O
members B-O O
of B-O O
these B-O O
family B-O O
of B-O O
proteins B-O O
. B-O O

The B-O O
gp160 B-O B-protein
-induced B-O O
AP-1 B-O B-protein
complex B-O I-protein
is B-O O
dependent B-O O
upon B-O O
protein B-O O
tyrosine B-O O
phosphorylation B-O O
and B-O O
is B-O O
protein B-O O
synthesis-independent B-O O
. B-O O

This B-O O
stimulation B-O O
can B-O O
also B-O O
be B-O O
abolished B-O O
by B-O O
inhibitors B-O O
of B-O O
protein B-O B-protein
kinase B-O I-protein
C B-O I-protein
, B-O O
but B-O O
it B-O O
is B-O O
unaffected B-O O
by B-O O
calcium B-O O
channel B-O O
blocker B-O O
or B-O O
cyclosporine B-O O
A B-O O
. B-O O

This B-O O
gp160 B-O B-protein
treatment B-O O
adversely B-O O
affects B-O O
the B-O O
functional B-O O
capabilities B-O O
of B-O O
T B-O B-cell_type
cells B-O I-cell_type
: B-O O
pre-treatment B-O O
of B-O O
CD4+ B-O B-cell_type
T B-O I-cell_type
cells B-O I-cell_type
with B-O O
gp160 B-O B-protein
for B-O O
4 B-O O
h B-O O
at B-O O
37 B-O O
degrees B-O O
C B-O O
inhibited B-O O
anti-CD3 B-O B-protein
-induced B-O O
interleukin-2 B-O B-protein
secretion B-O O
. B-O O

Effects B-O O
similar B-O O
to B-O O
gp160 B-O B-protein
were B-O O
seen B-O O
with B-O O
anti-CD4 B-O B-protein
mAb B-O I-protein
. B-O O

The B-O O
aberrant B-O O
activation B-O O
of B-O O
AP-1 B-O B-protein
by B-O O
gp160 B-O B-protein
in B-O O
CD4 B-O B-cell_type
positive B-O I-cell_type
T B-O I-cell_type
cells B-O I-cell_type
could B-O O
result B-O O
in B-O O
up-regulation B-O O
of B-O O
cytokines B-O B-protein
containing B-O O
AP-1 B-O B-DNA
sites B-O I-DNA
, B-O O
e.g. B-O O
interleukin-3 B-O B-protein
and B-O O
granulocyte B-O B-protein
macrophage B-O I-protein
colony-stimulating B-O I-protein
factor B-O I-protein
, B-O O
and B-O O
concurrently B-O O
lead B-O O
to B-O O
T B-O O
cell B-O O
unresponsiveness B-O O
by B-O O
inhibiting B-O O
interleukin-2 B-O B-protein
secretion B-O O
. B-O O

